severe acute respiratory syndrome corona virus <NUMBER> sarscov<NUMBER> emerged first time wuhan china december <NUMBER> type highly pathogenic human coronavirus hcov causes zoonotic diseases poses major threat public health vast majority patients coronavirus disease <NUMBER> covid <NUMBER> good prognosis still critical individuals even deaths <NUMBER> critically ill dead patients develop severe clinical manifestations early stages disease patients showed mild fever cough muscle soreness conditions patients deteriorated suddenly later stages disease process recovery acute respiratory distress syndrome ards multipleorgan failure occurred rapidly resulting death within short time <NUMBER> cytokine storm considered one major causes ards multipleorgan failure <NUMBER> plays important role process disease aggravation <NUMBER> clinical studies detected cytokine storm critical patients covid<NUMBER> therefore effectively suppressing cytokine storm important way prevent deterioration patients covid<NUMBER> infection save patients lives <NUMBER> article reviews mechanisms hcov infection induces cytokine storm options inhibit cytokine storm order provide reference clinical diagnosis treatment covid<NUMBER> jid yjinf m<NUMBER>g april <NUMBER> <NUMBER> <NUMBER> diseases humans <NUMBER> <NUMBER> far seven hcovs invade humans identified including αtype hcov<NUMBER>e hcovnl<NUMBER> βtype hcovhku<NUMBER> sarscov merscov hcovoc<NUMBER> <NUMBER>ncov causing present epidemic according pathogenicity hcovs divided mildly pathogenic hcovs including hcov<NUMBER>e hcovoc<NUMBER> hcovnl<NUMBER> hcovhku highly pathogenic covs including severe acute respiratory syndrome cov sarscov <NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> sarscov<NUMBER> mildly pathogenic hcovs infect upper respiratory tract cause seasonal mild moderate coldlike respiratory diseases healthy individuals contrast highly pathogenic hcovs hereinafter referred pathogenic hcovs hcovs infect lower respiratory tract cause severe pneumonia sometimes leading fatal acute lung injury ali ards pathogenic hcovs high morbidity mortality pose major threat public health <NUMBER> <NUMBER> <NUMBER> long believed cytokines play important role immunopathology viral infection rapid wellcoordinated innate immune response first line defense viral infection however dysregulated excessive immune responses may cause immune damage human body <NUMBER> <NUMBER> <NUMBER> relevant evidences severely ill patients hcovs suggest proinflammatory responses play role pathogenesis hcovs vitro cell experiments show delayed release cytokines chemokines occurs respiratory epithelial cells dendritic cells dcs macrophages early stage sarscov infection later cells secrete low levels antiviral factors interferons ifns high levels proinflammatory cytokines interleukin il<NUMBER> β il<NUMBER> tumor necrosis factor tnf chemokines cc motif chemokine ligand ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> <NUMBER> <NUMBER> <NUMBER> like sars merscov infects human airway epithelial cells thp<NUMBER> cells monocyte cell line human peripheral blood monocytederived macrophages dcs induces delayed elevated levels proinflammatory cytokines chemokines <NUMBER> <NUMBER> merscov infection plasmacytoid dendritic cells mononuclear macrophages dcs <NUMBER> induced produce large amount ifns serum cytokine chemokine levels significantly higher patients severe mers patients mild moderate mers <NUMBER> <NUMBER> elevated serum cytokine chemokine levels mers patients related high number neutrophils monocytes patients lung tissues peripheral blood suggesting cells may play role lung pathology <NUMBER> <NUMBER> <NUMBER> similar phenomena observed patients sarscov infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> production ifni ifnα β key natural immune defense response viral infections ifni key molecule plays antiviral role early stages viral infection <NUMBER> <NUMBER> delayed release ifns early stages sarscov merscov infection hinders bodys antiviral response <NUMBER> afterward rapidly increased cytokines chemokines attract many inflammatory cells neutrophils monocytes resulting excessive infiltration inflammatory cells lung tissue thus lung injury appears studies dysregulated andor exaggerated cytokine chemokine responses sarscovinfected merscovinfected cells could play important role pathogenesis sars mers animal models well elucidate role cytokines chemokines mediating pulmonary immunopathology hcov infection despite similar virus titers respiratory tract sarscovinfected old nonhuman primates likely develop immune dysregulation infected young primates leading severe disease manifestations <NUMBER> seems excessive inflammatory response rather virus titer relevant death old nonhuman primates <NUMBER> similarly balbc mice infected sarscov disease severity old mice related early disproportionately strong upregulation ardsrelated inflammatory gene signals <NUMBER> rapid replication sarscov balbc mice induces delayed release ifnα β accompanied influx many pathogenic inflammatory mononuclear macrophages <NUMBER> accumulated mononuclear macrophages receive activating signals ifnα β receptors surface produce monocyte chemoattractants ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> resulting accumulation mononuclear macrophages mononuclear macrophages produce elevated levels proinflammatory cytokines tnf il<NUMBER> il<NUMBER>β inducible nitric oxide synthase thereby increasing severity disease depleting inflammatory monocytemacrophages neutralizing inflammatory cytokine tnf protected mice fatal sarscov infection addition ifnα β mononuclear macrophagederived proinflammatory cytokines induce apoptosis cells hinders viral clearance <NUMBER> another consequence rapid viral replication vigorous proinflammatory cytokinechemokine response induction apoptosis lung epithelial endothelial cells ifnαβ ifnγ induce inflammatory cell infiltration mechanisms involving fasfas ligand fasl traildeath receptor <NUMBER> dr<NUMBER> cause apoptosis airway alveolar epithelial cells <NUMBER> <NUMBER> <NUMBER> apoptosis endothelial cells epithelial cells damages pulmonary microvascular alveolar epithelial cell barriers causes vascular leakage alveolar edema eventually leading hypoxia body therefore inflammatory mediators play key role pathogenesis ards ards leading cause death patients infected sarscov merscov <NUMBER> <NUMBER> known several proinflammatory cytokines il<NUMBER> il<NUMBER> il<NUMBER> β granulocytemacrophage colonystimulating factor reactive oxygen species chemokines ccl<NUMBER> ccl<NUMBER> ifn γ induced protein <NUMBER> ip<NUMBER> ccl<NUMBER> contribute occurrence ards <NUMBER> <NUMBER> <NUMBER> results support points view following sarscov infection high virus titers dysregulation cytokinechemokine response cause inflammatory cytokine storm inflammatory cytokine storm accompanied immunopathological changes lungs high levels expression il<NUMBER>b ifnγ ip<NUMBER> monocyte chemoattractant protein <NUMBER> mcp<NUMBER> detected patients covid<NUMBER> inflammatory cytokines may activate thelper type <NUMBER> th<NUMBER> cell response <NUMBER> th<NUMBER> activation key event activation specific immunity <NUMBER> however unlike sars patients patients covid<NUMBER> also elevated levels th<NUMBER> cellsecreted cytokines il<NUMBER> il<NUMBER> inhibit inflammatory response serum levels il<NUMBER>r il<NUMBER> patients covid<NUMBER> positively correlated severity disease ie critically ill patients severely ill patients ordinary patients <NUMBER> studies found compared covid<NUMBER> patients general wards patients intensive care unit icu display increased serum levels granulocyte colonystimulating factor ip<NUMBER> mcp<NUMBER> macrophage inflammatory protein<NUMBER>a tnfα studies suggest cytokine storm positively correlated disease severity <NUMBER> report severe newtype coronavirusinfected pneumonia showed <NUMBER> patients <NUMBER> required mechanical ventilation <NUMBER> patients <NUMBER> suffered ards moreover mortality elderly patients ards significantly elevated <NUMBER> jid yjinf m<NUMBER>g april <NUMBER> <NUMBER> <NUMBER> core pathological change ards pulmonary interstitial tissue damage caused nonspecific inflammatory cell infiltration <NUMBER> local excessive release cytokines decisive factor induces pathological change clinical manifestation <NUMBER> covid<NUMBER> inflammatory cytokine storm closely related development progression ards serum levels cytokines significantly increased patients ards degree increase positively correlated mortality rate <NUMBER> cytokine storm also key factor determining clinical course extrapulmonary multipleorgan failure <NUMBER> partially explains signs extrapulmonary organ failure elevated liver enzymes creatinine seen covid<NUMBER> patients without respiratory failure suggesting inflammatory cytokine storm cause damage extrapulmonary tissues organs summary newtype coronavirus infection causes inflammatory cytokine storm patients cytokine storm leads ards extrapulmonary multipleorgan failure important factor causes covid<NUMBER> exacerbation even death high virus titer subsequent strong inflammatory cytokine chemokine responses related high morbidity mortality observed pathogenic hcov infection experience treating sars mers shows reducing viral load interventions early stages disease controlling inflammatory responses immunomodulators effective measures improve prognosis hcov infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> ifnλ ifnλ primarily activates epithelial cells reduces mononuclear macrophagemediated proinflammatory activity ifnαβ <NUMBER> addition ifnλ inhibits recruitment neutrophils sites inflammation <NUMBER> sarscov merscov mainly infect alveolar epithelial cells aec ifnλ activates antiviral genes epithelial cells thereby exerting antiviral effects without overstimulating human immune system therefore ifnλ may ideal treatment studies applied pegylated nonpegylated interferons treatment hcovs efficacy varied significantly due application different treatment regimens early administration interferons certain benefits reducing viral load improves clinical symptoms patients certain extent however fails reduce mortality rates <NUMBER> <NUMBER> <NUMBER> exception early administration use interferons time periods bring benefits placebo treatment <NUMBER> corticosteroids class steroid hormones antiinflammatory functions corticosteroids commonly used suppress inflammation <NUMBER> sars epidemic corticosteroids primary means immunomodulation timely administration corticosteroids often leads early improvements reducing fever relieving radiation infiltration lung improving oxygenation <NUMBER> <NUMBER> <NUMBER> retrospective study <NUMBER> patients severe sars revealed proper administration glucocorticoids patients severe sars significantly reduced mortality rate shortened hospital stay moreover secondary infections complications rarely occurred glucocorticoidtreated patients <NUMBER> however studies showing administration corticosteroid therapy human sarscov infection led adverse consequences early treatment sars patients corticosteroids increased plasma viral load nonicu patients resulting aggravation disease <NUMBER> treatment patients covid<NUMBER> use glucocorticoids become major conundrum clinicians <NUMBER> timing administration dosage glucocorticoids important outcome severely ill patients early administration glucocorticoids inhibits initiation bodys immune defense mechanism thereby increasing viral load ultimately leading adverse consequences therefore glucocorticoids mainly used critically ill patients suffering inflammatory cytokine storm inhibition excessive inflammation timely administration glucocorticoids early stage inflammatory cytokine storm effectively prevents occurrence ards protects functions patients organs patients progressive deterioration oxygenation indicators rapid imaging progress excessive inflammatory response use glucocorticoid short term <NUMBER> days appropriate recommended dose equivalent methylprednisolone <NUMBER> mgkgday <NUMBER> noted large doses glucocorticoid may delay clearance coronavirus due immunosuppression chen et al analyzed treatment <NUMBER> wuhan patients covid<NUMBER> found <NUMBER> patients received ivig treatment <NUMBER> ivig therapy dual effects immune substitution immunomodulation practical application value treatment covid<NUMBER> needs confirmation future studies cytokine storm three important cytokines il<NUMBER> family il<NUMBER> β il<NUMBER> il<NUMBER> <NUMBER> studies focus inhibition il<NUMBER> β reduce cytokine storm attracted attention anakinra antagonist il<NUMBER> β used treat cytokine storm caused infection significantly improved <NUMBER>day survival rate patients severe sepsis <NUMBER> currently clinical experience applying specific il<NUMBER> family blockers treat covid<NUMBER> effects need verified vivo animal experiments clinical trials tocilizumab il<NUMBER> antagonist suppresses function immune system currently tocilizumab mainly applied autoimmune diseases rheumatoid arthritis <NUMBER> tocilizumab therapeutic effect infectioninduced cytokine storm <NUMBER> serum il<NUMBER> level significantly increased severely ill patients covid<NUMBER> clinical studies china shown tocilizumab effective treating severely ill patients extensive bilateral lung lesions elevated il<NUMBER> levels first dose <NUMBER> mgkg recommended dosage <NUMBER>mg <NUMBER> saline diluted <NUMBER> ml infusion time <NUMBER> h patients poor efficacy first dose additional dose applied <NUMBER> h dose maximum two cumulative dose tnfs key inflammatory factors trigger cytokine storm attractive targets controlling cytokine storm metaanalysis showed antitnf therapy significantly improved survival patients sepsis <NUMBER> antitnf therapy also achieved satisfactory outcomes treatment noninfectious april <NUMBER> <NUMBER> <NUMBER> diseases atherosclerosis <NUMBER> studies animal models shown tnfs contribute significantly acute lung injury impair cell response sarscovchallenged mice mice neutralization tnf activity loss tnf receptor provides protection sarscovinduced morbidity mortality <NUMBER> <NUMBER> however noted least later stages infection tnf detected serum patients sars present tnf blockers suggested treatment patients covid<NUMBER> efficacy tnf blockers treatment patients covid<NUMBER> deserves exploration ifnαβ limits viral replication inducing ifnstimulated gene however ifnαβ also exacerbates diseases enhancing recruitment function mononuclear macrophages innate immune cells although early interferon response protective effect mice infected sarscov delayed ifnαβ signaling causes imbalance antisarscov immune responses humans phenomenon indicates timing ifn treatment crucial outcome diseases based results ifnαβ receptor blockers antagonists administered later stages severe disease prevent excessive inflammatory responses <NUMBER> chloroquine inhibits production release tnf il<NUMBER> indicates chloroquine may suppress cytokine storm patients infected covid<NUMBER> <NUMBER> chloroquine phosphate used treatment adults aged <NUMBER> <NUMBER> china <NUMBER> recommended dosage diagnosis treatment new coronavirus pneumonia trial version <NUMBER> china follows weight <NUMBER> kg <NUMBER> mg time <NUMBER> times day <NUMBER> days treatment course weight less <NUMBER> kg <NUMBER> mg time first second days twice day <NUMBER> mg time third seventh days day ulinastatin natural antiinflammatory substance body protects vascular endothelium inhibiting production release inflammatory mediators ulinastatin widely used clinical practice treat pancreatitis acute circulatory failure ulinastatin reduces levels proinflammatory factors tnfα il<NUMBER> ifnγ increases level antiinflammatory factor il<NUMBER> <NUMBER> activities ulinastatin promote balance proinflammatory antiinflammatory responses humans thus interrupting cytokine storm induced vicious cycle inflammation animal studies show antiinflammatory effect highdose ulinastatin equivalent hormones <NUMBER> however unlike glucocorticoids ulinastatin inhibit immune functions unlikely cause sequelae femoral head necrosis therefore ulinastatin great application prospects treatment covid<NUMBER> mouse model influenza virus iav infection oxpl increases production cytokineschemokines lung macrophages tolllike receptor <NUMBER> tlr<NUMBER>tirdomaincontaining adapterinducing interferonβ signaling pathway thereby promoting occurrence ali <NUMBER> eritoran tlr<NUMBER> antagonist direct antiviral activity strong immunomodulatory functions eritoran effectively lowers production oxpl inflammatory cytokines chemokines iavinfected mice thereby reducing death <NUMBER> pathogenic human coronaviruses also cause high accumulation oxpl patients lung tissues resulting ali <NUMBER> thus seems eritoran oxpl inhibitors may also able alleviate hcovinduced inflammatory responses sphingosine<NUMBER>phosphate s<NUMBER>p signal lysophospholipid promotes cytokine synthesis secretion <NUMBER> s<NUMBER>p receptor signaling pathways significantly inhibit pathological damage induced hosts innate adaptive immune responses thereby reducing cytokine storm caused influenza virus infection <NUMBER> <NUMBER> mouse models iav infection sphingosine<NUMBER>phosphate receptor <NUMBER> s<NUMBER>p <NUMBER> signal transduction respiratory endothelial cells modulates pathogenic inflammatory responses <NUMBER> agonists targeting s<NUMBER>p <NUMBER> inhibit excessive recruitment inflammatory cells inhibit proinflammatory cytokines chemokines reduce morbidity mortality iav <NUMBER> <NUMBER> sarscov<NUMBER> also mainly infects human lung epithelial cells endothelial cells therefore s<NUMBER>p <NUMBER> agonists may potential therapeutic drugs reducing cytokine chemokine responses hcov patients whose cells generated excessive immune responses s<NUMBER>preceptor modulating drug siponimod approved <NUMBER> treat multiple sclerosis however clinical trials needed verify whether siponimod ideal alternative treatment cytokine storm important member stem cell family mesenchymal stem cells msc potential selfrenewal multidirectional differentiation also strong antiinflammatory immune regulatory functions msc inhibit abnormal activation lymphocytes macrophages induce differentiation regulatory cell treg subsets antiinflammatory macrophages respectively also inhibit secretion proinflammatory cytokines il<NUMBER> tnfα il<NUMBER> il<NUMBER> ifnγ thereby reducing occurrence cytokine storms <NUMBER> <NUMBER> time msc secrete il<NUMBER> hepatocyte growth factor keratinocyte growth factor vegf alleviate ards regenerate repair damaged lung tissues resist fibrosis <NUMBER> therefore many functions msc expected make effective method treatment covid<NUMBER> addition blood purification treatments currently used clinic practice remove inflammatory factors certain extent blood purification system including plasma exchange adsorption perfusion bloodplasma filtration etc remove inflammatory factors block cytokine storm reduce damage inflammatory response body therapy used severe critical patients early middle stages disease artificial liver technology led academician li lanjuan eliminate inflammatory factors large scale technology also used resist cytokine storm h<NUMBER>n<NUMBER> application covid<NUMBER> also achieved certain efficacy <NUMBER> early renal replacement therapy similar treatment principle artificial liver technology seems effective method control cytokine storm <NUMBER> <NUMBER> supplement ifnλ activate innate immunity <NUMBER> using immunomodulator restore immune balance <NUMBER> inhibiting production cytokines <NUMBER> scavenging cytokines <NUMBER> inhibiting mononuclear macrophage recruitment function <NUMBER> strengthening vascular barrier activating endothelial slitrobo<NUMBER> signal pathway autopsy report patients covid<NUMBER> revealed large amount inflammatory cell infiltration lungs deceased <NUMBER> one potentially effective treatment approach reduce recruitment mononuclear macrophages site inflammation small interfering rna sirnamediated silencing cc chemokine receptor type <NUMBER> ccr<NUMBER> demonstrated animal experiments improve outcome disease <NUMBER> <NUMBER> tolllike receptor <NUMBER> tlr<NUMBER> agonists stimulate mononuclear macrophages undergo strong inflammatory response time infection singlestranded rna ssrna viruses hcov therefore tlr<NUMBER> antagonists may able alleviate storm inflammatory factors caused sarscov<NUMBER> infection increased vascular permeability also hallmark change occurs process cytokine storm found animal infection models sepsis h<NUMBER>n<NUMBER> virus activation endothelial slitrobo<NUMBER> pathway drugs improved vascular permeability thereby reducing occurrence cytokine storm infection <NUMBER> inflammation essential part effective immune response difficult eliminate infections successfully without inflammation inflammatory response begins initial recognition pathogens pathogens mediate recruitment immune cells eliminates pathogens ultimately leads tissue repair restoration homeostasis however sarscov<NUMBER> induces excessive prolonged cytokinechemokine responses infected individuals known cytokine storm cytokine storm causes ards multipleorgan dysfunction leads physiological deterioration death timely control cytokine storm early stage means immunomodulators cytokine antagonists well reduction lung inflammatory cell infiltration key improving treatment success rate reducing mortality rate patients covid<NUMBER> fig <NUMBER> authors declare competing financial interests jid yjinf m<NUMBER>g april <NUMBER> <NUMBER> <NUMBER> contributors qy led writing manuscript jhm developed initial concept framework manuscript oversaw drafting manuscript authors contributed content drafting critical review manuscript study supported zhejiang university special scientific research fund covid<NUMBER> prevention control since december <NUMBER> frequent incidence pneumonia become distinctive feature infection caused novel coronavirus severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> wuhan hubei province china <NUMBER> cd<NUMBER> cell counts yet lacked evidence pulmonary changes upon imaging <NUMBER> common symptoms observed covid<NUMBER> patients malaise dry cough high fever symptoms diarrhea hemoptysis headache uncommon <NUMBER> recently centers disease control prevention usa expanded target symptoms covid<NUMBER> include chills repeated shaking chills muscle pain headache sore throat loss taste smell disease mild progress toward dyspnea andor hypoxemia even acute respiratory distress syndrome ards septic shock lead multiple organ dysfunction syndrome mods <NUMBER> main reason death outcomes following sarscov<NUMBER> infection respiratory failure changes heart liver function secondary related consequence disease <NUMBER> <NUMBER> <NUMBER> epidemiologic data suggest certain groups particular risk severe disease outcomes ie elderly select preexisting conditions although know link disease severity viral production cytokine storm cytokine release syndrome crs still unclear molecular triggers fuel onset cytokine storm quickly advance ards mods fatal outcome subset patients <NUMBER> <NUMBER> remains unknown observed cytokine storm resulting leukocyte changes impact highand lowrisk individuals way factors turn otherwise natural protective cytokine response infection lethal pathogenic process article summarize reports blood cytokine levels leukocyte activation examine differences immunopathogenesis mild severe cases covid<NUMBER> patients china data obtained reports april <NUMBER> april <NUMBER> supporting information fig s<NUMBER> also discuss emerging concepts interphase leukocyte biology disease pathogenesis last summarize findings ongoing clinical trials china united states seek control onset damage caused cytokine storm reduce morbidity mortality release cytokines response infection lead mild severe clinical manifestations hallmarks mildnonlethal cytokine release response infection include increased local temperature heat myalgia arthralgia nausea rash depression mild flulike symptoms concurrent immune activation body launches compensatoryrepair processes restore tissue organ function term cytokine storm first coined <NUMBER> describe graftvshost disease <NUMBER> term since extended describe similar sudden cytokine releases associated autoimmune hemophagocytic lymphohistiocytosis sepsis cancers acute immunotherapy responses infectious diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> cytokine storm occurs immune system overactivated infection drug andor stimuli leading high levels cytokines ifn il chemokines csf tnf etc released circulation widespread detrimental impact multiple organs <NUMBER> severe inflammatory responses induced cytokine storm start locally spread systemically causing collateral damage tissues <NUMBER> <NUMBER> date unclear determinants host response infection responsible triggering inflammatory sequence leading clinical syndrome associated high cytokine release general believed caused imbalance immunesystem regulation ie increase immune cell activation via tlr mechanism decrease antiinflammatory response <NUMBER> addition nk cells myeloid cells resident macrophages activated ifn amplifies subsequent tlrmediated stimulation includes release high levels tnf il<NUMBER> il<NUMBER> turn modulate nk cells <NUMBER> although il<NUMBER> acts increase nk ifnsecretion high il<NUMBER> levels also may limit immune response effects cytotoxic activity nk cells via downregulation intracellular perforin granzyme b levels <NUMBER> disease progresses cell antibody responses give rise additional cytokine responses leading greater sustained antigen release added tlr ligands viralinduced cytotoxicity <NUMBER> responses motion hostor pathogenrelated factors ie decreases pathogen load antiinflammatory responses genetics work together prevent dysregulated response crs allowed develop could cause tissue damage organ failure example lack negative feedback mechanism il<NUMBER> il<NUMBER> would expected increase severity cytokine responses toward pathogenic crs cytokine storm <NUMBER> hand targeting treatment disrupt formation cytokine storm using pharmacologic agents tocilizumab antiil<NUMBER> may stabilize advanced cases transitioning critical state <NUMBER> <NUMBER> onset sarscov<NUMBER> infection typically preferential infection respiratory track consequence dropletbased viral transfer however recent study <NUMBER> supports theory sarscov<NUMBER> also could potentially infect intestine enterocytes directly angiotensinconverting enzyme <NUMBER> ace<NUMBER> ace<NUMBER> highly expressed differentiated enterocytes may help explain diarrhea occurs acute infection well observed fecal shedding consequently broader infection footprint may impact source inflammatory cascades include tissues lung covid<NUMBER> disease cytokine storm common patients severetocritical symptoms time lymphocytes nk cell counts sharply reduced elevations levels ddimer creactive protein crp ferritin procalcitonin <NUMBER> consequences lethal cytokine storm exhibit diffuse alveolar damage characterized hyaline membrane formation infiltration interstitial lymphocytes <NUMBER> <NUMBER> collateral tissue damage organ failure poor outcomes people covid<NUMBER> accompanying uncontrolled inflammatory responses share similarities sars mers severe sars patients serum levels ifn il<NUMBER> il<NUMBER> il<NUMBER> tgf mcp<NUMBER> il<NUMBER> higher patients mildtomoderate symptoms <NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> levels also increased patients severely infected merscov <NUMBER> leukocyte cytokine changes severetocritical sarscov<NUMBER> infection detailed developing criteria predict diagnose cytokine storm covid<NUMBER> patients surrogate biomarkers key peak levels circulating cytokines routinely monitored change kinetics addition crp ferritin increases ddimer procalcitonin also associated higher likelihood developing continuing cytokine storm covid<NUMBER> patients <NUMBER> interest elevated crp ferritin levels associated onset cytokine storm patients receiving chimeric antigen receptor cell therapy <NUMBER> study changes occur leukocyte cytokine parameters described later may help identify biomarkers cytokine storm covid<NUMBER> patients following sections review <NUMBER> recently published studies examine changes circulating leukocytes cytokine profiles <NUMBER> covid patients see schematic information process used selecting literature supporting information fig s<NUMBER> humans monocytes macrophages express ace<NUMBER> consequently infected sarscov sarscov<NUMBER> <NUMBER> results activation transcription proinflammatory genes <NUMBER> intriguingly infection caused sarscov<NUMBER> appears markedly downregulate expression ace<NUMBER> peripheral blood pb monocytes per cell basis may secondary outcome viral binding <NUMBER> <NUMBER> wen et al <NUMBER> also observed abundance inflammatory cd<NUMBER> il<NUMBER> ifnactivated monocytes existed pb covid<NUMBER> patients addition sarscov<NUMBER> found trigger macrophages ace<NUMBER> generating il<NUMBER> expression spleen lymph nodes il<NUMBER> tnf il<NUMBER> pd<NUMBER> expression alveolar macrophages <NUMBER> <NUMBER> added mechanism might promote lymphocytopenia contribute cytokine storm initiating lung viral levels rise <NUMBER> <NUMBER> autopsy reports indicated inflammatory macrophages accumulated lungs covid<NUMBER> patients <NUMBER> turn reduced duration elevated blood levels inflammatory markers il<NUMBER> crp <NUMBER> however mechanism underlying sarscov<NUMBER> ′ ability dampen initial innate responses acute infection suppress typei ifns maximize viral release still needs additional study covid<NUMBER> progresses number neutrophils circulation gradually increase thus elevated neutrophil levels may useful predicting severity disease <NUMBER> zhang et al <NUMBER> reported neutrophiltolymphocyte ratio nlr combined igg might better predictor neutrophil count alone predicting severity covid<NUMBER> neutrophil extracellular traps nets extracellular webs dnahistones released neutrophils control infections also known exacerbate inflammation <NUMBER> <NUMBER> previous studies revealed aberrant nets might contribute ards cystic fibrosis excessive thrombosis cytokine storm il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> severe cases covid<NUMBER> elevated levels netosis cellfree dna myeloperoxidase mpodna noted frequently <NUMBER> indeed neutrophils uninfected persons exposed serum covid<NUMBER> patients vitro triggered netosis indicating patient sera may capacity promote netosis neutrophils <NUMBER> <NUMBER> apart contributing cytokine storm increased netosis likely also impacts onset venous arterial thrombosis covid<NUMBER> patients <NUMBER> finding raises hypothesis nets may central dysregulated pathologic mechanism driving cytokine release multiorgan damage ultimately leading respiratory failure coagulopathy moreover transcriptional analysis <NUMBER> data nk cell response covid<NUMBER> limited sars nk cells found useful predicting disease severity cd<NUMBER>b nk cells associated presence antisarscovspecific antibodies <NUMBER> despite role dendritic cells cells respiratory infections <NUMBER> <NUMBER> currently available evidence show link sarscov<NUMBER> infection modulation myeloid plasmacytoid dendritic cells reports cells may impact disease <NUMBER> compelling evidence exists covid<NUMBER> characterized marked decrease circulating b lymphocytes particularly severe critical stages covid<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> note lymphopenia patients severe covid<NUMBER> frequently occurs along aberrant activation monocytesmacrophages increase neutrophils <NUMBER> changes leukocyte subsets associated mild vs severe infection outcomes described following sections summarized figure <NUMBER> cell subsets change covid<NUMBER> infection progresses mild severe singlecell sequencing study found target inflammatory genes highly expressed cd<NUMBER> cells cd<NUMBER> ctls underwent clonal expansion recovery stage covid<NUMBER> patients <NUMBER> however patients advancing severe disease number lymphocytes remained low compared mildstage patients levels helper cell subsets including th<NUMBER> th<NUMBER> th<NUMBER> belownormal levels <NUMBER> cd<NUMBER> cd<NUMBER> cells associated increase cd<NUMBER> cd<NUMBER> <NUMBER> hladr cd<NUMBER> <NUMBER> cells <NUMBER> zheng et al <NUMBER> chen et al <NUMBER> reported cd<NUMBER> cells pb covid<NUMBER> patients exhibited overactivated phenotype indicative sustained adaptive immune response whether effective addition innate immune response interest activated cd<NUMBER> cell responses appear ineffective patients advance severe stages disease evidenced exhaustive phenotype cd<NUMBER> cells hladr tigit cd<NUMBER> cells <NUMBER> consistent onset cell exhaustion chen et al <NUMBER> found cells pb severe covid<NUMBER> patients expressed high levels pd<NUMBER> tim<NUMBER> expression levels pd<NUMBER> tim<NUMBER> cells also positively correlated disease severity activated cells could also add fuel cytokine storm stimulating inflammatory responses innate immune cells example shown expression il<NUMBER> csf<NUMBER> csf<NUMBER> cells may bind il<NUMBER>r colony stimulating factor receptor csfr expressed monocytes stimulate activation monocytes <NUMBER> th<NUMBER> cells patients severe covid<NUMBER> reported stimulate production il<NUMBER> inflammatory monocytes <NUMBER> together th<NUMBER> cells <NUMBER> may directly join innate immune cells sparking release proinflammatory cytokines contributing cytokine storm subsequent organ damage <NUMBER> <NUMBER> regulatory cells tregs play critical role dampening excessive inflammatory response well antiviral immune responses <NUMBER> therefore tregs may central maintaining balance antiviral immunity harmful cytokine storm date reports regarding treg cells covid<NUMBER> patients remain inconsistent studies found upregulated treg cells severe illness whereas others reported number tregs reduced unchanged covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> therefore role treg cells pathogenesis covid<NUMBER> needs clarified circulating b cells appear restored normal levels patients upon recovery covid<NUMBER> convalescent plasma cp infusion discussed later shown potentially effective treatment reported <NUMBER> severe covid<NUMBER> patients <NUMBER> findings support hypothesis humoral immune responses boost sarscov<NUMBER>specific antibodies important hosts resolution sarscov<NUMBER> infection likely would help protect reinfection <NUMBER> <NUMBER> <NUMBER> interest ability develop neutralizing antibody production memory infection may recovered patients recent data suggests many <NUMBER> recovered patients milder disease course may develop low titers neutralizing antibodies may convey higher risk reinfection <NUMBER> indeed several studies detected higher antibody titers recovery severe disease compared milder cases ie higher antibody titer recovered elderly patients compared younger patients often mild asymptomatic disease suggests disease course stronger immune response may also lead greater protection reinfection <NUMBER> <NUMBER> important note binding antibodies also play role antibodymediated phagocytosis antibodydependent cytotoxicity remains determined patients low total neutralizing antibody titers higher reinfection rates similar cd<NUMBER> cd<NUMBER> cells nk cells b cells also markedly decreased severe covid<NUMBER> patients compared mild patients counts b lymphocytes negatively associated viral burden <NUMBER> aside protection also remains undetermined prior exposure may prime bodys response leading antibodydependent enhancement ade effects greater infection amplification inflammation cascades previously thus ade present may hinder hosts ability manage inflammation lung tissues <NUMBER> analysis <NUMBER> covid<NUMBER> patients analyzed sarscov<NUMBER>specific igm iggs found severe critical disease high titer total antibodies well high igg response associated poor outcome prognosis <NUMBER> whether increase antibody titers disease represents secondary outcome hosts response high viral titers whether ade mechanism could contribute sudden rise viral load onset cytokine storm remains undetermined many proinflammation cytokines il<NUMBER> tnf il<NUMBER> il<NUMBER> il<NUMBER> ifn gcsf mcp<NUMBER> macrophage inflammatory protein <NUMBER> ip<NUMBER> ifninduced protein <NUMBER> others found significantly elevated severe covid<NUMBER> patients table <NUMBER> fig <NUMBER> profile similar found patients sars mers <NUMBER> <NUMBER> <NUMBER> shown table <NUMBER> elevation il<NUMBER> frequently measured detected severe cases sarscov<NUMBER> infection zhou et al <NUMBER> reported pathogenic gmcsfproducing th<NUMBER> cells severe covid<NUMBER> patients induced il<NUMBER> production cd<NUMBER> cd<NUMBER> monocytes thus accelerated inflammation associated cytokine storm elevated levels il<NUMBER> also found patients exacerbating disease progression evidenced chest ct <NUMBER> moreover chen et al <NUMBER> reported serum sarscov<NUMBER> viral load closely associated il<NUMBER> levels critical patients r <NUMBER> high levels il<NUMBER> may also contribute increase neutrophil cells decrease lymphocytes clearly il<NUMBER> may impact development ards covid<NUMBER> patients <NUMBER> rise il<NUMBER> may useful marker severe disease onset furthermore lungcentric coagulopathy also play important role pathophysiology severe covid<NUMBER> patients <NUMBER> increase increase il<NUMBER> <NUMBER> il<NUMBER> <NUMBER> il<NUMBER> ifn<NUMBER> <NUMBER> yunnan column <NUMBER> n number cases available data addition columns <NUMBER> <NUMBER> n number cases leukocyte cytokines changed overall according corresponding report tnf master proinflammatory cytokine involved pathogenesis autoimmune diseases rheumatoid arthritis ra consequently antitnf biologics become firstline treatment diseases <NUMBER> high levels tnf often produced initial response infectious disease <NUMBER> recent study shows level tnf <NUMBER> pgml higher il<NUMBER> <NUMBER> pgml plasma severe covid<NUMBER> patients <NUMBER> therefore investigation warranted define tnf impacts immunopathology well effectiveness antitnf therapy severe covid<NUMBER> patients addition examining il<NUMBER> tnf yang et al <NUMBER> th<NUMBER>type cytokine storm caused mobilization th<NUMBER> responses also observed sars mers patients <NUMBER> <NUMBER> reported high number ccr<NUMBER> ccr<NUMBER> th<NUMBER> cells least partially attributed immunopathology also present covid<NUMBER> patient ards <NUMBER> markedly elevated cytokines ie il<NUMBER> il<NUMBER> tnf gmcsf covid<NUMBER> patients associated th<NUMBER> responses <NUMBER> findings suggest th<NUMBER>type cytokine storm may lead associated onset organ damage commonly observed severe covid<NUMBER> patients <NUMBER> taken together staging sarscov<NUMBER> infection commonly divided four stages mildcommonseverecritical may different magnitudes cytokine release also possible qualitative features cytokine storm disease stages may point distinct host pathogen triggers eg cytokine storm without concomitant bacterial pneumonia figure <NUMBER> summarizes combined contribution blood lung tissue infiltrates shows added factors accompanying bacterial pneumonia may exacerbate cytokine responses central role pathogenesis sarscov<NUMBER> infection cytokine storm accompanying excessive inflammatory responses become therapeutic target treatment covid<NUMBER> patients immunotherapy strategies aimed curtailing cytokine storm investigation several countries table <NUMBER> additional therapies indirectly reduce viral burden secondarily reduce incidence cytokine storm summarized supporting information tables s<NUMBER>s<NUMBER> strategies date address specific type cytokine storm assume one size fits approach treating severe disease patients clinical reports showing elevated levels il<NUMBER> associated immunopathology disease severity covid<NUMBER> <NUMBER> provided strong scientific rationale examining effects il<NUMBER> receptor antagonists eg siltuximab clazakizumab sarilumab tocilizumab fact tocilizumab recommended china treat covid<NUMBER> patients bilateral pulmonary damage severe symptoms <NUMBER> early clinical reports tocilizumab showed fevers subsided <NUMBER> severe patients within <NUMBER> treatment <NUMBER> patients achieved recovery sufficient allow released hospital within <NUMBER> wk <NUMBER> guo et al <NUMBER> showed tocilizumab treatment <NUMBER> mg iv drip <NUMBER> patients restored cd<NUMBER>cd<NUMBER> ratio leading marked reduction sarscov<NUMBER> plasma viremia <NUMBER> deng colleagues also suggested upstream targets cyclic guanosine monophosphate gmp adenosine monophosphate amp synthase cgas anaplastic lymphoma kinase alk stimulator interferon genes sting may help reduce cell activation cytokine release <NUMBER> likewise jakstat signaling inhibitors baricitinib ruxolitinib also proposed preventing crs <NUMBER> treated patients saw reductions levels il<NUMBER> well shorter duration viral shedding <NUMBER> ifnbeta<NUMBER>b also noted beneficial added antiviral regimen includes lopinavir ritonavir <NUMBER> mscs adult stem cells ability selfreplicate show potential differentiation multiple cell types <NUMBER> mscs potential impact antiinflammatory activities producing immunosuppressive cytokines directly interacting inhibiting activation immune cells <NUMBER> table <NUMBER> supporting information table s<NUMBER> table <NUMBER> supporting information table s<NUMBER> clinics <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> also evidence immunosuppressive features tcm may convey beneficial effects prevention treatment cytokine storm <NUMBER> retrospective study reported matrine sodium chloride injection could markedly improve lymphopenia covid<NUMBER> patients possibly inhibiting pulmonary inflammatory cytokines <NUMBER> <NUMBER> vitro experiment zhu et al <NUMBER> found liquiritin could markedly inhibit replication sarscov inhibitors consequently suggested herbal medicines included agents might useful dampening cytokine storm patients <NUMBER> anticipate additional tcm strategies identified management cytokine storm covid<NUMBER> patients example ulinastatin natural antiinflammatory substance fresh human urine believed inhibit cytokine release subsequent tissue injury <NUMBER> currently investigation treatment covid<NUMBER> patients <NUMBER> addition tcm corticosteroid treatment shown dampen inflammatory cascade cytokine storm <NUMBER> recent study found early shortterm administration methylprednisolone could improve clinical outcome moderatetosevere covid<NUMBER> patients <NUMBER> although useful critical patients tool managing host inflammatory responses corticosteroids recommended high doses prolonged periods time may dampen normal immune responses could help contain viral infection <NUMBER> <NUMBER> <NUMBER> nevertheless number ongoing clinical trials table <NUMBER> supporting information table s<NUMBER> may show safe beneficial corticosteroidbased treatment indicated treating covid<NUMBER> last several immunomodulatory therapies including recombinant human ifnalpha rhgcsf iv immunoglobulin antibody vaccine nutritional supplements zinc vitamin c vitamin d<NUMBER> colchicine cellular therapy also investigation inhibiting cytokine storm table <NUMBER> supporting information table s<NUMBER> generally believed cytokine storm triggered sars defining shared populationspecific triggers amplifiers cytokine storm specific disease stages advance novel precision medicine strategies factors known contribute disease pathogenesis host genetics epigenetics microbiome mucosal infection apart lung immunoregulatory networks aging cooccurring disease exosomes complement neurologic endocrine polydrug environments etc yet fully investigated example fogarty et al <NUMBER> reported potential <NUMBER>fold higher thrombotic risk caucasians underscores potential impact race ethnicity may disease outcomes although coagulopathy seems severe complication covid<NUMBER> infection may necessarily related disease severity exclusively present cytokine storm <NUMBER> remains undetermined onset coagulopathy absence compromised lung capacity ventilationperfusion crs may related early press reports higher stroke incidence young middleaged infected patients united states indeed proposed predisposed individuals alveolar viral damage may trigger underlying inflammatory reaction promoting microvascular pulmonary thrombosis endothelial thromboinflammatory syndrome affecting microvascular beds beyond lung eg brain vital organs <NUMBER> immune factors identified review eg netosis il<NUMBER> macrophage activation antibody response etc may contribute damage microvascular beds damage predisposes incidence crs remains determined therefore need identify leading molecular triggers multiorgan failure cytokine storm order prevent added lethal outcomes regarding therapy timing best ways combine various treatments also remains determined eg early antiviral therapy followed anticrs therapy occurs <NUMBER> also need extend immunopathogenesis studies beyond adults based studies covid<NUMBER> clinical features pregnancy known neonates different adults <NUMBER> <NUMBER> example children rarely progress disease course requiring icu care regrettably limited clinical trial activity focusing children remains missed opportunity better address treat limit transmission group <NUMBER> greater advances areas allow selective treatments target key pathogenic components cytokine storm advance highly targeted precision medicine strategies authors declare conflicts interest httpsorcidorg<NUMBER> luis j montaner httpsorcidorg<NUMBER> growing recognition coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> possesses neurotropic properties lead neurological manifestations similar sars middle east respiratory syndrome mers covid<NUMBER> envisaged enduring cognitive psychological psychiatric consequences however data pertaining albeit limited growing anticipation covid<NUMBER> might cause delirium depression anxiety fatigue posttraumatic stress disorder ptsd rogers et al <NUMBER> recent report suggests immediate psychological distress especially higher levels depression anxiety ptsd symptoms quarantined patients covid<NUMBER> guo et al <NUMBER> observed sars survivors covid<NUMBER> survivors may also longterm psychiatric morbidities mak et al <NUMBER> various mechanisms proposed contribute neurobiological sequelae covid<NUMBER> sarscov<NUMBER> transmigrate brain disrupting blood brain barrier bbb interact angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor expressed brain tissue ace<NUMBER> receptor pleotropic roles stress response system mood regulation vian et al <NUMBER> sarscov<NUMBER> could affect brain behavior people causing direct neuronal damage ii immune injury iii hypoxia biogenesis contextually mechanisms consistently implicated pathogenetic pathways many psychiatric disorders however one pertinent question arises covid<NUMBER> associated immune changes influence risk progression outcomes psychiatric conditions genesis cytokine storm evident infectious noninfections disease states occurring throughout body including brain used describe underlying mechanisms multiple infectious diseases variola virus severe influenza h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> sars cns particularly vulnerable cytokine storms cytokines involved cytokine storm either produced within brain reach brain periphery especially context disrupted bbb permeability notably cytokine storm appears drive chronic neurotoxic neurodegenerative processes conditions like posttraumatic brain injury poststroke alzheimers disease multiple sclerosis classical example neuroinflammatory disorder cns suggested associated cytokine storm link <NUMBER> acute spike circulating inflammatory moieties also associated postoperative cognitive decline skvarc et al <NUMBER> evidence cns impact cytokine storm infectious diseases relatively sparse acute necrotizing encephalopathy ane severe type influenzaassociated encephalopathy rare complication influenza associated intracranial cytokine storms significant lack information whether cytokine storm leads neuroinflammation individuals covid<NUMBER> infection interestingly study based ct mri features first time reports presence covid<NUMBER> associated acute necrotizing encephalopathy indicating potential consequence cns cytokine storm patients covid<NUMBER> infection poyiadji et al <NUMBER> immunopathogenesis one predominant etiological models major psychiatric disorders activation immuneinflammatory pathways peripherally brain linked genesis progression neuropsychiatric disorders noteworthy neuropsychiatric conditions consistently linked chronic lowgrade inflammation implies sustained lowlevel inflammation throughout body systemic inflammation causing neuroinflammation welldocumented fact notion cytokine storm lead neuropsychiatric disorders comprehensively tested far cytokines involved cytokine storm associated neuropsychiatric disorders like schizophrenia bipolar disorder indirect evidence indicates cytokine storm could involved driving manifestation psychiatric symptoms influenza infections shown result cytokine storm besides sars mers also lead cytokine storm contextually influenza infections sars mers shown associated neuropsychiatric symptoms based understanding neurobiological consequences cytokine storm seems highly likely neuropsychiatric conditions concern whether patients psychiatric conditions experience psychiatric symptoms covid<NUMBER> pandemic recent study reports covid<NUMBER> severe negative psychological impact patients preexisting psychiatric conditions patients displayed higher risk developing symptoms ptsd depression anxiety stress insomnia hao et al <NUMBER> patients sarscov<NUMBER> infection mostly exhibit cytokine storm mean patients preexisting psychiatric disorders experience higher risk psychiatric episodes due dramatic increase inflammatory response elicited cytokine storm significant lack data towards notion seems possibility support towards derives studies showing coronavirus immunoreactivity based measures antibody levels seroprevalence certain coronavirus strains patients recent onset psychotic symptoms severance et al <NUMBER> study examining correlation psychological distress peripheral inflammation demonstrated positive correlation levels depression levels creactive protein crp among patients covid<NUMBER> quarantined patients depression symptoms guo et al <NUMBER> sarscov<NUMBER> triggering new neuropsychiatric conditions shown accompanied elevated crp levels propose sarscov<NUMBER> associated immediate newonset neuropsychiatric manifestations likely immunemediated presence cytokine storm involved severity mortality covid<NUMBER> appears escalate psychiatric manifestations also seems exert deleterious effects multiple organs systems lead longlasting changes brain behaviour longstanding theory chronic lowgrade inflammation lead psychiatric diseases may constitute full picture underlying pathway immediate psychological distress therefore assumed classical concept chronic lowgrade inflammation psychosis may require revision may well augmented cytokine storm model people suffering covid<NUMBER> recover without experiencing severe neuropsychiatric conditions shortterm delirium common neuropsychiatric symptom people preexisting neuropsychiatric conditions might reduced incidence sarscov<NUMBER> might protected covid<NUMBER> could explained light chroniclow midapril <NUMBER> severe acute respiratory distress syndrome coronavirus <NUMBER> sarscov<NUMBER> coronavirus responsible covid<NUMBER> infected <NUMBER>·<NUMBER> million people worldwide killing <NUMBER> <NUMBER> multifaceted methodology necessary pandemic reduce mortality panel awaiting safe effective vaccines antivirals substantially reduce death struggle identify effective therapy patients covid<NUMBER> admitted hospital early reports china detailing clinical features fever confusion respiratory distress coagulopathy laboratory features lymphopenia elevated creactive protein crp dimers lactate dehydrogenase soluble interleukin<NUMBER> il<NUMBER> receptorα ferritin severe covid<NUMBER> reminiscent cytokine storm syndrome <NUMBER> cytokine storm syndrome umbrella term describ ing various frequently fatal hyperinflammatory con di tions macro phage activation syn drome haemo phagocytic lymphohistiocytois cytokine release syn drome <NUMBER> many associated dis eases eg lupus lymphoma triggers eg dengue car tcell therapy result cytokine storm syndrome viral infections including pandemic influenza strains common triggers sarscov<NUMBER> added list several pathophysiological path ways result cytokine storm syndrome best studied pathway defective lymphocyte kill ing via perforin pathway homozygous defects perforin pathway genes cause familial haemophagocytic lymphohistiocytosis heterozygous mutations genes associated secondary haemophagocytic lymphohistiocytosis including fatal h<NUMBER>n<NUMBER> influenza <NUMBER> whether similar novel genetic defects contribute severity covid<NUMBER>associated cytokine storm syndrome unknown answered genomic sequencing patients admitted hospital covid<NUMBER>associated cytokine storm syndrome regardless mechanism cytokine storm syndromes share features inappropriately elevated proinflammatory cytokines il<NUMBER> il<NUMBER> interferonγ produced dysregulated host immune response resulting multiorgan failure cytokine storm syndromes identical covid<NUMBER>associated cytokine storm syndrome unique features including propensity early acute respiratory distress syndrome clotting higher serum ferritins lower il<NUMBER> concentration routinely noted cytokine storm syndromes <NUMBER> nonetheless covid<NUMBER> triggers hyperinflammatory response substantial number patients require hospital admis sion different therapies used years treat ment various cytokine storm syndromes therapies include broadly immunosuppressive approaches eg gluco corticoids calcineurin inhibitors targeted immunomodulatory therapies eg anticytokines janus kinase inhibitors <NUMBER> basis previous experience deadly coronaviruses severe acute respiratory distress syndrome middle east respiratory distress syndrome recommended glucocorticoid treatment patients covid<NUMBER> however targeting cytokines cytokine storm syndromes proved effective attractive lower frequencies associated sideeffects thus anticytokine approaches explored treating covid<NUMBER>associated cytokine storm syndrome il<NUMBER> easily measured therapies targeting il<NUMBER> available china early approaches treating covid<NUMBER>associated cytokine storm syndrome involved il<NUMBER> blockade dozens clinical trials studying blockade il<NUMBER> receptor early publications trials nontrial cohorts reporting mixed results nevertheless evidence blocking il<NUMBER> signalling might benefit patients covid<NUMBER> <NUMBER> il<NUMBER> another proinflammatory cytokine targeted treat various cytokine storm syndromes • safe effective vaccines future • public health measures eg social distancing • hospital intensive standard care eg proning • anticoagulation patients high risk clots eg elevated dimers • antiviral therapyawaiting published effective treatment • anticytokine storm therapy eg interleukin<NUMBER> blockade shutterstock storm syndrome otherwise safe setting <NUMBER> currently dozen clinical trials exploring il<NUMBER> blockade covid<NUMBER>associated cytokine storm syndrome awaiting results clinical trials case series anakinra treating covid<NUMBER>associated cytokine storm syndrome published three small cases series reported anakinra benefitting patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> lancet rheumatology thomas huet colleagues <NUMBER> describe larger prospective singlecentre cohort study historical control cohort demonstrating anakinra significantly reduced requirement invasive mechanical ventilation death patients received anakinra n<NUMBER> compared historical controls received usual care n<NUMBER> hazard ratio <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> p<NUMBER>·<NUMBER> patients admitted hospital consecutively enrolled basis laboratoryconfirmed sarscov<NUMBER> bilateral lung infiltrates imaging critical pulmonary function admission intensive care unit admission icu death occurred <NUMBER> <NUMBER> <NUMBER> patients anakinra group compared <NUMBER> <NUMBER> <NUMBER> patients historical control group investigators also demonstrated significant reduction oxygen requirement median <NUMBER> lmin iqr <NUMBER> <NUMBER> lmin <NUMBER> within week starting anakinra therapy associated decrease crp concentration anakinra group compared historical control group within <NUMBER> days starting anakinra therapy p<NUMBER>·<NUMBER> study potential biases nonrandomised nonblinded studies multivariate analysis used control potentially confounding factors bodymass index without change conclusions seven patients anakinra group four patients control group elevated liver enzymes substantial sideeffects study definitive evidence date anakinra benefit patients covid<NUMBER>associated cytokine storm syndrome significant reduction mortality associated anakinra use covid<NUMBER> study encouraging challenging times choice anakinra treat deadly cytokine storms wise remarkable benefittosideeffect ratio recombinant human protein binds il<NUMBER>α il<NUMBER>β halflife <NUMBER> h large therapeutic window <NUMBER> mgkg per day given intravenously subcutaneously well established favourable safety profile works quickly effectively various cytokine storm syndromes <NUMBER> top priority pandemic learn effective therapy clinical trial enrolment however difficult healthcare professionals regions overwhelmed covid<NUMBER> witness much death although important treat virus infected patients best cytokine storm syndrome present also must managed reduce mortality excessive host immune response awaiting controlled trial results anakinra provides hope severely affected covid<NUMBER> since december <NUMBER> coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> broken wuhan china spread rapidly countries world recently cell surface protein known angiotensinconverting enzyme ii ace<NUMBER> identified involved receptormediated endocytosis sarscov<NUMBER> entry cells <NUMBER> team nanshan zhong found <NUMBER> patients fever hospitalization <NUMBER> patients developed severe pneumonia <NUMBER> outbreak covid<NUMBER> infected patients would suddenly worsen developed acute respiratory distress syndrome ards shock tissue perfusion disorders later stage eventually die multiple organ failure aggravation mainly caused cytokine storm <NUMBER> <NUMBER> described detail last review <NUMBER> therefore block cytokine storm initiate antiinflammation therapy critical reducing death rate covid<NUMBER> clinically severe phase covid<NUMBER> accompanied high levels cytokine signalling signal janus kinasesignal transducer activator transcription jakstat pathway baricitinib expected interrupt passage intracellular assembly sarscov<NUMBER> target cells mediated ace<NUMBER> receptor also promises specific drug blocks cytokine storms suppressing jak<NUMBER>jak<NUMBER> <NUMBER> however clinical experience data baricitinib treatment covid<NUMBER> limited mechanism drug action applicable patients risks drug need recognized paper elaborate role cytokine storm mediated jakstat pathway severe covid<NUMBER> possible mechanisms baricitinib blocking sarscov<NUMBER> entry target cells controlling cytokine storm key points pharmaceutical care based latest research reports clinical trial progress drug instruction us fda provide reference treatment covid<NUMBER> cytokines group small proteins secreted stromal cells immune system cells used mainly intercell signaling communication variety biological functions regulating innate immunity adaptive immunity hematopoiesis cell growth differentiation repairing damaged tissues binding receptors cytokines mainly include interleukin il interferon ifn tumor necrosis factor tnf colony stimulating factor csf chemokine growth factor human body invaded bacteria viruses immune system release large number cytokines <NUMBER> <NUMBER> excessive uncontrolled release proinflammatory cytokines contributes cytokine storm outbreak covid<NUMBER> infected patients would suddenly worsen later stage eventually die multiple organ failure aggravation mainly caused cytokine storm <NUMBER> pathological mechanisms may closely relevant death covid<NUMBER> patients <NUMBER> number recently researches analyzed clinical characteristics covid<NUMBER> patients consistently found lymphocyte count significantly reduced patients pneumonia especially severe pneumonia numerous cytokines il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfα ifnγ significantly increased main cause cytokine storm especially il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> previous therapy controlling cytokine storm large doses glucocorticoid may delay clearance coronavirus cause complications glucocorticoid therapy addition clinical trials glucocorticoids used treat lung injury shock caused covid<NUMBER> <NUMBER> jak group cytoplasmic enzymes tyrosine kinase activity facilitate transmission signals cell surface interior extremely important proinflammatory cytokinemediated signaling process stat one crucial cytokineactivated transcription factors process immune response phosphorylated jak dimerized transports nucleus nuclear membrane regulate expression related genes pathway called jakstat signaling pathway promotes cytokine storm mediated excessive amounts cytokine simple efficient way <NUMBER> <NUMBER> jak members jak<NUMBER> jak<NUMBER> jak<NUMBER> tyk<NUMBER> <NUMBER> stat members stat<NUMBER> stat<NUMBER> stat<NUMBER> stat<NUMBER> stat<NUMBER>a stat<NUMBER>b stat<NUMBER> <NUMBER> <NUMBER> jak<NUMBER> jak<NUMBER> tyk<NUMBER> expressed indiscriminately throughout body whereas jak<NUMBER> expressed haematopoietic cells <NUMBER> activation jakstat pathway induced cytokine binding surface receptors culminates regulation transcription stats various cytokines growth factors transmit signals jakstat signaling pathway including il<NUMBER> gmcsf epidermal growth factor egf platelet derived growth factor pdgf ifn <NUMBER> example ifnγ signals via jak<NUMBER> jak<NUMBER> turn activate stat<NUMBER> whereas il<NUMBER> jakstat dependent cytokine signal via jak<NUMBER> jak<NUMBER> andor tyk<NUMBER> activates stat<NUMBER> cells <NUMBER> cytokine storm relatively common severe case often leads exacerbation covid<NUMBER> antiinflammation therapy may help preventing injury know variety antiinflammatory medications including jak inhibitor drugs predicted particular importance treatment severe covid<NUMBER> receptormediated endocytosis common pathway virus entry cells recently cell surface protein known angiotensinconverting enzyme ii ace<NUMBER> identified sarscov<NUMBER> humans animals ace<NUMBER> expressed cells kidney blood vessels heart importantly lung at<NUMBER> alveolar epithelial cells receptor used sarscov<NUMBER> infect lung cells <NUMBER> ace<NUMBER> receptor several regulators among ap<NUMBER>associated protein kinase<NUMBER> aak<NUMBER> cyclin gassociated kinase gak two pivotal regulators mediate clathrindependent endocytosis <NUMBER> baricitinib expected high binding affinity aak<NUMBER> gak interrupt passage intracellular assembly sarscov<NUMBER> target cells <NUMBER> accordingly baricitinib suggested trialed patients sarscov<NUMBER> acute respiratory disease order reduce viral entry associated inflammation nct<NUMBER> baricitinib interrupts passage intracellular assembly sarscov<NUMBER> target cells also reduces inflammation patients ards severe covid<NUMBER> cases jakstat signaling pathway participates cytokine storm excessive amounts cytokines bind receptors activates jaks occurs upon ligandmediated receptor multimerization since two jaks close enough transphosphorylation <NUMBER> activated jaks phosphorylate receptors activate phosphorylate main substrate stats phosphorylated stat dimerizes members stat family conserved sh<NUMBER> domains finally dimerized stats cytoplasm transferred nucleus combine specific dna elements regulate expression cytokineresponsive genes subsequently cytokine storm finally induced baricitinib atp competitive kinase inhibitor inhibits selectively effectively reversibly jak<NUMBER>jak<NUMBER> suppressing jak<NUMBER>jak<NUMBER> baricitinib intracellularly inhibits proinflammatory signal several cytokines il<NUMBER> il<NUMBER> il<NUMBER> ifnγ <NUMBER> demonstrated clinical benefits patients moderate severe ra including reducing incidence structural joint damage <NUMBER> drug might lower hyper inflammation socalled cytokine storm caused sarscov<NUMBER> would prevent damage lungs possibly organs see fig <NUMBER> however different views theory baricitinib treat cytokine storms needs clarified certain pathological conditions inflammatory process widely recognized localized protective response body attacked pathogens sarscov<NUMBER> jakstat primary signaling pathway regulated cytokines crucial initiating innate immunity orchestrating adaptive immune mechanisms finally constraining inflammatory immune responses <NUMBER> <NUMBER> seems using jak<NUMBER>jak<NUMBER> inhibitor treat viral disease might appear illogical given antiviral effects ifn largely mediated jakstat signalling pathway speculated early asymptomatic disease stages disease requiring admittance hospital approximately <NUMBER> covid<NUMBER> patients able clear virus endogenous antiviral mechanisms certainly including ifn therefore recommended baricitinib jak inhibitors given individuals <NUMBER> however covid<NUMBER> sars characterized exuberant inflammatory response akin socalled cytokine storm viral load correlated worsening symptoms <NUMBER> <NUMBER> clinically severe phase covid<NUMBER> accompanied high levels cytokine signalling signal jakstat pathway finding suggests hospital care required patients pathogenic sarscov<NUMBER> infection jakstat pathway inhibition might potential strategy patients moderate disease requiring hospital care peak sarscov<NUMBER> load occurs within approximately <NUMBER> days symptom onset later viral titre decreases patients cytokine storm causes severe phase disease <NUMBER> baracitinib shown favorable pharmacokinetic properties low plasma protein binding affinity minimal interaction cyp enzymes drug transporters <NUMBER> currently covid<NUMBER> outbreak baricitinib combined different antivirals since combination would decrease viral infectivity viral replication control cytokine storm baricitinib approved european union treatment ra patients <NUMBER> according us fda drug instructions baricitinib recommended adult patients moderately severely active ra inadequate response one tnf antagonist therapies recommended dose <NUMBER> mgd <NUMBER> far research reports extrara effects baricitinib known targeting cytokines cytokine receptors biologics revolutionized treatment many immune inflammatory diseases wallace dj et al found baricitinib signifiantly improved signs symptoms active systemic lupus erythematosus patients adequately controlled despite standard care therapy <NUMBER> recent studies reported baricitinib improved clinical signs symptoms patients moderatetosevere atopic dermatitis induced rapid reduction itch <NUMBER> baricitinib approved cytokine storm caused sarscov<NUMBER> however absolute lymphocyte countalc ＜<NUMBER>×<NUMBER> <NUMBER> l absolute neutrophil count anc＜<NUMBER>×<NUMBER> <NUMBER> l hemoglobin level hb＜<NUMBER> gdl egfr＜<NUMBER> mlmin<NUMBER>m <NUMBER> ast alt<NUMBER> times uln hand reported baricitinib ideal option management covid<NUMBER> ground research reports small samples <NUMBER> epidemiologic study reported alc nonsurvivors <NUMBER>×<NUMBER> <NUMBER> cellsl interquartile range <NUMBER>×<NUMBER> <NUMBER> cellsl another study reported alc patients receiving icu care <NUMBER>×<NUMBER> <NUMBER> l interquartile range <NUMBER>×<NUMBER> <NUMBER> l unfortunately baricitinib recommended patients alc＜<NUMBER>×<NUMBER> <NUMBER> l anc＜<NUMBER>×<NUMBER> <NUMBER> l based foregoing baratinib indeed suitable group patients receiving icu care fact conflict results current clinical trials recommended baricitinib moderate severe covid<NUMBER> patients according recent research reports baricitinib generally well tolerated whole smolen js analyzed <NUMBER> patients moderate severe active ra received baricitinib <NUMBER> total patientyears exposure median <NUMBER> yrs maximum <NUMBER> yrs found differences rates death adverse events leading drug discontinuation malignancies major adverse cardiovascular event serious infections seen baricitinib <NUMBER>mgd versus placebo however infections including herpes zoster significantly frequent baricitinib <NUMBER>mgd versus placebo <NUMBER> coincidentally metaanalysis baricitinib patients ra showed <NUMBER> mg baricitinib increased herpes zoster infection compared placebo <NUMBER> mg baricitinib <NUMBER> integrated analysis showed placebocontrolled period week <NUMBER> <NUMBER> events <NUMBER> per <NUMBER> personyears reported patients received <NUMBER> mg baricitinib <NUMBER> another integrated analysis showed older age obesity history dvtpe use selective cox<NUMBER> inhibitor independent risk factors venous thromboembolism <NUMBER> fact <NUMBER> <NUMBER> patients developed dvtpe risk factors adverse reactions data obtained series clinical study long course treatment baricitinib however shortterm use baricitinib ie <NUMBER> days might reactivate latent infections including herpesviruses tuberculosis covid<NUMBER> patients needs demonstrated based evidence pharmaceutical care baricitinib mainly includes following①avoid use baricitinib patients active serious infection active tb ② baricitinib recommended patients alc＜<NUMBER>×<NUMBER> <NUMBER> l anc＜ <NUMBER>×<NUMBER> <NUMBER> l hb＜<NUMBER> gdl ③ prompt investigation cause liver enzyme elevation recommended increases alt ast observed druginduced liver injury suspected interrupt baricitinib diagnosis excluded ④ baricitinib used caution patients risk factors older age obesity history dvtpe use selective cox<NUMBER> inhibitor following information mainly drug instructions us fda older adults baricitinib known substantially excreted kidney risk adverse reactions drug may greater patients impaired renal function patients hepatic impairment dose adjustment necessary patients mild moderate hepatic impairment use baricitinib studied patients severe hepatic impairment therefore recommended patients renal impairment recommended dose baricitinib patients moderate renal impairment egfr <NUMBER> mlmin<NUMBER>m <NUMBER> <NUMBER> mg daily baricitinib recommended use patients severe renal impairment egfr＜<NUMBER> mlmin<NUMBER> <NUMBER> cell surface protein ace<NUMBER> involved receptormediated endocytosis sarscov<NUMBER> entry cells baricitinib jak<NUMBER>jak<NUMBER> inhibitor might potential strategy baricitinib would interrupt passage intracellular assembly sarscov<NUMBER> target cells binding aak<NUMBER> gak hand jakstat signaling pathway participates cytokine storm moderate severe covid<NUMBER> cases baricitinib expected treat cytokine storm caused covid<NUMBER> suppressing jak<NUMBER>jak<NUMBER> number clinical trials registered around world one completed encouraging results universally participants administered baricitinib <NUMBER>mg qd <NUMBER> weeks refer current clinical trials determine drug usage applicable patients covid<NUMBER> look forward announcement results trials baricitinib generally well tolerated whole common important adverse reactions infections abnormal blood routine elevated liver enzymes dvtpe whether adverse reactions occur short course treatment covid<NUMBER> needs demonstrated baricitinib used caution patients risk factors human data use baricitinib pregnant women sufficient using baricitinib patients renal insufficiency attention paid dose adjustment discontinuation december <NUMBER> coronavirus disease <NUMBER> covid <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> first identified wuhan china spread rapidly many countries team nanshan zhong found <NUMBER> patients fever hospitalization <NUMBER> patients developed severe pneumonia <NUMBER> covid<NUMBER> progresses severe critical patients may develop severe cytokine storm secondary acute respiratory distress syndrome followed shock tissue perfusion disorders even multiorgan failure <NUMBER> cytokine storm important factor rapid progression covid<NUMBER> therefore treatment cytokine storm important part rescuing severe patients currently specific drug sarscov<NUMBER> cytokine storm induced covid<NUMBER> il<NUMBER> receptor antagonist tocilizumab approved us fda treatment cytokine release syndrome crs since il<NUMBER> one key cytokines involved infectioninduced cytokine storm treatment cytokine storm induced covid<NUMBER> tocilizumab broad prospects diagnosis treatment plan novel coronavirus pneumonia seventh trial edition china recommends tocilizumab immunotherapy drug critical patients <NUMBER> however clinical experience data tocilizumab treatment covid<NUMBER> limited paper several authors participated treatment consultation critical difficult patients specific experience clinical application tocilizumab explain role cytokine storm covid<NUMBER> mechanism tocilizumab treatment covid<NUMBER> key points pharmaceutical care according latest research reports clinical trial progress provide reference treatment covid<NUMBER> cytokines group small proteins secreted cells used mainly intercell signaling communication variety biological functions regulating innate immunity adaptive immunity hematopoiesis cell growth differentiation repairing damaged tissues binding receptors <NUMBER> cytokines mainly include interleukin il interferon ifn tumor necrosis factor tnf colony stimulating factor csf chemokine growth factor human body invaded bacteria viruses immune system release large number cytokines <NUMBER> <NUMBER> outbreak covid<NUMBER> infected patients would suddenly worsen later stage eventually die multiple organ failure aggravation mainly caused cytokine storm <NUMBER> considered cytokine storm kind overimmune phenomenon produced body response external stimuli uncontrolled release cytokines lead systemic inflammation <NUMBER> ferrara et al first proposed concept cytokine storm graftversushost disease <NUMBER> <NUMBER> sars concept cytokine storm gradually emerged due extremely high mortality associated multiorgan failure <NUMBER> recent years chimeric antigen receptor cart cells immunotherapy used transgenic cells attack cancer cells shown remarkable efficacy previously refractory malignancies however patients treated cart cells produce many potentially lifethreatening toxic reactions one clinically significant toxic reaction crs clinical symptoms crs involve multiple organ systems lifethreatening complications including fluidrefractory hypotension cardiac dysfunction respiratory failure coagulopathy renal liver failure crs occurs high level immune activation lymphocytes macrophages myeloid cells subsequent massive release inflammatory cytokines cart cellrelated crs marked elevation il<NUMBER> considered one main factor symptoms level il<NUMBER> ifnγ increase cart treatment stimulate differentiation helper th <NUMBER> cells inducing immunologic response development crs <NUMBER> many cases cytokine storm crs concept <NUMBER> previous therapy controlling cytokine storm large doses glucocorticoid may delay clearance coronavirus cause complications glucocorticoid therapy <NUMBER> therefore urgent find new specific drug treatment methods data analysis <NUMBER> hospitalized covid<NUMBER> patients published jama february <NUMBER> <NUMBER> <NUMBER> course disease revealed first time deceased patients neutrophil counts ddimer levels blood urea nitrogen creatinine levels continued increase dying patients lymphocyte counts continued decrease suggested virus induced increase number neutrophils caused cytokine storm leading clotting activation hypoxia shock acute kidney injury pathological mechanisms may closely relevant death covid<NUMBER> patients <NUMBER> number recently published articles analyzed clinical characteristics covid<NUMBER> patients consistently found lymphocyte count significantly reduced patients pneumonia especially severe pneumonia numerous cytokines il<NUMBER> il<NUMBER> il<NUMBER> tnf ifnγ significantly increased pointed high levels il<NUMBER> cytokines vivo main cause cytokine storm <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> jing et al studied lymphocyte subsets cytokines peripheral blood <NUMBER> patients covid<NUMBER> found cell count cytokine levels survivors severe infection gradually recovered level mild infection following time points <NUMBER> inflammatory trigger il<NUMBER> highly expressed patients covid<NUMBER> could induce differentiation b lymphocytes production antibodies also participate immune response body inducing proliferation differentiation lymphocytes <NUMBER> team haiming wei showed sarscov<NUMBER> infection cd<NUMBER> lymphocytes rapidly activated become pathogenic th <NUMBER> cells generate gmcsf etc cytokines environment induced inflammatory cd<NUMBER> cd<NUMBER> monocytes high expression il<NUMBER> accelerated inflammation aberrant excessive immune cells might enter pulmonary circulation huge numbers play immune damaging role leading lung functional disability quick mortality <NUMBER> il<NUMBER> also considered key mediator crs thus targeted drugs inhibit il<NUMBER> block crs cytokine storm <NUMBER> monoclonal antibody antagonize il<NUMBER> receptor tocilizumab promising prospects based efficacy several studies crs <NUMBER> <NUMBER> tocilizumab currently approved us fda treatment severe crs addition idiopathic arthritis rheumatoid arthritis giant cell arteritis significantly diagnosis treatment plan novel coronavirus pneumonia seventh trial edition china <NUMBER> recommends tocilizumab used patients extensive bilateral lung lesions severe lung diseases elevated il<NUMBER> levels laboratory tests mechanism tocilizumab treatment covid<NUMBER> remains unclear according previous studies il<NUMBER> secreted almost stromal cells immune system cells b lymphocytes lymphocytes macrophages monocytes dendritic cells mast cells nonlymphocytes fibroblasts endothelial cells keratinocytes glomerular mesangial cells tumor cells <NUMBER> normal circumstances level il<NUMBER> body low quickly synthesized strengthen bodys defense function infection injury excessive release il<NUMBER> cause crs severe crs higher serum peak concentration il<NUMBER> il<NUMBER> binds receptor il<NUMBER>r form complex binds signal transducer glycoprotein <NUMBER> gp<NUMBER> initiate signal transduction trigger downstream signal transduction gene expression il<NUMBER>r exists membranebound form mil<NUMBER>r also soluble form sil<NUMBER>r classical signal transduction pathway il<NUMBER> binds mil<NUMBER>r form complex binds gp<NUMBER> causing downstream reactions antiinflammatory effects limited cells express mil<NUMBER>r transsignaling pathway il<NUMBER> forms complex sil<NUMBER>r gp<NUMBER> initiates intracellular signal transduction absence mil<NUMBER>r pathway inflammatory effects <NUMBER> next steps induce synthesis acute reactive protein two completely different signaling pathways one il<NUMBER> signaling pathway mediated jakstat tyrosine kinase system mediated rasmitogenactivated protein kinase mapknfκbil<NUMBER> pathway former major pathway <NUMBER> <NUMBER> classical signal pathway many cells cannot respond il<NUMBER> signal lack expression il<NUMBER>r cells stimulated sil<NUMBER>ril<NUMBER> complex respond il<NUMBER> signal cause cell signal transduction <NUMBER> <NUMBER> transpresentation signal suppressed extracellular gp<NUMBER> extracellular gp<NUMBER> form complex sil<NUMBER>r prevent sil<NUMBER>r binding membranebound gp<NUMBER> <NUMBER> classical signal limited cells macrophages neutrophils cells etc express il<NUMBER>r plays leading role low level il<NUMBER> however level il<NUMBER> increases il<NUMBER> signal widely expressed gp<NUMBER> everywhere way il<NUMBER> trans signaling via sil<NUMBER>r activate virtually cells body regulate proinflammatory reactions blocking transsignaling effective variety preclinical chronic autoimmune disease models <NUMBER> tocilizumab humanized antiil<NUMBER>r monoclonal antibody bind mil<NUMBER>r sil<NUMBER>r inhibit classical transsignals may potential mechanism treatment cytokine storm covid<NUMBER> see fig <NUMBER> date several independent clinical trials initiated globally explore efficacy safety tocilizumab treatment patients covid<NUMBER> prospective multicenter randomized controlled clinical study led first affiliated hospital university science technology china registered chinese clinical trial registry study included <NUMBER> patients common type including critical risk factors severe covid<NUMBER> expected completed may <NUMBER> <NUMBER> see table <NUMBER> first phase study <NUMBER> covid<NUMBER> patients oldest patient aged <NUMBER> years including <NUMBER> severe patients <NUMBER> critical patients diffuse lesions lungs treatment <NUMBER> persistent fever treatment new regimen tocilizumab combined conventional therapy body temperature <NUMBER> patients fever dropped normal within <NUMBER> h meanwhile respiratory function oxygenation index improved different degrees ct scan showed obvious improvement pulmonary lesions <NUMBER> patients therefore patients severe covid<NUMBER> caused cytokine storm tocilizumab drug worthy clinical research addition genentech member roche group announced us fda approved phase iii clinical trial tocilizumab treat severe covid<NUMBER> pneumonia march <NUMBER> <NUMBER> randomized doubleblind placebocontrolled phase iii study evaluate safety efficacy intravenous tocilizumab added standard care adult patients hospitalized severe covid<NUMBER> pneumonia compared placebo plus standard care primary secondary endpoints include clinical status mortality mechanical ventilation icu variables patients followed <NUMBER> days postrandomization interim analysis conducted look early evidence efficacy <NUMBER> fig <NUMBER> potential mechanism tocilizumab treatment cytokine storm induced covid<NUMBER> sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> il interleukin mapk mitogenactivated protein kinase table <NUMBER> multicenter randomized controlled trial tocilizumab treatment covid<NUMBER> <NUMBER> alt alanine aminotransferase ast aspartate aminotransferase uln upper limit normal tocilizumab recommended adults pediatric patients aged ≥ <NUMBER> years cart cellinduced severe lifethreatening crs used alone combination glucocorticoids see table <NUMBER> specific usage dosage <NUMBER> doses exceeding <NUMBER> mg per infusion recommended crs patients duration single intravenous drip maintained <NUMBER> h subcutaneous administration recommended treatment crs clinical improvement signs symptoms crs occurs first dose <NUMBER> additional doses tocilizumab may administered interval consecutive doses least <NUMBER> h tocilizumab approved crs china however diagnosis treatment plan novel coronavirus pneumonia seventh trial edition china <NUMBER> recommended tocilizumab could used patients extensive lung lesions severe diseases high il<NUMBER> levels laboratory tests first dose <NUMBER> mgkg recommended dose <NUMBER> mg diluted <NUMBER> ml <NUMBER> sodium chloride injection infusion time <NUMBER> h patients poor efficacy first dose additional dose dose applied <NUMBER> h maximum <NUMBER> cumulative doses maximum <NUMBER> mg single dose since introduction tocilizumab shown good efficacy safety treatment variety autoimmune diseases ferfar et al <NUMBER> summarized number literatures tocilizumab treatment takayasu arteritis found use could reduce even stop dosage glucocorticoids samson et al <NUMBER> prospectively observed <NUMBER> patients giant cell arteritis treated prednisone combined tocilizumab <NUMBER> mgkg intravenous infusion every <NUMBER> weeks confirmed findings <NUMBER> weeks followup randomized doubleblind phase iii clinical study showed <NUMBER> patients takayasu arteritis treated tocilizumab experience serious infections deaths new prominent safety issues compared placebo group <NUMBER> ferfar et al <NUMBER> reviewed use tocilizumab treat <NUMBER> patients takayasu arteritis including <NUMBER> cases liver injury <NUMBER> cases infection <NUMBER> cases leukopenia incidence adverse drug reactions reached <NUMBER> consistent results chinese study safety tocilizumab treatment takayasu arteritis <NUMBER> however studies small sample size need confirmed multicenter large sample studies based studies drug instructions china us fda following adverse reactions need noted adverse reactions data obtained series randomized controlled clinical studies longcourse treatment tocilizumab however whether adverse reactions occur shortcourse treatment covid<NUMBER> needs demonstrated reasons safety monitoring tocilizumab mainly includes following three points <NUMBER> risk serious infections including tuberculosis bacteria invasive fungi viruses opportunistic infections leading hospitalization death severe infection occurs tocilizumab discontinued infection control perform latent tuberculosis test positive start treating tuberculosis starting tocilizumab monitor active tuberculosis patients treatment <NUMBER> tocilizumab used caution patients absolute neutrophil count anc <NUMBER>×<NUMBER> <NUMBER> l recommended patients anc <NUMBER> × <NUMBER> <NUMBER> l tocilizumab used caution patients platelet count less <NUMBER> × <NUMBER> <NUMBER> μl recommended patients platelet counts less <NUMBER> × <NUMBER> <NUMBER> μl <NUMBER> care taken starting tocilizumab patients whose alt ast rises <NUMBER>fold upper limit normal patients whose alt ast rises <NUMBER>fold upper limit normal tocilizumab recommended following information mainly drug instructions china us fda pregnant women known tocilizumab actively crosses placenta late pregnancy may affect fetal immune response yet possible predict drugrelated birth defects risk miscarriage animal reproduction studies <NUMBER> intravenous administration tocilizumab organogenesis cynomolgus monkeys may result miscarriage stillbirth doses higher maximum recommended dose intravenous administration <NUMBER> mgkg every <NUMBER> weeks animal experiments shown inhibition il<NUMBER> signal may interfere cervical maturation expansion contraction uterine muscle may potentially dangerous fetus <NUMBER> older adults current studies suggest patients aged ≥ <NUMBER> years treated tocilizumab higher rate severe infection patients ≤ <NUMBER> years due higher infection rate elderly general care taken treatment <NUMBER> patients liver damage lack pharmacokinetic data use tocilizumab patients liver damage patients renal impairment mild renal impairment creatinine clearance <NUMBER> mlmin ≥ <NUMBER> mlmin calculated cockcroftgault formula affect pharmacokinetics tocilizumab clinical trials giant cell arteritis approximately onethird patients moderate renal impairment baseline creatinine clearance <NUMBER> <NUMBER> mlmin effect tocilizumab exposure found patients <NUMBER> confirmed recent reports clinical characteristics covid<NUMBER> mechanism disease progression cytokine storm played key role rapid progress disease il<NUMBER> one key cytokines involved infectioninduced cytokine storm tocilizumab block downstream signal transduction binding mil<NUMBER>r sil<NUMBER>r play role treatment cytokine storm caused covid<NUMBER> currently usage dosage tocilizumab covid<NUMBER> still explored clinical use tocilizumab referred drug instruction us fda treatment crs diagnosis treatment plan novel coronavirus pneumonia seventh trial edition china aware risk serious infection neutropenia thrombocytopenia liver damage caused tocilizumab need adjust dose tocilizumab patients mild moderate renal insufficiency data using tocilizumab pregnant women patients liver injury insufficient official covid<NUMBER> deaths recorded uk excess <NUMBER> usa <NUMBER> world greater <NUMBER> excess death rate widely acknowledged accurate measure mortality current covid<NUMBER> pandemic even cumulative daily count covid<NUMBER> deaths uk excess death rate already exceeded <NUMBER> appropriate persevere existing management covid<NUMBER> infection without considering alternative management treatment patients covid<NUMBER> infection mainly supportive proportion patients also receive investigational treatment one form another varying degrees success specific treatments generally two types type treatment aimed virus either directly antiviral favipiravir oseltamivir umifenovir remdesivir others indirectly mechanisms chloroquine hydroxychloroquine azithromycin others type ii treatment aimed altering immune status patients either conferring passive immunity plasma rich covid<NUMBER> antibody patients recovered covid<NUMBER> infection druginduced immune modulationregulation rationale using immune modulation cytokine storm <NUMBER> detected patients severe covid<NUMBER> infection believed excessive cytokines products hyperactive immune inflammatory response mounted host virus dysregulated immune reaction akin autoimmunity thought lead observed lung injury correlated grim clinical outcome order counteract cytokine storm specific targeted nonspecific immune regulatory therapies tried least suggested follows specific immune regulatory investigational therapies include interlukin<NUMBER> inhibitor anakinra interlukin<NUMBER> inhibitors sarilumab siltuximab tocilizumab janus kinase inhibitor baricitinib axl kinase inhibitor bemcentinib nonspecific immune regulatory investigational therapies include corticosteroids including methylprednisolone colchicine interferon alpha beta host miscellaneous drugs also tried suggested including bevacizumab eidd<NUMBER> fingolimod ivermectin leronlimab lopinavir ritonavir tocilizumab multiplicity therapeutic agents considered possible investigational treatment highlights fact none far proved optimally safe effective may due limited understanding present mechanisms development cytokine storm terms steps involved sequence events observed presumed cause effect may indeed epiphenomena rather causallyrelated explain apparent failure even specific directed form therapies mentioned earlier purpose contribution draw attention potential certain therapeutic agents treatment severe inflammatory complications covid<NUMBER> infection believed cause respiratory failure death significant number patients rather viral infection per se agents widely used haematology well specialities however would appear overlooked treatment covid<NUMBER> complications hd iv ig established form treatment immune thrombocytopenic purpura itp mechanism action believed regulation immune response <NUMBER> impressive success therapy definitive treatment itp mainly control condition bring rapid increase platelet count whenever needed tried autoimmune conditions proved highly effective welltolerated present hd iv ig used treatment kawasaki disease guillainbarre syndrome chronic inflammatory demyelinating polyneuropathy number autoimmune dermatological conditions since severity covid<NUMBER> infection correlated development severe immune autoimmune inflammatory reaction cytokine storm logical expect hd iv ig also useful situation thanks immunomodulatory properties indeed published report china beneficial effect hd iv ig three patients covid<NUMBER> infection <NUMBER> emergence kawasaki like syndrome association covid<NUMBER> infection children responsive hd iv ig lends support treating cytokine storm covid<NUMBER> infection hd iv ig recognised kawasaki like syndrome paediatric form cytokine storm seen adult patients infected covid<NUMBER> chimeric mousehuman igg<NUMBER> monoclonal antibody targets cd<NUMBER> transmembrane protein expressed b cells rituximab primarily used conjunction chemotherapy treat haematological malignancies large diffuse nonhodgkin lymphoma chronic lymphocytic leukaemia <NUMBER> following discovery concomitant autoimmune disorders rheumatoid arthritis improved following rituximab treatment haematological malignancies rituximab also used treat expanding range autoimmune diseases including rheumatoid arthritis <NUMBER> autoimmune haemolytic anaemia pure red cell aplasia itp evans syndrome <NUMBER> vasculitis granulomatosis angiitis bullous skin disorders pemphigus systemic lupus erythematosus multiple sclerosis chronic inflammatory demyelinating polyneuropathy name rationale use rituximab covid<NUMBER> infection prevent andor treat cytokine storm depends multifaceted mode action rituximab downregulating immune responses least three major independent mechanisms antibody dependent cellular cytotoxicity complement mediated cytotoxicity apoptosis <NUMBER> based mechanisms rituximab successfully used treat wide range immuneautoimmune disorders reason expected useful treatment cytokine storm involves hyperactive immune reaction however since fully understand stage precise mechanism development cytokine storm whether involves b cell cannot certain without clinical trial rituximab use setting definitely efficacious furthermore use rituximab associated severe reactions avoidable certain precautions known familiar use knowledge rituximab reported used suggested use context covid<NUMBER> infection thalidomide promoted late <NUMBER>s anxiety sleep disturbance morning sickness realised <NUMBER> thalidomide use associated birth defects mainly antiangiogenic property <NUMBER> thalidomide available therapeutic use nearly forty years antitumour effect multiple myeloma discovered late <NUMBER>s since use gained popularity first line treatment multiple myeloma combination chemotherapy <NUMBER> forms leprosy erythema nodosum leprosum <NUMBER> tb tuberculous meningitis <NUMBER> second line treatment graft versus host disease <NUMBER> crohns disease rheumatic disorders dermatological conditions <NUMBER> thalidomide known antiinflammatory modulator immune responses effects cytokines interlukin<NUMBER> <NUMBER> <NUMBER> <NUMBER> importantly selectively inhibits production human monocyte tumour necrosis factor tnfalpha enhanced degradation tnfalpha mrna <NUMBER> <NUMBER> complicated reactions highly likely thalidomide effectively dampen cytokine storm addition causing lung injury may well trigger state hypercoagulability observed covid<NUMBER> patients tissue injury potent stimulator thrombin generation clot formation follows treatment cytokine storm would probably prevent andor treat lung injury well hypercoagulability however thalidomide set undesirable side effects including peripheral neuropathy thrombocytopenia anaemia paradoxically venous thromboembolism patients requiring treatment cytokine storm probably need treatment short term whereas side effects thalidomide treatment apart sleepiness likely appear relatively prolonged use nevertheless would prudent add low molecular weight heparin prophylactic dose treatment protocol knowledge thalidomide analogues reported used suggested use context covid<NUMBER> infection three investigational drugs proposed thalidomide easiest use taken orally whereas two administered intravenously proven safe effective randomised controlled clinical trial thalidomide likely become drug choice treat andor prevent cytokine storm fatal complication covid<NUMBER> infection main drawback teratogenic effect thalidomide taken pregnancy three proposed investigational treatments administered patients context randomised controlled clinical trials order derive maximum benefit use guide treatment patients future timing treatment crucial success since proposed treatment meant viral infection aimed treatment severe inflammatory complication treatment reserved first instance patients whose conditions deteriorated hospital admission success measured terms recovery prevention need treatment intensive care unit icu andor recovery reduction stay icu since recovery happen spontaneously best supportive care proposed trials sufficient discerning statistical power terms patient numbers demonstrate whether three investigational remedies used conjunction best supportive care either single agents combination superior control arm best supportive care superiority demonstrated investigation may progressed administer medicines proven anti cytokine storm activity admission patients covid<NUMBER> infection hospital randomised controlled trails aim preventing rather treating cytokine storms alternatively early treatment prevention complications admission hospital versus late treatment cases diagnosed cytokine storm complication may conducted different arms trails one stage rather two stages save patients lives time effort differences current management covid<NUMBER> infection alternative management aiming actively latter reduction development cytokine storm complication covid<NUMBER> infections reduction need icu admission importantly reduction mortality rate consequently patients recover clinically return community may develop sufficient protective immunity likely conferred vaccination may continue virus carriers may bad thing infection spreading community anyway unabated time silent manner infections symptomatic infections symptomatic otherwise contributing buildup active protective immunity community large herd immunity ease eventually end current lockdown safely without risking second subsequent waves covid<NUMBER> infection humanity pinning hopes development safe effective vaccine may may materialise even long term indications immune response may confer sufficient protection shortlived virus mutation another worrying consideration development safe effective antiviral therapy covid<NUMBER> seem present brighter prospect either presented third approach take sting deadly covid<NUMBER> convert tame infection deprive covid<NUMBER> cytokine storm downgrade behave like form influenza furthermore availability safe effective remedies proven randomised controlled clinical trials deadly feared complication covid<NUMBER> infection cytokine storm likely make decision ease eventually lift lockdown acceptable particularly parts united kingdom parts world reluctance ease lockdown authors declared potential conflicts interest respect research authorship andor publication article authors received financial support research authorship andor publication article hasan atrah httpsorcidorg<NUMBER> coronavirus infectious disease <NUMBER> spreading global scale caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> enveloped singlestranded rna virus belonging coronaviridae family genus betacoronavirus <NUMBER> nonstructural proteins virus play crucial role virus replication structural auxiliary proteins involved morphogenesis interfere host immunity response respectively <NUMBER> accumulating evidence suggests host immunity response contributing severe forms merscov sarscov sarscov<NUMBER> infections <NUMBER> <NUMBER> <NUMBER> immune response associated higher intensive care unit icu admissions mortality covid<NUMBER> fact higher concentrations granulocytecolony stimulating factor gcsf interferon gammainduced protein <NUMBER> ip<NUMBER> monocyte chemoattractant protein <NUMBER> mcp<NUMBER> macrophage inflammatory protein <NUMBER>alpha mip<NUMBER>a tumor necrosis factor alpha tnfα comparison nonicu patients reported patients covid<NUMBER> <NUMBER> another study higher levels interleukin<NUMBER> il<NUMBER> receptor interleukin<NUMBER> il<NUMBER> interleukin<NUMBER> il<NUMBER> interleukin<NUMBER> il<NUMBER> tnfα found deceased patients covid<NUMBER> compared patients recovered disease <NUMBER> immunologic reactions severe covid<NUMBER> may characterize cytokine storm associated untoward clinicopathological consequences cytokine storm outofcontrol cytokine release observed infectious noninfectious diseases leading hyperinflammation condition host fig<NUMBER> <NUMBER> uncontrolled cytokine response might accompanied immune cells activation including helper <NUMBER> cell th<NUMBER> differentiation cd<NUMBER> lymphocytes fact increased th<NUMBER> responses reported merscov sarscov sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> least <NUMBER> patients severe covid<NUMBER> eventually present lung injury acute respiratory distress syndrome ards involvement multiple organs within <NUMBER> days onset illness <NUMBER> severe cases develop respiratory failure show series pathological findings hyaline membrane formation inflammatory infiltration multinucleated syncytial cells lung pathology burst cytokine release leading morbidity mortality <NUMBER> <NUMBER> initial cellular entry phase saracov<NUMBER> requires binding envelope homotrimeric spike glycoprotein membranebound form angiotensinconverting enzyme <NUMBER> ace<NUMBER> target cell <NUMBER> <NUMBER> attachment virus ace<NUMBER> cellular receptor triggers internalization complex target cell leading downregulation ace<NUMBER> <NUMBER> ace<NUMBER> internalization subsequent downregulation would potentially result unopposed function angiotensin ii angii decreased levels angiotensin<NUMBER> <NUMBER> since angiotensin<NUMBER> key counterregulatory role many angiotensin type <NUMBER> receptor at<NUMBER>rrelated physiopathological functions saracov<NUMBER>mediated downregulation ace<NUMBER> resulting increased overall ratio ang ii angiotensin<NUMBER> leads deterioration pulmonary function lung injury <NUMBER> <NUMBER> therefore imbalance ace<NUMBER>ace levels covid<NUMBER> dysregulated angiotensinii at<NUMBER>r axis reninangiotensinaldosterone system raas may partially responsible cytokine storm resulting pulmonary damage <NUMBER> <NUMBER> loss modulatory effect angiotensin<NUMBER> via binding mas receptor masr attenuates inflammatory response may contributing factor hyperinflammation status severe cases covid<NUMBER> beyond ace<NUMBER> catalytic activity raas masrmediated actions interesting effects multiple molecular pathways involved inflammatory response cytokine release however potential cellular molecular mechanisms cytokine storm covid <NUMBER> yet explored extensively review specifically discuss complex inflammatory molecular consequents downregulation ace<NUMBER> context sarscov<NUMBER> particular emphasis complement system desarg<NUMBER>bk dabk addition ace angiotensiniiat<NUMBER>r ace<NUMBER>masr axes propose unifying molecular model better understand complex molecular events behind outofcontrol cytokine response severe covid<NUMBER> patients undoubtedly insight pivotal obtain harmonized therapeutic strategy confront deadly viral infection protect lungs cytokine storm reninangiotensinaldosterone system raas vasoactive peptides regulates blood pressure fluid volume sodium potassium balance elegant system also plays significant role promotion maintenance inflammation <NUMBER> appears activation raas system induce inflammation independent mechanism blood pressure at<NUMBER> receptor at<NUMBER>r kidney vasculature <NUMBER> secretion profibrotic cytokines transforming growth factor beta tfgβ stimulated raas activation <NUMBER> <NUMBER> <NUMBER> furthermore increased production ang ii activation at<NUMBER>r accompanied proinflammatory response via activation complement cascade including c<NUMBER>a c<NUMBER>b<NUMBER> <NUMBER> implies crosstalk raas complement system ang ii activate nuclear factor kappa b nfκb pathway <NUMBER> <NUMBER> via stimulation phosphorylation p<NUMBER> subunit nfκb <NUMBER> lead increased production il<NUMBER> <NUMBER> tnfα il<NUMBER>b il<NUMBER> <NUMBER> at<NUMBER>r activation ang ii regulates mitogenactivated protein kinases mapk erk<NUMBER> jnk p<NUMBER>mapk important functions cellular processes including release cytokines il<NUMBER> il<NUMBER> il<NUMBER> tnfα fig<NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> enzyme expressed heart kidneys testes gastrointestinal tract lungs <NUMBER> <NUMBER> cleaves angiotensin ang generate inactive ang<NUMBER> peptide changed vasodilatory peptide ang<NUMBER> ace peptidases ace<NUMBER> also directly metabolize ang ii generate ang<NUMBER> <NUMBER> sarscov<NUMBER> uses ace<NUMBER> type ii pneumocytes lung alveoli club cells bronchioles cellular entry receptor recently tmprss<NUMBER> major host protease ace<NUMBER> coexpression reported among subset type ii pneumocytes lung <NUMBER> attachment sarscov<NUMBER> spike sprotein ace<NUMBER> intracellular binding site downregulates ace<NUMBER> consequently following downregulation ace<NUMBER> ang ii level increases serum leading augmentation ang iiat<NUMBER>r axis activation followed transsignaling il<NUMBER>sil<NUMBER>ra complex gp <NUMBER>mediated activation stat<NUMBER> occurs lungs epithelial cells although sarscov<NUMBER> activates nfκb pattern recognition receptors simultaneous activation nfκb stat<NUMBER> enhances nfκb activation machinery il<NUMBER> amplifier hyperactivation nfκb via il<NUMBER> amp lungs induces cytokine storm subsequent ards observed severe covid<NUMBER> patients <NUMBER> <NUMBER> indeed downregulation ace<NUMBER> accompanied enhancement ang ii levels different types lung injury triggered pulmonary pathological changes commonly observed ards <NUMBER> given premises seems reasonable speculate depletion ace<NUMBER> activation aceangiotensin iiat<NUMBER>r axis might pivotal role clinical presentations covid<NUMBER> fact higher circulatory levels ang ii reported covid<NUMBER> patients control subjects plasma levels ang ii linearly associated lung injury <NUMBER> therefore contrast earlier clinical experts opinions raas inhibitors discontinued stable cases covid<NUMBER> discontinuation ace inhibitors arbs may potentially detrimental effects patients <NUMBER> <NUMBER> <NUMBER> recent study first clinical evidence shown ace inhibitors arb therapy covid<NUMBER> patients hypertension associated lower rate disease severity trend toward lower il<NUMBER> levels higher circulatory cd<NUMBER> cd<NUMBER> cells counts <NUMBER> protective effect ace<NUMBER> severe acute lung failure shown animal models <NUMBER> accumulating clinicalepidemiological evidence covid<NUMBER> implies sarscov<NUMBER> associated ace<NUMBER> depletion accompanied severe clinical course disease clinical epidemiological conditions jeopardize levels ace<NUMBER> expression including older age male sex medical conditions diabetes mellitus hypertension cardiovascular diseases obesity <NUMBER> <NUMBER> medical conditions covid<NUMBER> infectioninduced ace<NUMBER> depletion could overcome already exaggerated aceangiotensin iiat<NUMBER>r axis activity hence administration recombinant soluble ace<NUMBER> patients severe covid<NUMBER> infection may therapeutic modality however worthwhile consider targeting downstream aceangiotensin iiat<NUMBER>r axis il<NUMBER>stat<NUMBER> axis <NUMBER> combat observed cytokine storm covid<NUMBER> order prevent lung inflammation end organ damage ace<NUMBER> ang<NUMBER> ang<NUMBER> receptor mas constituents arm ras system counteracts attenuates effects aceang iiat<NUMBER>r axis <NUMBER> <NUMBER> ace<NUMBER> derives vasodilatory peptide ang<NUMBER> ang ii following cleavage activity vasodilatory peptide antiproliferative antithrombotic antiinflammatory activities <NUMBER> <NUMBER> <NUMBER> ang<NUMBER> reduces expression p<NUMBER> mapk nfκb inflammatory factors il<NUMBER> tnfα il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> thus ang<NUMBER> per se antiinflammatory effect ameliorates inflammatory damages revealed several animal studies <NUMBER> <NUMBER> shown ang<NUMBER> reduces inflammatory cardiac injury diabetic hypertensive rats <NUMBER> glomerular involvement mesangial proliferative glomerulonephritis mpgn rat models <NUMBER> protection vascular endothelium renal tubular cells diuresis vasodilationdependent ang<NUMBER> effects occur via masr <NUMBER> <NUMBER> mas receptors express epithelium bronchial smooth muscle therefore ang <NUMBER> could modulate acute chronic inflammatory processes lung via activation masr <NUMBER> range physiological effects ang <NUMBER> present different tissues heart brain kidney action masr <NUMBER> ang<NUMBER> also attenuates ang ii induced intercellular adhesion molecule<NUMBER> icam<NUMBER> vascular cell adhesion molecule<NUMBER> vcam<NUMBER> mcp<NUMBER> expression masr activation leading inhibition p<NUMBER>mapk nfκb pathways <NUMBER> erk <NUMBER> pathway modulates production il<NUMBER> <NUMBER> induces differentiation thelper toward th<NUMBER>type th<NUMBER> regulates immune responses producing antiinflammatory cytokines like il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER> additionally il<NUMBER> antiinflammatory cytokine may involved prevention tissue damage <NUMBER> <NUMBER> ang<NUMBER> modulates activity erk <NUMBER> therefore ang<NUMBER> antiinflammatory function via modulation nfκb mapk erk <NUMBER> pathways hence may proposed sarscov<NUMBER> associated suppression ace<NUMBER> would accompanied reduction mas receptormediated functions leads accentuation cytokines release frank inflammatory responses ang<NUMBER> exerts critical role counteracting proinflammatory effect raas protecting endothelial cell activation resulting lung damage inflammatory mediators cytokine storm administration ang<NUMBER> one similar agents patients covid<NUMBER> pneumonitis suggested <NUMBER> <NUMBER> kininkallikrein system includes kininogen kallikrein enzyme bradykinin bk<NUMBER> bk desarg<NUMBER>bk dabk <NUMBER> <NUMBER> active products system interact two distinct gprotein coupled receptors bradykinin b<NUMBER> receptor bkb<NUMBER>r bradykinin b<NUMBER> receptor bkb<NUMBER>r main ligand bkb<NUMBER>r dabk ligand bkb<NUMBER>r bk <NUMBER> <NUMBER> bkb<NUMBER>r could hardly detected peripheral tissues normal states however expressed cell types involved inflammation therefore inducible proinflammatory receptor <NUMBER> expression bkb<NUMBER>r specific receptor bradykinin pathway highly sensitive inflammatory mediators lipopolysaccharide lps interleukins <NUMBER> <NUMBER> <NUMBER> <NUMBER> also upregulated cytokines il<NUMBER>b tnfα <NUMBER> <NUMBER> <NUMBER> il<NUMBER> ifnɣ epidermal growth factor egf oncostatin increase rate bkb<NUMBER>r receptor mediated response <NUMBER> <NUMBER> <NUMBER> <NUMBER> mentioned il<NUMBER>b tnfαinduced bkb<NUMBER>r expression related nfκb activity <NUMBER> sodhi et al <NUMBER> showed activation bkb<NUMBER>r enhances neutrophil attraction tissue release chemokine cxc motif chemokine <NUMBER> cxcl<NUMBER> activity receptor leads expression fgf<NUMBER> <NUMBER> increased levels il<NUMBER>b <NUMBER> mcp<NUMBER> fig<NUMBER> <NUMBER> dabk known pulmonary inflammatory factor <NUMBER> <NUMBER> <NUMBER> <NUMBER> interesting ace<NUMBER> also cleaves terminal residue dabk <NUMBER> <NUMBER> reaction results deactivation dabk therefore could postulated covid<NUMBER>induced reduction ace<NUMBER> activity would accompanied increased activity dabk resulting accentuation aforementioned inflammatory cascade leading increased cytokine release hence targeting ace<NUMBER> dabk bradykinin b<NUMBER> receptor axis suggested authors <NUMBER> <NUMBER> prevent control ards patients severe covid<NUMBER> although several bkb<NUMBER> antagonists passed phase ii clinical trials none approved yet clinical use <NUMBER> complement system ancient system contributes innate immune response system includes many proteins cleavage products plays key functional role defense microorganisms including viruses viral inactivation complement cascade involves virus uptake clearance phagocytic cells coating virions resulting prevention attachment receptors virus lysis pore formation destruction membrane membrane attack complex formation c<NUMBER>b<NUMBER> <NUMBER> following viralinduced complement cascade activation inflammatory processes promoted complement factor <NUMBER>a c<NUMBER>a strongest inflammatory peptide complement cascade induces release proinflammatory cytokines <NUMBER> <NUMBER> <NUMBER> <NUMBER> c<NUMBER>a also induce secretion tnfα <NUMBER> <NUMBER> terminal products complement cascade induce production cytokines tnfα il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> terminal complement component c<NUMBER>b<NUMBER> induces release il<NUMBER> via activation redoxsensitive transcription factor nfκb activator protein<NUMBER> ap<NUMBER> <NUMBER> monocyte chemoattractant protein<NUMBER> mcp<NUMBER> vascular smooth muscle cells <NUMBER> also increased production c<NUMBER>a leads production proinflammatory cytokines il<NUMBER> il<NUMBER> tnfα <NUMBER> involvement complement system pathogenesis syncytial virus infection <NUMBER> <NUMBER> <NUMBER> hyper activation complement components including c<NUMBER>a sera c<NUMBER>b<NUMBER> lungs observed merscovinfected hdpp<NUMBER>transgenic mice lung spleeninduced pathological damages inflammatory responses alleviated blockade c<NUMBER>ac<NUMBER>ar axis transgenic mice <NUMBER> gralinski et al <NUMBER> showed mice models deficient c<NUMBER>c<NUMBER> loads lung milder sarscov induced pathologic features better respiratory function lower weight loss reduced pathologic findings respiratory system lower circulatory tissue cytokines chemokines despite equal lung viral loads compared controls results showed although complement system role virus replication activation complement system lungs sarscov infected mice might lead immune mediated damages lungs <NUMBER> complement cascade activated lectin pathway fig<NUMBER> priming immune system enhancing clearances viruses virusinfected cells <NUMBER> lectin pathway may also involved covid<NUMBER> pathogenesis recently gao et al <NUMBER> reported stimulated macrophages <NUMBER> <NUMBER> however c<NUMBER>ac<NUMBER>r axis inhibition available pharmaceutical agents would partial activity residual terminal complement components might remain therefore targeting upstream activators complement cascade c<NUMBER>ac<NUMBER>ar axis may effective restraining uncontrolled complement pathway activation severe covid<NUMBER> <NUMBER> recently compstatinbased complement c<NUMBER> inhibitor amy<NUMBER> administered patient ards due covid<NUMBER> good clinical responses high level safety reported <NUMBER> overall clinical benefits targeting c<NUMBER>ac<NUMBER>arc<NUMBER>ac<NUMBER>ar axis order control maladaptive immuneinflammatory consequences complement pathways severe covid covid<NUMBER> cytokine storm like cytokine storms infectious noninfectious conditions may considered complex network complex network cytokine response described tisoncik et al <NUMBER> series overlapping networks degree redundancy alternative pathways aforementioned pathogenesis socalled covid<NUMBER> cytokine storm four described distinct axes clarified cytokine storm complex network many components might crosstalk multiple known unknown interfaces interactions network state imply complex nature covid<NUMBER> cytokine storm dynamic equilibrium network components could disturbed multiple sites emerge untoward behavior covid<NUMBER> cytokine storm perturbation initiated via attachment sarscov<NUMBER> spike protein receptor ace<NUMBER> followed aceang iiat<NUMBER>r axis activation leading hyperactivation nfκb il<NUMBER> stats axis <NUMBER> normal dynamic equilibrium state aceang iiat<NUMBER>r axis activation counterbalanced ace<NUMBER>masr axis production ang<NUMBER> reduces expression p<NUMBER> mapk nfκb inflammatory factors il<NUMBER> tnfα il<NUMBER> <NUMBER> <NUMBER> <NUMBER> however sarscov<NUMBER> associated downregulation ace<NUMBER> suppresses immunomodulatory effects leading accentuation cytokine release response currently know dabk pulmonary inflammatory factor whose deactivation ace<NUMBER> deranged covid<NUMBER>induced reduction ace<NUMBER> activity derangement followed ace<NUMBER> dabk bradykinin b<NUMBER> receptor axis activation creates proinflammatory synergistic effect sarscov<NUMBER> associated aceang iiat<NUMBER>r axis activation resulting effect would inflammatory state neutrophil recruitment enhancement pathological pulmonary changes observed ards severe covid<NUMBER> already discussed involvement complement system pathogenesis sarscov<NUMBER> via nucleocapsid n proteinmediated masp<NUMBER> autoactivation binding mlb lectin arm c<NUMBER>ac<NUMBER>arc<NUMBER>ac<NUMBER>ar axis <NUMBER> however increased production ang ii activation at<NUMBER>r may accompanied proinflammatory response via activation complement cascade including c<NUMBER>a c<NUMBER>b<NUMBER> <NUMBER> implies crosstalk aceangiotensin iiat<NUMBER>r axis complement system similar complex networks elements complex network covid<NUMBER> cytokine storm may experience much crosstalk elements known unknown pathways networks example ang ii element aceang iiat<NUMBER>r induces tgfβ expression <NUMBER> <NUMBER> tgfβ role differentiation helper <NUMBER> cells naive cd<NUMBER> tcells th<NUMBER> cells generate il<NUMBER> gmcsf il<NUMBER> il<NUMBER> il<NUMBER> promotes production vast amount proinflammatory cytokines chemokines <NUMBER> <NUMBER> il<NUMBER> among cytokines significantly correlated lung injury murray score disease severity covid<NUMBER> <NUMBER> increment highly proinflammatory ccr<NUMBER> th<NUMBER> cd<NUMBER> cells reported covid<NUMBER> associated ards <NUMBER> therefore targeting il<NUMBER> helper <NUMBER> responses cytokine storm covid<NUMBER> suggested <NUMBER> <NUMBER> therapeutic plasma exchange wellknown therapeutic option considered treatment autoimmune diseases beneficial effect modality works elimination autoantibodies complement components immune complexes cytokines therefore option may valuable treatment severe covid<NUMBER> <NUMBER> however application therapeutic modality general approach confront cytokine storm hence approaches may considered treatment covid<NUMBER> driven cytokine storm order protect lungs injury table<NUMBER> according aforementioned axes may involved cytokine storm severe cases covid<NUMBER> potential targets could considered therapeutic options first one recombinant human ace<NUMBER> trials regarding efficacy safety agent clinicopathological settings related ace<NUMBER> decrement congestive heart failure chf <NUMBER> ards <NUMBER> <NUMBER> lung injury due viral illness respiratory syncytial virus rsv <NUMBER> reported findings safety efficacy promising recently monteil et al <NUMBER> reported human recombinant soluble ace<NUMBER> hrsace<NUMBER> prevent entry sarsc<NUMBER>v<NUMBER> human blood vessel organoid human kidney organoid finding may suggest highly compelling therapeutic intervention protect lung injury covid<NUMBER> suggested ace<NUMBER>bradykinindabk may involved inflammatory response sars cov<NUMBER> therefore blockade axis inhibiting bkb<NUMBER>r may ameliorate part cytokine storm occurs covid<NUMBER> infection lf<NUMBER> safotibant bkb<NUMBER>r antagonist promising antiinflammatory results <NUMBER> <NUMBER> several clinical trials conducted evaluate effect drug multiple medical settings promising results fig<NUMBER> <NUMBER> regarding pivotal role complement system cytokine storm activation th<NUMBER> every effort made suppress activation elegant cascade c<NUMBER>a potent component system good target alleviation proinflammatory responses severe covid<NUMBER> eculizumab monoclonal antibody high affinity c<NUMBER> near cleavage site <NUMBER> agent prevents formation c<NUMBER>a c<NUMBER>b<NUMBER> reported monoclonal antibody beneficial effects treatment diseases pathogenesis based complement activation <NUMBER> preliminary study conducted gao fig<NUMBER> <NUMBER> conclusion accumulating evidence suggests sarscov<NUMBER> driven ace<NUMBER> downregulation leads array complex intertwined molecular interactions via least four axes consisting dysregulation aceangiotensin iiat<NUMBER>r axis attenuation ace<NUMBER>masr axis increased activation ace<NUMBER>bradykinin b<NUMBER>rdabk axis activation complement cascades resulting observed cytokine storm severe covid<NUMBER> elucidation molecular events aforementioned axes might involved pathogenesis ards lung injury fulminant infections sarscov<NUMBER> promise novel therapeutic options prevention attenuation inflammatory cytokine release response observed nowadays patients severe covid<NUMBER> mm jr sf mk interpreted wrote manuscript mm supervised study authors read approved final manuscript award given iraj nabipour novo nordisk pars best innovator diabetes iran <NUMBER> remaining authors none declared technical assistance mr dara joukar drawing figures gratefully acknowledged authors also thank ms melissa yang phd kind language editing manuscript captions figures coronavirus disease <NUMBER> covid<NUMBER> clinical syndrome caused mutational rna virus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> initially occurring china december <NUMBER> spread world accepted pandemic world health organization march <NUMBER> <NUMBER> sarscov<NUMBER> betacoronavirus similar two coronaviruses causing deadly infections last two decades ie severe acute respiratory syndrome corona virus sarscov middle east respiratory syndrome corona virus merscov <NUMBER> although sarscov<NUMBER> infections may asymptomatic cause mild symptoms majority cases less lethal merscov infections may progress interstitial pneumonia acute respiratory distress syndrome ards nearly <NUMBER> cases especially older age comorbidities subgroup patients notable high levels serum ferritin ddimer levels hepatic dysfunction thrombotic tendency disseminated intravascular coagulation dic implicating occurrence macrophage activation syndrome mas also known secondary hemophagocytic lymphohistiocytosis shlh <NUMBER> <NUMBER> similar clinical laboratory findings also reported patients sarscov merscov infections <NUMBER> <NUMBER> context aimed review covid<NUMBER> infection special reference relationship cytokine storm purpose pubmed google academic searched april <NUMBER> <NUMBER> <NUMBER> original data studies including case reports case series addressed definition causes classification covid<NUMBER> hemophagocytosis mas hemophagocytic lymphohistiocytosis cytokine storm published english language peerreviewed journals included additional search fulltext articles keywords performed databases subscribed altınbaş university results search outlined follows firstly discussed pathogenesis immunologic features covid<NUMBER> infection followed normal interactions innate immune system viruses background cytokine storm secondary covid<NUMBER> infection finally management immunologic complications fever dry cough shortness breath myalgia fatigue tendency leucopenia radiological signs progressive pneumonia may cause ards similar clinical laboratory findings seen covid<NUMBER> sarscov merscov infections may suggest pathogenesis may also similar <NUMBER> believe hypothesis covering covid<NUMBER> pathogenesis explain high serum levels ferritin ddimer levels disproportionate severity infection well tendency monocytosis rather lymphocytosis including low number natural killer nk cytotoxic cells finally tendency dic indeed striking features mainly reflect presence mas cytokine storm spike glycoproteins immunogenic parts coronaviruses may bind angiotensinconverting enzyme<NUMBER> ace<NUMBER> receptors enter host cell similarities shown spike glycoproteins sarscov sarscov<NUMBER> distribution ace<NUMBER> receptor expression intensely surface alveolar epithelial type ii cells cardiac renal intestinal endothelial cells consistent target organs involved clinical picture covid<NUMBER> infection <NUMBER> <NUMBER> sarscov<NUMBER> spreads primarily direct contact droplets saliva discharge respiratory tract infected person coughs sneezes <NUMBER> following binding cell surface receptor ace<NUMBER> spike glycoprotein enters cell cytoplasm releases rna genome replicates resulting formation new viral particles cell disintegrates virus spreads cells immune system recognizes viral antigens antigenpresenting cells process antigens present natural killer cd<NUMBER>positive cytotoxic cells context major tissue histocompatibility mhc antigens usual presentation activates innate adaptive immunity causing production large amounts proinflammatory cytokines chemokines patients activation becomes massive cytokine storm develops resulting thrombotic tendency multiorgan failure eventually causing death <NUMBER> <NUMBER> another pathogenic mechanism independent binding cell surface ace<NUMBER> binding also speculated claiming virus might bind beta chain porphyrins inside erythrocytes resulting disturbance heme metabolism release iron however speculation needs investigation remains elusive <NUMBER> <NUMBER> zhang al reported number lymphocytes including cd<NUMBER> cd<NUMBER> subtypes especially nk cells much lower expected patients severe disease course <NUMBER> number regulatory cells also low severe lymphopenia early sign disease preceding pulmonary problems tends normalize patient improves lymphopenia included among diagnostic criteria china despite low numbers cd<NUMBER> cd<NUMBER> positive lymphocytes express high amount hladr<NUMBER> cd<NUMBER> showing hyperactivity additionally cd<NUMBER> cells harbor high concentrations cytotoxic granules ie <NUMBER> perforin positive <NUMBER> granulysin positive <NUMBER> granulysin perforin positive total leukocyte neutrophil counts neutrophillymphocyte ratio nlr increased especially severe cases nlr may used followup parameter patients covid<NUMBER> infection <NUMBER> <NUMBER> generally number cd<NUMBER> lymphocytes recovers <NUMBER> months whereas may take nearly year memory cd<NUMBER> lymphocytes recover sars cov infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> besides low numbers peripheral lymphocytes striking atrophy secondary lymphoid organs including lymph nodes spleen confirmed autopsy findings necrosisassociated lymph node spleen atrophy significant splenic cell degeneration focal hemorrhagic necrosis macrophage proliferation increased macrophage apoptosis spleen reported immunohistochemical staining showed decreased numbers cd<NUMBER> positive cd<NUMBER> positive cells lymph nodes spleen <NUMBER> <NUMBER> hand monocytes macrophages increased may explain elevated levels proinflammatory cytokines interleukin il<NUMBER> il<NUMBER> tumor necrosis factor tnfα il<NUMBER> patients turn cytokine storm discussed detail later great majority inflammatory cells infiltrating lungs monocytes macrophages autopsy findings showed presence monocytes macrophages moderate amount multinucleated giant cells associated diffuse alveolar injury however pulmonary infiltrating lymphocytes scarce mostly cd<NUMBER> positive findings different reported patients sarscov merscov infections <NUMBER> patients covid<NUMBER> elevated ddimer levels important persistent elevation confers poor prognosis development dic another problem characterized prolongation prothrombin time activated partial thromboplastin time high fibrin degradation products severe thrombocytopenia may lifethreatening <NUMBER> thrombotic tendency covid<NUMBER> patients probably caused endothelial cell activation damage due viral binding ace<NUMBER> receptor presence traditional risk factors venous thromboembolism found high among covid<NUMBER> patients high levels inflammatory mediators immunoglobulins may lead higher blood viscosity mechanical ventilation vascular interventions central venous catheterization may induce vascular endothelial damage severe critically ill patients anticardiolipin antibody levels also found high small groups reported combination factors may lead deep vein thrombosis even possibly lethal pulmonary thromboembolism therefore covid<NUMBER>infected patients whether hospitalized ambulatory need early prolonged prophylaxis low molecular weight heparin <NUMBER> <NUMBER> hand ischemic changes fingers toes mimicking vasculitis reported patients severe covid<NUMBER> <NUMBER> quick interpretation issues outlined shows disease starts simple viral infection goes control progresses towards deadly result development cytokine storm serious organ damage understand process occurs control process need know details pathogenesis covid<NUMBER> cytokine storm context normal innate immune system macrophages monocytes dendritic cells neutrophils express variety pattern recognition receptors prrs detect pathogenassociated molecular patterns pamps expressed infectious agents among prrs membranebound family tolllike receptors tlrs recognizes mainly pamps extracellular lesser account intracellular milieu triggered signaling process leads expression proinflammatory cytokineinducing transcription factors nfkb well activate interferon regulatory factors mediate type interferondependent antiviral response <NUMBER> second set pathogen recognition sensors present cytosol includes another family nucleotidebinding domain leucinerich repeat nlr proteins nlrp<NUMBER> nlrp<NUMBER> nlrp<NUMBER> nlrc<NUMBER> protein absent melanoma <NUMBER> aim<NUMBER> pyrin sensors essential detection endogenous dangerassociated molecular patterns damps expressed inside cell binding damps activates nlrs triggering formation multiprotein cytoplasmic complexes called inflammasomes convert procaspase<NUMBER> active caspase<NUMBER> caspase<NUMBER> converts proil<NUMBER>β active il<NUMBER>β important proinflammatory cytokine <NUMBER> <NUMBER> fig <NUMBER> noted signaling activation processes kept control serve benefit human body viruses pamps generally nucleic acids viral rna binds endosomal tlr<NUMBER> tlr<NUMBER> cytosolic receptors including rigi like receptors rlrs rlr family consists three members namely retinoic acidinduced gene rigi melanoma differentiationassociated gene <NUMBER> mda<NUMBER> laboratory genetics physiology <NUMBER> lgp<NUMBER> <NUMBER> <NUMBER> additionally rigi mda<NUMBER> two cards n terminal caspase activation recruitment domains upon binding rna rlr card interacts mavs mitochondrial adaptor antiviral signal protein leading activation gene coding type <NUMBER> interferons ifns type <NUMBER> ifns play important roles coordinating cellular immunity reactions viral infections thereby contributing normal antiviral immunity <NUMBER> normal conditions virusinfected cells destroyed nk cells innate immunity cd<NUMBER> positive cytolytic cells adaptive immunity using perforinmediated granulysin secretion leads apoptosis antigenpresenting cells relevant cytotoxic cells avoid unnecessary activation antigenic activity however defect occurs lymphocyte cytolytic activity whether due genetic problems acquired conditions may lead inability nk cytolytic cd<NUMBER> cells lyse infected activated antigenpresenting cells resulting prolonged exaggerated interactions innate adaptive immune cells case many proinflammatory cytokines including tnf interferonγ il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> secreted unrestrained way causing cytokine storm whole pathologic process starting defects lymphocyte cytolytic activity going increased macrophage activity whole immune system activation resulting cytokine storm ards multiorgan failure also called mas <NUMBER> <NUMBER> <NUMBER> lifethreatening condition one major causes death covid<NUMBER> patients consensus suggestion terminology used cytokine storm mas shlh chose use term cytokine storm secondary covid<NUMBER> however would irrefutable anyone use mas shlh terminology among patients initially reported wuhan occurrence mas cytokine storm ards heralded high levels serum proinflammatory cytokines ferritin past significantly higher serum levels il<NUMBER> ifnα ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> also detected patients severe sarscov merscov infections compared milder infections <NUMBER> clinical laboratory features mas include sustained fever elevated serum ferritin triglyceride levels pancytopenia fibrinolytic consumptive coagulopathy liver dysfunction splenomegaly besides low absent nk cell activity elevated serum levels scd<NUMBER> scd<NUMBER> presence hemophagocytosis defined engulfment blood cells including fig <NUMBER> generation inflammasome il<NUMBER> activation pathway eryhrocytes leucocytes platelets phagocytic cells support diagnosis mas <NUMBER> proposed predisposing factors mas cytokine storm secondary covid<NUMBER> infection discussed <NUMBER> impaired viral clearance main problem covid<NUMBER> infection impaired viral clearance like sarscov merscov infections viruses strategies combat host defense mechanisms sarscov merscov could produce vesicles double membranes without prrs replicate inside vesicles <NUMBER> strategies lead impaired antiviral immune response viral clearance although pcr test negative presence virus inclusion bodies pulmonary alveolar cells macrophages least <NUMBER> weeks still supports possibility failure virus clearance <NUMBER> <NUMBER> low levels type interferons another contributing factor low levels type interferons indeed important antiviral response viral clearance <NUMBER> cellular proteins recognize viral nucleic acids mediated stimulating interferons viral infections recognition viral rna mda<NUMBER> essential antiviral immunity deficiency mda<NUMBER> causes tendency viral infections humans <NUMBER> accessory protein merscov called <NUMBER>a binds doublestranded rna thereby blocking mda<NUMBER> activation ifn induction <NUMBER> noted people died <NUMBER> h<NUMBER>n<NUMBER> influenza outbreak showed lymphoid tissue atrophy associated high titer circulatory cytokines including il<NUMBER> <NUMBER> similar upregulation proinflammatory cytokines together downregulation antiviral cytokine observed merscov infection <NUMBER> <NUMBER> increased neutrophil extracellular traps nets neutrophils may kill invading pathogens including viruses engulfment microbes formation reactive oxygen species degranulation secretion antimicrobials also formation nets nets networks extracellular fibers primarily composed dna neutrophils bind kill extracellular pathogens minimizing damage host cells <NUMBER> barnes et al suggested neutrophils may contribute covid<NUMBER> pathogenesis utilizing nets based upon autopsy findings also suggested dornase alpha treatment may beneficial management infection <NUMBER> transfer dna fragments extracellular space may due release mitochondrial dna together disruption plasma membrane caused process known netosis netosis type programmed cell death distinct apoptosis necrosis viral rna proinflammatory cytokines may stimulate formation nets netosis although exact role nets antiviral immunity elucidated yet might contribute covid<NUMBER> pathogenesis <NUMBER> <NUMBER> <NUMBER> <NUMBER> miscellaneous mechanisms pyroptosis highly inflammatory caspase<NUMBER>dependent form programmed cell death occurs frequently upon infection intracellular pathogens part antimicrobial response postulated pyroptosis rapid plasmamembrane rupture release proinflammatory intracellular contents may also play role covid<NUMBER> pathogenesis rapid viral replication causes increased pyroptosis may lead massive release inflammatory mediators <NUMBER> <NUMBER> liu et al emphasized importance antibodies spike glycoprotein antisigg promoters proinflammatory monocytemacrophage accumulation lungs suggested viralspecific antibody response may cause pathological changes may responsible virusmediated lung injury <NUMBER> golonka et al speculated glycoprotein protein coronaviruses may undergo conformational change enter host cells fc region igg words proposed mechanism permitting antibodydependent enhancement viral entrance host cells <NUMBER> discussed corruption hem metabolism may one causes high serum free iron levels may contribute inflammation <NUMBER> recently ironmediated cell death known ferroptosis reported play role pathogenesis miscellaneous diseases <NUMBER> <NUMBER> role ferroptosis covid<NUMBER> pathogenesis place treatment target investigated taken together viral escape mechanisms avoid antiviral immunity together genetic acquired defects host defense may impair viral clearance resulting mas inappropriate immune activation causing ards multiorgan failure disease course variable ranging asymptomatic lethal may explained genetic host factors <NUMBER> may also explain number deaths may high families given genetic factors also play role primary hlhmas cases metaanalysis performed analyze countries hlhmas cases frequently reported frequency severe lethal covid<NUMBER> infections high <NUMBER> interestingly geographical distributions found similar genetic mutations causing tendency primary hlh may constitute risk factor severe disease course covid<NUMBER> opposite familial mediterranean fever fmfassociated genetic mutations may speculated confer milder disease course based upon historical hypothesis claiming mutations may confer resistance viral bacterial pathogens indeed lower death ratios covid<NUMBER> infections reported turkey israel may support speculation based https covid<NUMBER>whointaccessed <NUMBER> interestingly mas occurrence frequent fmf despite autoinflammatory disease <NUMBER> besides antiviral agents treatment immunologic complications including cytokine storm using appropriate immunosuppressive immunomodulatory drugs essential <NUMBER> <NUMBER> currently specific antiviral agent vaccine available covid<NUMBER> however many drugs familiar rheumatologists used based pharmacological properties corticosteroids cs chloroquine cq hydroxychloroquine hcq il<NUMBER>r antagonists including tocilizumab tcz il<NUMBER> antagonists including anakinra tnf inhibitors janus kinase inhibitors among agents used purpose <NUMBER> <NUMBER> hand nonsteroidal antiinflammatory agents especially ibuprofen recommended treatment covid<NUMBER> infection observations may exacerbate symptoms increasing ace<NUMBER> expression <NUMBER> two antimalarial agents commonly used rheumatology practice treating patients rheumatoid arthritis ra systemic lupus erythematosus sle sjögrens syndrome based upon immunomodulatory effects besides antimalarial effects cq hcq reported antiviral activity many viruses dengue ebola sars h<NUMBER>n<NUMBER> past recently reported also useful covid<NUMBER> included guidelines many countries including china italy <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cq hcq accumulate lysosomes raise ph level endosome may interfere virus entry andor exit host cells <NUMBER> besides two agents may interfere ace<NUMBER> receptors sarscov<NUMBER> upregulate expression enter cell binding receptors cq hcq may reduce glycosylation ace<NUMBER> receptors thereby preventing sarscov<NUMBER> effectively binding host cells <NUMBER> <NUMBER> recently wenzhonget al claimed antimalarials might block binding sars cov<NUMBER> virus porphyrins thus prevent entering virus cell <NUMBER> finally might block production proinflammatory cytokines including il<NUMBER> thereby blocking pathway subsequently leads ards whatever mechanisms multicenter studies performed china reported beneficial effects agents among patients covid<NUMBER> <NUMBER> although opposite reports seems cq hcq remain main drugs covid<NUMBER> one may wonder whether rheumatology patients already receiving hcq may protected covid<NUMBER> infections recently <NUMBER> patients rheumatic diseases receiving hcq treatment reported covid<NUMBER> infection one died although results study reported yet seems prophylactic treatment hcq may prevent covid<NUMBER> infection twitter trial httpstwittercomrheumcovid also observed patients developed covid<NUMBER> receiving hcq rheumatic patients frequently comorbidities use many drugs well also usual daily dose hcq <NUMBER> mg recommended dose covid<NUMBER> therefore recommend prophylactic use hcq prevent covid<NUMBER> infection covid<NUMBER> may enter inside cell endocytosis invade cell ap<NUMBER>associated protein kinase aak<NUMBER> member numbassociated kinase nak family serves clathrinmediated endocytosis regulator aak<NUMBER> inhibitors may prevent viral entry cell <NUMBER> <NUMBER> baricitinib inhibitor jakstat pathway used suppressing proinflammatory cytokine production systemic inflammation ra baricitinib also nak inhibitor particularly high affinity aak <NUMBER> <NUMBER> based upon basic data stebbing j et al suggested baricitinib<NUMBER> mg daily may combined antiviral treatment severe covid<NUMBER> infections <NUMBER> however inhibition ifn production result concomitant jakstat pathway blockage may cause impairment antiviral immunity <NUMBER> hand tofacitinib cannot inhibit aak<NUMBER> recommended purpose <NUMBER> tendency general infections possibility diverticulitis disadvantages jak inhibitors <NUMBER> mentioned sars covid<NUMBER> infections may cause mas cytokine storm lymphocytes hyperactivated enormous amount proinflammatory cytokines including il<NUMBER> il<NUMBER> contribute vascular permeability plasma leakage dic thereby causing pulmonary damage ards well multiorgan failure <NUMBER> cytokine storm related similar problems also observed chimeric antigen receptor cell cart treatment <NUMBER> tcz humanized antiil<NUMBER> receptor antibody inhibiting il<NUMBER> tcz currently used therapy ra temporal arteritis many autoimmune rheumatic diseases <NUMBER> also treatment cytokine storm may induced cart treatment <NUMBER> based observations tcz treatment also tried patients severe sarscov<NUMBER> infection complicated cytokine storm ards retrospective studies china reported resolution fever hypoxemia improvement serum crp levels pulmonary ct findings <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> experience also consistent reports treatment cytokine storm recommended tcz dose <NUMBER> mgkg iv single divided two doses <NUMBER> h intervalsmaximum dose <NUMBER> mg tendency general infections hepatotoxicity hypertriglyceridemia possibility diverticulitis main disadvantages tcz treatment <NUMBER> mentioned il<NUMBER> another proinflammatory cytokine playing dominant role cytokine storm sarscov<NUMBER> may cause pyroptosis il<NUMBER>β <NUMBER> anakinra recombinant il<NUMBER>r antagonist rhil<NUMBER>ra first il<NUMBER> blocking biologic agent produced anakinra blocks binding il<NUMBER>α il<NUMBER>β il<NUMBER>r thereby inhibits proinflammatory effects il<NUMBER> <NUMBER> anakinra found beneficial patients severe sepsis without significant adverse effects based upon data phase <NUMBER> randomized clinical trial <NUMBER> recommended sc adult dose anakinra ranges <NUMBER> <NUMBER> mg daily <NUMBER> mg three times weekly pediatric dose <NUMBER> mgkg daily bioavailability sc injections <NUMBER>with halflife <NUMBER> h presence renal failure gfr <NUMBER> mlmin given every <NUMBER> days hepatic disease require dose adjustment unlike tcz anakinra inhibit crp synthesis directly therefore serum crp levels used follow systemic acute phase response <NUMBER> another molecule produced ilblockage canakinumab high affinity fully humanized monoclonal antiil<NUMBER>β antibody igg<NUMBER>κ isotype following sc injection <NUMBER> mg peak serum concentration achieved <NUMBER> days recommended dose interval every <NUMBER> months <NUMBER> third molecule developed il<NUMBER> blockade rilonacept recombinant soluble il<NUMBER> receptor halflife rilonacept <NUMBER> days recommended loading dose <NUMBER> mgkg maximum dose <NUMBER> mg maintenance dose half loading dose weekly <NUMBER> use canakinumab rilonacept severe covid<NUMBER> infections reported yet tnfα key proinflammatory cytokine contributing various acute chronic inflammatory pathologies including autoimmune diseases septic shock antitnf agents commonly used treatment rheumatoid arthritis ankylosing spondylitis psoriatic arthritis serum tnfα levels moderately elevated patients sars much higher serum levels observed patients covid<NUMBER> infection positively correlated disease severity although antitnf treatment suggested potential treatment covid<NUMBER> sufficient data <NUMBER> <NUMBER> systemic corticosteroid cs treatment controversial severe ards nevertheless many physicians use treatment patients severe viral ards use recommended patients covid<NUMBER> based data patients h<NUMBER>n<NUMBER> sars mers <NUMBER> international guidelines recommend using moderate doses systemic cs treatment short time hemodynamic parameters improved following fluid replacement vasopressor support <NUMBER> <NUMBER> current use systemic corticosteroid treatment covid<NUMBER> infection limited patients lethal complications related cytokine storm ards acute cardiac injury renal failure patients higher serum levels ddimer since positive evidence coming randomized clinical trials guideline dated march <NUMBER> <NUMBER> recommend using systemic cs treatment patients covid<NUMBER> routinely <NUMBER> opinion methylprednisolone <NUMBER> mg daily <NUMBER> days addition tcz treatment may helpful cytokine storm may also help avoid rebound tcz ivig contains pooled polyclonal immunoglobulin g igg supplied plasma approximately thousand healthy blood donors clinical practice ivig used patients immune deficiencies treatment infectious diseases well treatmentresistant patients autoimmune diseases immunomodulatory agent previous favorable experience patients sars mers suggested use high dose ivig <NUMBER> gkg patients serious covid<NUMBER> infection early phase disease <NUMBER> <NUMBER> anticoagulation hydration overlooked increased tendency thrombosis ivig treatment covid<NUMBER> patients colchicine antiinflammatory immunomodulatory agent commonly used treatment gout fmf behçets syndrome long time colchicine suggested useful treatment complications covid<NUMBER> infection based ability inhibit il<NUMBER> production <NUMBER> colcorona colchicine coronavirus sarscov<NUMBER> trial phase <NUMBER> multicenter randomized doubleblind placebocontrolled multicenter study evaluate efficacy safety colchicine adult patients diagnosed covid<NUMBER> infection least one highrisk criterion currently results study reported yet clinicaltrialsgov identifier nct<NUMBER> many drugs interventions also proposed treatment covid<NUMBER> complications use low molecular weight heparin lmwh unfractionated heparin doses indicated prophylaxis venous thromboembolism strongly advised covid<NUMBER> patients hospitalized patients contraindication anticoagulation treated lower limb compression <NUMBER> prevention treatment cytokine storm possible lung fibrosis covid<NUMBER> pneumonia mesenchymal stem cells mscsbased immunomodulation treatment proposed suitable therapeutic approach purpose many studies currently ongoing <NUMBER> leng et al concluded iv transplantation mscs safe effective patients covid<NUMBER> pneumonia especially critically severe conditions <NUMBER> however currently approved mscbased approaches prevention andor treatment covid<NUMBER> patients first results clinical trials seem promising immune plasma transfusion passive immunization way old method used treatment many infections experience sarscov infection showed treatment could work given appropriate patient even family members caring covid<NUMBER> patients home <NUMBER> however based upon experience sarscov merscov infections risk antibodymediated disease enhancement hyperimmune globulin transfusion <NUMBER> short review relation pandemic covid<NUMBER> infection immunologic complication mas briefly debated mechanisms involved cytokine storm development complication occurs patients covid<NUMBER> infection discussed possible therapies reviewed study limitations firstly literature covid changing great speed chinese literature could included manuscript lack standard published studies differences treatment approaches chinese western sources chinese medicine remained obstacle making correct recommendations although sarscov<NUMBER> infections may asymptomatic cause mild symptoms cases immunologic complications mas cytokine storm may occur cases impairment sarscov<NUMBER> clearance due genetic viral features lower levels interferons increased neutrophil extracellular traps netosis increased pyroptosis create background complications presence genetic mutations causing tendency primary hlh may constitute risk factor severe disease course covid<NUMBER> immunologic complications like mashlh occur antiviral treatment alone enough combined appropriate antiinflammatory treatment early recognition appropriate treatment mas cytokine storm decrease morbidity mortality covid<NUMBER> infection requires collaboration infectious disease lung intensive care unit specialists experts immunologists rheumatologists hematologists author contributions april <NUMBER> <NUMBER> data started collected mehmet soy turned article article reviewed gokhan keser pamir atagündüz fehmi tabak isik atagündüz servet kayhan structured last version data carefully reviewed hematologically isik atagündüz additional contributions made article literature recommendations data availability resource scanning done google academic pubmed appropriate keywords original data studies including case reports case series addressed definition causes classification covid<NUMBER> hemophagocytosis mas hemophagocytic lymphohistiocytosis cytokine storm published english language peerreviewed journals included code availability code software ethics approval review article ethical approval declared procedures performed presents study accordance ethical standards institutional andor national research committee <NUMBER> helsinki declaration later amendments comparable ethical standards consent participate authors accepted last version article signed authors disclosure consent publication authors accepted last version article publication signed authors disclosure substantially higher agespecific cfr agespecific ratio confirmed cases italy spain countries low mean <NUMBER>ohd level suggest potential link severe vit deficiency severe covid<NUMBER> lead higher cfr direct link performance health care systems age distribution nation vitamin deficiency cfr covid<NUMBER> observed analysis published data status vit crp levels us laboratory data crp levels reported <NUMBER> patients china suggests proper supplementation vit across populations may reduce number severe covid<NUMBER> cases <NUMBER> percentage points lowering risk factors related cytokine storm analysis eliminate possibility circulation different subgenera covid<NUMBER> across globe factors recent global outbreak covid<NUMBER> imposed catastrophic impacts every society specifically among elderly populations currently treatment vaccine produced led many researchers look approaches reduce number severe covid<NUMBER> cases consequently reduce mortality rate disease time series analysis number confirmed deceased recovered cases illuminates patterns covid<NUMBER> impacted different populations may help us better understand defense mechanisms immune system covid<NUMBER> develop effective treatments viral infection italy spain reported substantially higher crude death rate countries <NUMBER> <NUMBER> despite presenting higher ranking overall health care system performance <NUMBER> experts suggested analysis agespecific case fatality ratio cfr timedelayed adjusted mortality ratio informative study covid<NUMBER> infection <NUMBER> <NUMBER> initial reports data obtained various studies suggest elderly age ≥<NUMBER> yo disproportionately impacted covid<NUMBER> substantially higher cfr elderly population compels agespecific analysis covid<NUMBER> data protection viral infections provided innate immune system adaptive immune system many individuals died due complications main risk factors covid<NUMBER> ards pneumonia acute kidney failure acute heart failure rhabdomyolysis clinical data obtained covid<NUMBER> patients china reported high concentrations cytokines gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα patients admitted icu indicates presence cytokine storm severe covid<NUMBER> cases <NUMBER> innate young populations adaptive elderly populations immune system plays important role regulating cytokine levels viral infections impact vit enhancing immune response including flu previous coronaviruses widely studied firmly established <NUMBER> <NUMBER> <NUMBER> vit also suppress cytokine storm may substantially increase chances avoiding severe case covid<NUMBER> <NUMBER> <NUMBER> researchers suggested potential association vit cfr <NUMBER> viral influenza pandemic also suppression cytokine storm <NUMBER> best knowledge randomized blinded experiment yet reported vit status cytokine levels patients covid<NUMBER> creactive proteins crp substances produced kidneys body trying fix damage arteries cells tissue autoimmunity infection causes <NUMBER> crp could used nonspecific marker indirectly measure severity cytokine storm severe covid<NUMBER> case article used reported patientlevel data association vit crp <NUMBER> model predict potential impact vit supplementation management alleviation cytokine storm estimated patientlevel crp data may lead reduction severe covid<NUMBER> cases countrylevel statistics vit deficiency covid<NUMBER> mortality ageadjusted cfr demographic variables investigated discussed data regarding number affected cases deaths recoveries covid<NUMBER> obtained kaggle <NUMBER> april <NUMBER> age distribution countries calculated data set provided united nations <NUMBER> agespecific cfr age distribution confirmed patients calculatedestimated based confirmed data available national agencies including spanish ministry health april <NUMBER> <NUMBER> <NUMBER> robert koch institute <NUMBER> hubei data estimated based results reported recent article <NUMBER> timeadjusted case mortality ratio cmr estimated number deceased patients day n divided number confirmed patients day n<NUMBER> agespecific case fatality rate calculated number deceased patients divided total number confirmed patients within age group day age brackets released data different adjustments considered based equal distribution assumption within age bracket age distribution germany used calculation accurately estimate age adjusted cfr ration confirmed cases based raw data available national agency calculation actual mortality rate covid<NUMBER> challenging task number deceased patients number confirmed patients time infection unknown <NUMBER> stricter bureaucratic screening policies implemented many countries makes calculation actual mortality rate challenging also makes difficult determine metric fair comparison statistics different countries analysis time events reported <NUMBER> deceased patients wuhan hubei china shows median time <NUMBER> days admission time death <NUMBER> days onset symptoms time death shown inset figure <NUMBER> <NUMBER> order determine fair metric comparison data countries time delay <NUMBER> days used calculation mortality rate timeadjusted mortality rate <NUMBER> days country reached steady state remained stable least next <NUMBER> days demonstrated figure <NUMBER> appears covid<NUMBER> progressing across countries four different mortality rates italy spain presented substantially higher mortality rate compared countries <NUMBER> <NUMBER> respectively mortality rate united kingdom france iran us <NUMBER> <NUMBER> respectively substantially lower italy spain however higher china switzerland <NUMBER> respectively germany south korea report lowest mortality rates <NUMBER> <NUMBER> respectively agespecific cfr agespecific cfr elderly covid<NUMBER> age brackets <NUMBER> yo ≤ age <NUMBER> yo age ≥<NUMBER> yo estimated available data results shown figure <NUMBER> italy spain france presenting substantially higher cfr <NUMBER> germany china south korea age bracket <NUMBER> yo ≤ age <NUMBER> yo italy spain present considerably higher cfr <NUMBER> patients age ≥ <NUMBER> germany south korea china hubei authorfunder granted medrxiv license display preprint perpetuity considerable difference cfr covid<NUMBER> among elderly italy spain suggests possibility unknown factors substantially increase fatality rate covid<NUMBER> elderly variables include age distribution confirmed patients total number tested cases country screening policy immune system among population factors ratio confirmed patients age bracket <NUMBER> yo ≤ age <NUMBER> yo age ≥ <NUMBER> yo showing figure <NUMBER> shows elderly people disproportionately likely display symptoms covid<NUMBER> age distribution countries shown supplementary material cannot explain demonstrated gap ratio confirmed elderly cases recent study shown <NUMBER> patients confirmed covid<NUMBER> show symptoms remain undetected <NUMBER> clear disproportionately high number confirmed patients italy spain france due targeted exposure elderly virus inability immune system managing severe covid<NUMBER> rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint response covid<NUMBER> countries implemented different strategies screening patients disease germany korea committed mass population screening uk france spain italy united states limited efforts tests patients severe symptoms shortness breath ratio confirmed cases tested cases country shown figure <NUMBER> indicates italy spain substantially higher ratio confirmed cases testing <NUMBER> times higher germany suggests actual number patients covid<NUMBER> countries greatly higher reported figures majority undetected covid<NUMBER> patients countries thus younger people display mild symptoms could reason notably higher ratio confirmed elderly patients covid<NUMBER> italy spain compared countries since age distribution countries shown figure <NUMBER> b cannot fully explain reported numbers addition large number patients covid<NUMBER> highly contagious nature virus make less likely virus target specific age group countries rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint ratio confirmed tested cases country b age distribution countries studied article <NUMBER> age distribution confirmed hospitalized admitted icu cases age distribution patients hospitalized admitted icu deceased illustrated figure <NUMBER> results presented demonstrate pattern containing two peaks one young patients one elderly population hypothesis cytokine storm immunosuppression major reason admission patients icu <NUMBER> cytokine storm might activated innate immune system young population <NUMBER> yo adaptive immune system could produced cytokine storm elderly highlighted red picture substantially higher number elderly patients age <NUMBER> yo admitted hospital figure <NUMBER> notably higher ratio deceased patients population figure <NUMBER> suggests potential importance management adaptive immune system patients covid<NUMBER> results suggest aberrant responses innate immune system elderly population may lead cytokine storms causes admitted icu higher ratio higher ratio deceased admitted icu patients elderly population age ≥ <NUMBER> suggests threshold severe consequences cytokine storm substantially lower aging high ratio children age <NUMBER> yo admitted icu might also linked interaction innate immune system covid<NUMBER> low ratio deceased admitted icu patients suggest high threshold consequence battle among z e r l n r n f r n c e u n e k n g l p n rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint status vit deficiency countries germany korea china switzerland iran france united kingdom italy spain evaluated different studies measuring mean <NUMBER>hydroxyvitamin <NUMBER>ohd concentration results shown figure <NUMBER> figure shows italy spain france three countries mean <NUMBER>ohd concentration smaller threshold defined severe vit deficiency italy reported mean <NUMBER>ohd concentration <NUMBER> spain reported <NUMBER>ohd concentration <NUMBER> presented highest mortality rates despite better health system performance ranking nations age distribution shown supplementary material justify trend evaluation age distribution confirmed patients would suggest italy spain present higher mortality rate south korea iran china however fully explain current gap example death rate number deadnumber confirmed patients day among patients aged <NUMBER> italy <NUMBER> substantially higher south korea <NUMBER> addition age distribution variation within confirmed patients european countries cannot explain gap italyspain germany switzerland france uk importantly case fatality substantially higher italy spain even considering specifically elderly ageadjusted cfr shown figure <NUMBER> led us investigate impact severe vit deficiency increase mortality rate figure <NUMBER> vit status compared via mean concentration <NUMBER>ohd country data obtained independent studies country <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> age distribution countries illustrated inset top right <NUMBER> results presented figures <NUMBER> <NUMBER> <NUMBER> show countries spain italy severe vit deficiency report substantially higher mortality rate crude adjusted cfr ages <NUMBER> yo ≤ age <NUMBER> yo age ≥ <NUMBER> yo germany south korea china switzerland iran us uk countries less severe vit deficiency key issue countries used screening policy result countries relatively little testing tend detect mild disease show similar rate severe disease detection since severe cases eventually tested symptoms worsen thus lowtesting countries would exhibit higher fatality rate large ratio confirmed cases age <NUMBER> countries restrict screening policies france spain italy compared countries less restrict screening policy suggests mild undetected diseases likely part younger population suggests impact screening policy comparison cfr elderly age ≥ <NUMBER> less sensitive impact screening policy crude mortality rate sensitivity analysis conducted mortality rate adjusted based ratio confirmedtested cases result provided figure <NUMBER> inset reduce error model limited analysis countries similar confirmedtested case ratio italy france iran usa china switzerland excluded germany south korea spain analysis adjusted mortality rate country based condition fixed confirmedtested case ratio <NUMBER> confirmedtested case ratio france exists data sets adjustment done including undetected mild covid<NUMBER> cases raw data countries modeling hypothesized undetected mild covid<NUMBER> countries population subjects confirmedtested ratio <NUMBER> half current ratio confirmed cases france adjusted data shown figure <NUMBER> shows france italy countries lowest mean <NUMBER>ohd levels present notable higher mortality rate iran us switzerland immunosenescence reduces chance survival patients presenting covid<NUMBER> perhaps bodys line defense may weaken deficiencies nutrients vitamins example well established expression vit receptors interactions immune cells tcells bcells antigenpresenting cells leads immune regulation enhancing innate immune system suppressing adaptive immune system <NUMBER> <NUMBER> overactivation adaptive immune system lead cytokine storm suppression via vit reduce cytokines level clinical data covid<NUMBER> patients suggests higher risk development severe covid<NUMBER> patients prior hypertension diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients conditions treated ace inhibitors angiotensin ii typei receptor blockers arbs increase expression angiotensinconverting enzyme <NUMBER> ace<NUMBER> lead severe infection covid<NUMBER> <NUMBER> variation ace<NUMBER> expression may play important role growth rate severity covid<NUMBER> <NUMBER> genetic mechanisms underlying hypertension association via ace<NUMBER> expression vit widely investigated <NUMBER> <NUMBER> <NUMBER> hypertension severe covid<NUMBER> patients characterized activated reninangiotensin system ras lungs vit neuroprotective mechanisms hypertension ace<NUMBER>ang<NUMBER>masr pathway helps reduce risk ras <NUMBER> intensive study <NUMBER> participants demonstrated impact vit lowering risk ras <NUMBER> trigger ras vit deficiency <NUMBER> reduces lung efficiency development fibrosis time <NUMBER> suggests patients italy spain severe vit deficiency may higher risk severe covid<NUMBER> addition vit plays important role regulating inflammatory cytokines suppressing inflammatory boosting antiinflammatory cytokines <NUMBER> <NUMBER> <NUMBER> crp <NUMBER> substantially reduces risk infection cardiovascular disease cvd substantially high odds ratio inflammatory cytokines <NUMBER> crp <NUMBER> patients severe covid<NUMBER> underlines potential importance vit boosting immune system reducing risk factors severe covid<NUMBER> clinical data confirmed covid<NUMBER> patients china <NUMBER> hospitals <NUMBER> provinces shows substantially higher frequency cases crp ≥ <NUMBER> mg among patients severe covid<NUMBER> <NUMBER> <NUMBER> cases <NUMBER> patients mild form disease <NUMBER> <NUMBER> cases <NUMBER> <NUMBER> relationship high crp vit widely investigated different clinical studies recent history cvd among covid<NUMBER> patients shown another important risk factor association vit needs investigated crp production liver subsequent concentration plasma increased response inflammation laboratory data collected nationwide <NUMBER> participants nhanes <NUMBER> analyzed li et al shows strong relationship severe deficiency vit high positive level crp <NUMBER> analysis reported data without adjustment demographic variables shown figure <NUMBER> suggests odds ratio <NUMBER> risk factor <NUMBER> high crp plasma subjects severely deficient vit <NUMBER>ohd <NUMBER> ngl means subjects severe deficiency vit <NUMBER> times higher risk production high crp hypothesized vit deficiency increases risk cytokine storm covid<NUMBER> patients increases concentration crp similar fashion reported healthy controls figure <NUMBER> also hypothesized risk high crp increases chance severe covid<NUMBER> sufficient supplementation vit might inhibited damage body leading less frequent production high concentration crp risk high crp patients normal vit levels <NUMBER> <NUMBER> reaches <NUMBER> patients severe deficiency vit using data provided table <NUMBER> risk severe covid<NUMBER> given vit status calculated based equation <NUMBER> risk factor high positive crp table <NUMBER> risk associated crp status given severe covid<NUMBER> covid<NUMBER> given crp status providedcalculated based data reported recent study <NUMBER> table <NUMBER> risk associated high crp given vit status providedcalculated based data reported study <NUMBER> recent study suggests respective case fatality rate cfr <NUMBER> <NUMBER> covid<NUMBER> patients without cvd history wuhan china <NUMBER> makes important determine mechanism reducing risk factor cvd <NUMBER> relative risk factor odds ratio <NUMBER> <NUMBER> estimated baseline ratio <NUMBER> calculated <NUMBER> based equation <NUMBER> <NUMBER> relative riskodds ratio <NUMBER>−p<NUMBER>p<NUMBER>×odds ratio <NUMBER> p<NUMBER> baseline risk normal status vit among population reduces risk cvd <NUMBER> calculated risk factor <NUMBER> reduction cvd among population reduces risk severe covid<NUMBER> based highly contagious nature covid<NUMBER> notably lower percentage confirmed younger cases low cfr suggest young patients especially young children get infected nearly asymptomatic inability innate immune system managing covid<NUMBER> shortage memory b cells leads misfire overactivation adaptive immune system producing high level cytokines cytokine storm aberrant responses innate immune system elderly compare younger patients may increase risk viral load <NUMBER> intensifies activation adaptive immune system production cytokine storm among population cytokine storm reported covid<NUMBER> patients <NUMBER> brings complications ards exacerbation effects pneumonia acute kidney failure acute heart failure rhabdomyolysis <NUMBER> cases becomes fatal addition weaker cytokine storm among elderly population fatal younger population threshold severe consequences lung damage substantially lower aging even moderate lung damage due cytokine storm may lead hypoxemia turn results mortality due underlying complications cvd time interval development notable adaptive immune response estimated week consistent current median time death covid<NUMBER> patients <NUMBER> days <NUMBER> <NUMBER> possible role ibuprofen worsening covid<NUMBER> treatment <NUMBER> explained action suppression innate immunity <NUMBER> <NUMBER> leads overactivation adaptive immune system may intensify cytokine storm become fatal elderly patients <NUMBER> <NUMBER> vit hand may help boosting innate immunity reduce viral load suppressing adaptive immune system may reduce cytokine storm <NUMBER> <NUMBER> role vit regulating immunity <NUMBER> <NUMBER> reduction cytokine storm may avoid complications caused cytokine storm elderly population italy spain countries severe vitd deficiency notably higher ratio confirmed elderly patients age ≥ <NUMBER> yo also higher cfr among elderly population age ≥ <NUMBER> yo countries germany china south korea sensitivity analysis among countries similar screening methods us france iran switzerland uk italy shows france country severe vit deficiency reported notably higher adjusted fixed confirmedtested ratio mortality rate fits hypothesis suggested based observed patientlevel clinical data <NUMBER> aberrant responses innate immune system elderly compare younger subject may increase risk covid<NUMBER> viral load increased viral load causes overactivation adaptive immune system produces cytokine storm patientlevel crp data used surrogate marker cytokine storm link association vit status used suggest potential link vit severe deficiency number severe covid<NUMBER> cases analysis suggested <NUMBER> reduction number severe covid<NUMBER> cases given normal vit status within population availability data showing direct link vit status specific markers cytokines accurate estimation could estimated merscov sarscov<NUMBER> also thought derived bat coronaviruses however <NUMBER> pathogenic bat free dna cytoplasm blood cannot <NUMBER> bring violent immune response bat produce severe inflammations <NUMBER> human hypothesized damage induced free dna reason severe <NUMBER> covid<NUMBER> explain many symptoms disease cytokine <NUMBER> storm ards muscus plug acute injuries heart liver kidney <NUMBER> special symptoms covid<NUMBER> hypothesis helpful better understand <NUMBER> etiology severe covid<NUMBER> cytokines <NUMBER> thus risk cytokine storm addition cytokines free dna <NUMBER> also destroy vascular endothelial cells directly <NUMBER> vitro study showed harm <NUMBER> human umbilical vein endothelial cells damage endothelial cells boost <NUMBER> dysfunctions multiple organs cytokine storm described follow <NUMBER> meanwhile cytokine storm also promote permeability blood vessels level <NUMBER> lymphocytes thought early identification risk factors severe <NUMBER> covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> hypothesized related free dnarelated cytokine <NUMBER> storm blood vessel damage explain many symptoms disease <NUMBER> including special symptoms covid<NUMBER> shown figure <NUMBER> fever admission hospital develop fever <NUMBER> hospital <NUMBER> thought delayed fever partly due increasing level <NUMBER> free dna addition amplification virus third many clinicians found <NUMBER> severe covid<NUMBER> patients experienced two attack even <NUMBER> viral load reduced thought attack due direct invasion research support manuscript december <NUMBER> outbreak pneumonia cases reported wuhan china outbreak linked huanan food market new virus <NUMBER>ncov called isolated <NUMBER> january <NUMBER> identified cause outbreak <NUMBER> <NUMBER>ncov virus rapidly spread across china many countries caused rapidly growing global outbreak <NUMBER> february <NUMBER> named disease covid<NUMBER> short coronavirus disease <NUMBER> <NUMBER> <NUMBER> march <NUMBER> total number covid<NUMBER> confirmed cases reached <NUMBER> globally <NUMBER> cases china <NUMBER> outside china covid<NUMBER> declared pandemic <NUMBER> <NUMBER> may <NUMBER> covid<NUMBER> confirmed <NUMBER> individuals globally deaths reaching <NUMBER> morality <NUMBER> united states highest number confirmed cases <NUMBER> cases <NUMBER> covid<NUMBER> caused sarscov<NUMBER> belongs betacoronaviruses subfamily coronaviruses enveloped positive single stranded large rna viruses although first data available covid<NUMBER> indicates possible animaltohuman transmission via wild animals huanan seafood market wuhan <NUMBER> <NUMBER> epidemiological data studies increasingly demonstrated virus transmits humantohuman droplets direct contact reporting individuals direct contact huanan seafood market diagnosed covid<NUMBER> secondary cases occurring hospitals among health care workers extensive contact covid<NUMBER> patients virus confirmed spread respiratory droplets coughs sneezes <NUMBER> <NUMBER> <NUMBER> ability host shed infection asymptomatic <NUMBER> studies also proposing possible fecooral transmission virus <NUMBER> covid<NUMBER> patients mainly adults older <NUMBER> years old male predominance preconceived notion pediatrics subjected infection later changed confirmed cases occurring pediatrics china worldwide <NUMBER> <NUMBER> however mortality still much adult group age <NUMBER> years adults preexisting cardiovascular diseases respiratory diseases endocrine diseases diabetics immunocompromised adults remain exposed serious complication covid<NUMBER> <NUMBER> although many patients covid<NUMBER> remain asymptomatic patients get pneumonia <NUMBER> cases require mechanical ventilation icu admission patients usually present fever dry cough shortness breath headache malaise muscle bony aches less common symptoms include sore throat confusion productive cough hemoptysis diarrhea nausea chest pain <NUMBER> progression pneumonia documented radiological findings usually occurs <NUMBER> weeks beginning symptoms signs pneumonia include decreased oxygen saturation deterioration blood gas multifocal glass ground opacities patchysegmental consolidation chest xray ct patients presenting late deteriorating hospitalized patients usually suffer acute respiratory distress syndrome ards acute respiratory failure acute renal injury multiorgan failure <NUMBER> <NUMBER> <NUMBER> complete blood picture covid<NUMBER> patients usually shows lymphopenia without total leukopenia lymphocyte count <NUMBER> × <NUMBER> <NUMBER> l associated severe disease <NUMBER> recent research reported severe cases covid<NUMBER> tend higher neutrophil lymphocyte ratio nlr nlr calculated routine blood picture dividing absolute neutrophil count absolute lymphocyte count indicates patients overall inflammatory status increasing nlr risk factor mortality infectious diseases also malignancy acute coronary syndrome intracerebral hemorrhage polymyositis dermatomyostis <NUMBER> platelet count usually normal mildly decreased creaction protein erythrocyte sedimentation rate usually increased procalcitonin levels normal elevation procalcitonin usually indicates secondary bacterial infection lactate dehydrogenase ferritin ddimer creatine kinase elevation associated severe disease elevation creatinine liver enzyme levels alt ast occurs complicated cases progressing multiorgan failure <NUMBER> newly emerging covid<NUMBER> continuing challenge medical health systems world scenario still getting worse covid<NUMBER> poses increasing threat humans fatality rate <NUMBER> far <NUMBER> covid<NUMBER> infection accompanied aggressive inflammatory response release large amount proinflammatory cytokines event known cytokine storm host immune response sarscov<NUMBER> virus hyperactive resulting excessive inflammatory reaction several studies analyzing cytokine profiles covid<NUMBER> patients suggested cytokine storm correlated directly lung injury multiorgan failure unfavorable prognosis severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> immune system exquisite mechanism capable responding various pathogens normal antiviral immune response requires activation inflammatory pathways immune system however aberrant exaggerated response hosts immune system cause severe disease remains uncontrolled <NUMBER> cytokines essential part inflammatory process cytokines produced several immune cells including innate macrophages dendritic cells natural killer cells adaptive b lymphocytes innate immune response viral infection pattern recognition receptors prrs recognize different molecular structures characteristic invading virus molecular structures referred pathogen associated molecular patterns pamps binding pamps prrs triggers start inflammatory response invading virus resulting activation several signaling pathways subsequently transcription factors induce expression genes responsible production several products involved hosts immune response virus among genes encoding several proinflammatory cytokines major transcription factors activated prrs nuclear factor kb activation protein <NUMBER> interferon response factors three seven transcription factors induce expression genes encoding inflammatory cytokines chemokines adhesion molecules sequence events results recruitment leukocytes plasma proteins site infection perform various effector functions serve combat triggering infection <NUMBER> three important proinflammatory cytokines innate immune response il<NUMBER> tnfα il<NUMBER> tissue macrophages mast cells endothelial epithelial cells major source cytokines innate immune response cytokine storm results sudden acute increase circulating levels different proinflammatory cytokines including il<NUMBER> il<NUMBER> tnfα interferon increase cytokines results influx various immune cells macrophages neutrophils cells circulation site infection destructive effects human tissue resulting destabilization endothelial cell cell interactions damage vascular barrier capillary damage diffuse alveolar damage multiorgan failure ultimately death lung injury one consequence cytokine storm progress acute lung injury severe form ards <NUMBER> ards leading low oxygen saturation levels major cause mortality covid<NUMBER> although exact mechanism ards covid<NUMBER> patients fully understood excessive production proinflammatory cytokines considered one major contributing factors <NUMBER> <NUMBER> <NUMBER> accumulating evidence suggests patients severe covid<NUMBER> suffer cytokine storm analysis cytokine levels plasma <NUMBER> covid<NUMBER> confirmed cases china revealed elevated levels il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> fgf gcsf gmcsf ifnγ ip<NUMBER> mcp<NUMBER> mip<NUMBER>a mip<NUMBER>b pdgf tnfα vegf patients admitted icu nonicu patients compared healthy adults patients included study pneumonia <NUMBER> patients admitted icu six patients died <NUMBER> multicenter retrospective study <NUMBER> covid<NUMBER> patients china evaluated predictors mortality covid<NUMBER> study analyzed data <NUMBER> cases resolved covid<NUMBER> <NUMBER> cases died covid<NUMBER> reported significantly higher levels il<NUMBER> mortality cases resolving cases <NUMBER> another study analyzing data <NUMBER> patients china reported increased levels il<NUMBER> il<NUMBER> tnfα severe cases n <NUMBER> patients compared moderate cases n <NUMBER> patients <NUMBER> similar study gao et al assessed <NUMBER> patients china reported levels il<NUMBER> significantly higher severe cases n <NUMBER> mild cases n <NUMBER> <NUMBER> similarly chen et al studied total <NUMBER> covid<NUMBER> patients divided three groups according relevant diagnostic criteria found il<NUMBER> higher critical cases n <NUMBER> patients severe cases n <NUMBER> patients il<NUMBER> higher severe cases mild cases n <NUMBER> cases <NUMBER> much data available yet regarding severe pediatric covid<NUMBER> patients study evaluated eight critically ill chinese pediatric covid<NUMBER> patients treated icu ages ranging <NUMBER> months <NUMBER> years reported increased levels il<NUMBER> il<NUMBER> ifnγ among laboratory findings <NUMBER> cytokine storm cs critical lifethreating condition requiring intensive care admission quite high mortality cs characterized clinical presentation overwhelming systemic inflammation hyperferritinemia hemodynamic instability multiorgan failure left untreated leads death trigger cs uncontrolled immune response resulting continuous activation expansion immune cells lymphocytes macrophages produce immense amounts cytokines resulting cytokine storm cs clinical findings attributed action proinflammatory cytokines like il<NUMBER> il<NUMBER> il<NUMBER> ifnγ tnfα <NUMBER> cs reported several viral infections including influenza h<NUMBER>n<NUMBER> virus <NUMBER> <NUMBER> influenza h<NUMBER>n<NUMBER> virus <NUMBER> two coronaviruses highly related covid<NUMBER> sarscov merscov <NUMBER> <NUMBER> proinflammatory cytokines eg il<NUMBER> il<NUMBER> tnfα antiinflammatory cytokines eg il<NUMBER> il<NUMBER> receptor antagonist elevated serum cs patients main contributors interplay cytokine storm il<NUMBER> tnfα absence immediate appropriate therapeutic intervention patients develop ards result acute lung damage followed multiorgan failure resulting death hence cs treated immediately otherwise mortality result <NUMBER> addition antiviral therapies directly target virus antiinflammatory therapies diminish cytokine responses suggested decrease morbidity mortality covid<NUMBER> patients early recognition cs prompt treatment lead better outcome several biological agents targeting cytokines proposed treating cs il<NUMBER> receptor antagonist anakinra used treatment rheumatoid arthritis proven helpful cytophagic histiocytic panniculitis secondary hemophagocytic lymphohistiocytosis disease associated severe cs <NUMBER> tocilizumab recombinant humanized il<NUMBER> receptor antagonist interferes il<NUMBER> binding receptor blocks signaling tocilizumab used treatment rheumatoid arthritis juvenile idiopathic arthritis giant cell arteritis proven valuable treatment cs triggered cart cell therapy hematological malignancies <NUMBER> downstream inhibitors cytokines eg jak inhibitors also explored treating cs il<NUMBER> frequently reported cytokine increased covid<NUMBER> patients il<NUMBER> elevated levels associated higher mortalities tocilizumab candidate drug used managing cytokine storm accompanying covid<NUMBER> encouraging results reported china tocilizumab used treatment <NUMBER> patients severe critical covid<NUMBER> clinical data showed symptoms hypoxygenmia ct opacity changes improved immediately treatment tocilizumab patients suggesting tocilizumab could efficient therapeutic agent treatment cytokine storm associated covid<NUMBER> <NUMBER> us food drug administration fda approved roches phase iii clinical trial use tocilizumab hospitalized patients severe covid<NUMBER> pneumonia trial planned include <NUMBER> patients severe covid<NUMBER> pneumonia <NUMBER> cytokine storm appears one common causes mortality recently declared pandemic covid<NUMBER> therapeutic approaches manage covid<NUMBER> cytokine storm might provide avenue decrease covid<NUMBER> associated morbidity mortality focus upcoming studies authors contributed gathering data writing editing revising manuscript immune responses clinical presentations radiological patterns quite heterogeneous among multitude people affected widespread covid<NUMBER> syndrome <NUMBER> one worst scenarios sustained socalled cytokine storm historically labelled secondary haemophagocytic lymphohistiocytosis shlh complication commonly encountered viral infections <NUMBER> influenza viruses ebola virus cytomegalovirus recently sarscov<NUMBER> implicated triggering cytokine storm <NUMBER> cytokine storm may provide possible mechanism certain subpopulations likely die covid<NUMBER> others immune system mounts effective adaptive response sarscov<NUMBER> infection cleared clinical manifestations absent prone complete recovery successful result mediated antiviral cd<NUMBER> helper th cell commitment associated activation cd<NUMBER> cytotoxic lymphocytes b celldriven response leading production specific antibodies <NUMBER> however human organism fails develop adequate adaptive immune reaction viral persistence consequent prolongation amplification innate immune mechanisms associated dysfunctional adaptive responses cause hyperinflammatory state underlying cytokine storm typical acute respiratory distress syndrome ards <NUMBER> words massive continuous release proinflammatory cytokines chemokines responsible severe even deadly attack lung besides comorbidities respiratory cardiovascular metabolic oncologic etc involved senescence immune system plays role worst outcomes observed elderly <NUMBER> <NUMBER> childhood adolescence instead high numbers naïve lymphocytes ready differentiate engage successful fight eventual new pathogens <NUMBER> indeed children currently paying low death toll sarscov<NUMBER> infection basis considerations present review focus pathogenic mechanisms underpinning lung damage induced cytokine storm triggered sarscov<NUMBER> well potential therapies targeting severe condition mechanisms viral infection sarscov<NUMBER> enveloped positivesense singlestranded rna βcoronavirus similar coronaviruses responsible severe acute respiratory syndrome sars middle east respiratory syndrome mers <NUMBER> <NUMBER> nucleocapsid consists genomic rna phosphorylated n protein embedded within phospholipid bilayers surfaced two spike proteins <NUMBER> latter include spike glycoprotein trimmer hemagglutininesterase ne among type iii transmembrane glycoprotein envelope e protein interposed <NUMBER> glycoprotein binds cell membrane receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> expressed within lower respiratory tract type <NUMBER> alveolar epithelial cells <NUMBER> <NUMBER> key function glycoprotein primed tmprss<NUMBER> human type <NUMBER> transmembrane serine protease thus facilitates virus entry host cells <NUMBER> glycoprotein comprises s<NUMBER> subunit mediating cellular tropism sarscov<NUMBER> s<NUMBER> subunit responsible viruscell membrane fusion <NUMBER> fusion followed penetration viral genomic rna cytoplasm inside target cells singlestranded viral rna recognised intracellular tolllike receptor <NUMBER> tlr<NUMBER> located endosomes <NUMBER> consequence infectious process sarscov<NUMBER> rna drives translation assembly viral proteins inside endoplasmic reticulum golgi apparatus newly formed vesicles contain viral particles fuse cell membrane thus releasing virus tissue destruction spreads throughout sarscov<NUMBER>infected cells trigger innate immune responses mediated mostly macrophages indeed tight intercellular communications occur ace<NUMBER>expressing lung epithelial cells macrophages <NUMBER> within context class major histocompatibility complex mhci macrophages present viral antigens lymphocytes thereby leading cell subset commitment activation <NUMBER> subsequent th<NUMBER>featured adaptive immune response contribute clear viral infection via release antiviral cytokines type interferons ifns however previously reported severe infections caused sars coronavirus may associated low levels ifn production <NUMBER> therefore pathobiologic scenario could characterised polarisation towards aberrant cell lineage dysregulated cytokine secretory pattern indeed shown recently sarscov<NUMBER> infection prime cd<NUMBER> lymphocytes differentiate pathogenic th<NUMBER> cells secreting high amounts interleukin<NUMBER> il<NUMBER> granulocyte macrophagecolony stimulating factor gmcsf figure <NUMBER> <NUMBER> cytokine milieu promotes activation cd<NUMBER> cd<NUMBER> monocytes turn release il<NUMBER> may migrate blood lung thus possibly becoming alveolar macrophages dendritic cells figure <NUMBER> <NUMBER> addition severely ill covid<NUMBER> patients develop dysfunctional immunophenotypes cd<NUMBER> cd<NUMBER> lymphocytes characterised high coexpression surface markers pd<NUMBER> programmed cell death protein<NUMBER> tim<NUMBER> tcell immunoglobulin mucindomain containing<NUMBER> predisposes rapid cell exhaustion viral infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> fact patients severe disease innate immune mechanisms fail induce effective virustargeted cytotoxic response normally implemented activated cd<NUMBER> cells <NUMBER> furthermore adaptive immune response induced sarscov<NUMBER> might also shaped predominant th<NUMBER> profile <NUMBER> crosstalking innate adaptive immune pathways lead lung epithelial cells activated monocytes macrophages lymphocytes massively one important cytokines produced consequence sarscov<NUMBER>induced tlr<NUMBER> signalling il<NUMBER> pleiotropic proinflammatory mediator promotes proliferation myeloid progenitor cells growth activation leukocytes well induces pyrexia synthesis acute phase proteins c reactive protein crp figure <NUMBER> <NUMBER> il<NUMBER> plays central role immune responses stimulating differentiation follicular helper cells tfh contributing together tgfβ development th<NUMBER> cells figure <NUMBER> <NUMBER> <NUMBER> activation socs<NUMBER> suppressor cytokine signalling<NUMBER> pathway il<NUMBER> also suppress phosphorylation signal transducer activator transcription<NUMBER> stat<NUMBER> thus impairing activity cd<NUMBER> cytotoxic natural killer cells <NUMBER> <NUMBER> furthermore via upregulation il<NUMBER> downregulation ifnγ il<NUMBER> inhibits antiviral th<NUMBER> cell commitment favours th<NUMBER> cell differentiation <NUMBER> elevated levels il<NUMBER> associated severe lung injury <NUMBER> il<NUMBER> suppress functions lymphocytes dendritic cells macrophages aimed eliminate coronaviruses thereby dampening ability immune system clear infections <NUMBER> therefore il<NUMBER> overproduction probably induced viruses sarscov<NUMBER> aim escaping immune surveillance active il<NUMBER>β il<NUMBER> originate inactive precursors via cleavage catalysed caspase<NUMBER> proteolytic enzyme operating within context multiprotein intracellular inflammasome complex <NUMBER> highly susceptible activation induced viral molecules il<NUMBER>β tnfα mostly generated activated macrophages present high concentrations bronchoalveolar lavage fluid balf patients ards stimulate neutrophil functions <NUMBER> <NUMBER> <NUMBER> tnfα also causes apoptotic death lung epithelial endothelial cells <NUMBER> high il<NUMBER> balf concentrations also detected subjects ards <NUMBER> il<NUMBER> powerful chemoattractant activator neutrophils whose apoptosis inhibited chemokine thus upon release monocytesmacrophages alveolar epithelial cells il<NUMBER> plays key role stimulating neutrophil survival recruitment lungs <NUMBER> il<NUMBER> synthesis effectively stimulated il<NUMBER>a il<NUMBER>f secreted il<NUMBER>dependent th<NUMBER> cells likely involved triggering cytokine storm associated lung neutrophilic infiltration <NUMBER> indeed high numbers th<NUMBER> lymphocytes found peripheral blood patients severe sarscov<NUMBER> infection <NUMBER> regard inflammatory cell influx sarscov<NUMBER>infected lungs key pathologic function also exerted gmcsf mediates relevant intercellular communications pathogenic th<NUMBER> cells cd<NUMBER> cd<NUMBER> monocytes figure <NUMBER> <NUMBER> high numbers cd<NUMBER> cd<NUMBER> monocytes detectable covid<NUMBER> patients severe involvement lungs cells actively participate journalssagepubcomhometar <NUMBER> induction amplification tissue infiltration macrophages <NUMBER> another proinflammatory mediator potentially involved cytokinechemokine storm characterising severe sarscov<NUMBER> infection chemokine ip<NUMBER> fact previously shown ip<NUMBER> upregulated bronchiolar alveolar epithelial cells well cells monocytesmacrophages infiltrating lungs subjects sars <NUMBER> ip<NUMBER> exerts strong chemotactic action lymphocytes monocytes natural killer cells <NUMBER> moreover high blood levels ip<NUMBER> detected patients died sars <NUMBER> thus likely ip<NUMBER> significantly contributes recruitment monocytesmacrophages lungs sars patients virusinduced production ip<NUMBER> could also responsible fast mobilisation followed subsequent apoptosis cells <NUMBER> mechanism might implicated impairment lymphocyte response sarscov<NUMBER> taken together considerations suggest critically ill covid<NUMBER> patients cytokine storm cytokine dysregulation lead remarkable pathological consequences indeed cytokine storm elicits immunological changes potentially weaken immune response aimed clear sarscov<NUMBER> infection lymphocytedependent protective responses sarscov<NUMBER> mediated cd<NUMBER> cd<NUMBER> cells may potentially fail overproduction il<NUMBER> tnfα fact cytokines inhibit cell proliferation activation thereby contributing development lymphopenia severely injured sarscov<NUMBER> infected patients <NUMBER> <NUMBER> consistent speculation reported high levels il<NUMBER> tnfα coexist relatively low counts cd<NUMBER> cd<NUMBER> cells <NUMBER> also hypothesised suppression functionally exhausted th<NUMBER> lymphocytes might concomitant immunological shift towards th<NUMBER>driven responses <NUMBER> <NUMBER> immunological changes likely occur often elderly negative impact aging protective efficiency afforded adaptive immune network new viral infections <NUMBER> cytokinechemokinemediated injury lung endothelial epithelial cells may impair integrity bloodair barrier thereby promoting vascular permeability well alveolar oedema infiltration inflammatory cells ie neutrophils macrophages hypoxia <NUMBER> addition presence within cytokine storm context fibrogenic factors tgfβ could favour tissue remodelling lung fibrosis <NUMBER> thus compromising gas exchange clinical setting urgent need detect laboratory parameters useful diagnose cytokine storm recent metaanalysis <NUMBER> studies globally including <NUMBER> patients <NUMBER> laboratory biomarkers suggests elevated serum levels il<NUMBER> ferritin paralleled high numbers white blood cells associated low lymphocyte platelet counts could provide valuable diagnostic platform critical covid<NUMBER> illness <NUMBER> data partially consistent recent explorative study carried <NUMBER> hospitalised covid<NUMBER> patients showed compared group less severe subjects severe patients characterised high blood levels il<NUMBER> fibrinogen sialic acid crp neutrophils <NUMBER> particular neutrophiltolymphocyte ratio nlr resulted significantly higher severely ill patients <NUMBER> thus suggesting decreased lymphocyte count might indicative existing impairment immune system several drugs currently approved treatment various diseases acting different molecular targets potentially useful lessen strength cytokine storm triggered sarscov<NUMBER> <NUMBER> however utilisation covid<NUMBER> patients mostly empirical lack published controlled trials showing reliable profile efficacy safety drugs include il<NUMBER> receptor antagonists il<NUMBER> receptor antagonists jak stat janus kinasessignal transducers activators transcription inhibitors corticosteroids hydroxychloroquine azithromycin effective inhibitor il<NUMBER> pathogenic action within context sarscov<NUMBER>induced <NUMBER> journalssagepubcomhometar cytokine storm appears tocilizumab recombinant humanised monoclonal antibody targeting il<NUMBER> receptor currently utilised treatment rheumatoid arthritis <NUMBER> <NUMBER> retrospective chinese study performed <NUMBER> severely ill covid<NUMBER> patients showed tocilizumab safely lowered fever crp well improving hypoxemia computed tomography ct scan lung lesions <NUMBER> basis positive results randomised controlled trial approved china aim testing tocilizumab subjects elevated il<NUMBER> levels interstitial pneumonia chictr<NUMBER> <NUMBER> tocilizumab also undergoing clinical investigation italy trial tocivid<NUMBER> nct<NUMBER> current chinese italian guidelines recommend use tocilizumab treatment covid<NUMBER> infection <NUMBER> particular italian guidelines suggest tocilizumab utilised patients interstitial pneumonia severe respiratory failure characterised high blood levels il<NUMBER> crpddimerfibrinogen ferritin <NUMBER> inhibitors jakstat signal transducers activators transcription signalling pathways baricitinib drug currently utilised treat rheumatoid arthritis potentially useful treatment cytokine storm indeed targeting jakstat signal transduction system baricitinib interferes functions adaptorassociated protein kinase <NUMBER> akk<NUMBER> cyclin gassociated kinase gak implicated viral endocytosis <NUMBER> fedratinib specific jak<NUMBER> inhibitor able reduce il<NUMBER> expression well repress gmcsf biological actions <NUMBER> therefore drug could contribute attenuate cytokine storm associated severe sarscov<NUMBER> infection another jak inhibitor ruxolitinib drug currently utilised treatment myelofibrosis ruxolitinib shown induce relevant clinical benefits covid<NUMBER> patients treated southern italy unpublished observations however studies needed corroborate validate positive preliminary data use systemic corticosteroids treatment covid<NUMBER>associated cytokine storm could value fact modulating cytokine production drugs might repress hyperinflammation associated covid<NUMBER>related ards <NUMBER> interesting observations suggest communityacquired pneumonia corticosteroids could increase rate therapeutic success also decrease number hospitalisation days time occurring reach clinical stability <NUMBER> however reported early use hydrocortisone subjects mers could delay viral clearance <NUMBER> moreover utilisation methylprednisolone sarscov<NUMBER> infected patients advanced ards progressive disease appears ameliorate respiratory symptoms ct abnormalities seem prolong overall survival <NUMBER> <NUMBER> nevertheless lack control arms conclusions based observational studies considered extreme caution chloroquine especially less toxic derivative hydroxychloroquine could block sarscov<NUMBER> entry inside target cells interfering glycosylation ace<NUMBER> receptors <NUMBER> drug also acts suppressing tlr<NUMBER> signalling inhibiting endosomal acidification essential viral replication <NUMBER> moreover hydroxychloroquine prevents endolysosomal fusion therapeutic action hydroxychloroquine potentiated azithromycin capable reducing proinflammatory activity il<NUMBER> tnfα <NUMBER> <NUMBER> conclusion dramatic outbreak sarscov<NUMBER> infection currently associated ongoing progress knowledge underlying pathogenic mechanisms shedding partial light immunophenotypic traits characterising infected patients susceptible development heavy lung damage caused cytokine storm indeed impairment antiviral immune response concurrent aberrant hyperinflammatory reaction facilitate especially elderly people comorbid conditions occurrence severe forms covid<NUMBER>related illness better understanding cytokine storm pathobiology also making possible explore therapeutic efficacy il<NUMBER> receptor antagonists jakstat inhibitors however require carefully evaluated definitely needed randomised controlled trials il<NUMBER> plays central role covid <NUMBER> cytokine storm extra figure illustrate point would needed domain therapeutic implications subheadings go like il<NUMBER> inhibitors steroids hydroxychloroquine azithromycin <NUMBER> comment regarding line <NUMBER> page <NUMBER> dysregulation impairment adaptive immunity spur cytokine storm however damage likely mediated adaptive innate immunity evident numerous elevated cytokines severe covid<NUMBER> <NUMBER> introduction page <NUMBER> starts nonspecific general comments suggest wrap lines delve topic cytokine storm salient facts reader loses interest suggestion start would look like cytokine storm historically labeled secondary hlh complication commonly encountered viral infections influenza ebv cmv recent covid<NUMBER> implicated triggering cytokine storm cytokine storm may provide possible mechanism certain subpopulations likely die covid<NUMBER> others please provide appropriate references <NUMBER> line <NUMBER> page <NUMBER> line <NUMBER> page <NUMBER> references enlisted related covid<NUMBER> provide beyond doubt proof senescence immune system risk factor covid<NUMBER> may well true would need experimental studies prove may written besides comorbidities involved senescence immune system plays role worst outcomes observed elderly <NUMBER> line <NUMBER> point already discussed suggest avoiding redundancy <NUMBER> line <NUMBER> context jump senescence immune system targeting cytokine storm therapeutics context <NUMBER> line <NUMBER> page <NUMBER> reference needs provided <NUMBER> line <NUMBER> page <NUMBER> reference <NUMBER> letter editor please avoid using secondary evidence support basic idea preferable credit original experimental studies illustrate point please make sure references <NUMBER> line <NUMBER> il <NUMBER> beta discussed stimulator neutrophil function manuscript talks il<NUMBER> talks il<NUMBER> gmcsf ip<NUMBER> organization manuscripts describing cytokines disorganized suggest start important interleukins il<NUMBER> supporting figure needs added talk important interleukins group fashion interleukins similar functions need clumped together unique function related cytokine mentioned separately manuscript lacks bigger picture interleukins connect dots describing one one help develop bigger picture <NUMBER> line <NUMBER> page <NUMBER> written criticallyill critically ill please proofread manuscript grammatical errors <NUMBER> line <NUMBER> summarizes cytokine events although mention salient features cytokine storm lacks stepwise organizational approach summarizing <NUMBER> therapeutic implications discussed article address diagnose cytokine storm clinician fulfill criteria h score devised uses ferritin value greater <NUMBER> time many patients already died based studies done covid<NUMBER> authors provide fair idea clinician comfortably able diagnose cytokine storm clinically think using therapeutic interventions page <NUMBER> page <NUMBER> therapeutic implications cytokine storm article starts medications favipiravir lopinavirritonavir context work separate mechanism antivirals little cytokine storm regarding hydroxychloroquine piece mentions role cytokines kept <NUMBER> start commonly used drugs tocilizumab commonly used talk jak inhibitors steroids discuss pros cons tocilizumab may may work clinical setting high viral load drives cytokine storm would unsuppressed use tocilizumab fear scientific community december <NUMBER> emergency novel coronavirus pneumonia wuhan china posed serious urgent threat medical health public world <NUMBER> <NUMBER> february <NUMBER> world health organization officially named <NUMBER>ncov severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> disease caused coronavirus disease <NUMBER> <NUMBER> january <NUMBER> declared covid<NUMBER> sixth public health emergency international concern march <NUMBER> made assessment covid<NUMBER> characterized pandemic third highly pathogenic coronavirus emerged rapidly since sarscov <NUMBER> merscov <NUMBER> <NUMBER> made public health care institutions around world face greater challenges sarscov<NUMBER> showed similar pattern infection clinical features even faster transmission rate <NUMBER> two coronaviruses already erupted <NUMBER> however particular attention acute lung injury ali systemic inflammatory response syndrome sirs acute respiratory distress syndrome ards occur sarscov merscov infected patients well severe patients covid<NUMBER> <NUMBER> cytokines found play key role driving appearance clinical features also core inflammation development <NUMBER> <NUMBER> consistent previous findings severe covid<NUMBER> patients showed significantly increased cytokines il<NUMBER> il<NUMBER> il<NUMBER> gscf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα characteristics cytokine storm <NUMBER> sarscov<NUMBER> infects body inflammatory response plays antiviral role strong cytokine storm due unbalanced response make huge damage patients therefore taking strategies suppress effectively cytokine storm essential way prevent deterioration patients covid<NUMBER> save patients lives great significance treatment critically ill patients reducing mortality rate review sarscov<NUMBER> occurrence mechanisms cytokine storm induced introduced detail including ways cytokines activated released cause cell organ damage therapeutic interventions prevent quell harmful process decreased <NUMBER> <NUMBER> abnormally elevated alt ast <NUMBER> <NUMBER> proinflammatory cytokines il<NUMBER>β il<NUMBER> tnfα increased ddimer creactive protein crp procalcitonin pct also increased <NUMBER> addition patients plasma angiotensin ii ang ii levels significantly increased related viral load lung injury <NUMBER> clinical manifestations pathology studies shown patients covid<NUMBER> mainly performed lung injury <NUMBER> deaths due multiple organ failure caused ards <NUMBER> <NUMBER> addition icu patients showed higher levels plasma cytokines like il<NUMBER> <NUMBER> ddimer crp pct <NUMBER> suggesting inflammatory responses played key role injuries may also related severity patients <NUMBER> even cause death owing lack direct evidence unclear process inflammatory response involved cytokines fully completed certain manifested clinical features directly related violent occurrence inflammation cytokine storm refers overproduction inflammatory cytokines wide range biological activity variety tissues cells mainly immune cells due different infection loss negative feedback immune turn cytokines drive positive feedback others immune cells continue recruit sites inflammation begetting growing inflammation exponentially organ damage short unceasing extreme activation attack autoimmune system main cytokines involved interleukin il interferon ifn tumor necrosis factor tnf colony stimulating factor csf chemokine family growth factor gf etc divided proinflammatory factors il<NUMBER>β il<NUMBER> il<NUMBER> tnf ifnγ antiinflammatory factors il<NUMBER> il<NUMBER> il<NUMBER> tgfβ based functions cytokine storms crucial cause ards systemic inflammatory response multiple organ failure <NUMBER> moreover viruses invade lung epithelial cells alveolar macrophages produce progeny nucleic acid stimulate infected cells release cytokines chemokines activating macrophages dendritic cells etc <NUMBER> much chemokines cytokines released cells attract inflammatory cells migrate site inflammation blood vessels thereby cascading amplification inflammatory response long believed wellcoordinated rapid innate immune response first line defense viral infection cytokines synthesized secreted immune cells involved induction period effect phases inflammatory reactions importantly activating initiation cytokine transcription mechanism promote secretion key link immune cells body detect pathogenassociated molecular pattern pamp virus pattern recognition receptor prr cell membrane immediately innate immune response system activated <NUMBER> among prrs typical tolllike receptor tlr<NUMBER> tlr<NUMBER> transmembrane receptor extracellular accessory proteins md<NUMBER> md<NUMBER> rp<NUMBER> involved recognition pamp <NUMBER> macrophages key cells host defense tlr<NUMBER> macrophages specifically recognizes intermediate product dsrna virus replication followed recruitment recruits signal transfer proteins myd<NUMBER> tirap tram trif cytoplasmic tir domain activation various kinases iraks tbk<NUMBER> ikks tumor necrosis factor receptorrelated factor <NUMBER> traf<NUMBER> according different adaptors eventually nfκb mapk jnkstat pathways activated promote transcription inflammatory cytokines produce ifn il<NUMBER>β il<NUMBER> etc coordinating local systemic inflammatory responses <NUMBER> figure <NUMBER> il<NUMBER>β il<NUMBER> major proinflammatory cytokines released viral infections <NUMBER> il<NUMBER>β enhances inflammatory responses bronchia alveolar patients lung injury time acute phase proteins hepatocytes stimulated il<NUMBER>β il<NUMBER> activate complement system complement cascade increases vascular permeability prr activates multiple cytokine transcription delayed ifnα β response il<NUMBER> always important star factor cytokine storms virusinfected lesions il<NUMBER> respond il<NUMBER> tnfα tlr signals trigger cisregulatory modules activate nfκb transcriptional signaling pathway binding site nuclear factor il<NUMBER> caatebpβ <NUMBER> important il<NUMBER> combines transmembrane receptor il<NUMBER>r generate il<NUMBER>il<NUMBER>r complex signal transduction component gp<NUMBER> dimerization induced complex activated janus kinase signal transduction transcription activators <NUMBER> figure <NUMBER> high levels il<NUMBER> activate coagulation system increase vascular permeability providing conditions rapid spread inflammation <NUMBER> reported higher levels il<NUMBER> severe patients covid<NUMBER> proves high levels il<NUMBER> may cause greater damage lung tissue <NUMBER> verified vitro sarscov protein induces upregulation il<NUMBER> tnfα mouse macrophages nfκb pathway <NUMBER> cytokinemediated inflammatory response pathway series intersecting networks one degree redundancy alternate pathways combinations tlr ligands initiate signal cascaded amplification lead activation multiple cytokine pathways main research focus current inflammatory responses regulation cytokines chemokines conventional lymphocytes cells b cells differentiate specific effector cells localize site infected instance cd<NUMBER>t cells differentiate th<NUMBER> cells produce ifnγ activate macrophages types cells induction il<NUMBER> thereby triggering defense intracellular pathogens time ifnγ induce transcription multiple chemokines besides il<NUMBER> induce differentiation cd<NUMBER>t cells cytotoxic cells eliminated viruses way lysing infected cells suicide consumption cytotoxic cells may cause decrease lymphocytes patients covid<NUMBER> <NUMBER> found lymphocytes vital source many chemokines express multiple molecule receptors <NUMBER> neutrophils macrophages drawn region injury il<NUMBER> mcp<NUMBER>chemotactic influences respectively secreting chemokines recruit cells participate battle pathogens accepted cell respond multiple chemokines expressing single type receptor complex relationship chemokines receptors makes chemokines rapidly replenish various microenvironments inflammatory storm continues develop <NUMBER> according report proinflammatory cytokines like tnf il<NUMBER> chemokines il<NUMBER> ccl<NUMBER> mcp<NUMBER> ccl<NUMBER> ccl<NUMBER> cxcl<NUMBER> significantly upregulated antiinflammatory factor il<NUMBER> lacking sars patients <NUMBER> showed lack antiinflammatory factors cause imbalance inflammatory response promote cytokine storm acute lung injury ali common consequence cytokine storm lung tissue systemic circulation <NUMBER> recently pulmonary pathology sarscov<NUMBER> infection showed major changes lung tissue showed diffuse alveolar damage alveolar edema proteinaceous exudates thickening alveolar walls evident desquamation pneumocytes hyaline membrane formation indicated ards <NUMBER> multinucleated giant cells alveolar cavity inflammatory infiltration lymphocytes pulmonary mesenchyme <NUMBER> addition patients pathological results confirmed number cd<NUMBER>t cd<NUMBER>t cells peripheral blood reduced overactivated high proinflammatory effects th<NUMBER> cells increased concentrating ccr<NUMBER>ccr<NUMBER> cd<NUMBER>t cells contain high concentrations cytotoxic granules mainly perforin granulysin cause severe immune damage patients <NUMBER> evidences showed patients extensive acute lung injury multiple organ failure may caused activation bodys immune system including innate immunity adaptive immunity resulting strong inflammatory storm angiotensin converting enzyme <NUMBER> ace<NUMBER> proved cellular receptor sarscov<NUMBER> <NUMBER> addition <NUMBER> mutations found sarscov<NUMBER> spike glycoprotein binding region suggesting coronavirus evolved gradually adapting human hosts <NUMBER> <NUMBER> though ace<NUMBER> exists various tissues coronary arteries vascular endothelium renal tubular epithelium <NUMBER> macrophages pulmonary alveolar epithelial mainly attacked targets <NUMBER> explains contribute acute lung injury mainly currently generally believed sarscov<NUMBER> considered susceptible populations animal models demonstrated older rhesus monkeys susceptible sarscov <NUMBER> upexpress ace<NUMBER> lower respiratory tract induced smoking may increase sensitivity sarscov<NUMBER> genetic analysis ace<NUMBER> found mutant expression higher east asian populations may indicate differences sarscov<NUMBER> infectivity among different populations <NUMBER> addition rapid virus replication causes cell pyroptosis immune evasion cell lysis triggered antifc antibodies trigger release mass proinflammatory cytokines chemokines therefore covid<NUMBER> patients clinical symptoms exacerbated may result combination cytopathic effects directly caused virus infection immunopathology injury caused violent cytokine storms molecular modeling structural analysis results <NUMBER>ncov receptors receptor binding domain rbd sarscov<NUMBER> effective interaction ace<NUMBER> compared sarscov <NUMBER> binding protein ace<NUMBER> first step virus enter target cells accomplished proteolytic cleavage fusion viral cellular membranes <NUMBER> speculated sarscov<NUMBER> might also cause lung tissue injury pathogenic mechanism <NUMBER> one hand sarscov<NUMBER> infects alveolar cells s<NUMBER> ace<NUMBER> transmembrane domains combine reduce level ace<NUMBER> resulting renin angiotensin system ras tilts towards aceang ii axis <NUMBER> meanwhile production ang ii absolutely relatively elevated causing macrophagocyte infiltration inducing cytokines adhesion molecules increase including il<NUMBER> monocyte chemotactic protein <NUMBER> mcp<NUMBER> vascular cell adhesion molecule <NUMBER> vcam<NUMBER> selectin e etc causing endothelial dysfunction <NUMBER> <NUMBER> besides downregulation ace<NUMBER> reduces protective effects acute lung injury <NUMBER> leading increased pulmonary capillary permeability pulmonary edema severe patients may die respiratory failure hand cell experiment studies vitro shown sarscov induces shedding ace<NUMBER> extracellular ectodomain promotes virus entry cells dependence tnfα converting enzyme tace function free sace<NUMBER> unknown currently may also mediate inflammation tissue injury <NUMBER> addition binding virus ace<NUMBER> might also involved intracellular pathway recognition pyroptosis new inflammatory form programmed cell death inflammation storms caused sarscov<NUMBER> infection may related cell pyroptosis research evidences chen et al showed sarscov viroporin <NUMBER>a protein activates nlrp<NUMBER> nodlike receptors protein <NUMBER> inflammasome causing il<NUMBER>β production <NUMBER> reduced cell counts increased il<NUMBER>β serum covid<NUMBER> patients may indicated activation cell pyroptosis variety extracellular pamps recognized tlrs <NUMBER> triggers activation nfκb signaling pathway upregulation inflammasome related components including inactivated nlrp<NUMBER> proil<NUMBER>β proil<NUMBER> subsequently nlrp<NUMBER> oligomerize connected procaspase<NUMBER> adaptor protein asc form multiprotein complex thereby activating caspase<NUMBER> <NUMBER> activated caspase<NUMBER> recruits incises members polymerizes gasdermin family gsdmd pathway downstream <NUMBER> simultaneously incises precursors il<NUMBER>β il<NUMBER> forming active il<NUMBER>β il<NUMBER> released extracellular recruit inflammation cells aggregate expand inflammatory response <NUMBER> besides active cleavage fragment gsdmd caused extensive cell perforation inserting lipid bilayer resulting cell swelling lysis followed release contents cellular matrix cytokines <NUMBER> mass endogenous molecules immune intracellular released oxidized phospholipids cellular matrix called damageassociated molecular patterns damp similar pamp known alarm singles also recognized nlrp<NUMBER> thereby progressively magnify inflammatory effects cause cell pyroptosis <NUMBER> figure <NUMBER> covid<NUMBER> patients often lymphopenia research still needed prove whether also related mechanism intracellular signaling mechanism cell pyroptosis induced pamps ifn core family innate antiviral immunity ， type interferons ifnα β essential especially innate immune response viruses microbial infections binding type interferon tis dimer receptor ifnar activates jakstat signal transduction pathway jak<NUMBER> tyk<NUMBER> kinases phosphorylate stat<NUMBER> stat<NUMBER> irf<NUMBER> form complex complexes enter nucleus initiate transcription ifnstimulated genes isg <NUMBER> vitro studies found rapid replication sarscov mice induces significant delayed ifnαβ response accompanied large influx pathogenic inflammatory mononuclear macrophages imm <NUMBER> leading lung cytokines chemokine increased vascular leakage virusspecific cell apoptosis hinder virus clearance addition studies demonstrated coronaviruses rapidly replicate host cells encode proteins nsp<NUMBER> antagonizes ifns response blocking stat<NUMBER> phosphorylation <NUMBER> <NUMBER> meanwhile structural proteins n inhibit ifns signaling deactivating traf<NUMBER> tbk<NUMBER>ikks mechanisms respectively <NUMBER> coronavirus structural nonstructural protein delayed response ifns amplifies inflammatory response promoting viral replication followed increase viral pamps turn pamps inhibit delayed ifn signaling stimulate prrinduced abnormal inflammatory responses <NUMBER> clear putative antiviral mechanisms confirmed stepbystep studies whether really important infectious viruses systemic antagonist pathways need studied generally considered antiviral antibodies play much important role viral clearance according reports response antisneutralizing antibodies nab dead patients developed significantly faster <NUMBER> vs <NUMBER> days higher level patients recovered sars <NUMBER> sarscov macaque experimental model inoculated protein antibody found antisigg facilitate severe lung injury early stages infection via eliminates wound healing macrophage response tgfβ production well promote inflammatory macrophages production factors mcp<NUMBER> il<NUMBER> <NUMBER> evidences suggested antisigg may also play important role lung injury caused acute sarscov<NUMBER> infection acute infection period <NUMBER> since fcr blockaded reducing production inflammatory cytokines considered virusantisigg complex may promote cytokine release binding fc receptors surface macrophages additionally antibodydependent cellmediated cytotoxicity adcc directly lyses target cells <NUMBER> whether complex associated antibodydependent enhancement ade <NUMBER> complement system activation patients covid<NUMBER> viral replication <NUMBER> remains proven studies sum rapid spread sarscov<NUMBER> forced medical institutions carry research prevention control worldwide efforts made slow spread covid<NUMBER> order provide better publichealth recommendations develop timely diagnostics therapeutics vaccines mentioned potential mechanisms based two outbreaks coronavirus current partial research <NUMBER> many new mechanisms still unknown new treatments developed based existing experience combating viral infections however present treatment strategies sarscov<NUMBER> infection supportive important effective antiviral therapies covid<NUMBER> assume discuss sarscov<NUMBER> likely associate similar cytokines storm therapeutic interventions targeting proinflammatory cytokines chemokines may help alleviate adverse inflammatory responses corticosteroids usually used suppress inflammation responses main means immunomodulatory therapy sars epidemic early patients found increased plasma viral load secondary infections <NUMBER> studies early administration ifn beneficial reducing viral load moderately improves clinical performance combination ribavirin also made certain therapeutic effect <NUMBER> ifnλ inhibited recruitment inflammatory cells production il<NUMBER>β without excessive stimulation immune system might become potential therapeutic direction <NUMBER> besides results management patients covid<NUMBER> xu et al showed artificial liver blood purification system quickly clear inflammation mediators suppress cytokine storms however repair system may delayed excessive clarity <NUMBER> however strategies still need tested clinical effectiveness addition evidence serine protease tmprss<NUMBER> plays important role sarscov<NUMBER> entry cellular tmprss<NUMBER> inhibitors prevent entry may become treatment option sarscov<NUMBER> neutralized serum recovery sars patients <NUMBER> showing good therapeutic effect therefore use intravenous immunoglobulin may viable option urgent treatment pulmonary inflammation meanwhile means vaccine development may effective means current vaccine production faces many obstacles requires researchers explore via international cooperation studies found may individual differences susceptibility cytokine storms innate immune response healthy people highly variable genetically confirmed tlr receptor example sepsis patients single nucleotide polymorphisms snps tlr<NUMBER> hypermorphic variants associated increased susceptibility organ dysfunction death grampositive bacteremia infection <NUMBER> tlr<NUMBER> major contributor lipopolysaccharide lps variants make individuals susceptible sepsis genomewide association studies gwas linked tlr<NUMBER> polymorphisms pathogen susceptibility disease severity <NUMBER> future researches likely reveal potential genetic variations affect host cytokine storms infection addition bodys immune pathological damage closely related viral load degree cytokine storm essential connection point plasma cytokines monitored dynamically assess degree cytokine storm timely effectively may great benefit care critically ill patients inflammatory response essential part immune system function otherwise pathogen difficult eliminate sarscov<NUMBER> might induce excessive prolonged cytokine responses resulting lung damage multiple organ failure far studies focused direct measurement cytokines chemokines peripheral blood context rapidly changing cytokine environment virus infection round understanding cause vigorous inflammatory response comprehensive understanding factors although existing researches shown occurrence pathogenic hcov infection violent cytokine storm caused immune pathological damage may real dead killer critically ill patients time human autopsy animal models studies provided evidences pathogenic mechanism inflammatory cytokines derived imm neutrophils however current researches limited detailed molecular biology principles broader epidemiology lacking therefore future researches focus identification specific inflammatory response signaling pathways patients animals infected hcov course include scientific effective application control spread virus worldwide authors declare known competing financial interests personal relationships could appeared influence work reported paper introduction plasmacytoid dc also supposed reason behind aggressive disease course dengue viral infections <NUMBER> human sarscov<NUMBER> virus causing covid<NUMBER> also leads dreaded course due cytokine storm lung tissue leading fatality <NUMBER> intervention inhibit cytokine storm generated prevent cases fatal outcome worldwide deaths due covid<NUMBER> increasing day day measures curb deaths underway obvious benefits patients risk elderly comorbid illness diabetes hypertension chronic airway diseases cancers inhibition cytokine storm may prevent emergence fatal lung injury observed many case reports cytokine milieu higher patients landing icu compared nonintensive care unit patients recruitment cytokine cytokine storm results fatal disease similar activation airway epithelial cells immune response airway epithelial response viral infection release various cytokines interleukin<NUMBER> il<NUMBER> tumor necrosis factorα tnfα granulocyte colonystimulating factor csf granulocytemacrophagecsf gmcsf <NUMBER> high il<NUMBER> levels associated disease severity ablation il<NUMBER> signaling il<NUMBER> receptor antibodies lead uncontrolled virus replication resulting greater mortality <NUMBER> tnfα hand leads impair viral replication enhances cytotoxic activity cytokine production leukocytes activates endothelial cells <NUMBER> elevated levels tnfα associated greater morbidity infection highly pathogenic virus blocking activity tnfα attenuates immunemediated pathology gmcsf elevated covid<NUMBER> <NUMBER> gmcsf leads activation dcs macrophages case recruited macrophages clear viralinfected cells phagocytosis seems overwhelmed immunemediated injury lung mortality due cytokine storm <NUMBER> one thing crystal clear fatal course covid<NUMBER> result mature immune response resultant cytokine storm leading fatal lung injury hence children mildmoderate disease elderly risk worldwide focus targeting il<NUMBER> tocilizumabil<NUMBER> receptor humanized antibody shown promising result dealing covid<NUMBER> patients previously used treat rheumatoid arthritis studies focusing targeting gmcsf however measures also put risk increased viral replication <NUMBER> measures potentially cause morbid outcome prolonged course disease may also lead increased community transmission nicotinamide leads inhibition poly adp ribose polymerase parp activity turn inhibits inducible nitric oxide synthase expression reduced free radicals proinflammatory cytokines restoration adenosine triphosphate <NUMBER> nicotinamide also used mitigate acute lung injury due bleomycin <NUMBER> nicotinamide structurally similar isoniazid pyrazinamide used treat tuberculosis nicotinamide used treating hiv <NUMBER> cases covid<NUMBER> infection resultant cytokine storm leading acute lung injury focus restoration atp nicotinamide supplementation approach may mitigate inflammatory response ultimately outcome elderly population otherwise deficient niacin putting increased risk tissue injury due covid<NUMBER> poor recovery tissue damage niacin supplementation help restoring tissue damage <NUMBER> may result better outcome aging leads slower metabolism reduced absorption dietary niacin targeting cytokine storm everyone targeting seems apt think tissue restoration prevention damage due cytokine storm supplementation key factors needed mitigating tissue injury taken consideration niacin supplementation shown reduction proinflammatory cytokines although animal model <NUMBER> vitro studies done endotoxemia due lipopolysaccharide ie outer membrane gramnegative bacteria known inducing cytokine storm due cytokine activation aberrant pathway leading sepsis reduced nicotinamide supplementation dosedependent manner <NUMBER> systematic review supplementation suggested vitamin b deficiency may weaken host immune response supplemented virusinfected patients enhance immune system therefore b vitamins could chosen basic option treatment covid<NUMBER> <NUMBER> systematic review also suggested role vitamin b<NUMBER> nicotinamide potential use vitamin b<NUMBER> treatment significantly inhibited neutrophil infiltration lungs produced strong antiinflammatory effect ventilatorinduced lung injury vili <NUMBER> one study done mice nicotinamide associated hypoxemia vili even mentioned neutrophilinduced lung injury reduced due niacin supplementation <NUMBER> parp plays important role immune response lung <NUMBER> parp<NUMBER> inhibitor decreased levels il<NUMBER> active plasminogen activator inhibitor <NUMBER> lungs attenuated leukocyte lung transmigration reduced pulmonary edema apoptosis <NUMBER> parp known pathogenesis mechanical vili <NUMBER> considering molecular mechanism covid<NUMBER> targeting parp sensible approach nicotinamide economical way deal parp inhibition parp inhibitors repurposed acute lung injury <NUMBER> parp inhibitors clinical development mimic nicotinamide moiety nicotinamide adenine dinucleotide hence nicotinamide first parp inhibitor activity parp<NUMBER> parp<NUMBER> used parp inhibitor <NUMBER> bodys niacin requirement met nicotinic acid nicotinamide present diet also conversion dietary proteincontaining tryptophan relative contribution tryptophan estimated follows <NUMBER> mg tryptophan <NUMBER> mg niacin <NUMBER> mg niacin equivalents <NUMBER> nicotinamide recommended daily allowance <NUMBER> mgkgday recommended daily allowance however dose needed parp inhibition <NUMBER> <NUMBER> mgkg high dose nicotinamide adverse effects nicotinamide rare occurred mainly high oral doses ≥<NUMBER>gday include nausea vomiting liver toxicity headache fatigue dizziness <NUMBER> must also know dealing immunity one must sure timing administration antioxidant modulate immunity suppression following figure may explain better way reactive oxygen species ros levels decide immune responses levels ros lead physiological responses inflammatory cells high levels intracellular ros levels result exaggerated inflammatory responses associated cytokine storm relatively low ros levels give hypoinflammatory response leading immunosuppression ros levels intermediate range result normal immune cell function use antioxidants may beneficial periods exaggerated inflammatory responses may detrimental periods relative immunosuppression thus efficacy antioxidants dependent individuals inflammatory response profile timing duration antioxidant administration critical demonstrating salutary effect therapeutic intervention individualizing dosing likely crucial element optimizing potential antioxidant strategy <NUMBER> declaration patient consent patients consent required patients study nil conflicts interest since december <NUMBER> scientific community globe confronted unprecedented challenge battle new infectious agent severe acute respiratory syndromecoronavirus sarscov<NUMBER> subsequently defined pandemic worrisomely high mortality rate although majority patients coronavirus <NUMBER> disease causes mildtomoderate symptoms consistent proportion infected subjects could develop respiratory failure acute respiratory distress syndrome ards sepsis <NUMBER> immunological perspective severity covid<NUMBER> seems correlate increased amount several cytokines particular interleukin il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tumour necrosis factorα tnfα granulocyte colonystimulating factor gcsf interferon ifn γinduced protein <NUMBER> kda cxcl<NUMBER> monocyte chemoattractant protein <NUMBER> macrophage inflammatory protein <NUMBER>α serum affected tissues <NUMBER> <NUMBER> addition cd<NUMBER> cells activated become pathogenic th<NUMBER> cells generate gcsf thereby augmenting expression il<NUMBER> cd<NUMBER> cd<NUMBER> monocytes <NUMBER> massive release proinflammatory mediators fuelled positive feedback loops aberrant activation immune system resembles socalled cytokine release syndrome group conditions sharing pathogenic mechanism although different aetiology <NUMBER> covid<NUMBER> cytokine storm accounts two main causes mortality disease <NUMBER> ards <NUMBER> secondary haemophagocytic lymphohistiocytosis shlh latter occurring small subset patients <NUMBER> needless say comforting hypothesise therapeutic role immunosuppression severe covid<NUMBER> last weeks increasing evidence supported immunomodulating compounds may beneficial severe covid<NUMBER> <NUMBER> <NUMBER> however guide therapeutic decisions heterogeneity umbrella cytokine storm syndromes must appraised <NUMBER> covid<NUMBER> cytokine storms adults initially described early <NUMBER>s following administration antitcell antibody muromonabcd<NUMBER> cytokine storm linked different conditions therapeutic agents overtime thereby broadening spectrum disease <NUMBER> cite alunno carubbi f rodríguezcarrio j storm typhoon cyclone hurricane patients covid<NUMBER> beware storm different origin rmd open <NUMBER>e<NUMBER> doi<NUMBER> rmdopen<NUMBER> nowadays term cytokine storm applies several fields medicine potentially serious complication immunotherapy several infectious neoplastic autoimmune diseases haemophagocytic lymphohistiocytosis hlh tcelldriven hyperinflammatory hyperferritinemic condition characterised persistent ifnγdependent stimulation tolllike receptors tlrs antigenpresenting cells tcell uncontrolled activation ultimately leading cytokine storm <NUMBER> according <NUMBER> histiocyte society recommendations hlh therapeutic strategies based concept heterogeneous disease variable aetiology severity hence treatment tailored control hyperinflammation glucocorticoids intravenous immunoglobulin cyclosporine etoposide historical anchor drugs treat identified disease triggers immunomodulating agents like il<NUMBER> il<NUMBER> inhibitors recommended selected cases including macrophage activation syndrome mas subtype shlh associated systemic juvenile idiopathic arthritis sjia adultonset stills disease aosd autoimmune disorders <NUMBER> context infection new viral agent adds another layer complexity management cytokine storm thus challenging translation evidence autoimmune diseases causal relation sarscov<NUMBER> shlh relies ability bind tlrs induce abovementioned cascade via activation inflammasome release il<NUMBER>ß <NUMBER> importantly lung tissue samples collected patients sarscov sars epidemic early <NUMBER>s reported exhibit hemophagocytosis features <NUMBER> however patients covid<NUMBER> develop fully blown shlh worse prognosis may neither fulfil hlh<NUMBER> diagnostic criteria table <NUMBER> <NUMBER> reach hlhprobability calculator hscore cutoff values authors developed hscore pointed underlying disease associated peculiar biologic abnormalities cutoff values laboratory criteria may need set accordingly <NUMBER> ruan et al described significantly higher ferritin levels severe covid<NUMBER> putting forward hypothesis represent prognostic marker disease however mean ferritin values patients better prognosis still hlh<NUMBER> cutoff ≥<NUMBER> µgl unclear many deceased patients reached hscore ferritin cutoff <NUMBER> ngml stage disease <NUMBER> recently proposed aosd mas catastrophic antiphospholipid syndrome septic shock characterised similar clinical picture elevated serum ferritin levels included socalled hyperferritinaemic syndrome <NUMBER> interestingly association pulmonary involvement hlh reported patients sjia mediated gene pathways related ifnγ response <NUMBER> lung imaging pattern inflammatory mediators appear similar patients covid<NUMBER> basis covid<NUMBER> pulmonary involvement could considered hyperferritinaemic syndrome regardless concomitant shlh <NUMBER> identification hemophagocytosis features covid<NUMBER> lung tissue assessment ferritin proinflammatory cytokines trends overtime along receiver operating characteristic curves computed data patients covid<NUMBER> would add significant knowledge matter particular would allow <NUMBER> confirm whether covid<NUMBER> yet another hyperferritinemic syndrome <NUMBER> clarify whether current hscore cutoff values reliable patients redefined <NUMBER> understand actual extent cytokine storm patients covid<NUMBER> regardless severity ultimately support clinicians decision start immunomodulating therapy compound moreover important understand whether severe forms covid<NUMBER>associated pneumonia ferritin mere acute phase protein rather active pathogenic mediator addition light proinflammatory role ferritin enriched heavy subunits heavy ferritin could interest evaluate heavylight ferritin ratio covid<NUMBER> <NUMBER> finally potential usefulness ferritinerythrocyte sedimentation rate ratio may immediate inexpensive easytoimplement biomarker needs considered <NUMBER> covid<NUMBER> cytokine storms children despite earlier reports outlined covid<NUMBER> morbidity mortality children low <NUMBER> recently several children novel multisystem inflammatory disease resembling toxic shock syndrome tss atypical kawasaki disease kd proven sarscov<NUMBER> infection observed uk likewise increased frequency kd reported italy <NUMBER> <NUMBER> tss rare lifethreatening condition due cases toxins produced staphylococcus aureus bacteria also related group streptococcus tss characterised fever diffuse macular erythroderma desquamation <NUMBER> weeks onset rash hypotension multisystem involvement three following organ systems gastrointestinal muscular mucous membrane renal hepatic hematologic central nervous system <NUMBER> however classified probable definite tss clinical picture necessary sufficient either two abovementioned bacteria need isolated biologic samples current circumstances whether viral isolates may also considered remains elucidated tempting speculate sarscov<NUMBER> alone combination could triggering facilitating tss hand kd acute systemic vasculitis characterised fever nonsuppurative conjunctival injection rash oral mucositis extremity changes cervical lymphadenopathy along scarlet fever meningococcaemia conditions represent differential diagnosis tss comes surprise elevated il<NUMBER>b il<NUMBER> levels addition monotype profile shifted intermediate monocytes common hallmarks kd <NUMBER> mas complication <NUMBER> patients kd however incidence likely underestimated many clinical laboratory features diseases overlap hlh <NUMBER> criteria low sensitivity specificity diagnosis mas complicating kd <NUMBER> recently classification criteria mas paediatric population released allow provide reliable epidemiological data <NUMBER> basis conceivable defined novel multisystem inflammatory disease may yet another condition caused covid<NUMBER>induced cytokine storm existing evidence although limited unlike adults children covid<NUMBER> good prognosis display normal ferritin levels underscores importance measure molecule severe covid<NUMBER> abovementioned multisystem inflammatory disease <NUMBER> <NUMBER> <NUMBER> furthermore comparing vascular involvement young lung involvement adultelderly help characterise pathogenic mechanisms behind sarscov<NUMBER> infection also gain understanding towards differential responses across lifespan latter may useful define personalised medicine algorithms better adjust existing ones aspects hyperinflammation covid<NUMBER> remain therefore elucidated known develop cytokine storm extent nonetheless several immunomodulating agents inhibiting activity ifnγ il<NUMBER>β tnfα il<NUMBER> janus kinase <NUMBER> <NUMBER>signal transducer activator transcription pathway investigation treatment selected cases covid<NUMBER> despite mainstay treatment hyperinflammation immunomodulatory agents doubleedged swords viral infection must managed caution special attention needs considered referring nonviral hyperinflammation treatment guidelines regard location timing viral phase deserve considerations guide treatment compounds first must noted disease timing associated distinct organs involved although originated lungs viral response phase leads host inflammatory response phase responsible hyperinflammation thus cytokine storm <NUMBER> exact overlap infection phase organ involvement needs precisely defined tempting speculate underlying immune inflammatory mechanisms differ across phases clear implications therapy conceivable local immune activation lungs precedes general hyperinflammation observed systemic level multiorgan failure observed late stages covid<NUMBER> severe infection aligned notion alternatively may hypothesised uncontrolled replication lungs due poor innate cd<NUMBER> mediated viral clearance may facilitate viral spreading via vasculature systemic compartment fact sarscov<NUMBER> binds ace<NUMBER> expressed lungs vascular endothelium may support idea indepth characterisation draining lymph node microenvironment pursued better delineate infection kinetics hence disease stages second acute inflammatory response infective agents observe rapid within <NUMBER> min increase tnfα il<NUMBER>β levels subsequent rise il<NUMBER> high levels il<NUMBER> last longer tnfα il<NUMBER>β levels rapidly decrease within <NUMBER> hours <NUMBER> therefore clinical trials need clarify outcome treating patients immunosuppressants different disease stages different extent pulmonary involvement regard interim results french corimunotoci openlabel randomised controlled trial recently announced <NUMBER> total <NUMBER> patients hospitalised covid<NUMBER> moderate severe pneumonia requiring intensive care upon admission enrolled study randomised <NUMBER> receive standard care without tocilizumab significantly lower proportion patients needed ventilation noninvasive mechanical died day <NUMBER> tocilizumab group confirming early intervention may major determinant ensure adequate tackling cytokine storm furthermore treatment glucocorticoids may beneficial patients develop ards especially light cost availability knowledge drug previous use hyperinflammation however linked exacerbation covid<NUMBER>associated lung injury <NUMBER> trials needed investigate optimal dosage timing glucocorticoids covid<NUMBER> treatment finally patients covid<NUMBER> yet treated antiviral agents clinicians pay attention viral load find balance ablating cytokine storm via use immunomodulating agents without significantly affecting host defence virus thereby preventing uncontrolled replication regard ideal scenario would combine treatments cytokine storm effective antiviral therapy thus reinforcing need disease stratification benefit treatment decisionmaking process conclusion although cytokine storm observe covid<NUMBER> similar observed diseases scenario complex initially thought due heterogeneity hyperinflammation addition question remains whether general phenomenon rather reaction lung possibly relation massive viral invasion secondary lack antiviral response deeper understanding origin different phases cytokine storm relation whole clinical picture disease evolution allow draw definitive conclusion nature natural history process better characterisation host immune response across disease stages systemiclung phase transition viral lung tropism needed acquisition notions allow confirm whether covid<NUMBER> considered hyperferritinaemic syndrome optimise management condition based disease stage stratification viral load cytokine signature ultimately tailor therapeutic approach improve disease prognosis coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> overwhelming spreading throughout world declared global pandemic far <NUMBER> million confirmed cases reported worldwide including <NUMBER> deaths treatment critically ill patients covid<NUMBER> remains challenge first report pathological characteristics patient died severe infection sarscov<NUMBER> demonstrated increased concentration highly proinflammatory cytokines <NUMBER> actually cytokine storm mediated overproduction proinflammatory cytokines observed large population critically ill patients covid<NUMBER> <NUMBER> cytokine storms result cardiovascular collapse multiple organ dysfunction cardiac arrest death epinephrine vasoactive agent routinely employed critical situation cardiac arrest however remains uncertain whether epinephrine also benefit cardiac arrest following cytokine storms occurred covid<NUMBER> patients question easy overlooked deserves deep consideration study published nature <NUMBER> staedtke et al used subcutaneously implanted osmotic pumps continuously release epinephrine norepinephrine dopamine mice treated lipopolysaccharide lps mice epinephrine norepinephrine dopamine showed exacerbated disease course higher levels interleukin <NUMBER> tumour necrosis factor chemoattractants compared lpstreated controls result revealed epinephrine may fuel cytokine storms effect epinephrine initiating cytokine storms confirmed different model system severe bacterial infection actually known immune cells macrophages activated inflammatory stimuli induce catecholamines respond autocrine manner amplifies inflammatory response <NUMBER> even idea epinephrine acts promote cytokine storms seems counterintuitive since molecules class used routinely treat low blood pressure associated cytokine storms integrated evidences suggest epinephrine stimulate cytokine catecholamine release autocrine amplification cascade might worsen cytokine storms covid<NUMBER> patients therefore clinic reassessment benefit epinephrine rescuing cardiac arrest caused cytokine storms covid<NUMBER> patients urgently needed retrospectively analysed <NUMBER> patients diagnosed covid<NUMBER> suffered rescue treatment epinephrine tongji hospital wuhan china january <NUMBER> march <NUMBER> <NUMBER> noticed <NUMBER> <NUMBER> patients survivors discharged hospital eventually severity disease may account mostly poor outcome however expected established role epinephrine fueling cytokine storms aggravated cytokine storms may also played role failure rescue beyond rapid defibrillation early initiation cardiopulmonary resuscitation therapies identified improve survival cardiac arrest patients reliably use epinephrine resuscitation mainstay agent cardiac arrest however safety effectiveness agent remains controversial <NUMBER> <NUMBER> vasopressin proposed alternative epinephrine cardiac arrest based finding levels markedly higher successfully resuscitated patients patients died <NUMBER> compared epinephrine vasopressin several advantages first increases arterial peripheral resistance without resulting direct myocardial stimulation moreover resistant acidosis longer halflife importantly fuel cytokine storms although common cardiac arrest compared epinephrine advantage use vasopressin identified outcomes clinical studies cardiac arrest covid<NUMBER> patients vasopressin still fully assessed considering cytokine storms occurred special population might limit use epinephrine clinical decision making must balance risks benefits treatment therefore time reevaluate effect epinephrine use covid<NUMBER> patients cytokine storms agents vasopressin compared epinephrine fully assessed opportunities alternative strategy elevated circulating levels cytokines associated variety infectious immunemediated conditions frequently termed cytokine storm explain protective functions cytokines ideal responses multifactorial origins drive responses become pathological ultimately leads vascular damage immunopathology worsening clinical outcomes defining cytokine storm basic concepts cytokine response recent reports elevated serum cytokine levels associated coronavirus disease <NUMBER> covid<NUMBER> raised questions relationship cytokine storms severe complications associated infection goal primer provide introduction current concepts largely lens sepsis hotchkiss et al <NUMBER> help understand underlying causes cytokine storms interact coagulation vascular health briefly discuss may help understand pathophysiology covid<NUMBER> historically recognition sepsis clinical condition associated presence bacterial infections blood definition expanded include infections suspected infections result immune dysregulation characterized systemic inflammation remote organ injury discuss elevated levels inflammatory cytokines notably interleukin il<NUMBER> il<NUMBER> il<NUMBER> gmcsf q<NUMBER> interferon ifn g tumor necrosis factor tnf interact complement coagulation systems induce disseminated intravascular coagulation dic respiratory failure acute respiratory distress syndrome ards hemophagocytic lymphohistiocytosis hlh histiocyte another term macrophage multiorgan failure finally given current covid<NUMBER> pandemic potential contribution different cytokines viral sepsis topic interest may provide opportunity interventions one conceptual framework immune system functions idea innate ability recognize invading organism provides signals condition cells immune system respond appropriately associated amplification protective response proportionate pathogen burden also influenced regulatory mechanisms limit immune hyperactivity infection controlled typically inflection point associated entry phase resolution repair allows return homeostasis figure <NUMBER>a cytokines direct role activation antimicrobial effector functions also provide regulatory signals specify amplify resolve immune response cardinal feature secreted proteins short halflives typically restrict communication cell types within lymphoid tissues sites inflammation highenough levels cytokines also systemic activities colony stimulating factors produced sites microbial invasion promote emergency granulopoiesis bone marrow associated increased production mobilization neutrophils monocytes infections systemic involvement presence increased levels cytokines impact wide range physiological processes consequently circumstances enhanced innate recognition elevated cell responses failure resolve manifest levels cytokines circulation exceed normal thresholds result collateral damage many experimental clinical conditions illustrate state figure <NUMBER> terms cytokine storm cytokine release syndrome crs hypercytokinaemia used describe variety conditions diverse etiologies outcomes ideal circumstances immune system provide proportionate appropriate response mediates resistance invading microorganisms allows host survive infection many infections coordinated production sustained circulating levels proinflammatory cytokines natural consequence appropriate innate adaptive response critical pathogen control many cytokines associated different forms sepsis cause fever induce cell death impact vascular physiology coagulation result potential cause significant widespread collateral tissue damage thus benefits sustained levels circulating cytokines promote microbial control balanced need limit immunemediated damage host experimental clinical perspective perhaps easily recognized form cytokine storm presence supranormal levels cytokines associated tissue damage beyond could attributed pathogen figure <NUMBER>a forms cytokines storms vary magnitude kinetics necessarily underlying infectious cause described see figures <NUMBER>b <NUMBER>c nevertheless circumstances ability neutralize cytokines mitigate tissue damage allow disease resolution highlights high levels markers inflammation also key contributors disease iii immune response unfettered one major themes immunology last <NUMBER> years increased emphasis checks balances limit every facet innate adaptive cellmediated humoral immunity include specialized regulatory cell types imbued antiinflammatory properties well multiple mechanisms mitigate deleterious effects cytokines since overproduction cytokines represents major challenge host health presence regulatory pathways suggests may result evolutionary pressure balance pathogen control tolerance collateral damage order survive infection example receptorligand systems cytokines characterized presence soluble receptors receptor antagonists decoy receptors expressed high levels tissues serum antagonists buffer surges cytokine activity limit immunopathology addition il<NUMBER> exemplifies ability cytokines antagonize inflammatory cell populations prevent immune hyperactivity nevertheless protective mechanisms limits excessive sustained production cytokines override regulatory mechanisms successful response infection invariably accompanied level inflammation apparent elevated production cytokines andor clinical symptoms ideally magnitude response related pathogen burden restricted organ systems involved microbial pathogenesis critical determinant events whereby variables replicative potential microorganism cell tissue tropism production toxins immune evasion strategies influence duration magnitude immune response whether local versus systemic involvement potential sequelae principles obvious relevance many primary microbial challenges humanity persistently infected range potentially lethal pathogens generally restrained immune competent host cause sepsis immunocompromised host reality illustrates concept hosts need able tolerate presence infections life threatening production cytokines damaging idea resilience face infection balance protective pathological responses new discussed ayres <NUMBER> describing diverse events drive innate adaptive responses basis cytokine storm helpful consider clinical consequences high levels cytokines figure <NUMBER> converge profound changes target tissues physiology host single organ spared host survival threatened hallmark cytokine storm persistent fever nonspecific constitutional symptoms weight loss joint muscle pain fatigue headache progressive widespread systemic inflammation leads loss vascular tone manifested drop blood pressure vasodilatory shock progressive organ failure context respiratory failure prominent also impact heart central nervous system kidneys clinical manifestations associated specific cytokines il<NUMBER> tnf linked fever constitutional symptoms capillary leak syndrome refers increase capillary permeability proteins manifested clinically hypotension edema acute respiratory failure kidney injury thought driven il<NUMBER> patients treated il<NUMBER> monoclonal antibody okt<NUMBER> targets cd<NUMBER> complex cells thereby inducing il<NUMBER> significant clinical problem abnormalities revealed clinical laboratory assays often driven underlying driver crs patients concomitant hlh pancytopenia reduced red blood cells rbcs white blood cells wbcs platelets elevated triglycerides ferritin predominate accompanying hepatosplenomegaly patients concurrent tumor lysis exhibit elevated uric acid ldh lactate acute kidney injury hemostatic imbalance manifest dic thrombocytopenia reduced platelet numbers observed almost clinical syndromes associated crs levels endogenous molecules important prognostic indicators secondary complications organ damage elevated triglycerides may cause pancreatitis uric acid induce kidney failure spontaneous intracranial cytokine storms many different underlying causes manifest different kinetics solid line depicts natural arc immune response infection period days weeks transitions resolution phase pathogen controlled microorganisms high replicative potential changes magnitude duration immune response result systemic immune pathology two dotted lines illustrate different arcs associated cytokine storm either increased amplitude failure enter resolution phase b rapid widespread engagement adaptive responses bacterially derived superantigens therapeutic interventions lead rapid surge immune activity hdays associated supraphysiological levels circulating cytokines c certain cancers systemic component lead sustained weeks months responses associated elevated cytokine production likewise chronic autoimmune diseases juvenile idiopathic arthritis jia lupus flares associated increased cytokine production also genetic defects closely linked aberrant cytokine production enhanced signaling failure fully control certain viral infections cause periodic spikes immune hyperactivity hemorrhages observed profound thrombocytopenia thus treating underlying driver crs cornerstone management avoid organ injury increased production myelopoiesis mobilization monocyte neutrophil populations bone marrow response many acute infections cytokines figure <NUMBER> populations typically considered proinflammatory imbued range antimicrobial activities recruited sites inflammation respond pathogenassociated molecular patterns pamps damageassociated molecular patterns damps producing il<NUMBER> il<NUMBER> il<NUMBER> tnf table <NUMBER> many experimental models injection high doses lps q<NUMBER> mimic gramnegative infections cecal ligation puncture model bacterial peritonitis innate responses dominated neutrophils monocytes sufficient induce cytokine storm eschews normal kinetics immune response figure <NUMBER> also examples primary genetic defects associated inappropriate activation inflammasome lead sustained production il<NUMBER> macrophages results relapsingremitting disease associated periodic fevers figure <NUMBER>c major function macrophages red pulp spleen remove senescent damaged rbcs erythrophagocytosis pathogens erythrocytes process critical clearance infected cells however sustained production ifng tnf lead macrophage activation syndrome associated hlh contributes anemia characteristic sepsis almost systemic infections alsamkari berliner <NUMBER> ability engage innate responses sufficient development cytokine storms activation cells ability produce high amounts effector cytokines il<NUMBER> ifng tnf also important two best examples illustrate rapid engagement cells result cytokine storms come development therapies enhance cell function treatment cancer clinical trial agonistic antibody costimulatory molecule cd<NUMBER> present cells provides notable illustration simultaneous activation large number cells results rapid induction cytokine storm suntharalingam et al <NUMBER> authors description events sobering within <NUMBER> minutes receiving single intravenous dose drug six volunteers systemic inflammatory response characterized rapid induction tnfa followed il<NUMBER> il<NUMBER> il<NUMBER> ifng accompanied headache myalgias nausea diarrhea erythema vasodilatation hypotension progressed pulmonary infiltrates lung injury renal failure dic reduced lymphocytes monocyte counts occurred correlated peak cytokine levels frequent observation associated experimental clinical examples cytokine storms transient reduction peripheral blood cell counts perceived indicator immunosuppression attributed death immune cells sequestration wbcs affected tissues includes adherence vascular endothelium may account apparent loss peripheral wbcs another example occurred patients acute lymphoid leukemia b cell lymphoma expressed cd<NUMBER> two patients cells genetically modified express chimeric antigen receptor car recognized cd<NUMBER> would allow modified cells eliminate tumor cells infusion car cells rapid onset crs characterized <NUMBER>to <NUMBER>fold increase levels ifng il<NUMBER> temporally correlated systemic inflammation fever evolved macrophage activation syndrome grupp et al <NUMBER> examples therapeutic interventions highlight rapid widespread activation cells bypass many natural negative cellextrinsic checkpoints systemic impact patient physiology natural examples microbial context important understand basis cell hyperactivation illustrated ability bacterial toxins superantigens associated streptococcus staphylococcus aureus crosslink major histocompatibility complex mhc tcr thus leading polyclonal activation cells high levels cytokine secretion development toxic shock syndrome another example mosquitotransmitted dengue virus secondary challenge heterologous virus result dengue hemorrhagic fever characterized high levels cytokines alterations vascular permeability dic surprisingly analysis postmortem tissues highlighted presence edema lungs relative absence tissue inflammation srikiatkhachorn et al <NUMBER> lack overt cellular infiltration disconcerting cellular immunologists trying understand cytokines mediate tissue damage last major influenza pandemic <NUMBER> caused h<NUMBER>n<NUMBER> strain patients associated presence coagulopathies haemophagocytosis analysis cohort fatal h<NUMBER>n<NUMBER> infections highlighted patients overt preexisting immune deficiencies many gene mutations previously associated development hlh indicating possible role risk factors mortality schulert et al <NUMBER> similarly patients lack perforin inability clear herpesviruses ebv q<NUMBER> cmv q<NUMBER> results sustained cell production ifng tnf results macrophage activation hlh types persistent situations underlying causes may resolved restricted infectious settings manifest conditions include malignancies autoimmune diseases well context transplantation figure <NUMBER>c examples overt cytokine storm apparent flares disease result crs vascular compartment coagulation complement discussed prominent clinical features cytokine storms characterized dic capillary leak syndrome loss blood pressure indicates crosstalk cytokines hemostasis absence systemic inflammation vascular endothelium employs numerous mechanisms maintain barrier function prevent aberrant coagulation common feature many systemic infections however endothelial cell death consequence cytolytic infection immunemediated pathways gives rise vascular damage development capillary leak syndrome endothelial cells would exposed circulating immunity <NUMBER> july <NUMBER> <NUMBER> <NUMBER> primer immuni <NUMBER> cytokines immune mediators multiple systems maintain quiescence inflammatory duress evolutionary conserved component hemostatic response tissue damage systemic infections includes development coagulation prevent blood loss part process fibrin deposition recruitment platelets form clots seal areas trauma many settings elevated systemic cytokine levels associated transient drop platelet numbers circulation likely reflecting consumption although continuous basal production neutrophils bone marrow systemic cytokines initiate emergency granulopoesis increased recruitment cells circulation inflammatory mediators promote neutrophil release nuclear dna form neutrophil extracellular traps nets snare pathogens also contribute thrombi formation process termed immunothrombosis engelmann massberg <NUMBER> also amplify production cytokines exemplified links thrombin inflammasome activation production il<NUMBER> events essentially host protective systemic inflammation lead widespread thrombus formation associated vascular occlusion tissue damage dic death host events sustained one consequence depletion clotting factors renders patients susceptible catastrophic bleeding critical spaces like brain thorax thus thrombi formation important role host protection needs carefully controlled prevent aberrant pathology another evolutionary conserved line defense invading pathogens intersects cytokine biology coagulation complement system arm innate response composed soluble proteins recognize lyse pathogens also act amplify cellular responses complex crosstalk cytokines complement system illustrated ability cytokines enhance production components complement cascade turn enhance inhibit cytokine production although complementmediated opsonization formation lytic complexes critical processes necessary pathogen elimination effector functions injurious bystander host cells given importance endothelium barrier function vascular tone hemostasis several safeguards surfacebound soluble complement regulatory proteins prevent excessive complementmediated injury normally quiescent endothelium failure safeguards excessive complement activation result endothelial injury manifest dysregulated coagulation hemostasis loss barrier function vascular tone vascular endothelium lung kidneys recognized particularly vulnerable sites complementmediated injury clinical implications widespread endothelial dysfunction discussed calming storm given potential cytokines cause tissue damage need mitigate effects high levels cytokines promote transition resolution phase immune response numerous natural receptor cytokine antagonists il<NUMBER> receptor antagonist il<NUMBER>ra feature cytokine signaling systems buffer systemic offtarget effects restrict immune activities local sites cytokine release cytokines regulatory pathways act directly limit magnitude immune response example il<NUMBER> produced many cell types subsets monocytes well natural killer nk b cells inhibits ability macrophage dendritic cell dc populations produce tnf il<NUMBER> il<NUMBER> il<NUMBER> decreases ability cells present antigen provide costimulation thus il<NUMBER> key negative regulator accessory functions required cell mediated responses numerous examples infection mice lack il<NUMBER> characterized elevated sustained circulating levels il<NUMBER> tnf ifng ie bona fide cytokine storm couper et al <NUMBER> paradoxically increased circulating levels il<NUMBER> infectious noninfectious stimulus barrier sites gut lungs leads tissue damage initiates complex series events circumstances leads vascular damage coagulation system critical tissue repair progress development dic early response invasiondamage q<NUMBER> characterized innate production cytokines induction emergency granulopoiesis leads mobilization neutrophils monocytes events engage amplify nk cell production proinflammatory cytokines promote capillary leak syndrome thrombus formation progress dic high circulating levels cytokines cause cell death tissue damage ability activate macrophages lead erythrophagocytosis anemia combination anemia alterations vascular hemostasis cytokinemediated damage result multiorgan failure characteristic cytokine storms humans assumption increased levels reflect presence negative feedback loop control magnitude response help resolution repair phase response existence immuneregulatory networks limit aberrant cytokine responses critical survive many infectious challenges cost many pathways block development sterile immunity infection promote pathogen persistence addition many patients survive sepsis longterm sequela include profound immunosuppression susceptibility secondary infections poor understanding mediated one explanation antiinflammatory regulatory networks returns precrisis levels function instead operate heightened state alternatively systemic action cytokines result remarkable changes cellular composition organization lymphoid structures bone marrow thymus spleen whether disruption loss immunological infrastructure contributes longterm dysregulation understood reports elevated serum cytokines ifng il<NUMBER> gmcsf associated coronaviruses severe acute respiratory syndrome coronavirus sarscov<NUMBER> middle east respiratory syndrome coronavirus merscov combined ards led relevant questions whether subset patients develop lifethreatening complications result cytokine storm min et al <NUMBER> zhang et al <NUMBER> time writing consensus yet emerged whether pneumonia ards associated covid<NUMBER> caused sarscov<NUMBER> consequence sustained virus replication whether aberrant recruitment macrophages neutrophils lungs vascular compartment may involved kinetics response sarscov<NUMBER> fits models induction conventional antiviral immunity crisis correlates likely peak phase cell responses nevertheless unclear immune hyperactivity failure resolve inflammatory response ongoing viral replication immune dysregulation underlies severe disease nevertheless reports increased levels thrombi formation endothelial cell death covid<NUMBER> patients would indicate damage vascular endothelium involvement cytokines immunothrombosis ackermann et al <NUMBER> fox et al <NUMBER> multiple studies deposited biorxiv medrxiv report elevated cytokine levels severely ill covid<NUMBER> patients successful use cytokine antagonists reviewed depth manjili et al <NUMBER> even able compare samples forms sepsis ards presence elevated cytokine levels patient clinically diagnosed covid<NUMBER> surprise whether cross threshold protective pathological unclear since preexisting conditions affect vascular health diabetes hypertension cardiovascular disease appear single largest factor underlies covid<NUMBER> pathogenesis possible comorbidities may decrease resilience lower ability tolerate systemic cytokines literature evolves important cytokine measurements standardized allow comparisons cohorts determine whether prognostic value identify patients develop bona fide cytokine storm application systems biology approaches already developed understand forms sepsis help guide design trials test whether approved antagonists il<NUMBER> tnf il<NUMBER> il<NUMBER> il<NUMBER> gmcsf ifng would prove useful manage severe covid<NUMBER> patients however appropriate note anticytokine therapies based use neutralizing antibodies filters remove circulating proteins failed improve mortality sepsis stage unclear covid<NUMBER> would exception also significant population patients immunemediated conditions currently treated antagonists tnf il<NUMBER> il<NUMBER>il<NUMBER> il<NUMBER> knowing whether interventions influence outcome sarscov<NUMBER> may help identify cytokines pathological also significant concerns cytokine neutralization would interfere antiviral responses lead increased complications associated respiratory pathogens nevertheless sophisticated approaches identify disease endotypes may provide new opportunities revisit deploy immunomodulatory therapies done retrospectively use il<NUMBER>ra sepsis shakoory et al <NUMBER> may beneficial develop strategies target cytokineinduced injury vascular compartment maintaining cytokine signaling tissues essential host defense also early understand whether patients survived severe forms covid<NUMBER> infection longterm sequelae similar associated sepsis survivors reports pediatric patients develop postsarscov<NUMBER> multisystem inflammatory syndrome includes vascular inflammation highlights issue natural arc induction resolution immune response magnitude duration coordinated array regulatory checks balances disruption arc lead hyper responses delay resolution phase elevated sustained cytokine production pathological however cytokine storms many variablesthe nature insult host immune status tissue affected crosstalk immune thrombosis complement activationthat influence magnitude kinetics responses thus clinical manifestations nevertheless numerous mechanisms allow host tolerate survive even thrive face immune stressors understanding natural processes may useful design ways manage distinct forms crs time writing still know enough state confidence bona fide cytokine storm underlies covid<NUMBER> pathologies rapid progress immune phenotyping patients help scientific community understand complexities disease perhaps research covid<NUMBER> provide impetus understand consequences dysregulated immunity vascular compartment development strategies target cytokines complement coagulation improve management forms sepsis elevated circulating levels cytokines associated variety infectious immunemediated conditions frequently termed cytokine storm explain protective functions cytokines ideal responses multifactorial origins drive responses become pathological ultimately leads vascular damage immunopathology worsening clinical outcomes defining cytokine storm basic concepts cytokine response recent reports elevated serum cytokine levels associated coronavirus disease <NUMBER> covid<NUMBER> raised questions relationship cytokine storms severe complications associated infection goal primer provide introduction current concepts largely lens sepsis hotchkiss et al <NUMBER> help understand underlying causes cytokine storms interact coagulation vascular health briefly discuss may help understand pathophysiology covid<NUMBER> historically recognition sepsis clinical condition associated presence bacterial infections blood definition expanded include infections suspected infections result immune dysregulation characterized systemic inflammation remote organ injury discuss elevated levels inflammatory cytokines notably interleukin il<NUMBER> il<NUMBER> il<NUMBER> granulocytemacrophage colonystimulating factor gmcsf interferon ifn g tumor necrosis factor tnf interact complement coagulation systems induce disseminated intravascular coagulation dic respiratory failure acute respiratory distress syndrome ards hemophagocytic lymphohistiocytosis hlh histiocyte another term macrophage multiorgan failure finally given current covid<NUMBER> pandemic potential contribution different cytokines viral sepsis topic interest may provide opportunity interventions one conceptual framework immune system functions idea innate ability recognize invading organism provides signals condition cells immune system respond appropriately associated amplification protective response proportionate pathogen burden also influenced regulatory mechanisms limit immune hyperactivity infection controlled typically inflection point associated entry phase resolution repair allows return homeostasis figure <NUMBER>a cytokines direct role activation antimicrobial effector functions also provide regulatory signals specify amplify resolve immune response cardinal feature secreted proteins short halflives typically restrict communication cell types within lymphoid tissues sites inflammation highenough levels cytokines also systemic activities colony stimulating factors produced sites microbial invasion promote emergency granulopoiesis bone marrow associated increased production mobilization neutrophils monocytes infections systemic involvement presence increased levels cytokines impact wide range physiological processes consequently circumstances enhanced innate recognition elevated cell responses failure resolve manifest levels cytokines circulation exceed normal thresholds result collateral damage many experimental clinical conditions illustrate state figure <NUMBER> terms cytokine storm cytokine release syndrome crs hypercytokinaemia used describe variety conditions diverse etiologies outcomes ideal circumstances immune system provide proportionate appropriate response mediates resistance invading microorganisms allows host survive infection many infections coordinated production sustained circulating levels proinflammatory cytokines natural consequence appropriate innate adaptive response critical pathogen control many cytokines associated different forms sepsis cause fever induce cell death impact vascular physiology coagulation result potential cause significant widespread collateral tissue damage thus benefits sustained levels circulating cytokines promote microbial control balanced need limit immunemediated damage host experimental clinical perspective perhaps easily recognized form cytokine storm presence supranormal levels cytokines associated tissue damage beyond could attributed pathogen figure <NUMBER>a forms cytokines storms vary magnitude kinetics necessarily underlying infectious cause described see figures <NUMBER>b <NUMBER>c nevertheless circumstances ability neutralize cytokines mitigate tissue damage allow disease resolution highlights high levels markers inflammation also key contributors disease iii immune response unfettered one major themes immunology last <NUMBER> years increased emphasis checks balances limit every facet innate adaptive cellmediated humoral immunity include specialized regulatory cell types imbued antiinflammatory properties well multiple mechanisms mitigate deleterious effects cytokines since overproduction cytokines represents major challenge host health presence regulatory pathways suggests may result evolutionary pressure balance pathogen control tolerance collateral damage order survive infection example receptorligand systems cytokines characterized presence soluble receptors receptor antagonists decoy receptors expressed high levels tissues serum antagonists buffer surges cytokine activity limit immunopathology addition il<NUMBER> exemplifies ability cytokines antagonize inflammatory cell populations prevent immune hyperactivity nevertheless protective mechanisms limits excessive sustained production cytokines override regulatory mechanisms successful response infection invariably accompanied level inflammation apparent elevated production cytokines andor clinical symptoms ideally magnitude response related pathogen burden restricted organ systems involved microbial pathogenesis critical determinant events whereby variables replicative potential microorganism cell tissue tropism production toxins immune evasion strategies influence duration magnitude immune response whether local versus systemic involvement potential sequelae principles obvious relevance many primary microbial challenges humanity persistently infected range potentially lethal pathogens generally restrained immune competent host cause sepsis immunocompromised host reality illustrates concept hosts need able tolerate presence infections life threatening production cytokines damaging idea resilience face infection balance protective pathological responses new discussed ayres <NUMBER> describing diverse events drive innate adaptive responses basis cytokine storm helpful consider clinical consequences high levels cytokines figure <NUMBER> converge profound changes target tissues physiology host single organ spared host survival threatened hallmark cytokine storm persistent fever nonspecific constitutional symptoms weight loss joint muscle pain fatigue headache progressive widespread systemic inflammation leads loss vascular tone manifested drop blood pressure vasodilatory shock progressive organ failure context respiratory failure prominent also impact heart central nervous system kidneys clinical manifestations associated specific cytokines il<NUMBER> tnf linked fever constitutional symptoms capillary leak syndrome refers increase capillary permeability proteins manifested clinically hypotension edema acute respiratory failure kidney injury thought driven il<NUMBER> patients treated il<NUMBER> monoclonal antibody okt<NUMBER> targets cd<NUMBER> complex cells thereby inducing il<NUMBER> significant clinical problem abnormalities revealed clinical laboratory assays often driven underlying driver crs patients concomitant hlh pancytopenia reduced red blood cells rbcs white blood cells wbcs platelets elevated triglycerides ferritin predominate accompanying hepatosplenomegaly patients concurrent tumor lysis exhibit elevated uric acid ldh lactate acute kidney injury hemostatic imbalance manifest dic thrombocytopenia reduced platelet numbers observed almost clinical syndromes associated crs levels endogenous molecules important prognostic indicators secondary complications organ damage elevated triglycerides may cause pancreatitis uric acid induce kidney failure spontaneous intracranial cytokine storms many different underlying causes manifest different kinetics solid line depicts natural arc immune response infection period days weeks transitions resolution phase pathogen controlled microorganisms high replicative potential changes magnitude duration immune response result systemic immune pathology two dotted lines illustrate different arcs associated cytokine storm either increased amplitude failure enter resolution phase b rapid widespread engagement adaptive responses bacterially derived superantigens therapeutic interventions lead rapid surge immune activity hourdays associated supraphysiological levels circulating cytokines c certain cancers systemic component lead sustained weeks months responses associated elevated cytokine production likewise chronic autoimmune diseases juvenile idiopathic arthritis jia lupus flares associated increased cytokine production also genetic defects closely linked aberrant cytokine production enhanced signaling failure fully control certain viral infections cause periodic spikes immune hyperactivity hemorrhages observed profound thrombocytopenia thus treating underlying driver crs cornerstone management avoid organ injury increased production myelopoiesis mobilization monocyte neutrophil populations bone marrow response many acute infections cytokines figure <NUMBER> populations typically considered proinflammatory imbued range antimicrobial activities recruited sites inflammation respond pathogenassociated molecular patterns pamps damageassociated molecular patterns damps producing il<NUMBER> il<NUMBER> il<NUMBER> tnf table <NUMBER> many experimental models injection high doses lipopolysaccharides lps mimic gramnegative infections cecal ligation puncture model bacterial peritonitis innate responses dominated neutrophils monocytes sufficient induce cytokine storm eschews normal kinetics immune response figure <NUMBER> also examples primary genetic defects associated inappropriate activation inflammasome lead sustained production il<NUMBER> macrophages results relapsingremitting disease associated periodic fevers figure <NUMBER>c major function macrophages red pulp spleen remove senescent damaged rbcs erythrophagocytosis pathogens erythrocytes process critical clearance infected cells however sustained production ifng tnf lead macrophage activation syndrome associated hlh contributes anemia characteristic sepsis almost systemic infections alsamkari berliner <NUMBER> ability engage innate responses sufficient development cytokine storms activation cells ability produce high amounts effector cytokines il<NUMBER> ifng tnf also important two best examples illustrate rapid engagement cells result cytokine storms come development therapies enhance cell function treatment cancer clinical trial agonistic antibody costimulatory molecule cd<NUMBER> present cells provides notable illustration simultaneous activation large number cells results rapid induction cytokine storm suntharalingam et al <NUMBER> authors description events sobering within <NUMBER> minutes receiving single intravenous dose drug six volunteers systemic inflammatory response characterized rapid induction tnfa followed il<NUMBER> il<NUMBER> il<NUMBER> ifng accompanied headache myalgias nausea diarrhea erythema vasodilatation hypotension progressed pulmonary infiltrates lung injury renal failure dic reduced lymphocytes monocyte counts occurred correlated peak cytokine levels frequent observation associated experimental clinical examples cytokine storms transient reduction peripheral blood cell counts perceived indicator immunosuppression attributed death immune cells sequestration wbcs affected tissues includes adherence vascular endothelium may account apparent loss peripheral wbcs another example occurred patients acute lymphoid leukemia b cell lymphoma expressed cd<NUMBER> two patients cells genetically modified express chimeric antigen receptor car recognized cd<NUMBER> would allow modified cells eliminate tumor cells infusion car cells rapid onset crs characterized <NUMBER>to <NUMBER>fold increase levels ifng il<NUMBER> temporally correlated systemic inflammation fever evolved macrophage activation syndrome grupp et al <NUMBER> examples therapeutic interventions highlight rapid widespread activation cells bypass many natural negative cellextrinsic checkpoints systemic impact patient physiology natural examples microbial context important understand basis cell hyperactivation illustrated ability bacterial toxins superantigens associated streptococcus staphylococcus aureus crosslink major histocompatibility complex mhc tcr thus leading polyclonal activation cells high levels cytokine secretion development toxic shock syndrome another example mosquitotransmitted dengue virus secondary challenge heterologous virus result dengue hemorrhagic fever characterized high levels cytokines alterations vascular permeability dic surprisingly analysis postmortem tissues highlighted presence edema lungs relative absence tissue inflammation srikiatkhachorn et al <NUMBER> lack overt cellular infiltration disconcerting cellular immunologists trying understand cytokines mediate tissue damage last major influenza pandemic <NUMBER> caused h<NUMBER>n<NUMBER> strain patients associated presence coagulopathies haemophagocytosis analysis cohort fatal h<NUMBER>n<NUMBER> infections highlighted patients overt preexisting immune deficiencies many gene mutations previously associated development hlh indicating possible role risk factors mortality schulert et al <NUMBER> similarly patients lack perforin inability clear herpesviruses epsteinbarr virus ebv cytomegalovirus cmv results sustained cell production ifng tnf results macrophage activation hlh types persistent situations underlying causes may resolved restricted infectious settings manifest conditions include malignancies autoimmune diseases well context transplantation figure <NUMBER>c examples overt cytokine storm apparent flares disease result crs vascular compartment coagulation complement discussed prominent clinical features cytokine storms characterized dic capillary leak syndrome loss blood pressure indicates crosstalk cytokines hemostasis absence systemic inflammation vascular endothelium employs numerous mechanisms maintain barrier function prevent aberrant coagulation common feature many systemic infections however endothelial cell death consequence cytolytic infection immunemediated pathways gives rise vascular damage development capillary leak syndrome endothelial cells would exposed circulating cytokines immune mediators multiple systems maintain quiescence inflammatory duress evolutionary conserved component hemostatic response tissue damage systemic infections includes development coagulation prevent blood loss part process fibrin deposition recruitment platelets form clots seal areas trauma many settings elevated systemic cytokine levels associated transient drop platelet numbers circulation likely reflecting consumption although continuous basal production neutrophils bone marrow systemic cytokines initiate emergency granulopoesis increased recruitment cells circulation inflammatory mediators promote neutrophil release nuclear dna form neutrophil extracellular traps nets snare pathogens also contribute thrombi formation process termed immunothrombosis engelmann massberg <NUMBER> also amplify production cytokines exemplified links thrombin inflammasome activation production il<NUMBER> events essentially host protective systemic inflammation lead widespread thrombus formation associated vascular occlusion tissue damage dic death host events sustained one consequence depletion clotting factors renders patients susceptible catastrophic bleeding critical spaces like brain thorax thus thrombi formation important role host protection needs carefully controlled prevent aberrant pathology another evolutionary conserved line defense invading pathogens intersects cytokine biology coagulation complement system arm innate response composed soluble proteins recognize lyse pathogens also act amplify cellular responses complex crosstalk cytokines complement system illustrated ability cytokines enhance production components complement cascade turn enhance inhibit cytokine production although complementmediated opsonization formation lytic complexes critical processes necessary pathogen elimination effector functions injurious bystander host cells given importance endothelium barrier function vascular tone hemostasis several safeguards surfacebound soluble complement regulatory proteins prevent excessive complementmediated injury normally quiescent endothelium failure safeguards excessive complement activation result endothelial injury manifest dysregulated coagulation hemostasis loss barrier function vascular tone vascular endothelium lung kidneys recognized particularly vulnerable sites complementmediated injury clinical implications widespread endothelial dysfunction discussed calming storm given potential cytokines cause tissue damage need mitigate effects high levels cytokines promote transition resolution phase immune response numerous natural receptor cytokine antagonists il<NUMBER> receptor antagonist il<NUMBER>ra feature cytokine signaling systems buffer systemic offtarget effects restrict immune activities local sites cytokine release cytokines regulatory pathways act directly limit magnitude immune response example il<NUMBER> produced many cell types subsets monocytes well natural killer nk b cells inhibits ability macrophage dendritic cell dc populations produce tnf il<NUMBER> il<NUMBER> il<NUMBER> decreases ability cells present antigen provide costimulation thus il<NUMBER> key negative regulator accessory functions required cell mediated responses numerous examples infection mice lack il<NUMBER> characterized elevated sustained circulating levels il<NUMBER> tnf ifng ie bona fide cytokine storm couper et al <NUMBER> paradoxically increased circulating levels il<NUMBER> infectious noninfectious stimulus barrier sites gut lungs leads tissue damage initiates complex series events circumstances leads vascular damage coagulation system critical tissue repair progress development dic early response microbial invasion tissue damage characterized innate production cytokines induction emergency granulopoiesis leads mobilization neutrophils monocytes events engage amplify nk cell production proinflammatory cytokines promote capillary leak syndrome thrombus formation progress dic high circulating levels cytokines cause cell death tissue damage ability activate macrophages lead erythrophagocytosis anemia combination anemia alterations vascular hemostasis cytokinemediated damage result multiorgan failure characteristic cytokine storms humans assumption increased levels reflect presence negative feedback loop control magnitude response help resolution repair phase response existence immuneregulatory networks limit aberrant cytokine responses critical survive many infectious challenges cost many pathways block development sterile immunity infection promote pathogen persistence addition many patients survive sepsis longterm sequela include profound immunosuppression susceptibility secondary infections poor understanding mediated one explanation antiinflammatory regulatory networks returns precrisis levels function instead operate heightened state alternatively systemic action cytokines result remarkable changes cellular composition organization lymphoid structures bone marrow thymus spleen whether disruption loss immunological infrastructure contributes longterm dysregulation understood reports elevated serum cytokines ifng il<NUMBER> gmcsf associated coronaviruses severe acute respiratory syndrome coronavirus sarscov<NUMBER> middle east respiratory syndrome coronavirus merscov combined ards led relevant questions whether subset patients develop lifethreatening complications result immunity <NUMBER> july <NUMBER> <NUMBER> <NUMBER> primer cytokine storm min et al <NUMBER> zhang et al <NUMBER> time writing consensus yet emerged whether pneumonia ards associated covid<NUMBER> caused sarscov<NUMBER> consequence sustained virus replication whether aberrant recruitment macrophages neutrophils lungs vascular compartment may involved kinetics response sarscov<NUMBER> fits models induction conventional antiviral immunity crisis correlates likely peak phase cell responses nevertheless unclear immune hyperactivity failure resolve inflammatory response ongoing viral replication immune dysregulation underlies severe disease nevertheless reports increased levels thrombi formation endothelial cell death covid<NUMBER> patients would indicate damage vascular endothelium involvement cytokines immunothrombosis ackermann et al <NUMBER> fox et al <NUMBER> multiple studies deposited biorxiv medrxiv report elevated cytokine levels severely ill covid<NUMBER> patients successful use cytokine antagonists reviewed depth manjili et al <NUMBER> even able compare samples forms sepsis ards presence elevated cytokine levels patient clinically diagnosed covid<NUMBER> surprise whether cross threshold protective pathological unclear since preexisting conditions affect vascular health diabetes hypertension cardiovascular disease appear single largest factor underlies covid<NUMBER> pathogenesis possible comorbidities may decrease resilience lower ability tolerate systemic cytokines literature evolves important cytokine measurements standardized allow comparisons cohorts determine whether prognostic value identify patients develop bona fide cytokine storm application systems biology approaches already developed understand forms sepsis help guide design trials test whether approved antagonists il<NUMBER> tnf il<NUMBER> il<NUMBER> il<NUMBER> gmcsf ifng would prove useful manage severe covid<NUMBER> patients however appropriate note anticytokine therapies based use neutralizing antibodies filters remove circulating proteins failed improve mortality sepsis stage unclear covid<NUMBER> would exception also significant population patients immunemediated conditions currently treated antagonists tnf il<NUMBER> il<NUMBER>il<NUMBER> il<NUMBER> knowing whether interventions influence outcome sarscov<NUMBER> may help identify cytokines pathological also significant concerns cytokine neutralization would interfere antiviral responses lead increased complications associated respiratory pathogens nevertheless sophisticated approaches identify disease endotypes may provide new opportunities revisit deploy immunomodulatory therapies done retrospectively use il<NUMBER>ra sepsis shakoory et al <NUMBER> may beneficial develop strategies target cytokineinduced injury vascular compartment maintaining cytokine signaling tissues essential host defense also early understand whether patients survived severe forms covid<NUMBER> infection longterm sequelae similar associated sepsis survivors reports pediatric patients develop postsarscov<NUMBER> multisystem inflammatory syndrome includes vascular inflammation highlights issue natural arc induction resolution immune response magnitude duration coordinated array regulatory checks balances disruption arc lead hyper responses delay resolution phase elevated sustained cytokine production pathological however cytokine storms many variablesthe nature insult host immune status tissue affected crosstalk immune thrombosis complement activationthat influence magnitude kinetics responses thus clinical manifestations nevertheless numerous mechanisms allow host tolerate survive even thrive face immune stressors understanding natural processes may useful design ways manage distinct forms crs time writing still know enough state confidence bona fide cytokine storm underlies covid<NUMBER> pathologies rapid progress immune phenotyping patients help scientific community understand complexities disease perhaps research covid<NUMBER> provide impetus understand consequences dysregulated immunity vascular compartment development strategies target cytokines complement coagulation improve management forms sepsis corticosteroids could used suppress cytokine storm used patients <NUMBER> however based evidence patients mers ards use corticosteroids provide survival benefit rather delayed clearance virus therefore systemic use corticosteroids recommended guidance <NUMBER> result alternatives dampening overwhelming cytokine release required know cytokine storm also occurs settings patients leukemia lymphoma receive chimeric antigen receptor car cells therapy cytokine release syndrome crs occurs infusion car cells <NUMBER> patients receiving car cells therapy crs elevated concentrations interferon γ tumor necrosis factor α interleukin il<NUMBER>b il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> granulocyte macrophage colony stimulating factor gmcsf macrophage inflammatory protein mip<NUMBER> cytokine profile crs related car cells infusion similar cases sarscov<NUMBER> infection antiil<NUMBER> receptor antibody tocilizumab effective controlling car cells infusion related crs response rate <NUMBER> <NUMBER> evidence provides us rationale using tocilizumab manage cytokine storm patients sarscov<NUMBER> infection another rationale using tocilizumab treat covid<NUMBER> il<NUMBER> enhance antiviral immunity decreases antiviral immunity patients covid<NUMBER> diao et al found serum il<NUMBER> negatively correlated cell numbers <NUMBER> mazzoni et al found elevation il<NUMBER> serum levels associated impairment cytotoxic activity patients covid<NUMBER> use tocilizumab restored cytotoxic potential nk cells <NUMBER> studies involving offlabel use tocilizumab shown potential efficacy drug treatment covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> another potential drug could considered treat cytokine storm etoposide used deplete monocytes suppress cytokine release hemophagocytic lymphohistiocytosis hlh <NUMBER> needs mentioned sarscovinfected mice inflammatory monocytemacrophage responses involved causing lethal pneumonia suggesting importance suppressing monocytemacrophage system treating severe pneumonia related sarscov <NUMBER> hyperactivation monocytesmacrophages described patients covid<NUMBER> singlecell analysis bronchoalveolar fluid revealed significantly increased proportions mononuclear phagocytes patients covid<NUMBER> especially severe disease patients severe disease mononuclear phagocytes showed predominance inflammatory monocytederived macrophages <NUMBER> macrophages could contribute acute inflammation also promote fibrosis generation additionally significant increase cd<NUMBER> cd<NUMBER> monocytes also detected patients severe covid<NUMBER> <NUMBER> cd<NUMBER> cd<NUMBER> monocytes expressed il<NUMBER> caused acceleration inflammation therefore etoposide could used inhibit hyperactivation monocytesmacrophages suppress overwhelming inflammation ameliorate pulmonary fibrosis potential drugs treating cytokine storm include jak<NUMBER> inhibitor ruxolitinib effective inhibiting monocyte activation cytokine release patients hlh <NUMBER> prospective randomized study shown promising efficacy ruxolitinib treatment severe covid<NUMBER> <NUMBER> trial ruxolitinib group showed significant decrease levels <NUMBER> cytokines compared control group suggesting ruxolitinib suppress cytokine storm patients severe covid<NUMBER> patients ruxolitinib group also faster chest ct improvement faster recovery lymphopenia ruxolitinib also welltolerated patients severe covid<NUMBER> indicating ruxolitinib could safely used treat patients covid<NUMBER> <NUMBER> additionally therapeutic plasma exchange reduce plasma cytokine concentrations rapidly successfully used treat hlh crs related car cells infusion <NUMBER> <NUMBER> suggesting plasma exchange may reasonable option severe patients cytokine storm preliminary study therapeutic plasma exchange reduced plasma il<NUMBER> level improved oxygenation status patients severe covid<NUMBER> ards <NUMBER> although admit supportive care antiviral therapy remain mainstay treating patients covid<NUMBER> recommend treatments controlling cytokine storm including tocilizumab etoposide ruxolitinib plasma exchange considered selected covid<NUMBER> patients cytokine storm pilot studies shown promising results treatments may also effective controlling cytokine storm randomized clinical trials needed evaluate treatments could reduce mortality patients covid<NUMBER> ym lf jyl drafted manuscript authors contributed article approved submitted version individuals syndrome ds show widespread chronic immune dysregulation population shows increased rates diverse autoimmune conditions including autoimmune thyroid disease <NUMBER> celiac disease <NUMBER> autoimmune skin conditions eg alopecia areata psoriasis vitiligo atopic dermatitis andor eczema hidradenitis suppurativa <NUMBER> <NUMBER> <NUMBER> <NUMBER> type <NUMBER> diabetes <NUMBER> <NUMBER> <NUMBER> molecular cellular levels individuals trisomy <NUMBER> show clear signs inflammation absence detectable infections elevated levels potent inflammatory cytokines chemokines <NUMBER> <NUMBER> changes diverse immune cell types indicative hyperactive proinflammatory cellular states <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition individuals trisomy <NUMBER> show severe consequences lung viral infections increased rates hospitalization respiratory syncytial virus rsv h<NUMBER>n<NUMBER> influenza infections <NUMBER> <NUMBER> well increased rates mortality bacterial pneumonia sepsis <NUMBER> <NUMBER> despite knowledge context ongoing coronavirus disease <NUMBER> covid<NUMBER> pandemic unclear individuals ds may respond severe acute respiratory syndrome cov <NUMBER> sarscov<NUMBER> infections may take several months enough epidemiological clinical data gathered address issue despite clear limitations imposed lack available data provide evidence individuals trisomy <NUMBER> considered high risk developing severe symptoms increased rates hospitalization intensive care secondary bacterial infections mortality sarscov<NUMBER> infections relative general population thus justifying increased monitoring specialized care covid<NUMBER> ds mounting evidence supports notion morbidity mortality sarscov<NUMBER> infections driven exacerbated immune response virus leading cascade events involving cytokine storm acute respiratory distress syndrome ards eventual myocardial damage multiorgan failure <NUMBER> <NUMBER> pathological cascade similar observed lethal lung viral infections presence virus lungs triggers first wave cytokines including type iii interferons ifns activation recruitment immune cells leading production cytokines chemokines exacerbated immune activation progressive shutdown respiratory function <NUMBER> cytokine storms also known cytokine release syndrome crs hypercytokinemia described drivers pathology myriad infectious noninfectious diseases <NUMBER> among infectious diseases cytokine storms postulated drive mortality severe viral infections influenza <NUMBER> including <NUMBER> spanish flu epidemic <NUMBER> h<NUMBER>n<NUMBER> bird flu <NUMBER> well <NUMBER> sars epidemic <NUMBER> hantavirus <NUMBER> ebola <NUMBER> smallpox <NUMBER> specific case covid<NUMBER> independent reports indicate magnitude cytokine storm correlates positively severity pathology likelihood needing intensive care death many inflammatory markers cytokines chemokines found significantly associated worse prognosis including creactive protein crp interleukin<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> granulocyte colonystimulating factor gcsf interferon ginduced protein <NUMBER> ip<NUMBER> monocyte chemoattractant protein<NUMBER> mcp<NUMBER> macrophage inflammatory protein<NUMBER>a mip<NUMBER>a tumor necrosis factor tnfa <NUMBER> <NUMBER> integrated current understanding role cytokine storms respiratory infections findings support notion combined antiviral treatments targeted immunosuppression therapeutic strategy covid<NUMBER> <NUMBER> multiple clinical trials testing impact targeted immunosuppressants inhibitors il<NUMBER> signaling eg tocilizumab sarilumab tnfa signaling eg humira il<NUMBER>b signaling eg anakinra janus kinase jak inhibitors eg ruxolitinib baricitinib tofacitinib hope attenuating cytokine storm improve prognosis exact mechanisms trisomy <NUMBER> causes immune dysregulation observed people ds remains elucidated however several genes encoded chromosome <NUMBER> established roles immune control overexpression could contribute general immune phenotype ds prominent among immune regulators encoded chromosome <NUMBER> four six interferon receptors two type ifn receptors ifnar<NUMBER> ifnar<NUMBER> type ii ifn receptor ifngr<NUMBER> il<NUMBER>rb serves receptor subunit type iii ifn ligands cytokines il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER> several lines evidence demonstrate hyperactivation ifn signaling ds first ifn receptors ifnrs encoded chromosome <NUMBER> overexpressed multiple cell types individuals trisomy <NUMBER> overexpression obvious box whisker plots displaying mrna expression type ifnrs encoded chromosome <NUMBER> ifnar<NUMBER> ifnar<NUMBER> data presented reads per kilobase transcripts per million rpkm mapped reads data generated via rna sequencing rnaseq transcriptome analysis described araya et al <NUMBER> sullivan et al <NUMBER> powers et al <NUMBER> mrna level multiple immune nonimmune cell types figure <NUMBER> <NUMBER> also cell surface level demonstrated recent mass cytometry analysis <NUMBER> different immune cell types <NUMBER> second immune nonimmune cell types people ds hypersensitive ifn stimulation demonstrated superinduction downstream jakstat signaling ifnstimulated genes isgs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> third transcriptome analyses revealed gene expression signatures indicative hyperactive ifn signaling diverse immune nonimmune cell types people ds <NUMBER> well brain tissue diverse mouse models ds carrying triplication ifnr cluster <NUMBER> addition many independent studies revealed changes indicative chronic autoinflammation people ds including elevation many cytokines chemokines known act downstream ifn signaling <NUMBER> <NUMBER> <NUMBER> <NUMBER> critical importance topic cytokine storms people ds show significantly elevated levels key cytokines crp il<NUMBER> il<NUMBER> tnfa ip<NUMBER> il<NUMBER> mcp<NUMBER> <NUMBER> <NUMBER> <NUMBER> strengthen point include data demonstrating individuals ds display signs mild cytokine storm even absence obvious infections figure <NUMBER> httpexplorertrisomeorg proteome lastly metabolomics studies plasma cerebrospinal fluid revealed individuals ds display dysregulation ifninducible kynurenine pathway tryptophan catabolism leading elevated levels quinolinic acid neurotoxic tryptophan catabolite <NUMBER> reduction copy number ifnrs reversed metabolic dysregulation vitro pointing ifnr triplication driving event body evidence indicates ifn response key mounting antiviral responses initiating amplifying cytokine storm much active people ds given knowledge several questions arise likely impact sarscov<NUMBER> infections immune response individuals ds individuals trisomy <NUMBER> less likely develop severe cytokine storm downstream pathology first glance ifn hyperactivity may considered beneficial sense may enable cells trisomy <NUMBER> mount stronger antiviral response first contact sarscov<NUMBER> first viral particles enter lung epithelial cells individual trisomy <NUMBER> consequent production type type iii ifn ligands may elicit stronger response neighboring epithelial cells resident immune cells overexpressing ifnrs theory stronger initial response could restrain viral spread potentially beneficial aspect would result lower rate sarscov<NUMBER> carriers among trisomy <NUMBER> however covs developed strategies evade antiviral effects ifn response studies sarscov<NUMBER> middle east respiratory syndrome cov merscov revealed genomes encode unusual number proteins dampen neutralize ifn signaling cascade reviewed kindler et al <NUMBER> enables viral disguise immune evasion rapid viral replication spread since sarscov<NUMBER> member betacoronavirus clade also includes sarscov<NUMBER> merscov likely sarscov<NUMBER> uses similar suite antiifn strategies <NUMBER> therefore ifn hyperactivity observed people ds may sufficient providing additional protection sarscov<NUMBER> infection event sarscov<NUMBER> evades initial immune response person trisomy <NUMBER> dampening ifn signaling lifelong chronic ifn hyperactivity experienced individuals likely prime immune system superinduction cytokine storm support notion type ifn signaling found detrimental mouse model sarscov<NUMBER> infection pathology <NUMBER> deletion one type ifnrs encoded chromosome <NUMBER> ifnar<NUMBER> prevented development sars pathology data animal models sarscov<NUMBER> address role ifnr copy number assuming two related viruses provoke similar pathological cascades follows exacerbated type ifn signaling observed ds would contribute exacerbated covid<NUMBER> pathology figure <NUMBER> evidence support notion upon confirmation sarscov<NUMBER> infection individuals ds likely develop stronger prolonged cytokine storm figure <NUMBER> respiratory viral infections viral particles enter lung tissue lungresident respiratory dendritic cells rdcs acquire antigens epithelial cells infected thus activated draining mediastinal cervical lymph nodes process viral antigens present naive circulating cells reviewed channappanavar et al <NUMBER> upon cell receptor tcr engagement peptidemajor histocompatibility complex mhc complexes surface rdcs cells become activated proliferate migrate infected lung tissue lung virusspecific effector cells contribute cytokine storm producing several proinflammatory cytokines chemokines ifng tnfa il<NUMBER> cxc motif chemokine ligand <NUMBER> cxcl<NUMBER> ip<NUMBER> turn recruit innate adaptive immune cells careful analysis lymphocyte recruitment lungs sarscov<NUMBER>infected mice three patterns immune cell infiltrates identified lung tissue <NUMBER> plasmacytoid dendritic cells pdcs infiltrated lung early first wave followed second wave natural killer nk cells nk cells macrophages cd<NUMBER> cells finally third wave involved neutrophils cd<NUMBER> cells experimental model sarscov<NUMBER> infection induced enhanced virusspecific cell response lungs coincided development pneumonitis viral clearance furthermore depletion cd<NUMBER> cells resulted diminished virusspecific antibody responses decreases production th<NUMBER> th<NUMBER> cytokines lung within framework given clear signs proinflammatory changes dcs monocyte lineages nk cells effector cells isolated individuals ds <NUMBER> predicted cascade events described exacerbated driven toward stronger cytokine storm first whole blood children ds exposed live influenza virus production tnfa il<NUMBER>b il<NUMBER> il<NUMBER> ifna ifng significantly elevated relative typical siblings <NUMBER> however vitro experiment viral clearance equivalent groups authors concluded production higher levels proinflammatory cytokines may responsible severe clinical course viral disease children second deep mapping immune system adults ds revealed many changes indicative enhanced proinflammatory state monocyte lineage among dcs <NUMBER> monocyte lineage ds driven toward intermediate nonclassical states associated inflammatory conditions diverse dc subsets show alterations consistent heightened state inflammation cytotoxic potential <NUMBER> thus predicted proinflammatory state myeloid cell types ds contribute enhanced cytokine production sarscov<NUMBER> particles cross lung epithelium encounter resident alveolar macrophages dcs third within cell compartment cell lineages adults ds show clear signs differentiation hyperactivation even absence obvious infections could explained chronic ifn hyperactivity <NUMBER> cd<NUMBER> cd<NUMBER> cells adults ds activated ex vivo via stimulation tcr akin occurs viral infection overproduce many key cytokines chemokines <NUMBER> upon activation cd<NUMBER> cells trisomy <NUMBER> overproduce il<NUMBER> il<NUMBER>a il<NUMBER> mip<NUMBER>a cd<NUMBER> cells overproduce tnfa ifng il<NUMBER> mip<NUMBER>a gm granulocytemacrophagecsf il<NUMBER> mip<NUMBER>b eotaxin <NUMBER> thus cells people ds likely fuel stronger cytokine storm infiltrate infected lung epithelia addition shown effector cd<NUMBER> cd<NUMBER> cells trisomy <NUMBER> resistant suppression regulatory cells tregs <NUMBER> tregs key players resolution infection dampening action effector cd<NUMBER> cd<NUMBER> cells virus cleared however effector cells people ds found refractory dampening tregs activation results proliferation effector cells relative euploid counterparts <NUMBER> although tregs trisomy <NUMBER> found capable suppressing effector cells typical people could suppress effector cells trisomy <NUMBER> pointing hyperactive resilient state effector cells ds <NUMBER> immune system person ds attacks sarscov<NUMBER>infected cells predicted cell response including cytokine overproduction stronger last longer may exacerbated additional proinflammatory changes nk cells adults ds <NUMBER> overall evidence supports notion covid<NUMBER> ds display stronger cytokine storm accelerated onset cytokinedriven pathology figure <NUMBER> well documented pandemics respiratory viral infections followed surge cases bacterial pneumonia supporting notion postviral state bacterial pneumonia susceptibility <NUMBER> <NUMBER> fact influenzarelated deaths due secondary infections bacteria commonly found nasopharyngeal tract streptococcus pneumoniae staphylococcus aureus <NUMBER> <NUMBER> spanish flu pandemic <NUMBER> <NUMBER> deaths attributed subsequent bacterial pneumonia <NUMBER> <NUMBER> later influenza pandemics <NUMBER>s <NUMBER>s percentage deaths due bacterial lung infections estimated <NUMBER> decreases explained broader use antibiotics <NUMBER> <NUMBER> covid<NUMBER> pandemic impact secondary bacterial infections likely decreased widespread use broadly acting antibiotics azithromycin however secondary bacterial infections remain concern particularly individuals ds importance secondary infections ds production type ifns antiviral response shown drive increased risk secondary bacterial infections mouse models knockout one type ifnrs encoded chromosome <NUMBER> improved survival clearance pneumoniae <NUMBER> harmful effects type ifn signaling seem driven impairment macrophage andor neutrophil function ifninduced cytokines prominently among antiinflammatory cytokine il<NUMBER> <NUMBER> <NUMBER> il<NUMBER> involved dampening resolution immune response consistently elevated baseline people ds <NUMBER> figure <NUMBER> furthermore one subunits il<NUMBER> receptor il<NUMBER>rb encoded one four genes ifnr cluster chromosome <NUMBER> il<NUMBER>rb serves subunit il<NUMBER> receptor also type iii ifns il<NUMBER> il<NUMBER> receptors <NUMBER> findings beg question would impact elevated il<NUMBER> signaling ds point evidence supports notion elevated il<NUMBER> signaling ds suffice bring balance clearly hyperactive overresponsive immune system analysis cells people ds observed cd<NUMBER> cells trisomy <NUMBER> overproduce il<NUMBER> upon stimulation also overproduce many proinflammatory cytokines tnfa ifng mip<NUMBER>a il<NUMBER> il<NUMBER> mip<NUMBER>b eotaxin <NUMBER> however suppressive effects il<NUMBER> antibacterial branch immune system could increase risk secondary bacterial infections <NUMBER> <NUMBER> role il<NUMBER> phenomenon well investigated pneumococcal pneumonia tuberculosis mouse model influenza treatment antiil<NUMBER> neutralizing antibodies inoculation pneumoniae resulted reduced bacterial outgrowth reduced lethality secondary bacterial pneumonia <NUMBER> case tuberculosis type ifn signaling shown actually promote mycobacterium tuberculosis bacterial expansion pathogenesis <NUMBER> explained ifndependent induction il<NUMBER> consequent impairment bacterial killing <NUMBER> observations support notion type ifn hyperactivity increased downstream il<NUMBER> signaling could drivers known susceptibility bacterial pneumonia people ds children ds <NUMBER>fold higher rate pneumonia typical children <NUMBER> bacterial pneumonia leading cause mortality adults ds <NUMBER> several reports documented impaired neutrophil function ds <NUMBER> <NUMBER> <NUMBER> therefore predicted individuals covid<NUMBER> ds would higher risk secondary bacterial lung infections covid<NUMBER> pandemic potential risk factors exacerbated covid<NUMBER> pathology ds evidence outlined indicates covid<NUMBER> ds would present accelerated progression toward dyspnea ards myocardial damage potential increased risk secondary bacterial infections addition impact immune dysregulation ds could modulated potential risk factors people ds unique profile cardiovascular cardiopulmonary disease <NUMBER> nearly <NUMBER> newborns ds affected form congenital heart disease chd many cases requires repair via heart surgery <NUMBER> however adults ds seem protected coronary heart disease <NUMBER> duality cardiac phenotype makes hard point assess impacts chd development covid<NUMBER> ds likely mild viable unrepaired chd risk factor severe covid<NUMBER> assessment less clear individuals undergone effective repair via cardiac surgery otherwise normal cardiac function addition diverse anatomic abnormalities upper airway considered major risk factors respiratory infections ds <NUMBER> <NUMBER> <NUMBER> dysphagia aspiration common ds could also increase predisposition lung infection population <NUMBER> <NUMBER> addition structural factors hypotonia increase likelihood proximal airway obstruction dysphagia ds <NUMBER> <NUMBER> obstructive sleep apnea osa common people ds <NUMBER> <NUMBER> often cause chronic intermittent hypoxia respiratory acidosis turn drive pulmonary hypertension condition also common ds <NUMBER> <NUMBER> therefore osa could indirectly create additional risk factor severity covid<NUMBER> accelerating hypoxemia predisposing pulmonary hypertension decreasing cardiopulmonary capacity studies support notion osa risk factor ards settings <NUMBER> <NUMBER> studies suggest obesity associated osa may higher risk factor ards osa <NUMBER> context covid<NUMBER> chronic lung disease obesity recognized risk factors autonomous impact osa specifically remains fully elucidated summary addition risks imposed immune dysregulation caused trisomy <NUMBER> risk factors could contribute severe form covid<NUMBER> ds overall combination immune dysregulation potential risk factors suggest individuals ds confirmed sarscov<NUMBER> infection undergo closer monitoring including rapid realtime monitoring inflammatory markers eg crp il<NUMBER> tnfa myocardial damage eg brain cell reports medicine <NUMBER> may <NUMBER> <NUMBER> <NUMBER> perspective open access natriuretic peptide cardiac troponin myoglobin secondary bacterial infections clinical trials targeted immunosuppressants performed around world individuals ds prime candidates intervention approaches tone cytokine storm clearly absence clinical epidemiological data define impact covid<NUMBER> population ds perspective hypotheses stated herein approached skepticism nevertheless hope analysis literature prompts physicians around world pay special attention individuals ds adopt measures counteract effects cytokine storm potential risk factors population jme wrote perspective guidance numerous conversations colleagues students postdoctoral fellows author listed coinventor provisional patents strategies attenuate cytokine storm covid<NUMBER> viral entry host results activation innate immune mechanism together synthesis secretion inflammatory mediators interaction specific viral components pattern recognition receptors host immune system activates cellular signalling pathways culminate production various cytokines cytokines elicit host response like extravasation leukocytes activation proliferation cell differentiation adaptive innate immune system <NUMBER> <NUMBER> interleukin il<NUMBER>αβ il<NUMBER> il<NUMBER> tumor necrosis factor tnfα interferon ifnαβ transforming growth factortgfβ major cytokines ccl<NUMBER>monocyte chemoattractant protein mcp<NUMBER> mcp<NUMBER> ccl<NUMBER>macrophage inflammatory protein mip<NUMBER>α ccl<NUMBER> chemokine cc motif ligand <NUMBER>rantes regulated activation normal cell expressed secreted ifnγinducible protein<NUMBER> ip<NUMBER>cxcl<NUMBER> cxc motif chemokine <NUMBER> chemokines released influenza virusinduced infection <NUMBER> <NUMBER> cytokines exert host antiviral responses different ways ifnαβ type <NUMBER> interferon inhibit viral replication thus inducing potent antiviral state host <NUMBER> tnfα triggers immune cells localization infection site activation caspases promote apoptosis <NUMBER> il<NUMBER> pleiotropic cytokine enhances inflammatory cell infiltration increasing membrane permeability activation mast cells subsequent release histamine vasodilator <NUMBER> il<NUMBER> mediates monocyte differentiation macrophages enhances mononuclear cell infiltration inflammation loci <NUMBER> moreover synergistically il<NUMBER> tgfβ induces maturation naive helper cells cd<NUMBER> helper <NUMBER> th<NUMBER> cells potential effectors pathogens interestingly il<NUMBER> also hinders treg expansion tgfβ <NUMBER> <NUMBER> enhancement type <NUMBER> immunity activation natural killer cells nkt cells thus forming early line defence viral infection biological actions il<NUMBER> viral infection <NUMBER> <NUMBER> although cytokines released either host protection response viral entry exacerbated cytokine release adversely affect host overreacting system organs named cytokine storm observed sars mers infection resulting associated severe complications multiple organ failure <NUMBER> studies established similar hypercytokinemiacytokine storm also taking part sarscov<NUMBER>covid<NUMBER> infection review highlight pathology pathogenesis j u r n l p r e p r f mers cov sars cov sars cov<NUMBER> main focus role cytokines pathology relation comorbidities covid<NUMBER> infection <NUMBER> epidemic outbreak <NUMBER> sarscov case fatality ratio <NUMBER> <NUMBER> higher older age group greater <NUMBER> less <NUMBER> younger age group sars cov entry cells mediated ace<NUMBER> angiotensin converting enzyme <NUMBER> receptor extremely expressed lung kidney heart liver tongue viral spike protein binds receptor followed viral fusion cell membrane involves priming protein proteases cell surface finally ends entry replication virus inside cell <NUMBER> shown ace<NUMBER> protective role ali <NUMBER> ace<NUMBER> play key role reninangiotensin system ras maintains blood pressure water electrolyte balance decreased expression ace<NUMBER> negatively affects ras system followed increased microvascular permeability inflammation <NUMBER> ace<NUMBER> expression also found regulated sars cov infections augments intensity lung injury <NUMBER> moreover increased viral load excessive immune cell infiltration increased innate immune response proinflammatory mediators also lead widespread lung injury sars suggesting cytokine storm direct cytopathogenic effect virus cause physiological decompensation observed sars cov infection <NUMBER> profiling systemic cytokine levels individuals suffering sarscov disease showed elevated concentrations helper <NUMBER> th<NUMBER> cytokines like ifnγ il<NUMBER> il<NUMBER> additionally cytokines promote inflammation like il<NUMBER> il<NUMBER> mcp<NUMBER> ip<NUMBER> cxcl<NUMBER>mig monokine induced gamma interferon il<NUMBER> tgfβ il<NUMBER> also increased <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> interestingly sars patients showed change blood il<NUMBER> il<NUMBER> j u r n l p r e p r f levels <NUMBER> increased amount mig mcp<NUMBER> ip<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> blood correlated disease severity sars patients <NUMBER> <NUMBER> interstitial infiltrates observed chest radiography merscov infected individuals laboratory investigation showed increased concentration ldh aspartate aminotransferase ast low eosinophil platelet count decreased albumin level <NUMBER> another major cytokine mediate organ damage cytokine storm il<NUMBER> excessive secretion il<NUMBER> results activation coagulation pathway conversion naive cells increase vascular permeability reduced cardiac function contribute increased disease severity <NUMBER> <NUMBER> sars patients also showed increased levels il<NUMBER> correlated disease progression <NUMBER> increased levels th<NUMBER> cd<NUMBER> cells seen covid<NUMBER> patients explained high levels il<NUMBER> implicated helper <NUMBER> th<NUMBER> cells development <NUMBER> <NUMBER> interestingly spike protein sars cov induced activation nfκb signalling resulting il<NUMBER> tnfα secretion murine macrophages <NUMBER> later another study reported inhibiting nfκb signalling demonstrated decreased il<NUMBER> levels increased animal survival sars <NUMBER> studies implicate il<NUMBER> key contributor pathophysiology cytokinestorm seen sars cov infections one proposed mechanisms decreased cells covid<NUMBER> infection could mediated increased levels il<NUMBER> increased interaction fas ligand moreover increased number lymphocytes observed patients sars cov<NUMBER> infection treated tocilizumab il<NUMBER> receptor antagonist <NUMBER> <NUMBER> yet studies required speculating exact mechanism sars cov<NUMBER> induced lymphopenia although occurrence copd covid<NUMBER> patients reported <NUMBER> <NUMBER> rate disease severity mortality rate markedly high <NUMBER> <NUMBER> respectively death rate covid<NUMBER> patients cvd <NUMBER> <NUMBER> observational studies shown bcg vaccination could reduce neonatal well childhood death rate <NUMBER> <NUMBER> retrospective crosssectional study conducted subsaharan african children <NUMBER> years demonstrated positive association bcg vaccination lower threat malaria <NUMBER> additionally epidemiological studies also established protective role bcg respiratory tract infections children predominantly virusmediated <NUMBER> <NUMBER> vaccination bcg enhanced ifnγ il<NUMBER> level thus providing immunity respiratory tract infection even elderly age group <NUMBER> bcg also provides nonspecific immune assistance like immunity pathogens mycobacteria like virus parasites reduces occurrence allergy attained mechanism termed trained immunity immunological recall innate immune system via epigenetic reprogramming <NUMBER> innate immune cells like monocytes nk cells macrophages undergo epigenetic modifications histones include methylation acetylation enhances gene expression il<NUMBER> tnfα il<NUMBER>β upon bcg vaccination thus trained phenotype innate immune cells results increase secretion proinflammatory cytokines exposure nonspecific pathogen enhancing host protection <NUMBER> <NUMBER> experimentally shown healthy subjects immunized bcg show increased production tnfα il<NUMBER>β response bacterial nonbacterial stimulants increased h<NUMBER>k<NUMBER>me<NUMBER> trimethylation histone h<NUMBER> lysine <NUMBER> exposed promoter regions proinflammatory cytokines leading increased expression <NUMBER> another study bcg vaccination reduced viremia experimental human yellow fever virus infection model inducing trained immunity epigenetic modification monocytes resulting increased production il<NUMBER>β <NUMBER> moreover bcg could enhance heterologous th<NUMBER>th<NUMBER> responses inducing longlasting release il<NUMBER> ifnγ il<NUMBER> thereby attaining nonspecific immune response infections <NUMBER> line several vivo studies murine models also reported bcg immunized mice expressed antimicrobial peptides bestowed protection malarial parasitemia <NUMBER> additionally prior bcg vaccination influenza virus challenged mice found considerable protection via secretion antibody activation cellmediated immunity <NUMBER> study conducted mice model understand effect bcg various viral infections like herpes simplex type <NUMBER> influenza a<NUMBER> encephalomyocarditis viruses showed increased resistance bcg immunised mice viruses compared control mice j u r n l p r e p r f <NUMBER> specifically bcg vaccinated newborn mice shown resistant herpes simplex type <NUMBER> infection <NUMBER> based observations proposed bcg vaccine potential act protective agent sars cov<NUMBER> provides antiviral immunity <NUMBER> sarscov<NUMBER> virus enhances generation il<NUMBER> ifnγ tnfα il<NUMBER>β mild severely infected patients <NUMBER> discussed earlier trained immunity bcg vaccine involves release cytokines thus providing antiviral state earlier protection sarscov<NUMBER> figure <NUMBER> ozdemir malini laloraya conceptualization writingreviewing editing supervision none authors declare known competing financial interests personal relationships could appeared influence work reported paper severe coronavirus disease covid<NUMBER> caused sarscov<NUMBER> virus frequently characterized pulmonary inflammation <NUMBER> lifethreatening cytokine storms involving release proinflammatory cytokines eg tnfα il<NUMBER> il<NUMBER> il<NUMBER> mcp<NUMBER> may contribute rapid systemic organ failure observed select critically ill covid<NUMBER> patients <NUMBER> however storm selflimiting singular event sarscov<NUMBER> causes massive cell death cellular debris activates inflammasomes <NUMBER> turn trigger macrophagederived eicosanoid storm surge proinflammatory bioactive lipid mediators prostaglandins leukotrienes fuels local inflammation <NUMBER> <NUMBER> <NUMBER> paradigm shift inflammation field resolution inflammation active biochemical process <NUMBER> implying hyperinflammation may result deficit resolution contrast classic antiinflammatory agents endogenous proresolution lipids terminate inflammatory response promoting clearance cellular debris specialized proresolving mediators spms including resolvins lipoxins protectins bioactive lipid autacoids mediate endogenous resolution stimulating macrophage phagocytosis cellular debris countering release proinflammatory cytokineschemokines <NUMBER> importantly loss inflammation resolution mechanisms plays role sustaining pathologic inflammation <NUMBER> endogenous resolution processes identified termination infectious diseases <NUMBER> including influenza <NUMBER> <NUMBER> <NUMBER> could thus harnessed averting dysregulated inflammation associated mortality covid<NUMBER> spms promote antiviral b lymphocytic activity influenza <NUMBER> suggesting may promising therapy covid<NUMBER> spm precursors including <NUMBER>hydroxydocosahexaenoic acid <NUMBER>hdha also identified potentially promising vaccine adjuvants protect primary influenza infection promote adaptive immunity <NUMBER> <NUMBER> thus use spms precursors combination covid<NUMBER> vaccines may novel effective therapeutic approach resolution inflammation also stimulated another pathway involving arachidonic acidderived epoxyeicosatrienoic acids eets mediators promote clearance cellular debris activate antiinflammatory programs inhibit several <NUMBER> viralinduced alveolar cell death accumulation apoptotic necrotic cellular debris debris elicits proinflammatory response macrophages <NUMBER> turn produce high quantities eicosanoids generating eicosanoid storm eicosanoids subsequently stimulate production proinflammatory cytokines <NUMBER> immune cells macrophages generating robust cytokine storm turn promotes leukocytosis immune cell infiltrates <NUMBER> robust inflammatory response viral infection promotes hyaline membrane formation <NUMBER> subsequent acute respiratory distress syndrome tissue levels spms eets decreased robust inflammatory setting right alveolus demonstrates covid<NUMBER> infection setting active inflammation resolution mechanisms case mild infection potentially following treatment spms seh inhibition increase eets eets promote generation spms arachidonic acid omega<NUMBER> fatty acids spms <NUMBER> stimulate macrophage phagocytosis efferocytosis <NUMBER> decrease proinflammatory cytokine production <NUMBER> inhibit leukocytosis thereby decrease inflammatory infiltrate <NUMBER> may stimulate adaptive immune response production antisarscov<NUMBER> antibodies key proinflammatory cytokines <NUMBER> <NUMBER> eets epoxy fatty acids specifically promote production spms lipoxins shifting arachidonic acid metabolism favor inflammation resolution <NUMBER> eets rapidly metabolized soluble epoxide hydrolase seh administration seh inhibitors sehis stabilize eet levels prevent lung inflammation improve lung function animal models making attractive potential therapeutic strategy covid<NUMBER> spms sehis downregulate transcription regulator nfκb <NUMBER> <NUMBER> center eicosanoidinduced cytokine storms promotes induction proinflammatory cytokines prostaglandin synthesis via cyclooxygenase cox combined pharmacological abrogation cox<NUMBER> seh activity also prevents cytokine eicosanoid storms via debris clearance mechanisms <NUMBER> offering another promising therapeutic intervention targeting individual proinflammatory cytokines may sufficient prevent covid<NUMBER> progression importantly spms terminate selfsustaining inflammatory processes induced covid<NUMBER> broadly inhibiting proinflammatory cytokine production promoting return tissue homeostasis <NUMBER> <NUMBER> <NUMBER> contrast antiinflammatory agents may contraindicated covid<NUMBER> patients spms sehis act significantly lower doses immunosuppressive <NUMBER> <NUMBER> moreover conventional antiinflammatory agents nsaids cox<NUMBER> inhibitors limiting eicosanoid storm may resolution toxic indiscriminately inhibit eicosanoid pathways produce resolution mediators thereby prevent active resolution <NUMBER> inhibiting resolution mediator production may potentially facilitate covid<NUMBER>induced tissue injury progression infection demonstrated many inflammatory disease models selectively promoting endogenous inflammation resolution mechanisms clears inflammatory exudates effectively promotes return tissue homeostasis compared classic antiinflammatory agents <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> clinical trials focus antiviral antiinflammatory strategies contrast stimulation inflammation resolution novel hostfocused alternative complement current therapies loss active resolution mechanisms <NUMBER> dysregulation spms eets sustained pathological inflammation lung diseases present new opportunity management covid<NUMBER> proresolving mediators well seh blockade may resolve potentially fatal cytokine storm severe pulmonary inflammation covid<NUMBER> patients see fig <NUMBER> importantly spms eets also shown attenuate pathologic thrombosis promote clot removal recognized key pathology covid<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> spms including resolvins lipoxins protectins well sehis currently clinical trials inflammatory diseases could rapidly translated management covid<NUMBER> complementing current antiviral strategies via debris clearance inflammatory cytokine suppression thus activating endogenous resolution pathways may novel therapeutic approach limit severe organ damage improve outcomes covid<NUMBER> patients ongoing pandemic coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respirat ory syndrome coronavirus <NUMBER> sarscov<NUMBER> caused <NUMBER> million confirmed cases <NUMBER> <NUMBER> deaths june <NUMBER>th <NUMBER> high intensive care unit icu admission rate mortality covid<NUMBER> continuously posing serious strain global healthcare system patients present mild moderate symptoms patients may develop lifethreatening sepsis respiratory failure acute respiratory distress syndrome ards multiple organ failure however current antiviral supportive therapies sufficient prevent treat complications especially severely ill covid<NUMBER> patients <NUMBER> thus urgent find underlying mechanism dominating lifethreatening complications well recognized lung damage multiorgan failure subgroup patients arise due overwhelming systemic hyperinflammation therefore promising antiinflammatory candidate agents targeting diverse mechanisms related cytokine storm therapeutically relevant mounting evidence demonstrated severely ill covid<NUMBER> patients presented elevated levels cytokines inflammatory indices serum il<NUMBER>β il<NUMBER> il<NUMBER> ddimer moderate symptoms suggesting involvement cytokine storm <NUMBER> cytokine storm represents exaggerated immune response characterized overproduction proinflammatory cytokines chemokines ifnγ tnfα il<NUMBER> il<NUMBER>β il<NUMBER> cxcl<NUMBER> cxcl<NUMBER> also observed viral diseases influenza severe acute respiratory syndrome sars middle east respiratory syndrome mers <NUMBER> adequate release cytokines critical bodys defense viral infection uncontrolled aberrant immune system activation lead organ injury current clinical evidence also confirmed correlation cytokine storm syndrome disease severity well unfavorable outcomes hospitalized covid<NUMBER> patients <NUMBER> association unfavorable prognosis presence overinflammation cytokine storm highlights necessity early identification cytokine storm implementation antiinflammatory treatment timely control hyperinflammatory response crucial prevent development progression irreversible ards multiorgan dysfunction accompanying covid<NUMBER> covid<NUMBER> patients widely used antiinflammatory immunemodulatory agents include corticosteroids intravenous immunoglobulin ivig corticosteroids methylprednisolone dexamethasone considered one options covid<NUMBER> patients cytokine storm <NUMBER> based inhibition many inflammatory genes previous clinical use viral diseases <NUMBER> th june preliminary results randomized controlled clinical trial released recovery randomised evaluation covid<NUMBER> therapy study group united kingdom study showed lowdose dexamethasone could reduce mortality onethird critically ill patients need mechanical ventilation <NUMBER> however previous studies associate use corticosteroid sars mers influenza higher risk delayed viral clearance longterm complications survivors <NUMBER> yet much remains unknown regarding impact corticosteroids clinical outcomes covid<NUMBER> combination effect drugs time window dosage administration safety profile well possible adverse effects currently dozens ongoing clinical trials addressing unsolved questions supplemental table ivig also used adjunctive drug treatment severe covid<NUMBER> patients purified blood product healthy donors exerts immunomodulatory effect mainly neutralizing virus antibodiespolyclonal immunoglobulin g igg could also block fcγ receptors involved natural adaptive immunity currently limited number clinical studies shown ivig treatment within <NUMBER>h admission reduced use mechanical ventilation duration icu stay hospitalization well <NUMBER>day mortality<NUMBER> however clinical evidence effectiveness managing clinical covid<NUMBER> infection warranted ongoing clinical trials ivig including convalescent patients listed supplemental table nodlike receptor protein <NUMBER> nlrp<NUMBER> inflammasome protein complex crucial hosts antiviral defense viral replication invading virus plus variety derived pathogenassociated molecular patterns pamps dangerassociated molecular patterns damps active nlrp<NUMBER> inflammasome upon activation nlrp<NUMBER> inflammasome induces pyroptosis well secretion il<NUMBER>β il<NUMBER> responsible recruitment neutrophils inflammatory sites assist virus eradication induction adaptive immune system however persistent activation nlrp<NUMBER> inflammasome excessive production inflammatory cells cytokine well pyroptosismediated cell damage jointly lead organ injury <NUMBER> activation inflammasome pathway indicated elevation il<NUMBER>βin severe covid<NUMBER> patients therefore drugs targeting nlrp<NUMBER> inflammasome il<NUMBER>β promising mitigating nlrp<NUMBER>inflammasome driven hyperinflammation pyroptosis cytokine storm syndrome severely ill covid<NUMBER> patients colchicine bioactive alkaloid compound isolated plant colchicum commonly used inflammatory diseases gout acts inhibitor nlrp<NUMBER> inflammasome interferes polymerization binding free tubulin dimers leading deregulation inflammatory cell activities release cytokines especially il<NUMBER> addition colchicine also suppresses production numerous cytokines pyrogens superoxides mediated white blood cells regard safety profile colchicine <NUMBER> patients administered therapeutic dose may exhibit gastrointestinal symptoms nausea vomit diarrhea side effects <NUMBER> overall colchicine may exploited potential candidate alleviating immune hyperactivity sarscov<NUMBER> infection recombinant il<NUMBER> receptor blocker anakinra il<NUMBER>βmonoclonal antibodies canakinumab also interest prospective study showed prospective cohort design showed treatment anakinra contributes substantial reduction mortality use invasive mechanical ventilation without bringing serious side effects critically ill covid<NUMBER> patients <NUMBER> due antiinflammatory effects drugs possible efficacy covid<NUMBER> gaining attention currently number registered studies clinicaltrials gov test effectiveness safety colchicine anakinra canakinumab covid<NUMBER> supplemental table level il<NUMBER> significantly increased covid<NUMBER> patients closely related ards severity outcome sarscov<NUMBER> infection subsequent release virus particles recruits monocytes macrophages leading release cytokine initiation adaptive immune responses process il<NUMBER> played essential role cases immune response eliminates lung infection patients recovered however others abnormal immune response triggered cytokine storm characterized persistent hypercytokinemia elevated il<NUMBER> tnfα il<NUMBER>β eventually aggravated lung injury even ripple effects entire body immune dysregulation severe covid<NUMBER> individuals driven il<NUMBER> il<NUMBER> deficiency shown reduce severity acute lung injury mouse model <NUMBER> therefore il<NUMBER> may potential target cytokine treat covid<NUMBER> related ards il<NUMBER> inhibitors tocilizumab recombinant humanized monoclonal il<NUMBER> blocking antibody could curb il<NUMBER> mediated proinflammatory pathway binding soluble membrane fraction il<NUMBER> receptor il<NUMBER>r probably via nuclear factor kappab stat<NUMBER> signaling pathway tocilizumab seemed effective covid<NUMBER> patients decreased use mechanical ventilation improved hypoxemia ct opacity changes severe cases clinical trials <NUMBER> tocilizumab prescribed treatment severe patients elevated il<NUMBER> level china since march <NUMBER> according diagnosis treatment program covid<NUMBER> national health commission china <NUMBER>th version notably il<NUMBER> could either inhibit accelerate viral replication function lung suffering infection chemical insults thus optimal timing antiil<NUMBER> administration essential therefore il<NUMBER> blockers could efficient therapeutic strategy treatment covid<NUMBER> present several registered studies way assess safety efficacy il<NUMBER> blockers supplemental table researches required evaluate shortterm longterm outcomes antiil<NUMBER> administration determine optimal time drug administration j u r n l p r e p r f bromodomain containing protein <NUMBER> brd<NUMBER> epigenetic reader acetylated lysines member bromodomain extra terminal domain bet family brd<NUMBER> regulates cell growth cell cyclerelated gene transcription combining acetylated histones suffering virus infection brd<NUMBER> plays role epithelialdriven nfκb dependent innate inflammation nfκb recruits brd<NUMBER> facilitates interaction nfκb brd<NUMBER> activates nfκb mediated proinflammatory signaling pathway moreover brd<NUMBER> inhibitors shown decrease recruitment macrophages infiltration cells <NUMBER> previous researches indicated potential role brd<NUMBER> inhibition antiviral response dna damage manner block attachment dna rna <NUMBER> well alleviating lung fibrosis one common sequelae covid<NUMBER> animal models ex vivo experiments <NUMBER> furthermore recent reports demonstrated transmembrane e protein sarscov<NUMBER> resident ergic golgi membranes could bound brd<NUMBER> <NUMBER> bet inhibitors like apabetalone rvx<NUMBER> jq<NUMBER> inhibit vascular inflammationrelated gene expression suppressing betmediated transcription triggered multiple proinflammatory stimuli bet inhibitors many reported effects inflammation airway remodeling cardiovascular disease cancers <NUMBER> though reported cases covid<NUMBER> treated brd<NUMBER> inhibitors date brd<NUMBER> inhibitors could considered potential candidate ameliorate hyperinflammation cytokine storm accompanying covid<NUMBER> pathophysiology severe covid<NUMBER> related aggressive inflammatory responses damage lung even ripple effects across body thus severity depends balance viral virulence host immune response infection occurs release recognition pathogenassociated molecular patterns pamps trigger production proinflammatory cytokines chemokines involving il<NUMBER>β il<NUMBER> il<NUMBER> tnfα macrophage inflammatory proteins normally healthy immune response clear infection inadequate immune response result accumulation activated immune cells lungs leading cytokine storm eventually damaging lung causing multiple organ failure circulation therefore one strategy treatment covid<NUMBER> block overwhelming inflammation emerging evidence suggested potential effects inflammation inhibitors treatment covid<NUMBER> especially severe cases immunomodulatory immunosuppressive therapies aimed curbing immune mediated damage covid<NUMBER> ongoing supplemental table necessary confirm therapeutic effects investigate administration timing clarify mechanism may render possible immunoregulation interventions arrest reverse devastating disease conflict interest none declared disclosure none declared gf chemokines cytokines participate immune responses activation multiple signaling pathways jakstat trafnfκb trafap<NUMBER> iraknfκb <NUMBER> term cytokine storm appeared first time article relating graftversushost disease <NUMBER> <NUMBER> interpretation mechanisms immune diseases chronic inflammation gradually scientists found viruses including cytomegalovirus streptococci influenza virus sarscov also evoke cytokine storms <NUMBER> <NUMBER> <NUMBER> <NUMBER> viral infection prrs activate irf nfκb pathways recognizing pamp promote release proinflammatory cytokines chemokines infected local epithelial cells macrophages cytokineactivated macrophages virusinfected dendritic cells dc lead broader immune response attracting inflammatory cells inflammatory sites releasing large number cytokines eventually results cytokine storm excessive cytokines may spill circulatory system cause systemic cytokine storms resulting multiple organ dysfunction <NUMBER> <NUMBER> previously found serum levels proinflammatory cytokines ifnγ il<NUMBER> il<NUMBER> il<NUMBER> transforming growth factorβ tgfβ chemokines ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> il<NUMBER> sarscov infected patients higher healthy individuals level antiinflammatory cytokine il<NUMBER> severe patients significantly lower healthy controls <NUMBER> <NUMBER> <NUMBER> beginning epidemic huang et al reported plasma levels il<NUMBER> il<NUMBER> gscf cxcl<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα higher covid<NUMBER> patients intensive care unit icu covid<NUMBER> patients outside icu <NUMBER> furthermore relatively higher level serum ferritin also seen deceased patients comparing discharged patients severe patients comparing mild patients <NUMBER> <NUMBER> thus pattern cytokine storm covid<NUMBER> patients thought similar secondary hemophagocytic lymphohistiocytosis shlh <NUMBER> <NUMBER> <NUMBER> unlike cytokines profile sars patients covid<NUMBER> patients remarkable increase antiinflammatory cytokines il<NUMBER> table <NUMBER> often seen hlh patients previous studies <NUMBER> <NUMBER> <NUMBER> compared increased cytokines increased il<NUMBER> frequently associated il<NUMBER> patients severe disease table <NUMBER> subsets activated cells well nonimmune cells like fibroblasts epithelial cells keratinocytes <NUMBER> <NUMBER> <NUMBER> <NUMBER> activate jakstat raserkcebp pⅰ<NUMBER>kakt pathways il<NUMBER>r signaltransducing coreceptor gp<NUMBER> <NUMBER> <NUMBER> il<NUMBER> also regulates b cell proliferation differentiation induces cell differentiation <NUMBER> <NUMBER> <NUMBER> although il<NUMBER> proposed involved repair lung injury mouse model influenza h<NUMBER>n<NUMBER> virus <NUMBER> contributes pathogenesis inflammatory autoimmunity diseases <NUMBER> <NUMBER> excessive production il<NUMBER> leads serious disease progression viral infection <NUMBER> <NUMBER> il<NUMBER> also pleiotropic cytokine limits terminates inflammatory responses inhibiting antigenpresenting cells apc proinflammatory cytokines production cell response <NUMBER> various subpopulations cd<NUMBER> helper th cells including th<NUMBER> th<NUMBER> th<NUMBER> produce il<NUMBER> important selfregulatory function th cells infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> although reducing il<NUMBER> levels could improve resistance infection animal models weakening control inflammatory responses may cause significant damage hosts time <NUMBER> thus il<NUMBER> plays central role maintaining balance damage protection th<NUMBER> cells produce il<NUMBER> regulates immune response <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> figure <NUMBER> similarity signaling network il<NUMBER> receptors il<NUMBER>r suggests common biological process among il<NUMBER> il<NUMBER> <NUMBER> reported il<NUMBER> cooperated il<NUMBER> eliminate pathogens modulate cellular immune response patient infected h<NUMBER>n<NUMBER> influenza virus produced immunosuppressive environment delayed virus clearance increase secondary infection <NUMBER> <NUMBER> pathological findings deceased covid<NUMBER> patient showed elevated il<NUMBER> il<NUMBER> increased highly proinflammatory ccr<NUMBER> ccr<NUMBER> th<NUMBER> peripheral cd<NUMBER> cells <NUMBER> rapid accumulation proinflammatory cytokines stimulates overreaction antiinflammatory response resulting severe immune injury patients chinese suggests increase il<NUMBER> indicator critical patients <NUMBER> recommend measuring il<NUMBER> il<NUMBER> signs cytokine storm intensification covid<NUMBER> patients great attention paid cytokine storm covid<NUMBER> infection address j u r n l p r e p r f immediate need reducing rising mortality antiinflammatory medications commonly used management cytokine storm includes gcs intravenous immune globulin ivig inflammatory cytokines antagonists il<NUMBER>r antagonists il<NUMBER>r antagonists jak inhibitors however gcs may slow clearance coronavirus <NUMBER> highdose ivig early stage clinical deterioration reported successful three cases <NUMBER> ongoing randomized controlled trial rct ivig severe covid<NUMBER> patients nct<NUMBER> may provide authoritative evidence treatment since il<NUMBER>β il<NUMBER> major cytokines involved pathogenesis shlh <NUMBER> il<NUMBER>r antagonist tocilizumab sarilumab il<NUMBER>r antagonists anakinra may effective choices retrospective study continuous intravenous infusion anakinra five patients established rapid serologic subsequent clinical improvement adult patients shlh <NUMBER> randomized placebocontrolled phase iii trial indicated anakinra reduced mortality sepsis patients features shlh <NUMBER> tocilizumab attracts attention compared anakinra found improve fever hypoxemia lung lesions crp levels severe covid<NUMBER> patients obvious adverse reactions retrospective studies several patients still aggravated <NUMBER> <NUMBER> serum level il<NUMBER> tocilizumab therapy tended spike initially decrease patients failed treatment exhibited persistent dramatic increase il<NUMBER> <NUMBER> <NUMBER> nevertheless cannot draw firm conclusions efficacy safety anakinra tocilizumab due limited sample size retrospective method present evidence studies required determine probability potential secondary infection find appropriate biochemical indicator monitoring therapeutic effect clinical trials evaluating anakinra nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> tocilizumab chictr<NUMBER> chictr<NUMBER> chictr<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> et al treatment covid<NUMBER> ongoing across world secondary bacterial infection found exacerbate viral pneumonia also related imbalance cells plasma cytokines <NUMBER> bacterial coinfection known associated approximately <NUMBER> viral respiratory tract infections requiring j u r n l p r e p r f hospitalization <NUMBER> early detection bacterial infection timely intervention help alleviate deterioration covid<NUMBER> procalcitonin pct released bacterial infectious tissues irritation proinflammatory cytokines specific marker serious bacterial infection compared creactive protein crp il<NUMBER> <NUMBER> pctbased strategy applied guide antibiotic use icu emergency wards since serum pct levels patients severe bacterial infections much higher simple viral infections nonspecific inflammatory diseases <NUMBER> <NUMBER> <NUMBER> antimicrobial interventions encouraged patients lower respiratory tract infection value pct <NUMBER>ngml <NUMBER>ngml likely highlylikely respectively undergo bacterial infection <NUMBER> <NUMBER> multiple studies shown pct levels increased critical deceased covid<NUMBER> patients table <NUMBER> li et al <NUMBER> reported <NUMBER> deceased patients elevated pct levels <NUMBER>ngml including pct <NUMBER> ngml <NUMBER> patients pct <NUMBER>ngml <NUMBER> patients pct value increased admission death another retrospective study <NUMBER> covid<NUMBER> patients higher proportions pct <NUMBER>ngml found severe cases mild cases <NUMBER> vs <NUMBER> <NUMBER> patients reached primary composite endpoint including admission icu use mechanical ventilation death higher proportion pct <NUMBER>ngml patients without endpoint events <NUMBER> vs <NUMBER> <NUMBER> correlation increased pct severe covid<NUMBER> also observed pediatric patients <NUMBER> findings although might better option previous studies shown addition antibacterial effects drugs also alleviate inflammatory reactions reducing accumulation proinflammatory cytokines regulating neutrophil function apoptosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> including mean ± sd median iqr median mixmax c pct value≥<NUMBER> pvalue comparison pct value two groups e pvalue comparison proportion patients increased pct value two groups tests pvalue <NUMBER> considered statistically significant cytokine release syndrome crs hypercytokinemia often referred cytokine storm postulated drive mortality severe respiratory viral infections influenza <NUMBER> including <NUMBER> spanish flu epidemic <NUMBER> h<NUMBER>n<NUMBER> bird flu <NUMBER> well severe acute respiratory syndrome coronavirus epidemic <NUMBER> sarscov<NUMBER> <NUMBER> increasing evidence supports notion mortality infections sarscov<NUMBER> causes coronavirus disease <NUMBER> driven exacerbated immune response virus leading cascade events involving cytokine storm acute respiratory distress syndrome ards often accompanied myocardial damage multiple organ failure <NUMBER> <NUMBER> pathological cascade resembles observed lethal viral lung infections immune response virus triggers primary wave cytokines including type type iii interferons ifns followed infiltration activation diverse immune cells production secondary cytokines chemokines including type ii ifn ifng accelerated immune activation progressive decline respiratory function <NUMBER> importantly many cytokines chemokines involved cytokine storm employ janus protein kinases jaks signal transduction cytokine analysis covid<NUMBER> patients indicate important role magnitude cytokine storm prognosis clinical outcome levels creactive protein crp il<NUMBER> time hospitalization reported significantly higher patients eventually died versus survived <NUMBER> different study patients admitted intensive care units icus showed significantly higher levels il<NUMBER> il<NUMBER> il<NUMBER> ip<NUMBER> mcp<NUMBER> mip<NUMBER>α gcsf tnfα relative nonicu patients <NUMBER> using artificial intelligence methods high levels circulating alanine aminotransferase alt marker liver inflammation associated progression toward ards <NUMBER> altogether findings support rationale combining antiviral treatment targeted immunosuppression therapeutic approach covid<NUMBER> <NUMBER> accordingly several clinical trials currently testing safety efficacy inhibitors il<NUMBER> signaling jakstat signaling furthermore hydroxychloroquine molecule shown attenuate tolllike receptor signaling cytokine production approved treatment rheumatoid arthritis systemic lupus erythematosus <NUMBER> <NUMBER> also testing many clinical trials covid<NUMBER> within context report relevant results obtained studies hyperactive immune response mouse model syndrome ds recently discovered trisomy <NUMBER> t<NUMBER> genetic cause ds causes consistent activation ifn transcriptional response multiple cell types <NUMBER> <NUMBER> <NUMBER> <NUMBER> explained fact four six ifn receptors encoded chromosome <NUMBER> ifnar<NUMBER> ifnar<NUMBER> ifngr<NUMBER> il<NUMBER>rb additional investigations proteome <NUMBER> metabolome <NUMBER> immune cell lineages <NUMBER> <NUMBER> people ds demonstrated t<NUMBER> causes <NUMBER> changes circulating proteome indicative chronic autoinflammation clear dysregulation ifninducible cytokines <NUMBER> <NUMBER> activation ifninducible kynurenine pathway leading elevated production neurotoxic tryptophan catabolites <NUMBER> <NUMBER> widespread hypersensitivity ifn stimulation across human immune system <NUMBER> <NUMBER> altogether results support notion ds understood good measure interferonopathy whereby increased ifn signaling could account many developmental clinical impacts t<NUMBER> report results generated investigation immune responses dp<NUMBER>yey mouse strain referred hereto dp<NUMBER> <NUMBER> widely used mouse model ds dp<NUMBER> strain carries segmental duplication murine chromosome <NUMBER> syntenic human chromosome <NUMBER> encoding <NUMBER> genes including four ifnrs found dp<NUMBER> mice overexpress ifnrs immune cell types tested display hypersensitivity type type ii ifn stimulation overproduce key cytokines display increased liver inflammation remarkably dp<NUMBER> mice display lethal immune responses upon challenge viral mimetic molecules tlr<NUMBER> agonist polyic pic tlr<NUMBER> agonist imiquimod phenotype observed wild type wt littermates mouse strains carrying triplications genomic regions syntenic chromosome <NUMBER> strikingly lethal immune phenotype associated cytokine storm blocked treatment small molecule inhibitor jak<NUMBER> kinase also decreases liver pathology overall results potential farreaching significance treatment covid<NUMBER> justifying deeper study jak inhibitors therapeutic strategy attenuate cytokine storm downstream organ failure condition also indicating individuals ds considered highrisk population covid<NUMBER> pandemic order model impact t<NUMBER> chronic innate immune responses mice employed dp<NUMBER> mouse strain harbors triplication region syntenic human chromosome <NUMBER> including four ifnrs figure <NUMBER>a <NUMBER> define relationship gene copy number ifnr protein expression evaluated surface expression ifnar<NUMBER> peripheral immune cells dp<NUMBER> mice flow cytometry dp<NUMBER>yey dp<NUMBER>yey mice hereafter referred dp<NUMBER> dp<NUMBER> three copies genes syntenic chromosome <NUMBER> disomic ifnrs <NUMBER> included controls figure <NUMBER>a expression ifnar<NUMBER> surface cd<NUMBER> white blood cells significantly higher dp<NUMBER> mice dp<NUMBER> dp<NUMBER> animals relative wt littermates figure <NUMBER>b different immune cell types analyzed flow cytometry ifnar<NUMBER> expression significantly higher cell types tested figure <NUMBER>c results consistent previous reports mrna overexpression ifnrs gene cluster various tissues dp<NUMBER> mice <NUMBER> <NUMBER> test whether upregulation ifnrs conferred stronger responses ifn ligands stimulated wt dp<NUMBER> blood samples ifna evaluated downstream phosphorylation stat<NUMBER> pstat<NUMBER> flow cytometry dp<NUMBER> cells responded strongly ifna defined significantly higher levels pstat<NUMBER> relative wt cells immune lineages examined figure <NUMBER>d widespread heightened response ifna observed dp<NUMBER> dp<NUMBER> cells however cell subsets dp<NUMBER> strain exhibited robust pstat<NUMBER> figure <NUMBER>ef although dp<NUMBER> mice two copies ifnr genes result suggests aspect triplication region chromosome <NUMBER> syntenic human chromosome <NUMBER> leads differential regulation type ifn signaling cells given one type ii ifn receptor subunits ifngr<NUMBER> also encoded murine chromosome <NUMBER> triplicated dp<NUMBER> mice next investigated response ifng stimulation indeed dp<NUMBER> cells responded strongly ifng stimulation cell types examined figure <NUMBER>g overall results suggest elevated expression ifnrs dp<NUMBER> mouse strain confers increased sensitivity type type ii ifns since dp<NUMBER> cells mount enhanced responses ifn ligands next investigated response dp<NUMBER> mice innate immune stimuli known trigger ifn response chronic systemic induction ifn signaling elicited repeated administration tlr<NUMBER> agonist polyinosinicpolycytidylic acid pic known produce acute spike type ifn production <NUMBER> days followed low persistent expression type ifn ligands robust cytokine response chronic phase <NUMBER> days <NUMBER> wt dp<NUMBER> mice given intraperitoneal injections <NUMBER> mgkg pic equivalent volume vehicle sham every day <NUMBER> days experiment completed day <NUMBER> remarkably dp<NUMBER> mice profoundly sensitive treatment largely tolerated wt mice figure <NUMBER>a body weight measurements course experiment revealed rapid weight loss dp<NUMBER> mice upon treatment figure <NUMBER>b eventually one twelve dp<NUMBER> mice removed study excessive weight loss <NUMBER> contrast wt animals lose much weight three nine survived end experiment figure <NUMBER>a b dp<NUMBER> dp<NUMBER> mice also tolerated chronic immune stimulation pic figure <NUMBER>cf although pic treatment caused weight loss dp<NUMBER> dp<NUMBER> mice percentage lost comparable wt levels picinduced weight loss clearly dosedependent mice receiving half lethal dose <NUMBER> mgkg displayed minor weight loss observable differences dp<NUMBER> wt mice figure s<NUMBER> order determine whether hypersensitivity restricted tlr<NUMBER> agonists broadly observed across activation pattern recognition receptors treated mice tlr<NUMBER> agonist imiquimod topical administration imiquimod causes ifn production acute skin inflammation systemic inflammation dehydration commonly employed model psoriasis <NUMBER> imiquimod treatment caused significant weight loss dp<NUMBER> mice despite daily administration supportive fluids led rapid termination study observation humane endpoint figure <NUMBER>gh contrast wt animals receiving identical treatment maintained weight figure <NUMBER>gh altogether results indicate hypersensitivity ifn stimulation observed cellular level dp<NUMBER> mice associates increased sensitivity lethality ifninducing viral mimetic agents organismal level next compared immune response dp<NUMBER> mice relative wild type littermates acute chronic responses pic first measured levels circulating ifna <NUMBER> hours first injection pic sham ifna levels induced pic stronger response dp<NUMBER> mice figure <NUMBER>a elevated ifn ligand production dp<NUMBER> mice consistent predicted fastforward loop driven increased ifnr expression ds <NUMBER> measured mrna expression several ifnstimulated genes isgs spleen wt dp<NUMBER> mice <NUMBER> hours single injection pic sham experiment revealed strong induction isg expression upon pic treatment several isgs significantly elevated dp<NUMBER> mice wt animals figure <NUMBER>b next measured levels several cytokines chemokines bloodstream <NUMBER> hours single pic injection expectedly pictreated animals showed increased levels many proinflammatory factors regardless genotype figure <NUMBER>c figure s<NUMBER>a acute phase significantly elevated inflammatory markers ip<NUMBER> cxcl<NUMBER> mcp<NUMBER> rantes ccl<NUMBER> kcgro cxcl<NUMBER> figure <NUMBER>c average dp<NUMBER> mice show significant differences expression cytokines relative wt littermates measured circulating cytokines chemokines chronic response compared serum levels dp<NUMBER> mice taken time harvest due reaching humane endpoint <NUMBER> weight loss levels wt littermates survived end <NUMBER>day experiment later stages chronic inflammation several inflammatory markers significantly elevated dp<NUMBER> animals mcp<NUMBER> mip<NUMBER>a wt littermates figure <NUMBER>d altogether results indicate activation tlr signaling leads strong induction key cytokine chemokines experimental paradigm several inflammatory markers elevated dp<NUMBER> mice although single cytokine chemokine stands sole driver phenotypes dp<NUMBER> mice mild overproduction several cytokines could potentially contribute exacerbated immune sensitivity next investigated markers liver inflammation injury serum levels enzymes alanine transaminase alt aspartate transaminase ast two commonly used markers hepatocyte injury significantly elevated upon pic treatment dp<NUMBER> mice reaching concentrations nearly order magnitude higher observed wt littermates figure <NUMBER>a prompted results investigated liver pathology liver tissue sections stained hematoxylin eosin evaluated trained histologist blinded treatment group genotype scoring liver pathology done procedures adapted mice <NUMBER> using validated histological scoring system <NUMBER> included parameters cell injury inflammation reactive changes leading overall liver pathology score analysis revealed dp<NUMBER> mice increased liver pathology even pic treatment demonstrated significantly higher levels cell injury inflammation reactive changes relative wt littermates figure <NUMBER>bc basal level liver pathology observed dp<NUMBER> dp<NUMBER> mice figure <NUMBER>de importantly upon treatment pic livers wt animals developed pathology scores comparable greater observed baseline dp<NUMBER> mice including signs strong recruitment andor expansion inflammatory cells pic administered dp<NUMBER> mice metrics liver pathology increased leading significantly higher overall pathology scores relative dp<NUMBER> sham treatment wt upon pic treatment figure <NUMBER>bc livers dp<NUMBER> dp<NUMBER> mice received pic also experienced increases liver pathology changes differ wt mice figure <NUMBER>de overall results indicate dp<NUMBER> mice display increased liver inflammation pathology baseline upon immune activation could potentially contribute heightened sensitivity ifninducing agents three types ifn signaling employ jak<NUMBER> kinase signal transduction combination either jak<NUMBER> tyk<NUMBER> figure <NUMBER>a therefore sought determine whether inhibiting jak<NUMBER> specifically would block lethality pathology caused pic treatment dp<NUMBER> mice end used jak<NUMBER>specific inhibitor incb<NUMBER> animals received dose <NUMBER> mgkg incb<NUMBER> equivalent volume methylcellulose used vehicle twice daily via oral gavage beginning <NUMBER> hours prior first pic injection every day course experiment remarkably dp<NUMBER> mice received jak<NUMBER> inhibitor survived pic treatment dp<NUMBER> animals received vehicle pic experienced weight loss euthanized figure <NUMBER>a analyzed impact jak<NUMBER> inhibition cytokine production comparing dp<NUMBER> mice treated pic without cotreatment jak<NUMBER> inhibitor importantly cytokine production strongly abrogated jak<NUMBER> inhibition figure <NUMBER>b figure s<NUMBER> lastly evaluated impact jak<NUMBER> inhibition markers liver inflammation injury indeed jak<NUMBER> inhibitor led reduction circulating levels alt ast well decrease overall liver pathology scores figure <NUMBER>c altogether results indicate blocking catalytic activity jak<NUMBER> kinase prevents lethality associated rampant innate immune response dp<NUMBER> mouse model efficacy treatment likely relies combination interrelated effects reduced cytokine production improved liver function covid<NUMBER> pandemic rapidly progresses worldwide dire need identify new prophylactic therapeutic strategies based recent data analyses inflammatory markers covid<NUMBER> <NUMBER> <NUMBER> prior knowledge inflammatory responses lethal viral lung infections targeted immunesuppression appreciated potential strategy prevent ards fulminant myocarditis organ failure mortality advanced stages condition <NUMBER> accordingly clinical trials diverse immunesuppressants started around world including inhibitors il<NUMBER> jakstat signaling demonstrate key role jak<NUMBER> kinase driving cytokine storms accompanying mortality mouse model lethal antiviral immune responses jak<NUMBER> one several jak kinases required mediating inflammatory signaling downstream large number cytokines including three types ifn signaling il<NUMBER> <NUMBER> show eliciting innate antiviral immune response tlr agonists lethal sensitized mouse model carrying triplication four six ifn receptors within days dp<NUMBER> mice rapidly lose weight die unattended concurrent induction many prominent cytokines linked severity covid<NUMBER>driven pathology il<NUMBER> tnfα il<NUMBER> ip<NUMBER> mcp<NUMBER> mip<NUMBER>α <NUMBER> furthermore dp<NUMBER> mice display exacerbated liver inflammation pathology together stronger production cytokines may converge pathological cascade leading wasting death importantly phenotypes blocked jak<NUMBER> inhibition based results propose jak inhibitors valid therapeutic approach attenuating cytokine storm covid<NUMBER> four jak inhibitors currently fdaapproved treatment diverse medical conditions jakafiruxolitinib jak<NUMBER> inhibitor approved myelofibrosis polycythemia vera graftversushostdisease xeljanztofacitinib jak<NUMBER> inhibitor approved rheumatoid arthritis psoriatic arthritis ulcerative colitis olumiantbaricitinib jak<NUMBER> inhibitor approved rheumatoid arthritis rinvoqupadacitinib jak<NUMBER> inhibitor also approved rheumatoid arthritis many jak<NUMBER>specific inhibitors currently developed tested clinical trials diverse inflammatory autoimmune conditions including molecule used study hypothesize jak inhibitors could superior agents terms attenuating cytokine storm caused covid<NUMBER> relative existing antiil<NUMBER> agents consist injectable monoclonal antibodies inhibit interaction il<NUMBER> receptor il<NUMBER>r <NUMBER> contrast jak inhibitors available drugs administered orally well characterized pharmacodynamics pharmacokinetics may provide appropriate strategy transiently tone cytokine storm prevent ards fulminant myocarditis furthermore jak<NUMBER> inhibitors block il<NUMBER> signaling also inflammatory pathways involved cytokine storm <NUMBER> depending degree inhibition various jak kinases predicted available jak inhibitors block various aspects cytokine storm potential varying degrees therapeutic benefit regards relevance therapeutic strategies covid<NUMBER> conditions associated cytokine storms study several limitations first mouse model fully reproduce human conditions associated cytokine storms although pandemic studies dp<NUMBER> mice originally driven interest studying immune dysregulation ifn hyperactivity ds note results consistent studies sarscov<NUMBER> demonstrating type ifn signaling contributes sarsdriven pathology mortality mice <NUMBER> predict observed rsv <NUMBER> h<NUMBER>n<NUMBER> <NUMBER> infections people ds develop severe complications upon sarscov<NUMBER> infection including higher rates hospitalization mortality hope results encourage special attention individuals ds including closer monitoring hyperinflammation covid<NUMBER> inclusion clinical trials targeted immunesuppressants table s<NUMBER> qrtpcr qrtpcr performed using applied biosystems viia<NUMBER>™ <NUMBER>well block real time pcr system qrtpcr master mix prepared applied biosystems sybr select master mix cfx standard curves run every primer pair qrtpcr experiment ensure efficient amplification target transcripts within experimental tissues samples run triplicate averaged normalized <NUMBER>s rrna primer sequences provided table s<NUMBER> cytokine measurements blood cytokine levels measured using mesoscale discovery assays andor biolegend legend plex assays per manufacturers instructions samples analyzed duplicate average used statistical analysis missing values set lower limit detection liver histopathology formalinfixed paraffinembedded pieces liver sectioned <NUMBER> microns stained hematoxylin eosin scoring liver pathology used procedures adapted mice described <NUMBER> table s<NUMBER> primers qrtpcr primers used qrtpcr analysis interferonstimulated genes <NUMBER>s rrna including gene refseq id forward primer sequence reverse primer sequence coronaviruses covs enveloped single positivestrand rna viruses belonging large subfamily coronavirinae infect mammals several animals <NUMBER> seven covs known cause human disease divided low high pathogenic covs <NUMBER> aggressively spread across globe infecting <NUMBER> million confirmed cases <NUMBER> three central variants current virus differ amino acid sequence identified namely b c ancestral type mutated type c found significant proportions outside east asia mainly europe united states b type mutated spread common type east asia <NUMBER> article protected copyright rights reserved covid<NUMBER>showsa complex profile many different clinical presentations similar many viral infections characteristics currently infected patients clinical outcomes may represent tip iceberg figure <NUMBER> patients may asymptomatic experience mild moderateor severe symptoms presented without pneumonia <NUMBER> <NUMBER> asymptomatic cases common date arescarceepidemiological surveys provide clear percentage asymptomatic cases <NUMBER> <NUMBER> approximately <NUMBER> patients severe cases require hospitalization <NUMBER> april <NUMBER> mortality rate approximately <NUMBER> confirmed cases worldwidebut vary significantly depending quality healthcare services hospital capacitythe case fatality ratio covid<NUMBER> estimated substantially higher recent influenza pandemics h<NUMBER>n<NUMBER> influenza <NUMBER> mean time onset death <NUMBER> days china <NUMBER> days china case fatality ratio determined <NUMBER> <NUMBER>·<NUMBER>·<NUMBER> <NUMBER> although clear asymptomatic cases exist <NUMBER> real percentage long carry virus known information obtained byscreening population virusspecific igm igg iga antibodies expected soon many centers willbe informative decisive factor controlling pandemic main indicator development population immunity nonsarscovs account <NUMBER> upper respiratory tract infections adults present mild common cold disease humans <NUMBER> patients common allergic diseases develop additional distinct symptoms severe outcomes allergic children show mild course similar tononallergic children <NUMBER> study <NUMBER> cases <NUMBER> <NUMBER> presented diarrhea <NUMBER> nausea vomiting patients positive sarscov<NUMBER> rna stool samples <NUMBER> cases previously existing condition chronic obstructive pulmonary disease complicated secondary bacterial pneumonia severe may represent complex immune pathogenesis <NUMBER> patients hypertension diabetes obesity chronic lung disease active smoking old age prone severe disease <NUMBER> cytokine storm takes place severe cases major factor high mortality multiorgan failure acute respiratory distress syndrome ards disseminated intravascular coagulation article protected copyright rights reserved worldwide spread zoonosis might practically impossible fully eradicate sarscov<NUMBER> virus containment pandemic challenging difficult identify virus carriers due nature diseasethere presumably high number asymptomatic virus carriers addition recently infected individuals onset symptoms clinically recovered individuals still carry virus many potentially susceptible domestic wild animals regular contact humans figure <NUMBER> main question learn live together virus humans pressing need improved understanding immunopathology much previous pathogen covid<NUMBER>has become number one reason morbidity mortality many countries even though pandemic likely brought control coming months unexpected outbreaks development viral resistance treatments vaccines highly possible due mutations virus coronavirusesare namedfortheir large spikes projecting envelope giving virusa crownlike shapeof approximately <NUMBER> nm envelope consists lipid bilayer derived cell membrane host four structural proteins spike envelope e membrane nucleoprotein n well variable number nonstructural proteins sarscov<NUMBER> recognizesangiotensinconverting enzyme <NUMBER> ace<NUMBER> attach cells particularly respiratory epithelial cellsof host figure <NUMBER> <NUMBER> <NUMBER> article protected copyright rights reserved process dependent host serine proteasetmprss<NUMBER> cleaves viral spike protein s<NUMBER>s<NUMBER> s<NUMBER> subunit allows fusion viral cellular membranes <NUMBER> interferons impaired antiviral response increasing nfkb activation proinflammatory cytokine production necroptosis <NUMBER> signaling events may lead increased cellular death hyperinflammation cytokine storm immunological memory innate immune system called trained immunity may affect spread intensity certain infections covid<NUMBER> pandemics hypothesized general bcg vaccination policies adopted different countries might impacted transmission patterns andor covid<NUMBER> associated morbidity mortality <NUMBER> article protected copyright rights reserved inflammation <NUMBER> limited knowledge innate immune response elevated levels acute phase reactants andcytokine storm reports date focused severe outcomes adaptive immune responses several innate immune signaling proteins targeted sarscov<NUMBER> viral proteins interferon ifn pathway targeted nsp<NUMBER> nsp<NUMBER> orf<NUMBER>b nfκb pathway targeted nsp<NUMBER> orf<NUMBER>c sarscov<NUMBER> orf<NUMBER> impede nup<NUMBER>rae<NUMBER> interferoninducible mrna nuclear export complex orf<NUMBER>b orf<NUMBER>c sarscov<NUMBER> canonical replication mentioned data shed light development antiviral sarscov<NUMBER> one antiviral drug remdesivira nucleoside analog rnadependent rna polymerase rdrp inhibitor treatment covid<NUMBER> <NUMBER> <NUMBER> human sarscov<NUMBER> infection classical respiratory viruslike clinical course <NUMBER> patients mild moderate selflimiting course involves far known aspects innate immune response b cell immunity antiviral neutralizing antibody response table <NUMBER> figure <NUMBER> interestingly sarscov<NUMBER> infects human cell lines via novel route cd<NUMBER> spike protein present surface lymphocytes <NUMBER> cd<NUMBER> also known basigin emmprin expressed many tissues cells plays role cell proliferation apoptosis tumor cell migration metastasis differentiation especially hypoxic conditions second isoform cd<NUMBER> called cd<NUMBER> ig<NUMBER>ig<NUMBER>ig<NUMBER> also characterized dysregulation cd<NUMBER> associated nearly every type cancer regulates matrix metalloproteinase mmp vascular endothelial growth factor production signals tumor cell invasion metastasis <NUMBER> block cd<NUMBER> protein meplazumab preventing sarscov<NUMBER> spike binding subsequent infection may also beneficial effects covid<NUMBER> treatment <NUMBER> article protected copyright rights reserved b cell epitopesupon entry host virus attaches invades cells expressing specific receptor order replicate virus inside tissue cells respiratory epithelial cells case sarscov<NUMBER> viral peptides presented class major histocompatibility complex mhc proteins cd<NUMBER> cytotoxic cells <NUMBER> article protected copyright rights reserved proteins lacked crossreactivity mers <NUMBER> structural proteins sarscov<NUMBER> genetically similar sarscov merscov <NUMBER> <NUMBER> known sarscov b cell epitopes map identically sarscov<NUMBER> respectively <NUMBER> clearly recognizable b cell epitopes represent potential eliciting robust cell antibody response sarscov<NUMBER> response mutual vaccine observation many b cell epitopes highly conserved sarscov sarscov<NUMBER> important vaccination strategies designed target immune response toward conserved epitope regions could generate immunity crossprotective across multiple coronaviruses also relatively resistant ongoing virus evolution protect mutated future virus strains <NUMBER> lymphopenia associated covid<NUMBER> important pathological finding severity criteria serves like biomarker possible target intervention minimize risk severe disease infectious agents human immunodeficiency virus hiv cause lymphopenia humans although part natural course expected type immune response observed influenza tuberculosis malaria sepsis <NUMBER> changes peripheral lymphocyte counts transition lymphocyte subgroups may suggest possiblemechanisms pathogenesis sarscov<NUMBER> infection limited numbers studies focused severe covid<NUMBER> cases relatively distinct profile decreased memory cells cytotoxic cd<NUMBER> cells flow cytometric analyses showed percentage cd<NUMBER> naïve cells cd<NUMBER> cd<NUMBER> cd<NUMBER>ra increased memory helper cells cd<NUMBER> cd<NUMBER> cd<NUMBER>ro decreased peripheral blood <NUMBER> percentage cd<NUMBER> cd<NUMBER> cd<NUMBER> cytotoxic cells also decreased severe cases however significant difference activated total cells cd<NUMBER> hladr activated cytotoxic cells cd<NUMBER> cd<NUMBER> hla dr severe patients also presented lower levels regulatory treg cells cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> low <NUMBER> addition overactivation cells manifested increase thelper th<NUMBER> high cytotoxicity cd<NUMBER> cells partially accounts severe immune injury <NUMBER> similar study levels peripheral lymphocyte subsets evaluated <NUMBER> patients covid<NUMBER> flow article protected copyright rights reserved cytometry course disease decrease total lymphocytes cd<NUMBER> cell cd<NUMBER> cell b cell natural killer nk cell counts observed authors suggested lymphopenia cd<NUMBER> cells could independent predictor covid<NUMBER> severity treatment efficacy <NUMBER> another earlier study analysing laboratory indexes twelve patients covid<NUMBER> showed decreased percentage lymphocytes cd<NUMBER> cell count <NUMBER> <NUMBER> patients covid<NUMBER> severe cases higher leukocyte neutrophil lower lymphocytes countswith high neutrophiltolymphocyte ratio well lower percentages monocytes eosinophils basophilsthe mean nk cells counts normal levels whilst b cells values low end normal range cells shown affected sarscov<NUMBER> cell count nearly half lower reference limit tend reduced severe cases <NUMBER> lymphocyte subset analysis revealed decreased percentage cd<NUMBER> cd<NUMBER> lymphocytes <NUMBER> <NUMBER> patients increased percentage cd<NUMBER> <NUMBER> <NUMBER> patients cd<NUMBER> <NUMBER> <NUMBER> patients cd<NUMBER> <NUMBER> <NUMBER> patients lymphocytes <NUMBER> study analyzing critically ill patients sarscov<NUMBER> pneumonia <NUMBER> patients showed lymphopenia <NUMBER> intensive care unit icu patients suffering infection median lymphocyte count <NUMBER> cellsmicrol normal values <NUMBER> cells per <NUMBER> microl <NUMBER> <NUMBER> observed lymphocytes patients covid<NUMBER> gradually decrease disease progresses older patients lower counts lymphocytes platelets higher risk severe disease increased length hospitalization <NUMBER> significant reduction lymphocyte counts theirrapid depletion may play role pathogenesis contribute progression severe covid<NUMBER> accordingly drugs targeting lymphocyte proliferation preventing apoptosis interleukin il<NUMBER> il<NUMBER> orprogrammed cell death protein <NUMBER> pd<NUMBER>pdl<NUMBER> inhibitors could help prevent lymphopenia restore lymphocyte counts severe patients <NUMBER> mean values three main subsets lymphocytes generally decreased severe patients covid<NUMBER> nk cells normal values b cells lower end normal range <NUMBER> view results lymphocyte percentage suggested predictive biomarker severity recovery article protected copyright rights reserved immunity subsequently cytokine storm destructive tissue inflammation figure <NUMBER> cytotoxic lymphocytes nk cells patients infected sarscov<NUMBER> essential mounting appropriate antiviral response <NUMBER> classical convention cell receptor cd<NUMBER> cytotoxic cells recognizes viral peptides article protected copyright rights reserved nk cd<NUMBER> cells restored parallel reduced expression nkg<NUMBER>a patients convalescing therapy <NUMBER> data suggest breakdown antiviral immunity may play role pathogenesis severity covid<NUMBER> cd<NUMBER> cells frequency nonexhausted pd<NUMBER> − ctla<NUMBER> − tigit − subset severe group significantly lower <NUMBER> suggested virus promotes initial excessive activation beginning disease followed subsequent exhaustion cd<NUMBER> cells similar many viral diseases increase virusspecific igm acute phase followed increase virusspecific igg later phases observed course covid<NUMBER> figure <NUMBER> <NUMBER> area fully open future research however anticipated infusion convalescent serum obtained fromalready recovered patients may prevent limit sarscov<NUMBER> infection <NUMBER> reported <NUMBER> seriously ill patients receiving convalescent serum therapy demonstrated improved lung function oxygenation reduced inflammation viral load <NUMBER> one million recovered patients today whose convalescent serum used passive immunization treatment prevention complement proteins c<NUMBER> c<NUMBER> patients covid<NUMBER> within normal range <NUMBER> increase noted igg igm antibody levels sarscov<NUMBER> nucleoprotein np receptorbinding domain rbd patients <NUMBER> days later onset symptoms early increase igm later followed development igg normal expected antibody response figure <NUMBER> however specific igg levels found already high levels serum time earlier igm sarscov<NUMBER> <NUMBER> another study sarscov<NUMBER> virusspecific igg igm reached article protected copyright rights reserved peak levels <NUMBER> days <NUMBER> days symptom onset respectively another interesting observation igg igm titers covid<NUMBER> severe group higher nonsevere group different types seroconversion reported synchronous seroconversion igg igm igm seroconversion earlier igg igm seroconversion later igg <NUMBER> study analyzing specific igm igg byenzyme immunoassay patients found seropositive igg igm day <NUMBER> day <NUMBER> hospital admission higher proportion patients study also earlier igg igm seroconversion <NUMBER> specific tcell responses able protect sarscov infection animal models <NUMBER> sensitivity specificity current commercial specific antibody kits evaluated independent laboratories whoconfirmed tests made available igabased enzymelinked immunosorbent assay elisa kit article protected copyright rights reserved sensitive less specific iggbased elisa kit <NUMBER> however new kits continuously coming market possible develop inhouse kits depending quality coated sarscov<NUMBER> antigen plates evaluation igm igg isotype virusspecific antibody levels together rtpcr shown table <NUMBER> homemade indirect elisa detecting igm iga igg antibodies sarscov<NUMBER> using purified recombinant nucleocapsid np proteins coating antigens studied development time specific antibodies significantly varied method method studyit <NUMBER> daysrange <NUMBER> <NUMBER> days specific igm iga whereas <NUMBER> days range <NUMBER> <NUMBER> days specific igg onset symptoms figure <NUMBER> <NUMBER> acute phase reactants potential diagnostic markers predictors disease outcome human animals <NUMBER> overall evaluation acute phase reactants covid<NUMBER> correlates high levels increased disease severity death table <NUMBER> <NUMBER> hospitalized covid<NUMBER> patients significantly higher levels ddimer crp procalcitonin pct associated severe disease compared nonsevere disease nonsurvivors higher levels neutrophils ddimer blood urea nitrogen creatinine compared recovered patients <NUMBER> anticoagulation therapy recommended covid<NUMBER> patients article protected copyright rights reserved dimer value <NUMBER> times higher normal upper limit except patients anticoagulant contraindications <NUMBER> table <NUMBER> research consensus standard approach needed identify acute phase reactants essential early diagnosis prediction follow patients <NUMBER> although covid<NUMBER> patients recover mild moderate disease one weeksome develop severe pneumonia second week followed cytokine storm ards multiorgan failure disseminated intravascular coagulation dic within <NUMBER>rd week disease figure <NUMBER> cytokine storm complex network severe molecular events unified clinical phenotype systemic inflammation multiorgan failure hyperferritinemiait consistently linked severity fatal disease outcome article protected copyright rights reserved including b cells cells nk cells macrophages dendritic cells neutrophils monocytes resident tissue cells epithelial endothelial cells release high amounts proinflammatory cytokines <NUMBER> cells blood stream virus degraded viral products reach body contribute cytokine storm cytokine storm also occur number infectious noninfectious diseases bacterial sepsis ebola hemorrhagic fevers influenza blunt trauma side effect immune stimulatory drugs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> although many cells involved mentioned multiple proinflammatory cytokines inflammasome activation appear play major role pathogenesis il<NUMBER> appears control tissue damage experimental models <NUMBER> proinflammatory eicosanoid storm may also accompany cytokine storm <NUMBER> balance proantiinflammatory proresolving lipid mediator response viral infection often decisive clinical outcome <NUMBER> among numerous molecules increase serum cytokine storm complements ifn il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> tumor necrosis factorα tnfα crucial importance <NUMBER> article protected copyright rights reserved previously reported ebola virus tim<NUMBER> protein induce cytokine storm <NUMBER> sarscov activates considerable level proinflammatory cytokines vitro tnfα il<NUMBER> il<NUMBER> release via tlr<NUMBER> tlr<NUMBER> almost <NUMBER>fold higher strong tlr<NUMBER> stimulating ssrna<NUMBER> <NUMBER> upon influenza infection high levels complement c<NUMBER> c<NUMBER> including fragments c<NUMBER>a c<NUMBER>a produced h<NUMBER>n<NUMBER> replicates lower respiratory tract leading complement activation c<NUMBER>a responsible acute lung injury <NUMBER> similar sars mers cytokine storm common feature severe covid<NUMBER> cases major reason ards multiorgan failure several levels evidence suggest mortality covid<NUMBER> due thevirusactivated cytokine storm syndrome <NUMBER> ards acute inflammatory lung injury leading severe sars manifesting acute hypoxemic respiratory failure bilateral alveolar opacities chest radiography article protected copyright rights reserved decreased lung compliance figure <NUMBER> <NUMBER> fifteen <NUMBER> patients <NUMBER> developed ards <NUMBER> weeks following sars infection <NUMBER> cases course covid<NUMBER> mild lifethreatening ards develops critically ill patients within <NUMBER> days onset disease <NUMBER> <NUMBER> reported incidence ards critical illness requiring icu admissionsvaries widely across multiple studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ards common older people comorbidities including hypertension diabetes coronary artery disease bronchitis ischemic disease central nervous system parkinsons disease <NUMBER> common complications frequently observed patients died covid<NUMBER> sepsis <NUMBER> followed respiratory failure <NUMBER> ards <NUMBER> septic shock <NUMBER> acute cardiac injury <NUMBER> heart failure <NUMBER> coagulopathy <NUMBER> secondary infection <NUMBER> acute kidney injury <NUMBER> <NUMBER> autopsy features covid<NUMBER> similar sars mers findings <NUMBER> <NUMBER> macroscopic features covid<NUMBER> likely observed chest may include pleurisy pericarditis lung consolidation pulmonary oedema secondary bacterial infection may superimposed viral infection lead purulent inflammation <NUMBER> early histopathological features reported two patients underwent surgical article protected copyright rights reserved resections lung adenocarcinoma later found sarscov<NUMBER> positive time operation patients asymptomatic respect covid<NUMBER> time operation nonspecific findings included oedema pneumocyte hyperplasia focal inflammation multinucleated giant cell formation hyaline membranes seen findings may reflect early changes acute lung injury infection <NUMBER> histopathological findings noted <NUMBER>yearold man died severe covid<NUMBER> infection microscopic findings included diffuse alveolar damage exudates <NUMBER> article protected copyright rights reserved sarscov<NUMBER> disease covid<NUMBER> associated significant morbidity mortality globally probably becomingone biggest health economic burden last <NUMBER> years covid<NUMBER> became major fights humansin modern times emphasizing importance need global strategy solidarity among nations zoonotic disease already spread globally several millions humans probably animals practically impossible eradicate covid <NUMBER> learn live together virus disease  article protected copyright rights reserved cd<NUMBER> cells severe lymphopenia <NUMBER> observed cd<NUMBER> cells predictor severe disease normal antiviral immunity requires cd<NUMBER> cd<NUMBER> th<NUMBER> response severe disease shows systemic severe inflammatory response cytokine storm cytokine storm response mainly th<NUMBER> inflammatory also major role inflammasome activation decreased circulating eosinophil numbers <NUMBER> <NUMBER> hospitalized patients acute phase virusspecific igm increases followed virus specific igg convalescence innate adaptive cytokines released high amounts linked severe disease high severe cases initially high values predictive severe disease article protected copyright rights reserved accepted article table <NUMBER> changes acute phase reactants serum biochemistry covid<NUMBER> article protected copyright rights reserved article protected copyright rights reserved remain sarscov<NUMBER> positive susceptible domestic wild animals specific immunological mechanisms discussed review article protected copyright rights reserved antibodies rapid viral clearance high dose exposure may cause severe disease delayed viral clearance may due lymphopenia leading inefficient b cell immunity subsequently cytokine storm destructive tissue inflammation novel coronavirus disease known covid<NUMBER> originated viral pneumonia unknown origin small province wuhan china december <NUMBER> causative agent named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> international virus classification commission two coronavirus mediated epidemic outbreak past two decades severe acute respiratory syndrome sars <NUMBER> middle east respiratory syndrome mers <NUMBER> within three months spread covid<NUMBER> various countries world causing rapid rise morbidity mortality compelled world health organisation declare pandemic march <NUMBER> <NUMBER> may <NUMBER> <NUMBER> around <NUMBER> diagnosed cases covid<NUMBER> <NUMBER> deaths reported source covid<NUMBER> situation report <NUMBER> <NUMBER> india total number confirmed cases <NUMBER> <NUMBER> deaths till date <NUMBER> last <NUMBER> months several studies covid<NUMBER> reported clinical features laboratory findings diagnostic evaluation individuals suffering disease mortality rate varies among various countries depends patient clinical profile presence comorbidities patients covid<NUMBER> suffer mild course disease manifesting clinical features viral pneumonia gradually recover supportive treatment proportion deteriorate severe form characterised loss respiratory function progressing adult respiratory distress syndrome occasional multiorgan failure <NUMBER> vaccine treat disease still development till way slow disease spread restricting infectivity tried initiating social distancing lockdown measures thus absence absolute cure becomes essential delineate molecular mechanisms virus known like sars mers considerable amount immune dysregulation may aid understanding pathophysiology disease aim review summarize inflammatory changes immune dysregulation outline possible underlying immunological mechanisms sarscov<NUMBER> international virus classification commission replaced earlier name novel coronavirus <NUMBER> ncov<NUMBER> sars like coronavirus <NUMBER> simply sarscov<NUMBER> member coronaviridae family viruses enveloped positive sense single strand rna viruses genome size <NUMBER> kb diameter <NUMBER> nm surface projections like crown electron microscope crown like appearance basis behind name coronavirus far four different genera coronaviruses identified b c among two members agenera <NUMBER>e nl<NUMBER> two bgenera hku<NUMBER> oc<NUMBER> known cause mild respiratory illnesses humans past <NUMBER> years two members bgenera sarscov merscov responsible epidemic outbreaks sars mers respectively people started admitted hospitals wuhan china features fever fatigue ards resembling pneumonia unknown origin december <NUMBER> viral genome sequencing five patients revealed identity previously unknown bgenera cov novel coronavirus <NUMBER> sequence similarity two batderived sarscov like coronaviruses batslcovzc<NUMBER> batslcovzxc<NUMBER> approximately <NUMBER> similarity merscov <NUMBER> like typical covs least ten open reading frames orfs genome sarscov<NUMBER> orf<NUMBER>ab first orf <NUMBER> total viral rna translated two large polyproteins polyproteins processed host nonstructural proteins nsps constitutes viral replicase transcriptase complex nsps help viral replication transcription rearranging membranes originating rough endoplasmic reticulum membranous vesicles remaining orfs present <NUMBER> genome encodes spike envelope e nucleocapsid n membrane proteins four main structural proteins virus <NUMBER> <NUMBER> also encode various accessory proteins play role viral replication functions identified far established sarscov<NUMBER> needs angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor primarily located lung gastrointestinal epithelia gain entry inside cells strength binding receptor binding motif protein significant predictor pathogenesis infection <NUMBER> earlier sarscov likely originated bats similar requirement ace<NUMBER> receptors gradually adapted ace<NUMBER> receptors species eventually infected humans changes protein sarscov<NUMBER> comparison sarscov marine bat forms coronaviruses clearly indicate several synonymous mutations nonsynonymous substitutions related gene <NUMBER> genomic changes rendered sarscov<NUMBER> capable attachment human cells member merscov bind functional receptor dipeptidyl peptidase <NUMBER> dpp<NUMBER> multiple species including humans lot studies clinical laboratory characteristics covid<NUMBER> published last four months mostly chinese population recently studies based populations countries like singapore united states european countries also reported major clinical manifestations patients covid<NUMBER> includes fever dry cough sore throat muscle pain fatigue cases may progress severe symptoms like acute respiratory distress syndrome requiring critical care form intensive care unit icu admission mechanical ventilation metaanalysis <NUMBER> different studies common clinical manifestations among <NUMBER> covid<NUMBER> patients fever cough dyspnoea among patients around <NUMBER> developed ards <NUMBER> patients required critical care <NUMBER> developed shock fatal outcomes observed <NUMBER> patients old age <NUMBER> years significantly associated severity disease <NUMBER> findings supported another metaanalysis included eight studies comprising <NUMBER> infected patients hypertension diseases respiratory cardiovascular system significant risk factors severity covid<NUMBER> <NUMBER> smoking history diabetes also added list comorbidities following metaanalysis emami et al data <NUMBER> patients systematically analysed <NUMBER> among routine laboratory parameters alanine transaminase alt lactate dehydrogenase ldh ddimer creactive protein ferritin significantly elevated severe cases covid<NUMBER> comparison nonsevere cases significantly lower absolute number lymphocytes cd<NUMBER> cd<NUMBER> cells along downregulation ifnc expression severe cases also observed <NUMBER> another preprint xiang et al reported serum urea creatinine cystatin c may potential biomarkers severity covid<NUMBER> <NUMBER> huang et al reported higher plasma levels interleukins il<NUMBER> il<NUMBER> il<NUMBER> inflammatory markers gscf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfa covid<NUMBER> patients requiring icu care versus nonicu patients <NUMBER> known underlying cytokine storm syndrome alteration expression immune cells may responsible disease progression mild severe form similar findings observed sarscov merscov infection thus present state pathogenic mechanisms sarscov<NUMBER> yet elucidated knowledge regarding changes cytokines immune dysregulation reported various population studies help identifying key molecular predictors explored deeper understanding molecular pathogenesis covid<NUMBER> cytokines chemokines critical mediators immune system play pivotal role antiviral immunity studies demonstrated primary cause ards multiorgan failure covid<NUMBER> associated cytokine storm <NUMBER> inflammatory response plays major role covid<NUMBER> pathogenesis cytokine storm increases severity disease cytokine storm cs phenomenon excessive inflammatory reaction mediated rapid production large amounts cytokines response infection <NUMBER> covid<NUMBER> initial delay cytokine chemokine secretion innate immune cells subsequent surge proinflammatory cytokines chemokines il<NUMBER> tnfa il<NUMBER> mcp<NUMBER> il<NUMBER> b ccl<NUMBER> ccl<NUMBER> ifns activated macrophages recruited lymphocytes cytokines induce recruitment activation adaptive immune cells like cells neutrophils nk cells along production proinflammatory cytokines thereby causing cytokine storm tissue damage studies drawn parallel immune dysregulation due covid<NUMBER> phenomena seen sarscov merscov <NUMBER> early stage sarscov mers cov disease delayed release ifn<NUMBER> ifnab primarily dendritic cells macrophages respiratory epithelial cells followed increasing levels proinflammatory cytokines disease progresses <NUMBER> rapid surge proinflammatory cytokines leads inflammatory infiltration lung tissue neutrophils monocytes cause lung injury moreover increased levels proinflammatory cytokines stimulate cell apoptosis delay viral clearance <NUMBER> enhanced viral replication heightened proinflammatory response injure lung epithelial lining causing deterioration alveolar cellular barriers endothelial cells also damaged leading changes microvasculature injuries result tissue hypoxia acute respiratory distress syndrome ards <NUMBER> <NUMBER> since genome sarscov<NUMBER> virus related sarscov merscov similar assumptions expected role host immune system towards virus uncontrolled viral replication results delayed antiviral ifn response turn mounts influx neutrophils macrophages site injury concomitant surge proinflammatory cytokines ie cytokine storm thus leading inflammatory injury respiratory system <NUMBER> cytokines elevated serum covid<NUMBER> patients il<NUMBER>b il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> gcsf gmcsf ifnc tnfa ip<NUMBER> mcp<NUMBER> mip<NUMBER>a mip<NUMBER>b particular il<NUMBER> il<NUMBER> tnfa ie cytokines secreted macrophages found significantly higher severe cases compared nonsevere cases <NUMBER> table <NUMBER> il<NUMBER> potent proinflammatory cytokine plays primary role cytokine storm therefore needs special attention covid<NUMBER> multifunctional cytokine involved formation follicular helper cells differentiation th<NUMBER> cell subsets generation plasma cells also known inhibit ifnc thereby suppress cd<NUMBER> cytotoxic cells <NUMBER> il<NUMBER> induces cell exhaustion indicated markers pd<NUMBER> tim<NUMBER> thus cellmediated immune response might suppressed cytokine storm il<NUMBER> <NUMBER> increased il<NUMBER> levels positive correlation disease severity suggestive role disease progression <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently study germany reported <NUMBER>fold increased risk respiratory failure median time mechanical ventilation <NUMBER> days cases il<NUMBER> levels <NUMBER> pgml <NUMBER> higher circulating levels il<NUMBER> also reported even <NUMBER>h death <NUMBER> <NUMBER> therefore il<NUMBER> either single parameter association parameters could used early identification patients risk respiratory failure tnfa proinflammatory cytokine acting via receptor tnfr<NUMBER> may lead apoptosis aged cells express high tnfr<NUMBER> <NUMBER> therefore also known cd<NUMBER> cells tend independent predictor covid<NUMBER> severity treatment efficiency ind j clin biochem ind j clin biochem proapoptotic cytokine studies covid<NUMBER> patients reported negative correlation tnfa cell count <NUMBER> <NUMBER> <NUMBER> tnfa levels significantly higher elderly patients <NUMBER> years along reduced cell counts increased levels cell exhaustion markers pd<NUMBER> tim<NUMBER> finding speculates role tnfa negative regulator cell survival proliferation <NUMBER> however studies reported significant difference tnfa levels covid<NUMBER> patients <NUMBER> <NUMBER> il<NUMBER>b family il<NUMBER> il<NUMBER> significant players ards known increase recruitment immune cells subsequent cytokine production <NUMBER> il<NUMBER> receptor signalling involved inflammatory damage respiratory epithelium study daily transcriptomic profiling three covid<NUMBER> patients revealed il<NUMBER> show significant expression changes prior deterioration respiratory function proinflammatory cytokines induced appearance symptoms respiratory dysfunction brief report hints plausible role il<NUMBER> pathway initial progression covid<NUMBER> related lung immunopathology <NUMBER> il<NUMBER>ß tnfa cytokines required development th<NUMBER> cells help th<NUMBER> mediated immune response increased vascular permeability <NUMBER> cytokines th<NUMBER> pathway like il<NUMBER> gmcsf increase covid<NUMBER> patients <NUMBER> also increased expression th<NUMBER> cells peripheral blood covid<NUMBER> patients suggests role th<NUMBER> cells cytokine storm covid<NUMBER> also reported patients sars mers <NUMBER> significantly elevated levels il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfa reported severely ill patients comparison nonseverely ill patients suggestive diverse cytokine profile two groups involvement cytokine storm disease progression severity <NUMBER> increased concentration il<NUMBER>ß ip<NUMBER> ifnc mcp<NUMBER> leads activation th<NUMBER> cell response aggravates cytokine storm similar rise proinflammatory cytokines occurred sarscov merscov infection <NUMBER> <NUMBER> contrary sars increase antiinflammatory cytokines th<NUMBER> cells il<NUMBER> il<NUMBER> also seen sarscov<NUMBER> patients <NUMBER> implications finding still yet clarified high serum cytokine levels sarscov<NUMBER> patients correlated decreased cell count peripheral blood suggesting plausible role disease progression diao et al reviewed total cell count il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfa ifnc <NUMBER> covid<NUMBER> patients admitted two different hospitals china <NUMBER> healthy individuals reported significantly higher levels il<NUMBER> il<NUMBER> tnfa correlation analysis revealed negative correlation total cell count cd<NUMBER> cd<NUMBER> cells interleukins ten follow patients il<NUMBER> il<NUMBER> tnfa ifnc levels significantly decreased recovery period illness time cell counts recovered normal levels thereby suggesting decline cell associated surge inflammatory cytokines covid<NUMBER> patients <NUMBER> similar negative correlation cell counts interleukins also reported studies <NUMBER> <NUMBER> contrary wan et al observed associations lymphocyte subsets cytokines disease evolution <NUMBER> chinese covid<NUMBER> patients <NUMBER> mild <NUMBER> severe reported significantly different cd<NUMBER> cd<NUMBER> il<NUMBER> il<NUMBER> pii two groups mild group significant positive correlations observed cd<NUMBER> cd<NUMBER> il<NUMBER> il<NUMBER> patients mild group il<NUMBER> within reference range higher survival rates correlation cell count interleukins <NUMBER> recent study attempted immunophenotype antiviral response covid<NUMBER> patients singlecell transcriptome sequencing using pbmcs <NUMBER> patients male young male elderly female young female elderly collected preicu icu post icu significant increase monocytes plasmacytoid dendritic cell populations icu samples compared pre post icu samples <NUMBER> therefore evidence delayed dampened type <NUMBER> interferon response initial stages infection subsequent increase active viral replication phenomenon also part sarscov pathogenesis <NUMBER> <NUMBER> reported gene signature icu samples showed elevated expression interferonstimulated genes isgs like ifitm<NUMBER> compared pre post icu samples suggestive critical viral load regulated type <NUMBER> interferon response type<NUMBER> ifn response disease progression onset ards <NUMBER> covid<NUMBER> induced ards mortality may mediated many factors alteration innate adaptive components immune system terms dampened cell response neutrophilia delayed type<NUMBER> ifn response plays significant role additionally increased expression granulysin perforin increase macrophage activated cytokines like il<NUMBER>ß il<NUMBER> tnfa leading cytokine storm increased cell exhaustion might contribute molecular pathogenesis approximately <NUMBER> patients suffering covid<NUMBER> progress critically ill severe cases clinical symptoms respiratory failure requiring ventilator support cytokine storm accompanies transition mild severe form disease covid<NUMBER> patients efficient synergy innate adaptive lineages immune system preliminary requirement effective disposal invading pathogens cells innate immunity monocyte macrophage granulocytes dendritic cells first act whenever invasion foreign molecules main function innate immunity includes opsonization direct clearance complement activation addition elimination via phagocytosis however another important function also process appropriately present invading pathogen order activate cells adaptive immune system responses adaptive immune cells aim eradicate pathogen also reserves memory future protection addition adaptive immunity also plays crucial role regulating extent immune response prevent overstimulation host injury understanding sars mers though still limited shown us disease pathogenesis included host immune dysregulation along direct damage caused viruses <NUMBER> understanding dysregulation innate adaptive immunity cell subsets may thus provide substantial insight immunopathogenesis sarscov<NUMBER> major mode transmission sarscov<NUMBER> primarily aerosolized droplets possibility faecooral route also exists <NUMBER> initial symptoms disease include fever dry cough rarely dyspnoea body ache headache diarrhoea viral load said reach peak <NUMBER> days post onset symptom <NUMBER> studies assessing clinical features covid<NUMBER> patients reported mean time admission onset symptoms <NUMBER> days iqr <NUMBER> ards typically set <NUMBER> th day iqr <NUMBER> <NUMBER> admission intensive care unit andor requirement mechanical ventilation seen <NUMBER> cases mean time <NUMBER> days iqr <NUMBER> <NUMBER> sarscov<NUMBER> known infect cells via surface receptors ace<NUMBER> tmprss<NUMBER> <NUMBER> cells known undergo viral replication induced pyroptosis leading release il<NUMBER>b damage associated molecular patterns damps pathogen associated molecular patterns pamps atp viral nucleic acid asc oligomers molecules induce generation proinflammatory cytokines chemokines il<NUMBER> il<NUMBER> macrophage chemoattractant protein<NUMBER> mcp<NUMBER> macrophage inflammatory protein<NUMBER>a mip<NUMBER>a macrophage inflammatory protein<NUMBER>b mip<NUMBER>b adjacent epithelial cells alveolar macrophages resultant microenvironment therefore attracts cells innate adaptive immunity proinflammatory cascade sets <NUMBER> <NUMBER> case mild form disease infected cells viral particles rapidly cleared away macrophages neutralized antibodies without resulting damage airways host response however cases disease progression seen take turn worse characterized excessive cellular infiltration systemic cytokine storm <NUMBER> <NUMBER> clinically diagnosed ards known major cause fatality severe covid<NUMBER> cases <NUMBER> age comorbidities identified associated covid<NUMBER> induced severe respiratory distress syndrome underlying mechanisms responsible cytokine storm immune dysregulation uncontrolled disease yet identified il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfa also higher patients requiring icu nonicu patients suggesting possible different cytokine profile severe mild cases <NUMBER> lung macrophages therefore among primary players effective host immunity sarscov<NUMBER> uncontrolled immunopathology covid<NUMBER> studies investigated monocyte macrophage lineage covid<NUMBER> patients concluded cell lineages contribute cytokine storm secretion mcp<NUMBER> ip<NUMBER> mip<NUMBER>a <NUMBER> single cell rnasequencing based characterization broncho alveolar lavage fluid balf three severely ill three mild covid<NUMBER> patients eight healthy controls revealed monocyte derived fcn<NUMBER> macrophages predominant macrophage balf <NUMBER> macrophages known highly inflammatory capable producing large amounts inflammatory cytokines also known involved cytokine storm <NUMBER> analysis peripheral blood mononuclear cell pbmc subsets covid<NUMBER> patients also shown elevated level cd<NUMBER> cd<NUMBER> monocyte subset compared healthy controls level highly inflammatory monocyte subset also seen higher covid<NUMBER> cases requiring intensive care <NUMBER> monocytes also showed higher expression il<NUMBER> gmcsf thus suggesting pivotal role advent cytokine storm <NUMBER> hladr expression cd<NUMBER> monocytes covid<NUMBER> patients found significantly low among severe cases compared mild cases levels improved treatment il<NUMBER> inhibitor toclizumab <NUMBER> higher levels ccl<NUMBER> monocyte chemotactic factor also seen blood covid<NUMBER> patients along increased transcription receptor ccr<NUMBER> <NUMBER> early studies wuhan china reported normal total leukocyte count imbalance neutrophil lymphocyte proportions covid<NUMBER> cases <NUMBER> <NUMBER> <NUMBER> wu et al studied immune profile <NUMBER> covid<NUMBER> cases reported significantly high neutrophil counts also significant reduction total lymphocyte count resulting skewed neutrophil lymphocyte ratio nlr <NUMBER> neutrophilia lymphocytopenia common findings presented several authors findings significant among severe cases compared mild cases healthy controls <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> proinflammatory cytokines chemokines il<NUMBER> tnf mcp<NUMBER> released response local inflammation infected lung epithelial cells macrophages attract leukocytes macrophages neutrophils site inflammation could explain observed peripheral lymphopenia neutrophilia proportion granulocytes monocytes basophils eosinophils observed low within normal limits <NUMBER> <NUMBER> <NUMBER> cells adaptive immune system activated response antigen presentation cytokine released macrophages dendritic cells viral invasion moderate decrease b nk cells significant decrease total cell count observed covid<NUMBER> cases <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> retrospective study involving <NUMBER> covid<NUMBER> patients reported significantly lower levels cells b cells nk cells cd<NUMBER> helper cell subset showed significant reduction severe cases compared mild cases immunosuppressive treg cells also reported significantly lower among cases showing severe disease progression authors thus reported lymphocyte subset might especially vulnerable dysregulation covid<NUMBER> <NUMBER> higher viral load also reported associated severe disease spectrum <NUMBER> another study <NUMBER> covid<NUMBER> patients attempted differentiate severe mild cases respect activation function exhaustion cd<NUMBER> cd<NUMBER> cells along lymphocyte populations peripheral blood <NUMBER> mild <NUMBER> severe cases authors reported significant decrease function cd<NUMBER> increased activation cd<NUMBER> cells subsequently might lead exhaustion cd<NUMBER> reduced cellular immune response covid<NUMBER> <NUMBER> existing cells found hyperactivated state indicated cd<NUMBER> cd<NUMBER> cd<NUMBER> expression addition ox<NUMBER> <NUMBER>bb expression cd<NUMBER> cd<NUMBER> cells respectively <NUMBER> ox<NUMBER> <NUMBER>bb tumor necrosis factor receptors tnfr implicated cell mediated cytokine production stimulation cells addition functional cell markers exhaustion markers ie tim<NUMBER> pd<NUMBER> coexpression also found significantly expressed severe cases <NUMBER> <NUMBER> <NUMBER> contrary adult cases study <NUMBER> paediatric patients showed increase cd<NUMBER> cd<NUMBER> cells decrease nk cells <NUMBER> general paediatric patients showed better prognosis adult patients could due lower concentration memory cells mount cytotoxic response potent enough cause tissue damage th follicular cells tfh required activation differentiation b cells thus important antibody mediated viral clearance tfh count reported elevated mild recovering covid<NUMBER> patients compared healthy controls <NUMBER> <NUMBER> case study patient nonsevere covid<NUMBER> revealed increase circulating tfh time viral load decreasing lower limit detection ct value <NUMBER> recruitment peripheral circulation immune cells including tfh seemed herald resolution symptoms case <NUMBER> interestingly authors another article preprint stage reported increased cd<NUMBER> cell exhaustion assessed expression pd<NUMBER> increased tfh cells peripheral blood <NUMBER> nonsevere covid<NUMBER> patients compared healthy controls <NUMBER> among cytokines seen elevated covid<NUMBER> th<NUMBER> pathway specific il<NUMBER> il<NUMBER>b tnfa gmcsf <NUMBER> findings prompted various authors investigate role th<NUMBER> sarscov<NUMBER> induced severe covid<NUMBER> cases case study patient severe covid<NUMBER> reported elevated count th<NUMBER> cells activated cd<NUMBER> cd<NUMBER> cells <NUMBER> another study reported decrease th<NUMBER> subset indicated low il<NUMBER> secretion <NUMBER> thus studies required delineate role th<NUMBER> specific response covid<NUMBER> recent review suggested major host immune dysregulations include dampened type<NUMBER> ifn response viral load induced hyperinflammation recruitment proinflammatory cells like neutrophils monocytes <NUMBER> type<NUMBER> ifn response crucial induction effective adaptive response controlling viral replication study conducted immunophenotyping antiviral response covid<NUMBER> patients used pbmcs <NUMBER> patients male young male elderly female young female elderly collected preicu icu post icu per finding single cell transcriptome sequencing authors reported significant increase monocytes plasmacytoid dendritic cell pdc populations icu samples <NUMBER> authors also reported gene signature icu samples showed elevated expression ddx<NUMBER> irf<NUMBER> tlr<NUMBER> interferon stimulated genes isgs like ifitm<NUMBER> compared per post icu samples therefore evidence delayed dampened type<NUMBER> ifn response initial stages infection subsequent increase active viral replication phenomenon also reported part pathogenesis sarscov <NUMBER> <NUMBER> subsequent study involving profiling immune cells whole blood transcriptome cytokine levels <NUMBER> covid<NUMBER> patients varying severity authors reported significant impaired type<NUMBER> ifn response critical patients impaired type<NUMBER> ifn response characterized reduced levels ifna ifnß along high il<NUMBER> tnfa levels study also revealed significant downregulation <NUMBER> isgs specify type<NUMBER> ifn response severe covid<NUMBER> cases pdc population also reduced patients comparison healthy controls <NUMBER> present scenario every day newer broader clinical aspects covid<NUMBER> searched focus also needs diverted towards one important issue ie much diversity response elicited towards disease different individuals sars cov<NUMBER> novel corona virus despite fact patients developed wide range symptoms severe abnormalities hand completely asymptomatic morbidity mortality diseases direct link individuals response disease <NUMBER> host genetic variation plays important role varied immune response turn results different disease outcome individuals polymeric genes host regulatory network influence immune responses foreign compounds correlation underlying genetic traits phenotypes displayed <NUMBER> host genetic variation impacts virus induced immune responses individuals <NUMBER> variability across human genes involved antigen presentation lymphocytes major factor determining susceptibility resistance wide range infections human leukocyte antigen hla major histocompatibility complex mhc molecules shown regulate varied level viral susceptibility differential response mhc gene family comprised <NUMBER> main subfamilies class ii iii genes located proximity chromosome <NUMBER> hlaabc belonging mhc classi hladp dm dq dr belonging mhc class ii mediate antigen presentation cells hla class ii reside cell membranes nucleated cells antigen presenting cells respectively mhci ii extracellular domains form peptide binding groove antigenic peptide derived different sources bind bound antigens based source intracellular endogenous extracellular exogenous presented either cd<NUMBER> cd<NUMBER> cells mhci mhcii respectively <NUMBER> hla already studied major component immune system responsible varied immune response pathogens hla genotype plays important role differential regulation activation cells well disease transmission duration <NUMBER> studies reported increased severity towards closely related sarscov diseases individuals hlab<NUMBER> genotype similarly response disease caused unrelated viruses human immunodeficiency virus <NUMBER> hiv<NUMBER> dengue virus also linked respective hla genotype host case hiv hlaa<NUMBER> reduces risk seroconversion <NUMBER> dengue hla alleles hlaa<NUMBER> hlab<NUMBER> associated susceptibility towards severe secondary disease among native thais <NUMBER> studies also investigated human genotype determine putative hla alleles affinity towards novel coronavirus sarscov<NUMBER> nguyen et al performed insilico analysis check binding affinity viral peptidemhc class across <NUMBER> different hla types total alleles studied hlaa<NUMBER> b<NUMBER> c<NUMBER> efficient conserved peptide presenters hlaa<NUMBER> b<NUMBER> c<NUMBER> shown fewer binding peptides sarscov<NUMBER> addition <NUMBER> different hla alleles humans show appreciable binding affinity three major class genes exhibit similarity peptide presentation across entire virus sarscov<NUMBER> proteome independent stage early late peptide production time <NUMBER> hlab<NUMBER> allele found least predicted binding sites sarscov<NUMBER> therefore individuals allele less active immune response thus vulnerable infection similar findings reported case sarscov infections difference hla haplotype may influence individuals response sarscov<NUMBER> infection certain haplotypes may associated increased disease severity thus hla genotyping may assist identifying individuals risk therefore hla testing highly recommended along covid<NUMBER> testing enhance sensitivity predict susceptibility disease severity rapid reliable method assist planning future vaccination strategy human infections coronavirus sars mers occurred past however present infection sarscov<NUMBER> evolved become pandemic contrast rest sarscov<NUMBER> shown similarities predecessors ie sarscov merscov terms genome sequence receptor affinity pathogenesis disease presentation however knowledge mers sars enough curb current covid<NUMBER> pandemic hence mandating need expand knowledge sarscov<NUMBER> small proportion infected patients progress severe stage needing critical care thus absence proper cure becomes essential delineate factors may aid severity assessment disease individuals risk developing severe symptoms identified early management disease may improve significant extent review attempted brief virology associated pathogenesis particularly aspects immunopathology invasion lung epithelial cells probably certain immune cells directly sarscov<NUMBER> via infectious aerosolized droplets heralds infection peripheral neutrophilia lymphocytopenia associated delayed exaggerated immune response mediate fatal ards multiorgan dysfunction resulting death covid<NUMBER> patients male gender increasing age comorbidities shown risk factors severe disease il<NUMBER> tnfa found potential markers disease severity il<NUMBER>ß mediated pyroptosis tissue injury hypothesised major molecular mechanism underlying pathogenesis covid<NUMBER> <NUMBER> cytokine storm phenomenon long studied sepsis associated conditions successful effective management far <NUMBER> future studies different population groups designed aim identify molecular targets may help early diagnosis predicting severity patients covid<NUMBER> moreover alternative treatment modalities like drug repurposing using interleukin inhibitors plasma therapy also another area needs exploration <NUMBER> thus vaccine available main stay treatment covid<NUMBER> cases continue supportive care use monoclonal antibodies mesenchymal stem cells plasma recovered patients still experimental stage precautious restricting movement successful solution reducing spread funding none conflict interest authors declare conflict interest may <NUMBER> <NUMBER> world health organization reported <NUMBER> cases covid<NUMBER> <NUMBER> reported deaths secondary complications related novel coronavirus <NUMBER> united states center disease control cdc reported <NUMBER> total cases transplants included special population patients may face increased risks covid<NUMBER> related complications given use chronic immunosuppressants immunosuppression population reduce cellmediated immunity may prolong viral shedding increase risk covid related complications <NUMBER> reported mcgonagle et al interleukin<NUMBER> il<NUMBER> plays important role lung repair following viral insults administration il<NUMBER> inhibitor drugs may timesensitive <NUMBER> report case covid<NUMBER> patient kidney liver transplant discuss use il<NUMBER> inhibitor prevent cytokine storm setting patient <NUMBER>yearold male kidney liver transplant recipient presented emergency department ed developing symptoms mild fever shortness breath cough vitals physical exam emergency department within normal limits except temperature <NUMBER> degrees celsius initial chest xray day admission day <NUMBER> unremarkable tested negative influenza covid<NUMBER> via polymerase chain reaction pcr admitted hospital time admission normal white blood cell count <NUMBER> x <NUMBER> <NUMBER> liter decreased absolute lymphocyte count <NUMBER> normal liver function tests cytomegalovirus bordetella pcr serology also negative home immunosuppressant regimen consisted mycophenolic acid <NUMBER> milligrams daily prednisone <NUMBER> milligrams daily tacrolimus <NUMBER> milligrams twice day day <NUMBER> admission patient switched oral prednisone methylprednisolone <NUMBER> milligrams administered every eight hours intravenously day <NUMBER> received cefepime <NUMBER> j u r n l p r e p r f gram six hours also received five doses hydroxychloroquine <NUMBER> milligrams days <NUMBER> day <NUMBER> fever subsided vitals remained within normal limits however developed increasing shortness breath new diffuse expiratory wheezes physical exam repeat chest xray showed right lower lobe infiltrates ct thorax without contrast showed right upper middle lower lobe infiltrates ground glass appearance consistent viral pneumonitis later progressed bilateral ground glass opacities pictured chest xray also showed improvement shown figure <NUMBER> overall began show clinical signs improvement mycophenolic acid tacrolimus discontinued day <NUMBER> table <NUMBER> shows lab results patient first seven days hospital stay however day <NUMBER> decompensated requiring intubation mechanical ventilation critical care team also placed rotator bed day <NUMBER> oxygen requirements substantially increased requiring increase oxygen <NUMBER> l time received second dose tocilizumab patient remained critically ill following intubation seven days intubation developed right sided pneumothorax required chest tube liver function tests blood urea nitrogen bun creatinine remained stable icu stay fully therapeutically heparinized well developed evidence secondary bacterial infection obtained consent administered <NUMBER> milliliters convalescent plasma remained stable without significant change condition next several days day <NUMBER> pneumothorax resolved began weaning ventilator severe acute respiratory disease <NUMBER> sarscov<NUMBER> highly infectious novel coronavirus patients <NUMBER> insufficient data clinical presentation management immunosuppressant regimens sot recipients <NUMBER> patients may differ immunocompetent population regards presentation diagnosis clinical course covid<NUMBER> <NUMBER> notably transplant patients may present mild atypical symptoms without fever thus physicians must maintain broad differential diagnoses high clinical suspicions <NUMBER> one case series five patients reported common symptoms admission fever cough myalgiafatigue sputum production <NUMBER> case reports identified patients vague abdominal discomfort <NUMBER> table <NUMBER> <NUMBER> subsequently body activates second defense mechanism known second wave results cytokine storm severe tissue damage <NUMBER> increases many inflammatory markers erythrocyte sedimentation rate esr creactive protein crp serum ferritin interleukins <NUMBER> <NUMBER> <NUMBER> procalcitonin interleukinreceptor found covid<NUMBER> patients <NUMBER> interleukin<NUMBER> il<NUMBER> marker recent interest role second wave resulting cytokine storm <NUMBER> il<NUMBER> signal transduction occurs via three main pathways classical signal transduction trans signal transduction trans presentation <NUMBER> classical signal transduction involves il<NUMBER> binding il<NUMBER>r forming complex il<NUMBER>il<NUMBER>r complex binds membrane gp<NUMBER> subsequently initiates intracellular transduction <NUMBER> trans signal transduction pathway occurs il<NUMBER> binding sil<NUMBER>r forming complex il<NUMBER>sil<NUMBER>r complex binds membrane gp<NUMBER> initiates intracellular signal transduction <NUMBER> trans presentation signal involves sgp<NUMBER> forming complex sil<NUMBER>r prevent sil<NUMBER>r binding membranebound gp<NUMBER> jakstata rasraf atkpi<NUMBER>k pathways activated <NUMBER> chen et al found sample <NUMBER> patients increased levels il<NUMBER> significantly correlated disease severity <NUMBER> another study reported significant association lymphopenia increased il<NUMBER> levels covid<NUMBER> nonsurvivors compared survivors <NUMBER> <NUMBER> findings suggest monitoring il<NUMBER> levels evaluate cytokine storm prognostic tool <NUMBER> however likely physicians routinely follow il<NUMBER> levels covid<NUMBER> patients solid organ transplants commonly reported lab value studies evaluated table <NUMBER> treatment tocilizumab monoclonal antibody binds il<NUMBER> receptor recently published <NUMBER> binding il<NUMBER>r tocilizumab inhibit classical trans signaling pathways leading reduction second wave response preventing cytokine storm <NUMBER> standard treatment dosing according diagnosis treatment protocol covid<NUMBER> <NUMBER> th edition first dose <NUMBER> mgkgday <NUMBER>mg diluted <NUMBER>ml <NUMBER> normal saline infused <NUMBER> hour period <NUMBER> maximal dose <NUMBER> mg maximal number administrations two <NUMBER> dosing based small trial <NUMBER> patients received tocilizumab addition standard care recommended diagnosis treatment protocol covid<NUMBER> <NUMBER> th edition including lopinavir methylprednisolone symptom relievers oxygen therapy <NUMBER> given small sample size need research appropriate dosing time multicenter randomized controlled trial currently ongoing china <NUMBER> another potential medication decreases il<NUMBER> levels metronidazole <NUMBER> vitro vivo studies shown metronidazole decreases serum il<NUMBER> levels <NUMBER> close monitoring immunosuppressive therapy sot recipients infected covid<NUMBER> necessary balance allowing adequate immune response suppress viral load preventing transplant rejection previous case reports hypothesized immunosuppressive therapy protects sot recipients dampening cytokine storm <NUMBER> case reports noted viral rna levels remain positive longer period immunocompetent patients <NUMBER> notable previous studies demonstrated ards occurs sars patients despite decreased viral load <NUMBER> important indicates antiviral therapy alone inadequate treatment supports hypothesis ards results cytokine storm <NUMBER> one case report liver transplant recipient tested positive covidj u r n l p r e p r f based lymphocyte subtests <NUMBER> suggests early il<NUMBER> intervention prevent cytokine storm could improve outcomes covid<NUMBER> positive sot recipients one main concerns il<NUMBER> blockade treatment covid<NUMBER> however appropriate timing start treatment possible blocking il<NUMBER> signal transduction lead reduction viral clearance <NUMBER> patients already immunosuppressed could lead much higher viral load compared immunocompetent patients additionally know whether il<NUMBER> alters levels circulating tacrolimus may suggest cessation immunosuppressive therapy initial cytokine storm resolved temporary removal immunosuppressive regiment likely beneficial transplant recipients clinical outcomes covid<NUMBER> seems mostly dependent virushost interaction another interesting finding many patients covid<NUMBER> potential second cytokine storm second cytokine storm may happened patient case report clinically improved developed recurrence respiratory distress required intubation il<NUMBER> levels also markedly elevated time suggesting ongoing cytokine response may reason several patients become severely hypoxic days stabilization may also suggest administer tocilizumab interval fashion approximately <NUMBER> days first administration conclusion limited data clinical presentation management appropriate treatment covid<NUMBER> patients recipients solid organ transplants use il<NUMBER> inhibitor patient resulted clinical improvement initially difficult determine tocilizumab played role management patient specifically preventing j u r n l p r e p r f respiratory failure cytokine storm appears play major role patients possible several experience second storm results severe respiratory distress intubation thromboembolic phenomena also appear play role respiratory failure single case represent complex strategy needed considering treatment covid<NUMBER> patients solid organ transplants studies necessary investigate treatment modalities covid<NUMBER> special populations j u r n l p r e p r f severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> infected <NUMBER> million people worldwide resulting pandemic responsible <NUMBER> deaths may <NUMBER> <NUMBER> <NUMBER> <NUMBER> severity coronavirus disease <NUMBER> covid<NUMBER> ranges asymptomatic infection critical illness one third hospitalized patients requiring mechanical ventilation intensive care unit icu <NUMBER> <NUMBER> <NUMBER> <NUMBER> fatality rates vary demographic groups old age certain comorbidities hypertension obesity diabetes associated higher risk subset patients severe covid<NUMBER> rapid progression pulmonary infiltrates multiorgan failure coincides dramatic increases inflammatory cytokines biochemical markers inflammation consistent covid<NUMBER> associated cytokine storm syndrome covidcss <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> high mortality rate associated covidcss led offlabel use targeted anticytokine therapies aimed blocking inflammatory cascade improving patient outcomes clinical trials conducted assess safety efficacy cytokine blockade covid <NUMBER> currently standard therapies covid<NUMBER> covidcss recent national institutes health nih guidelines recommended use investigational agents outside clinical trials <NUMBER> may <NUMBER> <NUMBER> united states food drug administration fda granted emergency use authorization antiviral drug remdesivir based asyet unpublished results national institute allergy infectious diseases niaid sponsored randomized control trial demonstrated reduced recovery time compared placebo <NUMBER> drug influence cytokine storm niaid trial compares prior study found benefit drug currently known <NUMBER> covidcss brought renewed attention cytokine storm syndrome general concept <NUMBER> <NUMBER> perhaps influenced military operation desert storm term cytokine storm coined describe hypercytokinemia seen graftversushost disease gvhd <NUMBER> <NUMBER> css since associated viral infections eg influenza severe acute respiratory syndromesars autoimmune diseases eg systemic lupus erythematosussle systemic juvenile idiopathic arthritisjia hematologic conditions hemophagocytic lymphohistiocytosishlh medications <NUMBER> <NUMBER> <NUMBER> examples latter include phase clinical trial tgn<NUMBER> anticd<NUMBER> monoclonal antibody caused severe cytokine storm healthy volunteers cytokine release syndrome crs following chimeric antigen receptor cart cell therapy <NUMBER> <NUMBER> wide heterogeneity conditions placed umbrella term underscore need better understand pathophysiology treatment diseases characterized hypercytokinemia recently css defined condition dysregulation perpetuated activation lymphocytes macrophages resulting secretion large quantities cytokines leading overwhelming systemic inflammation multiorgan failure high mortality <NUMBER> understanding hypercytokinemia immune dysregulation associated covid<NUMBER> urgent proposed covid<NUMBER> actually hypoinflammatory vasculopathy rather cytokine storm hypothesis based one study reporting relatively low interleukin<NUMBER> il<NUMBER> levels mean <NUMBER> pgml normal range <NUMBER> measured admission hospital one chinese study <NUMBER> however cytokine storm generally thought develop later course disease emerging data center others indicates patients covidcss degree hypercytokinemia ie il<NUMBER> levels <NUMBER> <NUMBER> pgml comparable conditions cart cell crs overlap clinical biochemical features covidcss cytokine storm syndromes associated conditions may allow insight underlying pathologic immune dysregulation covidcss inform strategies therapeutic intervention review summarize clinical features pathologic mechanisms standard investigational therapies css three welldefined hematological cytokine storm syndromes secondary hemophagocytic lymphohistiocytosis shlh idiopathic multicentic castleman disease imcd cart cell crs order compare contrast covidcss hlh hyperinflammatory syndrome fever cytopenias multiorgan dysfunction caused uncontrolled immune activation excessive cytokine production <NUMBER> primary hlh typically pediatric condition driven germline mutations impairing granulemediated cytotoxicity natural killer cytotoxic cells <NUMBER> secondary hlh syndromes observed adults often driven infection commonly viral epsteinbarr virus ebv cytomegalovirus cmv human immunodeficiency virus hiv malignancy lymphomas primary rheumatologic conditions termed macrophage activation syndromehlh subtype mashlh medications immune checkpoint inhibitors lamotrigine <NUMBER> hlh<NUMBER> diagnostic criteria table <NUMBER> developed pediatric population recommended guide diagnosis adults include soluble interleukin<NUMBER> receptor marker cell activation cytokinerelated diagnostic criterion <NUMBER> <NUMBER> <NUMBER> hlh<NUMBER> criteria may restrictive identifying patients may benefit immunomodulation hscore developed specifically secondary especially malignancy associated hlh adults unfortunately include cytokinerelated criteria <NUMBER> initially named hemophagocytosis seen tissue biopsy hemophagocytosis bone marrow aspirate common nonspecific feature adults <NUMBER> <NUMBER> clinical laboratory features include fevers often described hectic may exceed <NUMBER>°c organomegaly cytopenias coagulopathy profound hyperferritinemia often <NUMBER> μgl often rapidly worsen despite initial empiric antimicrobial therapy resulting eventual multisystem organ failure <NUMBER> <NUMBER> mortality remains high adults around <NUMBER> despite therapy though patients mashlh driven rheumatologic diseases better prognosis less aggressive immunosuppression secondary hlh syndromes <NUMBER> <NUMBER> castleman disease cd describes group syndromes shared clinical hyperinflammation histopathological features <NUMBER> diagnosis requires lymph node biopsy characteristic histopathology defined consensus guidelines residing spectrum histologic patterns regressed germinal centers prominent vascularization hyperplastic germinal centers prominent plasmacytosis <NUMBER> <NUMBER> idiopathic mcd characterized dysregulation il<NUMBER> mediated inflammation typically occurring <NUMBER>th <NUMBER>th decade life patients present lymphadenopathy one lymph node station constitutional symptoms fluid accumulation cytopenias <NUMBER> <NUMBER> liver kidney dysfunction well presence secondary autoimmune phenomenon also common <NUMBER> <NUMBER> profound inflammation disease reflected frequently observed polyclonal hypergammaglobulinemia imcdnot otherwise specified imcdnos subgroup <NUMBER> subset patients demonstrate aggressive clinical course thrombocytopenia ascites reticulin fibrosis renal dysfunction organomegaly tafro exhibit hypergammaglobulinemia seen imcdnos <NUMBER> <NUMBER> engineering car tcells bind tumourspecific epitopes elicit cellmediated death malignant cells major leap forward cancer therapy first implemented relapsed refractory bcell lymphoid malignancies cd<NUMBER> cart cell therapy demonstrated response rates <NUMBER> cd<NUMBER> bcell acute lymphoblastic leukemia nonhodgkin lymphoma <NUMBER> activation cart cells encounter target cells leads release granzyme perforin proliferation cart cell population supraphysiologic increase cytokines il<NUMBER> interferonγ cytokine release syndrome crs may occur <NUMBER> patients depending conditioning therapy cell construct icu admission rates <NUMBER> <NUMBER> <NUMBER> <NUMBER> crs grade <NUMBER> majority patients may severe <NUMBER> patients <NUMBER> crs typically presents within first <NUMBER> days following cart cell infusion fever defining feature followed hypotension tachycardia hypoalbuminemia capillary leak weight gain consumptive coagulopathy <NUMBER> <NUMBER> immune effector cell associated neurotoxicity syndrome icans varied symptom profile table <NUMBER> may also observed later onset episode crs shortly resolution <NUMBER> <NUMBER> <NUMBER> <NUMBER> icans also occur patients develop crs observation addition separate timeline development resulted separation icans crs consensus grading system distinct toxicity <NUMBER> <NUMBER> <NUMBER> crs may observed tumourdirected immune therapies including bispecific tcell engager drug blinatumumab <NUMBER> people contract covid<NUMBER> clinical course mild often asymptomatic majority able recover disease home individuals require hospitalization commonly present fever cough fatigue dyspnea <NUMBER> <NUMBER> <NUMBER> <NUMBER> routine laboratory investigations admission demonstrate lymphopenia elevated ddimer elevated crp chest imaging demonstrates bilateral patchy shadows ground glass opacities <NUMBER> <NUMBER> <NUMBER> <NUMBER> twelve <NUMBER> patients admitted hospital eventually develop severe hypoxemic respiratory failure require critical care support <NUMBER> <NUMBER> <NUMBER> <NUMBER> severe covid<NUMBER> disease per whochina working group definition includes following respiratory frequency ≥ <NUMBER>min blood oxygen saturation ≤ <NUMBER> pao<NUMBER>fio<NUMBER> ratio <NUMBER> andor lung infiltrates <NUMBER> lung field within <NUMBER> h <NUMBER> critical disease defined severe covid<NUMBER> following respiratory failure septic shock andor multiple organ dysfunctionfailure <NUMBER> multiorgan failure frequently reported population marked organomegaly reported one emerging facets severe covid<NUMBER> association hypercoagulable state ddimer elevation recognized early pandemic important prognostic marker predicting severe disease mortality <NUMBER> klok et al reported <NUMBER> incidence thrombotic complications covid patients admitted icu including demonstration venous thromboembolism vte <NUMBER> patients <NUMBER> increased thrombotic risk seen many inflammatory states reflects overlap regulation inflammation thrombosis <NUMBER> profound activation thrombotic pathways may unique feature covid<NUMBER> compared css remains confirmed studies pediatric population affected covid<NUMBER> emerging reports hyperinflammatory shock syndrome sharing features atypical kawasaki disease initial symptoms fever conjunctivitis rash gastrointestinal symptoms progress shock requiring vasopressor support fluid accumulation cardiac injury <NUMBER> delayedonset profound rise inflammatory markers suggest secondary pathologic immune response may share features adult covidcss study needed confirm observations consensus definition covidcss prudent recognize patients severe critical covid<NUMBER> infection develop dysregulated immune response toxic cytokine secretion <NUMBER> working definition covidcss institution used consideration adjunct immunomodulatory therapy critical covid<NUMBER> evidence derangement multiple inflammatory markers including ferritin <NUMBER> μgl crp <NUMBER> mgl although presently analyzing clinical laboratory parameters immune biomarkers il<NUMBER> il<NUMBER> produce nuanced definition recent consensus recommendations management adult hlh state primary secondary hlh including mashlh hyperferritinemic hyperinflammatory syndromes common terminal pathway different pathogenetic roots <NUMBER> concept common terminal pathway resulting diverse pathophysiological mechanisms reasonably extended cytokine storm syndromes including covidcss marked elevation inflammatory cytokines il<NUMBER> il<NUMBER> chemokines associated th<NUMBER> response ip<NUMBER> mcp<NUMBER> reported subset covid patients affirming notion cytokine storm disease <NUMBER> marked elevation il<NUMBER> bears resemblance hyperil<NUMBER> syndromes cart cell crs castleman disease hyperferritinemia coagulopathy parallels shlh <NUMBER> similarities differences pathophysiology covidcss hematological cytokine storm syndromes outlined adult secondary hlh disorders result many different etiologies triggers indepth understanding pathophysiology lacking inferring studies genetic defects primary hlh patients hlh syndrome results dysregulation unrestrained activation macrophages cytotoxic tcells nk cells leading observed endorgan damage <NUMBER> <NUMBER> <NUMBER> <NUMBER> inability resolve certain infections subsequent uncontrolled immune activation may explain amplified inflammatory response shlh viral bacterial fungal infections aberrant autonomous cytokine production malignant cells immune system may develop hlh observed lymphomas <NUMBER> <NUMBER> <NUMBER> secondary hlh complicate autoinflammatory conditions sle stills disease etc inappropriate response selfantigen driving continuous activation tcells macrophages <NUMBER> <NUMBER> observed responses ifnγ antibody therapy suggests may key factor perpetuating pathologic feedback loop inflammation murine models primary hlh implicated ifnγ dependant independent pathways <NUMBER> <NUMBER> <NUMBER> pathogenesis imcd less well understood syndrome driven human herpesvirus <NUMBER> hhv<NUMBER> poems increased il<NUMBER> seen majority patients response il<NUMBER> targeted therapy implicated dysregulation pathway main driver disease <NUMBER> elevated vascular endothelial growth factor vegf levels dysregulated mammalian target rapamycin table <NUMBER> comparison clinical characteristics hlh <NUMBER> <NUMBER> <NUMBER> <NUMBER> post cart cell therapy <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> imcd <NUMBER> <NUMBER> <NUMBER> covidcss <NUMBER> crs icans hlh hemophagocytic lymphohistiocytosis cart cellchimeric antigen receptor cell crscytokine release syndrome icans immune effector cellassociated neurotoxicity syndrome imcdidiopathic multicentric castleman disease covidcsscoronavirus disease <NUMBER> associated cytokine storm syndrome ebv epsteinbarr virus cmvcytomegalovirus ardsacute respiratory distress syndrome mtor signaling also observed patients <NUMBER> <NUMBER> cause elevated il<NUMBER> levels inappropriate inflammatory activation known associations imcd autoimmune malignant conditions may point shared pathophysiology asyetundiscovered infectious triggers also hypothesized development severity crs correlates cart cell expansion preclinical mouse studies also shown monocyte macrophage production il<NUMBER> il<NUMBER> major drivers inflammatory response <NUMBER> <NUMBER> <NUMBER> <NUMBER> subsequent endothelial activation results microvascular permeability clinical features capillary leak hypotension reduced serum albumin levels <NUMBER> autopsy evidence also suggests activated endothelial cells produce additional il<NUMBER> reinforcing pathologic inflammatory feedback loop <NUMBER> eventual bloodbrain barrier disruption result increased il<NUMBER> levels endothelial activation thought contribute severe icans <NUMBER> understanding covidcss rapidly evolving early clinical biochemical autopsy observations supplemented thorough preclinical studies closely related sarscov responsible <NUMBER> sars outbreak mouse models sarscov suggest delayed type interferon signaling promotes accumulation pathogenic inflammatory macrophages leading hypercytokinemia vascular leakage impaired cell responses <NUMBER> deleting ifngamma receptor depleting macrophages protected mice lethal infection without affecting viral load supporting inflammatory response may contribute severe disease pathology direct viral effects <NUMBER> subset patients covid<NUMBER> disease severity seems correlate inflammatory markers commonly implicated cytokine storm disorders including il<NUMBER>r il<NUMBER> il<NUMBER> tnf cytokines <NUMBER> <NUMBER> <NUMBER> patients covidcss development sepsis need intubation ards accompanied worsening inflammatory markers observed <NUMBER> <NUMBER> days illness onset consistent clinical deterioration due inflammatory sequelae <NUMBER> autopsy series <NUMBER> patients died covid<NUMBER> demonstrated il<NUMBER> production virusinfected macrophages present lymph nodes spleen tissue suggesting viralinfection leading macrophage production il<NUMBER> initial trigger inflammatory dysregulation <NUMBER> established investigational therapies shlh imcd cart crs summarized condition tables <NUMBER> potential therapies ongoing clinical trials covidcss summarized table <NUMBER> corticosteroids cornerstone managing hyperinflammatory disorders due broad effects leading reduced inflammatory mediators immune cell activity used alone combination cytotoxic therapies responses frequent often shortlived associated significant longterm toxicity hlh<NUMBER> protocol combines upfront dexamethasone etoposide specific reduction cell activity cytokine production <NUMBER> <NUMBER> cyclosporine may introduced <NUMBER> weeks <NUMBER> week per hlh<NUMBER> protocol though often poorly tolerated adult patients <NUMBER> <NUMBER> despite demonstrated efficacy pediatric hlh syndromes adults treated hlh<NUMBER> protocol variations demonstrate poor longterm survival around <NUMBER> <NUMBER> relapses secondary hlh occur frequently either despite standard therapy table <NUMBER> summary therapies secondary hemophagocytic lymphohistiocytosis <NUMBER> <NUMBER> <NUMBER> cohort pediatric mas <NUMBER> cyclosporine initiated week <NUMBER> hlh<NUMBER> protocol week <NUMBER> hlh<NUMBER> protocol jt england et al blood reviews xxx xxxx xxxx therapy intensity tapered mortality related infectious complications prolonged immunosuppression also common imcd corticosteroids frequently used adjunct therapy disease flares though half patients demonstrate improvement corticosteroids <NUMBER> high dose corticosteroid therapy poorly tolerated long term number lymphomalike chemotherapy options used treat patients imcd <NUMBER> steroidcontaining immunomodulatory regimens thalidomide cyclophosphamide prednisone also shown promising efficacy safety <NUMBER> use corticosteroids management crs following cart cells limited concern unwanted cytotoxic effects cart product reducing overall efficacy however given effectiveness rapidly reducing systemic inflammatory burden population corticosteroids still used secondline directed anticytokine therapy <NUMBER> <NUMBER> steroids particularly useful first line therapy treatment icans cns penetrating steroids dexamethasone preferred corticosteroids used frequently management covid<NUMBER> early days pandemic china reported use <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> indication therapy widely reported may due comorbid conditions copd asthma adjunct therapy sepsis analysis suggested improved outcomes patients ards treated steroids though conclusive ideal timing patient selection known <NUMBER> <NUMBER> <NUMBER> animal models human data closely related sarscov infection demonstrated early corticosteroid use may reduce initial inflammatory response raise concern increased viral replication shedding could worsen clinical outcomes increase viral transmission <NUMBER> <NUMBER> improved mechanistic understanding hyperinflammatory syndromes led therapies targeting specific cytokines implicated disease pathogenesis emapalumab monoclonal antibody targeting interferonγ demonstrated efficacy overall response rates <NUMBER> study pediatric hlh <NUMBER> based trial us food drug administration fda approved emapalumab use refractory recurrent progressive primary hlh children adults <NUMBER> though concern secondary infections particularly organisms responsive ifngamma driven immune reactions medication well tolerated majority patients including infectious complications prior therapy <NUMBER> <NUMBER> <NUMBER> data limited use emapalumab secondary hlh adults imcd disease process thought dependent elevated il<NUMBER> levels perpetuating hyperinflammatory state patients therefore use il<NUMBER> targeted therapy frontline management patients imcd without adjunctive steroids siltuximab monoclonal antibody directed il<NUMBER> placebo controlled trial shown reduction tumour burden symptomatic response third <NUMBER> patients responders sustained disease control <NUMBER> years followup <NUMBER> tocilizumab monoclonal antibody directed il<NUMBER> receptor demonstrated similar improvement symptoms biochemical markers disease activity single arm study <NUMBER> antiil<NUMBER> therapy well tolerated many years patients disease response though relapses may common following cessation therapy <NUMBER> <NUMBER> early observation substantial increase il<NUMBER> crs prompted introduction antiil<NUMBER> agents management receiving cart therapy good effect <NUMBER> tocilizumab fda approved use crs response rates <NUMBER> following <NUMBER> table <NUMBER> summary therapies cart cell cytokine release syndrome <NUMBER> <NUMBER> doses repeated every <NUMBER> <NUMBER> h crs symptoms begin improve tocilizumab used short courses limited period less concern serious adverse events may seen patients taking drug longterm rheumatologic indications tocilizumab administration demonstrated affect cart cell efficacy thus preferred first line agent corticosteroids tocilizumab appears effective icans likely cross bloodbrain barrier targets il<NUMBER> receptor direct il<NUMBER> lowering effect leading elevated systemic il<NUMBER> levels therapy without cns protection <NUMBER> <NUMBER> <NUMBER> direct targeting il<NUMBER> siltuximab may better cns response though studied clinical trials il<NUMBER> levels correlate disease severity hospitalized covid<NUMBER> patients antiil<NUMBER> therapy one first treatment strategies explored pandemic <NUMBER> <NUMBER> <NUMBER> <NUMBER> several published case reports well two larger case series china using tocilizumab treatment severe covid<NUMBER> demonstrating biochemical efficacy decrease markers inflammation impact clinical outcomes time intensive care mortality compared supportive care remains unknown <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent large series <NUMBER> consecutive patients severe covid<NUMBER> demonstrated clinical stability improvement <NUMBER> patients following administration tocilizumab <NUMBER> press release corimunotoci nct<NUMBER> multicentre openlabel randomized controlled trial tocilizumab moderate severe covid<NUMBER> suggested positive results study currently peerreview <NUMBER> optimal timing tocilizumab initiation unknown sound rationale earlier treatment patients demonstrating pathologic inflammatory response may ameliorate immunemediated lung injury repeated doses tocilizumab similar strategy use cart cell related crs may reasonable patients refractory covidcss serious risks tocilizumab short term include small risk bowel perforation acute hepatic failure osteonecrosis jaw <NUMBER> <NUMBER> case reports hypertriglyceridemia candidemia following tocilizumab infusion covid<NUMBER> reported <NUMBER> <NUMBER> concern use tocilizumab covid<NUMBER> could increase risk secondary infections delay viral clearance postulated report <NUMBER> cases viral myocarditis following tociluzumab covid<NUMBER> <NUMBER> safety concerns thoroughly evaluated future studies clinical trials tocilizumab siltuximab sarilumab il<NUMBER> receptor blocker currently conducted patients moderate severe covid<NUMBER> though trials specifically evaluating agents covidcss population yet planned addition wellknown anticoagulant properties heparins known antiinflammatory effects lowering il<NUMBER> levels specifically described <NUMBER> <NUMBER> <NUMBER> patients covid<NUMBER> retrospective study observed reduction il<NUMBER> levels patients treated lowmolecular weight heparin lmwh <NUMBER> given maturing evidence increased thrombotic risk covid<NUMBER> lmwh may good adjunct therapy covidcss reduce il<NUMBER> driven inflammation thrombotic risk optimal dosing strategies patients without proven thromboembolic disease currently known investigated upcoming clinical trials nct<NUMBER> il<NUMBER>receptor blockade anakinra used case series retrospective studies hlh clinical trial currently ongoing <NUMBER> <NUMBER> <NUMBER> anakinra hypothesized utility cart crs neurotoxicity based observation il<NUMBER> elevations precede il<NUMBER> spike murine crs models treatment anakinra therapy resulted reduction cytokines <NUMBER> <NUMBER> anakinra added benefit short halflife compared anticytokine therapies retrospective cohort study <NUMBER> patients covid<NUMBER> moderatetosevere ards hyperinflammation crp ≥<NUMBER> mgl andor ferritin ≥<NUMBER> ngml treated high dose anakinra demonstrated clinical improvement <NUMBER> patients improved survival compared historical controls <NUMBER> utriupper respiratory tract infection pmlprogressive multifocal leukoencephalopathy hhv<NUMBER>human herpesvirus<NUMBER> crcomplete response prpartial response pfsprogression free survival may used conjunction corticosteroids b may used monotherapy conjunction chemotherapycorticosteroids tnf inhibiting agents available management inflammatory conditions though time review reports tnf inhibition reported covid<NUMBER> use tnf inhibitors potential concern drugs also thought trigger shlh case reports <NUMBER> <NUMBER> <NUMBER> clinical trials tnf inhibition covid<NUMBER> planned implement cellular responses cytokines cell surface receptors must connect external environmental signals nucleus guide gene expression cell proliferation activity bottleneck inflammatory communication shared internal signaling molecular pathways facilitated creation targeted therapies inhibit multiple cytokine pathways simultaneously many cytokine growth receptors signal janus kinase jak signal transducer activators transcription stat pathway spurred development small molecular jak inhibitors treatment inflammatory neoplastic conditions <NUMBER> agents may advantageous disease states broader inhibition cytokine signaling required control inflammation compared table <NUMBER> potential therapies covid cytokine storm syndrome published data covid<NUMBER> april <NUMBER> <NUMBER> nih treatment guidelines select registered trials corticosteroids case series retrospective cohort studies found possible improved outcomes ards <NUMBER> <NUMBER> remains concern prolonged viral shedding <NUMBER> critically ill patients covid<NUMBER> • case reports case series report improvement fever inflammatory markers possible improvement cytokine storm ards inhibition il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> insufficient clinical data recommend either use following agents treatment covid<NUMBER> aiii • interleukin<NUMBER> inhibitors eg sarilumab siltuximab tocilizumab • interleukin<NUMBER> inhibitors eg anakinra pilot study <NUMBER> patients demonstrated improvement fever dyspnea hypoxia lower rate icu admission historical control <NUMBER> proposed effective consequences elevated cytokines observed covid<NUMBER> inhibiting jakstat pathway reducing downstream cytokine signaling <NUMBER> baricitinib may inhibit viral entry cells blockade ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> <NUMBER> panel recommends use janus kinase jak inhibitors eg baricitinib treatment covid<NUMBER> except context clinical trial aiii nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> inhibition complement activity reduce inflammation subsequent tissue injury lmwh improves coagulation dysfunction exerts antiinflammatory effects reducing il<NUMBER> increasing lymphocyte percentage retrospective cohort study <NUMBER> recommendation nct<NUMBER> nct<NUMBER> ivig case reports clinical improvement administered time respiratory deterioration <NUMBER> recommendation nct<NUMBER> nih national institutes health httpswwwcovid<NUMBER>treatmentguidelinesnihgovmas accessed may <NUMBER> <NUMBER> masmacrophage activation syndrome lmwh low molecular weight heparin ivigintravenous immune globulin targeted blockade single cytokines ruxolitinib jak<NUMBER> inhibitor already approved therapy myeloproliferative neoplasm rheumatologic disorders activity murine hlh models reducing inflammation ifnγ dependant independent pathways results reduced activity tissue infiltration tcells neutrophils <NUMBER> <NUMBER> case series relapsedrefractory hlh well single case upfront therapy moderate severity hlh described biochemical clinical efficacy treatment hlh ruxolitinib monotherapy <NUMBER> <NUMBER> <NUMBER> early phase clinical trials ongoing preliminary results demonstrated biochemical hematologic clinical recovery patients enrolled thus far <NUMBER> importantly treatment tolerated well adverse events reported especially contrast standard regimens prolonged chemotherapy combined high dose steroids patients tafro subtype imcd typically aggressive course substantial response il<NUMBER> blockade analysis molecular signaling pathways active imcd patients refractory antiil<NUMBER> agents implicated downstream activation pi<NUMBER>kaktmtor pathway common signaling cell receptor vegf pathways <NUMBER> use mtor inhibitor sirolimus met early success limited numbers patients clinical trial il<NUMBER> blockade refractory tafro patients underway <NUMBER> <NUMBER> <NUMBER> preclinical studies cells obtained patients imcd also indicated jak inhibitors may able interrupt il<NUMBER> driven mtor pathway activation <NUMBER> currently limited reports use jakstat cell signaling pathway inhibitors management covidcss use jak inhibitors attractive medications well tolerated short halflives potential target numerous inflammatory cytokine signaling pathways simultaneously ruxolitinib agent studied hlh jak inhibitors may potential advantages baricitinib oral jak<NUMBER> inhibitor currently approved treatment rheumatoid arthritis recently identified artificial intelligencebased technology potential immunomodulatory treatment strategy sarscov<NUMBER> <NUMBER> therapeutic doses baricitinib predicted inhibit clathrinmediated endocytosis viral entry cells blocking ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> <NUMBER> aak<NUMBER> regulates endocytosis numerous cell types expressing ace<NUMBER> receptor mediates sarscov<NUMBER> viral entry including lung at<NUMBER> alveolar epithelial cells <NUMBER> agent dampens inflammatory response could lead potential loss immunemediated viral control hypothesized antiviral effect makes baricitinib attractive investigational therapy agents target disordered inflammation alone concern baracitinib increased risk thrombosis may increase rate thrombotic complications already observed covid<NUMBER> <NUMBER> clinical experience covid<NUMBER> limited pilot study <NUMBER> patients demonstrated improvement fever dyspnea hypoxia lower rate icu admission historical control cohort <NUMBER> css disorders driven recognized characteristic hypercytokinemia however availability objective cytokine profiles limited clinicians forced evaluate base treatment decisions clinical signs symptoms inflammation widely available markers overall systemic inflammation utility cytokine levels diagnosis monitoring cytokine storm syndromes standardized currently limited research settings published values inflammatory markers cytokines observed cytokine storm conditions summarized table <NUMBER> importantly many assays routinely performed hospital laboratories clinical relevance remains determined future studies address analytical clinical validation markers table <NUMBER> biomarkers cytokine levels cytokine storm syndromes marker median range hlh <NUMBER> <NUMBER> <NUMBER> <NUMBER> mcd <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cart crs <NUMBER> <NUMBER> published covid<NUMBER> data crp mgl normal <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> median <NUMBER> <NUMBER> <NUMBER> ferritin iron storage protein creactive protein crp acute phase reactants widely available hospitals monitoring systemic inflammation hyperferritinemia common feature prompt evaluation secondary hlh levels <NUMBER> μgl observed <NUMBER> adult patients frequently excess <NUMBER> μgl <NUMBER> <NUMBER> patients crs also demonstrate elevated ferritin levels patients reaching peak <NUMBER> many excess <NUMBER> μgl <NUMBER> <NUMBER> patients experiencing higher grade crs greater median peak ferritin crp though significant overlap observed ranges <NUMBER> <NUMBER> similarly ferritin crp levels patients covid<NUMBER> reportedly higher patients severe compared moderate disease patients died compared recovered <NUMBER> <NUMBER> <NUMBER> experience covidcss patients icu observed ferritin levels range <NUMBER> μgl crp levels typically <NUMBER> mgl hoiland r et al manuscript review measurement ddimer fibrin degradation product widely available test shows active clot formation breakdown increase systemic inflammation reflects overlap physiologic inflammatory thrombotic pathways though frequently used evaluation cytokine storm disorders correlated severity crs following cart <NUMBER> ddimer levels correlate disease severity covid<NUMBER> admission ddimer <NUMBER> μgml emerged one earliest prognostic marker identify patients high mortality <NUMBER> pattern inflammatory markers may useful relying absolute values alone order establish diagnosis children sjia ratio ferritin erythrocyte sedimentation rate esr useful identifying patients mas <NUMBER> one study japanese hlh cases ratio sil<NUMBER>r ferritin predictive lymphomaassociated rather benign disease <NUMBER> soluble interleukin<NUMBER> receptor sil<NUMBER>r level integrated hlh<NUMBER> diagnostic criteria <NUMBER> adults secondary hlh levels <NUMBER> uml demonstrate good sensitivity specificity diagnosing adult hlh area curve <NUMBER> <NUMBER> confidence interval <NUMBER> <NUMBER> soluble il<NUMBER>r levels widely reported imcd one study found elevated levels <NUMBER> <NUMBER> cases <NUMBER> additionally observed patients antiil<NUMBER> therapy sil<NUMBER>r one earliest markers predicted disease relapse failure therapy <NUMBER> <NUMBER> cart crs observed sil<NUMBER>r levels markedly elevated patients severe compared nonsevere disease <NUMBER> patients covid<NUMBER> demonstrate higher sil<NUMBER>r levels severe fatal disease though levels thus far reported typically less <NUMBER> u ml <NUMBER> <NUMBER> <NUMBER> <NUMBER> il<NUMBER> key cytokine common pathophysiology css disorders important therapeutic implications hlh data available pediatric patients demonstrate moderate il<NUMBER> elevation though useful distinguishing hlh sepsis inflammatory conditions <NUMBER> idiopathic mcd conceptualized primarily disorder il<NUMBER> elevation though serum il<NUMBER> levels imcd may normal mildly elevated response rates il<NUMBER> blockade correlate baseline il<NUMBER> levels imcd many patients low il<NUMBER> levels improve therapy patients high il<NUMBER> levels show response <NUMBER> <NUMBER> il<NUMBER> levels peak disease flares imcd used monitor disease course il<NUMBER> blockade initiated serial monitoring useful tocilizumab sarilumab block receptor il<NUMBER> leading clinical improvement serum il<NUMBER> levels remain stable increase <NUMBER> similarly il<NUMBER> levels cannot accurately interpreted <NUMBER> months following last dose siltuximab cart crs demonstrates substantial increases il<NUMBER> correlates severity crs may orders magnitude greater levels reported imcd hlh <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> il<NUMBER> levels high patients severe fatal disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> institutions experience covidcss observed levels il<NUMBER> range <NUMBER> pgml manuscript review interferonγ plays central role pathogenesis hlh elevated serum levels help differentiate hlh sepsis inflammatory disorders children routine use diagnosis adults studied <NUMBER> <NUMBER> following emapalumab therapy interferonγ levels correlate disease response downstream targets interferon cxcl<NUMBER> cxcl<NUMBER> appear utility monitoring disease activity treatment response <NUMBER> <NUMBER> use cytokine measurements css diagnose monitor disease activity response therapy area need refinement monitoring response therapy requires depth knowledge drug targets expected impact cytokine levels laboratory testing downstream pathway activation data research experience needed order develop clinical acumen interpretation patterns profiles diseases covidcss many clinical pathologic similarities cytokine storm disorders therapy classic css conditions imcd secondary hlh hampered low numbers patients lack diagnostic clarity incompletely understood pathophysiology progress made introduction targeted therapy aimed interrupting positive feedback loops inflammatory pathways story crs following cart cell therapy comparatively rapid determination pathophysiology use existing medications treatment recent success future goals css include improved access immunophenotyping expression profiling inform understanding disease mechanisms enhancing diagnostic monitoring capabilities due lack currently available evidence nih guidelines management covid<NUMBER> recommend cytokine inhibition il<NUMBER> il<NUMBER> blockade specifically recommend offlabel use jak pathway inhibitors outside clinical trial <NUMBER> current industry sponsored trials sarilumab nct<NUMBER> tocilizumab nct<NUMBER> patients severecritical covid<NUMBER> underway however exclude critically ill patients requiring vasopressors therefore address question whether agents benefit critically unwell evidence css development consensus definitions covidcss may lead identification patients likely benefit immune modulating therapy use lessons learned hematologic cytokine storm syndromes help expedite rapid identification evaluation implementation treatments urgently needed covid<NUMBER> css • subset patients covid<NUMBER> develop syndrome characterized organ dysfunction marked elevation inflammatory markers dubbed cytokine storm syndrome css • date consensus definition covidcss fever organ dysfunction hypoalbuminemia capillary leak common covid<NUMBER> cytokine storm syndromes shlh imcd cart cell crs • covid<NUMBER> appears hypercoagulable state leading microvascular thrombosis feature distinct hypercytokinemia syndromes • therapies targeting specific cytokines common inflammatory signaling pathways demonstrated benefit hlh imcd cart crs well tolerated contexts role covid<NUMBER> css active investigation • pragmatic definition covidcss likely require combination clinical criteria fever hypotension critical illness widely available laboratory parameters crp ferritin ddimer well novel biomarkers il<NUMBER> il<NUMBER> cytokines immunophenotyping • consensus definitions css general covidcss particular particular attention relationship covid related coagulopathy vasculopathy • rapid coordinated investigations potentially beneficial agents targeting inflammatory pathways covid<NUMBER> css methodologically rigorous clinical trials • measurement biomarkers css including traditional laboratory parameters well genetic studies cytokine profiles lymphocyte immunophenotyping presentation course disease kamran shojania involved investigatorinitiated vasculitis study bristolmyerssquibb shahin jamal attended roche advisory board tocilizumab giant cell arteritis rheumatoid arthritis kevin hay attended advisory boards received honoraria celgene gilead related cart cell products james england alym abdulla ryan l hoiland cheryl l wellington mypinder sekhon agnes yy lee catherine biggs luke chenno conflicts interest declare severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> infected <NUMBER> million people worldwide resulting pandemic responsible <NUMBER> <NUMBER> deaths may <NUMBER> <NUMBER> <NUMBER> <NUMBER> severity coronavirus disease <NUMBER> covid<NUMBER> ranges asymptomatic infection critical illness one third hospitalized patients requiring mechanical ventilation intensive care unit icu <NUMBER> <NUMBER> <NUMBER> <NUMBER> fatality rates vary demographic groups old age certain comorbidities hypertension obesity diabetes associated higher risk subset patients severe covid<NUMBER> rapid progression pulmonary infiltrates multiorgan failure coincides dramatic increases inflammatory cytokines biochemical cart cell population supraphysiologic increase cytokines il<NUMBER> interferonγ cytokine release syndrome crs may occur <NUMBER> patients depending conditioning therapy cell construct icu admission rates <NUMBER> <NUMBER> <NUMBER> <NUMBER> crs grade <NUMBER> majority patients may severe <NUMBER> patients <NUMBER> crs typically presents within first <NUMBER> days following cart cell infusion fever defining feature followed hypotension tachycardia hypoalbuminemia capillary leak weight gain consumptive coagulopathy <NUMBER> <NUMBER> immune effector cell associated neurotoxicity syndrome icans varied symptom profile may also observed later onset episode crs shortly resolution <NUMBER> <NUMBER> <NUMBER> <NUMBER> icans also occur patients develop crs observation addition separate timeline development resulted separation icans crs consensus grading system distinct toxicity <NUMBER> <NUMBER> <NUMBER> crs may also observed tumourdirected immune therapies including bispecific tcell engager drug blinatumumab <NUMBER> people contract covid<NUMBER> clinical course mild often asymptomatic majority able recover disease home individuals require hospitalization commonly present fever cough fatigue dyspnea <NUMBER> <NUMBER> <NUMBER> <NUMBER> routine laboratory investigations admission demonstrate lymphopenia elevated ddimer elevated crp chest imaging demonstrates bilateral patchy shadows ground glass opacities <NUMBER> <NUMBER> <NUMBER> <NUMBER> twelve <NUMBER> patients admitted hospital eventually develop severe hypoxemic respiratory failure require critical care support <NUMBER> <NUMBER> <NUMBER> <NUMBER> severe covid<NUMBER> disease per whochina working group definition includes following respiratory frequency ≥<NUMBER>minute blood oxygen saturation ≤<NUMBER> pao<NUMBER>fio<NUMBER> ratio <NUMBER> andor lung infiltrates <NUMBER> lung field within <NUMBER> hours <NUMBER> critical disease defined severe covid<NUMBER> following respiratory failure septic shock andor multiple j u r n l p r e p r f organ dysfunctionfailure <NUMBER> multiorgan failure frequently reported population marked organomegaly reported one emerging facets severe covid<NUMBER> association hypercoagulable state ddimer elevation recognised early pandemic important prognostic marker predicting severe disease mortality <NUMBER> klok et al reported <NUMBER> incidence thrombotic complications covid patients admitted icu including demonstration venous thromboembolism vte <NUMBER> patients <NUMBER> increased thrombotic risk seen many inflammatory states reflects overlap regulation inflammation thrombosis <NUMBER> profound activation thrombotic pathways may unique feature covid<NUMBER> compared css remains confirmed studies pediatric population affected covid<NUMBER> emerging reports hyperinflammatory shock syndrome sharing features atypical kawasaki disease initial symptoms fever conjunctivitis rash gastrointestinal symptoms progress shock requiring vasopressor support fluid accumulation cardiac injury <NUMBER> delayedonset profound rise inflammatory markers suggest secondary pathologic immune response may share features adult covidcss study needed confirm observations consensus definition covidcss prudent recognize patients severe critical covid<NUMBER> infection develop dysregulated immune response toxic cytokine secretion <NUMBER> working definition covidcss institution used consideration adjunct immunomodulatory therapy critical covid<NUMBER> evidence derangement multiple inflammatory markers including ferritin <NUMBER> μgl crp <NUMBER> mgl although presently analyzing clinical laboratory parameters immune biomarkers il<NUMBER> il<NUMBER> produce nuanced definition recent consensus recommendations management adult hlh state primary secondary hlh including mashlh hyperferritinemic hyperinflammatory syndromes common terminal pathway different pathogenetic roots <NUMBER> concept common terminal pathway resulting diverse pathophysiological mechanisms reasonably extended cytokine storm syndromes including covidcss marked elevation inflammatory cytokines il<NUMBER> il<NUMBER> chemokines associated th<NUMBER> response ip<NUMBER> mcp<NUMBER> reported subset covid patients affirming notion cytokine storm disease <NUMBER> marked elevation il<NUMBER> bears resemblance hyper il<NUMBER> syndromes cart cell crs castleman disease hyperferritinemia coagulopathy parallels shlh <NUMBER> similarities differences pathophysiology covidcss hematological cytokine storm syndromes outlined adult secondary hlh disorders result many different etiologies triggers indepth understanding pathophysiology lacking inferring studies genetic defects primary hlh patients hlh syndrome results dysregulation unrestrained activation macrophages cytotoxic tcells nk cells leading observed endorgan damage <NUMBER> <NUMBER> <NUMBER> <NUMBER> inability resolve certain infections subsequent uncontrolled immune activation may explain amplified inflammatory response shlh viral bacterial fungal infections aberrant autonomous cytokine production malignant cells immune system may develop hlh observed lymphomas <NUMBER> <NUMBER> <NUMBER> secondary hlh complicate autoinflammatory conditions sle stills disease etc inappropriate response selfantigen driving continuous activation tcells macrophages <NUMBER> <NUMBER> observed responses ifnγ antibody therapy suggests may key j u r n l p r e p r f journal preproof factor perpetuating pathologic feedback loop inflammation murine models primary hlh implicated ifnγ dependant independent pathways <NUMBER> <NUMBER> <NUMBER> pathogenesis imcd less well understood syndrome driven human herpesvirus <NUMBER> hhv<NUMBER> poems increased il<NUMBER> seen majority patients response il<NUMBER> targeted therapy implicated dysregulation pathway main driver disease <NUMBER> elevated vascular endothelial growth factor vegf levels dysregulated mammalian target rapamycin signaling also observed patients <NUMBER> <NUMBER> cause elevated il<NUMBER> levels inappropriate inflammatory activation known associations imcd autoimmune malignant conditions may point shared pathophysiology asyetundiscovered infectious triggers also hypothesized development severity crs correlates cart cell expansion preclinical mouse studies also shown monocyte macrophage production il<NUMBER> il<NUMBER> major drivers inflammatory response <NUMBER> <NUMBER> <NUMBER> <NUMBER> subsequent endothelial activation results microvascular permeability clinical features capillary leak hypotension reduced serum albumin levels <NUMBER> autopsy evidence also suggests activated endothelial cells produce additional il<NUMBER> reinforcing pathologic inflammatory feedback loop <NUMBER> eventual bloodbrain barrier disruption result increased il<NUMBER> levels endothelial activation thought contribute severe icans <NUMBER> j u r n l p r e p r f understanding covidcss rapidly evolving early clinical biochemical autopsy observations supplemented thorough preclinical studies closely related sars cov responsible <NUMBER> sars outbreak mouse models sarscov suggest delayed type interferon signaling promotes accumulation pathogenic inflammatory macrophages leading hypercytokinemia vascular leakage impaired cell responses <NUMBER> deleting ifngamma receptor depleting macrophages protected mice lethal infection without affecting viral load supporting inflammatory response may contribute severe disease pathology direct viral effects <NUMBER> subset patients covid<NUMBER> disease severity seems correlate inflammatory markers commonly implicated cytokine storm disorders including il<NUMBER>r il<NUMBER> il<NUMBER> tnf cytokines <NUMBER> <NUMBER> <NUMBER> patients covidcss development sepsis need intubation ards accompanied worsening inflammatory markers observed <NUMBER> days illness onset consistent clinical deterioration due inflammatory sequelae <NUMBER> autopsy series <NUMBER> patients died covid<NUMBER> demonstrated il<NUMBER> production virusinfected macrophages present lymph nodes spleen tissue suggesting viral infection leading macrophage production il<NUMBER> initial trigger inflammatory dysregulation <NUMBER> established investigational therapies shlh imcd cart crs summarized condition tables <NUMBER> potential therapies ongoing clinical trials covidcss summarized table <NUMBER> corticosteroids cornerstone managing hyperinflammatory disorders due broad effects leading reduced inflammatory mediators immune cell activity used alone combination cytotoxic therapies responses frequent often shortlived associated j u r n l p r e p r f significant longterm toxicity hlh<NUMBER> protocol combines upfront dexamethasone etoposide specific reduction cell activity cytokine production <NUMBER> <NUMBER> cyclosporine may introduced <NUMBER> weeks <NUMBER> week per hlh<NUMBER> protocol though often poorly tolerated adult patients <NUMBER> <NUMBER> despite demonstrated efficacy pediatric hlh syndromes adults treated hlh<NUMBER> protocol variations demonstrate poor longterm survival around <NUMBER> <NUMBER> relapses secondary hlh occur frequently either despite standard therapy therapy intensity tapered mortality related infectious complications prolonged immunosuppression also common imcd corticosteroids frequently used adjunct therapy disease flares though half patients demonstrate improvement corticosteroids <NUMBER> high dose corticosteroid therapy poorly tolerated long term number lymphomalike chemotherapy options used treat patients imcd <NUMBER> steroidcontaining immunomodulatory regimens thalidomide cyclophosphamide prednisone also shown promising efficacy safety <NUMBER> use corticosteroids management crs following cart cells limited concern unwanted cytotoxic effects cart product reducing overall efficacy however given effectiveness rapidly reducing systemic inflammatory burden population corticosteroids still used therapy secondline directed anticytokine therapy <NUMBER> <NUMBER> steroids particularly useful first line therapy treatment icans cns penetrating steroids dexamethasone preferred corticosteroids used frequently management covid<NUMBER> early days pandemic china reported use <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> indication therapy widely reported may due comorbid conditions copd asthma adjunct therapy sepsis analysis suggested improved outcomes patients ards treated steroids though conclusive ideal timing patient selection known <NUMBER> <NUMBER> <NUMBER> animal j u r n l p r e p r f models human data closely related sarscov infection demonstrated early corticosteroid use may reduce initial inflammatory response raise concern increased viral replication shedding could worsen clinical outcomes increase viral transmission <NUMBER> <NUMBER> improved mechanistic understanding hyperinflammatory syndromes led therapies targeting specific cytokines implicated disease pathogenesis emapalumab monoclonal antibody targeting interferonγ demonstrated efficacy overall response rates <NUMBER> study pediatric hlh <NUMBER> based trial us food drug administration fda approved emapalumab use refractory recurrent progressive primary hlh children adults <NUMBER> though concern secondary infections particularly organisms responsive ifngamma driven immune reactions medication well tolerated majority patients including infectious complications prior therapy <NUMBER> <NUMBER> <NUMBER> data limited use emapalumab secondary hlh adults imcd disease process thought dependent elevated il<NUMBER> levels perpetuating hyperinflammatory state patients therefore use il<NUMBER> targeted therapy frontline management patients imcd without adjunctive steroids siltuximab monoclonal antibody directed il<NUMBER> placebo controlled trial shown reduction tumour burden symptomatic response third <NUMBER> patients responders sustained disease control <NUMBER> years followup <NUMBER> tocilizumab monoclonal antibody directed il<NUMBER> receptor demonstrated similar improvement symptoms biochemical markers disease activity single j u r n l p r e p r f arm study <NUMBER> antiil<NUMBER> therapy well tolerated many years patients disease response though relapses may common following cessation therapy <NUMBER> <NUMBER> early observation substantial increase il<NUMBER> crs prompted introduction antiil<NUMBER> agents management receiving cart therapy good effect <NUMBER> tocilizumab fda approved use crs response rates <NUMBER> following <NUMBER> doses median time response <NUMBER> days <NUMBER> <NUMBER> doses repeated every <NUMBER> <NUMBER> hours crs symptoms begin improve tocilizumab used short courses limited period less concern serious adverse events may seen patients taking drug longterm rheumatologic indications tocilizumab administration demonstrated affect cart cell efficacy thus preferred first line agent corticosteroids tocilizumab appears effective icans likely cross bloodbrain barrier targets il<NUMBER> receptor direct il<NUMBER> lowering effect leading elevated systemic il<NUMBER> levels therapy without cns protection <NUMBER> <NUMBER> <NUMBER> direct targeting il<NUMBER> siltuximab may better cns response though studied clinical trials il<NUMBER> levels correlate disease severity hospitalized covid<NUMBER> patients antiil<NUMBER> therapy one first treatment strategies explored pandemic <NUMBER> <NUMBER> <NUMBER> <NUMBER> several published case reports well two larger case series f rom china using tocilizumab treatment severe covid<NUMBER> demonstrating biochemical efficacy decrease markers inflammation impact clinical outcomes time intensive care mortality compared supportive care remains unknown <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent large series <NUMBER> consecutive patients severe covid<NUMBER> demonstrated clinical stability improvement <NUMBER> patients following administration tocilizumab <NUMBER> press release corimunotoci nct<NUMBER> multicentre openlabel randomized controlled trial tocilizumab moderate severe covid<NUMBER> suggested positive results study currently peerreview <NUMBER> optimal timing tocilizumab j u r n l p r e p r f initiation unknown sound rationale earlier treatment patients demonstrating pathologic inflammatory response may ameliorate immunemediated lung injury repeated doses tocilizumab similar strategy use cart cell related crs may reasonable patients refractory covidcss serious risks tocilizumab short term include small risk bowel perforation acute hepatic failure osteonecrosis jaw <NUMBER> <NUMBER> case reports hypertriglyceridemia candidemia following tocilizumab infusion covid<NUMBER> reported <NUMBER> <NUMBER> concern use tocilizumab covid<NUMBER> could increase risk secondary infections delay viral clearance postulated report <NUMBER> cases viral myocarditis following tociluzumab covid<NUMBER> <NUMBER> safety concerns thoroughly evaluated future studies clinical trials tocilizumab siltuximab sarilumab il<NUMBER> receptor blocker currently conducted patients moderate severe covid<NUMBER> though trials specifically evaluating agents covidcss population yet planned addition wellknown anticoagulant properties heparins known antiinflammatory effects lowering il<NUMBER> levels specifically described <NUMBER> <NUMBER> <NUMBER> patients covid<NUMBER> retrospective study observed reduction il<NUMBER> levels patients treated lowmolecular weight heparin lmwh <NUMBER> given maturing evidence increased thrombotic risk covid<NUMBER> lmwh may good adjunct therapy covidcss reduce il<NUMBER> driven inflammation thrombotic risk optimal dosing strategies patients without proven thromboembolic disease currently known investigated upcoming clinical trials nct<NUMBER> il<NUMBER>receptor blockade anakinra used case series retrospective studies hlh clinical trial currently ongoing <NUMBER> <NUMBER> <NUMBER> anakinra hypothesized utility cart crs neurotoxicity based observation il<NUMBER> elevations precede il<NUMBER> spike murine crs models treatment anakinra therapy resulted reduction cytokines <NUMBER> <NUMBER> anakinra added benefit short halflife compared anticytokine therapies retrospective cohort study <NUMBER> patients covid<NUMBER> moderatetosevere ards hyperinflammation crp ≥<NUMBER> mgl andor ferritin ≥<NUMBER> ngml treated high dose anakinra demonstrated clinical improvement <NUMBER> patients improved survival compared historical controls <NUMBER> tnf inhibiting agents available management inflammatory conditions though time review reports tnf inhibition reported covid<NUMBER> use tnf inhibitors potential concern drugs also thought trigger shlh case reports <NUMBER> <NUMBER> <NUMBER> clinical trials tnf inhibition covid<NUMBER> planned implement cellular responses cytokines cell surface receptors must connect external environmental signals nucleus guide gene expression cell proliferation activity bottleneck inflammatory communication shared internal signaling molecular pathways facilitated creation targeted therapies inhibit multiple cytokine pathways simultaneously many cytokine growth receptors signal janus kinase jak signal transducer activators transcription stat pathway spurred development small molecular jak inhibitors treatment inflammatory neoplastic conditions <NUMBER> agents may advantageous disease states broader inhibition cytokine signaling required control inflammation compared targeted blockade single cytokines ruxolitinib jak<NUMBER> inhibitor already approved therapy myeloproliferative neoplasm rheumatologic disorders activity murine hlh models reducing inflammation ifnγ j u r n l p r e p r f dependant independent pathways results reduced activity tissue infiltration tcells neutrophils <NUMBER> <NUMBER> case series relapsedrefractory hlh well single case upfront therapy moderate severity hlh described biochemical clinical efficacy treatment hlh ruxolitinib monotherapy <NUMBER> <NUMBER> <NUMBER> early phase clinical trials ongoing preliminary results demonstrated biochemical hematologic clinical recovery patients enrolled thus far <NUMBER> importantly treatment tolerated well adverse events reported especially contrast standard regimens prolonged chemotherapy combined high dose steroids patients tafro subtype imcd typically aggressive course substantial response il<NUMBER> blockade analysis molecular signalling pathways active imcd patients refractory antiil<NUMBER> agents implicated downstream activation pi<NUMBER>kaktmtor pathway common signalling cell receptor vegf pathways <NUMBER> use mtor inhibitor sirolimus met early success limited numbers patients clinical trial il<NUMBER> blockade refractory tafro patients underway <NUMBER> <NUMBER> <NUMBER> preclinical studies cells obtained patients imcd also indicated jak inhibitors may able interrupt il<NUMBER> driven mtor pathway activation <NUMBER> currently limited reports use jakstat cell signalling pathway inhibitors management covidcss use jak inhibitors attractive medications well tolerated short halflives potential target numerous inflammatory cytokine signaling pathways simultaneously ruxolitinib agent studied hlh jak inhibitors may potential advantages baricitinib oral jak<NUMBER> inhibitor currently approved treatment rheumatoid arthritis recently identified artificial intelligencebased technology potential immunomodulatory treatment strategy sarscov<NUMBER> <NUMBER> therapeutic doses baricitinib predicted inhibit clathrinmediated endocytosis viral entry cells blocking ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> <NUMBER> aak<NUMBER> regulates endocytosis numerous cell j u r n l p r e p r f types expressing ace<NUMBER> receptor mediates sarscov<NUMBER> viral entry including lung at<NUMBER> alveolar epithelial cells <NUMBER> agent dampens inflammatory response could lead potential loss immunemediated viral control potential antiviral effect makes baricitinib attractive investigational therapy agents target disordered inflammation alone concern baracitinib increased risk thrombosis may increase rate thrombotic complications already observed covid<NUMBER> <NUMBER> clinical experience covid<NUMBER> limited pilot study <NUMBER> patients demonstrated improvement fever dyspnea hypoxia lower rate icu admission historical control <NUMBER> table <NUMBER> importantly many assays routinely performed hospital laboratories clinical relevance remains determined future studies address analytical clinical validation markers ferritin iron storage protein creactive protein crp acute phase reactants widely available hospitals monitoring systemic inflammation hyperferritinemia common feature prompt evaluation secondary hlh levels <NUMBER> µgl observed j u r n l p r e p r f <NUMBER> adult patients frequently excess <NUMBER> µgl <NUMBER> <NUMBER> patients crs also demonstrate elevated ferritin levels patients reaching peak <NUMBER> many excess <NUMBER> µgl <NUMBER> <NUMBER> patients experiencing higher grade crs greater median peak ferritin crp though significant overlap observed ranges <NUMBER> <NUMBER> similarly ferritin crp levels patients covid<NUMBER> reportedly higher patients severe compared moderate disease patients died compared recovered <NUMBER> <NUMBER> <NUMBER> experience covidcss patients icu observed ferritin levels range <NUMBER> µgl crp levels typically <NUMBER> mgl hoiland r et al manuscript review measurement ddimer fibrin degradation product widely available test shows active clot formation breakdown increase systemic inflammation reflects overlap physiologic inflammatory thrombotic pathways though frequently used evaluation cytokine storm disorders correlated severity crs following cart <NUMBER> ddimer levels correlate disease severity covid<NUMBER> admission ddimer <NUMBER> μgml emerged one earliest prognostic marker identify patients high mortality <NUMBER> pattern inflammatory markers may useful relying absolute values alone order establish diagnosis children sjia ratio ferritin erythrocyte sedimentation rate esr useful identifying patients mas <NUMBER> one study japanese hlh cases ratio sil<NUMBER>r ferritin predictive lymphomaassociated rather benign disease <NUMBER> soluble interleukin<NUMBER> receptor sil<NUMBER>r level integrated hlh<NUMBER> diagnostic criteria <NUMBER> adults secondary hlh levels <NUMBER> uml demonstrate good sensitivity specificity diagnosing adult hlh area curve <NUMBER> <NUMBER> confidence interval <NUMBER> <NUMBER> soluble il<NUMBER>r levels widely reported imcd one study found elevated j u r n l p r e p r f levels <NUMBER> <NUMBER> cases <NUMBER> additionally observed patients antiil<NUMBER> therapy sil<NUMBER>r one earliest markers predicted disease relapse failure therapy <NUMBER> <NUMBER> cart crs observed sil<NUMBER>r levels markedly elevated patients severe compared nonsevere disease <NUMBER> patients covid<NUMBER> demonstrate higher sil<NUMBER>r levels severe fatal disease though levels thus far reported typically less <NUMBER> uml <NUMBER> <NUMBER> <NUMBER> <NUMBER> il<NUMBER> key cytokine common pathophysiology css disorders important therapeutic implications hlh data available pediatric patients demonstrate moderate il<NUMBER> elevation though useful distinguishing hlh sepsis inflammatory conditions <NUMBER> idiopathic mcd conceptualized primarily disorder il<NUMBER> elevation though serum il<NUMBER> levels imcd may normal mildly elevated response rates il<NUMBER> blockade correlate baseline il<NUMBER> levels imcd many patients low il<NUMBER> levels improve therapy patients high il<NUMBER> levels show response <NUMBER> <NUMBER> il<NUMBER> levels peak disease flares imcd used monitor disease course il<NUMBER> blockade initiated serial monitoring useful tocilizumab sarilumab block receptor il<NUMBER> leading clinical improvement serum il<NUMBER> levels remain stable increase <NUMBER> similarly il<NUMBER> levels cannot accurately interpreted <NUMBER> months following last dose siltuximab cart crs demonstrates substantial increases il<NUMBER> correlates severity crs may orders magnitude greater levels reported imcd hlh <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> il<NUMBER> levels high patients severe fatal disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> institutions experience covidcss observed levels il<NUMBER> range <NUMBER> pgml manuscript review interferonγ plays central role pathogenesis hlh elevated serum levels help differentiate hlh sepsis inflammatory disorders children routine use diagnosis adults studied <NUMBER> <NUMBER> following emapalumab therapy interferonγ levels j u r n l p r e p r f correlate disease response downstream targets interferon cxcl<NUMBER> cxcl<NUMBER> appear utility monitoring disease activity treatment response <NUMBER> <NUMBER> use cytokine measurements css diagnose monitor disease activity response therapy area need refinement monitoring response therapy requires depth knowledge drug targets expected impact cytokine levels laboratory testing downstream pathway activation data research experience needed order develop clinical acumen interpretation patterns profiles diseases covidcss many clinical pathologic similarities cytokine storm disorders therapy classic css conditions imcd secondary hlh hampered low numbers patients lack diagnostic clarity incompletely understood pathophysiology progress made introduction targeted therapy aimed interrupting positive feedback loops inflammatory pathways story crs following cart cell therapy comparatively rapid determination pathophysiology use existing medications treatment recent success future goals css include improved access immunophenotyping expression profiling inform understanding disease mechanisms enhancing diagnostic monitoring capabilities due lack currently available evidence nih guidelines management covid<NUMBER> recommend cytokine inhibition il<NUMBER> il<NUMBER> blockade specifically recommend offlabel use jak pathway inhibitors outside clinical trial <NUMBER> current industry sponsored trials sarilumab nct<NUMBER> tocilizumab nct<NUMBER> patients severecritical covid<NUMBER> underway however exclude critically ill patients requiring vasopressors therefore address question whether agents  covid<NUMBER> appears hypercoagulable state leading microvascular thrombosis feature distinct hypercytokinemia syndromes  therapies targeting specific cytokines common inflammatory signalling pathways demonstrated benefit hlh imcd cart crs well tolerated contexts role covid<NUMBER> css active investigation  pragmatic definition covidcss likely require combination clinical criteria fever hypotension critical illness widely available laboratory parameters crp ferritin ddimer well novel biomarkers il<NUMBER> il<NUMBER> cytokines immunophenotyping hlh hemophagocytic lymphohistiocytosis cart cell chimeric antigen receptor cell crscytokine release syndrome icans immune effector cellassociated neurotoxicity syndrome imcd idiopathic multicentric castleman disease covidcss coronavirus disease <NUMBER> associated cytokine storm syndrome ebv epsteinbarr virus cmv cytomegalovirus ardsacute respiratory distress syndrome considerable associated illness leading death transformed critical global public health issue current clinical investigation patients covid<NUMBER> showed strong upregulation cytokine interferon production critical infection sarscov<NUMBER>induced pneumonia current research suggests groups patients covid<NUMBER> might cytokine storm syndrome thus identification treatment hyperinflammation using existing approved therapies proven safety profiles address immediate need reduce rising mortality date specific therapeutic drug vaccine discovered treat covid<NUMBER> intensive research progress identify promising drug therapy hence several options proposed control fastemerging pandemic including antiviral drugs vaccines smallmolecules monoclonal antibodies oligonucleotides peptides interferons ifns covid<NUMBER> pathogenesis covid<NUMBER> caused sarscov<NUMBER> virus potentially fatal disease represents great global public health concern virus infects lower respiratory tract cause pneumonia human seems symptoms milder sars mers <NUMBER> much information mortality pathobiology cellular responses disease known probable course events postulated based past studies sarscov based cells likely infected j u r n l p r e p r f sarscov<NUMBER> infection roughly divided three stages asymptomatic phase without detectable virus ii nonsevere symptomatic upper airway conducting airway response iii hypoxia ground glass infiltrates progression acute respiratory distress syndrome ards high viral load correspond different clinical stages disease fig <NUMBER> <NUMBER> coronaviruses genome encodes four major proteins spike nucleocapsid n membrane envelope e protein helps viral entry target cell body research shown <NUMBER> percent covid<NUMBER> genome sarscov genome however amino acid residues needed receptor binding two viruses also suggests entry receptor ace<NUMBER> used sarscov sarscov<NUMBER> well <NUMBER> study published lancet shows ards main death cause covid<NUMBER> causing common immunopathological event sarscov<NUMBER> sarscov merscov infections <NUMBER> one main mechanisms ards cytokine storm deadly uncontrolled systemic inflammatory response resulting release large amounts proinflammatory cytokines chemokines immune effector cells sarscov infection <NUMBER> significantly high blood levels cytokines chemokines also noted patients covid<NUMBER> infection included il<NUMBER>β il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> basic fgf<NUMBER> gcsf gmcsf ifnγ ip<NUMBER> mcp<NUMBER> mip<NUMBER>α mip<NUMBER>β pdgfb tnfα vegfa severe cases admitted intensive care unit showed high levels proinflammatory cytokines including il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>α tnfα reasoned j u r n l p r e p r f promote disease severity <NUMBER> cytokine storm trigger violent attack immune system body cause ards multiple organ failure finally lead death severe cases sarscov<NUMBER> infection like occurs sarscov merscov infection <NUMBER> patients infected covid<NUMBER> showed higher leukocyte numbers abnormal respiratory findings increased levels plasma proinflammatory cytokines main pathogenesis covid<NUMBER> infection respiratory system targeting virus severe pneumonia rnaaemia combined incidence groundglass opacities acute cardiac injury <NUMBER> covid<NUMBER> cytokine storm actually refers phenomenon caused sarscov<NUMBER> infection replication variety cytokines body fluids rapidly produced viral infections triggering suicide attack human immune system fig <NUMBER> <NUMBER> direct cause death acute covid<NUMBER> sarscov<NUMBER> destroy human immune mechanism trigger excessive immunity causing cytokine storm moreover cytokine storm damages lungs multiple organs human body like heart kidney liver eventually leading multiple organ functions exhaustion <NUMBER> <NUMBER> studies shown sarscov<NUMBER> enters cells angiotensinconverting enzyme <NUMBER> ace<NUMBER> reason lung tissue become main invasion target sarscov<NUMBER> high expression ace<NUMBER> virus entered lung immune system sent large number immune cells lung tissue kill virus formed pneumonia patient showed fever cough difficulty breathing <NUMBER> however immune cells cannot locate virus accurately recognizing attack j u r n l p r e p r f indiscriminately recruit immune cells kill virus cytokine storm formed immune system may able kill virus certainly kill large number normal cells lung seriously damage function lung <NUMBER> <NUMBER> cytokine release syndrome crs seems affect patients severe conditions since lymphocytopenia often seen severe covid<NUMBER> patients crs caused sarscov<NUMBER> virus mediated leukocytes cells patients receiving cart therapy high wbccount common suggesting association lymphocytopenia differential diagnostic criterion covid<NUMBER> <NUMBER> one caveat mscs need activated ifnγ exert antiinflammatory effects may absent severely affected patients cells well activated sarscov<NUMBER> infection enhance effectiveness one could consider employing licensingapproach pretreat mscs ifnγ withwithout tnf il<NUMBER> <NUMBER> cytokinelicensed mscs could effective suppression hyperactive immune response promotion tissue repair licensedmscs effective lpsinduced acute lung damage <NUMBER> lung damage major hurdle recovery severe patients producing various growth factors mscs may help repair damaged lung tissue important mention various studies shown animal models bleomycininduced lung injury vitamin b<NUMBER> niacin nicotinamide highly effective preventing lung tissue damage <NUMBER> present specific drug therapy proven safe effective treating covid<NUMBER> food drug administration fdaapproved drugs specifically treat patients covid<NUMBER> although reports appeared medical literature lay press claiming successful treatment patients covid<NUMBER> variety agents definitive clinical trial data needed identify optimal treatments disease chemical agents previously used treat sars mers used potential candidates treat covid<NUMBER> number drugs combinational therapies identified using previously approved drugs could inhibit clathrinmediated endocytosis targeting viral protease regulating immunity inhibiting inflammatory cytokine surge improving pulmonary function reducing lung viral loads inhibitor host cell serine protease angiotensin receptor blockers lower risk acute respiratory distress syndrome ards death thereby inhibit viral infection cells table <NUMBER> also treatments covid<NUMBER> cytokine storm primarily focus antishock therapy include drugs targeting interleukin<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> interferongamma <NUMBER> randomized trials needed confirm therapeutics effectively treat covid<NUMBER>infected patients cytokine storm syndrome il<NUMBER> blockade recently reported use china successful outcomes individuals receiving part treatment <NUMBER> working prevent future outbreaks deadly coronavirus infections vaccine development discovering new repurposed antiviral medicines treat virus must also use knowledge disposal treat patients risk dying including covid<NUMBER>induced cytokine storms financial interests related review represent conflict interest j u r n l p r e p r f table <NUMBER> combinational remedies drugs potential targets covid<NUMBER> thalidomide glucocorticoids sarscov<NUMBER> regulating immunity inhibiting inflammatory cytokine surge <NUMBER> remdesivir ifna<NUMBER> improves pulmonary function reduce lung viral loads <NUMBER> chloroquine hydroxychloroquine sarscov<NUMBER> regulating immunomodulatory effects attenuation cytokine production inhibition autophagy <NUMBER> lopinavir ritonavir hiv merscov sarscov<NUMBER> inhibitor inhibits <NUMBER>clpro <NUMBER> lopinavir oseltamivir ritonavir targeting viral protease <NUMBER> lopinavir ritonavir interferon beta slightly reduces viral loads improving pulmonary function <NUMBER> convalescent plasma sarscov<NUMBER> inhibits virus entry target cells suppress viraemia <NUMBER> hydroxychloroquine azithromycin sarscov<NUMBER> viral load reduction inhibition replication <NUMBER> camostat mesilate hydroxychloroquine sarscov<NUMBER> inhibitor host cell serine protease angiotensin receptor blockers <NUMBER> darunavir umifenovir sarscov<NUMBER> viral load reduction inhibition replication <NUMBER> ribavirin interferonα sarscov<NUMBER> lower risk acute respiratory distress syndrome ards death <NUMBER> hydroxychloroquine nitazoxanide sarscov<NUMBER> adjuvant therapy covid<NUMBER> <NUMBER> fig <NUMBER> covid<NUMBER> pathogenesis phases potential therapeutic targets modified adopted siddiqi mehra <NUMBER> <NUMBER> j u r n l p r e p r f covid<NUMBER> named sarscov<NUMBER> spreading wuhan china spread globally rapidly <NUMBER> reported covid<NUMBER> viral genome <NUMBER> identity genome pathophysiology mechanisms sarscov <NUMBER> covid<NUMBER> infection affecting agegroups appears severe elderly adults <NUMBER> seems high proinflammatory cytokine release described cytokine storm pivotal pathophysiological mechanism elderly covid<NUMBER> patients <NUMBER> aging related increased levels systemic proinflammatory cytokines decreased levels systemic antiinflammatory cytokines hence chronic condition inflammation may created aged subjects known inflammaging <NUMBER> <NUMBER> ample studies indicated elevated levels interleukin il<NUMBER> il<NUMBER> tumor necrosis factorα tnf α well creactive protein crp aged subjects <NUMBER> <NUMBER> although exact underlying mechanism cytokine storm elderly adults severe covid<NUMBER> infection far clear however likely dysregulation cytokine homeostasis inflameaging phenomenon may play critical role risk cytokine storm subsequently acute respiratory distress syndrome ards elderly patients severe covid<NUMBER> infection seems cytokine storm phenomenon elderly patients severe covid<NUMBER> infection associated many agerelated pathophysiologic processes including alteration angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor expression <NUMBER> excess ros production <NUMBER> alteration autophagy <NUMBER> inflammatory phenotype senescent cell activity particularly adipose tissue <NUMBER> immunesenescence <NUMBER> well lack vitamin content <NUMBER> going review discuss mentioned agerelated pathophysiological pathways appear contribute dysregulation cytokine networks possibly cytokine storm elderly patients severe covid<NUMBER> infection shown covid<NUMBER> infection distinctive behavior among elderly adults severe infection compared children young adults none mild infection indeed covid<NUMBER> infection induce severe infection including pneumonia ards elderly adults sick patients children young adults <NUMBER> reason deadly cases covid<NUMBER> mainly seen elderly patients first going review compare possible pathophysiology mechanisms mild infection severe infection young elderly adults covid<NUMBER> respectively despite increasing evidences immune response pathogens however less known exact immunologic mechanism covid<NUMBER> infections shown fig <NUMBER> initiation immune response invading coronavirus begins direct infection bronchi bronchiole epithelium first antigenindependent innate immunity provides first line leukocytes defense microorganisms innate immune defense involves several cell types including leukocytes neutrophils eosinophils basophils monocytes macrophages lung epithelial cells mast cells natural killer nk cells <NUMBER> following initial covid<NUMBER> infection lungresident dendritic cells dcs become activated change antigenpresenting cells apcs indeed apcs first line defense recognizing various pathogens lung dcs resides airway epithelium alveolar septa pulmonary capillaries airway spaces <NUMBER> activated apcs ingests processes antigen migrate lymph nodes lymph nodes apc presents antigen form mhcpeptide complex naïve circulating helper cells th<NUMBER> inducing immune response <NUMBER> following activation th<NUMBER> receptor mhcpeptide complex helper cells become activated proliferate differentiated cd<NUMBER> helper lymphocytes cd<NUMBER> cytotoxic lymphocytes cells cd<NUMBER> th lymphocytes differentiated th<NUMBER> th<NUMBER> different cytokine profiles <NUMBER> th<NUMBER> cells drive cellular immunity released proinflammatory cytokines ifnγ il<NUMBER>β il<NUMBER> tnfα <NUMBER> reported cytokine ifnγ inhibit viral replication enhance antigen presentation <NUMBER> th<NUMBER> cells activated humoral immunity antibody production released antiinflammatory cytokines tgfβ il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER> fact balanced th<NUMBER> th<NUMBER> lymphocyte activity observed healthy adults covid<NUMBER> infection furthermore cd<NUMBER> lymphocytes cytotoxic cells cytotoxic cells secrete cytotoxic molecules granzyme b kill infected epithelial cells indeed cd<NUMBER> lymphocytes natural killer cells nk play critical contribution viral clearance <NUMBER> b cell responses covid<NUMBER> observed systemic blood pool <NUMBER> week initiation covid<NUMBER> symptoms autopsy patient covid<NUMBER> identified accumulation mononuclear cells likely monocytes cells lungs low levels hyperactive cells peripheral blood findings suggested likely cells attracted away systemic blood pool infected site lung control covid<NUMBER> infection <NUMBER> generally activation different th cells release ample cytokines chemokines recruit innate cellmediated humoral immunologic responses control covid<NUMBER> adults additionally seems balance proinflammatory antiinflammatory immune responses healthy adult shut immune activity right moment <NUMBER> observed ards pneumonia multiorgan dysfunction main immuneclinical symptoms covid<NUMBER> infection well accepted ards pneumonia deadly cases due severe inflammatory responses immune system socalled cytokine storm <NUMBER> hand severe multiorgan destruction due cytokine storm rather direct damaging effect virus <NUMBER> noteworthy covid<NUMBER> pathogen reached alveoli elderly weak adults proinflammatory immune responses become vigorous uncontrollable active furthermore impaired antiinflammatory responses elderly adults may correlate increased activity proinflammatory responses <NUMBER> hence elderly adults severe covid<NUMBER> infection cannot shut proinflammatory immune response several studies reported patients severe covid<NUMBER> exhibit markedly increased serum levels proinflammatory cytokines including ifnα ifnγ il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfα gcsf gmcsf ip<NUMBER> creactive protein crp mcp<NUMBER> mip<NUMBER>α <NUMBER> <NUMBER> <NUMBER> necessary mention cytokines storm directly may lead immune cell death tissue damage respiratory shut <NUMBER> example autopsy findings aged subjects revealed spleen atrophy necrosis lymph node necrosis hemorrhage kidney hepatomegaly degeneration neurons central nervous system covid<NUMBER> patients number immune cells also changed covid<NUMBER> infection <NUMBER> <NUMBER> indeed patients severe covid<NUMBER> infection patients mild infection lymphopenia common feature significantly reduced numbers cd<NUMBER> cells cd<NUMBER> cells b cells nk cells furthermore exhaustion markers nkg<NUMBER>a receptors nk cells cd<NUMBER> cells upregulated patients covid<NUMBER> <NUMBER> <NUMBER> histochemical staining showed cd<NUMBER> cells cd<NUMBER> cells decreased spleen lymph nodes addition lung characteristic diffused alveolar damage major infiltrated cells monocytes macrophages lymphocytes <NUMBER> tian colleagues <NUMBER> using postmortem biopsies identified alveolar damage fibrosis heart myocardial hypertrophy also lobular infiltration liver small lymphocytes four died cases covid<NUMBER> <NUMBER> addition cytokine storm viral particles covid<NUMBER> also directly induce multiple organ dysfunctions viral particles covid<NUMBER> infection identified bronchial type <NUMBER> alveolar epithelial cells fecal urine samples <NUMBER> <NUMBER> <NUMBER> hence suggested multiple organ dysfunction severe covid<NUMBER> patients also cause direct attack virus far clear whether cytokine storm direct effects virus synergistic effects contribute multiple organ failures severe covid<NUMBER> patients <NUMBER> proliferate differentiated cells cd<NUMBER> helper lymphocytes cd<NUMBER> cytotoxic lymphocytes cells healthy adults due sufficient vitamin level vd decrease expression proinflammatory genes immune cells balanced proinflammatory antiinflammatory activity causes shut immune system right moment going review link cytokine storm elderly patients covid<NUMBER> inflameaging aging related elevated systemic levels proinflammatory cytokines including il<NUMBER> il<NUMBER> tnfα il<NUMBER> ifnγ well acute phase proteins ample studies reported chronic mild inflammation aging described inflameaging phenomenon promote ageassociated disorders including diabetes mellitus alzheimers disease atherosclerosis etc accordingly seems increased generation proinflammatory markers inflameaging critical role process cytokine storm severe covid<NUMBER> patients enhanced mortality risk <NUMBER> <NUMBER> shown fig <NUMBER> several factors including alteration ace<NUMBER> receptor expression excess reactive oxygen species ros production senescent adipocytes activity alteration autophagy mitophagy immunesenescent well vitamin vd deficiency may associate inflameaging cytokine storm elderly patients covid<NUMBER> reninangiotensin system ras important regulator several physiologic events including cardiovascular blood volume natriuresis diabetes chronic renal disease hepatic fibrosis <NUMBER> <NUMBER> system composed two different pathways including angiotensinconverting enzyme aceangiotensin ii ang iiangiotensin receptor type <NUMBER> at<NUMBER> aceang iiat<NUMBER> pathway angiotensinconverting enzyme <NUMBER> ace<NUMBER>ang <NUMBER>mas receptor ace<NUMBER>ang <NUMBER>mas pathway two pathways opposing effects accommodate coordinated response specific triggers activity aceang iiat<NUMBER> pathway related tissue injury inflammation fibrosis <NUMBER> contrast activity ace<NUMBER>ang <NUMBER>mas pathway exerts antiinflammatory antifibrosis effects <NUMBER> <NUMBER> ace<NUMBER> degrades ang ii major substrate ace<NUMBER> generates ang<NUMBER> <NUMBER> recently well accepted ace<NUMBER> lung epithelial cells entrypoint receptors covid<NUMBER> particles <NUMBER> demonstrated highest expression ace<NUMBER> lungs type ii alveolar epithelial cells kidney heart also vascular beds <NUMBER> yu colleagues <NUMBER> revealed ace<NUMBER>ang<NUMBER>mas pathway markedly suppressed pancreatitis inhibition p<NUMBER> mapknfκb signaling pathway <NUMBER> fu colleagues <NUMBER> transfected ace<NUMBER> plasmid primary cultured human retinal pigment epithelium cells hrpe followed stimulation amyloidβ aβ observed overexpression ace<NUMBER> markedly decreased aβinduced inflammatory response activating ace<NUMBER> ang<NUMBER>mas pathway hrpe <NUMBER> respiratory syncytial virus ace<NUMBER> protected severe lung injury children experimental mouse model addition ards model ace<NUMBER> knockout mice displayed severe symptoms respiratory shut compared fig <NUMBER> link inflameaging cytokine storm elderly adults severe covid<NUMBER> several agingrelated factors may associate chronic inflammation cytokine storm elderly patients covid<NUMBER> wildtype mice <NUMBER> indeed treatment strategy using ace<NUMBER> analogs vector containing ace<NUMBER> result beneficial effects diabetic nephropathy hypertension cardiac disease <NUMBER> specific inhibitors at<NUMBER> receptors losartan shown effective animal models septic shock therefore mentioned studies suggested ace<NUMBER> pathway antiinflammatory effects several studies identified agerelated decline ace<NUMBER> expression <NUMBER> <NUMBER> <NUMBER> example study xudong colleagues <NUMBER> revealed agerelated difference ace<NUMBER> expression revealed rat lung observed ace<NUMBER> expression significantly reduced aging suggesting elevated ace<NUMBER> young adults compared age groups may contribute predominance sars attacks age group <NUMBER> using gtex gene expression data analysis chen colleagues <NUMBER> found markedly higher expression ace<NUMBER> asian females compared males furthermore found agedependent decline ace<NUMBER> expression also highly significant decrease type ii diabetic patients additionally established negative correlation ace<NUMBER> expression covid<NUMBER> fatality interestingly severe cases many vital tissues including little ace<NUMBER> expressed severely damaged covid<NUMBER> infection <NUMBER> evidences may partially suggest increase concentration ace<NUMBER> receptors lung epithelial cells children young adults may protective effect severe clinical manifestations due covid<NUMBER> infection therefore highly likely low ace<NUMBER> expression unbalance ang iiang<NUMBER> level aging lead cytokine storm lung shut <NUMBER> <NUMBER> however genetic basis ace<NUMBER> expression function different individuals still far clear <NUMBER> well accepted ros considered signaling molecule low concentrations also mediator inflammation high concentrations <NUMBER> main sources ros mitochondrial respiratory chain nadph oxidase <NUMBER> garrido colleagues <NUMBER> identified immune cells prematurely aging mice presented lower values antioxidant defenses higher values ros proinflammatory cytokines <NUMBER> hence suggested excess ros production aging turn inflammatory machine subsequently increased release proinflammatory cytokines including tnfα il<NUMBER>β il<NUMBER> il<NUMBER> adhesion molecules excess ros production aging initiate proinflammatory generation activation multiple transcription factors including human polynucleotide phosphorylase hpnpaseold<NUMBER> nuclear factor kappa b nfκb activator protein <NUMBER> ap<NUMBER> specificity protein <NUMBER> sp<NUMBER> peroxisome proliferatoractivated receptors ppars <NUMBER> <NUMBER> example reported hpnpaseold<NUMBER> upregulated senescence may promote activation nfκb pathway initiates production proinflammatory cytokines il<NUMBER> il<NUMBER> <NUMBER> furthermore expression hpnpaseold<NUMBER> induces ros production suggests hpnpaseold<NUMBER> could upstream signaling molecule increased ros generation subsequent proinflammatory cytokines aging addition hpnpaseold<NUMBER> nfκb also important transcription factor upregulated aging excess ros production resting states inhibitory protein ikb inactivated nfκb cytoplasm however ros production phosphorylate inhibitory ikb proteins leading nuclear translocation nfκb regulation gene transcription activated nfκb initiate secretion release proinflammatory cytokines including tnfa il<NUMBER> il<NUMBER> il<NUMBER> ifng inos cox<NUMBER> <NUMBER> interestingly excess ros production increase proinflammatory cytokines proinflammatory cytokines also increase ros production <NUMBER> instance identified proinflammatory cytokine il<NUMBER> increase ros generation increased expression nadph oxidase<NUMBER> lung cancer <NUMBER> additionally demonstrated proinflammatory cytokine interferonγ proinflammatory component bacterial cell wall lipopolysaccharide synergistically increase ros generation human pancreatitis nfκbdependent expression duox<NUMBER> member nadph oxidase family <NUMBER> hence excess ros production inflammation closely related taking part pathogenesis chronic inflammation inflameaging elderly adults autophagy conserved catabolic turnover pathway eukaryotic cells cellular material delivered lysosomes degradation autophagy process related maintenance cellular homeostasis dysregulation could lead development several agingrelated pathophysiological diseases <NUMBER> shown autophagy process decrease aging leads accumulation damaged macromolecules organelles decline autophagy aging induce dysfunctional mitochondria subsequent increased ros production <NUMBER> mitochondria major source ros context two major processes protection harmful effects ros including mitophagy antioxidant capacity one hand mitophagy characterized autophagic degradation mitochondria decreased aging <NUMBER> hand decreased mitophagy together decreased antioxidant capacity aging increased ros levels body excess production ros stress condition leading memory deficits anxietylike behavior increase proinflammatory cytokine secretion aging <NUMBER> <NUMBER> <NUMBER> <NUMBER> although exact underlying mechanism decline autophagy rise ros levels aging elevate proinflammatory cytokine release far clear however well accepted low activity autophagy process high level ros production aging activate upregulate nodlike receptors nlrs <NUMBER> nlrs type intracellular patternrecognition receptors prrs pathogen recognition monitor inflammation apoptosis signaling pathways receptors expressed many cell types including immune cells lymphocytes macrophages dendritic cells even epithelial cells <NUMBER> observed activation cytosolic nlrs increased aging many agerelated diseases type <NUMBER> diabetes mellitus example ebersole colleagues study <NUMBER> identified expression nlrs increased aging healthy oral mucosa <NUMBER> additionally luan colleagues <NUMBER> found nlrp<NUMBER> expression increased concanavalin ainduced hepatitis model autoimmune hepatitis <NUMBER> salminen colleagues <NUMBER> reported decrease autophagic capacity aging generates inflammatory situation means activation proinflammatory factors particular nlrp<NUMBER> <NUMBER> accepted nlrs activity increase expression caspase<NUMBER> proinflammatory cytokines including il<NUMBER>β il<NUMBER> leading cell death fig <NUMBER> example nadatani <NUMBER> reported caspase<NUMBER> induce pyroptosis unique form programmed cell death conversion proil<NUMBER>β proil<NUMBER> fig <NUMBER> role alteration mitophagy inflameaging subsequent cytokine storm elderly adults decline mitophagy aging increased ros production one hand excess ros production activate upregulate intracellular nodlike receptor type <NUMBER> nlr<NUMBER> nlrs overactivity increase expression caspase<NUMBER> proinflammatory cytokines including il<NUMBER>β il<NUMBER> leading pyroptosis cell death immune cells hand excess ros production increase proinflammatory molecules release activation multiple transcription factors including human polynucleotide phosphorylase hpnpaseold<NUMBER> nuclear factor kappa b nfκb activator protein <NUMBER> ap<NUMBER> specificity protein <NUMBER> sp<NUMBER> peroxisome proliferatoractivated receptors ppars active forms promotes inflammation pyroptosis dying cells release cytoplasmic proinflammatory contents extracellular fluid <NUMBER> similarly wangs colleagues revealed treatment acyvadcmk inhibitor nlrp<NUMBER>caspase<NUMBER> suppressed isofluraneinduced microglial inflammatory response aged mice <NUMBER> finding critical study supporting nlrp<NUMBER>caspase<NUMBER> pathway involved pathophysiology chronic inflammatory disease elderly adults fig <NUMBER> furthermore stranks <NUMBER> found macrophages aged mice exhibit markedly reduced autophagic flux compared young mice also reported reduced autophagy aging increased macrophage populations phagocytosis function decreased surface antigen expression increased inflammatory cytokine response <NUMBER> additionally animal model studies increase autophagy means caloric restriction also exercise result downregulation il<NUMBER>β production improve agingrelated proinflammatory profile seems crosstalk decline mitophagy pathways elevated ros level aging imbalance immune system activity elderly adults <NUMBER> senescent cells accumulate aging many animal human tissues leading chronic inflammation organ dysfunction <NUMBER> senescent cells lower cell viability well insufficient protection oxidative stress <NUMBER> additionally senescent cells release proinflammatory cytokines including il<NUMBER>α il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> ccl<NUMBER> tnfα granulocyte macrophages colonystimulating factor gmcsf growth regulated oncogene gro monocyte chemotactic protein mcp<NUMBER> mcp<NUMBER> mmp<NUMBER> mmp<NUMBER> <NUMBER> <NUMBER> immune effector main source inflammatory markers aging studies revealed importance adipose tissue inflammation aged animals elevated release interleukin <NUMBER> il<NUMBER> il<NUMBER>β well tnfα <NUMBER> <NUMBER> <NUMBER> adipose tissue dynamic structure plays important contribution modulating metabolism inflammation highly likely adipose tissue dysfunction instance obesity aging associated chronic inflammation aged subjects <NUMBER> petrakis colleagues <NUMBER> reported agerelated obesity leading increased susceptibility serious complications covid<NUMBER> compared younger individuals obese covid<NUMBER> patients adipose tissue interacts immune system increased lethality infection fat tissueassociated cytokines adipokines release adipocytes released amyloida adipokine act directly macrophages increased generation proinflammatory cytokines mortality rate young adults covid<NUMBER> normal body mass index approximately <NUMBER> however mortality rate obese elderly adults covid<NUMBER> approximately <NUMBER> <NUMBER> addition obesity covarrubias colleagues found aging senescent cells significantly accumulate visceral white adipose tissue inflammatory cytokines found supernatant senescent cells induced macrophages proliferate express cd<NUMBER> cell activation marker <NUMBER> alicka colleagues <NUMBER> found adiposederived stem cells older groups exhibited increased gene expression proinflammatory gene mirnas il<NUMBER> il<NUMBER>β tnfα mir<NUMBER>b<NUMBER>p mir<NUMBER>p apoptosis markers p<NUMBER> p<NUMBER> caspase<NUMBER> caspase<NUMBER> <NUMBER> ghosh colleagues <NUMBER> reported decreased autophagy activity aging associated increased adipose tissue er stress inflammation old adipose tissuederived stromal vascular fraction cells svfs mice also revealed accumulation autophagy substrates lc<NUMBER>ii p<NUMBER> increased old svfs implicated impaired autophagy activity furthermore reported old svfs reduced expression autophagy markers also analyzed decreased autophagy activity old svfs correlated increased secretion proinflammatory cytokines including il<NUMBER> mcp<NUMBER> <NUMBER> therefore elevated release proinflammatory cytokines senescence adipocytes possibly leads elevated risk cytokine storm covid<NUMBER> infection poor prognosis patients progressive age function innate adaptive immune system undergoes physiological morphological alteration throughout lifetime characterized immunesenescence <NUMBER> <NUMBER> indeed immunesenescence described progressive loss immune effectors innate cellmediated immune systems aging <NUMBER> normal physiologic immunity depends effective crosstalk innate adaptive immune systems senescent immune effectors markedly impact health elderly individuals <NUMBER> going briefly report agerelated alteration innate adaptive immune cells macrophages central effector cells innate immune system many physiological functions <NUMBER> macrophage produce several protnfα il<NUMBER> il<NUMBER> antiinflammatory il<NUMBER> tgfβ acute phase proteins glucocorticoids molecules enzymes growth factors nitric oxide toxic reactive radicals metalloproteinases inhibitors metalloproteinases clearance pathogens proceeds antiinflammatory effectors macrophages turn macrophage inflammatory activities <NUMBER> therefore pathogeninduced inflammatory episode balance macrophage modulating secretion present tissues aging generation several macrophageinduced factors reduced including fibroblast growth factor vascular endothelial growth factor epithelial growth factor tgfβ toxic free radicals expression nitric oxide synthase additionally phagocytic chemotactic activity macrophages also decreased decline production macrophagespecific chemokines including macrophage inflammatory protein mip<NUMBER> mip<NUMBER> advanced age macrophages also display antigenpresenting activity expressing major histocompatibility class mhc leading crosstalk innate cellmediated immune system reported progressive age expression mhcii decreased mice humans <NUMBER> <NUMBER> natural killer nk cells another cytotoxic effector innate immune system involved early fast faster cells defense virus infection challengers <NUMBER> nk cells macrophages linking innate cellmediated immune system nk cells regulate immune function generation release various cytokines <NUMBER> increase numbers circulating nk cells reported aging <NUMBER> one important cytokines cytotoxic activity nk cells il<NUMBER> increases killing properties proliferation nk cells healthy young individual il<NUMBER> induce ifn secretion nk cells effect decreased elderly <NUMBER> furthermore aging change nk cells phenotypes increase cd<NUMBER> dim cells decrease cd<NUMBER> bright cells addition aging increase expression immunesenescence marker cd<NUMBER> nk cell populations <NUMBER> dendritic cells dcs another component innate immune system critical role immunity tolerance resident dcs immature capture pathogens converts mature form known antigenpresentation cells apcs upregulation mhc expression mature apcs monitor th<NUMBER> th<NUMBER> function contrast immature dcs induce tolerance selfantigens <NUMBER> physiological condition dcs take selfantigen apoptotic cells transport lymph nodes <NUMBER> migration presentation pathogens th<NUMBER> cells undergo several phenotype alterations including upregulation mhc class ii molecules downregulation adhesion molecules <NUMBER> furthermore dcs generate release various cytokines modulate inflammatory responses <NUMBER> reported increased agerelated proinflammatory cytokines induce activation maturation dcs panda colleagues <NUMBER> identified increase proinflammatory cytokines released dcs elderly adults <NUMBER> moreover activity dcs elderly adults higher young individuals <NUMBER> ageing also accompanied profound consistent alterations tcell immunity <NUMBER> although tcell numbers diminish aging however tcell pool exhibit potent agerelated alterations including poor tcell mitogen responses inverted cd<NUMBER>cd<NUMBER> tcell ratio reduced proportion naive cells well increased proportion memory cells older animals human <NUMBER> additionally aging related overproduction proinflammatory cytokines cells leading immune pathology <NUMBER> cd<NUMBER>cd<NUMBER>− subset cells expanded memory cell population shortened telomeres suggesting longer reflective history <NUMBER> humans almost cells express cd<NUMBER> birth proportion cd<NUMBER> declines age <NUMBER> <NUMBER> increase cells observed consistently used prognostic indicator immunesenescence older populations <NUMBER> demonstrated aging also changes cytokine profile th<NUMBER> cells il<NUMBER> il<NUMBER> rather th<NUMBER> type il<NUMBER> ifng leading mild agerelated inflammation elderly adults aging also potentially affect th cells pool ratio th<NUMBER> cells regulatory cells increased aging leading basal inflammatory state elderly adults <NUMBER> th<NUMBER> cells proinflammatory phenotype balance tregulatory antiinflammatory cells cells derived common precursor th<NUMBER> <NUMBER> regulatory cells subset characterized high expression cd<NUMBER> foxp<NUMBER> transcriptional factor function differentiation regulatory cells <NUMBER> addition antiinflammatory effects regulatory cells also recognize selfantigens <NUMBER> furthermore ageing correlated disruption lymphocyte telomerase upregulation <NUMBER> accepted shortened lymphocyte telomeres associated variety ageassociated pathologies <NUMBER> furthermore aging naïve tcells show multiple alterations including shortening telomeres reduced production il<NUMBER> diminished ability differentiate effectorcells loss number function naïve tcells increasing cd<NUMBER> cd<NUMBER>ro cd<NUMBER> clones aged subjects <NUMBER> cd<NUMBER>cells responsible production proinflammatory cytokines resistant apoptosis proposed undergoing cells senescence due shortening telomeres reduction proliferative capacity <NUMBER> interestingly proinflammatory cytokines also implicated ageassociated alterations tcell immunesenescence indeed inflammatory conditions elderly adults lead alterations tcell immunity instance agerelated increased cytokine tnfα potent stimulator tcd<NUMBER> cell senescence tcell differentiation <NUMBER> humoral immunity mediated b lymphocytes critical role modulation adaptive immunity responses b lymphocytes produce different types antibodies eliminating challengers additionally b lymphocytes important role immune system presentation antigens secretion cytokines <NUMBER> b lymphocytes arising hematopoietic stem cells bone marrow prob lymphocytes differentiate preb b lymphocytes <NUMBER> ample studies identified aging accompanied quantitative qualitative alteration b lymphocyte pool <NUMBER> number b lymphocytes levels serum immunoglobulin antibody analyzed aging hematopoietic stem cells bone marrow aged mice less effective generating b lymphocytes compared young mice number size germinal centers b lymphocytes also decreased aging production precursor b lymphocytes bone marrow number prob preb lymphocytes decreased aged mice human <NUMBER> shown aged prob lymphocytes havean impaired ability respond il<NUMBER> also human naïve igm memory b lymphocytes impaired aging <NUMBER> percentage igm memory b lymphocytes markedly decreased however total numbers b lymphocytes decreased additionally antibody level decreased aged subjects addition affinity protective ability antibodies aged mice decreased compared young mice <NUMBER> <NUMBER> also reported immune response influenza old mice less igg level young mice also young mice mostly igg<NUMBER> plasma level highaffinity antibody contrast aged mice mostly igm plasma cells <NUMBER> hence antigenspecific antibody responses decline old mice decreased function b lymphocytes antigenspecific antibody response antibody affinity aging attributed lack th function function b lymphocytes tdependent <NUMBER> <NUMBER> taken together immunesenescence alterations cannot properly fit cellmediating humeral immune response elderly adults immune system appears maintain mild inflammatory state elderly adult therefore suggested fragile mildly overactive immune system elderly adults cannot turn proinflammatory machine covid<NUMBER> infection clinical findings severe patients covid<NUMBER> infection consistent mention literature several manifestations including lymphopenia reduced numbers cd<NUMBER> cells cd<NUMBER> cells b cells natural killer nk cells monocytes eosinophils basophils reported severe patients covid<NUMBER> infection <NUMBER> schouten colleagues <NUMBER> identified increasing proinflammatory cytokines aging also correlated severity ards may partially explain agedependent difference <NUMBER> vd together vitamin receptor vdr classical functions bone calciumphosphorus homeostasis nonclassical function antiinflammatory immuneregulatory function <NUMBER> <NUMBER> vdr expressed several types immune cells including monocytes macrophages b lymphocytes well dcs <NUMBER> additionally α<NUMBER>hydroxilase enzyme converts inactive metabolite vd <NUMBER>oh d<NUMBER> active form <NUMBER>oh<NUMBER>d<NUMBER> expressed majority immune cells macrophages <NUMBER> liu colleagues <NUMBER> reported expression vdr α<NUMBER>hydroxylase increased macrophages following exposure pathogen <NUMBER> finding suggested intracrine immuneregulatory function vd shown fig <NUMBER> vd decrease expression proinflammatory genes tnfα il<NUMBER> monocyte chemotatic protein<NUMBER> mcp<NUMBER> il<NUMBER>β immune cells suppressing excessive ros production increasing intracellular glutathione levels suppressing nfκb p<NUMBER> map kinase expression excess ros production increase nfkb expression immune cells leading excess secretion proinflammatory cytokines including tnfa il<NUMBER> il<NUMBER> il<NUMBER> ifng inos cox<NUMBER> <NUMBER> activation p<NUMBER> map kinase pathway also increase il<NUMBER> mcp<NUMBER> generation immune cells stimulation signal transducer activator transcription<NUMBER> stat<NUMBER> <NUMBER> seems pathogen challengers turn macrophages stimulation pprs tlr<NUMBER>or nlrs activation tlrs nlr increase intracellular vdr α<NUMBER>hydroxylase expression complex vd vdr together decrease proinflammatory cytokines increase autophagy activity macrophages antimicrobial product generation including cathelicidin βdefensin macrophages <NUMBER> addition immune regulatory effects vd macrophages also suppress differentiation migration human dcs decrease expression mhcii dcs characterized tolerogenic properties <NUMBER> <NUMBER> tolerogenic dcs increase number il<NUMBER> producing cd<NUMBER> tcells regulatory cells elevated circulating cd<NUMBER> regulatory antiinflammatory functions also attenuated inflammatory response teffector cells tolerogenic actions dcs mediated increased expression foxp<NUMBER> transcription factor <NUMBER> furthermore vd also make complex vdr lymphocytes leading suppression proliferation hoe colleagues <NUMBER> reported vd markedly decreased proinflammatory cytokines tnfα ifnγ il<NUMBER>β il<NUMBER> ifnγ response bacterial ligands exposure vd also increased level antiinflammatory cytokine il<NUMBER> <NUMBER> hence vd modulate innate adaptive immune responses elderly adults risk vd deficiency due several factors including decreased prevd production poor skin integrity decreased dietary intake vd increasing adiposity obesity decreased renal function well less time spent outdoors <NUMBER> vd deficiency linked various agingrelated inflammatory diseases including rheumatoid arthritis asthma inflammatory bowel disease multiple sclerosis cardiovascular disease hypertension diabetes mellitus cancer <NUMBER> additionally correlation vd deficiency risk respiratory tract infection covid<NUMBER> <NUMBER> example ilie colleagues <NUMBER> examine association mean levels vd <NUMBER> european countries morbidity mortality caused covid<NUMBER> analysis data identified negative correlations mean levels vd average <NUMBER> mmoll country number covid<NUMBER> cases addition negative correlation observed mean levels vd mortality covid<NUMBER> cases also reported vd levels severely low aging population especially spain italy switzerland vulnerable countries relation covid<NUMBER> <NUMBER> additionally ebadi montanoloza <NUMBER> reported vd suppress expression proinflammatory markers including il<NUMBER>α il<NUMBER>β well tnfα therefore vd deficiency aging related overexpression th<NUMBER> cytokines also reported <NUMBER> patients covid<NUMBER> <NUMBER> mortality covid<NUMBER> observed africanamerican population chicago greater risk vd deficiency <NUMBER> reports polymorphism vdr gene including polymorphisms foki apai taqi associated vd deficiency increased risk inflammatory diseases <NUMBER> hence vd vdr pathway together important antiinflammatory function fig <NUMBER> role vitamin content proinflammatory cytokine release young elderly adults covid<NUMBER> infection following exposure covid<NUMBER> particles young adults sufficient vitamin content increasing intracellular glutathione levels suppressing excessive ros production suppressing nfκb nuclear factor kappa b p<NUMBER> map kinase expression contrast vitamin deficiency elderly adults leads overactivity p<NUMBER> map kinase stat signal transducers activator transcription ros nfκb pathways immune cells elderly adults severe covid<NUMBER> infection cannot turn proinflammatory immune machine immune effectors decreasing proinflammatory cytokine generation increasing antiinflammatory cytokines immune cells furthermore lack vd aged subjects associated proinflammatory phenotype immune cells leading likely increasing risk elderly adults chronic mild inflammation condition <NUMBER> chronic inflammatory condition likely leads cytokine storm elderly covid<NUMBER> patients summary seems young adults balanced proinflammatory antiinflammatory cytokine networks fig <NUMBER> therefore balanced immune system limit progression covid<NUMBER> infection however elderly patients balanced immune response young adults shown fig <NUMBER> advancing age immune system appears maintain condition mild inflammation activation body pathogens covid<NUMBER> infection exaggeratedly increase amplitude immune response known cytokine storm mentioned alteration ace<NUMBER> receptor expression oxidative stress adipose tissueand immunesenescent cell activity lack vd content well decrease autophagy mitophagy may contribute high amplitude immune response external challengers elderly adults high amplitude immune response elderly adults favor induction cytokine storm death severe critical cases covid<NUMBER> infection nevertheless covid<NUMBER> infection deadly elderly patients aging process dependent several markers including genes coronaviruses common human mammalian positivestrand rna viruses <NUMBER> december <NUMBER> new strain coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> identified pathogenic cause coronavirus disease <NUMBER> covid<NUMBER> april <NUMBER> <NUMBER> <NUMBER> confirmed cases <NUMBER> deaths covid<NUMBER> worldwide <NUMBER> although patients covid<NUMBER> experience mildtomoderate disease approximately <NUMBER> progress severe pneumonia <NUMBER> develop acute respiratory distress syndrome ards septic shock andor multiple organ failure rapidly lead death <NUMBER> vaccines specific antiviral treatments yet proven effective covid<NUMBER> current clinical management consists palliative treatments organ support moribund patients understanding immunopathologic mechanism appropriately targeting key pathways involved potential minimize pulmonary immune injury mortality following infection sarscov<NUMBER> binds alveolar epithelial cells activates innate adaptive immune responses <NUMBER> cd<NUMBER> cd<NUMBER> cells play important role balancing adaptive immune response pathogens potential development autoimmunity excessive inflammation <NUMBER> activation cytotoxic cd<NUMBER> cells vital clearing virus infected cells also induces immune injury tissues <NUMBER> hand rapidly activated cd<NUMBER> cells become pathogenic helper <NUMBER> cells generate proinflammatory cytokines chemokines <NUMBER> marked production cytokines chemokines leads recruitment lymphocytes leukocytes site infection however massive release cytokines occur part positive feedback loop associated immune response amplification resulting cytokine release syndrome cytokine storm <NUMBER> j u r n l p r e p r f journal preproof cytokine storm appears common manifestation severe covid<NUMBER> compared healthy controls patients covid<NUMBER> experienced elevated plasma levels interleukin il<NUMBER>β il<NUMBER>rα il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> granulocyte colony stimulating factor gcsf granulocytemacrophage colonystimulating factor gmcsf interferon gamma ifnγ interferon gammainduced protein <NUMBER> ip<NUMBER>cxcl<NUMBER> monocyte chemotactic protein<NUMBER> mcp<NUMBER> macrophage inflammatory protein mip<NUMBER>α plateletderived growth factorbb mip<NUMBER>β basic fibroblast growth factor tumor necrosis factor alpha tnfα vascular endothelial growth factor <NUMBER> furthermore patients admitted intensive care unit higher plasma levels il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>α tnfα compared patients require critical care high levels proinflammatory cytokines lead massive immune cell infiltration lungs patients covid<NUMBER> resulting alveolar damage decreased lung function rapid progression death <NUMBER> <NUMBER> indeed respiratory failure ards leading cause mortality associated covid<NUMBER> <NUMBER> among cytokines implicated covid<NUMBER>associated cytokine storm several signal predominantly via janus kinase jaksignal transducer activator transcription stat pathway il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> ifnγ gcsf gmcsf dependent jak<NUMBER> jak<NUMBER> furthermore ip<NUMBER> mcp<NUMBER> mip<NUMBER>α ifnγ dependent <NUMBER> <NUMBER> tnfα shown activate jakstat signaling tnf receptor <NUMBER>dependent manner <NUMBER> <NUMBER> data suggest jak inhibition could ameliorate hyperinflammatory state associated severe covid<NUMBER> ruxolitinib incb<NUMBER> selective inhibitor jak<NUMBER> jak<NUMBER> approved treatment myelofibrosis mf polycythemia vera steroidrefractory acute graftversusj u r n l p r e p r f journal preproof <NUMBER> host disease sragvhd <NUMBER> vitro pharmacology ruxolitinib studied using enzymes cellbased assays biochemical assays ruxolitinib demonstrated potent inhibition jak<NUMBER> jak<NUMBER> half maximal inhibitory concentration ic<NUMBER> values single digit nanomolar range table <NUMBER> <NUMBER> ruxolitinib consistently demonstrated robust inhibition jakstat signaling cellbased assays whole blood assays inhibition phosphorylated stat<NUMBER> following stimulation il<NUMBER> prototype cytokine signals effect ruxolitinib also evaluated major histocompatibility complexmismatch mouse model agvhd characterized significant upregulation inflammatory cytokines ifnγ tnfα il<NUMBER> peripheral blood fig <NUMBER> <NUMBER> ruxolitinib <NUMBER> mgkg bid treatment significantly reduced inflammatory cytokine milieu circulation differences j u r n l p r e p r f journal preproof <NUMBER> observed proportion peripheral cd<NUMBER> cd<NUMBER> cells groups treated ruxolitinib fig <NUMBER> detrimental effects donor engraftment alloreactive gvhd data consistent previous reports suggesting ruxolitinib immunomodulatory immunedepleting effects <NUMBER> <NUMBER> data supporting reduction cytokine burden emerged multiple clinical studies ruxolitinib mf type myeloproliferative neoplasm progressive cytopenias bone marrow fibrosis splenomegaly driven hyperinflammatory state <NUMBER> plasma levels proinflammatory cytokines including ifnα il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> well creactive protein intracellular adhesion molecule <NUMBER> vascular adhesion molecule <NUMBER> matrix metalloproteinase <NUMBER> significantly higher baseline patients mf compared healthy controls fig <NUMBER>a one cycle therapy ruxolitinib <NUMBER> days levels proinflammatory biomarkers decreased fig <NUMBER>b changes related jak<NUMBER> mutational status disease subtype indicating effects ruxolitinib patients mf reflective broad antiinflammatory effect addition constitutive phosphorylation stat<NUMBER> andor stat<NUMBER> observed baseline patients mf doseand timedependent reduction phosphorylated stat<NUMBER> observed treatment ruxolitinib highrisk mf <NUMBER> <NUMBER> anemia thrombocytopenia frequent anygrade grade <NUMBER> adverse events experienced sragvhd condition characterized allogeneic hyperinflammatory response lead organ damage death <NUMBER> ruxolitinib approved sragvhd based results phase <NUMBER> reach<NUMBER> trial <NUMBER> ruxolitinib proteomics analysis revealed robust changes expression inflammatory mediators treatment ruxolitinib corticosteroids il<NUMBER>receptor alpha among significantly downregulated proteins <NUMBER> hemophagocytic lymphohistiocytosis hlh another disease elevation many proinflammatory cytokines eg ifnγ il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> ip<NUMBER> mip<NUMBER>α tnfα frequently results cytokine storm <NUMBER> <NUMBER> ruxolitinib <NUMBER> mg bid demonstrated improvement symptoms inflammatory markers treatment patients hlh <NUMBER> <NUMBER> <NUMBER> two consecutive patients treated ruxolitinib rapid reduction fever observed <NUMBER> study <NUMBER> patients hlh overall response rate <NUMBER> complete response rate <NUMBER> <NUMBER> <NUMBER> patients responded significant reduction levels ifnγ il<NUMBER> mip<NUMBER>α ip<NUMBER> another study five patients secondary hlh two additional patients treated offprotocol <NUMBER> achieved response time first assessment day <NUMBER> three patients achieving complete response <NUMBER> furthermore hematologic parameters including platelet red blood cell neutrophil counts improved within first week ruxolitinib treatment patients treated onprotocol also experienced substantial improvements ferritin soluble il<NUMBER> receptor concentrations <NUMBER> mg bid ruxolitinib generally well tolerated population sudden surge hospitalization patients covid<NUMBER> high mortality rate hospitalized patients encouraged treating physicians look repurpose approved drugs lessen burden disease increased understanding immunopathology severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> monoclonal antibodies targeting il<NUMBER> likely impact cytokine storm associated covid<NUMBER> given il<NUMBER> among cytokines reported elevated patients compared healthy individuals time writing antiil<NUMBER> antibody products tocilizumab sarilumab evaluated phase <NUMBER> studies <NUMBER> <NUMBER> however cytokines il<NUMBER> il<NUMBER> il<NUMBER> ifnγ gcsf gmcsf also elevated may equally important inflammatory response patients severe covid<NUMBER> cytokines signal jak<NUMBER> andor jak<NUMBER> likely treatment ruxolitinib result broader antiinflammatory activity targeting one cytokines alone fig <NUMBER> addition mf sragvhd hlh noted jak inhibitors shown promise several autoimmune inflammatory diseases rheumatoid arthritis psoriasis ulcerative colitis <NUMBER> ruxolitinib first jak inhibitor approved united states european union indicated first mf others since approved notable differences selectivity profiles approved jak inhibitors ruxolitinib balanced jak<NUMBER>jak<NUMBER> inhibitor good selectivity nonjanus kinases tofacitinib panjak inhibitor upadacitinib jak<NUMBER> inhibitor fedratinib jak<NUMBER> inhibitor activity fltkinase nonkinase proteins differences result distinct biomarker activity profiles singer et al determined gene signatures four different jak inhibitors panel <NUMBER> human primary cell systems concluded ruxolitinib biomarker profile consistent broad antiinflammatory activity <NUMBER> differences selectivity may turn responsible differentiated safety profiles example fedratinib shows high incidence gastrointestinal intolerance cases wernickes encephalopathy <NUMBER> whereas tofacitinib associated increased risk j u r n l p r e p r f journal preproof lymphomas well cardiovascular events patients <NUMBER> years age older least one cardiovascular risk factor <NUMBER> nonmelanoma skin cancers elevated lipid parameters occurred patients treated ruxolitinib <NUMBER> dosedependent reversible cytopenias commonly observed ruxolitinib treatment patients mf pv gvhd <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> use ruxolitinib also associated viral reactivation including cytomegalovirus herpes zoster virus <NUMBER> <NUMBER> suggesting potential increase infections ruxolitinib treatment pharmacokinetic profile ruxolitinib characterized rapid oral absorption short terminal elimination halflife approximately <NUMBER> hours fig <NUMBER>a well concentrationdependent reversible pharmacodynamic effect fig <NUMBER>b <NUMBER> profile contrast antibodies tocilizumab halflife approximately <NUMBER> weeks <NUMBER> jak inhibitors fedratinib halflife <NUMBER> hours <NUMBER> thus ruxolitinib conducive shortterm therapy withdrawal needed based similarity reported elevation cytokine levels covid<NUMBER> hlh mf dose ranges <NUMBER> <NUMBER> mg bid may result adequate inhibition cytokine signaling minimizing adverse events furthermore anticipated patients would receive ruxolitinib approximately <NUMBER> days brief time period minimize risk longterm infection complications severe cytopenias although preclinical models clinical data show lack impact tcell function immune response ruxolitinib treatment pharmacologically relevant doses <NUMBER> <NUMBER> <NUMBER> would prudent select patients likely develop cytokine storm based evolving clinical criteria hscore identify best time initiate treatment based onset symptoms clinical indicators respiratory distress need supplemental oxygen taken together data suggest ruxolitinib pharmacologically achievable doses may able mitigate hyperinflammatory state observed patients experiencing covid<NUMBER>j u r n l p r e p r f journal preproof associated cytokine storm indeed early clinical evidence supports premise team northern italy reported use ruxolitinib four hospitalized patients requiring supplemental oxygen clinical improvement seen four patients <NUMBER> furthermore emerging data ongoing investigatorinitiated trials suggest potential benefit ruxolitinib manageable adverse event profile <NUMBER> <NUMBER> <NUMBER> <NUMBER> randomized trial <NUMBER> patients wuhan china patients treated ruxolitinib numerically shorter time clinical improvement compared treated standard care median <NUMBER> vs <NUMBER> days better outcome survival <NUMBER> vs <NUMBER> deaths control arm <NUMBER> importantly although higher rates grade <NUMBER> anemia thrombocytopenia observed ruxolitinib study increase grade <NUMBER> cytopenias patients receiving ruxolitinib experienced significantly shorter time improvement lymphopenia compared standard care median <NUMBER> vs <NUMBER> days hazard ratio <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> additionally increase infections seen ruxolitinib treatment patients encouraging early clinical results combined thorough understanding evidence supporting posited mechanism action ruxolitinib covid<NUMBER>associated cytokine storm urgent need treatments patients severe disease support expedited investigation ruxolitinib patients covid<NUMBER> phase <NUMBER> clinical trials table <NUMBER> vitro enzymatic functional potency ruxolitinib <NUMBER> ic<NUMBER> nrf<NUMBER> transcription factor regulates cellular redox balance expression wide array genes involved immunity inflammation including antiviral actions nrf<NUMBER> activity declines age making elderly susceptible oxidative stressmediated diseases include type <NUMBER> diabetes chronic inflammation viral infections published evidence suggests nrf<NUMBER> activity may regulate important mechanisms affecting viral susceptibility replication examined gene expression levels genechip microarray rnaseq assays found potent nrf<NUMBER>activating composition pb<NUMBER>® downregulates ace<NUMBER> tmprss<NUMBER> mrna expression human liverderived hepg<NUMBER> cells ace<NUMBER> surface receptor tmprss<NUMBER> activates spike protein sarscov<NUMBER> entry host cells furthermore endotoxinstimulated primary human pulmonary artery endothelial cells report marked downregulation pb<NUMBER> <NUMBER> genes encoding cytokines include il<NUMBER>beta il<NUMBER> tnfα cell adhesion molecules icam<NUMBER> vcam<NUMBER> eselectin group ifnγinduced genes many cytokines specifically identified cytokine storm observed fatal cases covid<NUMBER> suggesting nrf<NUMBER> activation may significantly decrease intensity storm nrf<NUMBER> activator pb<NUMBER>® potential therapeutic agent covid<NUMBER> nrf<NUMBER> transcription factor encoded humans nfe<NUMBER>l<NUMBER> gene called many master regulator cellular redox homeostasis <NUMBER> well guardian healthspan gatekeeper species longevity <NUMBER> nrf<NUMBER> regulates genes defend us oxidative stress including superoxide dismutases catalase numerous peroxidases glutathione metabolism well hundreds genes involved scores important metabolic pathways <NUMBER> individual vulnerabilities various structural catalytic gene products damage inactivation reactive oxygen species ros may lead degenerative diseases metabolic dysfunctions importantly nrf<NUMBER> declines age <NUMBER> <NUMBER> contributes greatly frailty associated aging <NUMBER> <NUMBER> <NUMBER> nrf<NUMBER> transcriptionally upregulates genes combat oxidative stress loss allows oxidative stress go unmitigated drive aging phenotype <NUMBER> <NUMBER> <NUMBER> oxidative stress therefore common theme among key features associated aging process collectively referred hallmarks aging disrupts proteostasis <NUMBER> alters genomic stability <NUMBER> alters susceptibility viral microbial infections <NUMBER> leads cell death agerelated thermo fisher scientific waltham usa lps lipopolysaccharides escherichia coli o<NUMBER>b<NUMBER> sigmaaldrich st louis mo usa utilized human hepg<NUMBER> cell line hepatocellular carcinoma primary human pulmonary artery endothelial cells hpaecs genomic assays hepg<NUMBER> cells hpaecs suitable models present work nrf<NUMBER> pathway responds normal manner nrf<NUMBER> activators <NUMBER> <NUMBER> reported mutations nrf<NUMBER>keap<NUMBER> hepg<NUMBER> cells american type culture collection manassas va usa cultured maintained standard methods using optimem medium <NUMBER> fetal bovine serum fbs geneticinpenicillinstreptomycin hpaecs procured lonza morristown nj usa catalog cc<NUMBER> cultured endothelial basal media<NUMBER> lonza catalog cc<NUMBER> supplemented endothelial growth factors optimized aortic pulmonary arterial endothelial cells lonza catalog cc<NUMBER> hpaec subculturing limited six passages order prevent senescence dedifferentiation hpaecs seeded density <NUMBER> × <NUMBER> <NUMBER> cells per <NUMBER> mm tissue culture dishes incubated <NUMBER> • c <NUMBER> co <NUMBER> <NUMBER> confluence experiments performed hpaecs <NUMBER> confluence used human il<NUMBER> quantiglo elisa rd systems minneapolis mn usa according manufacturers instructions determine concentration il<NUMBER> protein released hpaecs cultured various conditions examine effects pb<NUMBER> gene expression hepg<NUMBER> cells cells subcultured <NUMBER>well plates treated overnight <NUMBER> control <NUMBER> µgml pb<NUMBER> <NUMBER> mgml extract <NUMBER> ethanol examine effects pb<NUMBER> genes induced endotoxin exposure may contribute cytokine storm observed covid<NUMBER> illness examined model proinflammatory lipopolysaccharide lpstreated human pulmonary arterial endothelial cells without treatment pb<NUMBER> four groups hpaec <NUMBER> confluence cultured <NUMBER>well plates groups <NUMBER> <NUMBER> received pb<NUMBER>at <NUMBER> µgml groups incubated <NUMBER> h groups <NUMBER> <NUMBER> received lps <NUMBER> ngml groups incubated additional <NUMBER> h cells washed twice pbs extracted trizol total rna isolation total rna purified qiagen rneasy cleanup columns qiagen inc valencia ca usa previously described <NUMBER> sample rna concentration determined absorbance <NUMBER> nm nanodrop spectrophotometer thermo fisher scientific waltham usa rna quality assessed agilent tapestation <NUMBER> agilent santa clara ca usa gene expression levels determined university colorado anschutz medical center genomics microarray core facility aurora co usa genechip <NUMBER> ivt plus reagent kit affymetrixthermo fisher scientific waltham usa used convert <NUMBER> ng total rna cdna according manufacturers protocol labeled sample assayed affymetrix primeview human gene expression array read affymetrix genechip scanner <NUMBER> affymetrixthermo fisher scientific waltham usa gene transcript variants examined using <NUMBER> perfectly matched pm probes intensity expression genes microarray evaluated using affymetrix genechip antioxidants <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> software affymetrixthermo fisher scientific waltham usa supported pairwise comparison microarray chips illumina hiseq libraries <NUMBER> assays based <NUMBER> biological replicates treatment group prepared hepg<NUMBER> cell samples using <NUMBER> ng total rna following manufacturers instructions truseq rna kit illumina san diego ca usa kit mrna first isolated total rna using polya selection mrna fragmented primed creation doublestranded cdna fragments following cdna fragments amplified selected size purified cluster generation subsequently mrna template libraries sequenced illumina hiseq <NUMBER> platform illumina san diego ca usa singlepass <NUMBER> bp reads university colorado anschutz medical center genomics microarray core facility aurora co usa samples sequenced depth provide approximately <NUMBER>m singlepass <NUMBER> base reads per sample derived sequences analyzed custom computational pipeline comprising opensource gsnap <NUMBER> cufflinks <NUMBER> r sequence alignment determination differential gene expression <NUMBER> reads generated mapped gsnap <NUMBER> human genome grch<NUMBER> expression fpkm derived using cufflinks <NUMBER> differential expression analyzed anova using r data presented mean ± standard error mean sem oneway anova tukey multiple comparisons testing students test unpaired data performed using prism software version <NUMBER> graphpad software san diego ca usa statistical significance set p value <NUMBER> using elisa assay il<NUMBER> determined pretreatment hpaecs pb<NUMBER> decreased lpsinduced release il<NUMBER> protein hpaecs study hpaecs plated described <NUMBER> h treated <NUMBER> µgml pb<NUMBER> extract corresponding amounts vehicle control additional <NUMBER> h incubation cells treated adding <NUMBER> ng lps vehicle control per ml medium four treatment groups run triplicate <NUMBER> h lps treatment aliquots cell culture medium removed well il<NUMBER> measurement elisa lps stimulation vehiclepretreated hpaecs greatly increased release il<NUMBER> protein culture media lpsinduced il<NUMBER> release reduced <NUMBER> cells pretreated pb<NUMBER> p <NUMBER> results shown figure <NUMBER> illumina hiseq libraries <NUMBER> assays based <NUMBER> biological replicates treatment group prepared hepg<NUMBER> cell samples using <NUMBER> ng total rna following manufacturers instructions truseq rna kit illumina san diego ca usa kit mrna first isolated total rna using polya selection mrna fragmented primed creation doublestranded cdna fragments following cdna fragments amplified selected size purified cluster generation subsequently mrna template libraries sequenced illumina hiseq <NUMBER> platform illumina san diego ca usa singlepass <NUMBER> bp reads university colorado anschutz medical center genomics microarray core facility aurora co usa samples sequenced depth provide approximately <NUMBER>m singlepass <NUMBER> base reads per sample derived sequences analyzed custom computational pipeline comprising opensource gsnap <NUMBER> cufflinks <NUMBER> r sequence alignment determination differential gene expression <NUMBER> reads generated mapped gsnap <NUMBER> human genome grch<NUMBER> expression fpkm derived using cufflinks <NUMBER> differential expression analyzed anova using r data presented mean ± standard error mean sem oneway anova tukey multiple comparisons testing students test unpaired data performed using prism software version <NUMBER> graphpad software san diego ca usa statistical significance set p value <NUMBER> using elisa assay il<NUMBER> determined pretreatment hpaecs pb<NUMBER> decreased lpsinduced release il<NUMBER> protein hpaecs study hpaecs plated described <NUMBER> h treated <NUMBER> μgml pb<NUMBER> extract corresponding amounts vehicle control additional <NUMBER> h incubation cells treated adding <NUMBER> ng lps vehicle control per ml medium four treatment groups run triplicate <NUMBER> h lps treatment aliquots cell culture medium removed well il<NUMBER> measurement elisa lps stimulation vehiclepretreated hpaecs greatly increased release il<NUMBER> protein culture media lpsinduced il sarscov<NUMBER> entry human cell depends expression ace<NUMBER> binding tmprss<NUMBER> proteolytic activation spike protein <NUMBER> examined effects pb<NUMBER> expression two genes inhibition protease activity tmprss<NUMBER> shown block viral entry <NUMBER> also examined expression plasminogen activator inhibitor<NUMBER> pai<NUMBER> encoded serpine<NUMBER> gene normal plasma component known potent inhibitor tmprss<NUMBER> <NUMBER> ace<NUMBER> mrna downregulated <NUMBER>fold tmprss<NUMBER> downregulated <NUMBER>fold pb<NUMBER> human liverderived hepg<NUMBER> cells seen figure <NUMBER> impediments may completely block viral entry may significantly impair slowing rate viral progression furthermore pb<NUMBER> strongly upregulated serpine<NUMBER>pai<NUMBER> <NUMBER>fold pb<NUMBER> downregulated hdac<NUMBER> human liver cells <NUMBER>fold also shown figure <NUMBER> humans hdac<NUMBER> appears responsible deacetylation attenuation nrf<NUMBER> activity <NUMBER> cytokine lif important antiviral cellular response viral infection <NUMBER> <NUMBER> upregulated <NUMBER>fold pb<NUMBER> recent evidence plasmin trigger substantial proinflammatory release cytokines <NUMBER> examined effect pb<NUMBER> plasminogen plg mrna expression finding downregulated <NUMBER>fold thus six gene regulatory effects pb<NUMBER> would appear counter viral attempts enter cell andor usurp control oxidative stress response antioxidants <NUMBER> <NUMBER> x peer review <NUMBER> <NUMBER> <NUMBER> release reduced <NUMBER> cells pretreated pb<NUMBER> p <NUMBER> results shown figure <NUMBER> sarscov<NUMBER> entry human cell depends expression ace<NUMBER> binding tmprss<NUMBER> proteolytic activation spike protein <NUMBER> examined effects pb<NUMBER> expression two genes inhibition protease activity tmprss<NUMBER> shown block viral entry <NUMBER> also examined expression plasminogen activator inhibitor<NUMBER> pai<NUMBER> encoded serpine<NUMBER> gene normal plasma component known potent inhibitor tmprss<NUMBER> <NUMBER> ace<NUMBER> mrna downregulated <NUMBER>fold tmprss<NUMBER> downregulated <NUMBER>fold pb<NUMBER> human liverderived hepg<NUMBER> cells seen figure <NUMBER> impediments may completely block viral entry may significantly impair slowing rate viral progression furthermore pb<NUMBER> strongly upregulated serpine<NUMBER>pai<NUMBER> <NUMBER>fold pb<NUMBER> downregulated hdac<NUMBER> human liver cells <NUMBER>fold also shown figure <NUMBER> humans hdac<NUMBER> appears responsible deacetylation attenuation nrf<NUMBER> activity <NUMBER> cytokine lif important antiviral cellular response viral infection <NUMBER> <NUMBER> upregulated <NUMBER>fold pb<NUMBER> recent evidence plasmin trigger substantial proinflammatory release cytokines <NUMBER> examined effect pb<NUMBER> plasminogen plg mrna expression finding downregulated <NUMBER>fold thus six gene regulatory effects pb<NUMBER> would appear counter viral attempts enter cell andor usurp control oxidative stress response figure <NUMBER> regulation proand antiviral genes pb<NUMBER> hepg<NUMBER> cells cultured overnight <NUMBER>well plates control vs <NUMBER> µgml pb<NUMBER> gene expressions determined using rnaseq analysis four biological replicates six genes differed control p <NUMBER> examine effects pb<NUMBER> genes may contribute covid<NUMBER>induced cytokine storm examined model lipopolysaccharide lpstreated hpaecs without treatment pb<NUMBER> results seen figure <NUMBER> <NUMBER> genes significantly upregulated lps absence pb<NUMBER> group <NUMBER> vs group <NUMBER> normalized <NUMBER> indicated red bar percent suppression reflecting decreased expression seen group <NUMBER> lps pb<NUMBER> vs group <NUMBER> lps alone sixteen cytokines including two colony stimulating factors shown green mrnas downregulated pb<NUMBER> indicated average percent inhibition group cytokines <NUMBER> two proinflammatory interleukins il<NUMBER>b il<NUMBER> showed mrnas inhibited <NUMBER> <NUMBER> respectively three proinflammatory cytokineinduced adhesion molecules intercellular adhesion molecule <NUMBER> icam<NUMBER> vascular cell adhesion molecule <NUMBER> vcam<NUMBER> endothelial cell selectin sele suppressed average <NUMBER> tumor necrosis factor tnf mrna reduced <NUMBER> group five tnfinduced proteins tnfaips repressed even averaging <NUMBER> four genes representing tnf family downregulated average <NUMBER> family five interferoninducible genes shown downregulated average <NUMBER> acrosstheboard reduction genes contribute cytokine storm noteworthy intensity storm predicts icu fatalities covid<NUMBER> <NUMBER> transforming storm manageable shower therefore major therapeutic objective clinical management covid<NUMBER> patients inhibited <NUMBER> <NUMBER> respectively three proinflammatory cytokineinduced adhesion mo intercellular adhesion molecule <NUMBER> icam<NUMBER> vascular cell adhesion molecule <NUMBER> vcam endothelial cell selectin sele suppressed average <NUMBER> tumor necrosis facto mrna reduced <NUMBER> group five tnfinduced proteins tnfaips even averaging <NUMBER> four genes representing tnf family downregul average <NUMBER> family five interferoninducible genes shown downregu average <NUMBER> acrosstheboard reduction genes contribute cytokine st noteworthy intensity storm predicts icu fatalities covidtransforming storm manageable shower therefore major therapeutic objectiv clinical management covid<NUMBER> patients last decade seen <NUMBER> publications nrf<NUMBER> involvement homeostasis inflammation immunity neurodegeneration aging diseases associat last decade seen <NUMBER> publications nrf<NUMBER> involvement redox homeostasis inflammation immunity neurodegeneration aging diseases associated aging ischemiareperfusion injury many areas relatively little published regarding roles viral infectivity resistance despite rather tantalizing studies kesic et al showed sirna knockdown nrf<NUMBER> expression human nasal epithelial cells effectively decreased nrf<NUMBER> mrna nrf<NUMBER> protein expression cells correlated significantly increased entry influenza abangkok<NUMBER> h<NUMBER>n<NUMBER> serotype replication transduced human cells <NUMBER> importantly also demonstrated enhancing nrf<NUMBER> activation via supplementation sulforaphane sfn epigallocatechin gallate egcg increased antiviral mediators absence viral infection also abrogated viral entry yegeta et al took different approach increased oxidative stress manipulating nrf<NUMBER> expression genetically alternatively exposing mice exogenous oxidative stresscigarette smoke <NUMBER> cigarette smokeexposed nrf<NUMBER>deficient mice showed higher rates mortality wildtype mice influenza virus infection enhanced peribronchial inflammation lung permeability damage mucus hypersecretion cho et al <NUMBER> similarly studied respiratory syncytial virus rsv infection single important virus causing acute respiratory tract infections children found nrf<NUMBER> −− mice infected rsv showed antioxidants <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> significantly increased bronchopulmonary inflammation epithelial injury mucus cell metaplasia well nasal epithelial injury compared similarly infected nrf<NUMBER> wt mice nrf<NUMBER> −− mice also showed significantly attenuated viral clearance ifnγ greater weight loss importantly pretreatment oral sulforaphane significantly limited lung rsv replication virusinduced inflammation nrf<NUMBER> wt mice komaravelli et al <NUMBER> <NUMBER> <NUMBER> noted rsv causes increased production ros actively lowers expression antioxidant enzymes increasing rate proteasomal degradation nrf<NUMBER> <NUMBER> h postinfection nrf<NUMBER>dependent gene transcription increased indicating cell control responding insult viral infection increase oxidative stress <NUMBER> h postinfection however concentration nrf<NUMBER> dropped significantly half preinfection level reflecting changeofcontrol favor virus accomplish rsv increased nrf<NUMBER> ubiquitination triggering proteasomal degradation representing one example viruses subvert cellular antioxidant defenses taken together studies demonstrate ability nrf<NUMBER> impede viral entry slow viral replication reduce inflammation weight loss mortality without providing much detailed insight genes pathways involved first challenge facing virus particularly virus jumping one host species another gaining entry cell fairly common ports entry ldlr icam<NUMBER> lead endosomal entry shared among various viral families <NUMBER> sarscov<NUMBER> however seems largely totally restricted specific mode entry unique mode entry may greatest vulnerability virus opening door potentially effective therapies substantial evidence suggests transmembrane protease encoded tmprss<NUMBER> gene plays critical role entry sars mers coronavirus <NUMBER> asian h<NUMBER>n<NUMBER> influenza virus several h<NUMBER>n<NUMBER>subtype influenza virus infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> suggesting targeting tmprss<NUMBER> could novel antiviral strategy treat coronavirus <NUMBER> hoffmann coworkers found infection sarscov<NUMBER> virus responsible covid<NUMBER> may depend almost exclusively host cell factors ace<NUMBER> tmprss<NUMBER> <NUMBER> spike protein coronaviruses facilitates viral entry target cells entry depends binding protein cellular receptor ace<NUMBER> facilitates viral attachment surface target cells addition entry requires protein priming cellular protease tmprss<NUMBER> entails protein cleavage allows fusion viral cellular membranes figure <NUMBER> priming blocked clinically proven protease inhibitors tmprss<NUMBER> camostat mesylate <NUMBER> <NUMBER> nafamostat mesylate <NUMBER> nafamostat remarkably potent ic <NUMBER> nanomolar range blocking cellular entry merscov vitro clinically tested antiviral humans drug appears available present oral formulation lack specificity concern possible side effects <NUMBER> may prove suitable treatment severe covid<NUMBER> cases tmprss<NUMBER> also blocked human antiprotease plasminogen activator inhibitor<NUMBER> pai<NUMBER> <NUMBER> shown figure <NUMBER> iwatayoshikawa et al <NUMBER> found knockout tmprss<NUMBER> improved pathology immunopathology bronchi andor alveoli infection mice sarscov completely prevented loss body weight especially noteworthy sarscov infection tmprss<NUMBER> sole mechanism entry case sarscov<NUMBER> thus data showing pb<NUMBER> downregulated ace<NUMBER> <NUMBER>fold downregulated tmprss<NUMBER> <NUMBER>fold upregulated pai<NUMBER> potent tmprss<NUMBER> inhibitor <NUMBER>fold figure <NUMBER> strongly suggest pb<NUMBER> treatment might diminish ability sarscov<NUMBER> bind host cell obtain spike protein activation result less ace<NUMBER> tmprss<NUMBER> cell surface result <NUMBER>fold increase plasma pai<NUMBER> would inhibit remaining tmprss<NUMBER> dittmann et al <NUMBER> found influenza virus iav infection provokes host response necessary sufficient viral inhibitionincreased production pai<NUMBER> found iav proteolytic cleavage viral coat protein hemagglutinin host proteases plasmin tmprss<NUMBER> requirement maturation infectivity progeny particles addition recombinant pai apical side haec significantly reduced iav growth compared carrier control <NUMBER> inhibition infectivity <NUMBER> h postinfection contrast addition αpai<NUMBER> antibody dramatically enhanced iav growth thus many viruses rely host endoand exoproteases various entry maturation functions moreover found tmprss<NUMBER> necessary sarscov<NUMBER> infection among trypsinlike proteases effectively inhibited pai<NUMBER> <NUMBER> tmprss<NUMBER> also blocked human antiprotease plasminogen activator inhibitor<NUMBER> pai<NUMBER> <NUMBER> shown figure <NUMBER> iwatayoshikawa et al <NUMBER> found knockout tmprss<NUMBER> improved pathology immunopathology bronchi andor alveoli infection mice sarscov completely prevented loss body weight especially noteworthy sarscov infection tmprss<NUMBER> sole mechanism entry case sarscov<NUMBER> thus data showing pb<NUMBER> downregulated ace<NUMBER> <NUMBER>fold downregulated tmprss<NUMBER> <NUMBER>fold upregulated pai<NUMBER> potent tmprss<NUMBER> inhibitor <NUMBER>fold figure <NUMBER> strongly suggest pb<NUMBER> treatment might diminish ability sarscov<NUMBER> bind host cell obtain spike protein activation result less ace<NUMBER> tmprss<NUMBER> cell surface result <NUMBER>fold increase plasma pai<NUMBER> would inhibit remaining tmprss<NUMBER> dittmann et al <NUMBER> found influenza virus iav infection provokes host response necessary sufficient viral inhibitionincreased production pai<NUMBER> found iav proteolytic cleavage viral coat protein hemagglutinin host proteases plasmin tmprss<NUMBER> requirement maturation infectivity progeny particles addition recombinant pai apical side haec significantly reduced iav growth compared carrier control <NUMBER> inhibition infectivity <NUMBER> h postinfection contrast addition αpai<NUMBER> antibody dramatically enhanced iav growth thus many viruses rely host endoand exoproteases various entry maturation functions moreover found tmprss<NUMBER> necessary sarscov<NUMBER> infection among trypsinlike proteases effectively inhibited pai<NUMBER> <NUMBER> recent publication kumar et al <NUMBER> used computer modeling predict withaferin withanone present extracts ayurvedic plant ashwagandha withania somnifera stably interact catalytic site tmprss<NUMBER> mimicking pharmaceutical inhibitor camostat <NUMBER> occurs via ace<NUMBER> receptors spike protein must cleaved indicated scissors representing serine protease tmprss<NUMBER> allow entry cell <NUMBER> activated spike protein penetrates cell membrane <NUMBER> allowing entry viral genome <NUMBER> replicated translated assembled mature virus particles <NUMBER> left tmprss<NUMBER> inhibition shown antiviral drugs camostat nafamostat well plasminogen activator inhibitor pai<NUMBER> encoded serpine<NUMBER> gene pb<NUMBER> upregulates pai<NUMBER> downregulates tmprss<NUMBER> ace<NUMBER> hepg<NUMBER> cells recent publication kumar et al <NUMBER> used computer modeling predict withaferin withanone present extracts ayurvedic plant ashwagandha withania somnifera stably interact catalytic site tmprss<NUMBER> mimicking pharmaceutical inhibitor camostat mesylate <NUMBER> <NUMBER> <NUMBER> addition kumar et al found withanone downregulated tmprss<NUMBER> gene similarly report pb<NUMBER> figure <NUMBER> ashwagandha one three components pb<NUMBER> probability pb<NUMBER> may inhibit enzymatic activity tmprss<NUMBER> well downregulating expression mrna quite apart direct involvement viral entry mechanisms pb<NUMBER> downregulates hdac<NUMBER> human liverderived hepg<NUMBER> cells <NUMBER>fold also shown figure <NUMBER> acetylation nrf<NUMBER> increases binding nrf<NUMBER> cognate response element target gene promoter increases nrf<NUMBER>dependent transcription target genes <NUMBER> humans hdac<NUMBER> appears isozyme responsible deacetylation attenuation nrf<NUMBER> activity <NUMBER> likely gene upregulated rsv infection described komaravelli et al <NUMBER> thus pb<NUMBER> inhibiting deacetylation subsequent degradation nrf<NUMBER> maintains active acetylated nrf<NUMBER> nucleus longer time counteracting one mechanisms enumerated viruses attempt commandeer control cells redox status indirectly amplifying nrf<NUMBER>dependent actions upregulation cytokine lif important antiviral cellular response viral infection shown strongly upregulated pb<NUMBER> figure <NUMBER> countering potential attempts virus downregulate lif gene expression downregulated h<NUMBER>n<NUMBER> infection knockdown lif increased virus titers three influenza strains investigated indicating important role lif virus defense <NUMBER> vivo studies performed lif knockout mice infected rsv lif knockout mice yielded higher virus titers compared control mice lif signaling shown critical protection lung injury <NUMBER> discussed role pai<NUMBER> preventing tmprss<NUMBER> activating sarscov<NUMBER> spike protein mention also made many would consider real job blocking conversion plasminogen encoded plg gene plasmin urokinasetype plasminogen activator upa tissue plasminogen activator tpa fibrinolysis first recognized function plasmin one might expect high expression pai<NUMBER> would cause low plasmin levels might risk factor venous thrombosis genetic plasminogen deficiency however strongly associated risk thrombosis <NUMBER> study <NUMBER> subjects homozygous mutations plg gene little detectable plasmin <NUMBER> clinical inflammation conjunctivae ligneous conjunctivitis <NUMBER> experienced venous thrombosis <NUMBER> new roles however recognized plasmin regarding cytokine release <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cytokine storm syndrome form systemic inflammatory response triggered variety factors severe infections occurs large numbers leukocytes activated release inflammatory cytokines turn activate yet leukocytes sato et al found pharmacological inhibition plasmin significantly prevented mortality mouse model acute graftversushost disease proposing plasmin inhibition could offer novel therapeutic strategy control deadly cytokine storm results graftversushost disease preventing tissue destruction <NUMBER> macrophage activation syndrome mas lifethreatening disorder characterized cytokine storm multiorgan dysfunction due excessive immune activation mouse model mas shimazu et al saw similar prevention lethality concluding plasmin regulates influx inflammatory cells production inflammatory cytokineschemokines <NUMBER> plasminogen also implicated activation astrocytes produce array proinflammatory cytokines <NUMBER> figure <NUMBER> report pb<NUMBER> downregulates plasminogen mrna <NUMBER>fold liver cells thus vivo speculate combined downregulation plasminogen <NUMBER>fold increase pai<NUMBER> covalently reacts deactivates tissueand urokinasetype plasminogen activators may significantly attenuate plasmininduced cytokine storm phenomenon hyperinflammation covid<NUMBER> associated elevation proinflammatory cytokines interleukins tumor necrosis factorα tnf large number tnfinduced proteins granulocyte colony stimulating factor gcsf csf<NUMBER> among <NUMBER> hospitalized covid<NUMBER> patients wuhan china elevated il<NUMBER>b ip<NUMBER>cxcl<NUMBER> mcp<NUMBER>ccl<NUMBER> sixteen patients subsequently admitted icu even higher plasma levels gcsfcsf<NUMBER> ip<NUMBER>cxcl<NUMBER> mcp<NUMBER>ccl<NUMBER> mip<NUMBER>accl<NUMBER> tnfα intensity cytokine storm strong prognosticator mortality <NUMBER> genes encoding covid<NUMBER>related cytokines appear figure <NUMBER> significantly upregulated lpstreated hpaecs significantly downregulated pb<NUMBER> treatment importantly growing number studies conclude cytokine storm syndrome direct cause death covid<NUMBER> fatalities <NUMBER> <NUMBER> <NUMBER> <NUMBER> speculate welldocumented agerelated loss nrf<NUMBER> expression <NUMBER> <NUMBER> potential contributor occurrence cytokine storm longitudinal study <NUMBER> confirmed covid<NUMBER> patients <NUMBER> showed <NUMBER> severe cases compared <NUMBER> milder cases older mean age <NUMBER> vs <NUMBER> significantly elevated creactive protein mean <NUMBER> vs <NUMBER> mgl showed consistently higher neutrophil counts lower lymphocyte counts throughout two week observation period observations <NUMBER> <NUMBER> document clear predilection severity covid<NUMBER> infection directly associated age intensity inflammatory response presumably inversely associated nrf<NUMBER> expression <NUMBER> production selfamplifying nature acute inflammatory response demands prompt subsequent survival response host tissue break selfsustaining attraction neutrophils inflamed tissues propose robust oxidative stressinduced activation nrf<NUMBER> young healthy individuals follows gathering storm rescues host tissues irretrievable selfinflicted damage older individuals presence comorbidities may involve chronic inflammation nrf<NUMBER>activation response may insufficient break selfperpetuating cycle events figure <NUMBER> illustrates proposed sequence events propose activating larger fraction limited nrf<NUMBER> available elderly otherwise compromised patients might allow like younger counterparts shut cytokine production stop escalating cytokine storm begin recovery repair phase inflammatory episode activation boost suboptimal levels nrf<NUMBER> provided several pharmacological agents well better number phytochemical activators show pb<NUMBER> observation period observations <NUMBER> <NUMBER> document clear predilection severity covid<NUMBER> infection directly associated age intensity inflammatory response presumably inversely associated nrf<NUMBER> expression <NUMBER> production selfamplifying nature acute inflammatory response demands prompt subsequent survival response host tissue break selfsustaining attraction neutrophils inflamed tissues propose robust oxidative stressinduced activation nrf<NUMBER> young healthy individuals follows gathering storm rescues host tissues irretrievable selfinflicted damage older individuals presence comorbidities may involve chronic inflammation nrf<NUMBER>activation response may insufficient break selfperpetuating cycle events figure <NUMBER> illustrates proposed sequence events propose activating larger fraction limited nrf<NUMBER> available elderly otherwise compromised patients might allow like younger counterparts shut cytokine production stop escalating cytokine storm begin recovery repair phase inflammatory episode activation boost suboptimal levels nrf<NUMBER> provided several pharmacological agents well better number phytochemical activators show pb<NUMBER> nrf<NUMBER> within hours nearby tissues inhibiting tissue cytokine production rescuing host cells damage permitting <NUMBER> repair clean recovery alternatively <NUMBER>a older cells deficient nrf<NUMBER> may unable mount nrf<NUMBER> sufficient activation break selfsustaining chain reaction resulting uncontrolled cytokine storm ultimately destroys host tissue leads death robust activation limited nrf<NUMBER> available older cells may provided pharmacological phytochemical nrf<NUMBER> activators <NUMBER> initiation occurs bacterial viral infection triggers <NUMBER> local production cytokines endothelial cells call inflammatory cells neutralize invasion <NUMBER> attack ensues superoxide secondary oxidants produced phagocytosis occurs cytokines released first responders calling subsequent waves activated inflammatory cells <NUMBER> young healthy cells oxidative stress generated battle activates nrf<NUMBER> within hours nearby tissues inhibiting tissue cytokine production rescuing host cells damage permitting <NUMBER> repair clean recovery alternatively <NUMBER>a older cells deficient nrf<NUMBER> may unable mount nrf<NUMBER> sufficient activation break selfsustaining chain reaction resulting uncontrolled cytokine storm ultimately destroys host tissue leads death robust activation limited nrf<NUMBER> available older cells may provided pharmacological phytochemical nrf<NUMBER> activators worth noting longitudinal study covid<NUMBER> patients <NUMBER> reported remarkably higher concentration serum ferritin severe cases averaging <NUMBER> µgl range <NUMBER> <NUMBER> versus milder cases averaging <NUMBER> µgl range <NUMBER> <NUMBER> ferritin long recognized source iron released inflammatory conditions superoxide radical <NUMBER> <NUMBER> <NUMBER> <NUMBER> intense oxidative stress precipitated cytokine storm release iron would catalyze lipid peroxidation greatly amplify host tissue injury covid<NUMBER> already added short list known hyperferritinemic diseasesall characterized high serum ferritin lifethreatening hyperinflammation sustained cytokine storm eventually leads multiorgan failure <NUMBER> ferroptosis newly described form regulated cell death iron dependent causes cell death mitochondrial dysfunction toxic lipid peroxidation nrf<NUMBER> implicated key deterministic component modulating onset outcomes ferroptotic stress <NUMBER> studied three different phenomena may involved vulnerability sarscov<NUMBER> interactive phenomena present single cell type first objective study effects pb<NUMBER> expression ace<NUMBER> tmprss<NUMBER> could studied presumed pointofentry cells including alveolar type ii cells <NUMBER> hpaecs <NUMBER> <NUMBER> clinical laboratory suggestions virus may invade many organs containing cell types coexpress ace<NUMBER> tmprss<NUMBER> heart gut kidney eye including liver showed downregulation ace<NUMBER> tmprss<NUMBER> thus liver also relevant cell study entry genes second objective examine whether pb<NUMBER> could limit systemic plasmin activity downregulation plg andor upregulation pai<NUMBER> plasma proteins produced cells lung case liver source plasminogen appropriate cell type examine source pai<NUMBER> plasma known may liver muscle third objective whether pb<NUMBER> could downregulate cytokines identified participating cytokine storm phenomenon believe focus primary hpaecs appropriate although complete picture would include study inflammatory cell types hpaecs generate <NUMBER> cytokines examined sounding systemic alarm recruits inflammatory cells infected organ type ii alveolar cell little capacity producing cytokines <NUMBER> studying intervention break inflammatory cycle leading cytokine storm believe vascular endothelial cells may single important players potential limitation study use lps surrogate sarscov<NUMBER> induce inflammatory response propose one evolutionary driving force nrf<NUMBER> pathway may provide failsafe brake outofcontrol inflammatory events increase oxidative stress site intense inflammatory locus may intended trigger system activate nrf<NUMBER> allowing end assault point invader likely vanquished host may able survive fact cadre genes induced nrf<NUMBER> long referred survival genes <NUMBER> shown group <NUMBER> genes linked respiratory virus infectivity resistance associated immune response responsive pharmacological nrf<NUMBER> activation seems possible sum total multiple antiviral effects may confer degree resistance attenuate viral replication rate alleviate symptoms limiting microvascular injury perhaps allow successful navigation cytokine storm particular problem covid<NUMBER> even though neverending evolutionary war wits continues viruses occasionally win battle scenario complex multifaceted antiviral mechanisms regulated nrf<NUMBER> serves underscore importance central transcription factor keeping us protected functional sars outbreak <NUMBER> coronaviruses cov showcased potential epidemic spread significant pathogenicity humans mainly known causes mild respiratory gastrointestinal disease <NUMBER> last two decades three novel betacoronaviruses severe acute respiratory syndrome sarscov middle east respiratory syndrome merscov sarscov<NUMBER> crossed species barrier caused significant outbreaks characterized high casefatality rates humans <NUMBER> <NUMBER> <NUMBER> latest addition human pathogenic coronaviruses hcovs sarscov<NUMBER> cause covid<NUMBER> time submission review sarscov<NUMBER> infected <NUMBER> million people worldwide claimed <NUMBER> lives threatening many httpsgisanddatamapsarcgiscomappsopsdashboardindexhtmlbda<NUMBER>fd<NUMBER> <NUMBER>b<NUMBER>e<NUMBER>ecf<NUMBER> following epidemiological clinical features covid<NUMBER> pathophysiological mechanisms already available future therapeutic options discussed based limited evidence available extrapolation related viral disease first hcovs described <NUMBER> e<NUMBER>cov oc<NUMBER>cov <NUMBER> <NUMBER> part group currently four known seasonal hcovs shcov also includes hku<NUMBER>cov nl<NUMBER>cov discovered <NUMBER> <NUMBER> <NUMBER> shcovs globally endemic frequently cause common colds accounting <NUMBER> respiratory tract infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> fourth birthday <NUMBER> children show antibodies directed least one shcovs <NUMBER> <NUMBER> antishcovs antibodies provide crossimmunity antibodymediated protection infection species within group <NUMBER> overall pathogenic potential comparatively low immunocompromised infants elderly preexisting pulmonary disorders shcovs cause severe respiratory sepsislike presentations <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> oc<NUMBER> displays neurotropism cause demyelination cns infections vulnerable patient groups <NUMBER> <NUMBER> estimates contribution annual respiratory illness vary shcovs remain asymptomatic approximately <NUMBER> cases <NUMBER> <NUMBER> <NUMBER> stark contrast clinical presentation encountered infections socalled novel coronaviruses sarscov merscov sarscov<NUMBER> associated morbidity casefatality ratios far exceed ones shcovs <NUMBER> years <NUMBER> health care workers contact sars patients demonstrated low seroconversion rate <NUMBER> asymptomatic individuals less <NUMBER> affected children postcontainment seroprevalence among children considered highrisk significant exposure extremely low suggests subclinical sars among children occurred <NUMBER> <NUMBER> <NUMBER> approximately <NUMBER> sars patients required intensive care support acute respiratory distress syndrome ards half died within following <NUMBER> days <NUMBER> severe clinical phenotype sars replicated emergence mers <NUMBER> continues circulate albeit lesser extent <NUMBER> date <NUMBER> cases mers occurred worldwide presenting severe pneumonia resulting respiratory multiorgan failure casefatalityratio <NUMBER> <NUMBER> individuals comorbidities males immunocompromised considered particularly high risk previous novel coronavirus outbreaks severity clinical manifestation puzzled clinicians common features included massive inflammatory cell infiltration lungs resulting acute lung injury ali ards highly elevated inflammatory markers serum evidence monocytemacrophage activation activated coagulation proinflammatory cytokine chemokine profiles <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> soon led implication host response important factor fulminant disease process <NUMBER> animal models sars suggest lung inflammation intensifies viral clearance peaking late <NUMBER> days infection <NUMBER> similar observations made human sars patients suggests clinical deterioration later disease course likely due uncontrolled viral replication rather uncontrolled immune responses associated damage <NUMBER> <NUMBER> similar descriptions clinical presentations covid<NUMBER> emerging presenting features cough fever subacutely progress respiratory distress acute respiratory distress sydrome ards <NUMBER> patients elderly underlying comorbidities especially cardiovascular disease diabetes mellitus chronic pulmonary disorders renal disease especially risk httpswwwepicentroissitcoronavirusbollettinoreportcovid<NUMBER>marzoengpdf <NUMBER> <NUMBER> <NUMBER> <NUMBER> estimated <NUMBER> covid<NUMBER> patients develop respiratory symptoms requiring supplemental oxygen approximately <NUMBER> develop need mechanical ventilation <NUMBER> <NUMBER> <NUMBER> cdc reports overall casefatality rate <NUMBER> though higher <NUMBER> patients <NUMBER> years age <NUMBER> among critically ill requiring mechanical ventilation <NUMBER> pulmonary tissue impedes alveolar gas exchange addition one fifth hospitalized patients develop significant cardiovascular morbidity characterized troponin rise tachyarrhythmias thromboembolic events strongly associated mortality risk <NUMBER> <NUMBER> <NUMBER> common features covid<NUMBER> patients requiring hospitalization intensive care level support therefore severe pneumonia hypoxic respiratory failure subacute onset evolving ards clinical picture characterized fevers lymphopenia highly elevated creactive protein proinflammatory cytokines serum ferritin ddimers histopathological evidence prominent pulmonary infitrate dominated monocytes macrophages vasculitis hypercoagulability seen <NUMBER> <NUMBER> based current knowledge clinical pictures disease pathology progression sarscov<NUMBER> infections similar causing significant morbidity mortality may associated hyperinflammatory responses subset patients coronaviruses highly prevalent animal pathogens wide host range overall thousands species coronaviruses known <NUMBER> <NUMBER> currently seven covs recognized human pathogens <NUMBER> family coronaviridae divided two subfamilies coronavirinae torovirinae coronavirinae include genera alpha betacoronaviruses infecting mammals gamma deltacoronaviruses infect mammals birds human covs e<NUMBER> nl<NUMBER> human pathogenic alpha oc<NUMBER> hku<NUMBER> novel covs including sarscov<NUMBER> betacoronaviruses potential toroviruses cause disease humans unknown httpstalkictvonlineorgictvreportsictv<NUMBER>threportpositivesensernaviruses<NUMBER>wposrnaviruses<NUMBER>coronaviridae coronaviruses covs large enveloped viruses singlestranded nonsegmented positive sense rna genome spans approximately <NUMBER> kilobases making largest known genome rna virus <NUMBER> rna viruses covs readily evolve mutation homologous nonhomologous recombination expands host range facilitates crossing species barriers extensive animal reservoirs especially among bats genetic recombination among covs plasticity terms receptor use renders covs highly effective host switching sometimes across wide taxonomic distances <NUMBER> <NUMBER> hcovs thought zoonoses novel coronaviruses sarscov merscov sarscov<NUMBER> comparatively poorly adapted humans affects pathogenic potential <NUMBER> <NUMBER> genomic proximity animal covs may allow ongoing interspecies recombination events observed mers <NUMBER> merscov sarscov sarscov<NUMBER> natural reservoir bats infection humans likely occurred intermediate hosts including dromedary camels mers masked palm civet sars pangolin sarscov<NUMBER> <NUMBER> wild palm civets carry sarscov must assumed j u r n l p r e p r f proximity animals markets facilitates recombination events emergence novel viruses may pathogenic humans <NUMBER> <NUMBER> coronaviruses spherical shape prominent feature clublike projections virus surface referred spikes virus membrane contains four structural components spike envelope e membrane nucelocapsid n protein <NUMBER> figure <NUMBER> sarscov sarscov<NUMBER> protein primary determinant host tropism pathogenicity main target neutralizing antibodies therefore great interest terms immunological response vaccine design <NUMBER> spike structure formed homotrimers sglycoproteins consists two subunits whereby s<NUMBER> forms part involved receptor recognition s<NUMBER> highly conserved anchors protein viral membrane facilitates viral fusion <NUMBER> <NUMBER> <NUMBER> s<NUMBER> contains hypervariable loop differs greatly betacoronaviruses size sequence viral entry requires proteolysis protein two locations process utilizes host proteases results irreversible conformational changes protein <NUMBER> <NUMBER> antisarscov antibodies humans mimic receptor engagement thus modeling conformational protein changes upon antigenantibody interaction <NUMBER> amino acid sequence receptor binding sites sarscov<NUMBER> <NUMBER> homologous sarscov suggesting similar even identical cell entry mechanisms viruses <NUMBER> nl<NUMBER> sarscov sarscov<NUMBER> use transmembrane angiotensin converting enzyme ace<NUMBER> host receptor whereas mers cov utilizes dipetidylpeptidase<NUMBER> dpp<NUMBER> <NUMBER> receptors transmembrane ectoenzymes highly conserved among mammals thus facilitating interspecies transfer however enzymatic activity necessary successful binding fusion <NUMBER> <NUMBER> <NUMBER> binding affinity protein sarscov<NUMBER> ace<NUMBER> high high sequence conformational conservation protein observed across sarscov<NUMBER> sarscov allows level cross neutralization two viruses vitro <NUMBER> <NUMBER> hemagglutinin residues enhance binding allowing interactions sialic acid residues host cell surfaces betacoronaviruses feature yet another structural protein hemagglutininesterase binds sialic acid cell surfaces <NUMBER> figure <NUMBER> may enhance virus ability bind invade host cell surfaces may constitute virulence factor novel hcovs data sarscov<NUMBER> still sparse aforementioned parallels sarscov merscov may allow extrapolation knowledge understand sarscov<NUMBER> escapes hosts immune response notably sarscov<NUMBER> shares almost <NUMBER> rna sequence homology sarscov <NUMBER> merscov <NUMBER> sarscov<NUMBER> exhibiting additional genomic regions compared sarscov particular viral spike protein binds host cell receptor <NUMBER> amino acids longer sarscov closely related coronaviruses <NUMBER> thus possible even likely sarscov<NUMBER> uses similar immune evasion strategies coronaviruses additional yet undiscovered mechanisms may also utilized sarscov<NUMBER> <NUMBER> mentioned sarscov sarscov<NUMBER> use ace<NUMBER> host cell receptor establish infection figure <NUMBER>a <NUMBER> ace<NUMBER> expressed almost organs body ace<NUMBER> shown highly expressed surfactant producing type <NUMBER> alveolar cells ciliated goblet cells airways cells likely provide portal entry virus humans <NUMBER> <NUMBER> <NUMBER> high ace<NUMBER> expression also observed intestinal epithelium <NUMBER> furthermore ace<NUMBER> expressed cardiac cells vascular endothelia may explain cardiovascular complications patients <NUMBER> sarscov infection immune cells including monocytesmacrophages cells observed clear date whether extent sarscov<NUMBER> also infect cell types ace<NUMBER> also lower levels ubiquitously expressed monocytes macrophages may also provide entry mechanism immune cells sarscov<NUMBER> however receptors andor phagocytosis virus containing immune complexes may also involved figure <NUMBER>b <NUMBER> <NUMBER> <NUMBER> host response clearance viral infections heavily relies type interferon t<NUMBER>ifn expression <NUMBER> expression t<NUMBER>ifn downstream signals modulate cell responses reprogram cells antiviral state subsequently promoting infection control pathogen clearance <NUMBER> first step immune cells sense viral infection identification virus derived pattern associated molecular patterns pamps viral rna bind activate pattern recognition receptors prrs inon immune cells result immune cell activation figure <NUMBER> rnas viruses sarscov sarscov<NUMBER> merscov detected endosomal rna prrs including tolllike receptors tlr<NUMBER> <NUMBER> andor cytoplasmic rna sensors namely retinoic acidinducible gene rigi melanoma differentiationassociated protein <NUMBER> mda<NUMBER> figure <NUMBER> usually tlr<NUMBER> activation results nuclear translocation transcription factors nfκb irf<NUMBER> rig<NUMBER>mda<NUMBER> activation result activation irf<NUMBER> turn triggers increased expression t<NUMBER>ifn irf<NUMBER> innate proinflammatory cytokines il<NUMBER> il<NUMBER> tnfα nfκb <NUMBER> <NUMBER> context t<NUMBER>ifn innate proinflammatory cytokines promote expression autoamplification t<NUMBER>ifn activate ifnα receptor complex ifnar results phosphorylationactivation stat family transcription factors <NUMBER> <NUMBER> figure <NUMBER> il<NUMBER> il<NUMBER> tnf receptor activation feeds proinflammatory j u r n l p r e p r f cytokine expression though transcription factor nfκb figure <NUMBER> <NUMBER> <NUMBER> <NUMBER> activation priming innate adaptive immune responses result pathogen clearance recovery however proportion infected individuals sarscov merscov likely sarscov<NUMBER> evade immune system recognition suppression mechanisms phenomenon associated severe disease poorer prognosis <NUMBER> <NUMBER> <NUMBER>figure <NUMBER> red symbols sarscov shown alter ubiquitination degradation rna sensors rigi mda<NUMBER> inhibits activation mitochondrial antiviralsignaling protein mavs essential activation nuclear translocation irf<NUMBER> response cytoplasmic rna sensor activation furthermore sarscov likely sarscov<NUMBER> inhibit tnf receptorassociated factors traf <NUMBER> <NUMBER> central induction irf<NUMBER> response tlr<NUMBER> andor rigi mda<NUMBER> ligation well nfκb signalling pathways usually activated response tlr<NUMBER> ligation cytokine receptor signaling <NUMBER> lastly novel coronaviruses counteract t<NUMBER>ifn signaling inhibition stat family transcription factor phosphorylation <NUMBER> taken together suppression innate immune mechanisms infected epithelial cells extent infected monocytesmacrophages allow novel coronaviruses proliferate without triggering innate antiviral response machinery cells however later stage infected cells undergo cell death release virus particles together intracellular components trigger innate inflammatory mechanisms recognition prrs inon innate immune cells result innate immune activation resultant expression proinflammatory cytokines including il<NUMBER>β il<NUMBER> tnfα etc adaptive immune cells become involved hosts defense viral infections lymphocytes play central role antiviral response including cd<NUMBER> cell derived cytokines cd<NUMBER> cell mediated cytotoxicity b cell activation resulting antibody production novel coronaviruses may also partially escape mechanisms induction cell apoptosis <NUMBER> however lymphocytes may also become depleted due expression proinflammatory cytokines infected innate immune cells become recruited lungs trigger hyperinflammation seen development cytokine storm <NUMBER> symptoms covid<NUMBER> disease may sometimes slightly milder comparison infections sarscov merscov several key pathogenassociated clinical features disease similar extrapolate knowledge already known pathophysiology sars mers covid<NUMBER> sars mers several key findings associated poor outcomes cohort studies suggest hyperinflammation may linked severe disease three early studies wuhan linked cytopenia andor significantly elevated inflammatory parameters severe disease unfavorable outcomes one study involving <NUMBER> patients reported neutrophilia <NUMBER> lymphopenia <NUMBER> increased systemic inflammatory proteins il<NUMBER> <NUMBER> crp <NUMBER> common symptoms covid<NUMBER> disease <NUMBER> another study involving <NUMBER> individuals linked severe disease culminating icu admission mortality neutrophilia lymphopenia <NUMBER> third study reported significant leukopenia <NUMBER> lymphopenia <NUMBER> thrombopenia <NUMBER> anemia <NUMBER> hypofibrinogenemia <NUMBER> hypoalbuminemia <NUMBER> cohort <NUMBER> patients died covid<NUMBER> <NUMBER> <NUMBER> observations line findings severe lethal cases sars mers increased numbers neutrophils monocytesmacrophages present airways <NUMBER> <NUMBER> groups reported severe clinical phenotypes icu dependency patients associated increased plasma levels innate chemokines specifically cxc motif chemokine <NUMBER> cxcl<NUMBER>interferon gammainduced protein <NUMBER> ip<NUMBER> chemokine cc motif ligand <NUMBER> ccl<NUMBER>monocyte chemoattractant protein <NUMBER> mcp<NUMBER> macrophage inflammatory protein mip<NUMBER>accl<NUMBER> proinflammatory cytokine tnfα <NUMBER> indeed similar situation reported sars mers uncontrolled inflammation centrally contributes poor outcomes <NUMBER> <NUMBER> <NUMBER> though seemingly contradictory mechanisms immune evasion discussed enhanced innate immune activation including increased t<NUMBER>ifn il<NUMBER>β il<NUMBER> tnfα expression centrally contributes morbidity mortality covid<NUMBER> mers sars one possible explanation induction endothelial vascular cell damage cell death result viral replication virusinduced inflammatory cell death including necrosis pyroptosis result proinflammatory cytokine expression uninfected immune cell recruitment activation <NUMBER> mice infected sarscov exhibit excessive t<NUMBER>ifn secretion myeloid cells infected tissues indeed immune evasion suppression antiviral responses t<NUMBER>ifn expression respiratory epithelia results high viral loads <NUMBER> hypothesized infected monocytesmacrophages neutrophils recruited site infection exhibit strong poorly controlled inflammatory responses resulting tissue damage systemic inflammation contribute morbidity mortality <NUMBER> figure <NUMBER> another factor thought contribute organ damage poor outcomes early production neutralizing antibodies coronaviruses antibodydependent enhancement ade phenomenon shown contribute damage accrual viral infections shown promote cellular uptake virus particles bound immune complexes binding fcγ receptors fcγr may contribute aforementioned persistent viral replication immune cells including newly infected antigenpresenting cells also immune complex mediated inflammatory responses figures <NUMBER> contribute tissue organ damage including acute respiratory distress syndrome ards <NUMBER> <NUMBER> <NUMBER> indeed subset covid<NUMBER> patients reportedly develop vasculitic lesions blood vessel occlusion infarctions histopathologic reports tissue sections suggests features associated immune complex mediated vasculitis including infiltration monocytes lymphocytes within around blood vessels wall thickening focal hemorrhage <NUMBER> <NUMBER> <NUMBER> <NUMBER> true number systemic autoimmuneinflammatory conditions uncontrolled activation immune responses likely limited innate mechanisms result proinflammatory cytokine expression presence nuclear antigens cell tissue damage adaptive immune cells may become activated trigger second wave inflammation potentially patients deteriorate <NUMBER> days infection indeed adaptive immune cells namely lymphocytes observed lung tissue sections covid<NUMBER> patients ards andor cytokine storm may drive inflammation later disease stages similar mechanisms reported influenza viral infections <NUMBER> <NUMBER> overall severely ill covid<NUMBER> patients experiencing cytokine storm exhibit lymphopenia sometimes atrophy lymphatic tissues namely lymph nodes spleen <NUMBER> <NUMBER> <NUMBER> line reports primary secondary forms hemophagocytic lymphohistiocytosis hlh associated cytokine storm result inflammatory cell death hypocellularity lymphatic organs <NUMBER> poor outcomes associated age indeed children appear contract sarscov<NUMBER> usually develop severe symptoms complications surprising children prone viral infections including severe manifestations <NUMBER> children get exposed seasonal coronaviruses <NUMBER> th birthday seroconverts however antibody titres wane time obvious <NUMBER> years <NUMBER> may reduce immune response sarscov<NUMBER> elderly limited crossreactivity antiseasonal coronavirus antisars antibodies exists also contribute increased inflammation complications immunological recall effects exist antiseasonal coronavirus titres increase sera convalescent sars patients <NUMBER> may influence immune pathology mentioned antibodybound virions enter susceptible cells macrophages fcγ receptor ligation process termed antibodydependent enhancement ade <NUMBER> viral infections eg dengue fever ade allows immune cell infection reduces type ifn dependent antiviral responses promoting proinflammatory il<NUMBER> tnfα expression <NUMBER> <NUMBER> furthermore massive recall antibody production individuals history exposure seasonal coronaviruses waning titres elderly result immune complex deposition promote inflammation damage including immune complex vasculitis <NUMBER> mortality <NUMBER> however heterologous immune responses unrelated antigens may also contrite inflammationrelated complications frequently adults exhibit memory cells specific antigens never exposed crossreactive memory cells narrow cell response favoring high affinity clones indeed limited memory cell repertoires feature immune senescence associated disease progression cell mediated damage viral infections virus hepatitis infective mononucleosis <NUMBER> mentioned ace<NUMBER> acts transmembrane cellular receptor sarscov<NUMBER> allowing cell infection <NUMBER> variable ace<NUMBER> expression patterns affect disease susceptibility tissues eg respiratory epithelia vs immune cells potentially also individuals men vs women children vs adults thereby determining disease progression outcomes recently suggested ace<NUMBER> expression highest children young women expression decreases age lowest individuals chronic disease including diabetes hypertension inversely correlating risk severe disease unfavorable outcomes <NUMBER> ace<NUMBER> facilitates viral entry cells also plays role controlling infection inflammation ace<NUMBER> part ace<NUMBER>angiotensin<NUMBER>mas system counteracts proinflammatory effects angiotensin<NUMBER> catalyzes angiotensin<NUMBER> processing angiotensin<NUMBER> counteracts vasoconstriction modulates leukocyte migration cytokine expression fibrogenic pathways <NUMBER> thus ace<NUMBER> contributes limiting tissue inflammation favoring repair mechanisms furthermore high ace<NUMBER> expression may benefit sarscov<NUMBER> virus particles may compete angiotensin<NUMBER> cell surface binding sites cellular uptake thus relatively increased ace<NUMBER> expression may explain children young adults especially young women relatively protected covid<NUMBER> associated complications taken together novel coronaviruses sarscov<NUMBER> may effectively suppress early t<NUMBER>ifn responses contributes uncontrolled virus replication resulting delayed potentially increased cytokine responses later stages early sufficient control virus replication pathogen clearance may altered individuals risk elderly patients diabetes metabolic syndrome etc <NUMBER> <NUMBER> healthy children young people hand may effectively control viral load early stages infection less frequently develop severe disease lifethreatening complications lastly early antibody production may result integration viable virus immune cells increased viral replication resulting immune complex mediated pathology may contribute pathology young patients obvious risk factors <NUMBER> rapid spread sarscov<NUMBER> infection globally led immediate need vaccine therapeutic intervention prevent treat covid<NUMBER> disease due speed virus spread globally studies potential therapeutics j u r n l p r e p r f interventions vaccine candidates due minimal severity sars <NUMBER> deaths globally mers <NUMBER> deaths globally epidemics studies generate vaccine therapeutic closely related coronaviruses undertaken could efficacy covid<NUMBER> disease clinical trials testing treatments covid<NUMBER> undertaken results large randomized studies though remain outstanding stage result following sections mistaken evidence based treatment recommendations reflect mostly anecdotal experience experimental treatment extrapolation data related conditions expert opinion figure <NUMBER> hydroxychloroquine medical use chloroquine dates back decades phosphate sulphate derivatives administered antimalarials hydroxychloroquine widely used immunomodulatory agent systemic lupus erythematosus addition chloroquine antiviral activity influenza chikungunya virus seasonal covs sars <NUMBER> <NUMBER> <NUMBER> <NUMBER> viruses cell entry replication sarscov<NUMBER> depends phdependent internalization endocytosis lysosomal fusion figure <NUMBER> weak base hydroxychloroquine follows cellular ph gradient accumulates acid environment endolysosomes acidic cell organelles thereby alkalinizing endosomes addition hydroxychloroquine interferes terminal glycosylation ace<NUMBER> interfering virus binding <NUMBER> antiviral activity chloroquine derivatives sarscov<NUMBER> identified vitro early <NUMBER> based drug rapidly introduced clinical use preliminary reports suggested improved viral clearance clinical outcomes covid<NUMBER> patients receiving <NUMBER>days course hydroxychloroquine <NUMBER> small french pilot study randomizing <NUMBER> patients covid<NUMBER> suggested accelerated viral clearance patients treated combination hydroxychloroquine azithromycin <NUMBER> however others challenged results found benefit either disease outcome viral clearance <NUMBER> disappointingly largest also retrospective study date assessing hydroxychloroquine combination azithromycin found benefit indeed increased mortality risk among patients receiving hydroxychloroquine <NUMBER> study exploring chloroquine diphosphate two dosing regimens forced terminate early concerns increased mortality high dose arm authors conclude treatment high dose chloroquine <NUMBER> days sufficiently safe longer used severe sarscov<NUMBER> patients <NUMBER> immunomodulatory effects hydroxychloroquine well established may enhance therapeutic effect covid<NUMBER> complicated macrophage activation cytokine storm <NUMBER> alkalization endosomes reduces proteolysis chemotaxis phagocytosis receptor recycling interferes processing epitopes displayed antigenpresenting cells <NUMBER> overall contributes decreased production il<NUMBER> il<NUMBER> prostaglandins alters intracellular calcium tlr dependent signaling furthermore j u r n l p r e p r f preventing acidification lysosomes hydroxychloroquine impairs cellular autophagy critical step innate adaptive immunity activation <NUMBER> finally hydroxychloroquine antithrombotic effects may beneficial covid<NUMBER> inflammatory stimuli endothelial injury activate coagulation promote microthrombus formation <NUMBER> <NUMBER> generally deemed safe administered correct dosing close monitoring therapeutic range chloroquine derivatives narrow side effects include conduction defects cardiomyopathy retinopathy hypoglycemia <NUMBER> <NUMBER> azithromycin mentioned synergistic effects azithromycin hydroxychloroquine sarscov<NUMBER> observed vitro appeared translate clinical practice <NUMBER> <NUMBER> <NUMBER> interestingly azithromycin also weak base also accumulates endosomes alkalinizing effect least equivalent hydroxychloroquine addition antimicrobial properties azithromycin sometimes used immunomodulatory properties especially patients chronic pulmonary disorders azithromycin polarizes macrophages towards antiinflammatory m<NUMBER> phenotype inhibits proinflammatory stat<NUMBER> nfκb signaling pathways <NUMBER> <NUMBER> context antiinflammatory effects particular interest azithromycin used patients requiring intensive care noncovid<NUMBER> related ards associated significant reduction mortality shorter time extubation <NUMBER> <NUMBER> <NUMBER> adverse cardiac effects proarrhythmogenic properties hydroxychloroquine especially combination macrolide antibiotics azithromycin deserves particular mention <NUMBER> hydroxychloroquine azithromycin lesser extent lopinavir associated prolongation qtc interval increase risk tachyarrhythmias sudden cardiac death careful consideration patient risk profile pretreatment ecg assessment monitoring pharmacokinetics fluid electrolyte status polypharmacy essential management critically ill covid <NUMBER> patients <NUMBER> remdesivir nucleoside analogues nucleoside analogues explored treatment options covid<NUMBER> candidates include favipiravir geldesivir ribavirin remdesivir latter received attention remdesivir prodrug adenosine <NUMBER> originally developed treatment hemorrhagic fever viruses namely ebola ebov marburg viruses underperformed ebov treatment compared antibody strategies antiviral vitro activity mers sars <NUMBER> <NUMBER> competing atp substituting adenosine rna synthesis remdesivir inhibits viral rna dependent rna polymerase rdrp <NUMBER> human mitochondrial rdrp show significantly lower affinity remdesivir compared viral counterparts mitigating side effects host cell <NUMBER> presence covspecific proofreading exonucleases capable removing phosphorylated remdesivir rna chain could present potential development j u r n l p r e p r f resistance remdesivir treatment murine hepatitis virus mouse model showed conferring resistance tradeoff viral fitness magnitude sufficient significantly attenuate viral pathogenicity <NUMBER> timing administration animal models ebov mers crucial remdesivirs efficacy benefit achieved given early <NUMBER> keeping aforementioned phases disease highest virus replication rates early disease hostmediated damage immune responses later stages recent case report however highlights persisting benefits also late administration <NUMBER> remdesivir underwent vitro testing wuhan virus research institute early sarscov<NUMBER> outbreak <NUMBER> identified potently inhibiting viral infection cell cultures concentrations readily achievable vivo first used successfully covid<NUMBER> patient january <NUMBER> <NUMBER> since remdesivir employed compassionate use basis results use <NUMBER> day course reported <NUMBER> patients sarscov<NUMBER> <NUMBER> required ecmo <NUMBER> mechanical ventilation <NUMBER> baseline <NUMBER> significantly reducing mortality assessment randomized controlled trials needed two place china treatment moderate severe covid<NUMBER> recruitment terminated march following declaration containment nct<NUMBER> nct<NUMBER> trials currently ongoing europe north america effective reduction pulmonary viral load animal models acceptable safety profile ebola patients small group covid<NUMBER> patients remdesivir may offer effective viable future treatment option combination lopinavir ritonavir lpvr better known tradenames aluvia® kaletra® frequently used antiretroviral treatment hiv combining two protease inhibitors limits otherwise extensive cyp<NUMBER>a<NUMBER> activation drug metabolism thereby resulting much improved bioavailability lpv <NUMBER> proteases critical viral replication cleave structural functional proteins precursor viral polypeptides figure <NUMBER> thus enabling maturation infectious virion particle lpvr mainly metabolized liver thus preexisting hepatic impairment considered relative contraindication <NUMBER> sars lpvr combination ribavirin associated significant reduction unfavorable outcomes ards death compared ribavirin alone <NUMBER> versus <NUMBER> <NUMBER> similar observations made retrospective cohort study involving <NUMBER> sars patients lpvr associated significantly reduced mortality need intubation <NUMBER> <NUMBER> currently investigated use mers patients ongoing randomized clinical trial early use lpvr recommended based aforementioned pathophysiological considerations rather clinical data view vitro activity sars mers limited clinical data available lpvr treatment critically ill sarscov<NUMBER> patients randomized openlabel trial undertaken wuhan china <NUMBER> recruited almost <NUMBER> covid<NUMBER> patients j u r n l p r e p r f randomized either standard treatment added lpvr <NUMBER> days whilst confirming safety lpvr use covid<NUMBER> significant differences seen groups relation survival time recovery thus leaving authors question whether combination lpvr nucleoside analogue ribavirin would resulted improved outcomes trials exploring therapeutic potential lpvr currentlyongoing httpswwwremapcaporgcoronavirus httpswwwwhointemergenciesdiseasesnovelcoronavirus<NUMBER>globalresearchonnovelcoronavirus<NUMBER>ncovsolidarityclinicaltrialforcovid<NUMBER>treatments recombinant soluble ace<NUMBER> ace<NUMBER> identified key molecule cell invasion see therapeutic blockade control disease aid viral clearance suggested <NUMBER> however unselective ace blockade currently available agents may problematic could alter angiotensin<NUMBER> <NUMBER> antiinflammatory antifibrotic properties <NUMBER> indeed depletion ace<NUMBER> sarscov<NUMBER> may potentially contribute increased disease activity critically ill covid<NUMBER> patients animal studies ace<NUMBER> protects ards <NUMBER> <NUMBER> <NUMBER> angiotensin ii contributes pulmonary pathology including edema fibrosis <NUMBER> thus accumulation angiotensin ii absence ace<NUMBER> may aggravate disease organ damage consequently ace<NUMBER> induction recently suggested covid<NUMBER> treatment <NUMBER> <NUMBER> <NUMBER> <NUMBER> however effects ace<NUMBER> may vary tissues environments intestinal epithelia produce much higher levels ace<NUMBER> bronchial epithelia notable patients develop gastrointestinal symptoms symptoms tend mild patients remain sarscov<NUMBER> positive stool samples long respiratory specimen became negative <NUMBER> <NUMBER> <NUMBER> <NUMBER> based observations one could suggest highlevel ace<NUMBER> expression seen intestine contrast respiratory tract children young people compared individuals risk elderly especially obese chronically ill may protect inflammation tissue damage however additional factors immunological microenvironment regionally variable microbiomes may significantly affect virus uptake replication andor clearance thus exact roles ace<NUMBER> context covid<NUMBER> remains unveiled may complex administration recombinant human ace<NUMBER> neutralize virions prior attachment host cells also explored therapeutic option future attempt exploiting antiinflammatory effect ace<NUMBER> ang<NUMBER>mas axis noncovid<NUMBER> related ards first pilot trials humans published <NUMBER> whilst data supporting efficacy ards treatment option remains outstanding treatment appeared safe well tolerated type <NUMBER> interferons mentioned sarscov<NUMBER> effective inhibits expression type <NUMBER> interferons <NUMBER> resulting tissue damage expression proinflammatory cytokines chemokines infected monocytesmacrophages promote excessive immune cell infiltration cytokine responses <NUMBER> recently also abortive infection j u r n l p r e p r f lymphocytes sarscov<NUMBER> suggested <NUMBER> detailed characterization remains outstanding altogether unaltered virus replication presence tissue damage inflammatory cytokine expression explain ards cytokine storms covid<NUMBER> overcoming immune evasion enhancing antiviral activity may logical treatment strategy sars mers patients recombinant interferons used varying success antiviral activity recombinant ifnα<NUMBER>a ifnα<NUMBER>b ifnβ<NUMBER>a ifnβ<NUMBER>b shown vitro mers sars sars cov<NUMBER> neither mortality viral clearance affected recombinant interferons mers <NUMBER> <NUMBER> however time administration may critical suggested mouse model ifn treatment mers <NUMBER> therefore human patients may received treatment late fully effective plasma convalescent patients convalescent plasma ie plasma individuals following covid<NUMBER> resolution rich immunoglobulins directed sarscov<NUMBER> entertained possible treatment option <NUMBER> <NUMBER> anecdotal use sars mers ebola influenza patients supports use neutralizing andor immunomodulatory agent <NUMBER> <NUMBER> however larger randomized controlled assessment hyperimmune intravenous immunoglobulin use severe influenza <NUMBER> <NUMBER> ebola <NUMBER> showed intervention superior placebo similarly rigorously evaluated data use coronaviral infections lacking use sarscov<NUMBER> <NUMBER> feasibility study exploring use mers found many survivors antibody titres high enough thus limiting donor pool <NUMBER> variable dosing issues surrounding donor recruitment times rapidly increasing patient numbers drawbacks regarding safety widespread use human blood products limit availability utility widely available treatment option finally viruses subject ade searscov<NUMBER> see nonneutralizing antibodies option plasma therapy also holds significant risks complication recently exemplified antizika virus antibodies enhancing dengue virus infection <NUMBER> thus administration hyperimmuneconvalescent plasma may carry risk significant illness upon future exposure related yettoemerge coronaviruses mentioned current management covid<NUMBER> mainly supportive approved treatments based scientific evidence available main causes death include ards cytokine storm syndrome also referred macrophage activation syndrome mas secondary hemophagocytic histiocytosis hlh <NUMBER> <NUMBER> <NUMBER> <NUMBER> indeed ards occurs <NUMBER> patients cytokine storm syndrome <NUMBER> considering impressively rapid development systemic pulmonary inflammation subset patients covid<NUMBER> early identification control derailed immune responses utmost importance based data chinese cohorts markers associated cytokine storm j u r n l p r e p r f conditions may predictive poor outcomes covid<NUMBER> include leukopenia lymphopenia thrombopenia hypoalbuminemia significantly elevated crp il<NUMBER> hyperfibringenemia prolongedthrombin time <NUMBER> <NUMBER> <NUMBER> however needs tested prospectively sensitive specific biomarker may identified first data cytokine storm syndrome catastrophic effects tissues organs generated patients familial hlh mutations associated genes including prf<NUMBER> unc<NUMBER>d stx<NUMBER> stxp<NUMBER> lyst xiap others result systemic inflammation controlled death <NUMBER> standard treatment conditions include highdose corticosteroids dexamethasone calcineurin inhibitor cyclosporine chemotherapy etoposide ultimately stem cell transplantation <NUMBER> underlying molecular causes familial hlh different covid<NUMBER> associated cytokine storm syndrome clinical fevers organomegaly patients laboratory features cytopenias massively elevated inflammatory parameters including crp esr ferritin hypalbuminemia hyperfibrinogenaemia etc consequences tissue organ damage death overlap furthermore based observations h<NUMBER>n<NUMBER> influenza pandemic <NUMBER> significant proportion individuals developing diseaseassociated secondary cytokine storm syndrome may mutations one genes associated familial hlh h<NUMBER>n<NUMBER> <NUMBER> fatalities associated mutations genes associated perforin pathway <NUMBER> thus clinical management covid<NUMBER> associated cytokine storm syndrome may extent informed know familial hlh however treatment covid<NUMBER> associated cytokine storm targeted include cytotoxic drugs andor stem cell transplantation secondary infection hopefully cleared corticosteroids used primary secondary forms hlh control inflammation ards <NUMBER> <NUMBER> first preliminary data sars covid<NUMBER> suggest highdose steroids beneficial effects lung injury <NUMBER> <NUMBER> instead highdose corticosteroids associated complications forms ards including avascular osteonecrosis <NUMBER> short courses lowor mediumdose corticosteroids however suggested benefit chinese cohort critically ill covid<NUMBER> patients <NUMBER> taken together limited data efficacy safety corticosteroids ards anecdotal conclusive controlled trials exist use associated widely variable effects pathogen clearance evidence efficacy lacking highdose corticosteroids cannot generally recommended treatment covid<NUMBER> <NUMBER> use low dose regimens must trialed formal controlled studies <NUMBER> mentioned immune complexes containing viable virus may mediate infection activate fcγ receptors andor deposited tissues organs lastly resulting proinflammatory responses <NUMBER> note ards cytokine storm sars coincided serum conversion majority patients supporting arguments furthermore patients ultimately died seroconverted significantly earlier compared individuals recovered infection <NUMBER> <NUMBER> based observations ivig may benefit patients inhibiting fcγ receptors limiting antibodydependent enhancement discussed furthermore aforementioned classical antiinflammatory effects may limit systemic inflammation antipathogen properties may supportive cases bacterial superinfection patients previously cleared sarscov<NUMBER> developed specific antibodies <NUMBER> <NUMBER> blockade cytokines associated hyperinflammation covid<NUMBER> targeted approach compared use systemic corticosteroids promising therapeutic avenue indeed first anecdotal reports suggest efficacy least patients il<NUMBER> receptor antagonist tocilizumab used successfully patients secondary cytokine storm syndrome <NUMBER> including covid<NUMBER> <NUMBER> <NUMBER> several studies started launched investigating efficacy safety tocilizumab patients secondary cytokine storm syndrome covid<NUMBER> including chictr<NUMBER> china <NUMBER> recombinant il<NUMBER> receptor antagonist anakinra originally developed control cytokine storm associated tissue damage sepsis patients <NUMBER> subsequently anakinra successfully used patients cytokine storm syndrome secondary autoimmuneinflammatory <NUMBER> <NUMBER> infectious malignant disease <NUMBER> anakinra may significant potential controlling hyperinflammation severe covid<NUMBER> disease considering absence severe sideeffects aforementioned sepsis trials <NUMBER> reduced frequency neutropenia hepatotoxicity compared tocilizumab currently anakinra trialled randomised placebocontrolled study children adults covid<NUMBER> associated cytokine storm syndrome china nct<NUMBER> <NUMBER> jak small molecules relatively new concept used systemic autoimmuneinflammatory conditions jaks involved cytokine receptor signaling including limited il<NUMBER> receptor well type <NUMBER> type <NUMBER> ifn receptors <NUMBER> <NUMBER> mediate phosphorylation stat family transcription factors turn involved proinflammatory cytokine expression thus jak inhibitors efficiently limit cytokine expression may aid controlling cytokine storms <NUMBER> however jaks also centrally involved controlling expression t<NUMBER>ifn plays key role limiting virus replication initiating pathogen clearance <NUMBER> least initial stages covid<NUMBER> disease virus replication infection may limited epithelium sarscov<NUMBER> likely limits t<NUMBER>ifn expression see therefore additional j u r n l p r e p r f inhibition jak small molecules may counterproductive limit pathogen containment clearance may cause unforeseeable complications thus jak inhibition may suitable targetdirected treatment option covid<NUMBER> associated cytokine storm syndrome andor ards knowledge least two clinical trials ongoing test efficacy safety jak inhibitors severe covid<NUMBER> chictr<NUMBER> chictr<NUMBER> previously discussed mechanisms infection immune evasion dysregulation innate adaptive immune responses cause significant concern among patients systemic immune modulating treatments including patients malignant systemic autoimmuneinflammatory diseases based previous coronavirus outbreaks sars mers first small observational studies covid<NUMBER> cohorts risk factors poor outcomes include old age presence comorbidities diabetes metabolic syndrome etc obesity male sex coronary heart disease chronic obstructive pulmonary disease kidney disease <NUMBER> note immune modulation suppression identified risk factor poor prognosis china italy <NUMBER> <NUMBER> could generally considered good news immune suppression associated altered immune function may predispose patients infection potentially prolong virus spreading furthermore covid<NUMBER> associated lymphopenia patients receiving immune modulating treatment may prone secondary infections bacterial pneumonia discussed immune modulating drugs may protect viral infections antimalarial drugs chloroquine hydroxychloroquine may inhibit tissue infection viral replication <NUMBER> <NUMBER> furthermore immune modulating medications antimalarial drugs classical well biologic dmards others may prevent control cytokine storm syndromes uncontrolled discontinuation immune modulating treatment may result disease flares autoimmuneinflammatory conditions organ rejection transplant patients reoccurrence malignancies top obvious effects may also increase risk viral infection thus national international societies including acr eular recommend continuation treatment absence symptoms alterations existing treatment regimens agreement close monitoring responsible clinical service <NUMBER> <NUMBER> international collaboration needed way safely assess individual risk vulnerable patient groups reliable data available close clinical monitoring social distancing prioritized j u r n l p r e p r f immunity exist significant proportion humans develop severe disease novel coronavirus sarscov<NUMBER> threat millions globally sarscov<NUMBER> capacity escape innate immune responses allows pathogen produce large copy numbers primarily infected tissues usually airway epithelia infection innate immune cells andor recruitment uninfected cells circulation primary site infection massive immune reactions induce hyperinflammation result cytokine storm lifethreatening complications beginning understand host factors differential expression cell surface proteins may determine infection risk disease presentation outcomes unveiling tissue stage specific factors contributing pathology result new effective disease stage specific therapeutic approaches control virus replication limiting inflammatory damage vaccinations become available rna viruses usually activate tlr<NUMBER> andor <NUMBER> endosomes b cytosolic rna sensors rigi mda<NUMBER> c sarscov<NUMBER> effectively suppresses activation tnf receptorassociated factors traf <NUMBER> <NUMBER> thereby limiting activation transcription factors nfκb irf<NUMBER> <NUMBER> thereby suppressing early proinflammatory responses type interferons ifn proinflammatory effector cytokines il<NUMBER> il<NUMBER> tnfα red symbols furthermore novel covs inhibit activation stat transcription factors response type ifn receptor activation limits antiviral response mechanisms altogether prohibits virus containment activation antiviral programs recruitment immune cells b tissue monocytesmacrophages express ace<NUMBER> significantly lower extent making infection route less likely however immune complexes consisting ineffective antibodies eg seasonal covs virus particles may taken macrophages fcγ receptors resulting infection b process referred antibody directed enhancement ade virions inhibit type ifn signaling infected macrophages allowing proinflammatory il<NUMBER> il<NUMBER> tnfα expression may contribute hyperinflammation cytokine storm syndrome cd inhibited type <NUMBER> ifn signaling suppresses antiviral programs increased il<NUMBER> il<NUMBER> tnfα expression autoamplifies positive feedback loops f j u r n l p r e p r f figure <NUMBER> inflammatory response monocytes macrophages uninfected monocytesmacrophages blood stream invade lungs detect virus particles andor cytoplasmic nuclear components within immune complexes particles taken cell presented tlrs activating nfκb andor irf dependent proinflammatory pathways bc result uninfected monocytesmacrophages produce significant amounts proinflammatory cytokines de recruit additional innate adaptive immune cells cause additional tissue damage approved evidencebased treatments available covid<NUMBER> number treatments promise potential virus particles may caught inactivated using antibodies convalescent patients recombinant soluble ace<NUMBER> protein may bind sarscov<NUMBER> andor mediate antiinflammatory effects prevent pulmonary damage hyperinflammation hydroxychloroquine potentially combination azithromycin change ph endosomes reduce virus entry replication furthermore medications immunemodulating effects may control proinflammatory cytokine expression antiviral treatment protease inhibitors lopinavir ritonavir etc andor nucleoside analogues remdesivir etc limit virus replication sarscov<NUMBER> suppresses antiviral cytokine production virus clearance may also supported substitution type <NUMBER> interferons activate cytokine receptor ifnar induce antiviral cellular programs hyperinflammation resulting tissue damage may prevented immune modulation blocking il<NUMBER> signaling eg recombinant il<NUMBER> receptor antagonist anakinra il<NUMBER> signaling eg il<NUMBER> receptor antibody tocilizumab may limit immune activation tissue damage cytokine storms additional less specific effects may mediated corticosteroids immunoglobulins hydroxychloroquine andor azithromycin severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> new βcoronavirus responsible pandemic viral pneumonia known covid <NUMBER> disease started wuhan china december <NUMBER> rapidly spread throughout world <NUMBER> april <NUMBER> <NUMBER> overall outbreak caused <NUMBER> deaths approximately <NUMBER> infections sarscov<NUMBER> shares genomic similarities two human coronaviruses sarscov merscov <NUMBER> <NUMBER> respectively caused fatal infections past <NUMBER> years <NUMBER> covid<NUMBER> causes wide spectrum clinical manifestations ranging asymptomatic paucisymptomatic forms cough fever myalgia malaise fullblown viral pneumonia lead acute respiratory distress syndrome ards <NUMBER> <NUMBER> currently three phenotypes observed covid<NUMBER> patients indicating three stages infections progression extent mild benign infection <NUMBER> patients minor nonspecific symptoms progress severe disease ii moderate overt pneumonia without hypoxia localized inflammation <NUMBER> patients requiring hospitalization iii severe systemic hyperinflammation ards <NUMBER> patients require critical care management risk fatal outcome <NUMBER> <NUMBER> <NUMBER> despite multiple targeted nontargeted interventions treatment yet proven effective treating covid<NUMBER> numerous clinical trials ongoing pandemic progresses pathophysiology covid<NUMBER> becoming clearer potential multiple cytokine andor anticytokine interventions raised indeed reported covid<NUMBER> associates states immunodeficiency hyperinflammation latter manifested cytokine storm paper summarize todays principal findings attempt establish definitive view covid<NUMBER> pathophysiology focusing one key question lung injury directly induced virus remains poorly explained patients high viral loads long virusshedding periods higher risk severe covid<NUMBER> <NUMBER> early onset rapid viral replication may cause massive epithelial endothelial cell apoptosis vascular leakage well proinflammatory mediator release <NUMBER> furthermore hace<NUMBER> downregulation shedding viral protein cause dysfunction reninangiotensin system exacerbate inflammation vascular permeability leading acute lung injury <NUMBER> <NUMBER> finally recent data suggested sarscov<NUMBER> directly infect cells receptordependent proteinmediated membrane fusion <NUMBER> nevertheless cells low expression level hace<NUMBER> suggesting either alternative receptor high protein affinity hace<NUMBER> cell infection abortive meaning sarscov<NUMBER> cannot replicate within cells rather induces cell death <NUMBER> sarscov infection modulation tnfαconverting enzyme tace adam<NUMBER> spike protein sarscov hace<NUMBER> induces tnfα production may accentuate cell apoptosis <NUMBER> <NUMBER> vein xiong et al reported upregulation apoptosis autophagy p<NUMBER> pathways pbmcs covid<NUMBER> patients compared healthy controls <NUMBER> epidemiological studies demonstrated elevation acute phase reactants patients covid<NUMBER> including esr creactive protein crp serum amyloid ferritin suggesting rapid activation innate immune response <NUMBER> <NUMBER> <NUMBER> <NUMBER> accordingly covidpulmonarycentric disease driving accumulated immune cells lungs restricting immune response particular organ stated typei ifn critical protecting viral infections since promotes intracellular rna degradation virus clearance induces tissue repair triggers prolonged adaptive immune response <NUMBER> <NUMBER> <NUMBER> typei ifn mainly produced plasmacytoid dendritic cells pdcs less sensitive productive viral infection andor virusmediated cytotoxicity produce inflammatory cytokines tnfα il<NUMBER> control cell response <NUMBER> <NUMBER> pdcs circulating immune cells act sentinels activated physical contact virallyinfected cells transfer pamps tlr<NUMBER> sensors pdcs part process termed interferogenic synapse <NUMBER> considering <NUMBER> overlap sarscov sarscov<NUMBER> speculated latter uses similar strategies dampen innate immune response nevertheless sarscov<NUMBER> appears lower pathogenicity sarscov <NUMBER>fatality rate suggesting lesser ifn antagonism <NUMBER> hand exceptional genetic defects j u r n l p r e p r f immunosenescence may account reduced typei ifn response greater severity covid<NUMBER> accordingly increased age associated poorer outcome <NUMBER> <NUMBER> <NUMBER> <NUMBER> mouse models sarscov merscov infections delayed typei ifn response may explain severe disease compromised virus control paradoxical hyperinflammation induced typei ifn <NUMBER> leads influx neutrophils monocytesmacrophages major sources proinflammatory cytokines apoptosis cells epithelial endothelial cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> acute inflammatory mechanisms damage pulmonary microvascular alveolar barrier cause vascular leakage alveolar edema converging ards therefore strength response also timing would appear play critical role coronavirus infection figure <NUMBER> vitro sarscov<NUMBER> displays greater sensitivity typei ifn sarscov <NUMBER> furthermore sarscov<NUMBER> impair stat<NUMBER> phosphorylation interestingly mildmoderate infection sarscov<NUMBER> associated potent typei ifn response characterized robust expression isgs patients balfs <NUMBER> moreover preliminary results revealed early ifn production peripheral blood patients mildmoderate severe forms first week covid<NUMBER> trouilletassant et al press contrast <NUMBER> displayed ifn production another study found typei ifn response high days <NUMBER> mildtomoderate patients reduced severe patients striking downregulation ifnstimulated genes <NUMBER> results line previous conclusions would indicate characteristics typei ifn response terms kinetics intensity could linked clinical outcome <NUMBER> exactly sarscov<NUMBER> escapes typei ifn patients remains elucidated lymphopenia one prominent markers covid<NUMBER> observed <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> analyses shown subsets lymphocytes decreased including cd<NUMBER> cd<NUMBER> cytotoxic cells <NUMBER> <NUMBER> natural killer nk cells memory regulatory cells <NUMBER> along b cells <NUMBER> lower lymphocyte counts closely linked severe disease <NUMBER> <NUMBER> addition quantitatively decreased cells exhibit elevated exhaustion levels reduced functional diversity <NUMBER> <NUMBER> cell numbers negatively correlated serum il<NUMBER> il<NUMBER> tnfα higher levels exhaustion markers pd<NUMBER> tim<NUMBER> <NUMBER> <NUMBER> <NUMBER> patients severe form covid <NUMBER> less multifunctional nonfunctional cd<NUMBER> cells well fewer nonexhausted cd<NUMBER> cells patients mild covid<NUMBER> <NUMBER> several explanations posited explain sarscov<NUMBER>induced lymphopenia first virus directly infect cells cannot replicate within cells <NUMBER> cell infection may thus result cell death apoptosis necrosis pyroptosis <NUMBER> <NUMBER> <NUMBER> second number inhibitory cytokines released infected lung macrophages epithelial cells first wave hypercytokinemia including tnfα causes cell apoptosis <NUMBER> il<NUMBER> known prevent cell proliferation <NUMBER> typei ifn regulates lymphocyte recirculation <NUMBER> cell exhaustion characterizing severe covid<NUMBER> may stem increased pd<NUMBER> tim<NUMBER> expression elevated levels inhibitory il<NUMBER> <NUMBER> increased il<NUMBER>induced expression socs<NUMBER> <NUMBER> <NUMBER> <NUMBER> interestingly il<NUMBER> il<NUMBER> cytokines responsible expansion differentiation various cell subsets increased sera patients either mildmoderate severe forms covid<NUMBER> <NUMBER> nevertheless increased levels likely represent attempts immune system reverse lymphopenia cell exhaustion lastly lymphopenia thought result immune cells redistribution accumulation lymphocytes lungs lymphoid organs <NUMBER> however though pathological results scarce contradictory would seem alveolar interstitial tissues invaded lymphocytes rather monocytes macrophages moderate numbers multinucleated giant cells <NUMBER> intriguingly autopsies revealed secondary lymphoid tissues destroyed atrophied spleen decreased lymphocyte numbers accompanied significant cell degeneration focal hemorrhagic necrosis plus macrophage proliferation phagocytosis lymph nodes atrophied number decreased signs necrosis immunohistochemical staining demonstrated decreased rates cd<NUMBER> cd<NUMBER> cells spleen lymph nodes <NUMBER> sudden rapidly progressing clinical deterioration widely mentioned late stages covid<NUMBER> around <NUMBER> days often manifests unexpected aggravation symptoms fever dyspnea correlated increased levels acute phase reactants esr crp ferritin coagulopathy elevated titers ddimers disseminated intravascular coagulation cell lysis ck ldh <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> severe patients clinical laboratory parameters correlated increased levels proinflammatory cytokines il<NUMBER>β il<NUMBER>ra il<NUMBER> tnfα sil<NUMBER>rα evocative cytokine storm <NUMBER> <NUMBER> <NUMBER> <NUMBER> interestingly ards occurs sarscov patients despite diminishing viral load suggesting exuberant host immune response may responsible outcome rather viral virulence cytokine profile strongly reminiscent cytokine release syndrome crs seen car cell therapy hemophagocytic lymphohistiocytosis hlh <NUMBER> <NUMBER> numerous authors paralleled covid<NUMBER> cytokine storm either primary reactive hlh rehlh close resemblance including high fever cytopenia j u r n l p r e p r f hyperferritinemia abnormal liver tests coagulopathy pulmonary involvement including ards occurring approximately <NUMBER> patients rehlh <NUMBER> <NUMBER> <NUMBER> adults rehlh often triggered viral infections observed <NUMBER> <NUMBER> sepsis cases <NUMBER> herpesviridae eg epsteinbarr virus influenza major triggers cytokine storms <NUMBER> systemic diseases like systemic lupus erythematosus autoinflammatory adultonset stills disease pediatric counterpart also complicated cytokine storm known macrophage activation syndrome identical rehlh <NUMBER> <NUMBER> <NUMBER> conditions il<NUMBER>β il<NUMBER> ifnγ il<NUMBER> key mediators hyperinflammation similar observed sarscov<NUMBER> infection immunodeficiency linked abnormal cell number function genetically determined primary hlh appears primum mobile cytokine storms <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> although alternative pathway primary hyperactivated innate immunity possible likely cytokine storm occurs due combination defective delayed first line defense followed persistent hypercytokinemia il<NUMBER> il<NUMBER>β tnfα dysfunctional cell response generally cytotoxicity results impaired clearance apoptic cells infectedactivated macrophages increase viral replication dissemination followed il<NUMBER>ifnγ feedforward loop activating macrophages culminating multiple cytokine release hemophagocytosis coagulopathy ards figure <NUMBER> <NUMBER> <NUMBER> <NUMBER> mediators may fuel vicious cycle including nk cell function impairment il<NUMBER> <NUMBER> macrophage activation hchain ferritin <NUMBER> <NUMBER> <NUMBER> quite importantly hemophagocytosis reported lung tissues patients succumbed sarscov infection <NUMBER> thus covid<NUMBER> onset ards may consequence hlhlike syndrome first period lung damage mainly localized within lungs due prior accumulation large amounts innate immune cells systemic features hlh lacking extremely high titers ferritinemia organomegaly severe endorgan disease probably consequence lymphoid organ immune cell depopulation <NUMBER> analysing precisely immunopathology sarscov<NUMBER>related ards giamarellosbourboulis et al come conclusion two patterns immune dysfunction exist worsening covid<NUMBER> one pattern highly suggestive macrophage activation syndrome hyperferritinemia elevated h score <NUMBER> patients driven il<NUMBER>β ii one pattern immune dysregulation driven il<NUMBER> <NUMBER> latter characterized combination hypercytokinemia immunoparalysis indicated decreased hladr molecules cd<NUMBER> monocytes global lymphopenia including cd<NUMBER> nk cells interestingly il<NUMBER> blockade tocilizumab partially restored hladr expression cd<NUMBER> monocytes increased circulating lymphocyte count number key points stand overview immunopathology sarscov<NUMBER> infection <NUMBER> virus induces impairment hyperactivation immune system sequential latter seems ensue former least partially <NUMBER> early viral clearance typei ifn key preventing viral replication cell exhaustion subsequent cytokine storm <NUMBER> therapies applicable administered right timing ie nonetheless except advanced age elevated body mass index comorbid conditions still lack robust prognostic factors <NUMBER> <NUMBER> <NUMBER> <NUMBER> routine nonroutine markers monitored help evaluate risk developing cytokine storm however present cutoff value yet proposed markers would great benefit analyze trends depth along daily clinical evaluation since typei ifns key role antiviral response low delayed ifn response associated poor outcome ifnα ifnβ emerged potentially effective drugs sarscov<NUMBER> <NUMBER> <NUMBER> evidence mainly derived experience sarscov merscov infections <NUMBER> vivo typei often used combination antiviral drugs lopinavirritonavir <NUMBER> <NUMBER> <NUMBER> <NUMBER> ribavirin <NUMBER> <NUMBER> <NUMBER> vitro ifnα β systematically demonstrated robust efficacy coronaviruses proved disappointing transposed human diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> multiple biases trials prevented drawing conclusions biases include coronavirus escape strategies typei ifn limited sample sizes heterogeneous experimental designsclinical conditions nature ifn isoform administration route plus difficulties assessing whether disease outcome linked typei ifn drugs used combination key points emerged studies ifnβ<NUMBER>b ifnβ<NUMBER>a potent subtypes sarscov inhibition probably even sarsj u r n l p r e p r f cov<NUMBER> <NUMBER> <NUMBER> <NUMBER> ii typei ifn must administered soon possible infection ideally symptom onset although late phase possible tissue damage <NUMBER> <NUMBER> <NUMBER> <NUMBER> iii although ifnα inhalation lower sarscov<NUMBER> infection rate serve prophylaxis treatment chinese guidelines <NUMBER> preferred solutions remain betterevaluated safer intravenous subcutaneous routes <NUMBER> <NUMBER> amounted zero groups whereas <NUMBER> new covid<NUMBER> cases diagnosed among medical personnel period despite problems major bias study suggests ifnα<NUMBER>b could serve efficient prophylactic covid<NUMBER> additional welldesigned studies involving timely administration ifnα thus eagerly awaited lymphopenia lymphocyte exhaustion hallmarks covid<NUMBER> possibly responsible cytokine storm due defective clearance virus infected cells thus tempting speculate il<NUMBER> major cytokine promoting lymphocyte expansion possibly reversal cell exhaustion may useful restoring immune system homeostasis il<NUMBER> exerts antiapoptotic properties induces potent proliferation naive memory cells leading replenishment circulating pool cd<NUMBER> cd<NUMBER> <NUMBER> <NUMBER> il<NUMBER> also increases cell receptor repertoire diversity <NUMBER> promote expression cell adhesion molecules improving capacity cells traffic infection sites <NUMBER> importantly administration recombinant il<NUMBER> ril<NUMBER> induce hyperinflammatory response stimulating adaptive immunity indeed ril<NUMBER> successfully used treat cell exhaustion following septic shock restore cd<NUMBER> cells hiv patients evidence clinical deterioration proinflammatory marker exacerbation tnfα il<NUMBER> crp <NUMBER> <NUMBER> surprisingly time writing review trial registered yet evaluate strategy study launched perfect timing lymphocyte restoration would need strictly determined j u r n l p r e p r f il<NUMBER> major mediator within cytokine storm levels closely correlated ards severity outcome along blood sarscov<NUMBER> viral load <NUMBER> <NUMBER> <NUMBER> recent metaanalysis reported <NUMBER>fold higher serum levels patients complicated covid<NUMBER> compared patients noncomplicated disease <NUMBER> inhibitors il<NUMBER> receptor successful treating cytokine storm syndromes rehlh associated adultonset stills disease <NUMBER> crs secondary car cell therapies <NUMBER> <NUMBER> several drugs available including il<NUMBER> receptor inhibitors tocilizumab sarilumab il<NUMBER> inhibitors siltuximab clazakizumab sirukumab <NUMBER> trend though statistical difference toward lower mortality tocilizumab welltolerated yet author reported two mild liver test disturbances one ventilatoracquired pneumonia mixed results must clarified notably since experimental models shown il<NUMBER> either suppress facilitate viral replication <NUMBER> one crucial remaining question answer optimal timing antiil<NUMBER> administration early drugs may adversely affect viral clearance late drugs may effective enough used context clinical trial due knowledge gap <NUMBER> il<NUMBER>β natural antagonist ie il<NUMBER>ra observed peripheral blood balf patients covid<NUMBER>induced pneumonia <NUMBER> <NUMBER> <NUMBER> <NUMBER> striking result since il<NUMBER>β short halflife serum rarely isolated peripheral blood finding suggests high levels il<NUMBER>β production reinforced reports indicating il<NUMBER>b il<NUMBER>r<NUMBER> gene upregulations <NUMBER> il<NUMBER>β proinflammatory cytokine activated secreted upon activation inflammasome <NUMBER> nlrp<NUMBER> mostfrequently studied inflammasome activated danger signals suggested viroporin e protein orf<NUMBER> proteins sarscov merscov <NUMBER> <NUMBER> <NUMBER> pyroptosis also associated coronavirus infection <NUMBER> <NUMBER> elevated il<NUMBER>β central ards <NUMBER> hlh <NUMBER> <NUMBER> indeed hlh wellknown frequent complication <NUMBER> juvenile adultonset stills disease whith pathophysiology marked high levels il<NUMBER>β <NUMBER> <NUMBER> anakinra recombinant il<NUMBER>ra proved effective treating hlh via continuous intravenous infusion <NUMBER> <NUMBER> currently used il<NUMBER>induced autoinflammatory diseases including cryopyrinopathies dominant nlrp<NUMBER> gainoffunction <NUMBER> familial mediterranean fever pyrin inflammasome deregulation <NUMBER> pfapa <NUMBER> stills disease <NUMBER> reanalysis data phaseiii randomized trial anakinra associated significant survival improvement patients severe sepsis features rehlh without triggering serious adverse events <NUMBER> today anakinra evaluated context provide study nct<NUMBER> canakinumab monoclonal antibody targeting il<NUMBER>β also investigated singlearm observational study nct<NUMBER> however longer halflife <NUMBER> days may problematic infected patients il<NUMBER> mainly produced macrophages inactive precursor processed inflammasomeactivated caspase<NUMBER> like il<NUMBER>β <NUMBER> <NUMBER> binding il<NUMBER>r il<NUMBER> combination il<NUMBER> acts cd<NUMBER> cd<NUMBER> cells nk cells induce ifnγ major driver macrophage activation syndrome ie hlh <NUMBER> <NUMBER> <NUMBER> <NUMBER> il<NUMBER> one upregulated cytokines sera balf covid<NUMBER> patients <NUMBER> <NUMBER> addition il<NUMBER> reported biomarker stills disease levels correlated disease activity <NUMBER> high levels serum il<NUMBER> also reported patients newlydescribed autoinflammatory disease associating pulmonary alveolar proteinosis j u r n l p r e p r f recurrent macrophage activation syndrome il<NUMBER>papmas <NUMBER> tadekinig alfa recombinant il<NUMBER> binding protein il<NUMBER>bp naturallyoccurring inhibitor il<NUMBER> shown encouraging results stills disease <NUMBER> <NUMBER> interestingly ril<NUMBER>bp uused successfully treat <NUMBER>week old girl lifethreatening nlrc<NUMBER>associated hyperinflammation hlh refractory corticosteroids il<NUMBER> blockade antitnf cyclosporine vedolizumab <NUMBER> although blocking il<NUMBER> could interest covid<NUMBER> clinical evidence registered rct assessing safety efficacy ril<NUMBER>bp framework intriguingly central cytokine storm occurrence sarscov infection <NUMBER> ifnγ found elevated sera balfs patients severe forms covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> actually even conflicting results showing mild elevation sera nonsevere patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> however one metaanalysis shown link high il<NUMBER>ifnγ ratio disease severity thereby indicating lower levels ifnγ rather predict poorer outcomes <NUMBER> emapalumab monoclonal antibody directed ifnγ approved treating pediatric adult primary hlh patients refractory recurrent progressive disease intolerance conventional therapy despite lack clinical trial data adults <NUMBER> <NUMBER> however single rct <NUMBER> patients serious adverse reactions occurred <NUMBER> recipients including bacterial viral opportunistic infections multiple organ dysfunction syndrome addition data mouse models suggest simultaneously inhibiting multiple cytokinesignaling pathways jak inhibitors may effective targeting ifnγ alone <NUMBER> <NUMBER> rcts ongoing evaluate emapalumab hlh either primary j u r n l p r e p r f reactive nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> covid<NUMBER> nct<NUMBER> tnf present covid<NUMBER> patients blood diseased tissues levels even higher patients severe disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> since tnf inhibitors readily available wellevaluated drugs authors postulate sufficient evidence conduct clinical trials covid<NUMBER> <NUMBER> nevertheless literature remains scanty exploring possible treatments cytokine storm hlh indeed case reports described benefits etanercept <NUMBER> <NUMBER> <NUMBER> studies shown may trigger worsen disease progression <NUMBER> <NUMBER> <NUMBER> however cases argue tnf inhibitors use covid<NUMBER> tnf neutralization provides protection sarscov infection animal models <NUMBER> ii antitnf induce rapid decrease il<NUMBER> il<NUMBER> concentrations patients active rheumatoid arthritis <NUMBER> iii antitnf trigger reduction adhesion molecules vascular endothelial growth factor partly responsible capillary leak <NUMBER> <NUMBER> iv antitnf lead less leucocyte traffick inflamed tissues due reduced adhesion molecules chemokines subsequent reduction cell content exudate <NUMBER> suggested initial assessments tnf inhibitors done patients moderate disease soon possible admission hospital <NUMBER> date single rct evaluating adalimumab covid<NUMBER> registered chictr<NUMBER> j u r n l p r e p r f corticosteroids potent cytokine inhibitors working several mechanisms mainly inhibiting nfκb transcription factor cornerstone treatments cytokine storms hlh associated autoimmuneautoinflammatory diseases however use managing sarscov<NUMBER> patients currently highly contested <NUMBER> <NUMBER> <NUMBER> indeed systematic review observational studies corticosteroids administered sarscov infected patients reported survival benefit plus potential harm although mostly inconclusive <NUMBER> similarly systematic review observational studies influenza found higher risk mortality secondary infections highdose corticosteroids <NUMBER> study patients given corticosteroids merscov infection revealed delayed clearance virus zero effect corticosteroids mortality <NUMBER> finally previous guidelines recommend corticosteroid use treating sepsis absence refractory shock recent statement triggered analysis two rcts made weak recommendation use corticosteroids sepsis patients <NUMBER> altogether become apparent corticosteroids may detrimental beneficial covid<NUMBER> well idsa recommends used outside clinical trials <NUMBER> however given data derived previous infections corticosteroids binding hace<NUMBER> vitro inhibit viral cycle <NUMBER> addition used autoimmune inflammatory diseases mainly systemic lupus erythematosus immunomodulating properties hypothesized action tied ability accumulate lysosomes raise ph interfere antigen degradation presentation cd<NUMBER> cells <NUMBER> <NUMBER> data also indicate reduce proinflammatory il<NUMBER> il<NUMBER> tnfα <NUMBER> <NUMBER> lastly inhibit endosomal tlrs antiinflammatory effects inhibiting prostaglandin synthesis lipid peroxidation <NUMBER> <NUMBER> <NUMBER> altogether chloroquine hydroxychloroquine thought able reduce viral load prevent cytokine storm time writing review seven articles reporting clinical data observational studies clinical trials either positive n<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> negative n<NUMBER> results <NUMBER> <NUMBER> <NUMBER> <NUMBER> definitive conclusions currently drawn major biases studies <NUMBER> several rcts also ongoing evaluate j u r n l p r e p r f journal preproof drugs context covid<NUMBER> n<NUMBER> registered wwwclinicaltrialsgov n<NUMBER> chinese clinical trial registry conclusion noteworthy several national guidelines already include chloroquine hydroxychloroquine whereas idsa recommends reserving use combination azithromycin clinical trials drugs currently investigated jak inhibitors ie tofacitinib nct<NUMBER> baricitinib nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> ruxolitinib nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> colchicine jakstat pathway lies downstream several cytokines increased hlh thus attractive target abrogate signaling multiple cytokine pathways <NUMBER> however caution applied using jak inhibitors covid<NUMBER> complicated coagulopathy increased frequency thromboembolic events fda recently warned clinicians increased thromboembolism risk jak inhibitors <NUMBER> ii treatment jak inhibitors associated increased frequency herpes zoster virus reactivation iii panjak inhibitors may repress cytokines required antiviral defense typei ifn immune restoration il<NUMBER> il<NUMBER> <NUMBER> <NUMBER> colchicine longestablished drug antiinflammatory properties used treat patients behçets disease familial mediterranean fever colchicine inhibits il<NUMBER>β subsequent inflammatory cascade principally blocking pyrin lesser extent nlrp<NUMBER> inflammasome activation data indicating pyrin activated upon sarscov<NUMBER> infection would appear rather unlikely j u r n l p r e p r f hand nlrp<NUMBER> likely activated following virus entry cell <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> nevertheless inhibition nlrp<NUMBER> inflammasome colchicine firmly demonstrated since vitro prevent il<NUMBER>β secretion induced typical nlrp<NUMBER> stimuli ie atp nigericin <NUMBER> five rcts currently way test efficacy colchicine covid<NUMBER> patients nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> rapid diffusion covid<NUMBER> drives urgent search effective treatments mainly severe forms disease polyphasic nature secondary cytokine storm ards resulting poor outcomes plus overwhelmed intensive care units hospitals early stages disease treatment focus reducing viral load either specific antivirals stimulating typei ifn later selected patients therapies targeting proinflammatory cytokines could suppress hyperinflammation cytokines il<NUMBER> could theoretically trigger immune restoration clinical practice unfortunately patients unlikely detected early enough ie beforeat symptom onset benefit antiviral strategies therefore factors predict progression toward severe forms disease present urgently needed awaited determinants highlystructured approach includes immune monitoring would thus utmost importance j u r n l p r e p r f associated circulating levels il<NUMBER> il<NUMBER> tnfα ifnγ c reactive protein antiinflammatory agents believed combat severe covid<NUMBER> patients suggest antiinflammatory drugs used carefully based observation least patients tested circulating levels inflammatory cytokines launching antiinflammatory treatment summary study benefit guidance covid<NUMBER> clinical treatment strategy pandemic outbreak coronavirus disease <NUMBER> covid<NUMBER> sharply spreading world severity viral disease usually positive association immunemediated inflammatory responses aggressive persistent inflammatory response leads high risk multiorgan failure death <NUMBER> antiviral drugs generally effective approach treat severe viral infection however resistant viruses may arise upon administration antiviral drugs <NUMBER> thus antiinflammation agents critical releasing severity disease viral clearance overproduction inflammatory cytokines results cytokine storm cytokine storm indicates excessive release proinflammatory cytokines including c reactive protein proinflammatory cytokines tnfα il<NUMBER> et al <NUMBER> extraordinary body evidences suggest severe covid<NUMBER> patients cytokine storm <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> high levels cytokines manifest destructive process leading pneumonia vascular endotheliitis coagulopathy lifethreatening respiratory symptoms covid<NUMBER> patients <NUMBER> <NUMBER> moreover coagulopathy recently showed associated covid<NUMBER> severity caucasian patients <NUMBER> however relationship cytokines storm covid<NUMBER> pathology still keeps elusive analyzed cytokines level covid<NUMBER> patients admitted intensive care unit icu hypoxemic respiratory failure found cytokine storm il<NUMBER> il<NUMBER> tnfα ifnγ c reactive protein absent <NUMBER> patients observation suggest antiinflammation agents apply patient although icu highlight circulating levels inflammatory cytokines tested antiinflammatory treatment case inhibition essential excessive cytokines priming immune responses sarscov<NUMBER> nonappropriate antiinflammatory treatment might harmful context covid<NUMBER> pandemic total <NUMBER> patients <NUMBER> <NUMBER> years old confirmed sarscov<NUMBER> positive nasopharyngeal swabs clinical characteristics chest ct scans indicate patients severe covid<NUMBER> patients admitted icu inflammatory cytokines immune cells peripheral blood patients detected patients admitted icu hypoxemic respiratory failure comorbidities hypertension <NUMBER> <NUMBER> diabetes <NUMBER> <NUMBER> <NUMBER> surviving patients discharged icu hospital ward discharged home showed table <NUMBER> inflammatory cytokines including c reactive protein il<NUMBER> il<NUMBER> il<NUMBER> tnfα ifnγ normal value range compared reference value cases showed il<NUMBER> il<NUMBER> tnfα ifnγ c reactive protein level associated severe covid<NUMBER> pathology however il<NUMBER> il<NUMBER> level severe covid<NUMBER> patients reference value indicate covid<NUMBER> patients severe clinical characteristics independent circulating levels inflammatory cytokines peripheral blood including il<NUMBER> il<NUMBER> tnfα ifnγ c reactive protein prognostic prediction based machine learning tools <NUMBER> study c reactive protein normal range patients admitted icu patients surviving observation consistent reports indicating c reactive protein biomarkers covid<NUMBER> mortality <NUMBER> dissertation level role proinflammatory cytokines pathophysiology covid<NUMBER> critical evaluation anticytokine therapy present limited experience cytokine inhibitors affects covid<NUMBER> patients sarscov<NUMBER> might well adapt humans viral genomic rna intermediates recognized immune sysytem activation downstream inflammation cascades study emphasizes circulating levels il<NUMBER> il<NUMBER> tnfα ifnγ c reactive protein associated severity covid<NUMBER> symptoms address severe covid<NUMBER> independent inflammation response would fundamental question us understand covid<NUMBER> pathophysiology covid<NUMBER> disparate features term severity mortality spread across countries striking variation mortality rates observed different countries <NUMBER> enormous differences human leukocyte antigen hla haplotype might confer article protected copyright rights reserved different immune response sarscov<NUMBER> leads variation severity mortality spread rates covid<NUMBER> <NUMBER> however causation covid<NUMBER> severity mortality requires investigation reports showed cytokine storm correlated severity mortality covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> correlation indicate causation viral replication also could drive consequent severity covid<NUMBER> janus kinase jak inhibitors targeting cytokines jakdependent signaling thought potential restrain excessive level cytokine signaling <NUMBER> currently il<NUMBER>r il<NUMBER> inhibitors used covid<NUMBER> patients already launched experts hope il<NUMBER>r il<NUMBER> inhibitors could inhibit hyperinflammatory response covid<NUMBER> patients independent viral clearance <NUMBER> hypothesis blocking cytokine storm eases covid<NUMBER> severity needs careful investigation based observation least patients tested circulating levels inflammatory cytokines launching antiinflammatory treatment icu intensive care unit crp c reactive protein coauthors approved manuscript agreed publication patient consents participate study applicable authors conflict interest declare article protected copyright rights reserved funding work supported grants state key laboratory veterinary biotechnology <NUMBER> qw authors contributions qw conceptualized study qw wl analyzed data wl jz contributed manuscript preparation wl wz yl collected patients information qw wrote first draft manuscript authors contributed revising manuscript read approved final version publication coronavirus disease <NUMBER> covid<NUMBER> severe public health emergency worldwide caused severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> <NUMBER> number confirmed cases mortality rate increasing worldwide world health organization acknowledged covid<NUMBER> pandemic march <NUMBER> <NUMBER> <NUMBER> currently many efforts diagnose number patients symptoms close contacts prevent spread community may prevent spreading virus perfectly moreover many confirmed cases occurring diagnosis definite guideline initial therapeutic approach therefore many patients dying covid<NUMBER> symptoms severe patients hospitalized treatment done though established yet currently however treatment provided isolated home shelter among also cases severe lung injury cytokine storm progressed <NUMBER> leading sudden death case fatality rates countries especially italy spain high effective therapeutic measures urgently needed <NUMBER> review discuss important points dedicated management patients covid<NUMBER> help reducing morbidity mortality risk develop acute lung injury followed acute respiratory distress syndrome ards eventually death circumstance called cytokine release syndrome crs cytokine storm <NUMBER> main pathogenesis covid<NUMBER> may similar viruses influenza others however efforts make potential hypothesis covid<NUMBER> could cause higher incidence acute lung injury ards cytokine storm death viruses going make simple hypothetical model inflammatory processes cytokine storm covid<NUMBER> understand pathophysiology covid<NUMBER> associated lung injury ards cytokine storm • first covid<NUMBER> sarscov<NUMBER> first attached angiotensin converting enzyme <NUMBER> ace<NUMBER> receptors nasopharynx respiratory epithelium <NUMBER> • second host immune responses initiated entry covid <NUMBER> cells proinflammatory cytokines induced covid<NUMBER> formed various kinds immune cells cells bcells macrophages others <NUMBER> <NUMBER> • third degree increase proinflammatory cytokines determines degree covid<NUMBER>induced lung injury increase proinflammatory cytokines higher injury lung tissue severe ards could related higher mortality • fourth degree increase proinflammatory cytokines covid<NUMBER> higher induced viruses especially effect pronounced older age comorbid conditions • fifth reason effect less pronounced younger age groups may obscure could due immaturity immune system predominance th<NUMBER> immunity th<NUMBER> groups • sixth reason effect pronounced older age groups comorbid conditions may obscure could due preexisting subclinical subtle inflammations represented increased highsensitive crp hscrp groups • seventh exaggerated increase proinflammatory cytokines covid<NUMBER> could due hyperactivation various kinds immune cells response nprotein covid<NUMBER> called cytokine storm • eighth increase proinflammatory cytokines induced covid<NUMBER> cytokine storm cause acute lung injury ards eventually multiorgan failure • ninth cytokine storm may start early course disease later stage according degree activation host immune response may rapidly progressive time • tenth may clinicopathologic noncorrelations <NUMBER> patient may asymptomatic mild symptoms despite severely progressed conditions delay appropriate treatment early stage pathogenesis covid<NUMBER> summarized fig <NUMBER> regarding immunity <NUMBER> states <NUMBER> immunosuppressive state <NUMBER> normal immune state also classified lower normal normal upper normal <NUMBER> hyperimmune state <NUMBER> normal persons distributed <NUMBER> <NUMBER> scale according degree antiviral immunity mostly represented th<NUMBER> response person immunocompromised heshe minus points scale lower minus number located severe immunosuppressive condition number higher <NUMBER> person get hyperactivated host immune response lung injury ards multiorgan failure person infected usual respiratory viruses rhinovirus influenza heshe fever sore throat caused host immune response however degree increase inflammatory reaction <NUMBER> person number immunity scale <NUMBER> infected viruses number scale increase <NUMBER> however degree increase inflammatory reaction patients current covid<NUMBER> <NUMBER> therefore person number immunity scale <NUMBER> infected covid<NUMBER> number scale increase <NUMBER> means high probability patient progress cytokine storm due hyperactivated immune response might lead death younger age groups immune system may immature may predominance th<NUMBER> immunity th<NUMBER> <NUMBER> might number immunity scale <NUMBER> therefore even though infected covid<NUMBER> number increased <NUMBER> covid<NUMBER> number located <NUMBER> <NUMBER> therefore lower possibility progress severe cytokine storm may explain less mortality group however person older age group multiple comorbidities aging process atherosclerosis hypertension diabetes mellitus metabolic syndrome chronic kidney disease might preexisting subclinical subtle inflammations represented increased hscrp groups <NUMBER> therefore might number immunity scale <NUMBER> therefore infected covid<NUMBER> number <NUMBER> increased covid<NUMBER> number located <NUMBER> <NUMBER> therefore high possibility progress severe cytokine storm may explain high mortality group surely additional factors influence susceptibility severity covid<NUMBER> genetic variant different polymorphisms environmental factors smoking addition basic <NUMBER> increase degree inflammatory reaction patient progressed cytokine storm number rapidly increase <NUMBER> going discuss use steroids later basic increase <NUMBER> various proinflammatory cytokines induced covid<NUMBER> might suppressed shortcourse low dose steroids early stage disease steroids may effective later stage disease ards multiorgan failure suppress cytokine storm <NUMBER> cannot suppressed even though high dose steroids used recently hydroxychloroquine shown effective covid<NUMBER> <NUMBER> drug may reduce increase degree inflammatory reaction however know agent may better decreasing inflammatory reactions much number might decreased steroids hydroxychloroquine addition rate bacterial complications increase accordance progression time covid<NUMBER> think bacterial complication combined cytokine storm severe inflammatory reactions although theory may perfect may helpful understand pathogenesis potential harms covid<NUMBER> guide patients treated evidence based medicine ebm conscientious explicit judicious reasonable use modern best evidence making decisions care individual patients <NUMBER> ebm integrates clinical experience patient values best available research information <NUMBER> many clinicians applying treatment current coronavirus covid<NUMBER> based previous experiences mers sars however exactly evidencebased since covid<NUMBER> different evidencebased largescale randomized placebocontrolled trial covid<NUMBER> urgently conducted however difficult find appropriate drug covid<NUMBER> pandemic state take long time although effort also done concurrently addition even results small rcts meaningful often reversed larger rct performed <NUMBER> moreover although results metaanalysis may considered best evidence interpreted caution metaanalysis results significant even though results individual rcts statistical significance <NUMBER> furthermore claimed published research findings false useful <NUMBER> <NUMBER> though also interpreted caution numerously published metaanalyses also misleading <NUMBER> addition guidelines suggested experts also mistake <NUMBER> context find best strategies protect humans form harms covid<NUMBER> even though apply several therapeutic strategies investigated sars mers interpreted caution cannot apply ebm immediately covid<NUMBER> pandemic also make every effort find wise ways solve problems situation experiencebased approach may also important pandemic era many publications urgently published even though case reports case series covid<NUMBER> causing severe public health emergency word mortality rapidly increasing world would like remind basic principle treatment patients often forget harm <NUMBER> think harms means harms would look like pandemic thought summarized potential harms things regarding covid<NUMBER> summarized table <NUMBER> <NUMBER> continuing smoking significant harm respiratory epitheliums dont recommend cessation smoking time causing significant harm patients <NUMBER> cytokine storm considered significant harm important cause death dont make every effort prevent process early course disease causing significant harm patients <NUMBER> currently asymptomatic patients mild symptoms severe radiologic findings bacterial complications lead sudden death radiologic examinations treatment done patients severe symptoms develop may considered significant harm dont make every effort detect patients treat early course disease causing significant harm patients <NUMBER> currently covid<NUMBER> infected patients divided two groups one person isolated home medications provided person developed severe symptoms time admitted hospital currently many patients covid<NUMBER> recommended home severe symptoms develop due infectivity others think patient group moderate symptoms early treatment done steroids antibiotics progress severe conditions let home significant harm dont provide medications steroids antibiotics time covid<NUMBER> test monitor patient even phone considering practically difficult patient points current potential harms novel covid<NUMBER> disease • smoking cessation recommended pandemic era may significant harm • although cytokine storm considered significant harm important cause death efforts prevent process early course disease • person covid<NUMBER> isolated home receive medications treatment severe symptoms dyspnea develops • although asymptomatic patients covid<NUMBER> mild symptoms severe radiologic findings radiologic examinations given patients severe symptoms develop • although mild patients covid<NUMBER> bacterial complications stage treatment given severe symptoms develop • misinterpretation results various studies including systematic review without considering biases lead false guidance treatment covid<NUMBER> significant harm visit clinic policy changed pandemic era medications given patients liberally usual situations causing significant harm patients hesitating use steroids antibiotics may harm patients covid<NUMBER> <NUMBER> something better nothing currently established guidelines covid<NUMBER> rely previous treatments sars mers influenza expert opinions recently investigators discussing beneficial effect hydroxychloroquine covid<NUMBER> based vitro studies much experience dont interests use elderberry supplements shown effective cold influenza randomized doubleblind placebocontrolled study metaanalysis <NUMBER> <NUMBER> <NUMBER> treatments elderberry supplements betadine mouth nasal spray causing significant harms think something better nothing <NUMBER> misinterpretation various studies including systematic review without considering biases lead false guidance treatment covid<NUMBER> significant harm <NUMBER> role experts evidencebased medicine metaresearch important reduce harm patients pandemic era see table <NUMBER> addition may current harms pandemic era also urgently discussed based pathogenesis covid<NUMBER> infection principles mentioned would like suggest <NUMBER> recommendations covid<NUMBER> urgently considered pandemic era first smoking cessation encouraged always recommended general population also difficult people covid<NUMBER> predominantly damage respiratory epitheliums lungs least recommended recently also hypothesized individuals exposed nicotine prior exposure virus primed higher risk nicotine directly impact putative receptor virus ace<NUMBER> lead deleterious signaling lung epithelial cells <NUMBER> addition several cytokines including il<NUMBER> il<NUMBER> tnfα induced smoking might trigger cytokine storm covid<NUMBER> still know whether short duration smoking cessation could reduce susceptibility severity covid<NUMBER> beneficial something smoking cessation better nothing second povidoneiodine polyvinylpyrrolidoneiodine pvpi betadine mouth nasal spray applied kill covid<NUMBER> viruses reduce number covid<NUMBER> viruses enter cells covid<NUMBER> initiated attachment virus pharynx respiratory epithelium causes sore throat currently however know whether number virus attached pharynx respiratory epithelium influence severity covid<NUMBER> easily speaking inhaled <NUMBER> viruses inhaled <NUMBER> viruses infection risk disease severity different currently cannot proved easily however considering effectiveness mask prevents respiratory infections less exposure likely prevent infection indirect evidence one previous metaanalysis showed physical measures highly effective preventing spread sars wearing masks odds ratio <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> number needed treat nnt <NUMBER> <NUMBER> <NUMBER> vs wearing n<NUMBER> masks <NUMBER> <NUMBER> <NUMBER> nnt <NUMBER> <NUMBER> <NUMBER> <NUMBER> make potential hypothesis <NUMBER> viruses inhaled attached throat may cleared host immunity however <NUMBER> viruses inhaled attached throat go fight virus host immunity viruses cleared host immunity person free virus viruses win may replicate exponentially within relatively short time cause viremia blood situation still know whether degree viremia viral load might correlated degree host hyperimmune response whether reduction viruses throat example using betadine mouth spray gargles could decrease degree viremia blood currently inhibiting angiotensin converting enzyme <NUMBER> ace<NUMBER> blocking angiotensin receptor <NUMBER> ar<NUMBER> considered key target sarscov<NUMBER> vaccination covid<NUMBER> therapy <NUMBER> due finding authors recommend use angiotensin converting enzyme inhibitors acei angiotensin receptor <NUMBER> blockers arbs <NUMBER> currently findings suggestions cant transferred clinical practice easily acei arbs widely used clinical daily practice clinical studies made set covid<NUMBER> outbreak far even basic science due pathophysiological mechanisms eg effectiveness blocking ar<NUMBER> limited <NUMBER> due substantiated benefitrisk evaluation therapy arbs acei cannot recommended addition know many ace<NUMBER> receptors could downregulated blocked antibodies vaccines many entries viruses could inhibited developed however blocking entry virus potential therapeutic target think direct killing virus throat betadine mouth nasal spray might efficacious receptor downregulation several studies showed severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov could inactivated pvpi vitro <NUMBER> <NUMBER> one phase <NUMBER> study shows application pvpi nasal spray nasal mucosa result demonstrable limitation nasal function detectable damage multilayer ciliated epithelium nose <NUMBER> anyone buy betadine mouth nasal spray gargles without prescription overthecounter medicines cause significant harm reason use applied person feels sore throat early course disease although side effects pvpi use rare adverse effect iodine precautions also recognized pvpi cause allergic reactions used patients suffering thyroid diseases <NUMBER> even exist studies pvpi sarscov<NUMBER> either due benefitrisk evaluation pvpi used patients infected sarscov<NUMBER> mild • hydroxychloroquine used secondary drug patients worsening symptoms • policy drug use changed like giving steroids antibiotics patients time diagnostic test drive system reduce harms patients autoimmunity reviews xxx xxxx xxxx symptoms without allergies pvpi thyroid diseases person visiting crowded places airport also applied easily third use elderberry supplements considered early course disease although tested coronavirus elderberry supplements shown effective cold influenza randomized doubleblind placebocontrolled study metaanalysis <NUMBER> <NUMBER> <NUMBER> currently one cleveland clinic news reported emily bamforth use elderberry supplements <NUMBER> although several reports beneficial effect elderberry supplements several viral infections <NUMBER> <NUMBER> <NUMBER> hypotheses potential immunologic mechanisms beneficial effect elderberry supplements focusing covid<NUMBER> well known angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor sarscov <NUMBER> recent study showed sarscov<NUMBER> covid<NUMBER> spike glycoproteins also uses ace<NUMBER> enter cells receptorbinding domains sarscov<NUMBER> sarscov bind similar affinities human ace<NUMBER> correlating efficient spread sarscov<NUMBER> among humans <NUMBER> although less discussed ace<NUMBER> shown cd<NUMBER>l lsign encoded clec<NUMBER>m also receptor sarscov <NUMBER> study cd<NUMBER>l expressed human lung type ii alveolar cells endothelial cells potential targets sarscov large glycoprotein sarscov might use ace<NUMBER> cd<NUMBER>l virus infection pathogenesis <NUMBER> addition chan et al demonstrated individuals homozygous clec<NUMBER>m tandem repeats less susceptible sars infection lsign expressed nonsars sarscovinfected lung <NUMBER> also showed compared cells heterozygous lsign cells homozygous lsign show higher binding capacity sarscov higher proteasomedependent viral degradation lower capacity trans infection suggesting homozygosity lsign plays protective role sars infection <NUMBER> summary first encounter virus host might binding attachment receptors receptors might play important role infection large number enveloped viruses capturing concentrating transmitting infectious virions <NUMBER> virus reaches target cell cascade events generally starting interaction viral envelope glycoproteins specific entry receptors coreceptors necessary order trigger viruscell membrane fusion <NUMBER> although much studied coronavirus capture transmission hiv<NUMBER> ctype lectin lsign inhibited carbohydratebinding agents cbas <NUMBER> study mannoseand nacetylglucosamine glcnacspecific cbas dosedependently prevented virus capture lsignexpressing <NUMBER> trexlsign cells <NUMBER> coronavirus also uses lsign receptor entry one study suggested influenza virus coronavirus infections might also qualify treated cbas <NUMBER> keyaerts et al evaluated effect <NUMBER> plant lectins different specificities coronavirus <NUMBER> showed plant lectins possessed marked antiviral properties coronaviruses ec<NUMBER> values lower microgramml range middle nanomolar range nontoxic cc<NUMBER> <NUMBER> microgml strongest anticoronavirus activity found predominantly among mannosebinding lectins addition number galactose nacetylgalactosamine glucose nacetylglucosaminespecific plant agglutinines exhibited anticoronaviral activity <NUMBER> also found significant correlation rvalue <NUMBER> ec<NUMBER> values <NUMBER> mannosespecific plant lectins effective two coronaviruses little correlation seen activity types lectins <NUMBER> therefore reported two targets possible antiviral intervention identified replication cycle sarscov first target located early replication cycle probably viral attachment second target located end infectious virus cycle <NUMBER> de clercq summarized various compounds reported exhibit vitro activity sarscov though illdefined mode action selectivity indexes <NUMBER> valinomycin glycopeptide antibiotics plant lectins hesperetin glycyrrhizin aurintricarboxylic acid chloroquine niclosamide nelfinavir calpain inhibitors among plant lectins chloroquine discussed potential treatment covid<NUMBER> included <NUMBER> hypothesis tested later merscov epidemic coronaviruses enveloped viruses spike proteins present surface responsible virus entry target cell <NUMBER> merscov also cause high mortality rate <NUMBER> vaccine available therapeutic options merscov infections limited palliative supportive care search specific antiviral treatments urgently needed <NUMBER> millet et al thought lectins attractive anticoronavirus candidates highly glycosylated nature spike protein tested antiviral effect griffithsin grft lectin isolated red marine alga griffithsia sp merscov infection <NUMBER> demonstrated griffithsin potent inhibitor merscov infection without significant cytotoxicity <NUMBER> griffithsin inhibited entry host cells particles pseudotyped merscov spike protein suggesting griffithsin inhibits spike protein function entry binding step <NUMBER> compounds found elderberries phenolic acids flavonoids vitamins lectins aroma compounds etc <NUMBER> similar lectin called sambucus nigra fruit specific agglutinin snaif identified minor protein ripe elderberry fruits <NUMBER> although elderberry supplements tested current covid<NUMBER> pandemic lectin components might inhibit spike protein function entry binding step mentioned unknown effects currently anyone buy elderberry supplements without prescription overthecounter medicines cause significant harm reason use applied early course disease although reports increase cytokines elderberry supplements <NUMBER> elderberry supplements also various kinds effects surely however also weigh benefit risk use elderberry supplements like otcs know even otcs eg tylenol many adverse effects drug information addition also look evidencebased systematic review elderberry elderflower sambucus nigra natural standard research collaboration <NUMBER> could applied current covid<NUMBER> pandemic point able guide use elderberry supplements general population patients covid<NUMBER> elderberry supplements used covid<NUMBER> early course disease understand previous efficacy potential adverse effects fourth use oral steroids actively considered early course disease cause death covid<NUMBER> ards organ failure due cytokine storm hyperactivated host immune response considering suppress prevent process early course disease think increase various proinflammatory cytokines induced covid<NUMBER> may suppressed shortcourse low dose steroids early stage disease may effective later stage disease ards multiorgan failure situation assimilated forest fire first small fire cigarette butts detected hiker early early covid<NUMBER> extinguished small amounts water kronbichler et al autoimmunity reviews xxx xxxx xxxx low dose steroids easily wild forest fires spread persistent high fever dyspnea mountain without early suppression cannot suppressed despite every effort numerous fire trucks longterm use high dose steroids mountains burned destructed lung requiring ecmo one recent systematic review reporting use steroids may harmful patients covid<NUMBER> <NUMBER> however result interpreted caution quality included studies extremely low many biases many studies missing included studies use steroids vs use result generalized patients early course disease mild symptoms one study investigated structural arrangement n protein explaining first steps interaction nucleic acid initial stages virus structure assembly <NUMBER> nucleocapsid n protein covid<NUMBER> nearly <NUMBER> amino acid sequence identity sarscov n protein antibodies sarscov may cross react covid<NUMBER> may provide crossimmunity similar fashion sarscov n protein covid<NUMBER> may play important role suppressing rna interference rnai overcome host defense <NUMBER> rat models nprotein sarscov pathogenicity could induce obvious pulmonary inflammatory reaction acute lung injury related increase imbalance proinflammatory antiinflammatory cytokines <NUMBER> study glucocorticoids could effectively alleviate pulmonary inflammatory reaction induced nprotein sarscov supporting beneficial role steroids inflammatory reactions caused nprotein current covid<NUMBER> <NUMBER> according chinese governments daily report <NUMBER> patients covid<NUMBER> developed severe fatal illness therefore chinas national health commission released fifth trial version diagnosis treatment scheme pneumonitis covid<NUMBER> provided systematic treatment strategy severe cases systematic corticosteroids treatment methylprednisolone <NUMBER> mg per kg body weight <NUMBER> days recommended adjuvant therapy <NUMBER> zou et al recently showed systematic corticosteroids therapy first <NUMBER> days severe patients could enhance oxygen saturation sao<NUMBER> arterial oxygen tension pao<NUMBER>inspiratory oxygen fraction fio<NUMBER> corticosteroids exert intervention survival ncp patients complicated ards shock multiple organ injury <NUMBER> nevertheless concluded corticosteroids phase ards would effectively inhibit furious inflammatory storm gain valuable time controlling infection preventing secondary multiorgan damage shock implies corticosteroids synergistic biological effects combined intensivists treatment severe fatal ncp patients <NUMBER> however mentioned think increase various proinflammatory cytokines induced covid<NUMBER> may suppressed shortcourse low dose steroids early stage disease may effective later stage disease ards multiorgan failure later stage may big fire cannot suppressed easily one another thing short course low dose oral steroids easily prescribed treatment urticaria afraid prescribing use oral steroids acute covid<NUMBER> setting even though many patients progress severe disease patients mild symptoms severe radiologic findings lower percentage progressing cytokine storm early use steroids even though found statistically nonsignificant pvalue <NUMBER> several patients rescued therefore interpret results based pvalue cautiously conversely misinterpretation misunderstanding pvalue cause significant harm patients covid<NUMBER> recently groups showed beneficial effect hydroxychloroquine <NUMBER> reports evidence hydroxychloroquine coronavirus vitro study <NUMBER> <NUMBER> therefore doctor first used drug patient covid<NUMBER> might done treatment nonevidencebased medicine try oral steroids patients covid<NUMBER> early course disease fifth use oral antibiotics actively considered patient feels good secondary bacterial infection might aggravate acute immunological lung injury induced several cytokines eg il<NUMBER> il<NUMBER> tnfα covid<NUMBER> controlled clinical trials evaluating use empiric antimicrobials covid<NUMBER> patients coronavirus driven diseases therefore recommendations based viral diseases like influenza <NUMBER> furthermore another guideline treating covid<NUMBER> patients released guidelines suggest blind inappropriate use antibacterial drugs especially combination broadspectrum antibacterial drugs avoided patients mild symptoms <NUMBER> however guidelines current covid<NUMBER> situation definitely different usual viral infections patients mild symptoms severe radiologic features sudden death furthermore bacterial superinfection hard detect cannot easily diagnosed symptoms covid<NUMBER> bacterial superinfection may overlap data prevalence bacterial superinfection patients covid<NUMBER> limited <NUMBER> influenza pneumonia often associated staphylococcus aureus coinfection especially virulent <NUMBER> initiating empiric antibacterial therapy adults communityacquired pneumonia test positive influenza recommended recent clinical practice guidelines <NUMBER> therefore suggest according clinical manifestations patients accompanying bacterial infection cannot ruled patients take antibacterial drugs communityacquired pneumonia amoxicillin azithromycin fluoroquinolones <NUMBER> empirical antibacterial treatment severe patients cover possible pathogens deescalating therapy pathogenic bacteria clarified <NUMBER> addition current special situation also considered currently patient diagnosed covid<NUMBER> heshe isolated home recommended severe symptoms developed come hospital medications provided however think dangerous situation persons might mild symptoms despite severe progression lung injury patients become feel dyspnea come hospital time might late recovery receive intravenous antibiotics also various kinds multiple drugs speculate many patients became get severe symptoms might bacterial complications reported bacterial coinfection associated approximately <NUMBER> viral respiratory tract infections requiring hospitalization <NUMBER> incidence bacterial complications covid<NUMBER> unknown yet considering patients covid<NUMBER> get severe symptoms observed respiratory viral diseases speculate bacterial complications might combined severe conditions also mild conditions patient usual respiratory viral infections heshe visit clinic prescribed antibiotics however current situation patient covid<NUMBER> cannot visit usual clinic wait recover get dyspnea virus damages throat lungs bacteria oral cavity cause secondary infection cannot exactly evaluated diagnosed laboratory examinations bacteria culture procalcitonin may exact due false negative bacteria cannot examined situation based medical principle harm waiting patient deteriorate severe harm therefore prevent deterioration patient covid<NUMBER> oral antibiotics oral steroids given patient time covid<NUMBER> recommended patient high fever feels bad take antibiotics steroids empirically acceptable pandemic era many patients dying due complications covid<NUMBER> doctor monitor guide patients phone calls better enough medical personnels current situation liberal early use oral antibiotics steroids may harm may different situation usual common cold situation experiences patient feels bad earlier antibiotics steroids used patients condition recover sixth hydroxychloroquine used secondary drug patients worsening symptoms covid<NUMBER> chloroquine metabolite hydroxychloroquine antimalarial agents demonstrated antiviral effects sarscov sarscov<NUMBER> vitro <NUMBER> <NUMBER> chloroquine inhibitory effects multiple rna viruses vitro chloroquine showed antiviral clinical beneficial effects treatment dengue chikungunya virus infections influenza prophylaxis <NUMBER> news briefing suggested use <NUMBER> patients showed superior control inhibiting exacerbation pneumonia improving lung imaging findings promoting virus negative conversion shortening disease course data published yet <NUMBER> recent consensus document recommended chloroquine phosphate <NUMBER> mg twice daily minimum <NUMBER> days <NUMBER> another study found hydroxychloroquine potent chloroquine vitro based data hydroxychloroquine <NUMBER> days <NUMBER> mg twice daily loading dose <NUMBER> mg recommended <NUMBER> recent systematic review found published studies covid<NUMBER> patients <NUMBER> furthermore adding azithromycin hydroxychloroquine <NUMBER> mg daily treatment seemed beneficial outcome small french cohort <NUMBER> however also cautious interpreting results hydroxychloroquine current situation based vitro studies small number case series also adverse effects hydroxychloroquine also considered situation think hydroxychloroquine used routine treatment covid<NUMBER> condition patients worsens despite use steroids antibiotics hydroxychloroquine used secondary drug seventh policy drug use changed reduce mortality patients usual situation patient visit clinic frequently according condition therefore steroids antibiotics given timely based judgement doctors however pattern examination diagnosis treatment cannot done covid<NUMBER> era doctors prescriptions surely important diagnose treat patients however mentioned patients waiting recovery deterioration severe symptoms treatment done meanwhile patient infected occur covid<NUMBER> gets fever visit different clinics treatment standardized among doctors doctor concerns fever nature rapid deterioration covid<NUMBER> may use steroids antibiotics early doctors may make guidelines practical use antibiotics steroids hydroxychloroquine patients use drugs also include benefit adverse effect drug policy proposing give drugs patients freely although range drug also discussed korea diagnosis covid<NUMBER> done drive suggestion make another drive place give drugs patients avoid dissemination infection infected patient go hospital treatment heshe infect patients also good drugs given patient visiting screening clinic example time drive diagnosis explain detail benefit adverse effect drug doctor check result covid<NUMBER> guides patient taking drugs phone calls also patient take drugs hisher judgement concept based <NUMBER> treatment covid<NUMBER> established <NUMBER> even though patient visits doctor treatment patterns different among doctors <NUMBER> steroids frequently used mild diseases urticaria <NUMBER> exactly know presence absence secondary infection patient get fever oral antibiotics <NUMBER> days acceptable treatment routine clinical practice <NUMBER> hydroxychloroquine also given patients recommended patients symptoms worsen despite use steroids antibiotics heshe take hydroxychloroquine recognizing adverse effect drug symptoms worsen patient surely visit hospital well covid<NUMBER> causing severe public health emergency mortality rapidly increasing word era suggested <NUMBER> recommendations rescue patients reduce morbidity mortality due covid<NUMBER> based immunological point view table <NUMBER> may personal opinions believe may beneficial control complications exerted covid<NUMBER> addition conflicting evidences publications regarding opinions however would like remind basic principle treatment patients often forget harm think deeply harm harm addition would like say something better nothing acceptable level clinical practice hope opinions transferred cdc also clinicians researchers many institutions covid<NUMBER> could finished rapidly possible hemophagocytic lymphohistiocytosis hlh comprises two different conditions may difficult distinguish one another primary form occurs due genetic disorders secondary form triggered various infections autoimmuneautoinflammatory diseases chemicals <NUMBER> <NUMBER> recent reports suggest cytokine storm caused novel coronavirus infection covid<NUMBER> significant similarities clinical laboratory findings disorder due accelerated deterioration patients general status hemophagocytic syndrome hps necessitates timely diagnosis initiation lifesaving treatment hps hlh acute rapidly progressive systemic inflammatory disorder characterized cytopenia excessive cytokine production hyperferritinemia common clinical manifestations hlh acute unremitting fever lymphadenopathy hepatosplenomegaly multiorgan failure due massive cytokine release clinical condition considered cytokine storm syndrome hlh primary acquired secondary reactive forms primary form mostly seen childhood caused various mutations genetic inheritance therefore called familial hlh fhlh fig <NUMBER> secondary hlh shlh may caused presence underlying disorder secondary malignant infectious autoimmuneautoinflammatory stimulus <NUMBER> <NUMBER> <NUMBER> clinical condition first reported scott et al <NUMBER> first reported four cases identified atypical hodgkins lymphoma characterized pronounced histiocytic erythrophagocytosis bone marrow cellular proliferation lymph nodes medulla spleen periportal area later scott et al named clinical entity histiocytic medullary reticulocytosis hmr pronounced phagocytosis intense hyperplasia medullary areas light data obtained accepted welldifferentiated reticulum cell sarcoma malignant process <NUMBER> <NUMBER> designated hemophagocytic lymphohistiocytosis term macrophage activation syndrome mas used first <NUMBER> <NUMBER> hlh working group classified hps primary secondary hlh <NUMBER> <NUMBER> <NUMBER> review aim contribute rheumatologists awareness lifethreatening rare complication hlh cytokine storm prevent possible misdiagnosis presence clinical laboratory features covid<NUMBER> resembling mimicking underlying newonset rheumatological condition hope review support collaboration rheumatologist hematologists colleagues treat covid<NUMBER> patients first place infectious disease specialists pneumologists intensive care physicians manuscript selection procedure numbers given fig <NUMBER> briefly medlinepubmed searched inception april <NUMBER> following terms used data searching hemophagocytic syndrome macrophage activation syndrome hemophagocytic lymphohistiocytosis cytokine storm increase weight recent publications selection restricted past <NUMBER> years limited numbers earlier key references manually selected finally covid<NUMBER> applied algorithm fulltext manuscripts published english language peerreviewed journal included free fulltext articles available https pubme dncbinlmnih selected fulltext articles indexed web science scopus downloaded using ebsco discovery services author ms collected data wrote manuscript authors gts ia carefully reviewed data perspective hematologist author pa reviewed article immunologic rheumatologic aspects prepared tables translated english gave manuscripts final form statistical method used database search following terms hemophagocytic syndrome macrophage activation syndrome hemophagocytic lymphohistiocytosis cytokine storm yielded <NUMBER> results inception april <NUMBER> selection restricted past <NUMBER> years limited numbers earlier key references selected algorithm resulted <NUMBER> manuscripts addition covid<NUMBER> resulted <NUMBER> publications <NUMBER> studies together four sections online book used final review fulltext manuscripts published english language peerreviewed journal included used data index papers table creation figures quarter total phlh cases genetic transition therefore advisable question history consanguineous marriage infections especially viral frequently trigger inappropriate cytotoxic immune response presence genetic conditions mutations cd<NUMBER> cells natural killer nk cells homozygous compound heterozygous digenic heterozygous mutations two different genes result loss performance cytolytic pathway proteins prf<NUMBER> stx<NUMBER> unc<NUMBER>d unc<NUMBER> pathogenesis syndrome underlined activation proliferation lymphocytes mainly cd<NUMBER> cytotoxic cells natural killer nk cells leading overactivation proliferation macrophages resulting phagocytosis bone marrow hematopoietic cells andor reticuloendothelial system cells organs hypersecretion several cytokines including interferongamma ifnγ interleukin il<NUMBER> il<NUMBER> il<NUMBER> tumor necrosis factoralpha tnfα <NUMBER> <NUMBER> fig <NUMBER> important immunological abnormality primary reactive hlh impaired cytotoxic cell function normal physiological conditions virusinfected cell tumor cell encountered cd<NUMBER> cytotoxic cells nk nkt cells release perforin tetrameric protein creates pores target cell facilitates entry granzymes disrupts target cells membrane containing cytolytic granules granzymes proteins involved triggering apoptosis target cell initiate cytolytic destruction target cell process proceed normally perforin granzymes must structurally normal properly distributed cell packaged granules content granules enter target cell via exocytosis immunological synapse cytotoxic cell target disruption process genetic mutations leads development primary familial hlh normal conditions perforin granzymes contribute destruction target cells elimination immuneactivating stimulus eventually results apoptosis cytotoxic cells together reduced antigen stimulation physiological downregulation called activationinduced cell death critical control immune response failure clear antigenic stimulus reason results persistence strengthening immune response immune activation driven high levels macrophage activation proinflammatory cytokines released activated immune cells resulting hemophagocytosis tissue damage organ failure inflammatory symptoms syndrome <NUMBER> <NUMBER> <NUMBER> <NUMBER> numerous serum proinflammatory cytokine levels including il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnf ifnγ found significantly high hlh patients sera patients prognosis worsens levels cytokines increase inability clear antigenic stimulation certain infections malignant autoimmuneautoinflammatory processes leads inappropriate immune stimulation selfsustaining hyperinflammatory condition known cytokine storm characterized excessive persistent high cytokines levels listed <NUMBER> hlh may classified cytokine storm syndrome presence intense rapid cytokine elevation cytokine storm emerged important underrecognized cause death covid<NUMBER> <NUMBER> <NUMBER> high levels antiinflammatory cytokines also observed hlh especially overproduction il<NUMBER> indicating mechanism albeit insufficient suppress hyperactivation th<NUMBER> cells monocytemacrophage functions patients disease <NUMBER> source il<NUMBER> probably hemophagocytes may imply hemophagocytosis compensatory reaction hlh <NUMBER> <NUMBER> phlh related immunodeficiency syndromes inheritance defective genes involved control cytolysis eg prf<NUMBER> stx<NUMBER> unc<NUMBER>d unc<NUMBER> leads uncontrolled proliferation survival cd<NUMBER> cells impairing cytolytic activity cytotoxic lymphocytes <NUMBER> <NUMBER> children certain immunodeficiency syndromes chédiakhigashi syndrome hermanskypudlak syndrome type ii griscelli syndrome partial albinism xlinked lymphoproliferative disease xmen disease itk interleukine<NUMBER>inducible cell kinase deficiency lysinuric protein intolerance cd<NUMBER> deficiency chronic granuloma also possess genetic defects associated impaired cytolysis risk developing familial hlh specific xlinked immune deficiencies signaling lymphocytic activation molecule associated protein sap xlinked apoptosis inhibitor xiap deficiency also associated hlh triggered epsteinbarr virus ebv <NUMBER> <NUMBER> <NUMBER> phlh rare <NUMBER> live births condition usually develops first years life kept mind phlh accepted widely pediatric disease may develop first symptoms adulthood patients shlh may cytolytic genes underlying hypomorphic defects found phlh well indeed <NUMBER> shlh mas patients reported carry heterozygous dominantnegative mutations known familial hlh genes therefore researchers suggest mas shlh familial hlh may considered members disease spectrum <NUMBER> <NUMBER> <NUMBER> interesting finding prevalence mutations differs certain populations linked perforin mutations common turks <NUMBER> <NUMBER> hand unlike primary hlh patients observed differences pattern lymphocyte activation differentiation shlh patients may imply differences pathogenesis two conditions example amman et al demonstrated expression hla dr<NUMBER> perforin activated cd<NUMBER> cells higher genetically predisposed hlh patients <NUMBER> shown lymphomas resulting shlh produce proinflammatory cytokines initiate permanently stimulate activation cytotoxic lymphocytes nk cells triggers syndrome epsteinbarr virus ebv common infectious trigger primary secondary hlh interesting finding association ebv normally infects b lymphocytes also infect cd<NUMBER> cytotoxic lymphocytes resulting ebvassociated hlh <NUMBER> secondary forms hlh triggered infections malignancies autoimmuneautoinflammatory diseases medications frequently shlh triggered infections termed hlhassociated infection cases history traveling present particular infectious especially ebv members herpesvirus family hiv bacteria fungi triggers clinical picture malignancies especially leukemia lymphoma termed hlhassociated malignancy among common triggers <NUMBER> hlh develops association autoimmuneautoinflammatory rheumatological disease often referred mas discussed detail however worth pointing authors prefer use term mas secondary hlh interestingly secondary hlh may arise iatrogenically due drugs used treatment primary disease <NUMBER> ramoscallas et al reported metaanalysis <NUMBER> hlh cases disease frequent japan france china south korea taiwan italy spain turkey <NUMBER> infections drugs common reported causes adults least <NUMBER> three possible triggering factors distribution causes varied countries malignancies leading cause japan korea taiwan china france italy whereas autoimmune diseases frequent spain usa secondary hlh develops context rheumatological diseases often referred mas reported frequently systemic juvenile idiopathic arthritis sjia still disease patients <NUMBER> strippoli et al suggested trilayer mechanism hlh secondary rheumatic diseases firstly genetic tendency defects cytotoxic activity cd<NUMBER> nk cells genetic predisposition tlr hyperresponse followed high disease activity caused high proinflammatory state mediated high levels cytokines il<NUMBER> finally activation immune cells cells macrophages triggered viral infection leads cytokine storm <NUMBER> <NUMBER> sjia cases develop mas adults reported association cases adult onset still disease aosd lesser extent systemic lupus erythematosus sle cases mas well known lifethreatening complication rheumatic diseases similar sjia <NUMBER> aosd patients develop mas activation shared innate immunopathogenic pathways including il<NUMBER> il<NUMBER> leads similar systemic inflammation aosd sjia therefore surprising mas common complication diseases <NUMBER> <NUMBER> hypothesis supported observation gainoffunction mutations gene encoding innate immune protein nlrc<NUMBER> promote spontaneous formation nlrc<NUMBER> inflammasome production il<NUMBER> family cytokines il<NUMBER>β il<NUMBER> inflammatory cell death autoinflammatory diseases complicated mas <NUMBER> similar sjia mas aosd may either occur onset ora later stage mostly triggered viral infections <NUMBER> patients mas may lead ards death course covid<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> therefore mas kept mind covid<NUMBER> patient signs rapid clinical laboratory deterioration every rheumatologist alert cytokine storm severe complication covid<NUMBER> symptoms covid<NUMBER> fever arthralgia myalgia resembling seen several rheumatologic diseases <NUMBER> mas occurring early stages aosd characterized neutrophilic leucocytosis laboratory finding may used differential diagnosis later course aosd mas may coincide disease flares infections use antiinflammatory drugs sulfasalazine methotrexate hydroxychloroquine antitnf agents secondary hlh mas characterized fever pulmonary insufficiency liver failure neurological symptoms signs pancytopenia coagulopathy could explained reason instead fever rises typically afternoons chills aosd unremitting fever common presence mas therefore persistent fever despite treatment infections develops course sjia aosd raise suspicion mas <NUMBER> <NUMBER> pulmonary involvement found half shlh patients patients may develop acute respiratory distress syndrome ards requires mechanical ventilation ards poor prognosis common severe shlh requiring intensive care <NUMBER> neurological involvement sign poor prognosis well usually sign established shlh several clinical signs symptoms cns involvement ranging mood personality changes seizures muscle weakness extremities cranial nerve palsy decreased consciousness coma may develop acute renal failure necessitating chronic renal replacement may seen worsens outcome <NUMBER> <NUMBER> <NUMBER> <NUMBER> aosd mas cases leukocyte platelet count hemoglobin albumin fibrinogen levels significantly lower nonmas aosd cases however ferritin ldh triglyceride levels develops due tnfα suppression lipoprotein lipase significantly higher patients mas <NUMBER> <NUMBER> serum ferritin levels critical value diagnosis probability mas levels <NUMBER> ngml rather weak probability mas increases values <NUMBER> <NUMBER> value <NUMBER> ngml <NUMBER> μl higher <NUMBER> specificity <NUMBER> sensitivity presence mas ferritin dynamic test rises rapidly extensively early inflammatory period decreases significantly active treatment cessation inflammation ratio baseline recovery may reach <NUMBER> high levels persisting despite active treatment decline less <NUMBER> associated poor prognosis preand posttreatment levels laboratory parameters ddimer triglycerides platelet levels ldh transaminases differ much <NUMBER> may useful diagnosis presence hyperferritinemia association cytopenia various series low levels fibrinogen due procoagulant effects tnfα increased lysis absence significant increase sedimentation despite increased crp may used support diagnosis mas <NUMBER> thrombocytopenia hypofibrinogenemia lead ecchymoses bleeding especially critical cases since hemophagocytosis latestage finding may detected early bone marrow examinations bone marrow findings may correlate clinical symptoms high ferritin levels therefore essential diagnosis <NUMBER> <NUMBER> one wait hemophagocytosis proven initiate treatment bone marrow biopsy available necessary since hemophagocytosis bone marrow may support therapy presentscd<NUMBER> marker cell activation scd<NUMBER> marker hemophagocytosis specific markers hlh however aforementioned parameters included mas classification criteria made sjia due difficulties routine use <NUMBER> hlh<NUMBER> criteria include scd<NUMBER> sil<NUMBER>rα ≥ <NUMBER> uml <NUMBER> summary crucial exclude hlhmas sjia aosd patients covid<NUMBER> suddenly deteriorate presence often remitting high fever additional pulmonary andor neurological symptoms cytopenia abnormal ferritin ldh levels <NUMBER> <NUMBER> <NUMBER> diagnostic tools hlh<NUMBER> score hscore mh score timely diagnosis hlh particular importance patients may critically ill delay diagnosis contributes poor outcome diagnosis based mainly clinical laboratory criteria single laboratory test clinical finding pathognomonic widely used hlh<NUMBER> criteria set developed histiocyte society table <NUMBER> <NUMBER> score developed estimate individuals risk reactive hps primary secondary hlh clinical laboratory features scored given table <NUMBER> <NUMBER> scoring following nine variables used three clinical variables underlying immunosuppression high fever organomegaly five biochemical variables triglycerides ferritin serum transaminases fibrinogen presence cytopenia one cytological findings hemophagocytosis bone marrow table <NUMBER> median score patients positive phlh diagnosis <NUMBER> interquartile range iqr <NUMBER> <NUMBER> iqr <NUMBER> patients negative diagnosis probability suffering hps less <NUMBER> hs score ≤ <NUMBER> <NUMBER> hscore ≥ <NUMBER> cutoff <NUMBER> <NUMBER> sensitivity <NUMBER> specificity hlh note bone marrow hemophagocytosis mandatory hlh diagnosis scoring system available online general use httpsaint antoi neaphpfrscore ferritin values prognostic value septic patients additionally <NUMBER> belgian group addressed issue detail onset disease hscore effective hlh<NUMBER> criteria accurately identifying hlh children adults diagnostic sensitivity specificity <NUMBER> <NUMBER> children <NUMBER> <NUMBER> adults respectively hscores performance dropped levels similar hlh<NUMBER> criteria <NUMBER> accuracy specificity patients clinical condition worsens authors concluded hscore children generally useful hlh<NUMBER> criteria adults hscore useful patients initial presentation authors also concluded originally published cutoff value <NUMBER> optimally adapted according target patient group interest <NUMBER> another group addressed issue rheumatological diseases proposed adopted cutoff value target population various rheumatological diseases cohort <NUMBER> patients rheumatological diseases <NUMBER> hlh <NUMBER> controls optimal cutoff value found <NUMBER> sensitivity <NUMBER> specificity <NUMBER> <NUMBER> although shlhmas phlh lifethreatening conditions mortality rate patients phlh much higher era treatment protocols involving aggressive chemotherapy immunosuppression <NUMBER> phlh patients survived <NUMBER> year diagnosis therefore extremely important start hlh<NUMBER> treatment protocol containing etoposide patients phlh immediately yet patients phlh need hematopoietic stem cell transplantation final treatment <NUMBER> contrast treatment shlhmas depends clinical severity may either treated moderate increase corticosteroid dosage aggressive immunosuppressives drugs may favored first therapeutic approach <NUMBER> reasons important differentiate phlh phlhmas early possible however diagnostic workup required phlh takes time may readily performed everywhere instance clinical laboratory features gain importance known sjia patient clinical diagnosis mas relatively simple presence typical clinical features mas coincides onset sjia may substantially difficult distinguish mas phlh according data large series international mas cases sjia patients approximately <NUMBER> reported mas episodes occurred onset sjia mimicked characteristics underlying disease <NUMBER> first attempt determine laboratory properties separate mas phlh performed lehmberg et al <NUMBER> important issue report <NUMBER> mas patients included study clinical manifestations mas appeared diagnosis sjia neutrophil counts crp significantly higher massjia patients high levels sil<NUMBER>ra observed frequently phlh minoia et al proposed sophisticated composite score distinguish better phlh mas macrophage activation syndromehemophagocytic lymphohistiocytosis mh score creation mh score based much larger data set <NUMBER> patients mas <NUMBER> patients hlh mh score consists six demographic clinical laboratory variables age onset neutrophil count fibrinogen level presence splenomegaly platelet count hemoglobin level multivariate analysis done assess weight variable contribution diagnosis phlh mh score initially developed based data <NUMBER> patients validated using data remaining <NUMBER> patients mh score performed extremely well validation study mh score ranged <NUMBER> <NUMBER> median value <NUMBER> <NUMBER>st<NUMBER>rd quartile <NUMBER> <NUMBER> <NUMBER>st<NUMBER>rd quartile phlh mas respectively probability receiving diagnosis phlh less one percent score less one <NUMBER> score ≥ <NUMBER> cutoff value ≥ <NUMBER> best performance separating phlh mas <NUMBER> however cases sjia sle kawasaki disease cytopenia liver enzyme elevations may also related activity underlying diseases discriminatory value may lower case advisable make decision based patients history clinical complaints response treatment criteria developed ravelli et al overcome difficulties encountered diagnosis mas developing sjia cases table <NUMBER> important difference hlh<NUMBER> absence scd<NUMBER> measurement calculated sensitivity specificity classification set <NUMBER> <NUMBER> respectively <NUMBER> hlh<NUMBER> criteria set reliable tool diagnosis hlh hscore estimates best risk hlh mh score differentiates reliably mas phlh pediatric cases hscore accurate used onset disease adult patients cutoff values recommended hscore may vary depending underlying disease advisable use <NUMBER> classification criteria assess mas course sjia described hlh lifethreatening medical condition early diagnosis rapid intervention lifesaving noted shlhcytokine storm may main reason rapid deterioration seen covid<NUMBER> patient despite treatment hla<NUMBER> protocol patients phlh need allogeneic stem cell transplant secondary forms mas rarely necessitate transplantation cases triggering factors infection malignancy medication searched remission possible combined immunosuppressive treatment shlhmas cases early use highdose steroids successful alone half reported adult cases steroidresistant unlike phlh patients rarely need hemopoietic stem cell transplantation due mas developing result severe sjia <NUMBER> carter et al favor immediate treatment <NUMBER> g intravenous methylprednisolone per day <NUMBER> days combined ivig <NUMBER> gkg <NUMBER> days consider repeating every <NUMBER> days due halflife <NUMBER> days firstline treatment shlh <NUMBER> emergence established hlh features clinical deterioration despite treatment may necessitate early initiation il<NUMBER> blocker anakinra <NUMBER> personal experience caught early course patient often relieves elimination triggering factors medication medium dose corticosteroid therapy evidence sjiarelated mas suggests early use anakinra il<NUMBER> blockade would also beneficial adult mas population anakinra effective mas treatment corticosteroids ivig cyclosporin etoposide fail control disease time combination corticosteroids <NUMBER> encouraging use anakinra associated improved outcome patients sepsis mas features gives appropriate signal safe use context shlh even triggered infection <NUMBER> refractory mas cases doses <NUMBER> mg anakinra four times day may required achieve remission <NUMBER> anakinra safely used treatment autoinflammatory diseases sjia fmf rheumatology outpatient clinics studies anakinra canakinumab rilonacept reported il<NUMBER> blockade alone sufficient prevent mas course sjia studies corticosteroids cyclosporin andor drugs added treat mas patients <NUMBER> interestingly tocilizumab useful treatment hlh however mas also reported patients receiving tocilizumab cases clinical laboratory findings mas lower ferritin levels frequency hepatomegaly normal crp may become less subtle tocilizumab treatment <NUMBER> cytokine storm seen course covid<NUMBER> effectively treated tocilizumab anakinra <NUMBER> <NUMBER> rituximab may place treatment combination drugs shown reduce ebv viral load serum ferritin levels improve overall clinical outcome patients ebvrelated hlh <NUMBER> already first cases mas association covid<NUMBER> cases treated successfully jak inhibitors baricitinib il<NUMBER> il<NUMBER> blockers accumulating <NUMBER> hlh may triggered genetic conditions infections including covid<NUMBER> malignancies autoimmuneautoinflammatory diseases drugs hlh suspected patients unexplained progressive fever cytopenia ards neurological renal impairment differentiation primary secondary forms hlh utterly important since primary forms hlh require complicated treatments hematopoietic stem cell transplantation covid<NUMBER> pandemic develops large numbers patients rare complications viral infections hlh accumulate increasing cases covid<NUMBER> severe complications cytokine storm hlh may necessitate closer collaboration rheumatologists hematologists intensive care physicians infectious disease specialists pneumologists likely treat patients first place early recognition hemophagocytic lymphohistiocytosis severe complication cytokine storm possible using diagnostic sets criteria knowing shortcomings advantages specific patient groups studies addressing performance criteria sets diagnosis setting covid<NUMBER> necessary severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> emerged wuhan china become threat whole world disease associated sarscov<NUMBER> termed coronavirus disease<NUMBER> world health organization declared covid<NUMBER> global pandemic affecting <NUMBER> countries resulting <NUMBER> confirmed cases <NUMBER> <NUMBER> deaths <NUMBER> april <NUMBER> still counting <NUMBER> main reason disease severity covid<NUMBER> due aberrant excessive cytokine production leading pathophysiology called cytokine storm acute respiratory distress syndrome ards <NUMBER> <NUMBER> <NUMBER> serum infected patients showed increased levels proinflammatory cytokines il<NUMBER> tnfα il<NUMBER>β ifnγ mcp<NUMBER> mip<NUMBER>a resulting cytokine storm <NUMBER> building observation patients given corticosteroids reduced inflammationinduced lung damage however previous studies influenza virus suggest adjunctive corticosteroid therapy rather increase mortality also corticosteroid therapy patients middle east respiratory syndrome mers resulted delayed viral clearance <NUMBER> altogether suggesting cautious use corticosteroids covid<NUMBER> patients hence due limited effectiveness corticosteroids use alternate immunomodulators could suggested present emergence novel sarscov<NUMBER> late <NUMBER> merscov sarscov considered highly pathogenic two cov contribute acute lung pathology result cytokine storm infected patients could lethal left untreated <NUMBER> earlier study sarscov infection nonhuman primates cynomolgus macaques resulted increased expression ifnα ifnβ ifnγ ifnλ mrna level lungs infected macaque <NUMBER> similarly sarscov infection balbc mice showed increase proinflammatory cytokine secretion eventually leading lethal acute lung injury high fatality rate mice <NUMBER> mouse model mers coronavirus cov infection demonstrated enhanced expression ccl<NUMBER> il<NUMBER> tnfα mrna level lungs infected mice comparative invitro infection studies sarscov merscov showed viruses upregulated expression tnfα il<NUMBER> il<NUMBER> mrna level monocytes derived macrophages <NUMBER> context sarscov<NUMBER> reports emerging china epicenter covid<NUMBER> showed similar trend cytokine profile sarscov merscov <NUMBER> severe cases covid<NUMBER> patients showed increased serum cytokine levels il<NUMBER> tnfα il<NUMBER>β ifnγ mcp<NUMBER> mip<NUMBER>a il<NUMBER> <NUMBER> <NUMBER> another lifethreatening complication namely ards could developed often elderly covid<NUMBER> patients result cytokine storm <NUMBER> <NUMBER> <NUMBER> according recent research patients ards reduced serum s<NUMBER>p levels compared healthy controls associated nonpulmonary organ failure <NUMBER> context detection serum s<NUMBER>p level covid<NUMBER> patients may worth exploring serves biomarker ards associated disease severity earlier reported therapeutic intervention using s<NUMBER>p sphingosine<NUMBER>phosphate analogs infectious diseases <NUMBER> <NUMBER> unpublished study s<NUMBER>p analogs mycobacterium tuberculosis h<NUMBER>ra infected macrophages showed treatment s<NUMBER>p analogs results blunting much proinflammatory response also intriguingly leading clearance bacterial load additionally s<NUMBER>p signaling reviewed potential target provide therapeutic benefits pulmonary disorder <NUMBER> h<NUMBER>n<NUMBER> influenza virus infection intratracheal aalr r<NUMBER>amino<NUMBER>heptyloxyphenyl<NUMBER>methylbutanol s<NUMBER>p analog treatment showed improved survivability mice challenged h<NUMBER>n<NUMBER> compared conventional antiviral therapy walsh et al provide evidence intratracheal administration aalr infected mice resulted reduced lung tissue injury showed histopathological enzymatic studies <NUMBER> bronchoalveolar lavage bal fluid mice revealed reduced proinflammatory cytokines ifnα il<NUMBER> ifnγ chemokine including ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> aalr treatment doesnt clear viral load nevertheless doesnt impair host ability clear viral load supported unchanged viral neutralizing antibodies treated untreated groups <NUMBER> similarly rp<NUMBER> treatment functional agonists s<NUMBER>pr<NUMBER> reduced mortality influenza virusinfected mice reduction cytokinechemokines ifnα ccl<NUMBER> il<NUMBER> ifnγ production <NUMBER> group later studies efficacy rp<NUMBER> mouse model respiratory syncytial virus oral administration rp<NUMBER> showed enhanced survival paramyxovirus pmv infection mice displayed reduced inflammation lungs normal morphology alveolar sacs infected mice rp<NUMBER> therapy decrease ifnγ tnfα ccl<NUMBER> ccl<NUMBER> cxcl<NUMBER> il<NUMBER>α il<NUMBER> secretion also observed bal fluid rp<NUMBER> treated infected mice <NUMBER> authors revealed rp<NUMBER> treatment reduced cd<NUMBER> natural killer nk cells lung infiltrate infected mice lesser number tnfα il<NUMBER> producing ifnγ cd<NUMBER> cells stimulated immunodominant peptides pmv confirmed lymph nodes lungs infected mice compared mice received vehicle <NUMBER> previous study sarscov demonstrates infiltration cd<NUMBER> cell nk cells lungs infected mice late phase infection surprisingly instead cd<NUMBER> cells cd<NUMBER> cells required viral clearance whereas cd<NUMBER> cells rather associated lung pathology viral infection <NUMBER> hence suggested s<NUMBER>p analogs may block infiltration immune cells inflammatory phenotype particularly cd<NUMBER> cells secreting tnfα ifnγ may prevent acute lung injury covid<NUMBER> recent study zhao et al presented similar approach s<NUMBER>pr<NUMBER> agonist cym<NUMBER> providing therapeutic benefits h<NUMBER>n<NUMBER> infected mice intratracheal delivery cym<NUMBER> results marked reduction lung injury proinflammatory cytokine chemokines production ifnα ifnγ tnfα il<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> bal fluid infected mice furthermore therapeutic efficacy cym<NUMBER> improved presence antiviral drug oseltamivir <NUMBER> s<NUMBER>p signaling influences myriad downstream signaling role cym<NUMBER> regulation mitogenactivated protein kinase mapk nuclear factor kappalightchainenhancer activated b cells nfκb studied cym<NUMBER> treatment results reduced phosphorylation status mapk erk<NUMBER> jnk<NUMBER> p<NUMBER> subunit nfκb resulting inactivation signal hence cytokine production <NUMBER> cym<NUMBER> treatment resulted degradation interferon alpha receptor <NUMBER> ifnar<NUMBER> deactivation signal transducer activator transcription <NUMBER> stat<NUMBER> thereby limiting ifnα response <NUMBER> recommending s<NUMBER>p potential therapy covid<NUMBER> must also discuss possible risk associated s<NUMBER>p analogs common consequence cytokine storm acute lung injury results ards proves fatal seen severe cases sarscov<NUMBER> infected patients hence critical maintain cytokine homeostasis response pulmonary infection targeting proinflammatory immune cells activating antiinflammatory pathways <NUMBER> however targeting proinflammatory immune cells may <NUMBER> paramyxovirus reduced inflammation lungs <NUMBER> <NUMBER> reduced lung injury proinflammatory cytokine <NUMBER> advisable approach also limits capacity host clear infection therefore cautious use s<NUMBER>p analogs combination antiviral therapy suggested ensure clearance infection without compromising host defense also worth noting activation s<NUMBER>p signaling tuberculosis infection dual action host protection disease progression depends stage tuberculosis infection s<NUMBER>p treatment early infection profound effect reduction infection disease associated histopathology contrary s<NUMBER>p treatment acute tuberculosis infection exacerbates disease <NUMBER> therefore explore proper therapeutic potential s<NUMBER>p analogs criteria must taken consideration importantly s<NUMBER>p analogs shown therapeutic efficacy animal model pulmonary infections role humans studied yet human trials related s<NUMBER>p analogs immunotherapy dedicated diseases multiple sclerosis subacute lupus erythematosus crohns disease etc <NUMBER> fingolimod fty<NUMBER> s<NUMBER>p analog recently approved clinical trials test efficacy covid<NUMBER> however due broad specificity fty<NUMBER> s<NUMBER>pr<NUMBER> s<NUMBER>pr<NUMBER> specific s<NUMBER>p analogs rp<NUMBER> cym<NUMBER> must also investigated minimize offtarget effects sarscov<NUMBER> induced cytokine storm serious immunopathology could lead death infected patients s<NUMBER>p analogs earlier protected pulmonary infection dampening cytokine storm table <NUMBER> taken together reports emphasize need consider s<NUMBER>p analogs potential immunomodulators ameliorating sarscov<NUMBER> induced cytokine storm several studies correlated cytokine storm lung pathophysiology advocated use immunomodulators therapeutic intervention <NUMBER> regard fda approved drug multiple sclerosis fty<NUMBER> s<NUMBER>pr modulator recently clinical trial assess role immunomodulator covid<NUMBER> <NUMBER> new vaccine antiviral treatment covid<NUMBER> may take time alternatively hostdirective therapy could current weapon choice sarscov<NUMBER> <NUMBER> note dampening sarscov<NUMBER> induced cytokine storm s<NUMBER>p analogs warrants attention form robust randomized clinical trials prove hypothesis datasets presented study included articlesupplementary material early december <NUMBER> several pneumonia cases unknown origin observed wuhan china pathogen identified novel enveloped rna β coronavirus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> virus showed phylogenetic similarities sarscov merscov viruses view similarities bat coronaviruses postulated bats could primary hosts sarscov<NUMBER> hypothesis suggested infection originated via transmission wild animals illegally sold huanan seafood wholesale market january <NUMBER> th <NUMBER> world health organization declared coronavirus disease <NUMBER> covid <NUMBER> public health emergency international concern march <NUMBER> th director general referred covid<NUMBER> pandemic may <NUMBER> th <NUMBER> number confirmed cases covid<NUMBER> exceeded <NUMBER> million worldwide <NUMBER> covid<NUMBER>related deaths epidemic put public health systems severe strain western countries developing world sarscov<NUMBER> displays efficient transmission pattern compared sarscov merscov <NUMBER> retaining high transmission rate also asymptomatic incubation period <NUMBER> clinical spectrum covid<NUMBER> syndrome varies remarkably going asymptomatic forms acute bilateral pneumonias requiring hospitalization common presenting symptoms include fever fatigue dry cough laboratory tests often show lymphopenia elevated lactate dehydrogenase levels chest computed tomographic scans show typical pattern bilateral patchy shadows ground glass opacity significant percentage cases requires admission intensivecareunits icu due acute respiratory distress syndrome requires mechanical ventilation support subgroup patients severe covid<NUMBER> experience socalled cytokine storm syndrome characterized fulminant fatal hypercytokinemia associated multiorgan failure term cytokine storm become increasingly used authors scientific articles also popular media likely widespread use term related rather immediate meaning actually recalls role immune system producing uncontrolled generalized inflammatory response <NUMBER> seems casual term cytokine storm first employed describing j u r n l p r e p r f events modulating onset graftversushost disease <NUMBER> condition characterized impressively powerful activation immune system cytokine storms characterize wide spectrum infectious noninfectious diseases since <NUMBER> associated avian h<NUMBER>n<NUMBER> influenza virus infection <NUMBER> apart immediate significance term cytokine storm biological clinical consequences immune system hyperactivity far less known making worthwhile briefly overviewed several similarities clinical features covid<NUMBER> previously identified betacoronavirus infections shared clinical findings include patients present fever dry cough dyspnea bilateral groundglass opacities chest ct scans <NUMBER> however physiopathology mechanisms sarscov merscov sustain high pathogenicity yet completely unveiled since first reports covid<NUMBER> disease appeared clear acute respiratory distress syndrome ards accounted significant number deaths among infected patients ards regarded hallmark immunemediated clinical consequence sarscov<NUMBER> similarly described sarscov merscov infections <NUMBER> acute respiratory distress syndrome ards devastating event estimated mortality approximately <NUMBER> defined presence bilateral lung infiltrates severe hypoxemia ards occur variety clinical situations including pneumonia sepsis pancreatitis blood transfusion ards pathogenesis involves inflammatory injury alveolocapillary membrane results increased lung permeability exudation proteinrich pulmonary edema fluid airspaces leading end respiratory insufficiency <NUMBER> shown previous data literature increased circulating levels proinflammatory cytokines eg interferon γ interleukin il <NUMBER>b il<NUMBER> il<NUMBER> chemokines cxcl<NUMBER> ccl<NUMBER> associated pulmonary inflammation extensive lung involvement sars patients similarly happens merscov infection <NUMBER> far covid <NUMBER> infection concerned huang et al recently reported infected patients also show high levels proinflammatory cytokines chemokines <NUMBER> demonstration increased levels il<NUMBER>b ifnγ cxcl<NUMBER> ccl<NUMBER> strongly pointed toward activation thelper<NUMBER> th<NUMBER> cell function importantly called cytokine storm emerged main factor driving j u r n l p r e p r f severe clinical course concept originated observation covid<NUMBER> patients requiring icu admission displayed higher concentrations cxcl<NUMBER> ccl<NUMBER> tnfα compared infection less severe require icu admission complicate issue highlighted patients sarscov<NUMBER> infection difference sarscov infection also increased secretion th<NUMBER>immuneoriented cytokines il<NUMBER> il<NUMBER> whose main effect suppress inflammation <NUMBER> taken together data clearly indicate sarscov infection ards ultimate result cytokine storm scenario release immune effector cells large amounts proinflammatory cytokines ifnα ifnγ il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfα tgfβ chemokines cxcl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> precipitates sustains aberrant systemic inflammatory response <NUMBER> <NUMBER> <NUMBER> <NUMBER> cytokine storm readily followed immune system attacking body turn cause ards multiple organ failure final result death least severe cases sarscov<NUMBER> infection <NUMBER> cytokine storm consequent ards results effects combination many immuneactive molecules interferons interleukins chemokines colonystimulating factors tnfalpha represent main components involved development cytokine storm briefly overviewed interferons family cytokines central role virusdirected innate immunity binds specific receptors result expression genes encoding protein antiviral immunomodulatory properties sequence events supported therapeutic use ifns viral diseases chronic hepatitis also nonviral conditions including leukemia lymphoma melanoma multiple sclerosis <NUMBER> <NUMBER> tumor necrosis factor α tnfα pyrogen cytokine released immune cells acute phase inflammation infection central cytokine viral diseases associated number chronic inflammatory autoimmune diseases <NUMBER> j u r n l p r e p r f <NUMBER> colonystimulating factors csf proteins associated inflammatory conditions components amplification cascade ultimately increases cytokine production macrophages sites inflammation effect perpetuates inflammatory reaction <NUMBER> interleukins family cytokines involved immune cells differentiation activation mediate traffic immune cells site infection induce increase acute phase signaling activate epithelial cells mediate production secondary cytokines <NUMBER> among interleukin<NUMBER> il<NUMBER> deserves extensive discussion view involvement coronavirusinduced cytokine storm il<NUMBER> crucially involved acute inflammation due role regulating acute phase response <NUMBER> produced almost stromal cells b lymphocytes lymphocytes macrophages monocytes dendritic cells mast cells nonlymphocytic cells fibroblasts endothelial cells keratinocytes glomerular mesangial cells tumor cells <NUMBER> production cytokine increased il<NUMBER>β tumor necrosis factor tnfα <NUMBER> il<NUMBER> may also responsible activation helper <NUMBER> th<NUMBER> cells dendritic cellt cell interaction <NUMBER> covid<NUMBER> affected patients high th<NUMBER> cells activation could result virusdriven increased production il<NUMBER> immune system il<NUMBER> plays key role pathogenesis cytokine storm owing pleiotropic properties several studies showed serum levels il<NUMBER> increased covid<NUMBER> patients circulating levels positively related disease severity <NUMBER> <NUMBER> <NUMBER> reason high serum il<NUMBER> levels suggested predictors disease severity <NUMBER> <NUMBER> indeed animal models sarscov infection inhibition transcription factor il<NUMBER> turn production associated reduced mortality <NUMBER> present covid<NUMBER> pandemic use tocilizumab therapeutic agent proposed tocilizumab humanized antiil<NUMBER> receptor igg<NUMBER> monoclonal antibody used treatment rheumatoid arthritis chronic inflammatory diseases <NUMBER> blocking il<NUMBER>receptor interaction tocilizumab inhibits il<NUMBER>mediated signal transduction although clinical data use tocilizumab covid<NUMBER> patients derive small series authors recommend use critically ill covid<NUMBER> patients significantly elevated il<NUMBER> levels <NUMBER> chemokines large family cytokines characterized powerful chemotactic effect chemokines j u r n l p r e p r f act chemoattractants migration immune system cells also involved several processes including development function innate adaptive immune system embryogenesis cancer metastasis <NUMBER> <NUMBER> promptly secreted variety cells response viral microbial infections <NUMBER> chemokines act powerful chemoattractants recruit inflammatory cells migrate intravascular space across endothelium epithelium inflammation site according chemokine gradient <NUMBER> role one specific chemokine cxcl<NUMBER> previously referred interferonγ inducible protein <NUMBER> kda ip<NUMBER> highlighted ards experimental models patients indeed mouse model il<NUMBER> induced ards upregulation mouse cxcl<NUMBER> analogue mob<NUMBER> mrna observed initiation lung injury <NUMBER> several studies also showed intratracheal injection mob<NUMBER> mice induced pulmonary migration leukocytes alveolar space massive recruitment neutrophils especially monocytes event rapidly followed microvascular injury pulmonary edema typical ards <NUMBER> <NUMBER> cxcl<NUMBER> signaling appears critical factor onset ards shown mice models ards induced either acid aspiration viral infection influenza h<NUMBER>n<NUMBER> virus briefly ichikawa et al demonstrated wildtype mice developing ards increased levels cxcl<NUMBER> mainly due increased secretion infiltrating neutrophils induced autocrine loop mechanism chemotaxis inflamed neutrophils leading fulminant pulmonary inflammation contrary cxcl<NUMBER> andor receptor cxcr<NUMBER> knockout mice showed decreased lung injury severity increased survival response viral nonviral lung injury <NUMBER> moreover cxcl<NUMBER> expression lung significantly upregulated induction ards lipopolysaccharide lps mouse model lung injury neutralization cxcl<NUMBER> anticxcl<NUMBER> antibody lead amelioration lung injury <NUMBER> cxcl<NUMBER> also referred il<NUMBER> another chemokine considered potential prognostic biomarker ards clinical course <NUMBER> indeed cxcl<NUMBER> levels found elevated plasma <NUMBER> <NUMBER> <NUMBER> <NUMBER> bronchoalveolar lavage fluid <NUMBER> <NUMBER> <NUMBER> patients ards direct role cxcl<NUMBER> progression ards proven rabbit acidinduced ards lead <NUMBER>fold increase cxcl<NUMBER> levels j u r n l p r e p r f alveolar fluids note pretreatment anticxcl<NUMBER> antibody prevented development typical acute lung injury <NUMBER> although chemokines crucially involved regulation maintenance immune responses role onset coronavirusinduced cytokine storm still poorly investigated chemokines family low molecular weight proteins expressed constitutively inducible manner several types cells chemokines play important role inflammatory response attracting leukocytes sites infection small proteins also contribute homeostatic circulation leukocytes tissues <NUMBER> present <NUMBER> chemokines <NUMBER> chemokine receptors recognized classified chemokines named according recent nomenclature classifies according chemical structure c cc cxc cx<NUMBER>c families <NUMBER> binding chemokines receptors responsible chemoattractant ability chemokine receptors belong seventransmembranespanning gproteincoupled receptors expressed primarily leukocytes also cells eg endothelial cells <NUMBER> many functions chemokines include control cell proliferation differentiation regulation angiogenesis immune inflammatory responses tumor growth metastasis <NUMBER> <NUMBER> <NUMBER> recently several studies investigated involvement chemokines coronavirusrelated infective disease emerged specific chemokines could play crucial role development covid<NUMBER>related symptoms thus confirming previously known types coronaviruses sars mers <NUMBER> <NUMBER> findings could somehow expected view wellknown role chemokines viral infections addressing specific relationship chemokines coronavirus infections mandatory briefly overview general role chemokines viral infections viruses contrast actions chemokines viruses infectious agents small size simple composition multiply living cells animals plants bacteria viruses contain nucleic acid either dna deoxyribonucleic acid rna ribonucleic acid several proteins viruses even considered organisms since freeliving ie require host cell thus viruses need elude host immune defense infect cells order reproduce survive <NUMBER> chemokinechemokine receptorrelated immune defenses main obstacles bypassed viruses chemokines play direct antiviral effect inducing array phenomena lead cells determine antiviral state phenomena include activation apoptosis direct killing infected cells activated immune cells chemokines also recruit immune cells site infection fight intruder <NUMBER> viral infections associated enhanced expression several chemokines particular interferonsinducible ones interferons produced mammalian cell involved rapid efficient host innate response viruses powerful ifn response triggered first contact virus slow viral multiplication buy time organism establish efficient adaptive immune response <NUMBER> ifns stimulate surrounding cells express potent antiviral proteins including enzymes transcription factors cell surface glycoproteins cytokines chemokines <NUMBER> <NUMBER> moreover inhibit cell proliferation regulate apoptosis modulate immune response <NUMBER> among interferonsinduced molecules chemokine cxcl<NUMBER> currently regarded main player organism antiviral response <NUMBER> particularly respiratory tract infections several studies demonstrated cxcl<NUMBER> levels evaluated serum bronchialalveolar washing fluid nasal secretions consistently correlate severity duration acute respiratory tract infection due viral infections <NUMBER> <NUMBER> <NUMBER> also chemokine cxcl<NUMBER> involved inflammation immune cell trafficking context viral infections cxcl<NUMBER> plays major role initial control respiratory tract infection due chemotactic activity neutrophils monocytes <NUMBER> cxcl<NUMBER> levels nasal washing fluid correlate symptoms severity acute respiratory tract infections <NUMBER> although majority cases strong chemokine action efficiently contrast viral infections viruses acquire capacity escaping j u r n l p r e p r f surveillance system furthermore viruses use chemokine system network favor several strategies viruses mimic components chemokine system producing molecules similar chemokines interact receptor molecules generate incongruous signal leading disorganized immune response viruses <NUMBER> inhibition interferoninduced antiviral response several viruses impair intracellular receptors devoted pathogen recognition toll like receptors intracellular rna sensors <NUMBER> taken together data indicate viruses interfere chemokinechemokinereceptors system using properties modify intracellular signaling final result disseminate infection strict relationship conaviruses infection chemokines thoroughly investigated sarscov merscov epidemics initial data available regarding sarscov<NUMBER> related syndrome covid<NUMBER> since first reports sars seemed clear severe clinical manifestations disease could ascribed viral activity per se immunemediated mechanism rather direct virusinduced damage would drive clinical progression <NUMBER> indeed physiopathology point view interesting observation demonstration viral titers seemed paradoxically diminish severe phase disease humans several animal models <NUMBER> data vivo studies showed several circulating chemokines cxcl<NUMBER> ccl<NUMBER> cxcl<NUMBER> inflammatory cytokines il<NUMBER> il<NUMBER> il<NUMBER> elevated patients sarscov <NUMBER> <NUMBER> cxcl<NUMBER> also considered excellent prognostic marker sars disease progression <NUMBER> <NUMBER> particular jiang et al showed cxcl <NUMBER> serum levels significantly increased early stage sars remained elevated resolution moreover persistently elevated cxcl<NUMBER> serum levels followup predictive worse outcome infection <NUMBER> findings prompted vitro studies aimed investigating relationship sars chemokine system spiegel et al demonstrated addition direct effect epithelial lung cells sarscov could also enter macrophages dendritic cells <NUMBER> appeared crucial viral entrance cells lead abortive infection eg virus enters hostcell cannot successfully complete replication yet virus elicited secretion proinflammatory chemokines dendritic macrophages cells <NUMBER> finding confirmed vivo serum levels wide spectrum cytokines chemokines produced dendritic cells macrophages elevated sarscov infected patients <NUMBER> furthermore infection sarscov human primary myeloidderived dendritic cells followed impaired defensive ifnβ response paralleled moderate upregulation pro inflammatory cytokines tnfα il<NUMBER> much significant upregulation inflammatory chemokines cxcl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> <NUMBER> authors suggested lack response antiviral interferons presence chemokine upregulation could represent mechanism immune evasion sarscov <NUMBER> line hypothesis direct exposure lung epithelial cells <NUMBER> peripheral blood mononuclear cells pbmcs <NUMBER> coming sars infected patients viral proteins sprotein nprotein induced prompt release several chemokines including cxcl<NUMBER> cxcl<NUMBER> vitro geneexpression studies also reported pbmc normal healthy donors inoculated sarscov showed early enhancement expression several chemokines belonging cc family ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> receptors j u r n l p r e p r f ccr<NUMBER> ccr<NUMBER> cxcl family cxcl<NUMBER> il<NUMBER> <NUMBER> additional data came animal models sarscov infection mice infected sarscov clinical features syndrome showed agedependent increase severity similarly observed humans related increased level proinflammatory cytokines chemokines paralleled reduction tcell responses <NUMBER> another study showed mice infected sarscov robust virus replication accompanied delayed type interferon secretion caused rapidly fatal pneumonia delayed type iinterferon signaling promoted accumulation pathogenic inflammatory monocytemacrophages resulting increase cytokine il<NUMBER> chemokine ccl<NUMBER> lung levels vascular leakage impaired virusspecific cell responses <NUMBER> data suggest coronaviruses particular sarscov peculiar ability counteract antiviral ifn response pointing toward fact severity disease might due immune dysregulation rather level viremia dysregulation would characterized insufficient type interferon response little late paralleled aberrant proinflammatory chemokine secretion alveolar macrophages dendritic cells pneumocytes <NUMBER> <NUMBER> vitro data suggest class viruses particular sarscov uses several strategies avoid type ifn response passive active <NUMBER> <NUMBER> passive mechanisms include induction double membrane vesicles dmv perinuclear sites within cytoplasm rna synthesis takes place strategy may help hide protect rna replication intermediates sensed intracellular rnasensors thus avoiding activation ifn cascade <NUMBER> <NUMBER> active mechanisms include direct action viral proteins transcription factors intracellular signaling molecules regulate ifn cascade particular sarscov protein orf<NUMBER> able inhibit action interferon regulatory transcription factor<NUMBER> irf<NUMBER> transcription factor ifn genes <NUMBER> <NUMBER> fact sarscov infection would upregulate transcription cxcl<NUMBER> significantly downregulating ifns signaling could seem paradoxical however transcriptional enhancement cxcl<NUMBER> could due direct effect nuclear factor kappalightchainenhancer activated b cells nfkb <NUMBER> triggered sarscov <NUMBER> even authors confirm early observation <NUMBER> similarly upregulation cxcl<NUMBER> gene expression could due direct effect virus cellular level indeed intestinal lung cells lines infected sarscov promptly increase secretion cxcl<NUMBER> <NUMBER> observation would fit notion expression cxcl<NUMBER> dependent transcription factor activator protein <NUMBER> ap<NUMBER> shown strongly upregulated sarscov <NUMBER> <NUMBER> merscov epidemics several studies aimed understanding pathogenic mechanisms underlying severe often fatal pneumonia performed available data suggest merscov infection shares immunological aspects sarscov infection terms involvement chemokine system first increase serum levels cxcl<NUMBER> compared controls observed also merscov patients importantly persistent cxcl<NUMBER> increase associated disease severity <NUMBER> regard case two paradigmatic patients diagnosed merscov worth noting one fatal outcome experienced impaired ifn response together relevant increase serum cxcl<NUMBER> levels one favorable outcome displayed upregulation ifns irf<NUMBER> less pronounced increase serum cxcl<NUMBER> levels <NUMBER> vitro studies also support relevance chemokines merscov patients <NUMBER> study evaluated expression several chemokines cytokines cell lysates polarized airway epithelial cells infected merscov sarscov results showed cxcl<NUMBER> upregulated greater extent merscov infection compared sarscov difference ccl<NUMBER> cxcl<NUMBER> strongly upregulated sarscov merscov <NUMBER> addition dendritic cells infected merscov significant downregulation ifn response paralleled striking elevation cxcl<NUMBER> observed <NUMBER> strong induction cxcl<NUMBER> secretion observed also monocytederived macrophages infected merscov <NUMBER> <NUMBER> interesting data come also experimental mouse model merscov infection significant increase cxcl<NUMBER> expression observed lung brain tissue infection merscov <NUMBER> briefly inoculation two viruses ex vivo human lung tissue explants showed sarscov<NUMBER> capable compared sarscov infecting replicating human lung furthermore sarscov<NUMBER> infection less able trigger expression ifns suggesting sarscov sarscov<NUMBER> might differ ability modulate production proinflammatory cytokines chemokines example could worth highlighting sarscov infection upregulated <NUMBER> <NUMBER> proinflammatory factors evaluated sarscov<NUMBER> upregulated five namely cxcl<NUMBER> il<NUMBER> ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> interestingly cxcl<NUMBER> transcription upregulated sarscov sarscov<NUMBER> infection opposite observed cxcl<NUMBER> <NUMBER> potential involvement chemokine system sarscov<NUMBER> infection already evident first covid<NUMBER> series described chinese physicians early january <NUMBER> reported several proinflammatory cytochines chemokines including cxcl<NUMBER> cxcl<NUMBER> ccl<NUMBER> tnfα ifnγ j u r n l p r e p r f higher plasma covid<NUMBER> patients compared healthy controls importantly among infected patients cxcl<NUMBER> ccl<NUMBER> tnfα circulating concentrations ifnγ found significantly higher patients requiring admission intensive care units compared patients experiencing less severe clinical course <NUMBER> j u r n l p r e p r f sarscov<NUMBER> related syndrome covid<NUMBER> known scientific community since less <NUMBER> months clearly much yet understood challenge next future increase understanding physiopathology novel infectious disease hopefully advances comprehension mechanisms sustaining clinical course patientsrelated factors driving final outcome helpful developing effective preventive strategies andor therapeutical options based current knowledge cytokine storm appears one dangerous potentially lifethreatening event related covid<NUMBER> sustaining major clinical consequences immune mediated events related response sarscov<NUMBER> infection role chemokinechemokine receptor system extensively characterized final goal identify targeted therapeutic strategies although lessons previous sars mers epidemics drawn still much order conclude whether sarscov<NUMBER> virus behaves way predecessors characterized peculiar specificities clearly hideandseek challenge virus immune defenses also help us understanding extremely variable spectrum clinical manifestations covid<NUMBER> appears range asymptomatic cases possibly lethal bilateral pneumonia multiorgan failure particularly older people severe cases disease characterized acute lung injury ards latter typically treated positive airway pressure oxygen pronation invasive ventilation stage characterized neutrophilia lymphocytopenia lung consolidation bilateral nodular peripheral ground glass opacities chest xrays ace<NUMBER> protein widely expressed surface epithelial microvascular pericytes traverse multiple organs allowing cell types infected virus <NUMBER> <NUMBER> recruitment immune cells sites infection results widespread inflammation endothelial dysfunction lung heart kidney liver brain prominent endotheliitis submucosal vessels apoptotic bodies <NUMBER> even viral loads decline patient type cytokine release syndrome rapidly develop characterized disseminated intravascular coagulation dic causing liver damage renal dysfunction cardiovascular inflammation coagulopathy death <NUMBER> <NUMBER> studies definitely connect known mechanisms aging pathogenesis viruses perspective offer potential mechanistic explanations covid<NUMBER> advances people others especially older patients including differences immune system glycation epigenome inflammasome activity biological age also discuss therapies may improve immunity viral infection enhancing ability older people recover severe covid<NUMBER> enzymes airway epithelial cells upper respiratory tract endocytosed replicated top left alerting immune system viruses travel alveoli infect type <NUMBER> pneumocytes youthful system lower left recognized alveolar macrophages ams dendritic cells pictured release cytokines present antigens cells adaptive immune cells cells appropriate receptors activate lymphocytes directly kill infected cells preventing spread virus neutrophils migrate sites infection clear infected cell debris aged system top right viral alert signals initially slow resulting greater viral replication defective macrophages cells limited repertoire receptors less effective lower right cells infected inducing high levels inflammatory cytokine signaling endothelial cell lining capillary becomes inflamed fibroblasts activated sarscov<NUMBER> viral components cytokines enter bloodstream fluid fills alveolus reducing lung capacity virus infects microvascular pericytes organs cytokine storm initiates microvasculature clotting causing severe hypoxia coagulopathy organ failure created biorender ability control viral load one best prognostics whether patient mild severe covid<NUMBER> symptoms <NUMBER> immune system effectively suppress eliminate sarscov<NUMBER> must perform four main tasks <NUMBER> recognize <NUMBER> alert <NUMBER> destroy <NUMBER> clear mechanisms known dysfunctional increasingly heterogeneous older people <NUMBER> <NUMBER> tasks relevant covid<NUMBER> progression older people yet clear <NUMBER> aging immune system changes two major ways one gradual decline immune function called immunosenescence hampers pathogen recognition alert signaling clearance confused cellular senescence agingrelated phenomenon whereby old dysfunctional cells arrest cell cycle become epigenetically locked proinflammatory state secrete cytokines chemokines classic immune system change aging chronic increase systemic inflammation called inflammaging arises overactive yet ineffective alert system <NUMBER> abundance recent data describing pathology molecular changes covid<NUMBER> patients points immunosenescence inflammaging major drivers high mortality rates older patients within immunosenescence defects innate adaptive immune systems innate immunosenescence characterized ineffective pathogen recognition macrophage activation reduction natural killer nk cell cytotoxicity whereas adaptive immunosenescence characterized thymic atrophy accumulation anergic memory lymphocytes cases agerelated changes thought due pathogenic genetic lifestyle factors affect cells epigenetic status diversity immune cells innate immune system bodys first line defense coronaviruses sentinel cells macrophages dendritic cells recognize structurally conserved viral proteins via singlepass membranespanning receptors called tolllike receptors tlrs expressed cell surfaces defects tlr function innate immune cells known increase severity pneumonia mice especially context aging chronic inflammaging <NUMBER> alveolar macrophages ams mononuclear phagocytes surveil lungs dust allergens remnants pathogens tlrs detect invader ams respond producing type interferons attract immune cells site infection present antigens lymphocytes <NUMBER> <NUMBER> although ams increase number aging plasticity convert proand antiinflammatory states greatly reduced <NUMBER> exemplified weak cytokine response tlr activation <NUMBER> figure <NUMBER> inability ams older individuals recognize viral particles convert proinflammatory state likely accelerates covid<NUMBER> early stages whereas advanced stages ams likely responsible excessive lung damage recent study comparing immune cell composition bronchoalveolar lavage fluid moderate severe covid<NUMBER> patients showed severe cases macrophages phenotypically proinflammatory expressing higher levels ccr<NUMBER> cxcr<NUMBER> recruit innate immune cells compared macrophages moderate covid<NUMBER> cases expressed tcell attracting chemokines <NUMBER> prolonged monocyte activation wellknown cause severe lung injury rhesus monkeys <NUMBER> cases sars caused sarscov<NUMBER> higher numbers pulmonary neutrophils macrophages correlated development ards greater lung damage <NUMBER> decline neutrophil activity might also partly responsible aging cells progressively lose ability migrate sites infection kill infected cells <NUMBER> <NUMBER> nk cells major component innate immunity potent cytotoxic activity unlikely cause covid<NUMBER> severity numbers relatively stable aging <NUMBER> mouse model sars necessary normal viral clearance <NUMBER> discern cell types play destructive roles detailed analyses covid<NUMBER> patient autopsy tissue needed additionally production diversity mucins protective glycoproteins found mucosal barriers throughout body also change aging <NUMBER> <NUMBER> although role immunity coronaviruses humans understudied immunosenescence adaptive immune system also likely factor determines whether patient progresses severe covid<NUMBER> figure <NUMBER> situated heart thymusa primary lymphoid organ site cell development maturation early thymic progenitors bone marrowis one first tissues experience aging age <NUMBER> thymus average <NUMBER> original size <NUMBER> coincident activation inflammasome component nlrp<NUMBER> caspase<NUMBER> proapoptotic protease <NUMBER> <NUMBER> buildup intrathymic adipocytes reduces thymic cellularity deteriorates thymic microenvironment thymic atrophy also contributes reduction naïve cells accumulation memory lymphocytes resulting defective immunosurveillance exhaustion b cells cytotoxic cells helper cells <NUMBER> common effects aging adaptive immune system include decline production fresh naïve cells less expansive cell receptor tcr repertoire cell metabolic dysfunction weaker activation cells <NUMBER> <NUMBER> clonal populations cd<NUMBER> cells expand aging limiting diversity whereas cd<NUMBER> cells retain fairly diverse tcrs <NUMBER> instead suffer activation deficits <NUMBER> interestingly one study found supercentenariansdefined adults <NUMBER> years oldtend unusual population cytotoxic cd<NUMBER> cells whose activation doesnt decline age take effector functions usually performed cd<NUMBER> cells <NUMBER> cell behavior may explain older people even people <NUMBER> able survive covid<NUMBER> measuring repertoire frequency tcrs patients spectrum ages disease severity performed determine loss cell diversity reason sarscov<NUMBER> viral loads tend spike older people young factors increase risk cytokine storm covid<NUMBER> fatality tightly controlled activation innate immune system essential viral recognition clearance cytokine storm result sustained activation inflammatory signaling cascade result hypercoagulation small blood vessels leads tissue damage dic multiorgan failure inflammaging immunosenescence contribute development cytokine storm ddimer fibrin degradation product prognostic disseminated intravascular coagulation dic elevated levels cytokine il<NUMBER> associated clinic increased fatality epigenetic dysregulation immune system reninangiotensin system ras may increase fatality risk variety biological clocks shown predict human health longevity accurately chronological age individual biological age greater chronological age thought undergoing accelerated aging may increase risk covid<NUMBER> fatality individuals comorbidities cardiovascular disease diabetes obesity copd greater risk covid<NUMBER> fatality conversely individuals live healthy lifestyles consume geroprotectors metformin resveratrol nad boosters may decreased risk fatality created biorender aging repertoire cells decline aging numbers <NUMBER> years old increasingly low cell numbers condition known lymphopenia <NUMBER> cells express low levels ace<NUMBER> lymphopenia covid<NUMBER> patients unlikely caused direct sarscov<NUMBER> infection <NUMBER> case hiv one proposed cause cell paucity exhaustion immune system driven repeated exposures viruses ones lifetime <NUMBER> <NUMBER> <NUMBER> hypothesis based several studies tracked morbidity mortality people <NUMBER> chronically infected human cytomegalovirus cmv <NUMBER> <NUMBER> cycles cmv reemergence associated vast immune system remodeling including pronounced exhaustion cd<NUMBER> cells predictive allcause mortality chronological age studies indicate cell depletion due cumulative exposure many different pathogens lifestyle factors cmv alone <NUMBER> <NUMBER> chromosomal level major cause immune exhaustion telomere shortening viralspecific memory cd<NUMBER> cells induces cellular senescence state cell cycle arrest hyperinflammation prevents expansion upon reinfection <NUMBER> fact severe covid<NUMBER> cases bronchoalveolar cd<NUMBER> cells appear reduced expansion capability <NUMBER> peripheral blood cells express high levels immuneexhaustion marker pd<NUMBER> <NUMBER> make theory plausible b cellsadaptive immune cells produce antibodies response coronavirus antigens <NUMBER> also less diverse less responsive aging <NUMBER> <NUMBER> total b cells numbers decrease aging memory b cells accumulate naïve b cells depleted may lead loss diversity b cell repertoire although yet definitively demonstrated humans <NUMBER> changes igg glycosylation patterns however shown strongly associate age inflammation predict ageassociated disease development <NUMBER> particular igg nglycans appear predictive biological aging however bcell intrinsic extrinsic regulation glycosylation aging require study due lack sun exposure decreased production vitamin half older people deficiency vitamin <NUMBER> reduces efficacy adaptive innate immune responses increases risk infection <NUMBER> vitamin levels older people correlated preserved features immunity cd<NUMBER> cd<NUMBER> ratio lower levels proinflammatory cytokines stimulus <NUMBER> <NUMBER> although studies see benefit vitamin supplementation risk duration lower respiratory infections <NUMBER> majority especially antibody deficiency increased susceptibility respiratory tract infections <NUMBER> <NUMBER> recent metaanalysis <NUMBER> randomized placebocontrolled trials concluded vitamin supplementation prevented <NUMBER> acute respiratory infections <NUMBER> health professionals recommended vitamin supplementation older people general especially agedcare residents critically ill patients strategy improving chances covid<NUMBER> survival course covid<NUMBER> older patients reduce viral titers rapidly descend state shock involving hyperactivation immune system hypercoagulation small blood vessels <NUMBER> <NUMBER> rapid uncontrolled inflammatory signaling cascade typically occurs later stages infection known cytokine storm exacerbates dyspnea hypoxemia triggers inflammation major tissues lungs kidneys heart liver brain cytokine storm syndrome defined lifethreatening organ dysfunction caused maladaptive host response infectious trigger <NUMBER> resulting vascular inflammation emerging cause complementassociated microvascular injury thrombosis severe covid<NUMBER> cases <NUMBER> initial trigger cytokine storm yet known likely involves immune systems detection large quantity viral antigens released dying cells older people particularly prone cytokine storms also unclear cytokine profiles latestage covid<NUMBER> patients similar patients secondary haemophagocytic lymphohistocytosis type cytokine storm triggered systemic viral infection including increased levels interleukin il<NUMBER> il<NUMBER> il<NUMBER> creactive protein crp granulocytecolony stimulating factor gcsf interferonγ inducible protein <NUMBER> ip<NUMBER> monocyte chemoattractant protein<NUMBER> mcp<NUMBER> macrophage inflammatory protein <NUMBER>α mip<NUMBER>α tumor necrosis factorα tnfα <NUMBER> <NUMBER> <NUMBER> even predictive death serum cytokine profiles increase fibrin degradation product ddimer released blood clots microvasculature prognostic dic <NUMBER> ddimer widely regarded key indicator severity latestage covid<NUMBER> ddimer levels naturally increase age likely reflecting aging higher basal level vascular inflammation <NUMBER> could predispose patients severe covid<NUMBER> would therefore informative know precytokine storm levels ddimer levels could predict likely develop cytokine storm cytokine storms high levels il<NUMBER> cause vascular endothelial cells secrete fibrin causes dic lung may underlie hypoxemia seen patients seemingly functional lungs left untreated clots leach additional clotting factors bloodstream increasing risk bleeding coagulopathy multiorgan failure drugs tocilizumab actemra block il<NUMBER> receptor activity currently used patients advanced stages <NUMBER> one two fatal cases covid<NUMBER> experience cytokine storm <NUMBER> age <NUMBER> <NUMBER> though may many simultaneous triggers storm abundant evidence indicates inflammaging major driver exacerbated obesity poor diets oral health microbial dysbiosis sedentary lifestyles <NUMBER> <NUMBER> example rodents inflammaging increases risk cytokine storm syndrome <NUMBER> humans age correlates higher basal circulating levels proinflammatory cytokines including il<NUMBER> tnfα il<NUMBER>α crp <NUMBER> <NUMBER> central player could help explain predisposition cytokine storms nlrp<NUMBER> major protein component inflammasome aging steady increase abundance activity nlrp<NUMBER> immune cells including ams lung upon chronic stimulation contribute pulmonary fibrosis <NUMBER> nlrp<NUMBER> inflammasome activation requires two steps first priming step induced tlrs tumor necrosis factor receptor activation leads activation nfκb promotes expression nlrp<NUMBER> proil<NUMBER>β proil<NUMBER> second step also called activation step triggered range stimuli emerge infections tissue damage nucleic acids invading pathogen proteins <NUMBER> older individuals nlrp<NUMBER> may poised hyperactivation sarscov<NUMBER> antigens nlrp<NUMBER> activity direct control sirtuin <NUMBER> sirt<NUMBER> member nad dependent sirtuin family deacetylases sirt<NUMBER> <NUMBER> aging nad levels decline reducing activity sirtuins <NUMBER> old mice especially deficient sirt<NUMBER> decreased glucose tolerance increased insulin resistance <NUMBER> decline exacerbated covid<NUMBER> might promote hyperactivation nlrp<NUMBER> trigger cytokine storms covid<NUMBER> patients <NUMBER> maintaining nad levels may therefore alleviate covid<NUMBER> symptoms possibility supported recent data showing sarscov<NUMBER> proteins hyperactivate polyadpribose polymerases parp<NUMBER> <NUMBER> <NUMBER> <NUMBER> deplete cellular nad <NUMBER> additionally nad precursors lower inflammation human subjects <NUMBER> <NUMBER> mechanisms infection coronaviruses support hypothesis nlrp<NUMBER> activation trigger cytokine storms aged sarscov<NUMBER> orf<NUMBER>a protein example potent activator proil<NUMBER>β gene transcription protein maturation two main signals required activation nlrp<NUMBER> <NUMBER> macrophages sarscov<NUMBER> orf<NUMBER>b robustly activates nlrp<NUMBER> inflammasome interacting directly leucine rich repeat domain nlrp<NUMBER> cytosolic dotlike structures <NUMBER> suggesting another twostep model inflammaging nlrp<NUMBER> basal overactivation first step sarscov<NUMBER> antigenmediated hyperactivation second step triggers cytokine storm chronic diseases hyperactivity inflammasome plays dominant role development type <NUMBER> diabetes agerelated diseases <NUMBER> indeed older adults upregulation two inflammasomerelated gene sets correlate increased risk hypertension metabolic dysfunction oxidative stress mortality <NUMBER> individuals age <NUMBER> expressed lower levels inflammasome modules less likely die within seven years <NUMBER> taking together known effects coronavirus proteins nad nlrp<NUMBER> two stages inflammasome activation data provide plausible explanation comorbidities positively correlate cytokine storms fatality covid<NUMBER> patients age hematological cancers obesity next major risk factor covid<NUMBER> fatality similar type <NUMBER> diabetes <NUMBER> obesity well known increase activity nlrp<NUMBER> stimulate low grade inflammation mice including higher levels serum chemokines lower neutralizing antibodies effector memory cells viral infection <NUMBER> accordingly may help explain obesity associated lower survival covid<NUMBER> sarscov<NUMBER> merscov infections obesityrelated human diseases cardiovascular disease chronic kidney disease diabetes predispose patients cytokine storms table <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition causing endothelium microvasculature become leaky obesity type <NUMBER> diabetes may increase ability sarscov<NUMBER> infect surrounding pericytes appear express ace<NUMBER> levels far greater surrounding cells <NUMBER> dysregulation epigenome resulting changes gene expression aging strongly implicated biomarkers potentially underlying causes chronic disease states aging relocalization chromatin modifiers theory aging postulates symptoms aging loss resilience result lifetime accumulation epigenetic changes <NUMBER> <NUMBER> changes may caused part redistribution chromatin factors nuclear proteins sirt<NUMBER> hdac<NUMBER> parp<NUMBER> away regular loci sites dsdna break repair back causing epigenetic noise accumulate may iteratively erase cellular identity <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> process thought manifest dna methylation changes set pace biological clock tissues hematopoietic cells <NUMBER> <NUMBER> abundance evidence indicating agerelated changes hosts epigenome compromise immune cell composition function <NUMBER> negatively impact viral defenses <NUMBER> <NUMBER> including adaptive immune memory <NUMBER> <NUMBER> coronaviruses known mediate epigenetic alterations potentially accelerating rate immune system ages merscov example antagonizes host antigen presentation altering dna methylation mark silences genes encoding major histocompatibility complexes <NUMBER> similarly sarscov<NUMBER> changes histone methylation long noncoding rnas accompanied activation interferonresponse genes <NUMBER> measuring dna methylation age immune cells blood cell types infection could help elucidate aged epigenome impacts disease severity virus alters aged epigenome vulnerability aged sarscov<NUMBER> may also effects epigenome viral entry initiated physical interaction viral spike glycoprotein receptor ace<NUMBER> cell surface protein <NUMBER> genetic differences ace<NUMBER> pursued cause covid<NUMBER> severity <NUMBER> little attention paid epigenetic differences humans ace<NUMBER> ubiquitously expressed epithelial tissues body highly alveolar epithelial cells enterocytes small intestine <NUMBER> ace<NUMBER> regulated body transcriptionally posttranscriptionally posttranslationally <NUMBER> although role regulation covid<NUMBER> still poorly understood mice rats ace<NUMBER> expression decreases age associated increase aortic fibrosis inflammation <NUMBER> <NUMBER> healthy human lungs ace<NUMBER> expression appear change age <NUMBER> even though ace<NUMBER> highly expressed lungs cigarette smokers <NUMBER> metaanalysis covid<NUMBER> deaths however identify smoking significant risk factor <NUMBER> ace<NUMBER> promoter hypomethylation lymphocytes correlates transcriptional activation patients lupus <NUMBER> implying transcription ace<NUMBER> controlled methylation although mechanism systematically investigated known however methylation one seven cpgs ace<NUMBER> promoter decreases age cpgs bordered longrange promoterenhancer contacts may change time <NUMBER> bisulfite sequencing ace<NUMBER> gene paired transcriptomic fourdimensional chromatin analyses necessary understand causal relationship promoter methylation ace<NUMBER> expression disease outcome elucidation sars pathogenesis complicated fact ace<NUMBER> also part reninangiotensin system ras regulates immunity fibrosis blood pressure metabolism ace<NUMBER> counteracts vasoconstriction caused angiotensin aging converting enzyme ace cleaving product angiotensin ii likely due role vasodilation reducing inflammation ace<NUMBER> partially protects sepsisinducedand sarsinduced severe acute lung injury mice <NUMBER> <NUMBER> asthmainduced airway inflammation rats <NUMBER> changes dna methylation aging known affect ras <NUMBER> <NUMBER> <NUMBER> analysis ace<NUMBER> gene expression lungs covid<NUMBER> patients pulmonary arterial hypertension chronic obstructive pulmonary disease found correlation ace<NUMBER> expression covid<NUMBER> severity <NUMBER> thus agerelated dysregulation ace<NUMBER> could explain age risk factor covid<NUMBER> complications cardiovascular disease hypertension predispose patients develop aggressive form covid<NUMBER> effects ace inhibitors used commonly beyond middle age control blood pressure generally believed neutral covid<NUMBER> <NUMBER> <NUMBER> due opposing roles ras ace<NUMBER> expression appears increase ace inhibited likely providing yet unknown protective function <NUMBER> inhibiting ace<NUMBER> expression blocking ace<NUMBER> accessibility could prevent viral entry may lead vasoconstriction hypertension instead promising ace<NUMBER>targeted therapeutic strategy infuse human recombinant soluble ace<NUMBER> airway bloodstream bind sarscov<NUMBER> spike glycoprotein receptor preventing binding ace<NUMBER> host cell surfaces <NUMBER> slowing cell infection rates sirtuins family nad dependent lysine deacylases control numerous aspects stress resistance pathogen defenses sirt<NUMBER> nuclear histone deacetylase suppresses viral replication chronic inflammation <NUMBER> binding promoter region ace<NUMBER> sirt<NUMBER> upregulates transcription conditions cell stress <NUMBER> aging perhaps particularly course covid<NUMBER> levels nad decline likely due increased nad consumption cd<NUMBER> glycohydrolase <NUMBER> increased transcription polyadpribosyl transferases parp<NUMBER> parp<NUMBER> parp <NUMBER> parp<NUMBER> mice humans infected sarscov<NUMBER> <NUMBER> coronaviruses also possess adpribosylhydrolase depletes nad apparently disrupt cell signaling dna repair gene regulation apoptosis <NUMBER> <NUMBER> <NUMBER> negatively regulating activity nlrp<NUMBER> sirt<NUMBER> related protein sirt<NUMBER> seem play key roles suppressing acute lung inflammation sepsis <NUMBER> mice lacking sirt<NUMBER> example display aggravated inflammasome activation increased production lung proinflammatory mediators including intercellular adhesion molecule <NUMBER> icam<NUMBER> highmobility group box <NUMBER> hmgb<NUMBER> dramatic reduction lung claudin<NUMBER> vascular endothelialcadherin expression <NUMBER> result nad depletion mouse models uncontrolled diabetes dna repair blunted leading pulmonary inflammation senescence fibrosis <NUMBER> could explain diabetics susceptible covid<NUMBER> sirt<NUMBER> also attenuates acute inflammatory response deacetylation h<NUMBER>k<NUMBER> tnfα promoter <NUMBER> another nuclear sirtuin sirt<NUMBER> attenuates nfkb signaling deacetylating h<NUMBER>k<NUMBER> <NUMBER> thus decline nad known mislocalization sirt<NUMBER> sirt<NUMBER> across genome aging <NUMBER> <NUMBER> could major contributors agedependency covid<NUMBER> symptoms nad precursors nmn nr <NUMBER> suggested possible treatments covid<NUMBER> especially older people <NUMBER> clinical studies needed determine nad supplementation would benefit early stages sarscov<NUMBER> reduce replication nad treatment acute covid<NUMBER> hasten recovery past decade variety biological clocks developed predict human health longevity accurately chronological age including based dna methylation patterns <NUMBER> <NUMBER> <NUMBER> <NUMBER> inflammaging <NUMBER> gene expression patterns <NUMBER> frailty <NUMBER> <NUMBER> serum proteins <NUMBER> igg glycosylation <NUMBER> <NUMBER> <NUMBER> given clocks provide quantitative measure rate aging individual overall resilience biological clocks may useful identifying atrisk populations predicting within populations likely progress severe covid<NUMBER> estimates based twin studies place contribution nongenetic factors predicted covid<NUMBER> phenotype <NUMBER> <NUMBER> total disease burden old age approximately <NUMBER> <NUMBER> indeed lifestyle factors affect epigenome calorie intake may increase susceptibility covid<NUMBER> epigenetic age greater chronological age various disease contexts lower longlived humans providing strong evidence epigenetic age reflects biological age <NUMBER> <NUMBER> ageassociated changes epigenome profound effects aging immune system including cell function cytokine production macrophage pattern recognition dna methylation believed set pace aging clock several mammalian tissues including hematopoietic cells immune system <NUMBER> <NUMBER> epigenetic clocks measure dna methylation specific cpg sites widely used measure biological age disease susceptibility <NUMBER> <NUMBER> restoration thymus using drug cocktail metformin growth hormone dehydroepiandrosterone led reversal features immunosenescence specifically increasing naïve cells decreasing senescent pd<NUMBER> cells along reversal epigenetic clock <NUMBER> years <NUMBER> epigenetic age may better biomarker chronological age predicting variation lifestyle factors ageassociated comorbidities increase susceptibility covid<NUMBER> may also help determine covid<NUMBER> infection accelerates epigenetic age hope test measuring dna methylation ages peripheral blood samples thousands covid<NUMBER> patients correlating methylation age measurements clinical outcomes changes glycosylation aging may also predispose older individuals severe covid<NUMBER> <NUMBER> glycosylation enzymatic process carbohydrates called glycans sialic acid mannose fucose covalently attached proteins lipids typically cell surface bloodstream individuals repertoire glycans notable example type nglycans attached immunoglobulins <NUMBER> changes age environmental factors smoking poor diet <NUMBER> type glycans attached iggs affects proand antiinflammatory properties <NUMBER> decreased galactosylation iggs associated central adiposity <NUMBER> inflammaging context diabetes <NUMBER> biological clocks based igg glycosylation able predict chronological age within <NUMBER> years improved inclusion clinical parameters <NUMBER> thus changes glycome age could serve indicator biological age could potentially predict covid<NUMBER> severity aging also changes glycome via nonenzymatic glycation reducing sugars circulating extracellular compartments covalently bind proteins lipids form advanced glycation end products ages ages present large quantities western diet greater consumption dietary ages increases serum tnfα <NUMBER> ages tend accumulate hyperglycemic conditions contribute pathology many agerelated disease type <NUMBER> diabetes obesity <NUMBER> ages may increase covid<NUMBER> severity aged inhibiting nlrp<NUMBER> inflammasome early stages viral infection <NUMBER> inflammatory program activated sarscov<NUMBER> <NUMBER>a protein <NUMBER> ages also play role activating procoagulation pathways <NUMBER> potentially contributing dic observed covid<NUMBER> patients glycosylation patterns specific older people may also impact viral entry sarscov<NUMBER> spike protein heavily glycosylated <NUMBER> modifications highly conserved coronaviruses sarscov<NUMBER> shares <NUMBER> <NUMBER> glycosylated nlinkages sarscov<NUMBER> <NUMBER> case human influenza virus variation sialic acid structures surface cells lining upper lower respiratory tracts dictates tropism agedependent binding efficiency virus <NUMBER> changes coronavirus spike protein aging might affect viral transmission pathogenesis yet known use glycation prognostic marker covid<NUMBER> necessary map glycome hundreds patient samples varying degrees covid<NUMBER> severity including asymptomatic individuals individuals heterogeneity immune system increases aging <NUMBER> may explain differences susceptibility infectious diseases biological clock based immune system called immage recently developed predicts allcause mortality older adults accurately even dna methylation clocks <NUMBER> immage overcomes limitation interhuman immune heterogeneity tracking immune cell frequencies gene expression changes longitudinally within individuals computationally predicting individuals homeostatic immune state changes time though individuals exhibit variation immune celltype composition changes fall three stages converge common attractor point correlates age indicative overall physiological resilience <NUMBER> way immage measures entropic relationship age immune system remodeling rate predict survival immage even able capture predict effect inflammaging cardiovascular system covid<NUMBER> fatality closely tied cardiovascular disease inflammaging clock may prove accurate identifying covid<NUMBER>susceptible individuals aging studies still needed determine viral infections alter biological clocks whether variation biological age predicts covid<NUMBER> severity advanced age far greatest risk factor covid<NUMBER> fatality independent underlying comorbidities <NUMBER> striking fact led many researchers speculate whether molecules target aging called geroprotectors could used combat infections older people <NUMBER> <NUMBER> primarily via regulation cellular metabolism mammalian target rapamycin mtor signaling pathway controls several immune functions antigen presentation immune activation differentiation cytokine production <NUMBER> <NUMBER> low dose mtor inhibitors exhibit hormetic effect older people seemingly improving immunity reducing rates infection <NUMBER> <NUMBER> people <NUMBER> years old took mtor inhibitors six weeks responded robustly challenged influenza vaccine showed reduced levels tcell exhaustion marker pd<NUMBER> <NUMBER> similar clinical trial protection infection increase antiviral gene expression observed even year <NUMBER>week course mtor complex <NUMBER> mtorc<NUMBER> inhibitors <NUMBER> though result reproduced phase <NUMBER> trial metformin blood glucose lowering geroprotector activates <NUMBER>ampactivated protein kinase ampk inhibits mtor pathway also suggested possible drug combat severe sarscov<NUMBER> infection older people addition potential insulinsensitizing antiviral effect <NUMBER> metformin confers myriad antiaging benefits including improving mitochondrial metabolism decreasing inflammatory cytokines protecting genomic instability decreasing cellular senescence <NUMBER> may bolster aging bodys resistance covid<NUMBER> results ongoing targeting aging metformin tame clinical trials others reveal whether antiaging drugs protective sarscov<NUMBER> infection <NUMBER> <NUMBER> sarscov<NUMBER> infections severe fatal aged known viable hypotheses emerging include changes immune cell repertoire epigenome nad levels inflammasome activity biological clocks covalent modifications human viral proteins figure <NUMBER> much figure <NUMBER> agerelated changes increase covid<NUMBER> susceptibility aging immune system undergoes immunosenescence tcell diversity alterations chronic activation innate immune system known inflammaging hallmarks aging immune system cripple bodys ability clear sarscov<NUMBER> virus initiate sustain cytokine storms cause acute organ injury dic multiorgan failure ageassociated decline nad results derepression nlrp<NUMBER> inflammasome older people exacerbating cytokine storm coronaviruses also possess adpribosylhydrolase depletes alreadylow nad levels older people leveling epigenetic landscape aging results changes immune cell composition function decrease immune systems ability mount response infection epigenetic dysregulation ace<NUMBER> may also impact increased viral loads older people dysregulation ras aging context ageassociated disease cardiovascular disease hypertension copd obesity contributes severity covid<NUMBER> infection glycome controls variety immune signaling pathways changes aging context metabolic diseases example decreases igg galactosylation contribute chronic inflammation biological clocks measure different biomarkers biological age may explain increased covid<NUMBER> susceptibility accurately advanced chronological age created biorender aging remains elucidated still besides understanding basis cytokine storms coagulopathy known sarscov<NUMBER> easily damages broad array tissues older people rarely young clear whether older people develop stronger weaker functional immunity seroconversion long protection last compared younger people aged immune responses vaccination also often weak defective <NUMBER> <NUMBER> <NUMBER> whereas autoimmunity increases <NUMBER> therefore designing vaccines sarscov<NUMBER> important consider older people may respond well vaccines young people studies follow longterm consequences sarscov<NUMBER> infection older people also critical understand longterm health consequences covid<NUMBER> pathology fibrosis scaring lungs microischemic events cardiopulmonary dysfunction neuropsychological disability <NUMBER> could significantly reduce viral resistance lifespan older middleaged people recover severe cases covid<NUMBER> exciting potentially impactful technologies combat covid<NUMBER> viral pandemics activate bodys defenses aging <NUMBER> <NUMBER> eventually advances field may even possible reverse age cells tissues <NUMBER> <NUMBER> <NUMBER> <NUMBER> highrisk older individuals respond viral infections though young thank first responders essential employees public health leaders physicians scientists continuing work tirelessly treat covid<NUMBER> patients protect vulnerable populations prevent spread virus n march <NUMBER> elderly married couple living long island ny presented emergency department symptoms suspicious covid<NUMBER> infection wife a<NUMBER>yearold woman presented complaints subjective fevers minimal dry cough headaches oneweek duration denied chills rhinorrhea diarrhea abdominal pain shortness breath two days earlier presented similar symptoms discharged home past medical history significant seronegative rheumatoid arthritis diagnosed <NUMBER> hypertension coronary artery disease hyperlipidemia gastroesophageal reflux previously hand surgery cataract surgery etanercept <NUMBER> mg weekly methotrexate <NUMBER> mg weekly <NUMBER> years olmesartan metoprolol omeprazole nortriptyline recent travel history admission temperature <NUMBER>º c pulse <NUMBER> beatsminute respiratory rate <NUMBER> breathsminute blood pressure <NUMBER> mmhg body mass index bmi <NUMBER> kg <NUMBER> lungs clear auscultation murmur appreciated signs synovitis joint deformities remainder physical exam reported without abnormalities abnormal laboratories included sodium <NUMBER> mmoll reference range rr <NUMBER> chloride <NUMBER> mmoll rr <NUMBER> glucose <NUMBER> mgdl rr <NUMBER> alanine transaminase <NUMBER> uil rr <NUMBER> aspartate transaminase <NUMBER> uil rr <NUMBER> white blood cell count <NUMBER> cellsmm <NUMBER> rr <NUMBER> lymphocyte count <NUMBER> cellsmm <NUMBER> rr <NUMBER> procalcitonin <NUMBER> ngml rr <NUMBER> creactive protein crp <NUMBER> mgdl rr <NUMBER> day <NUMBER> hospitalization erythrocyte sedimentation rate esr rr <NUMBER> mmh ddimer within normal limits interleukin <NUMBER> il<NUMBER> <NUMBER> pgml rr <NUMBER> negative quantiferon tb test mitogen <NUMBER> iuml chest xray chest computed tomography ct clear without infiltrates elevated temperature <NUMBER>° c hospital day <NUMBER> symptoms quickly abated nasopharyngeal swab obtained admission positive sarscov<NUMBER> polymerase chain reaction pcr viracor eurofins lees summit mo require supplemental oxygen hydroxychloroquine azithromycin antiviral agents receive acetaminophen receive methotrexate etanercept hospitalization husband <NUMBER>yearold man presented emergency department complaining high fevers <NUMBER>º c severe dry cough previous <NUMBER> hours along fatigue myalgias shortness breath frontal headaches lightheadedness medical history significant ankylosing spondylitis hypertension hypothyroidism benign prostatic hypertrophy supraventricular tachycardia ablation neuropathy hyperlipidemia medications included secukinumab <NUMBER> mg subcutaneous every four weeks previous <NUMBER> months amlodipine hydrochlorothiazide losartan nortriptyline levothyroxine rosuvastatin tamsulosin admission patients vital signs temperature <NUMBER>° c respiration rate <NUMBER> breathsminute blood pressure <NUMBER> mmhg pulse oximeter <NUMBER> room air weight <NUMBER> kg physical exam clear breath sounds auscultation evidence complete blood count showed thrombocytopenia <NUMBER>mm <NUMBER> rr <NUMBER> lymphocyte count normal <NUMBER>mm <NUMBER> rr <NUMBER> crp <NUMBER> mgdl rr <NUMBER> chest xray admission clear free infiltrates next three days patient continued fevers became progressively dyspneic requiring supplemental oxygen chest ct performed day <NUMBER> showed several small areas groundglass opacities see figure <NUMBER> p <NUMBER> day <NUMBER> lactate dehydrogenase <NUMBER> iul ferritin <NUMBER> ngml ddimer <NUMBER> ngml crp <NUMBER> mgdl higher normal ranges nasopharyngeal swab obtained admission positive sarscov<NUMBER> pcr day <NUMBER> patients condition worsened became hypoxemic due interval development diffuse patchy airspace opacities bilaterally chest x ray see figure <NUMBER> requiring intubation mechanical ventilation day <NUMBER> patient remained mechanical ventilation completed fiveday course hydroxychloroquine azithromycin steroids secukinumab administered hospitalization severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> rna virus first reported wuhan hubei province china december <NUMBER> <NUMBER> april <NUMBER> <NUMBER> million people worldwide confirmed covid<NUMBER> infection <NUMBER> deaths occurred <NUMBER> mortality higher elderly little known covid<NUMBER> infection immunocompromised patients particularly rheumatic diseases biologics report two cases husband wife receiving different diseasemodifying antirheumatic drugs dmards markedly different clinical presentations hospital courses wife patient rheumatoid arthritis received etanercept methotrexate prior hospitalization mild clinical course required major therapeutic intervention husband ankylosing spondylitis received secukinumab progressed critical covid<NUMBER> disease requiring mechanical ventilation cases present intriguing considerations regarding immunological underpinning covid clinical course covid<NUMBER> varies mild critical possibly progressing death cytokine storm macrophage activation syndrome mas secondary hemophagocytic lymphohistiocytosis shlh disease processes triggered infections autoimmune diseases drugs malignancy clinically cytokine storm presents syndrome excessive immune activation causes fever pancytopenia hyperferritinemia splenomegaly hepatitis encephalopathy coagulopathy etiology thought caused excessive activation proliferation lymphocytes macrophages massive hypersecretion proinflammatory cytokines including interleukin <NUMBER> beta il<NUMBER>β il<NUMBER> interferonγ ifnγ tumor necrosis factor α tnfα <NUMBER> <NUMBER> huang et al described cytokine profile similar shlh associated covid<NUMBER> disease severity characterized increased il<NUMBER> il<NUMBER> granulocytecolony stimulating factor ifnγ inducible protein <NUMBER> monocyte chemoattractant protein <NUMBER> macrophage inflammatory protein <NUMBER>α tnfα well known il<NUMBER> il<NUMBER>β blockade successfully used treating mas secondary systemic juvenile idiopathic arthritis sjia <NUMBER> <NUMBER> success led clinical trials onethird patients achieved clinical remission <NUMBER> <NUMBER> additionally il<NUMBER> receptor inhibitor anakinra associated improved survival sepsis maslike features <NUMBER> similarly il<NUMBER> antagonist tocilizumab could suppress cytokine storm suggested early promising results small cohort covid<NUMBER> patients <NUMBER> therefore worthwhile exploring whether blocking cytokines involved mas shlh may beneficial cases cytokine storm covid<NUMBER> infection tnfα may play key role cytokine storm tnfα <NUMBER> kd homotrimeric transmembrane protein expressed surface macrophages lymphocytes natural killer cells smooth muscle cells fibroblasts tnfα along ifnγ plays significant role immune response viral infections tnfα ifnγ exhibit crosstalk level tnf receptor <NUMBER> tnfr<NUMBER> induce activation macrophages ifnγ signaling causes nuclear localization stat<NUMBER>α precludes recruited tnfr<NUMBER> leading enhanced tnfαinduced nfκb activation <NUMBER> <NUMBER> <NUMBER> blocking ifnγ emapalumab described successfully treating secondary hlh due multiple viral infections <NUMBER> emapalumab human monoclonal antibody ifnγ acts block binding cell surface receptors activation inflammatory signals emapalumab used treat severe hlh serum ifnγ levels elevated <NUMBER> <NUMBER> similarly tnfα inhibition may theoretically increase risk viral infections could potentially beneficial cases cytokine storm <NUMBER> literature <NUMBER> sarscov infection suggested viral infection associated decreased angiotensinconverting enzyme <NUMBER> ace<NUMBER> expression leading increased activity reninangiotensin system responsible lung injury <NUMBER> spike protein sarscov sarss induces ace<NUMBER> shedding via process tightly linked tnfα production <NUMBER> vitro study il<NUMBER> tnfα upregulated recombinant protein sarscov suggesting tnf inhibitors il<NUMBER> antagonists may potentially reduce inflammatory storm sarscov<NUMBER> lung damage <NUMBER> cases possible pretreatment etanercept rheumatoid arthritis female patient could resulted blunted il<NUMBER> response indirectly may contributed mild case covid<NUMBER> support hypothesis patients normal plasma il<NUMBER> level minimally elevated crp inflammatory markers remained within normal limits sha et al demonstrated cohort hiv patients pretreated etanercept tnfα il<NUMBER> levels blunted stimulation il<NUMBER> case also suggests possibility tnfα inhibitor etanercept could minimize abort potential cytokine storm contrast covid<NUMBER> infection husband critical drug secukinumab receiving may aggravated viral infection secukinumab human igg<NUMBER>κ monoclonal antibody binds protein il<NUMBER>a host defense il<NUMBER>a shown mostly beneficial infection caused extracellular bacteria fungi <NUMBER> primary function helper th <NUMBER> cells appears control gut microbiota well clearance extracellular bacteria fungi <NUMBER> <NUMBER> il<NUMBER>a il<NUMBER> receptor signaling shown play protective role host defenses many bacterial fungal pathogens including klebsiella pneumoniae mycoplasma pneumoniae candida albicans coccidioides posadasii histoplasma capsulatum blastomyces dermatitidis <NUMBER> however il<NUMBER>a seems detrimental viral infection influenza promoting neutrophilic inflammation <NUMBER> appears clinical picture covid<NUMBER> characterized strong immune response lung parenchyma mononuclear cells mainly lymphocytes direct effect viral replication <NUMBER> autopsy study cases suggested overactivation cells manifest increase th<NUMBER> high cytotoxicity cd<NUMBER> cells accounts part severe immune injury although study suggested involvement th<NUMBER> th<NUMBER>associated cytokines measured case th<NUMBER> cells il<NUMBER> involved cytokine storm response il<NUMBER>β tnfα promote th<NUMBER> responses leading vascular permeability leakage wu et al proposed inhibiting th<NUMBER> response may beneficial <NUMBER> two cases highlight disparate clinical courses may experienced patients rheumatic disease infected sarscov<NUMBER> immunologic mechanisms underpinning severe manifestations covid <NUMBER> yet elucidated observations may begin provide clarity important however acknowledge limitations interpreting cases particular clinical course covid <NUMBER> may highly heterogeneous even among patients otherwise similar characteristics relative contribution potential riskfactors eg gender genetic milieu concomitant medications impossible differentiate impact biologic agents used patient said cases raise intriguing questions regarding pathogenesis covid<NUMBER> potential risks benefits specific immunosuppressive agents patients covid<NUMBER> potential role biologic agents management severe covid<NUMBER> warrant study r coronavirus <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sars cov<NUMBER> declared global pandemic since march <NUMBER> viral outbreak raised serious concerns among public patients health conditions medical community rheumatologists particularly concerned patients represent population autoimmune rheumatic disorders mostly immunosuppressive agents susceptible infection much learnt covid<NUMBER> general little known covid<NUMBER> severity outcomes patients rheumatic diseases rd herein conjunction literature review report case series patients rd infected covid<NUMBER> retrospective chart review conducted <NUMBER> hospitalized patients stony brook university hospital early march <NUMBER> end april <NUMBER> including <NUMBER> cases previously published rheumatologist patients underlying rd disease modifying antirheumatic drugs dmards prior developing covid<NUMBER> patients diagnosis covid<NUMBER> made based clinical grounds polymerase chain reaction samples nasopharyngeal swabs addition literature search pubmed scopus web science databases conducted december <NUMBER> may <NUMBER> <NUMBER> using terms covid<NUMBER> rheumatic disease biologic search process result depicted prisma figure <NUMBER> english language articles reported single case case series covid<NUMBER> rd reviewed relevant information covid<NUMBER> rheumatic disease <NUMBER> demographic clinical therapeutic data outcomes patients gathered literature relevant literature regarding virus sars immune response cytokine storm also searched <NUMBER> may <NUMBER> <NUMBER> descriptive statistics used demographic clinical therapeutic data <NUMBER> cases hospital summarized table <NUMBER> <NUMBER> covid<NUMBER> hospitalized patients rd <NUMBER> men <NUMBER> women mean age <NUMBER> ± <NUMBER> years common symptoms among <NUMBER> patients fever cough <NUMBER> patients <NUMBER> patients mild infection <NUMBER> developed severe covid<NUMBER> related respiratory complications including <NUMBER> ankylosing spondylitis patient secukinumab requiring mechanical ventilation <NUMBER> granulomatous polyangiitis gpa patient underlying lung involvement rituximab developed superimposed viral pneumonia requiring supplemental oxygenation <NUMBER> patients elevated acute phase reactants <NUMBER> patients mild covid<NUMBER> lymphopenia <NUMBER> patients severe infection normal lymphocyte counts high levels interleukin il<NUMBER> none patients exhibited exacerbation underlying rds lupus patient normal complement levels negative antidouble stranded dna antibodies case acute worsening chronic renal insufficiency thought secondary dehydration diarrhea gpa patient show disease flare evidenced stable renal function negative antineutrophil cytoplasmic antibody days watery diarrhea associated nausea vomiting decreased oral intake without abdominal pain also lowgrade fevers chills generalized myalgias three weeks ago vital signs temperature <NUMBER> <NUMBER> c blood pressure <NUMBER> mmhg heart rate <NUMBER>min breathing rate <NUMBER>min so<NUMBER> <NUMBER> room air physical examination showed tachycardia otherwise normal tested positive sarscov<NUMBER> receive special treatment except hemodialysis discharged home <NUMBER> days hospitalization <NUMBER>yearold hispanic woman diagnosis gpa two months ago presented fevers severe dry cough shortness breath april <NUMBER> treated high dose steroids four weekly infusions rituximab <NUMBER> months ago gpa stabilized prednisone <NUMBER>mg daily presentation tachycardic tachypneic respiration rate <NUMBER>min oxygen saturation <NUMBER> room air improvement upon placed <NUMBER> nonrebreather physical exam demonstrated bilateral decreased breath sounds correlated chest radiography findings bilateral multifocal opacities laboratory evaluation revealed elevated inflammatory markers table <NUMBER> tested positive sarscov<NUMBER> received <NUMBER>day course hcq however due poor clinical improvement subsequently received one dose tocilizumab <NUMBER> mg inflammatory markers oxygen requirement improved require mechanical ventilation literature data covid<NUMBER> rd clinical data outcomes published cases summarized antagonists may potentially reduce cytokine storm covid<NUMBER> related lung damage <NUMBER> data together suggest tnfα antagonist may considered treatment strategy severe covid<NUMBER> future case <NUMBER> patient developed severe virusrelated complications unclear whether secukinumab monoclonal antibody il<NUMBER>a could play negative role case contrasting autopsy study covid<NUMBER> infected cases suggested pathogenic role th<NUMBER> potential benefit blocking th<NUMBER> <NUMBER> addition <NUMBER> covid<NUMBER> <NUMBER> hospitalized data indicate il<NUMBER>a inhibitors influence viral disease course patient sle minimal viral symptoms without worsening underlying ild vitro study hcq shown inhibit endosomelysosome system acidification suppress proinflammatory cytokines <NUMBER> hcq currently studied multiple clinical trials<NUMBER> however therapeutic efficacy hcq covid<NUMBER> remains controversial studies showed benefit <NUMBER> records identified database searching n <NUMBER> additional records identified sources n <NUMBER> records duplicates removed n <NUMBER> records excluded based title abstract content n <NUMBER> fulltext articles assessed eligibility n <NUMBER> fulltext articles without cases excluded n <NUMBER> studies included qualitative synthesis n <NUMBER> studies included quantitative synthesis metaanalysis n <NUMBER> tocilizumab used treat cytokine storm covid<NUMBER> patients targets il<NUMBER>r <NUMBER> humanized monoclonal antibody hmab also antagonist il<NUMBER>r il<NUMBER> level significantly increased serum covid<NUMBER> infected severe patients il<NUMBER> one major cytokines create inflammatory storm may consequence impair oxygen diffusion due respiratory muscles become fatigued may finally leads respiratory failure case tocilizumab may right therapeutic choice treat critical patients clinical trial study china found hmab useful treatment severely affected covid<NUMBER> patients augmented il<NUMBER> levels study initial dose used article protected copyright rights reserved similarly sarilumab also applied therapeutic purpose cytokine storm covid<NUMBER> patients also humanized monoclonal antibody also antagonist il<NUMBER>r clinical trials sarilumab initiated therapy cytokine storm syndrome sarscov<NUMBER> infected victims <NUMBER> therapeutic molecules il<NUMBER> receptor antagonist property applied cure cytokine storm syndrome sarscov<NUMBER> infected patients il<NUMBER>r antagonist may one best choices treat severe covid<NUMBER> patients however open questions needs answered molecular mechanism number published studies implicated nrf<NUMBER> regulator susceptibility respiratory viral infections recent review lee <NUMBER> points virusinduced modulation host antioxidative response turned crucial determinant progression several viral diseases virus needs keep oxidative stress level optimal viral reproduction higher normal support viral metabolism high kill host cell viruses evolved mechanisms manipulating nrf<NUMBER> pathway directions depending needs virus importantly taking control away host cell among types virus studied influenza virus respiratory syncytial virus rsv human metapneumovirus hmpv <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> phenomenon also seen nonrespiratory viruses including dengue virus denv <NUMBER> rotavirus <NUMBER> herpes simplex virus <NUMBER> zika virus <NUMBER> hiv <NUMBER> suggesting regulation oxidative stress may need common viruses nrf<NUMBER> activators may offer multiple ways regain control important pathways increase resistance slow viral replication recently described phytochemical composition pb<NUMBER> potently activates nrf<NUMBER> controlling multiple steps involved process especially via akt<NUMBER>pi<NUMBER>kgsk<NUMBER>fyn pathway <NUMBER> purpose study evaluate effects nrf<NUMBER> activation via pb<NUMBER> human liverderived hepg<NUMBER> cells well primary human pulmonary artery endothelial cells culture regarding expression genes known important antiviral activity general well genes specific relevance sarscov<NUMBER> covid<NUMBER> plant extracts rosemary extract rosmarinus officinalis standardized <NUMBER> carnosol <NUMBER> carnosic acid obtained flavex rehlingen germany ashwagandha extract withania somnifera standardized <NUMBER> withaferin obtained verdure sciences noblesville usa luteolin standardized <NUMBER> luteolin sophora japonica obtained jiaherb pine brook nj usa making pb<NUMBER> solutions rosemary ashwagandha luteolin powders mixed <NUMBER> ratio mass extracted <NUMBER> mg mixed powder per ml ethanol overnight supernatant isolated <NUMBER> cell culture media antibiotics purchased thermo fisher scientific waltham usa lps lipopolysaccharides escherichia coli o<NUMBER>b<NUMBER> sigmaaldrich st louis mo usa utilized human hepg<NUMBER> cell line hepatocellular carcinoma primary human pulmonary artery endothelial cells hpaec genomic assays hepg<NUMBER> hpaec cells suitable models present work nrf<NUMBER> pathway responds normal manner nrf<NUMBER> activators <NUMBER> <NUMBER> reported mutations nrf<NUMBER>keap<NUMBER> cells cultured maintained standard methods using optimem medium <NUMBER> fetal bovine serum fbs geneticinpenicillinstreptomycin hepg<NUMBER> cells using egm<NUMBER>mv medium hpaec cells lonza morristown nj hpaec subculturing limited six passages order prevent senescence dedifferentiation used human il<NUMBER> quantiglo elisa rd systems minneapolis mn according manufacturers instructions determine concentration il<NUMBER> protein released hpaec pretreated overnight <NUMBER> h <NUMBER> ugml pb<NUMBER> vehicle control exposed <NUMBER> h <NUMBER> ngml lps vehicle control evaluate whether il<NUMBER> protein levels increase upon lps exposure whether pb<NUMBER> attenuates lpsinduced il<NUMBER> protein increase briefly hpaec cells seeded using egm<NUMBER>mv medium <NUMBER> h hpaec cells treated <NUMBER> ugml pb<NUMBER> extract corresponding amounts vehicle control additional <NUMBER> h incubation cells treated <NUMBER> ngml lps vehicle control treatment group run triplicate <NUMBER> hours lps treatment aliquots cell culture medium removed well il<NUMBER> measurement elisa examine effects pb<NUMBER> gene expression hepg<NUMBER> cells cells cultured overnight <NUMBER>well plates control vs <NUMBER> μgml pb<NUMBER> extract <NUMBER> mgml <NUMBER> ethanol treatment examine effects pb<NUMBER> genes induced endotoxin exposure may contribute cytokine storm observed covid<NUMBER> illness examined model proinflammatory lipopolysaccharide lps treated human pulmonary arterial endothelial cells without treatment pb<NUMBER> hpaec cells cultured overnight <NUMBER>well plates four conditions control untreated pb<NUMBER>treated <NUMBER> µgml lpstreated <NUMBER> ngml pb<NUMBER> lps treated briefly cultured cells washed two times pbs wells treated trizol total rna isolated total rna purified using qiagen rneasy cleanup columns qiagen inc valencia ca usa rna concentration sample derived hpaec determined based absorbance <NUMBER> nm a<NUMBER> using nanodrop spectrophotometer thermo fisher scientific waltham usa integrity total rna samples examined agilent tapestation <NUMBER> agilent santa clara ca usa transcriptional analysis done university colorado amc genomics microarray core facility aurora co usa per standard protocol <NUMBER> ng starting total rna converted cdna genechip <NUMBER> ivt plus reagent kit affymetrixthermo fisher scientific waltham usa following manufacturers protocol standard sample labeling sample hybridized affymetrix primeview human gene expression assay followed examination affymetrix genechip scanner <NUMBER> affymetrixthermo fisher scientific waltham usa briefly transcript variants represented use <NUMBER> perfectly matched pm probes affymetrix genechip software program affymetrixthermo fisher scientific waltham usa determines intensity expression genes array provides pairwise comparison chips total <NUMBER> ng total rna hepg<NUMBER> cells used prepare illumina hiseq libraries <NUMBER> assays based <NUMBER> biological replicates treatment group according manufacturers instructions truseq rna kit illumina san diego ca usa kit first isolates mrna total rna using polya selection fragments primes mrna creation doublestranded cdna fragments subsequently amplified size selected purified cluster generation mrna template libraries sequenced single pass <NUMBER> bp reads illumina hiseq <NUMBER> platform illumina san diego ca usa university colorado amc genomics microarray core facility aurora co usa sequenced depth provides <NUMBER>m singleread <NUMBER> bases reads per sample ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint mrnaseq profiling derived sequences analyzed applying custom computational pipeline consisting opensource gsnap <NUMBER> cufflinks <NUMBER> r sequence alignment ascertainment differential gene expression <NUMBER> short reads generated mapped human genome grch<NUMBER> gsnap <NUMBER> expression fpkm derived cufflinks <NUMBER> differential expression analyzed anova r data presented mean ± standard error mean sem significant differences determined oneway anova post hoc tukey multiple comparisons testing students test unpaired data using prism software version <NUMBER> graphpad software san diego ca usa p value <NUMBER> considered statistically significant using elisa assay determined pretreatment hpaec pb<NUMBER> decreased lpsinduced release il<NUMBER> protein hpaec cells study treated hpaec cells <NUMBER> h <NUMBER> ugml pb<NUMBER> vehicle negative control stimulated pretreated hpaec cells <NUMBER> h <NUMBER> ngml bacterial lipopolysaccharide lps vehicle negative control lps stimulation vehiclepretreated hpaec significantly increased release il<NUMBER> protein culture media lpsinduced il<NUMBER> release significantly attenuated p<NUMBER> pretreatment hpaec cells pb<NUMBER> figure <NUMBER> sarscov<NUMBER> entry human cell depends ace<NUMBER> binding tmprss<NUMBER> proteolytic activation spike protein <NUMBER> examined effects pb<NUMBER> expression two genes inhibition protease activity tmprss<NUMBER> ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint shown block viral entry <NUMBER> also examined expression plasminogen activator inhibitor<NUMBER> pai<NUMBER> encoded serpine<NUMBER> gene normal plasma component known potent inhibitor tmprss<NUMBER> <NUMBER> ace<NUMBER> mrna regulated <NUMBER>fold tmprss<NUMBER> downregulated <NUMBER>fold pb<NUMBER> human liverderived hepg<NUMBER> cells seen figure <NUMBER> impediments may completely block viral entry may significantly impair slowing rate viral progression furthermore pb<NUMBER> strongly regulated serpine<NUMBER>pai<NUMBER> <NUMBER>fold pb<NUMBER> downregulates hdac<NUMBER> human liver cells <NUMBER>fold also shown figure <NUMBER> humans hdac<NUMBER> appears responsible deacetylation attenuation nrf<NUMBER> activity <NUMBER> cytokine lif important antiviral cellular response viral infection <NUMBER> <NUMBER> regulated <NUMBER>fold pb<NUMBER> recent evidence plasmin trigger substantial proinflammatory release cytokines <NUMBER> examined effect pb<NUMBER> plasminogen plg mrna expression finding regulated <NUMBER>fold thus six gene regulatory effects pb<NUMBER> would appear counter viral attempts enter cell usurp control oxidative stress response examine effects pb<NUMBER> genes may contribute covid<NUMBER>induced cytokine storm examined model lipopolysaccharide lps treated hpaec without treatment pb<NUMBER> results seen figure <NUMBER> <NUMBER> genes significantly upregulated lps normalized <NUMBER> indicated red bar pb<NUMBER> sixteen cytokines including two colony stimulating factors shown green mrnas downregulated pb<NUMBER> indicated average percent inhibition group cytokines <NUMBER> two proinflammatory interleukins il<NUMBER>b il<NUMBER> showed mrnas inhibited <NUMBER> <NUMBER> respectively three proinflammatory cytokineinduced adhesion molecules intercellular adhesion molecule <NUMBER> icam<NUMBER> vascular cell adhesion molecule <NUMBER> vcam<NUMBER> endothelial cell selectin sele suppressed average <NUMBER> tumor necrosis factor tnf mrna reduced <NUMBER> group five tnfinduced proteins tnfaips repressed even averaging <NUMBER> four genes representing tnf family downregulated average <NUMBER> also family five interferoninducible genes shown downregulated average six genes differed control p <NUMBER> ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> acrosstheboard reduction genes contribute cytokine storm noteworthy intensity storm predicts icu fatalities covid<NUMBER> transforming storm manageable shower therefore major therapeutic objective clinical management covid<NUMBER> patients last decade seen <NUMBER> publications nrf<NUMBER> involvement redox homeostasis inflammation immunity neurodegeneration aging diseases associated aging ischemiareperfusion injury many areas relatively little published regarding roles viral infectivity resistance despite rather tantalizing studies kesic et al showed sirna knockdown nrf<NUMBER> expression human nasal epithelial cells effectively decreased nrf<NUMBER> mrna nrf<NUMBER> protein expression cells correlated significantly increased entry influenza abangkok<NUMBER> h<NUMBER>n<NUMBER> serotype replication transduced human cells <NUMBER> importantly also demonstrated enhancing nrf<NUMBER> activation via supplementation sulforaphane sfn epigallocatechin gallate egcg increased antiviral mediators absence viral infection also abrogated viral entry yegeta et al took different approach increased oxidative stress manipulating nrf<NUMBER> expression genetically alternatively exposing mice exogenous oxidative stresscigarette smoke <NUMBER> cigarette smokeexposed nrf<NUMBER>deficient mice showed higher rates mortality wildtype mice influenza virus infection enhanced peribronchial inflammation lung ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint permeability damage mucus hypersecretion cho et al <NUMBER> similarly studied respiratory syncytial virus rsv infection single important virus causing acute respiratory tract infections children found nrf<NUMBER> mice infected rsv showed significantly increased bronchopulmonary inflammation epithelial injury mucus cell metaplasia well nasal epithelial injury compared similarly infected nrf<NUMBER> wt mice nrf<NUMBER> mice also showed significantly attenuated viral clearance ifnγ greater weight loss importantly pretreatment oral sulforaphane significantly limited lung rsv replication virusinduced inflammation nrf<NUMBER> wt mice komaravelli et al <NUMBER> <NUMBER> <NUMBER> noted rsv causes increased production ros actively lowers expression antioxidant enzymes increasing rate proteasomal degradation nrf<NUMBER> <NUMBER> h postinfection nrf<NUMBER>dependent gene transcription increased indicating cell control responding insult viral infection increase oxidative stress <NUMBER> h postinfection however concentration nrf<NUMBER> dropped significantly half preinfection level reflecting changeofcontrol favor virus accomplish rsv increased nrf<NUMBER> ubiquitination triggering proteasomal degradation representing one example viruses subvert cellular antioxidant defenses taken together studies demonstrate ability nrf<NUMBER> impede viral entry slow viral replication reduce inflammation weight loss mortality without providing much detailed insight genes pathways involved first challenge facing virus particularly virus jumping one host species another gaining entry cell fairly common ports entry ldlr icam<NUMBER> lead endosomal entry shared among various viral families <NUMBER> sarscov<NUMBER> however seems largely totally restricted specific mode entry unique mode entry may greatest vulnerability virus opening door potentially effective therapies substantial evidence suggests transmembrane protease encoded tmprss<NUMBER> gene plays critical role entry sars mers coronavirus <NUMBER> asian h<NUMBER>n<NUMBER> influenza virus several h<NUMBER>n<NUMBER> subtype influenza virus infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> suggesting targeting tmprss<NUMBER> could novel antiviral strategy treat coronavirus <NUMBER> hoffmann coworkers found infection sarscov<NUMBER> virus responsible covid<NUMBER> may depend almost exclusively host cell factors ace<NUMBER> tmprss<NUMBER> <NUMBER> spike protein coronaviruses facilitates viral entry target cells entry depends binding protein cellular receptor ace<NUMBER> facilitates viral attachment surface target cells addition entry requires protein priming cellular protease tmprss<NUMBER> entails protein cleavage allows fusion viral cellular membranes figure <NUMBER> priming blocked clinically proven protease inhibitors tmprss<NUMBER> camostat mesylate <NUMBER> <NUMBER> nafamostat mesylate <NUMBER> nafamostat remarkably potent ic<NUMBER> nanomolar range blocking cellular entry merscov vitro clinically tested antiviral humans drug appears available present oral formulation lack specificity concern possible side effects <NUMBER> may prove suitable treatment severe covid<NUMBER> cases tmprss<NUMBER> also blocked human antiprotease plasminogen activator inhibitor<NUMBER> pai<NUMBER> <NUMBER> shown figure <NUMBER> iwatayoshikawa et al <NUMBER> found knockout tmprss<NUMBER> improved pathology immunopathology bronchi andor alveoli infection mice sarscov completely prevented loss body weight especially noteworthy sarscov infection tmprss<NUMBER> sole mechanism entry case sarscov<NUMBER> thus data showing pb<NUMBER> regulated ace<NUMBER> <NUMBER>fold regulated tmprss<NUMBER> <NUMBER>fold regulated pai<NUMBER> potent tmprss<NUMBER> inhibitor <NUMBER>fold figure <NUMBER> strongly suggest pb<NUMBER> treatment might diminish ability sarscov<NUMBER> bind host cell obtain spike protein activation result less ace<NUMBER> tmprss<NUMBER> cell surface result <NUMBER>fold increase plasma pai<NUMBER> would inhibit remaining tmprss<NUMBER> dittmann et al <NUMBER> found influenza virus iav infection provokes host response necessary sufficient viral inhibitionincreased production pai<NUMBER> found iav proteolytic cleavage viral coat protein hemagglutinin host ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint proteases plasmin requirement maturation infectivity progeny particles addition recombinant pai apical side haec significantly reduced iav growth compared carrier control <NUMBER> inhibition infectivity <NUMBER> h post infection contrast addition pai<NUMBER> antibody dramatically enhanced iav growth thus many viruses rely host endoand exoproteases various entry maturation functions moreover found tmprss<NUMBER> among trypsinlike proteases effectively inhibited pai<NUMBER> <NUMBER> quite apart direct involvement viral entry mechanisms pb<NUMBER> downregulates hdac<NUMBER> human liverderived hepg<NUMBER> cells <NUMBER>fold also shown figure <NUMBER> acetylation nrf<NUMBER> increases binding nrf<NUMBER> cognate response element target gene promoter increases nrf<NUMBER>dependent transcription target genes <NUMBER> humans hdac<NUMBER> appears isozyme responsible deacetylation attenuation nrf<NUMBER> activity <NUMBER> likely gene upregulated rsv infection described komaravelli et al <NUMBER> thus pb<NUMBER> inhibiting deacetylation subsequent degradation nrf<NUMBER> maintains active acetylated nrf<NUMBER> nucleus longer time counteracting one mechanisms enumerated viruses attempt commandeer control cells redox status indirectly amplifying nrf<NUMBER>dependent actions upregulation cytokine lif important antiviral cellular response viral infection shown strongly upregulated pb<NUMBER> figure <NUMBER> countering potential attempts virus downregulate lif gene expression downregulated h<NUMBER>n<NUMBER> infection knockdown lif increased virus titers three influenza strains investigated indicating important role lif virus defense <NUMBER> vivo studies performed lif knockout mice infected rsv lif knockout mice yielded higher virus titers compared control mice lif signaling shown critical protection lung injury <NUMBER> discussed role pai<NUMBER> preventing tmprss<NUMBER> activating sarscov<NUMBER> spike protein mention also made many would consider real ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint job blocking conversion plasminogen encoded plg gene plasmin urokinasetype plasminogen activator upa tissue plasminogen activator tpa fibrinolysis first recognized function plasmin one might expect high expression pai<NUMBER> would cause low plasmin levels might risk factor venous thrombosis genetic plasminogen deficiency however strongly associated risk thrombosis <NUMBER> study <NUMBER> subjects homozygous mutations plg gene little detectable plasmin <NUMBER> clinical inflammation conjunctivae ligneous conjunctivitis <NUMBER> experienced venous thrombosis <NUMBER> new roles however recognized plasmin regarding cytokine release <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cytokine storm syndrome form systemic inflammatory response triggered variety factors severe infections occurs large numbers leukocytes activated release inflammatory cytokines turn activate yet leukocytes sato et al found pharmacological inhibition plasmin significantly prevented mortality mouse model acute graftversushost disease proposing plasmin inhibition could offer novel therapeutic strategy control deadly cytokine storm results graftversushost disease preventing tissue destruction <NUMBER> macrophage activation syndrome mas lifethreatening disorder characterized cytokine storm multiorgan dysfunction due excessive immune activation mouse model mas shimazu et al saw similar prevention lethality concluding plasmin regulates influx inflammatory cells production inflammatory cytokineschemokines <NUMBER> plasminogen also implicated activation astrocytes produce array proinflammatory cytokines <NUMBER> figure <NUMBER> report pb<NUMBER> downregulates plasminogen mrna <NUMBER>fold liver cells thus vivo speculate combined downregulation plasminogen <NUMBER>fold increase pai<NUMBER> covalently reacts deactivates tissueand urokinasetype plasminogen activators may significantly attenuate plasmininduced cytokine storm phenomenon hyperinflammation covid<NUMBER> associated elevation proinflammatory cytokines interleukins tumor necrosis factorα tnf large number tnfinduced proteins granulocyte colony stimulating factor gcsf csf<NUMBER> among <NUMBER> hospitalized covid<NUMBER> patients wuhan china elevated il<NUMBER>b ip<NUMBER>cxcl<NUMBER> mcp<NUMBER>ccl<NUMBER> sixteen patients subsequently admitted icu even higher plasma levels gcsfcf<NUMBER> ip<NUMBER>cxcl<NUMBER> mcp<NUMBER>ccl<NUMBER> mip<NUMBER>accl<NUMBER> tnfα intensity cytokine storm strong prognosticator mortality <NUMBER> genes encoding covid<NUMBER>related cytokines appear figure <NUMBER> significantly regulated lpstreated hpaec significantly regulated pb<NUMBER> treatment speculate welldocumented agerelated loss nrf<NUMBER> expression <NUMBER> <NUMBER> potential contributor occurrence cytokine storm longitudinal study <NUMBER> confirmed covid<NUMBER> patients <NUMBER> showed <NUMBER> severe cases compared <NUMBER> milder cases older mean age <NUMBER> vs <NUMBER> significantly elevated creactive protein mean <NUMBER> vs <NUMBER> mgl showed consistently higher neutrophil counts lower lymphocyte counts throughout two week observation period observations <NUMBER> <NUMBER> document clear predilection severity covid<NUMBER> infection directly associated age intensity inflammatory response presumably inversely associated nrf<NUMBER> expression production selfamplifying nature acute inflammatory response demands prompt subsequent survival response host tissue break selfsustaining attraction neutrophils inflamed tissues propose robust oxidative stressinduced activation nrf<NUMBER> young healthy individuals follows gathering storm rescues host tissues irretrievable selfinflicted damage older individuals presence comorbidities may involve chronic inflammation nrf<NUMBER>activation response may insufficient break selfperpetuating cycle events figure <NUMBER> illustrates proposed sequence events propose activating larger fraction limited nrf<NUMBER> available elderly otherwise compromised patients might allow like younger counterparts shut cytokine production stop escalating cytokine storm begin recovery repair phase inflammatory episode activation boost ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint suboptimal levels nrf<NUMBER> provided several pharmacological agents well better number phytochemical activators show pb<NUMBER> worth noting longitudinal study covid<NUMBER> patients <NUMBER> reported remarkably higher concentration serum ferritin severe cases averaging <NUMBER> gl range <NUMBER> <NUMBER> versus milder cases averaging <NUMBER> gl range <NUMBER> <NUMBER> ferritin long recognized source iron released inflammatory conditions superoxide radical <NUMBER> <NUMBER> <NUMBER> <NUMBER> intense oxidative stress precipitated cytokine storm release iron would catalyze lipid peroxidation greatly amplify host tissue injury covid<NUMBER> already added short list known hyperferritinemic diseases characterized high serum ferritin life threatening hyperinflammation sustained cytokines storm eventually leads multiorgan failure <NUMBER> ferroptosis newly described form regulated cell death irondependent causes cell death mitochondrial dysfunction toxic lipid peroxidation nrf<NUMBER> implicated key deterministic component modulating onset outcomes ferroptotic stress <NUMBER> obvious weakness study directly study either sarscov<NUMBER> cells likely provide virus point entry lung epithelial cells however studied three different phenomena may involved vulnerability interactive phenomena present single cell type first objective study effects pb<NUMBER> expression ace<NUMBER> tmprss<NUMBER> studied presumed pointofentry cells objective specific sarscov<NUMBER> plan examine multiple lung cell types using ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint singlecell rnaseq analysis clinical laboratory suggestions virus may invade many organs body including liver showed regulation ace<NUMBER> tmprss<NUMBER> second objective examine whether pb<NUMBER> could limit systemic plasmin activity regulation plg andor upregulation pai<NUMBER> plasma proteins produced cells entered virus case liver source plg look appropriate cell type source pai<NUMBER> plasma isnt known may liver muscle third objective whether pb<NUMBER> could regulate cytokines identified participating cytokine storm phenomenon believe focus primary hpaec appropriate although complete picture would include study inflammatory cell types hpaec get local alarm signal infected epithelial lung cells hpaec actually generate <NUMBER> cytokines examined sounding systemic alarm brings inflammatory cells infected organ studying intervention break inflammatory cycle believe vascular endothelial cells may important players substantial literature documents ability increasing cellular nrf<NUMBER> levels either genetic manipulations treatment nrf<NUMBER> activators inhibit viral entry proliferation broad range viruses addition several specific mechanisms whereby viruses able wrest control nrf<NUMBER> pathway away host cell controlling synthesis posttranslational modification proteasomal degradation nrf<NUMBER> demonstrated pursued therapeutic opportunities importantly pointofentry host protein tmprss<NUMBER> membranebound serine protease appears essential requirement sarscov<NUMBER> covid <NUMBER> virus tmprss<NUMBER> appears amenable inhibition pai<NUMBER> encoded serpine<NUMBER> gene upregulated pb<NUMBER> tmprss<NUMBER> gene appears downregulated pb<NUMBER> would serve decrease activity downregulation hdac<NUMBER> pb<NUMBER> would lead increase acetylation nrf<NUMBER> increase activity upregulation lif pb<NUMBER> would expected protect lung viralinduced pathology infection lif knockdown increased virus titers finally perhaps importantly pb<NUMBER> substantially suppresses production multiple major contributors cytokine storm syndrome known direct cause death covid<NUMBER> fatalities seems possible sum total multiple antiviral effects may attenuate symptoms perhaps allow successful navigation cytokine storm even though neverending evolutionary warofwits continues viruses occasionally win battle scenario complex multifaceted antiviral mechanisms regulated nrf<NUMBER> serves underscore importance central transcription factor keeping us protected functional nrf<NUMBER> transcription factor encoded humans nfe<NUMBER>l<NUMBER> gene called <NUMBER> many master regulator cellular redox homeostasis <NUMBER> well guardian <NUMBER> healthspan gatekeeper species longevity <NUMBER> nrf<NUMBER> regulates genes defends <NUMBER> us oxidative stress including superoxide dismutases catalase numerous peroxidases <NUMBER> glutathione metabolism well hundreds genes involved scores important metabolic <NUMBER> pathways <NUMBER> individual vulnerabilities various structural catalytic gene products <NUMBER> damage inactivation reactive oxygen species ros may lead degenerative diseases <NUMBER> metabolic dysfunctions importantly nrf<NUMBER> declines age <NUMBER> <NUMBER> contributes greatly <NUMBER> frailty associated aging <NUMBER> <NUMBER> <NUMBER> nrf<NUMBER> transcriptionally upregulates genes combat <NUMBER> oxidative stress loss allows oxidative stress go unmitigated drive aging phenotype <NUMBER> <NUMBER> <NUMBER> <NUMBER> oxidative stress therefore common theme among key features associated <NUMBER> aging process collectively referred hallmarks aging disrupts proteostasis <NUMBER> <NUMBER> alters genomic stability <NUMBER> alters susceptibility viral microbial infections <NUMBER> leads <NUMBER> cell death agerelated frailty <NUMBER> often defines vulnerable population <NUMBER> situations one currently face coronavirus pandemic <NUMBER> <NUMBER> ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> <NUMBER> number published studies implicated nrf<NUMBER> regulator susceptibility <NUMBER> respiratory viral infections recent review lee <NUMBER> points virusinduced modulation <NUMBER> host antioxidative response turned crucial determinant progression <NUMBER> several viral diseases virus needs keep oxidative stress level optimal viral <NUMBER> reproduction higher normal support viral metabolism high <NUMBER> kill host cell viruses evolved mechanisms manipulating nrf<NUMBER> pathway <NUMBER> directions depending needs virus importantly taking control away <NUMBER> host cell among types virus studied influenza virus respiratory syncytial virus rsv <NUMBER> human metapneumovirus hmpv <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> phenomenon also seen nonrespiratory <NUMBER> viruses including dengue virus denv <NUMBER> rotavirus <NUMBER> herpes simplex virus <NUMBER> zika virus <NUMBER> <NUMBER> hiv <NUMBER> suggesting regulation oxidative stress may need common <NUMBER> viruses nrf<NUMBER> activators may offer multiple ways regain control important <NUMBER> pathways increase resistance slow viral replication recently described phytochemical <NUMBER> composition pb<NUMBER> potently activates nrf<NUMBER> controlling multiple steps involved process <NUMBER> especially via akt<NUMBER>pi<NUMBER>kgsk<NUMBER>fyn pathway <NUMBER> <NUMBER> purpose study evaluate effects nrf<NUMBER> activation via pb<NUMBER> human <NUMBER> liverderived hepg<NUMBER> cells well primary human pulmonary artery endothelial cells prevent senescence dedifferentiation hpaec seeded density <NUMBER> x <NUMBER> <NUMBER> cells per <NUMBER> <NUMBER> mm tissue culture dishes incubated <NUMBER> c <NUMBER> co<NUMBER> <NUMBER> confluence <NUMBER> experiments performed hpaec <NUMBER> confluence data presented mean ± standard error mean sem oneway anova <NUMBER> tukey multiple comparisons testing students test unpaired data performed using prism <NUMBER> software version <NUMBER> graphpad software san diego ca usa statistical significance set <NUMBER> p value <NUMBER> using elisa assay il<NUMBER> determined pretreatment hpaec pb<NUMBER> <NUMBER> decreased lpsinduced release il<NUMBER> protein hpaec cells study hpaec <NUMBER> cells plated described <NUMBER> h treated <NUMBER> ugml pb<NUMBER> extract six genes differed control p <NUMBER> ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> <NUMBER> suppressed average <NUMBER> tumor necrosis factor tnf mrna reduced <NUMBER> <NUMBER> group five tnfinduced proteins tnfaips repressed even averaging <NUMBER> four <NUMBER> genes representing tnf family downregulated average <NUMBER> also family <NUMBER> five interferoninducible genes shown downregulated average <NUMBER> acrossthe<NUMBER> board reduction genes contribute cytokine storm noteworthy intensity <NUMBER> storm predicts icu fatalities transforming storm <NUMBER> manageable shower therefore major therapeutic objective clinical management <NUMBER> covid<NUMBER> patients last decade seen <NUMBER> publications nrf<NUMBER> involvement redox <NUMBER> homeostasis inflammation immunity neurodegeneration aging diseases associated <NUMBER> aging ischemiareperfusion injury many areas relatively little published <NUMBER> regarding roles viral infectivity resistance despite rather tantalizing studies kesic ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> <NUMBER> <NUMBER> cigarette smokeexposed nrf<NUMBER>deficient mice showed higher rates mortality wild studies demonstrate ability nrf<NUMBER> impede viral entry slow viral replication reduce <NUMBER> inflammation weight loss mortality without providing much detailed insight <NUMBER> genes pathways involved first challenge facing virus particularly virus jumping one host species <NUMBER> another gaining entry cell fairly common ports entry ldlr <NUMBER> icam<NUMBER> lead endosomal entry shared among various viral families <NUMBER> sarscov<NUMBER> however seems largely totally restricted specific mode entry unique mode entry may greatest vulnerability virus opening door ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint attempt commandeer control cells redox status indirectly amplifying nrf<NUMBER> dependent actions upregulation cytokine lif important antiviral cellular response viral infection <NUMBER> shown strongly upregulated pb<NUMBER> figure <NUMBER> countering potential attempts <NUMBER> virus downregulate lif gene expression downregulated h<NUMBER>n<NUMBER> infection knock<NUMBER> lif increased virus titers three influenza strains investigated indicating important <NUMBER> role lif virus defense <NUMBER> vivo studies performed lif knockout mice <NUMBER> infected rsv lif knockout mice yielded higher virus titers compared control mice lif <NUMBER> signaling shown critical protection lung injury <NUMBER> discussed role pai<NUMBER> preventing tmprss<NUMBER> activating sars cov<NUMBER> spike protein mention also made many would consider real job <NUMBER> blocking conversion plasminogen encoded plg gene plasmin urokinase<NUMBER> type plasminogen activator upa tissue plasminogen activator tpa fibrinolysis first <NUMBER> recognized function plasmin one might expect high expression pai<NUMBER> would cause low <NUMBER> plasmin levels might risk factor venous thrombosis genetic plasminogen deficiency <NUMBER> however strongly associated risk thrombosis <NUMBER> study <NUMBER> subjects ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> <NUMBER> <NUMBER> infection directly associated age intensity inflammatory response presumably <NUMBER> inversely associated nrf<NUMBER> expression <NUMBER> production selfamplifying nature <NUMBER> acute inflammatory response demands prompt subsequent survival response host tissue <NUMBER> break selfsustaining attraction neutrophils inflamed tissues propose <NUMBER> robust oxidative stressinduced activation nrf<NUMBER> young healthy individuals follows <NUMBER> gathering storm rescues host tissues irretrievable selfinflicted damage older <NUMBER> individuals presence comorbidities may involve chronic inflammation nrf<NUMBER> activation response may insufficient break selfperpetuating cycle events figure <NUMBER> inhibiting tissue cytokine production rescuing host cells damage permitting <NUMBER> repair cleanup recovery alternatively <NUMBER>a older cells deficient nrf<NUMBER> may unable mount nrf<NUMBER> activation sufficient break selfsustaining chain reaction resulting uncontrolled cytokine storm ultimately destroys host tissue leads death robust activation limited nrf<NUMBER> available older cells may provided pharmacological phytochemical nrf<NUMBER> activators ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint already added short list known hyperferritinemic diseases <NUMBER> characterized high serum ferritin life threatening hyperinflammation sustained <NUMBER> cytokines storm eventually leads multiorgan failure <NUMBER> ferroptosis newly described <NUMBER> form regulated cell death irondependent causes cell death mitochondrial <NUMBER> dysfunction toxic lipid peroxidation nrf<NUMBER> implicated key deterministic <NUMBER> component modulating onset outcomes ferroptotic stress <NUMBER> <NUMBER> studied three different phenomena may involved vulnerability sarscov<NUMBER> <NUMBER> interactive phenomena present single cell type first objective <NUMBER> study effects pb<NUMBER> expression ace<NUMBER> tmprss<NUMBER> could studied presumed point<NUMBER> ofentry cells including alveolar type ii cells <NUMBER> hpaec <NUMBER> <NUMBER> clinical <NUMBER> laboratory suggestions virus may invade many organs containing cell types coexpress <NUMBER> ace<NUMBER> tmprss<NUMBER> heart gut kidney eye including liver showed regulation <NUMBER> ace<NUMBER> tmprss<NUMBER> thus liver also relevant cell study entry genes <NUMBER> second objective examine whether pb<NUMBER> could limit systemic plasmin activity <NUMBER> regulation plg andor upregulation pai<NUMBER> plasma proteins produced cells <NUMBER> lung case liver source plg appropriate cell type examine <NUMBER> source pai<NUMBER> plasma isnt known may liver muscle third objective whether <NUMBER> pb<NUMBER> could regulate cytokines identified participating cytokine storm <NUMBER> phenomenon believe focus primary hpaec appropriate although complete <NUMBER> picture would include study inflammatory cell types hpaec generate <NUMBER> <NUMBER> cytokines examined sounding systemic alarm recruits inflammatory cells infected <NUMBER> organ type ii alveolar cell little capacity producing cytokines <NUMBER> studying <NUMBER> intervention break inflammatory cycle leading cytokine storm believe <NUMBER> vascular endothelial cells may single important players potential limitation <NUMBER> study use lps surrogate sarscov<NUMBER> induce inflammatory response <NUMBER> propose one evolutionary driving force nrf<NUMBER> pathway may provide <NUMBER> failsafe brake outofcontrol inflammatory events increase oxidative stress site <NUMBER> intense inflammatory locus may intended trigger system activate nrf<NUMBER> <NUMBER> allowing end assault point invader likely vanquished <NUMBER> host may able survive fact cadre genes induced nrf<NUMBER> long referred <NUMBER> survival genes <NUMBER> shown group <NUMBER> genes linked respiratory virus infectivity resistance <NUMBER> associated immune response responsive pharmacological nrf<NUMBER> activation seems <NUMBER> possible sum total multiple antiviral effects may confer degree resistance may <NUMBER> attenuate viral replication rate may alleviate symptoms limiting microvascular injury <NUMBER> perhaps allow successful navigation cytokine storm particular problem ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint nrf<NUMBER> transcription factor encoded humans nfe<NUMBER>l<NUMBER> gene called <NUMBER> many master regulator cellular redox homeostasis <NUMBER> well guardian <NUMBER> healthspan gatekeeper species longevity <NUMBER> nrf<NUMBER> regulates genes defends <NUMBER> us oxidative stress including superoxide dismutases catalase numerous peroxidases <NUMBER> glutathione metabolism well hundreds genes involved scores important metabolic <NUMBER> pathways <NUMBER> individual vulnerabilities various structural catalytic gene products <NUMBER> damage inactivation reactive oxygen species ros may lead degenerative diseases <NUMBER> metabolic dysfunctions importantly nrf<NUMBER> declines age <NUMBER> <NUMBER> contributes greatly <NUMBER> frailty associated aging <NUMBER> <NUMBER> <NUMBER> nrf<NUMBER> transcriptionally upregulates genes combat <NUMBER> oxidative stress loss allows oxidative stress go unmitigated drive aging phenotype <NUMBER> <NUMBER> <NUMBER> <NUMBER> oxidative stress therefore common theme among key features associated <NUMBER> aging process collectively referred hallmarks aging disrupts proteostasis <NUMBER> <NUMBER> alters genomic stability <NUMBER> alters susceptibility viral microbial infections <NUMBER> leads <NUMBER> cell death agerelated frailty <NUMBER> often defines vulnerable population <NUMBER> situations one currently face coronavirus pandemic <NUMBER> lee <NUMBER> points virusinduced modulation <NUMBER> host antioxidative response turned crucial determinant progression <NUMBER> several viral diseases virus needs keep oxidative stress level optimal viral <NUMBER> reproduction higher normal support viral metabolism high <NUMBER> kill host cell viruses evolved mechanisms manipulating nrf<NUMBER> pathway <NUMBER> directions depending needs virus importantly taking control away <NUMBER> host cell among types virus studied influenza virus respiratory syncytial virus rsv <NUMBER> human metapneumovirus hmpv <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> phenomenon also seen nonrespiratory <NUMBER> viruses including dengue virus denv <NUMBER> rotavirus <NUMBER> herpes simplex virus <NUMBER> zika virus <NUMBER> <NUMBER> hiv <NUMBER> suggesting regulation oxidative stress may need common <NUMBER> viruses nrf<NUMBER> activators may offer multiple ways regain control important <NUMBER> pathways increase resistance slow viral replication recently described phytochemical <NUMBER> composition pb<NUMBER> potently activates nrf<NUMBER> controlling multiple steps involved process <NUMBER> especially via akt<NUMBER>pi<NUMBER>kgsk<NUMBER>fyn pathway <NUMBER> <NUMBER> purpose study evaluate effects nrf<NUMBER> activation via pb<NUMBER> human <NUMBER> liverderived hepg<NUMBER> cells well primary human pulmonary artery endothelial cells hpaec <NUMBER> culture endothelial cell recently implicated major player tissue <NUMBER> destruction caused covid<NUMBER> varga prevent senescence dedifferentiation hpaec seeded density <NUMBER> x <NUMBER> <NUMBER> cells per <NUMBER> <NUMBER> mm tissue culture dishes incubated <NUMBER> c <NUMBER> co<NUMBER> <NUMBER> confluence <NUMBER> experiments performed hpaec <NUMBER> confluence data presented mean ± standard error mean sem oneway anova <NUMBER> tukey multiple comparisons testing students test unpaired data performed using prism <NUMBER> software version <NUMBER> graphpad software san diego ca usa statistical significance set <NUMBER> p value <NUMBER> using elisa assay il<NUMBER> determined pretreatment hpaec pb<NUMBER> <NUMBER> decreased lpsinduced release il<NUMBER> protein hpaec cells study hpaec <NUMBER> cells plated described <NUMBER> h treated <NUMBER> ugml pb<NUMBER> extract six genes differed control p <NUMBER> last decade seen <NUMBER> publications nrf<NUMBER> involvement redox <NUMBER> homeostasis inflammation immunity neurodegeneration aging diseases associated <NUMBER> aging ischemiareperfusion injury many areas relatively little published <NUMBER> regarding roles viral infectivity resistance despite rather tantalizing studies kesic <NUMBER> cigarette smokeexposed nrf<NUMBER>deficient mice showed higher rates mortality wild studies demonstrate ability nrf<NUMBER> impede viral entry slow viral replication reduce <NUMBER> inflammation weight loss mortality without providing much detailed insight <NUMBER> genes pathways involved first challenge facing virus particularly virus jumping one host species <NUMBER> another gaining entry cell fairly common ports entry ldlr <NUMBER> icam<NUMBER> lead endosomal entry shared among various viral families <NUMBER> sarscov<NUMBER> however seems largely totally restricted specific mode entry unique mode entry may greatest vulnerability virus opening door upregulation cytokine lif important antiviral cellular response viral infection <NUMBER> shown strongly upregulated pb<NUMBER> figure <NUMBER> signaling shown critical protection lung injury <NUMBER> discussed role pai<NUMBER> preventing tmprss<NUMBER> activating sars cov<NUMBER> spike protein mention also made many would consider real job intervention break inflammatory cycle leading cytokine storm believe <NUMBER> vascular endothelial cells may single important players potential limitation <NUMBER> study use lps surrogate sarscov<NUMBER> induce inflammatory response <NUMBER> propose one evolutionary driving force nrf<NUMBER> pathway may provide <NUMBER> failsafe brake outofcontrol inflammatory events increase oxidative stress site <NUMBER> intense inflammatory locus may intended trigger system activate nrf<NUMBER> <NUMBER> allowing end assault point invader likely vanquished <NUMBER> host may able survive fact cadre genes induced nrf<NUMBER> long referred <NUMBER> survival genes <NUMBER> shown group <NUMBER> genes linked respiratory virus infectivity resistance <NUMBER> associated immune response responsive pharmacological nrf<NUMBER> activation seems <NUMBER> possible sum total multiple antiviral effects may confer degree resistance may <NUMBER> attenuate viral replication rate may alleviate symptoms limiting microvascular injury <NUMBER> perhaps allow successful navigation cytokine storm particular problem late december <NUMBER> severe coronavirus outbreak emerged china caused novel virus sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> coronoviridae family <NUMBER> <NUMBER> infection quickly spread world world health organization officially named infection covid<NUMBER> coronavirus disease <NUMBER> february <NUMBER>th <NUMBER> declared covid<NUMBER> pandemic march <NUMBER>th <NUMBER> <NUMBER> confirmed cases <NUMBER> deaths ascribed covid<NUMBER> worldwide may <NUMBER>th <NUMBER> source situation report <NUMBER> mortality rate around <NUMBER> however could overestimation since everyone tested covid<NUMBER> main route transmission persontoperson via respiratory droplets <NUMBER> <NUMBER> primary prevention strategies quarantine social distancing hand hygiene main methods prevent infection since vaccine specific antiviral treatment yet sarscov<NUMBER> considerable genetic resemblance around <NUMBER> sarscov virus causative organism <NUMBER> sars severe acute respiratory syndrome epidemic <NUMBER> <NUMBER> sarscov<NUMBER> spike proteins surface using proteins binds target human cells receptor sarscov<NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> mainly expressed epithelial cells renal proximal tubular cells enterocytes endothelial cells <NUMBER> <NUMBER> attachment ace<NUMBER> virus endocytosed cell interacts talllike receptors tlrs inside endosome interaction promotes type interferon ifn response increases expression proinflammatory cytokines nuclear factor ĸb nfĸb <NUMBER> <NUMBER> two main reactions immune system virus initial innate immune response type ifns described secondary adaptive immune response may lead cytokine storm initial ifn response aims contain clear virus effectively early peak seems crucial effective control <NUMBER> resolution ifn activity generated innate immune response required recovery <NUMBER> initial ifn response macrophages activated ifnαβ receptors produce chemoattractants proinflammatory cytokines <NUMBER> another reaction virus presentation spike protein antigens cells antigenpresenting cells results activation b cells production antispike immunoglobulins immunoglobulins bind spike proteins viruses coated viruses could internalized macrophages fc receptors <NUMBER> macrophages release proinflammatory cytokines may contribute cytokine storm adaptive phase <NUMBER> <NUMBER> cellulartissue damage covid<NUMBER> probably occurs two ways <NUMBER> direct damage virus viral replication <NUMBER> harmful effects exaggerated immune response resulting cytokine storm means uncontrolled excessive release proinflammatory cytokines <NUMBER> mice nonhuman primate studies showed disproportionate immune response rather virus titer related death sarscov infection <NUMBER> <NUMBER> infection mild affected individuals could cause severe clinical situation mainly characterized acute respiratory distress syndrome ards cytokine storm lead mortality <NUMBER> cytokine storm result uncontrolled immune activation leads hyperinflammation multiorgan disease <NUMBER> although everyone susceptible infected novel virus covid<NUMBER> affects specific group individuals severe disease main risk groups elderly patients smokers individuals chronic diseases diabetes mellitus hypertension <NUMBER> <NUMBER> <NUMBER> pandemic ensues observe children affected less experience mild form disease case infection <NUMBER> <NUMBER> cohort study including <NUMBER> covid<NUMBER> patients wu et al reported <NUMBER> cases <NUMBER> years age <NUMBER> assume immunosuppressant patients constituted primary risk group covid<NUMBER> however current data conferred immunosuppression specific risk factor severe fatal disease consistent epidemiologic data previous coronavirus epidemics namely sars mers middle east respiratory syndrome <NUMBER> drugs currently used tested covid<NUMBER> treatment mostly ones used patients rheumatic diseases thus rheumatologists participate multidisciplinary management covid<NUMBER> patients well hand immunosuppressants put patients rheumatic diseases vulnerable group pandemic thus making effective accurate decisions management strategies regarding patients critical based currently available scientific evidence much possible review aims provide overview covid<NUMBER> pandemic pediatric rheumatologists perspective aspects covid<NUMBER> resembling rheumatic diseases possible reasons children affected less severely hypothetic role available vaccines preventing covid<NUMBER> unique position patients rheumatic diseases pandemic covid<NUMBER> patients rheumatic diseases literature covid<NUMBER> treatment drugs used rheumatic diseases discussed also systematic literature search conducted identify covid<NUMBER> patients rheumatic diseases scopus medlinepubmed databases searched november <NUMBER>st <NUMBER> may <NUMBER>th <NUMBER> entering following keywords coronavirus disease <NUMBER> covid<NUMBER> sarscov<NUMBER> rheumatology rheumatic disease according published guidance narrative reviews <NUMBER> complete list search terms used determining articles including covid<NUMBER> patients rheumatic diseases provided supplementary table <NUMBER> case reports original research articles editorials review articles focus covid<NUMBER> analyzed following parameters noted studies including covid<NUMBER> patients underlying rheumatic disease age sex underlying rheumatic disease age diagnosis rheumatic disease features associated rheumatic disease comorbidities previous current treatment rheumatic disease covid<NUMBER>related symptoms method covid<NUMBER> diagnosis covid<NUMBER> treatment outcome features regarding cessation reinitiation immunosuppressive therapies search restricted english articles seventeen articles describing <NUMBER> covid<NUMBER> patients rheumatic diseases found literature search fig <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> among patients one pediatric patient <NUMBER>monthold infant kawasaki disease covid<NUMBER> <NUMBER> characteristics patients presented table <NUMBER> <NUMBER> patients female n <NUMBER> common underlying rheumatic diseases systemic lupus erythematosus sle n <NUMBER> rheumatoid arthritis ra n <NUMBER> nine <NUMBER> <NUMBER> patients died note konig et al report outcomes regard mortality covid<NUMBER> cohort including <NUMBER> sle patients <NUMBER> addition articles presented table four articles reported covid<NUMBER> patients rheumatic diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> articles included since details reported patients garg et al presented agestratified covid<NUMBER>associated hospitalization rates us patients <NUMBER> report three <NUMBER> patients mentioned rheumaticautoimmune disease one patients age range <NUMBER> years two ≥ <NUMBER> years age xu et al mentioned gout patients covid<NUMBER> cohort including <NUMBER> patients <NUMBER> patient experience survey study sirotich et al reported <NUMBER> patients rheumatic diseases diagnosis covid<NUMBER> based symptoms physician diagnosis positive laboratory tests <NUMBER> however details provided patients including underlying rheumatic diseases cohort <NUMBER> sarscov<NUMBER> positive patients gendelman et al reported three chronic hydroxychloroquine hcq seven chronic colchicine treatment <NUMBER> mention underlying diseases patients currently exact reason children experience milder disease remains unknown several factors could contribute situation however specific effects factors regard covid<NUMBER> studied yet <NUMBER> children travel less adults may protective <NUMBER> <NUMBER> smoking issue childhood respiratory tracts children exposed air pollution shorter time compared adults <NUMBER> <NUMBER> common comorbidities adulthood like type <NUMBER> diabetes mellitus hypertension frequent among children <NUMBER> <NUMBER> upper respiratory tracts children usually colonized variety microorganisms may compete sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> children innate immune response robust adaptive immune system less educated immature compared adults <NUMBER> <NUMBER> may result sufficient clearance virus lack exaggerated adaptive response duret <NUMBER> moutsopoulos <NUMBER> tomelleri <NUMBER> emmi <NUMBER> favalli <NUMBER> cases duret <NUMBER> moutsopoulos <NUMBER> tomelleri <NUMBER> emmi <NUMBER> favalli <NUMBER> comorbidities duret <NUMBER> moutsopoulos <NUMBER> tomelleri <NUMBER> emmi <NUMBER> favalli <NUMBER> covid duret <NUMBER> moutsopoulos <NUMBER> tomelleri <NUMBER> emmi <NUMBER> favalli <NUMBER> time <NUMBER> ace<NUMBER> expression patterns children could different adults <NUMBER> <NUMBER> last childhood vaccines may provide protective effect covid<NUMBER> discussed detail factors could combined overall effect however keep mind children immune covid<NUMBER> although rarely disease could severe complicated children well <NUMBER> although pandemic seems affect children less severely endangers mass vaccination programs polio measles <NUMBER> could result epidemics preventable infectious diseases especially among children another point deserves mention neonates covid<NUMBER>positive mothers although anecdotal reports exist direct evidence vertical transmission sarscov<NUMBER> mother child <NUMBER> chen et al detected virus amniotic fluid umbilical cord blood breast milk samples mothers covid<NUMBER> pharynx swabs neonates born mothers covid<NUMBER> <NUMBER> analyzing differences different risk groups may provide critical clues disease pathogenesis may develop new strategies fight novel foe covid<NUMBER> seems affect different countries varying severity several epidemiological observational studies performed results show differences childhood vaccination policies may partially describe difference covid<NUMBER> severity however nearly articles nonpeer reviewed results derived indirect analyzes epidemiologic data thus studies vulnerable selection bias uncontrolled confounding factors might significantly deviated results confounding factors population age ethnicity testing rates covid<NUMBER> infection stage pandemic country income levels major policy decisions quarantine providing selfprotecting equipment like masks another limiting factor possible dissect effect one specific vaccine bcg bacillus calmetteguerin kinds studies since associations may also caused another vaccine mediating protective effect thus results observational epidemiologic studies evaluated caution considering mentioned points studies mainly put forward two vaccines candidates reducing damage caused covid<NUMBER> bcg mmr measles mumps rubella noteworthy discussed protective effects childhood vaccines covid<NUMBER> currently hypothetical scientific proof published yet bacillus calmetteguerin bcg live attenuated vaccine derived isolate mycobacterium bovis used vaccine tuberculosis <NUMBER> epidemiologic analyzes showed incidence covid<NUMBER> death rate significantly lower countries bcg vaccination programs compared without program <NUMBER> possible draw reliable conclusions yet however previous studies including randomized controlled trials suggested nonspecific protection infections induced bcg vaccine <NUMBER> since mycobacterium bacterium sarscov<NUMBER> virus unlikely protective effect comes crossprotection based similar molecular structures previous studies shown two possible mechanisms explain nonspecific protection provided bcg vaccine <NUMBER> heterologous immunity trained immunity heterologous immunity means cd<NUMBER> cd<NUMBER> memory cells produced bcg vaccine situation could activated antigenindependent manner <NUMBER> <NUMBER> <NUMBER> <NUMBER> activation could caused cytokine stimulation secondary infection known bcg vaccine induces histone modifications epigenetic changes human monocytes promoter sites genes encoding proinflammatory cytokines interleukin <NUMBER> il<NUMBER> tnfα tumor necrosis factor <NUMBER> causes active innate immune response restimulation trained immunity <NUMBER> <NUMBER> <NUMBER> may contribute effective clearance virus case covid<NUMBER> arts et al recently shown bcg vaccination reduced level viremia yellow fever vaccination effect correlated induction cytokine response <NUMBER> another possible pathway may activation ifngamma pathway two studies nct<NUMBER> nct<NUMBER> underway test nonspecific protective effect bcg vaccine covid<NUMBER> indirect epidemiologic analyses also suggest protective role mmr vaccine covid<NUMBER> <NUMBER> bianchi et al demonstrated considerable proportion individuals show protective immunoglobulin g igg titer measles <NUMBER> years vaccination <NUMBER> shanker et al hypothesized agerelated decline immunogenicity measles vaccine could explanation covid<NUMBER> mainly adult disease measles vaccine provides crossresistance covid<NUMBER> <NUMBER> franklin et al demonstrated igg titers rubella increased sarscov<NUMBER> infection cases might suggest structural homology rubella sarscov<NUMBER> <NUMBER> reported <NUMBER> amino acid sequence homology existing macrodomains sarscov<NUMBER> rubella virus <NUMBER> homology fusion protein measles virus spike protein sarscov<NUMBER> report evidence supporting data however notpeer reviewed article remains unknown whether resemblance enough cause crossreactive immune defense take time researchers develop effective vaccine covid<NUMBER> thus wise analyze crossresistance vaccines already used however studies designed carefully control confounding factors considering available data early conclude protective effect vaccine moment another point possible predict fast immune system develop response protect covid<NUMBER> exists another vaccine bcg mmr vaccines moment childhood vaccinations applied according routine vaccination schedules country recommendations new vaccination plans could arise accumulating evidence crossprotectiveness vaccines covid<NUMBER> main characteristics covid<NUMBER> leukopenia thrombocytopenia myocarditis interstitial pneumonia could also observed rheumatic diseases sle systemic sclerosis <NUMBER> <NUMBER> <NUMBER> however clinically significant features mainly inflammatory characteristics mimic diseases clinical features pathogenesis common pathways pathogenesis highlights drugs rheumatologists use candidates covid<NUMBER> treatment pediatric rheumatologists familiar entity since significant portion common rheumatic diseases systemic juvenile idiopathic arthritis jia sle kawasaki disease present complication <NUMBER> secondary hemophagocytosis called macrophage activation syndrome mas pediatric rheumatology practice thus experience rheumatologists important realized severe end covid<NUMBER> clinical spectrum multisystem hyperinflammatory syndrome progressing cytokine storm shock situation resembles secondary hemophagocytic lymphohistiocytosis hlh mas said aware covid<NUMBER>associated cytokine storm identical mas shares certain common features high ferritin creactive protein crp lactate dehydrogenase ldh low platelet lymphocyte counts <NUMBER> also differ aspects instance decrease erythrocyte sedimentation rate esr commonly observed mas <NUMBER> however seem mandatory feature covid<NUMBER>associated cytokine storm <NUMBER> <NUMBER> moreover zhang et al reported patients severe covid<NUMBER> persistently high esr <NUMBER> interesting data come autopsy findings sarscovinfected patients demonstrating secondary lymphoid tissues destroyed <NUMBER> may explain absence splenomegaly significant feature covid<NUMBER>associated cytokine storm although included criterion diagnosing hlh <NUMBER> scarce autopsy data regarding covid<NUMBER> one report autopsy findings two patients barton et al reported splenomegaly one patient detected remote splenectomy <NUMBER> menter et al shared autopsy findings <NUMBER> covid<NUMBER> patients mentioned observe extensive depletion lymphoid cells <NUMBER> increasing reports laboratory values histopathological features critically ill covid<NUMBER> patients provide clues similarities differences covid<NUMBER>associated cytokine storm secondary hlh mas however believe experience pediatric rheumatologists contributed management severe covid<NUMBER> patients antiil<NUMBER> antiil<NUMBER> strategies employed cytokine storm covid<NUMBER> patients intensive care units <NUMBER> another similar feature rheumatic diseases immune complex vasculitis could observed secondary occlusion blood vessels immune complexes including spike proteins antispike immunoglobulins <NUMBER> <NUMBER> may represent yet another form immune complex vasculitis hepatitis brelated polyarteritis nodosa pan immune complexes containing hbsag skin lesions increasingly reported features covid<NUMBER> similar findings rheumatic diseases bouaziz et al reported violaceous macules livedoid rash purpura necrotic nonnecrotic similar skin manifestations systemic vasculitis severe iga vasculitis henochschönlein purpura pan <NUMBER> also mentioned chill blainlike lesions patients similar ones observed interferonopathies like aicardigoutieres syndrome savi stingassociated vasculitis onset infancy <NUMBER> interestingly chillblainlike lesions also found children adolescents otherwise asymptomatic regard covid<NUMBER> <NUMBER> may well high ifn levels induced virus hand one wonders whether background levels high ifn would protect covid<NUMBER> children autoinflammatory interferonopathies savi aicardi goutières syndrome acroischemia reported covid<NUMBER> patients well <NUMBER> <NUMBER> feature also observed severe vasculopathies deficiency adenosine deaminase <NUMBER> <NUMBER> <NUMBER> vascular lesions could due immune complex vasculitis disseminated intravascular coagulation positive antiphospholipid antibodies may also contribute pathogenesis recently reported <NUMBER> need histopathologic data understand exact pathogenesis features another surprising feature covid<NUMBER> development kawasakilike disease children recently riphagen et al reported hyperinflammatory shock eight children similar features atypical kawasaki disease kawasaki disease shock syndrome toxic shock syndrome <NUMBER> seven patients required mechanical ventilation cardiovascular stabilization although significant respiratory involvement observed initial tests covid<NUMBER> negative one children died <NUMBER> days sarscov<NUMBER> detected postmortem another child tested positive sarscov<NUMBER> discharge authors mentioned positive antibodies detected afterward seven children coronary arteries severely dilated one creactive protein procalcitonin ferritin triglycerides ddimers elevated note ferritin level highest child died <NUMBER> ϻgl range <NUMBER> ϻgl rest series laboratory features observed clinical situation similar seen kawasaki disease shock syndrome li et al previously demonstrated higher levels crp procalcitonin triglycerides ddimers patients kawasaki disease shock syndrome compared patients kawasaki disease <NUMBER> finally covid<NUMBER> reported present large vessel stroke young patients <NUMBER> still data infection rate course covid<NUMBER> patients rheumatic diseases mentioned although rheumatology practice mainly focuses immunosuppression caused disease treatment disease variety immune dysregulation besides immune suppression exists different rheumatic diseases one group autoinflammatory recurrent fever syndromes familial mediterranean fever fmf cryopyrinassociated periodic syndrome caps know pyrin nlrp<NUMBER> inflammasomes overactivated fmf caps respectively <NUMBER> <NUMBER> mefv mutations associated fmf thought provide advantage infections tuberculosis plague mediterranean basin past <NUMBER> findings nih national institute health group suggested idea individuals carrying mefv mutation might selective advantage plague <NUMBER> effect covid<NUMBER> patients eliminate sarscov<NUMBER> efficiently overactive inflammasome contribute exaggerated immune response complicate disease know answers moment caps also raises interesting questions activation nlrp<NUMBER> inflammasome sarscov observed previously <NUMBER> <NUMBER> another microorganism activates nlrp<NUMBER> streptococcus pneumonia <NUMBER> previously walker et al observed pneumococcal vaccines could trigger severe local systemic inflammatory reaction caps patients <NUMBER> hypothesized trigger pneumococcal polysaccharides already overactivated nlrp<NUMBER> inflammasome might caused reactions raised concern use vaccines caps patients could concern valid case covid<NUMBER> since caps rare disease current data let us answer question either another confounding factor fmf caps patients mainly colchicine antiil<NUMBER> therapies currently tested covid<NUMBER> treatment date one report covid<NUMBER> patient caps antiil<NUMBER> treatment experienced mild disease course recovered couple days without treatment <NUMBER> previous data suggest mutations main causative genes primary hlh gene encoding perforin also associated secondary hlhmas <NUMBER> also mutations genes nlrc<NUMBER> associated rare monogenic autoinflammatory diseases causing tendency recurrent mas nlrc<NUMBER>related disease characterized earlyonset recurrent fever enterocolitis repeated episodes mas <NUMBER> patients carrying variants genes may also prone cytokine storm associated covid <NUMBER> future data course covid<NUMBER> setting rare monogenic autoinflammatory diseases provide insights disease pathogenesis sle prototype autoimmune diseases main risk factor seems like immunosuppressive therapies use sle treatment however sawalha et al reported epigenetic dysregulation sle resulted ace<NUMBER> overexpression might cause specific tendency covid<NUMBER> patient group <NUMBER> another debate literature focused hypothetical prophylactic effect hcq used majority sle patients discussed another issue debate patients already treating established diagnosis rheumatic disease considerable amount patients degree disease control means balance immune dysregulation autoimmunityautoinflammation immunosuppressionimmune modulation therapies patients rheumatic diseases diagnosedtreated yet could form another specific vulnerable group covid<NUMBER> last immunosuppression known risk factor infections although emerge risk factor previous coronavirus epidemics sars mers situation remains unknown current covid<NUMBER> pandemic <NUMBER> still enough evidence would safe consider patients risky taking precautions discontinuing immunosuppressive therapies since important disease control moreover active disease significant risk factor increased rate infections <NUMBER> <NUMBER> data gathering international rheumatology covid<NUMBER> registries provide answers questions minds essential make early conclusions resistance tendency covid<NUMBER> regarding specific rheumatic disease treatment solid scientific evidence obtained hallmarks covid<NUMBER> treatment currently antiviral drugs drugs interfering viral entry immunosuppressive drugs mainly ones targeting cytokines primarily focus drugs used rheumatology practice since early strong immune response required effective clearance virus following exaggerated adaptive immune response tuned timing duration immunosuppressive therapies critical currently specific antiviral drug sarscov<NUMBER> however several broadspectrum antivirals remdesivir lopinavirritonavir proposed tested covid<NUMBER> treatment remdesivir nucleotide analog effective sarscov merscov bat cov strains <NUMBER> grein et al reported clinical improvement <NUMBER> <NUMBER> <NUMBER> patients severe covid<NUMBER> received least one dose remdesivir <NUMBER> mortality rate group lower general mortality rate severe covid<NUMBER> <NUMBER> versus <NUMBER> respectively however recent randomized doubleblind placebocontrolled study <NUMBER> patients remdesivir group versus <NUMBER> placebo group wang et al reported remdesivir associated statistically significant clinical benefits although adequately tolerated patients <NUMBER> ongoing clinical trials remdesivir use covid<NUMBER> eg nct<NUMBER> nct<NUMBER> lopinavir protease inhibitor also tested covid<NUMBER> treatment used combined ritonavir inhibits cyp<NUMBER>amediated metabolism lopinavir previous reports showed lopinavirritonavir improved clinical outcomes sars mers patients <NUMBER> recent randomizedcontrolled trial hospitalized adult covid<NUMBER> patients <NUMBER> patients lopinavir ritonavir group versus <NUMBER> standard care group cao et al reported benefit associated lopinavir ritonavir treatment beyond standard care <NUMBER> ongoing trials provide data regarding efficacy safety lopinavirritonavir covid<NUMBER> treatment eg chictr<NUMBER> nct<NUMBER> nsaids nonsteroidal antiinflammatory drugs commonly used rheumatology practice actually may benefit musculoskeletal symptoms covid<NUMBER> <NUMBER> pediatric rheumatology practice nsaids primary therapeutic options especially treatment oligoarticular jia ibuprofen reported increase ace<NUMBER> expression <NUMBER> anecdotal reports exist severe disease course patients using nsaids <NUMBER> however current evidence specific causal association nsaid use severe disease course covid<NUMBER> <NUMBER> <NUMBER> previous studies also suggested association nsaid use higher rates complications respiratory tract infections <NUMBER> <NUMBER> currently possible draw solid evidencebased conclusion nsaid use glucocorticoids repress transcription proinflammatory genes <NUMBER> may used management sepsis septic shock small doses short term <NUMBER> studies show beneficial effects glucocorticoids treatment coronavirus sars mers pneumonia <NUMBER> <NUMBER> <NUMBER> hand studies reported adverse effects use corticosteroids coronavirus infection <NUMBER> recently tsai et al demonstrated early corticosteroid treatment associated significantly increased hospital mortality adult patients influenzaassociated ards <NUMBER> regarding covid<NUMBER> wu et al demonstrated methylprednisolone treatment appeared decrease risk death among patients acute respiratory distress syndrome <NUMBER> retrospective cohort study including <NUMBER> covid<NUMBER> patients wang et al observed early lowdose shortterm application methylprednisolone associated better clinical outcomes show significant difference regard mortality rate <NUMBER> however possible conclude positive effect since data scarce moment recommends routine glucocorticoid use covid<NUMBER> treatment randomized controlled trials planned analyze effectivenesssafety glucocorticoid therapy covid<NUMBER> patients chictr<NUMBER> nct<NUMBER> nct<NUMBER> provide better evidence may enlighten role glucocorticoids covid<NUMBER> hydroxychloroquine hcq antimalarial agent mainstay treatment especially sle <NUMBER> weak base hcq accumulates acidic environments lysosomes endosomes increasing ph endosomes hcq interferes tlrvirus interaction <NUMBER> also interferes glycosylation ace<NUMBER> maturation process viral proteins <NUMBER> <NUMBER> result may prevent viral entry subsequent stimulation proinflammatory pathways considering mechanisms appeared candidate prophylaxis treatment covid<NUMBER> assess prophylactic use shah et al systematically reviewed literature determined five studies three invitro studies two clinical opinions <NUMBER> unfortunately possible conclude prophylactic effect hcq based data lines gendelman et al observe protective effect chronic hcq use retrospective study including <NUMBER> covid<NUMBER> patients <NUMBER> thus enough evidence supporting prophylactic use hcq studies randomized controlled design required openlabel nonrandomized clinical trial small patient group <NUMBER> patients <NUMBER> controls gautret et al showed hcq treatment significantly associated viral load reduction efficient results azithromycin added <NUMBER> studies underway obtain better level evidence eg nct<NUMBER> nct<NUMBER> currently hcq used treatment covid<NUMBER> countries prophylaxis however considering lack evidence supporting prophylactic use risk short supplies patients need drug prophylactic treatment recommended stage monti et al reported <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> patients sle taking hcqchloroquine cq infection sarscov<NUMBER> <NUMBER> moreover frequency hospitalization differ regard hcqcq use <NUMBER> hcq also associated certain sideeffects retinal toxicity significant concern since mainly associated longterm use <NUMBER> however hcq use previously associated qt interval prolongation <NUMBER> besides azithromycin used combination hcq covid<NUMBER> treatment also drug cause qt prolongation <NUMBER> thus drugs used caution treatment covid<NUMBER> note saleh et al reported observe torsade de pointes arrhythmogenic death large cohort covid<NUMBER> patients treated cq n <NUMBER> hcq n <NUMBER> <NUMBER> mentioned qtc interval significantly longer combination group cq hcq azithromycin compared monotherapy group cqhcq jak janus kinase inhibitors used pediatric rheumatology patients extensively used adult rheumatology drugs currently used treatment jia autoinflammatory interferonopathies <NUMBER> <NUMBER> jak inhibitors suggested interfere viral entry inhibiting aak<NUMBER> key regulator sarscov<NUMBER> endocytosis detailed <NUMBER> may also beneficial inhibiting proinflammatory effects ifns exaggerated immune response phase baricitinib selective jak<NUMBER> jak<NUMBER> inhibitor <NUMBER> may exert antiviral effect doses used treatment ra <NUMBER> emerging potential treatment option covid<NUMBER> jak inhibitors may beneficial severe end spectrum ifn response contributes cytokine storm cameron et al demonstrated prominent ifnα ifnγ signaling deceased sars patients compared low ifnαγ signaling patients discharged hospital <NUMBER> however window opportunity early phase narrow difficult determine since patient asymptomatic phase viral entry shortly followed strong ifn response critical viral clearance ifns act jakstat pathway increase expression ifn response genes type ifns primary defense viral infections <NUMBER> jak inhibitors interfere antiviral immune response increased risk herpes zoster simplex infections previously reported jak inhibitor use <NUMBER> since effective containment clearance virus depends effective abrupt type ifn response initiation jak inhibitors early phase covid<NUMBER> could interfere immune defense thus jury benefit drugs covid<NUMBER> cytokine storm similar secondary hlhmas occurs patients covid<NUMBER> huang et al demonstrated serum levels several proinflammatory cytokines including il<NUMBER> il<NUMBER> tnfα increased hyperinflammatory phase covid<NUMBER> <NUMBER> data called use drugs targeting cytokines mainly antiil<NUMBER> antiil<NUMBER> antitnf candidates severe covid<NUMBER> treatment zhou et al observed il<NUMBER> levels higher deceased covid<NUMBER> patients survivors <NUMBER> studies also reported elevation il<NUMBER> levels patients severe covid<NUMBER> <NUMBER> <NUMBER> tocilizumab il<NUMBER> receptor monoclonal antibody use associated significant clinical improvement several observational studies <NUMBER> <NUMBER> <NUMBER> however matched controls treated without tocilizumab studies retrospective casecontrol study <NUMBER> patients treated tocilizumab versus <NUMBER> patients treated without tocilizumab klopfenstein et al reported death andor intensive care unit admissions higher among patients treated without tocilizumab treated tocilizumab <NUMBER> versus <NUMBER> respectively <NUMBER> sciascia et al performed pilot prospective singlearm study n <NUMBER> reported improvement respiratory laboratory parameters tocilizumab treatment <NUMBER> moreover case reports successful use tocilizumab treatment severe childhood covid<NUMBER> <NUMBER> <NUMBER> based data antiil<NUMBER> treatment currently studied drug treatment covid<NUMBER>associated cytokine storm nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> chictr<NUMBER> chictr<NUMBER> antiil<NUMBER> drugs also among promising therapies cytokine storm associated covid<NUMBER> recent retrospective cohort study cavalli et al evaluated anakinra treatment covid<NUMBER> <NUMBER> compared outcome <NUMBER> patients standard treatment hcq lopinavirritonavir addition mechanic ventilation <NUMBER> patients taking highdose intravenous iv anakinra addition standard treatment mechanic ventilation overall survival mechanic ventilationfree survival frequent highdose anakinra group standard treatment group <NUMBER> versus <NUMBER> <NUMBER> versus <NUMBER> respectively ongoing trials anakinra covid<NUMBER> probably provide higher level evidence efficacy treatment nct<NUMBER> nct<NUMBER> antiil<NUMBER> treatment indeed suggested pediatric rheumatologists firstline treatment <NUMBER> also ongoing trials antitnf use covid<NUMBER> chictr<NUMBER> chictr<NUMBER> combination different biologic agents may also considered selected severe cases severe cases secondary hlhmas antiifnγ treatment critical therapeutic option also ongoing trial omapalumab antiifnγ monoclonal antibody anakinra covid<NUMBER> nct<NUMBER> also registered trials planned test efficacy leflunomid ecluzimab ruxolitinib <NUMBER> readers referred review lythgoe et al summarizing ongoing trials management covid<NUMBER> pandemic <NUMBER> addition trial worth mentioning openlabel phase ii trial colchicine use covid<NUMBER> treatment <NUMBER> convalescent plasma treatment emerged promising option control severe covid<NUMBER> absence specific antivirals strategy passive immunization based utilizing hyperimmune igg antibodies produced individuals recovering covid<NUMBER> <NUMBER> several case series clinical improvement reduction viral load reported <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however matched controls studies thus ongoing clinical trials probably provide higher level evidence data efficacy safety convalescent plasma therapy covid<NUMBER> also cautious considering potential severe reactions associated convalescent plasma use anaphylactic reactions transfusionrelated acute lung injury <NUMBER> moment international rheumatology societies including acr american college rheumatology eular european league rheumatism pres pediatric rheumatology european society recommend continuation immunosuppressive treatment patients rheumatic diseases previous studies sle ra patients provided data increased rate infections cases high disease activity <NUMBER> <NUMBER> thus primary aim effective disease control patients rheumatic diseases considerable amount rheumatology patients drugs currently tested prophylaxis treatment covid<NUMBER> difficult predict effects already treatments infection rate severity discussed concern severe disease patients using nsaids safe site nsaids may proposed primary treatment rheumatic diseases may discontinued primary drugs disease control covid<NUMBER> pandemic pain control acetaminophen could selected nsaids since hcq immunomodulatory rather immunosuppressive drug probably interferes viral entry might protective effect patients treated hcq however sle patients considered resistant covid<NUMBER> recently increasing reports covid<NUMBER> patients sle <NUMBER> <NUMBER> <NUMBER> <NUMBER> mathian et al reported clinical picture course covid<NUMBER> sle patients treated hcq <NUMBER> authors concluded hcq seem prevent covid<NUMBER> least severe forms patients sle since sle patients study received longterm treatment hcq blood concentrations drug within therapeutic range findings konig et al lines mentioned <NUMBER> data glucocorticoid use also complex challenging interpret pediatric rheumatologists always aiming decrease glucocorticoid use keep glucocorticoid dose low possible control disease activity probably following principle logical get evidence drugs jak inhibitors antiil<NUMBER> antiil<NUMBER> antitnf agents immunosuppressives might interfere effective clearance virus early phases disease thus drugs early phase infection could disadvantage rheumatology patients hand drugs might prevent development cytokine storm making milder disease course possible currently enough data covid<NUMBER> disease course patients rheumatic diseases treated biologic drugs table <NUMBER> survey study italy filocamo et al reported confirmed covid<NUMBER> case among <NUMBER> pediatric patients biologic dmards chronic rheumatic diseases <NUMBER> current guidelines recommend continuing immunosuppressive therapies providing disease control proper patient education virus active covid<NUMBER> immunosuppressive therapy discontinued rheumatology patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> another important topic reinitiate therapies case reports song et al <NUMBER> mihai et al <NUMBER> immunosuppressive therapies reinitiated <NUMBER> days negative test result covid<NUMBER> expert opinion article sarziputtini et al suggested drugs reinitiated two negative swabs <NUMBER> last least decisions affected initiating treatment patients newly diagnosed rheumatic disease covid<NUMBER> pandemic possible may recommended test sarscov<NUMBER> initiating biologics tuberculosis however exact response question remains unknown currently issue also hot topic pandemic since currently know possibility latent disease covid<NUMBER> gupta et al performed survey among rheumatologists india assess attitudes physicians initiating antirheumatic therapies covid<NUMBER> pandemic <NUMBER> observed almost <NUMBER> respondents preferred earlier taper glucocorticoids inactive disease <NUMBER> respondents inclined initiate hq patients borderline indications almost half reduced usage biologic drugs covid<NUMBER> pandemic high mortality rate poorer outcome particularly elderly patients individuals comorbidities limited data infection rate disease course patients rheumatic diseases almost data regarding pediatric rheumatology patients continue medicines control disease activity pediatric rheumatology patients since uncontrolled disease high disease activity place patients higher risk group regard infections said one needs decide treatment individual basis considering personal risk factors critical reach early conclusions prophylactic effects drugs currently use pediatric rheumatology practice although disease mostly mild course children children immune covid<NUMBER> different clinical manifestations kawasakilike disease related sarscov<NUMBER> infection use accumulating current scientific evidence common sense making decisions treatment patients follow primary prevention principles hand hygiene social distancing e<NUMBER> <NUMBER> presently need therapeutic molecules covid<NUMBER> outbreak severity mortality disease associated high level release cytokine patients known crs cytokine release syndrome cytokine storm syndrome il<NUMBER> type proinflammatory cytokine release severe covid<NUMBER> patients cytokine initiates crs jakstat pathway tocilizumab humanized monoclonal antibody designed bind mil<NUMBER>r membrane bound receptor il<NUMBER> sil<NUMBER>r soluble receptor il<NUMBER> inhibit jakstat signaling pathway finally stops cytokine storm syndrome however need understand tocilizumab bound mil<NUMBER>r sil<NUMBER>r similarly also need understand real molecular mechanism activity tocilizumab key words tocilizumab therapeutic option cytokine storm syndrome covid<NUMBER> since december <NUMBER> deadly viral disease grasps almost entire world pathogenic effect threatens civilization impact never seen main cause disease recognized new member coronavirus family namely sarscov<NUMBER> disease popularly known covid<NUMBER> disease first reported wuhan china primary wellknown symptoms disease include fever respiratory distress inability breathe spontaneously ultimately leads pneumonia <NUMBER> however symptoms including different kinds neurological symptoms <NUMBER> diarrhea could also considered clinical signs associated disease moreover found severity mortality disease closely associated high levels cytokine release critical patients ultimately results crs cytokine release syndrome popularly known cytokine storm <NUMBER> strong correlation theprogress disease severe critical <NUMBER> surprisingly association crs cytokine storm high morbidity something unique sarscov<NUMBER> also reported previous viral infection caused coronaviruses like sarscov merscov <NUMBER> also reported various previous scientific informations interleukin<NUMBER> il<NUMBER> plays pivotal role kind elicit immunogenic response observed strong involvement particular interleukin inducing crs correspond higher rate morbidity associated different viral infections sars cov mers cov also diseases <NUMBER> concentrations serum il<NUMBER> normal condition less tends increases infection injury human body il<NUMBER> kind proinflammatory cytokine two types signaling pathways classical trans signaling pathway employed interleukin molecule initiate immune response classical pathway il<NUMBER> bind receptor ie mil<NUMBER>r membrane bound receptor il<NUMBER> present cell surface mainly immunogenic cells complex bind anther signaling transducer molecule glycoprotein <NUMBER> gp<NUMBER> complex turn transduce signaling pathway jakstat janus kinasessignal transducer activator transcription pathway <NUMBER> turn activate different kinds inflammatory effects innate immune system natural killer nk cells neutrophils macrophages well acquired immune system b cells <NUMBER> classical cis signaling pathway confined immunogenic cells whereas il<NUMBER> also activate huge proinflammatory effect via alternative signaling pathway ie trans signaling pathway pathway interleukin bind receptor present cell surface rather kind soluble arch med res e<NUMBER> <NUMBER> form receptor sil<NUMBER>r forming complex gp<NUMBER> dimer possibly present cell surface specifically different kinds endothelial cells <NUMBER> trans signaling pathway il<NUMBER> potentially induce proinflammatory response possibly every type cells present system moreover also reported previously il<NUMBER> almost secreted kind immune stromal cells <NUMBER> imperative note signaling il<NUMBER> plays important role inducing cytokine storm classical trans signaling pathway seriously affected covid patients order check control deadly effect particular interleukin molecules present applied block signaling pathway one molecule act effective antagonist il<NUMBER> signaling tocilizumab humanized monoclonal antibody specifically designed bind mil<NUMBER>r sil<NUMBER>r soluble receptor il<NUMBER> inhibit classical trans signaling pathway figure <NUMBER> though underlying molecular mechanism action humanized antibody still clear reported drug plays important role betterment serious covid patients currently efficacy particular drug tested globally different laboratories also approved usfda stage iii clinical trials still lot scientific exploration needed confirm real molecular mechanism activity potential conflict interest declared authors coronavirus including sars mers caused two largescale pandemics last two decades <NUMBER> <NUMBER> although viral evasion host immune responses virusinduced cytopathic effects believed critical disease severity studies humans died sars animal models suggested excessive aberrant host cytokine storm resulting exuberant immunopathology lethal disease <NUMBER> <NUMBER> <NUMBER> inflammatory cytokine storm refers immune system gone awry excessive inflammatory response flaring control cytokine storms associated wide variety infectious noninfectious diseases including graftversushost disease autoimmune disease severe virus infection multiple organ dysfunction syndromes chimeric antigen receptor cart cell therapy <NUMBER> <NUMBER> reported following sarscov infection dysregulated cytokinechemokine responses higher virus titers cause inflammatory cytokine storm lung immunopathological injury <NUMBER> <NUMBER> inflammation associated cytokine storm may begin one local site spread throughout body via systemic circulation <NUMBER> <NUMBER> similarly patients infected sarscov<NUMBER> reported recently increased plasma concentrations inflammation related cytokines including interleukins il <NUMBER> <NUMBER> <NUMBER> granulocytecolony stimulating factor gcsf interferoninducible protein <NUMBER> ip<NUMBER> monocyte chemoattractant protein <NUMBER> mcp<NUMBER> macrophage inflammatory protein <NUMBER> alpha mip<NUMBER>a tumour necrosis factor  tnf especially moribund patients <NUMBER> importantly covid<NUMBER> patients developed characteristic pulmonary ground glass changes imaging peripheral lymphocytes decreasing <NUMBER> <NUMBER> <NUMBER> importantly large number inflammatory immune cell infiltrations also found covid<NUMBER> patient pulmonary pathology <NUMBER> <NUMBER> phenomena suggest severe pulmonary inflammation cytokine storm also exist sarscov<NUMBER> infection present symptomatic treatments organ support moribund patients mainstays clinical managements <NUMBER> urgent identify immunopathology mechanism delay pulmonary immune injury patients infected sarscov reported severity pulmonary immune injury correlated extensive infiltration neutrophils macrophages lungs <NUMBER> <NUMBER> accompanied increased numbers neutrophils monocytes lower cd<NUMBER> cd<NUMBER> cell counts peripheral blood samples <NUMBER> <NUMBER> <NUMBER> identify immune characteristic patients infected sarscov<NUMBER> peripheral blood samples patients severe pneumonia collected immune analysis consistent previous clinical characteristics reports <NUMBER> <NUMBER>d e <NUMBER>bb cd<NUMBER> tnfrs<NUMBER> activationinduced costimulatory molecule important prime immune responses cytotoxic cd<NUMBER> cells <NUMBER> icu patients infected sarscov<NUMBER> expression <NUMBER>bb increased significantly compared healthy controls supplementary fig <NUMBER>d e reported coexpression tim<NUMBER> pd<NUMBER> may represent subset cells severe exhaustion virus infections <NUMBER> <NUMBER> worth noting much higher percentage coexpression tim<NUMBER> pd<NUMBER> subset exist cd<NUMBER> cd<NUMBER> cells covid<NUMBER> patients supplementary fig <NUMBER>f especially icu patients suggesting exhausted status cells patients infected identify key pathogenic cytokines main source cytokines interferon ifn tnf granulocytemacrophage colonystimulating factor gmcsf il<NUMBER> selected analyzed intracellular cytokine staining inflammatory mediators proven critical primary cause inflammatory cytokine storm patients infected sarscov merscov <NUMBER> <NUMBER> without restimulation pma incubation monensin high percentage gmcsf il<NUMBER> expressions could found cd<NUMBER> cells covid<NUMBER> patients icu nonicu patients compared healthy controls fig <NUMBER>a c icu patients severe pneumonia showed correlated higher percentage gmcsf il<NUMBER> cd<NUMBER> cells fig <NUMBER>a c pathogenic th<NUMBER> cells ifnγ gmcsf expression reported central nervous system inflammation <NUMBER> importantly aberrant pathogenic th<NUMBER> cells coexpressing ifn gmcsf exist icu patients infected sarscov<NUMBER> whereas little found nonicu patients healthy controls indicating pathogenic th<NUMBER> cells correlative evidence patients severe disease play critical role hyperinflammatory responses sarscov<NUMBER> pathogenesis fig <NUMBER>b meanwhile tnf significantly upregulated cd<NUMBER> cells covid<NUMBER> patients supplementary fig <NUMBER>a b cd<NUMBER> cells icu patients also showed higher expression gmcsf compared nonicu patients healthy controls il<NUMBER> tnf found cd<NUMBER> cells supplementary fig <NUMBER>c neither nk cells b cells secreting source gmcsf il<NUMBER> supplementary fig <NUMBER>eh gmcsf recently involved pathogenesis inflammatory autoimmune diseases mechanism controls diverse pathogenic capabilities inflammatory myeloid cells among myeloid cells monocyte pathogenic gmcsf responsive cells require gmcsf initiate tissue damage mouse human <NUMBER> <NUMBER> identify whether inflammatory monocyte exist covid<NUMBER> patients phenotype subpopulation monocytes analysis cd<NUMBER> cd<NUMBER> inflammatory monocyte subsets seldom exist healthy controls contrast significantly higher percentage cd<NUMBER> cd<NUMBER> inflammatory monocyte exists peripheral blood covid<NUMBER> patients percentage cd<NUMBER> cd<NUMBER> monocyte much higher severe pulmonary syndrome patients icu fig <NUMBER>a c moreover monocyte covid<NUMBER> patients also showed capability secrete gmcsf importantly significantly higher expression il<NUMBER> secreted inflammatory monocyte especially icu patients let inflammatory storm even worse fig <NUMBER>b meanwhile number gmcsf monocytes il<NUMBER> monocytes increased rapidly fig <NUMBER>e suggesting potential high risk inflammatory cytokine storm caused monocytes may migrate lung develop macrophage monocyte derived dendritic cells thus covid<NUMBER> patients gmcsf potentially links severe pulmonary syndromeinitiating capacity pathogenic th<NUMBER> cells gmcsf ifn inflammatory signature monocytes cd<NUMBER> cd<NUMBER> high expression il<NUMBER> progeny activated immune cells may enter pulmonary circulation large numbers played immune damaging role severe pulmonary syndrome patients fig <NUMBER> study provides detailed immunopathology report sarscov<NUMBER> suggesting excessive activated immune response caused pathogenic gmcsf th<NUMBER> cells inflammatory cd<NUMBER> cd<NUMBER> monocytes may connect pulmonary immunopathology leading deleterious clinical manifestations even acute mortality sarscov<NUMBER> infections consistent situation sarscov merscov <NUMBER> <NUMBER> remarkable children always experience mildmoderate clinical illness elderly individuals exhibit worse outcomes infection sarscov<NUMBER> indicating mature excessive immune response towards pathogenic human coronavirus infections play key role inducing severe pulmonary syndrome even organ failure specific new drugs targeted sarscov<NUMBER> may take long time evaluate develop critical moment several marketed drugs target inflammatory storm reduce immunopathology could considered <NUMBER> tocilizumab specifically bind membrane bound il<NUMBER> receptor soluble il<NUMBER> receptor inhibit signal transduction first il<NUMBER> blocking antibody approved marketing proved safety effectiveness therapy rheumatoid arthritis <NUMBER> order verify whether targeted il<NUMBER> receptor inflammatory signals may potentially right way save severe covid<NUMBER> patients launched clinical trial using tocilizumab block interleukin <NUMBER> receptor chictr<NUMBER> severe patients recruited right inspiring clinical results including quickly decreased temperature respiratory function improved many urgent questions remain answered evidence alveolar washing fluid organs autopsy covid<NUMBER> patients needed verify whether aberrant pathogenic immune cells play fatal immune damage cause organ functional disability mortality details see supplementary data supplementary data available nsr online representative density plots showing analysis gmcsf il<NUMBER> expressions gated cd<NUMBER> cd<NUMBER> monocyte cells isolated peripheral blood healthy controls icu nonicu patients covid<NUMBER> c statistics calculated percentage cd<NUMBER> cd<NUMBER> subsets monocytes statistics calculated percentage gmcsf il<NUMBER> cells cd<NUMBER> monocytes e statistics calculated cell number gmcsf cd<NUMBER> il<NUMBER> cd<NUMBER> monocytes data represent mean ± sem oneway anova p<NUMBER> considered statistically significant pathogenic cd<NUMBER> th<NUMBER> gmcsf ifn cells rapidly activated produce gmcsf inflammatory cytokines form cascade signature inflammatory monocytes cd<NUMBER> cd<NUMBER> high expression il<NUMBER> progeny activated immune cells may enter pulmonary circulation large numbers played immune damaging role severe pulmonary syndrome patients monoclonal antibodies targets gmcsf interleukin <NUMBER> receptor may potentially prevent curb immunopathology caused covid<NUMBER> coronavirus disease <NUMBER> covid<NUMBER> broke throughout world total number deaths <NUMBER> patients confirmed covid<NUMBER> progressed acute respiratory distress syndrome ards rapidly incident rate high <NUMBER> <NUMBER> many require mechanic ventilation cohort intensive care unit icu italy <NUMBER> cases need respiratory support among <NUMBER> patients <NUMBER> cases supported mechanical ventilation <NUMBER> apart desperate lacking ventilator world mechanical ventilation could also cause barotrauma ventilatorassociated lung injury cytokine storm disclosed main pathological characteristic covid<NUMBER> <NUMBER> also direct pathogenic contributor induce ards cytokines could eliminated effectively extracorporeal blood purification ebp <NUMBER> thus could interrupt initiation progression inflammation cascade scenario covid<NUMBER> accordingly may chance avoiding incubation mechanical ventilation herein report case severe sarscov<NUMBER> infection cytokine storm completely recovered cytokine storm using extracorporeal blood purification <NUMBER>yearold male presented hospital <NUMBER>day history fever <NUMBER>day history cough chest distress patient history gallstone got fever day <NUMBER> february <NUMBER> <NUMBER> chill headache muscle soreness fatigue nausea cough chest distress shortness breath day <NUMBER> quarantined hotel tested positive j u r n l p r e p r f sarscov<NUMBER> day <NUMBER> received oseltamivir moxifloxacin lianhua qingwen capsule chinese medicine outpatient admitted hospital fever cough mild chest distress day <NUMBER> arbidol hydroxychloroquine oseltamivir lianhua qingwen capsule administered supplemental oxygen delivered nasal cannula <NUMBER> lmin alterations hepatic function showed levels alanine aminotransferase <NUMBER> ul normal range <NUMBER> ul aspartate aminotransferase <NUMBER> ul normal range <NUMBER> ul elevated cd<NUMBER> cd<NUMBER> cell counts markedly decreased supplemental table day <NUMBER> chest ct indicated multiple groundglass opacities bilateral lungs day <NUMBER> supplemental figure <NUMBER> ac peak temperature <NUMBER>°c date vital signs remained clinically stable except oxygen saturation <NUMBER> providing oxygen <NUMBER> lmin il<NUMBER> <NUMBER> pgml almost <NUMBER> folds normal range ≤<NUMBER> pgml indicated initiation cytokine storm day <NUMBER> figure <NUMBER> ebp including double plasma molecular adsorption system bs<NUMBER> ha<NUMBER>ii jafron china plasma exchange <NUMBER> ml thus applied remove cytokines day <NUMBER> bs<NUMBER> ha<NUMBER>ii installed series plasma separator ec<NUMBER>w asahi blood flow velocity <NUMBER> mlmin separating speed <NUMBER>mlmin duration treatments <NUMBER> hours plasma exchange conducted intravenous methylprednisolone <NUMBER> mg daily used suppress inflammation reaction patient largely stable chest distress exacerbated blood phlegm developed day <NUMBER> progressed type respiratory failure partial pressure oxygen <NUMBER> mmhg partial pressure carbon dioxide <NUMBER> mmhg <NUMBER> oxygen saturation oxygen flow <NUMBER> lmin highflow oxygen <NUMBER> lmin initiated keep oxygen saturation values <NUMBER> hydroxychloroquine discontinued due long qt interval ebp therapy continued days <NUMBER> <NUMBER> respectively patient transferred icu day <NUMBER> given acute inflammatory reaction methylprednisolone improved <NUMBER> mg twice daily piperacillintazobactam <NUMBER> g administered intravenously every <NUMBER> hours initiated concerning hospitalacquired pneumonia acetylcysteine used dilute phlegm human serum albumin supportive care also administered clinical condition patient improved day <NUMBER> stable j u r n l p r e p r f thereafter hepatic function back normal well body temperature returned normal day <NUMBER> igm antisarscov<NUMBER> identified <NUMBER> auml normal value <NUMBER> auml day methylprednisolone gradually reduced discontinued day <NUMBER> lesions chest ct confined day <NUMBER> alleviated day <NUMBER> almost disappeared day <NUMBER> supplemental figure <NUMBER> low flow rate oxygen <NUMBER> lmin delivered instead highflow oxygen day <NUMBER> discontinued day <NUMBER> asymptomatic rest shortness breath activity training renal function unaffected immunoglobulin levels including igg igm iga ige normal throughout clinical course complement c<NUMBER> level staying normal range <NUMBER> gl hospital duration supplemental table <NUMBER> c<NUMBER> level <NUMBER> gl normal range <NUMBER> gl reduced day <NUMBER> back normal <NUMBER> gl day <NUMBER> nucleic acid testing sarscov<NUMBER> negative four different times discharged day <NUMBER> management covid<NUMBER> critical cases still challenging nowadays respiratory circulation supports mechanic ventilation extracorporeal membrane oxygenation ecmo almost last defense severe covid<NUMBER> <NUMBER> although specific methods intervene progression critical cases unknown effects ebp treatment covid<NUMBER> associated cytokine storm emphasized outcome present case covid<NUMBER> ards promising pulmonary fibrosis observed date ebp suggested interrupt inflammation cascade stop progression cytokine storm case obvious peak levels cytokines bent initiation ebp day <NUMBER> ha<NUMBER> improved oxygenation lung mechanics removing circulating alveolar cytokine levels <NUMBER> bs<NUMBER> adsorbed bilirubin attenuate liver injury <NUMBER> ebp combined double plasma molecular adsorption system plasma exchange directly reduce cytokines although methylprednisolone also administered synchronously identified significant time point il<NUMBER> reduce seventh day rather first three days ards <NUMBER> pathogenesis covid <NUMBER> infection subject active research however effective therapy yet developed disease caused sars cov <NUMBER> coronavirus initially sars cov <NUMBER> infects upper respiratory tract epithelial cells infection limited cells disease usually manifests mild symp toms severe pneumonia develop virus enters alveoli lungs infects type ii pneumo cytes infection inhibits interferon response upregulates expression chemokines attracting immune cells monocytes b lymphocytes <NUMBER> excessive extravasation cells vessels alve oli considered main cause pathogenic changes lungs leading development respiratory fail ure acute respiratory distress syndrome ards <NUMBER> severe cases covid <NUMBER> infection virus enter bloodstream infect endothelial target cells kidneys esophagus bladder ileum heart tissues central nervous system endogenous damage associated molecular patterns damps released dead cells additionally activate immune cells sup port development cytokine storm thus severe forms covid <NUMBER> infection multiple organ failure asso ciated hyperactivation immune system observed patients covid <NUMBER> infection critical condition often high systemic inflammatory param eters including levels c reactive protein cytokines il <NUMBER> tnfα il <NUMBER> etc <NUMBER> <NUMBER> increased generation reactive oxygen species ros immune cells oxidative stress <NUMBER> inevitably accompanies cytokine storm inflammatory cytokines ros act together activating pulmonary epithelial endothelial cells leads disassembly cell contacts increased permeability influx edematous fluid alveoli resulting impaired gas exchange lungs addition cytokine storm oxidative stress lead ros dependent apoptosis endothelial cells <NUMBER> contributes release coagulation factors clot formation <NUMBER> corticosteroids inflammatory cascade inhibitors based monoclonal antibodies currently used treatment cytokine storm covid <NUMBER> infec tion tocilizumab anti il <NUMBER> secukinumab anti il <NUMBER>a canakinumab anti il <NUMBER>β ruksolitinib phosphate biochemistry moscow vol <NUMBER> <NUMBER> <NUMBER> jak kinase inhibitor etc <NUMBER> use corticosteroids treatment covid <NUMBER> infection showed noticeable constraints related primarily suppression specif ic immunity increased risk secondary bacterial pneumonia <NUMBER> <NUMBER> limitations monoclonal anti body therapy include narrowly targeted action one many inflammatory cytokines thus extremely important develop new approaches pre vent cytokine storm covid <NUMBER> infection transcription factor nrf<NUMBER> nuclear factor ery throid <NUMBER> related factor <NUMBER> responsible adaptation cells electrophilic oxidative stresses mal condition nrf<NUMBER> located cytoplasm bound inhibitor keap<NUMBER> targets nrf<NUMBER> ubiquitination subsequent degradation presence elec trophiles ros keap<NUMBER> nrf<NUMBER> complex dissociates nrf<NUMBER> migrates nucleus stimulates transcription target genes antioxidant response element sequences promoters <NUMBER> nrf<NUMBER> controls expression genes participating antioxi dant response redox homeostasis biogenesis mito chondria etc activation genes protects cells inflammation <NUMBER> nrf<NUMBER> stimulates expression hemoxygenase ho <NUMBER> responsible degrada tion pro inflammatory free heme formation anti inflammatory compounds co bilirubin nrf<NUMBER> also upregulates production antioxidant enzyme nadph quinone oxidoreductase nqo<NUMBER> well key enzymes glutathione biosynthesis functions main cellular antioxidant nrf<NUMBER> knockout mice suffer uncontrolled inflammatory reaction involving activation innate immune cells increased production cytokines chemokines ros factors contribute cell tissue dam age <NUMBER> nrf<NUMBER> activation results suppression inflamma tion antioxidant response also nrf<NUMBER> transcriptional repressor activity human macrophages nrf<NUMBER> inhibits expression inflammatory cytokines il <NUMBER>β il <NUMBER> tnfα <NUMBER> shown numerous animal inflammatory models nrf<NUMBER> inducers decreased circulating levels proinflam matory cytokines <NUMBER> <NUMBER> <NUMBER> protective role nrf<NUMBER> activation numerous inflammatory processes also demonstrated airway epithelium vascular endothelium <NUMBER> <NUMBER> dozens clinical trials cur rently underway test efficacy nrf<NUMBER> inducers prevention treatment inflammatory respirato ry diseases main facts observations justifying feasibility nrf<NUMBER> activation treatment covid <NUMBER> infec tion summarized <NUMBER> excessive inflammation covid <NUMBER> infection associated high lethality <NUMBER> activation nrf<NUMBER> reduces inflammatory response preventing expression inflammatory cytokines <NUMBER> activation macrophage inflammasomes <NUMBER> <NUMBER> nrf<NUMBER> inducers also reduce inflammatory reactions patients acute chronic diseases <NUMBER> <NUMBER> ards main mortality factor covid <NUMBER> patients <NUMBER> activation nrf<NUMBER> protects airway epitheli um disassembly intracellular tight junctions inflammatory exposure subsequent develop ment ards <NUMBER> <NUMBER> impaired vascular permeability key event covid <NUMBER> pathogenesis leading endothelial dys function thrombosis <NUMBER> induction nrf<NUMBER> protects vascular endothelium damage caused oxida tive stress inflammatory cytokines <NUMBER> <NUMBER> severe cases covid <NUMBER> accompanied increased oxidative stress <NUMBER> cases successful treatment covid <NUMBER> glutathione <NUMBER> key enzymes glutathione biosynthesis controlled nrf<NUMBER> <NUMBER> decrease nrf<NUMBER> activity promotes oxidative stress nrf<NUMBER> activation increases glutathione content body restores redox balance organism <NUMBER> <NUMBER> age important risk factor severe covid <NUMBER> infection <NUMBER> nrf<NUMBER> activity decreases age <NUMBER> <NUMBER> hyperglycemia another risk factor covid <NUMBER> infection <NUMBER> nrf<NUMBER> activity reduced patients hyperglycemia <NUMBER> <NUMBER> mortality severity covid <NUMBER> infection higher men compared women <NUMBER> sexual differ ences nrf<NUMBER> activity humans unknown female mice higher nrf<NUMBER> activity compared males <NUMBER> far attempts made investigate nrf<NUMBER> inducers therapeutic drugs reduce oxida tive stress inflammation infections caused sars cov <NUMBER> task solved repurposing drugs drug candidates able activate nrf<NUMBER> response wide range compounds used acti vate nrf<NUMBER> including following <NUMBER> sulforaphane plant derived compound found cruciferous plants broccoli brussels sprouts effect sulforaphane reducing circulato ry inflammatory cytokines demonstrated many animal models <NUMBER> currently <NUMBER> clinical tri als sulforaphane conducted targeting chronic obstructive pulmonary disease asthma arthritis cancer others sulforaphane well tolerated orally daily doses <NUMBER> μmol reaching therapeutic plasma con centrations <NUMBER> <NUMBER> dimethyl fumarate dimethyl ester fumaric acid usa approved fda treatment recurrent multiple sclerosis trade name tecfidera germany psoriasis trade name fumaderm interestingly dimethyl fumarate reduces biochemistry moscow vol <NUMBER> <NUMBER> <NUMBER> inflammatory reactions nrf<NUMBER> dependent <NUMBER> nrf<NUMBER> independent ways <NUMBER> <NUMBER> <NUMBER> sodium thiosulfate drug used intravenously orally safe substance used treat various intoxications sodium thiosulfate hydrogen sulfide h <NUMBER> donor nrf<NUMBER> inducer hydrogen sulfide maintains redox balance cells anti inflammatory property <NUMBER> compounds releasing h <NUMBER> anti inflammatory antiviral activities wide range pathogenic viruses <NUMBER> review paper recently published justifying use inhaled form sodium thiosulphate patients covid <NUMBER> infection <NUMBER> <NUMBER> epigallocatechin <NUMBER> gallate polyphenol found green tea non toxic compound displays anti inflammatory activity vitro vivo <NUMBER> addition epigallocatechin <NUMBER> gallate inhibitor furin protease processes sars cov <NUMBER> protein facilitates virus penetration cell <NUMBER> <NUMBER> <NUMBER> resveratrol plant polyphenol resveratrol acti vates nrf<NUMBER> decreasing expression negative regulator keap<NUMBER> activates sirt<NUMBER> deacetylase <NUMBER> oral administration resveratrol leads decrease levels inflammatory cytokines il <NUMBER>β tnf activation expression nrf<NUMBER> target genes nqo<NUMBER> glutathione transferase <NUMBER> resveratrol enhances synthesis endogenous glutathione pro tects alveolar epithelial cells oxidative stress <NUMBER> drugs mainly used treat chronic rather acute inflammatory conditions therapeutic effica cy nrf<NUMBER> inducers unknown cytokine storm ards potentially nrf<NUMBER> inducers used prevent cytokine storm manifestation combination already used anti inflammatory drugs proposed drugs toxicity bioavail ability already known allows quick start relevant clinical trials reduce oxidative stress inflammation covid <NUMBER> infection seems reason able use nrf<NUMBER> inducers together glutathione biosynthesis precursors eg n acetylcysteine ther apy used reduce damage cells tissues prevent respiratory failure ards funding work received financial support patients sarscov<NUMBER> infections experience lymphopenia inflammatory cytokine storms severe stage disease leading multiorgan damage exact pattern immune system changes condition disease process unclear available knowledge indicated nfkappab pathway induced several mediators significant role cytokine storm various mechanisms therefore identifying state immune cells dominant mechanisms production cytokines incorporated cytokine storm sarscov<NUMBER> new member beta coronavirus structural proteins consist spike envelope e nucleocapsid n membrane protein among glycoprotein surface virus plays significant role adhesion entry host cells proteins bind angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor host cell surface <NUMBER> virus enters host cells endocytosis translation proteins replication rna occurred cytoplasm cells golgi apparatus endoplasmic reticulum system attachment vesicle containing viral particles cell membrane <NUMBER> virus released activated antigenpresenting cells apc consequently stimulated humoral cellular immunity systems well mitogenactivated protein kinase mapk pathway nfkappab signaling pathway regulated gene expression altered immune cell differentiation <NUMBER> result proinflammatory cytokines release <NUMBER> unfolded protein production er stress induction <NUMBER> patients sarscov<NUMBER> infections declared covid<NUMBER> probably develop different stages disease asymptomatic mild stage headache fatigue fever diarrhea well severe stage excessive decrease lymphocyte count failure vital organs frequently lungs <NUMBER> exact pattern immune system changes condition disease process unclear <NUMBER> diabetes mellitus dm defined abnormal glucose metabolisms insulin functions well recognized result relative absolute defect insulin secretion variable degrees systemic insulin resistance common form dm type two heterogeneous complication attributed insulin resistance obesity oxidative stress lowgrade chronic inflammation background <NUMBER> <NUMBER> insulin anabolic hormone secreted beta cells pancreas responsible glycemic control facilitating glucose utilization regulating nutrient hemostasis stimulating gene expression cell survival development metabolic actions insulin exerted differently three primary target tissues additional negative regulation hormonesensitive lipase activity insulin leads decrease free fatty acid efflux adipose tissues <NUMBER> <NUMBER> <NUMBER> lack insulin sensitivity blood glucose elevated anabolic action insulin reduced end products become glycosylated oxidative stress increased insulin starts function binding extracellular alphasubunit insulin receptors insr targeted tissues induces intracellular betasubunit autophosphorylation acted like trigger several intracellular signaling cascades downstream tyrosine phosphorylation insulin receptor substrates irs<NUMBER> leading activate phosphatidylinositol <NUMBER> kinase pi<NUMBER>k growth factor receptorbinding protein <NUMBER> grb<NUMBER> mapk signaling pathways <NUMBER> <NUMBER> pi<NUMBER>k pathway activated several serinethreonine kinases like protein kinase b pkb also known akt <NUMBER> largely contributed insulin metabolic actions including glucose hemostasis lipid protein synthesis well antiinflammatory response akt proteins major investigated serinethreonine kinases involving insulin resistance realized akt<NUMBER> activation reduced adipocytes skeletal muscle dm type two leading higher inflammatory condition mapk pathway another intracellular signal responsible gene expression affects cell development inflammatory cascades intervening pi<NUMBER>kakt pathway certain conditions mapk act serine protease irs interfere insulin signaling inappropriate activation <NUMBER> insulin resistance obesity major features dm type two denoted insufficient response targeted tissues insulin <NUMBER> exact mechanism insulin resistance yet determined insidious role inflammation underlying obesity insulin resistance dm suggested several studies <NUMBER> understanding hypoglycemic effect salicylate antiinflammatory agent via inhibition inhibitor nuclear factor kappab kinase ikk origin studies <NUMBER> <NUMBER> subsequent researches highlighted positive relationship inflammation insulin resistance also identified obesity essential factor development insulin resistance dm type two <NUMBER> downregulation insulin receptors seen obesity leading decrease insulin sensitivity <NUMBER> irs<NUMBER> common mediator attributed insulin signaling dysregulation <NUMBER> reduced levels irs<NUMBER> also associated insulin resistance hyperinsulinemia reduce irs expression negative transcription regulating <NUMBER> suppressors cytokine signaling socs inflammatory proteins overwhelming irs inflammation activates socs<NUMBER> socs<NUMBER> induce ubiquitination finally disintegration irs proteins <NUMBER> <NUMBER> activation insulin receptor stimulates tyrosine phosphorylation irs<NUMBER> directing signal transduction two major inflammatory pathways inhibit signal propagation serine kinase activity <NUMBER> previously mentioned nfkappab pathway plays crucial role inflammatory response silenced nfkappab inhibitor ikappab resting cells fulminate serine phosphorylation activity ikk ikappab results ikappab degradation inflammatory condition <NUMBER> <NUMBER> ikk subset signaling close association obesity metabolic disorders <NUMBER> cjun nh<NUMBER>terminal kinase jnk<NUMBER> another serine kinase involves inflammatory signals jnkap<NUMBER> pathways also regulates nfkappab process <NUMBER> <NUMBER> docking analysis cd<NUMBER> covid<NUMBER> glycoprotein conducted vankadari et al significant interaction proteins found <NUMBER> dpp<NUMBER> cd<NUMBER> main receptor merscov caused transmission various species humans <NUMBER> recent years role dpp<NUMBER> chronic inflammation proved dpp<NUMBER> cd<NUMBER> glycoprotein cell surface <NUMBER>kda molecular weight <NUMBER> dpp<NUMBER> activity shown mice rats humans present kidney intestine lungs liver lymph node thymus prostate spleen monocytes epithelial cell lymphocyte <NUMBER> macrophages natural killer nk cells b cells cells express dpp<NUMBER> protein protein multifunctional involved cytokine production dna synthesis signaling activation cell proliferation <NUMBER> interferons upregulate expression dpp<NUMBER> il<NUMBER> tumor necrosis factor tnfalpha involved dpp<NUMBER> translation translocation cd<NUMBER> role regulating migration maturation cd<NUMBER> tcell antibody production cytokine secretion immunoglobulin class switching exact role protein immune cells clear cd<NUMBER> cells strong ability migrate via endothelial cells <NUMBER> dpp<NUMBER> also interact caveolin<NUMBER> apc integral protein membrane smooth muscle cells macrophages endothelial cells dpp<NUMBER> caveolin<NUMBER> interaction lead carma<NUMBER>lipid rafts carma<NUMBER> belongs maguk family caspase recruitment domain <NUMBER>containing membraneassociated kinase whose role regulation nfkappab activation lymphocytes <NUMBER> dimerization cd<NUMBER> essential binding carma<NUMBER> interaction carma<NUMBER>dimeric cd<NUMBER> via cytoplasmic tail second one binding apc cd<NUMBER> causes caveolin<NUMBER> phosphorylation interleukin<NUMBER> receptorassociated serinethreonine kinase <NUMBER> irak<NUMBER> tollinteracting protein tollip dissociation caveolin<NUMBER> <NUMBER> irak<NUMBER> tollip involved tolllike receptor tlr signaling pathway <NUMBER> afterward phosphorylation irak<NUMBER> occurred activates nfkappab <NUMBER> activation may cause tnfalpha secretion consequently jnk activation parallel nfkappab activation induces m<NUMBER> macrophage different interleukins secretion including il<NUMBER> il<NUMBER> il<NUMBER> fig <NUMBER> <NUMBER> likewise secretion tnfalpha caused nfkappab inflammation activates dpp<NUMBER> causes migration maturation cd<NUMBER> tcell especially th<NUMBER> th<NUMBER> cytokine secretion dpp<NUMBER> probably also role induction hypoxiainducible factor<NUMBER> hif<NUMBER> alpha <NUMBER> exaggerates inflammation fig <NUMBER> dpp<NUMBER> different role immune system inflammationrelated disease immune responses cell activation also enhances inflammation tlr pathway dpp<NUMBER> inhibitors like sitagliptin affect adipocytes macrophages antiinflammatory agent <NUMBER> inhibition dpp<NUMBER> reduces inflammation intensity different states <NUMBER> severe stage covid<NUMBER> associated lymphopenia inflammatory cytokine storm caused multiorgan damage <NUMBER> therefore identification state immune cells dominant mechanisms production cytokines incorporate cytokine storm important step therapeutic approach studies identified diabetic patients higher risk covid<NUMBER> infections <NUMBER> due dpp<NUMBER> expressed different cell surfaces dpp<NUMBER> inhibitors addition antidiabetic effect inhibit cell proliferation production proinflammatory cytokines reduce severity inflammation sitagliptin dpp<NUMBER> inhibitor reduce inflammatory response <NUMBER> interestingly docking studies also suggested additional association dpp<NUMBER> glycoproteins new coronavirus <NUMBER> addition fact inflammatory mediators active individuals covid<NUMBER> blocking predominant pathway could beneficial present hypothesis suggests new therapeutic approach linking covid<NUMBER> pathogenesis diabetes potential sitagliptin mechanisms molecular levels apcs like dendritic cells present viral antigens cells play significant role immunity system leads production cytokines activation cd<NUMBER> cells innate immune system includes macrophage dendritic cells neutrophils cells express pattern recognition receptors prrs like tlr detecting viral microbial compartments <NUMBER> <NUMBER> dysregulation immune system like inflammatory cytokine storm lymphopenia confirmed severity coronaviruses <NUMBER> however inflammation proper biological response pathogens inflammatory responses also act double aged sword infection conditions <NUMBER> covid<NUMBER> infection changes immune system cause deregulation immune system higher expression inflammatory pathways especially nfkappab induces production proinflammatory cytokines via different mechanisms leading cytokine storms increased proinflammatory cytokines level lungs prevents proper function lungs possibly causes lung failure <NUMBER> <NUMBER> stimulus inflammation initiated receptors activation developed within intracellular signaling like nfkappab pathway ikappab protein inhibitor nfkappab activation presenting cytoplasm physiological state whereas inflammatory condition prrs activates ikk inhibitor kinas ikappab leads ikappab degradation eventually causes translocation nfkappab nucleus induce transcription inflammatory genes <NUMBER> activation nfkappab signaling responsible induction naïve cell activation proliferation leads induction chemokine expression additionally inflammatory effect different innate immune cells tcr cell receptor signaling <NUMBER> proinflammatory effect nfkappab macrophage extremely studied activated macrophages different phenotypes including m<NUMBER> activated alternatively m<NUMBER> macrophage m<NUMBER> phenotype produce antiinflammatory cytokines like il<NUMBER> il<NUMBER> m<NUMBER> form produces inflammatory cytokines like il<NUMBER> il<NUMBER>beta il <NUMBER> il<NUMBER> tnfalpha il<NUMBER> involve different inflammatory conditions <NUMBER> il<NUMBER> proinflammatory cytokine triggers nfkappab pathway allows translocate transcript finally release inflammatory mediators <NUMBER> nfkappab pathway essential transcription factor induction m<NUMBER> phenotype macrophage essential expression proinflammatory genes encode il<NUMBER>beta il<NUMBER> tnfalpha cyclooxygenase two il<NUMBER> <NUMBER> nfkappab induces differentiation inflammatory cells consist th<NUMBER> th<NUMBER> mediate inflammatory response involved different autoimmune diseases inflammatory conditions th<NUMBER> secretes interferongamma ifngamma contributes inflammatory processes nfkappab promotes secretion cytokines affecting tcr signaling increases differentiation th<NUMBER> cells <NUMBER> th<NUMBER> secrete il<NUMBER> recruits neutrophils monocytes site inflammation aberrant activation nfkappab pathway stimulates tlr produce il<NUMBER> induce th<NUMBER> differentiation increase production ifngamma il<NUMBER>beta cells <NUMBER> <NUMBER> mentioned tlrs members prps group involved activation inflammatory processes tlrs signaling activates intracellular signaling processes leads nfkappab translocation nucleus <NUMBER> patients covid<NUMBER> multiorgan damages like liver heart kidney disorders acute respiratory distress syndrome monocyte chemo attract protein<NUMBER> mcp<NUMBER> compared nonicu patients <NUMBER> clear sever cases covid<NUMBER> patients higher neutrophillymphocyte higher level inflammatory cytokines like il<NUMBER> il<NUMBER> lower account cd<NUMBER>t cells level compared covid<NUMBER> patients lower ratio neutrophillymphocyte <NUMBER> peripheral blood covid<NUMBER>patients number lymphocytes decreased excessive activated status condition activated cd<NUMBER> cells higher expression level cd<NUMBER> cd<NUMBER> cd<NUMBER> activated cd<NUMBER> cells higher level healthy control individuals <NUMBER> <NUMBER> presence lowgrade chronic inflammation diabetes nfkappab pathway almost always excited elevated nfkappab pathway expression diabetes affects immune system patients diabetic patients could also suffer high levels th<NUMBER> th<NUMBER> explode inflammatory cascade uncontrolled manner <NUMBER> activation innate immune system adipose tissue suggested connection inflammation obesity diabetes <NUMBER> weight gain causes adipose tissue remodeling expansion inadequate supporting vasculature leading higher oxygen supply consequently trigger cellular hif<NUMBER> promote inflammation state <NUMBER> part inflammation state adipokines may alter mcp<NUMBER> mip il<NUMBER> il<NUMBER> il<NUMBER>beta tnfalpha increased well adiponectin il<NUMBER> less secreted <NUMBER> <NUMBER> higher factors activate adipose tissue macrophages cells leading release proinflammatory chemokine attract immune cells <NUMBER> <NUMBER> various evidence indicated adipose tissue macrophages play major role confront inflammation metabolic organs also determined predominantly antiinflammatory m<NUMBER>type macrophages transformed proinflammatory m<NUMBER>macrophages obese population <NUMBER> <NUMBER> ikk plays vital role obesity metabolic disorders also involved interferon signaling essential fighting viral infections <NUMBER> enhanced production ifngamma adipose hepatic tissue may also cause insulin resistance contributing switch m<NUMBER> macrophages m<NUMBER> phenotype <NUMBER> free fatty acids also able promote nfkappab tlr<NUMBER> activation leading m<NUMBER>subset overcome <NUMBER> <NUMBER> one coexisting complications diabetes obesityinduced insulin resistance major role ongoing inflammation via macrophage switching m<NUMBER> type release various cytokine especially il<NUMBER> tnfalpha increase th<NUMBER> th<NUMBER> cells stimulation tlr<NUMBER> finally activation ikk fig <NUMBER> macrophages also exert inflammatory responses via jnk<NUMBER> signaling important component obesityinduced insulin resistance <NUMBER> proinflammatory cytokines tnfalpha il<NUMBER> disturb insulin action consequently leads systemic local insulin resistance <NUMBER> tnfalpha impairs insulin function irs<NUMBER> tyrosine phosphorylation blockade adipose muscle tissue <NUMBER> generally reported patients dm susceptible viral infections covid<NUMBER> exception <NUMBER> various reasons diabetic patients likely develop covid<NUMBER> symptoms progress complications patients dm shown increased receptor expression virus entry impaired immunity response decreased phagocytic activity reduced viral elimination dysregulated inflammatory cytokines higher susceptibility hyperinflammatory states accordingly closer look mechanisms could reveal way treat covid<NUMBER> diabetic population patients diabetes associated higher risk sarscov<NUMBER> infection complications new clinical challenges exhibited controlling covid<NUMBER> diabetes <NUMBER> <NUMBER> epidemiological documentations declared severe clinical manifestation complications patients covid<NUMBER> comorbid diabetes <NUMBER> chronic state lowgrade inflammation increased formation glycosylated end products oxidative reactive stress may contribute enhanced susceptibility individuals diabetes one suggesting sites intervention diabetes covid<NUMBER> ikk particular relative role nfkappab signaling well simultaneously association insulin resistance viral infection combat chronic expression ikk diabetes shows double burden diabetes viral infections <NUMBER> although basal inflammatory activity among diabetic hosts strong clinical evidence supported delayed dysregulated inflammatory signals followed impaired immune responses aligned inflammation ace<NUMBER> expression furin level two important binding mediators mediate virus entry initiate viral pathogenesis augmented diabetic hosts <NUMBER> <NUMBER> altered glucose metabolism oxidative stress directly impaired phagocytic activity neutrophils macrophages <NUMBER> together defective apc recruitment function initiation adaptive immunity delayed diabetic populations unique cytokine profile diabetic state also modifies acquired immunity arms tcell subset cd<NUMBER> th<NUMBER> th<NUMBER> cd<NUMBER> cytotoxic cells ctl upregulated whereas cd<NUMBER> th<NUMBER> regulatory treg cells diminished <NUMBER> <NUMBER> treg cells important role immunological tolerance cd<NUMBER> involved autoreactive cells suppression vivo studies showed prevented progression diabetes <NUMBER> diabetes also delays bcells activation may considerable regulatory effects functional immune response <NUMBER> insert fig <NUMBER> bold role dpp<NUMBER> different disorders like inflammation cancer immune disease diabetes put dpp<NUMBER> inhibitors spotlight <NUMBER> hand parallel analysis covid<NUMBER> diabetes mellitus pathogenesis proposed control inflammation interfering critical points major signaling pathways may provide new therapeutic approaches sitagliptin dpp<NUMBER>inhibitor class oral diabetic agents treating diabetes mellitus type two <NUMBER> market since <NUMBER> patients uncontrolled diabetes mellitus coronary artery disease consumed sitagliptin better inflammatory state <NUMBER> dpp<NUMBER> inhibitors may antiinflammatory effect independent effect glp<NUMBER> level dpp<NUMBER> inhibitors supposed decrease expression cd<NUMBER> immune cell surface led inhibition innate immune system activity data suggest positive role dpp<NUMBER> inhibitors like sitagliptin controlling inflammation due increase glp<NUMBER> hand studies believe dpp<NUMBER> inhibitors adjust activity innate immune system tcell activation act antiinflammatory agent <NUMBER> alogliptin dpp<NUMBER> inhibitor inhibited inflammation mediated macrophage due presence lps u<NUMBER> cells nga et al study <NUMBER> sitagliptin reduces inflammation mostly affecting nfkappab signaling pathway <NUMBER> also decreases apoptosis wholly partially suppresses il<NUMBER>beta il<NUMBER> levels <NUMBER> inhibits tnfalpha secretion dosedependently vitro <NUMBER> makdissi tlr<NUMBER> leads nfkappab suppression besides plasma concentration il<NUMBER> creactive protein decreased week four two respectively <NUMBER> covid<NUMBER> becoming global health threat due highly contagious leading mortality rates covid<NUMBER> patients reached late sever stages developed remarkable lymphocytopenia inflammatory cytokine storm caused multiorgan damage pathogenesis sarscov<NUMBER> infection shows immune system dysregulation major role wellknown inflammatory pathway nfkappab nfkappab involves defective cycle induces inappropriate cd<NUMBER>t cell differentiation inflammatory signals causes systemic inflammatory condition various organs involved proinflammatory cytokines consecutively lead cytokine storm hand diabetes mellitus metabolic disorder closely associated obesity insulin resistance revealed inflammatory process ambiguous role diabetes onset development considering fact diabetic patients likely contract covid<NUMBER> infection signaling analysis diabetesinflammation linkage indicates persistent nfkappab activity low grade chronic inflammatory state among diabetic population control inflammation important step covid<NUMBER> diabetes mellitus treatment modulating macrophage transformation cell differentiation via suppression dpp<NUMBER> tnfalpha tlr<NUMBER> parallel approaches added direct nfkappab suppression due different role dpp<NUMBER> immune system inflammationrelated disease immune responses cell activation especially th<NUMBER> th<NUMBER> inflammatory effect dpp<NUMBER> inhibitors considered useful discussed drug class meet antiinflammatory goals owning effects immune system drug inhibitory effect various interleukins cytokines il<NUMBER> il<NUMBER>beta tnfalpha approved different vitroin vivo studies recent evidence sarscov<NUMBER> docking analysis interestingly shown interaction glycoprotein dpp<NUMBER> receptors magnifies dpp<NUMBER> inhibitors role sitagliptin decreases inflammation via suppressing main inducers different characters nfkappab signaling pathway hence dpp<NUMBER> inhibitors like sitagliptin good candidate controlling inflammation authors declare conflicts interest global disease burden johns hopkins university httpscoronavirusjhuedumaphtml <NUMBER> million infections <NUMBER> deaths worldwide social distancing cities countries around world remains means available limit impact virus transmission time unprecedented response worlds biomedical research community seeks identify treatments covid<NUMBER> include antiviral drug vaccine development current clinical observations indicate sarscov<NUMBER> infection range inapparent nonsymptomatic infection respiratory illness presenting spiking fever dry cough accompanied high rate humanhuman transmission one serious complications corona virus disease covid<NUMBER> development atypical upper respiratory tract pneumonia poses major challenge clinicians terms disease management abnormal uncontrolled production cytokines observed critically ill patients covid<NUMBER> pneumonia <NUMBER> ensuing uncontrolled cytokine storm covid<NUMBER> patients centrally involved exacerbation symptoms disease development represents major factor contributing covid<NUMBER> mortality sense covid<NUMBER> disease shares similarities viral diseases sars mers influenza development cytokine storm warning sign disease escalation support observations retrospective study <NUMBER> patients covid<NUMBER> <NUMBER> showed sarscov<NUMBER> infected patients present clinically mild symptoms minority patients progressively declined infection eventually died acute respiratory distress syndrome ards multiple organ dysfunction syndrome mod guidelines diagnosis treatment sarscov<NUMBER> infected pneumonia first published january <NUMBER> th <NUMBER> recommended first time cytokine monitoring applied improve curative rate reduce mortality <NUMBER> view severe morbidity mortality covid<NUMBER> pneumonia review current understanding treatment human coronavirus infections perspective dysregulated immune response emerging reemerging viruses ebola zika chikungunya h<NUMBER>n<NUMBER> dengue sars mers led numerous global public health crises recent years continue threaten public health security unfortunately viruses often difficult control due lack approved antiviral drugs vaccines addition sarscov<NUMBER> two novel coronaviruses emerged global health threats since <NUMBER> namely severe acute respiratory syndrome coronavirus sarscov <NUMBER> transmitted <NUMBER> countries middle east respiratory syndrome coronavirus merscov <NUMBER> transmitted <NUMBER> countries severe pneumonia caused pathogenic human coronaviruses hcov often associated induced hypercytokinemia also termed cytokine storm immunocompetent individuals uncontrolled overproduction inflammatory cytokines contributes acute lung injury acute respiratory distress syndrome ards secretion multiple cytokines also termed cytokine release syndrome crs closely j u r n l p r e p r f related development clinical symptoms example ifnγ cause fever chills headaches dizziness fatigue tnfα cause flulike symptoms similar ifnγ fever general malaise fatigue also cause vascular leakage cardiomyopathy lung injury acutephase protein synthesis <NUMBER> il<NUMBER> important target crs induced adoptive cell therapy lead vascular leakage activation complement coagulation cascade leading characteristic symptoms severe crs diffuse intravascular coagulation dic <NUMBER> <NUMBER> noteworthy il<NUMBER> likely cause cardiomyopathy promoting myocardial dysfunction often observed patients crs <NUMBER> addition activation endothelial cells may also one hallmarks severe crs endothelial dysfunction lead capillary leakage hypotension coagulopathy <NUMBER> figure <NUMBER> taken together studies argue virusinduced immunopathological events play crucial role fatal pneumonia observed hcov infections <NUMBER> development cytokine storm potentially fatal immune condition characterized rapid proliferation hyperactivation cells macrophages natural killer cells overproduction <NUMBER> inflammatory cytokines chemical mediators released immune nonimmune cells <NUMBER> <NUMBER> viral infections aberrant release proinflammatory factors leads lung epithelial endothelial cell apoptosis damages lung microvascular alveolar epithelial cell barrier leading vascular leakage alveolar edema hypoxia uncontrolled production proinflammatory factors containing il<NUMBER> il<NUMBER> il<NUMBER>β gmcsf chemokines ccl<NUMBER> ccl<NUMBER> ip<NUMBER> ccl<NUMBER> together reactive oxygen species cause ards leading pulmonary fibrosis death <NUMBER> sarscov infected patients high levels serum proinflammatory cytokines ifnγ il<NUMBER> il<NUMBER> il<NUMBER> tgfβ chemokines ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> il<NUMBER> detected cases severe disease compared patients uncomplicated sars <NUMBER> mers infection high levels serum proinflammatory cytokines il<NUMBER> ifnα chemokines il<NUMBER> cxcl<NUMBER> ccl<NUMBER> likewise observed severe disease compared mild moderate disease <NUMBER> contrast sars mers doctors wuhan central south hospital found levels il<NUMBER> il<NUMBER> il<NUMBER> gscf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnf α significantly elevated blood severely ill patients compared patients mild illness <NUMBER> level il<NUMBER> blood severe group <NUMBER> higher mild group <NUMBER> <NUMBER> furthermore histological examination biopsy samples obtained patient died severe sarscov<NUMBER> infection showed increased concentration highly proinflammatory ccr<NUMBER>ccr<NUMBER> th<NUMBER> cd<NUMBER> cells suggesting cell hyperactivation contributesdin part severe immune injury patient <NUMBER> pulmonary examination patients early phase sarscov<NUMBER> pneumonia also revealed patchy inflammatory cell infiltration however pathological results early stage sarscov<NUMBER> pneumonia require confirmation <NUMBER> short aberrant release multiple cytokines appears trigger cytokine storm produces immunopathogenic damage tissues organs even immune response seeks suppress eradicate virus figure <NUMBER> j u r n l p r e p r f view observations therapeutic strategies treat cytokine storm pathogenesis severe covid<NUMBER> pneumonia deserve special attention accordance current guidance <NUMBER> supportive therapy remains important management strategy pneumonia including supplemental oxygen therapy conservative fluid management empiric antimicrobial application time need noteworthy use glucocorticoids remains controversial current guidance recommends corticosteroids used sarscov<NUMBER>induced lung injury shock except setting clinical trial however clinical settings frontline physicians china tend use corticosteroids prudently low moderate dosage patients sarscov<NUMBER> infection <NUMBER> period sars epidemic <NUMBER> <NUMBER> corticosteroids generally used clinicians immunomodulatory treatment according clinical feedback could bring early beneficial changes including decline fever resolution radiographic lung infiltrates improvement oxygenation <NUMBER> <NUMBER> however studies indicated opposite clinical outcomes systematic review sars mers influenza infections indicated survival benefit possible harm avascular necrosis psychosis diabetes delayed viral clearance secondary infections corticosteroids <NUMBER> opinion use corticosteroids recommended patients hcov infections although corticosteroids may used prudently critically ill patients treatment patients sarscov<NUMBER> infection clinicians pay close attention impact immune inflammatory factor release several effective cytokine storm blockers therapeutic methods reported clinical process covid<NUMBER> pneumonia window period diagnosis occurrence mods <NUMBER> days window majority patients tend improve <NUMBER> whereas <NUMBER> patients progress severe pneumonia <NUMBER> mortality <NUMBER> <NUMBER> improve prognosis suggest patients covid<NUMBER> pneumonia given immunotherapy treatment time diagnosis order block possibility subsequent cytokine storm early use immunological intervention evaluation patients mods may reduce mortality severe patients figure <NUMBER> position <NUMBER> one strategy received considerable attention face covid<NUMBER> use convalescent plasma also called passive antibody therapy treat patients advanced disease treatment uses plasma patient survived covid<NUMBER> infection provide neutralizing antibodies virus antibodies available active immediately limited time example one study five patients critically ill covid<NUMBER> mechanical ventilation received convalescent plasma <NUMBER> <NUMBER> days admitted hospital shenzhen china patients improved three discharged <NUMBER> days hospital two patients stable condition well controlled clinical evaluation strategy currently ongoing light positive anecdotal responses another potential treatment involves use antiil<NUMBER> monoclonal antibody siltuximab johnson johnson used previously treat consequences cytokine storm following cart cell therapy cancer interleukin<NUMBER> il<NUMBER> become key point crs originally described bcell differentiation factor<NUMBER> bsf<NUMBER> macrophage granulocyte induction factor<NUMBER> mgi<NUMBER> il<NUMBER> significant proinflammatory pyrogenic properties given chronic overproduction covid<NUMBER> patients antiil<NUMBER> monoclonal antibody may beneficial controlling cytokine release also il<NUMBER> inhibitor secukinumab novartis used specific treatment severe patients covid<NUMBER> pneumonia <NUMBER> control th<NUMBER> cell activation additional observation indicated expression levels cd<NUMBER> cd<NUMBER> low il<NUMBER> levels high patients severe pneumonia suggesting cell subsets cytokine levels could used one predictor transition mild severe pneumonia <NUMBER> pegylated nonpegylated interferons ifn intensive study time however case hcov infection results ifn therapy mixed predicted animal human hcov infection models early application ifn slightly beneficial reduce viral load improve clinical outcome however delayed ifn administration benefitscompared placebo group early application ifn ribavirin moderately improved disease severity without affecting mortality <NUMBER> use sifalimumab monoclonal antibody produced multiple ifn subtypes medimmune examined clinically could hold promise situations constitutive ifn production early use ifn beneficial effects sarscovinfected animal model although timing ifn treatment crucial determining course disease use ifnαβ receptor inhibitors antagonists could considered approach avoid excessive inflammatory reactions late stage severe hcov infection <NUMBER> since sarscov merscov infect mainly airway epithelial cells ifnλ stimulates antiviral gene expression cells without overstimulating immune system ifnλ might option therapy hcov infection oxidized phospholipids oxpl demonstrated promote acute lung injury increasing production cytokineschemokines lung macrophages via tlr<NUMBER>trif signaling influenza virus iavinfected mice <NUMBER> recent study therapeutic administration tlr<NUMBER> antagonist eritoran protected mice lethal iav infection decreasing levels oxpl inflammatory cytokineschemokines <NUMBER> pathogenic human coronaviruses cause acute lung injury promote production oxpl lungs strategies oxpl suppression using eritoran boc sciences similar compounds may value controlling hcov induced inflammation signal transduction sphingosine<NUMBER>phosphate receptor <NUMBER> s<NUMBER>p<NUMBER> mouse endothelial cells j u r n l p r e p r f nfected influenza virus shown contribute pathogenesis inflammation responses <NUMBER> targeted s<NUMBER>p<NUMBER> antagonism inhibited recruitment inflammatory cells limited proinflammatory cytokinechemokine release reduced mortality morbidity induced influenza virus <NUMBER> s<NUMBER>p<NUMBER> antagonism may considered potential therapy hcovinfected individuals limit cytokine responses results studies animal models borne claims imms paly pathogenic roles process fatal hcov infections mice cardiac inflammation model systemic administration optimized lipid nanoparticles including ccr<NUMBER>silenced small interfering rna sirna effectively degrade ccr<NUMBER> mrna destroy imm recruitment inflammatory site thus improving outcome disease <NUMBER> hcovs singlechain rna viruses tlr<NUMBER> agonist r<NUMBER> synthetic singlechain rna analog stimulates imms causes exuberant inflammatory response therefore imm specific tlr<NUMBER> signal may promote excessive inflammatory response caused hcov infection therefore tlr<NUMBER> antagonist targeted approach alleviate inflammation reaction could useful continuous renal replacement therapy crrt may benefit severe patients removing potentially harmful components maintaining haemodynamic metabolic status addition conventional aim maintaining renal function crrt used regulate immune response patients sepsis goal regulate circulating levels inflammatory cytokine mediators shown studies demonstrating removal inflammatory mediators containing cytokines complement tnfα il<NUMBER>β il<NUMBER> il<NUMBER> complement factors c<NUMBER>a c<NUMBER>a crrt <NUMBER> present need welldesigned clinical trial evaluate efficacy treatment regimen covid<NUMBER> infection patients develop systemic inflammatory response syndrome sirs mods characterized uncontrolled release inflammatory mediators giving rise cytokine storm contributes increased mortality ards summary experimentations required understand changes immune response patients covid<NUMBER> infection mechanisms abnormal cytokine expression covid<NUMBER> pneumonia accurate prediction targeted intervention course covid<NUMBER> pneumonia essential improve patient survival figure <NUMBER> summary process onset sarscov<NUMBER> pathogenesis potential treatment options virusinduced cytokine storm j u r n l p r e p r f <NUMBER> pathogenesis covid<NUMBER> respiratory infection major way related referred cytokine storm cytokine storm syndrome css hypercytokinemia etc ie hyperinflammatory response response explosive production proinflammatory cytokines tnfα il<NUMBER>β others occurs greatly exaggerating generation moleculedamaging reactive oxygen species free radicals <NUMBER> severe cases cytokine storm responsible obvious signs covid<NUMBER> infection including fever lung injury causes cough shortness breath longterm complication lung fibrosis death causative factor related hyperinflammatory state immune cells ability dramatically change metabolism similar cancer cells many solid tumors immune cells macrophagesmonocytes inflammatory conditions abandon mitochondrial oxidative phosphorylation atp production favor cytosolic aerobic glycolysis also known warburg effect <NUMBER> switch driven transcription factor hif<NUMBER>α hypoxia inducible factor<NUMBER>α serinethreonine kinase mtor mammalian target rapamycin proteins change aerobic glycolysis allows immune cells become highly phagocytic accelerate atp production intensify oxidative burst provide abundant metabolic precursors required enhanced cellular proliferation increased synthesis release cytokines fig <NUMBER> number drugs proposed treatments prevent reduce severity covid<NUMBER> infection one agent suggested potentially useful regard endogenously synthesized molecule melatonin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> melatonin initially discovered thought exclusively product vertebrate pineal gland however consideration identification melatonin prokaryotic bacteria <NUMBER> j u r n l p r e p r f <NUMBER> mitochondria evolved endosymbiotic theory uncommonly high levels assayable melatonin mitochondria <NUMBER> speculated eventually documented indoleamine synthesized organelle <NUMBER> given cells exceptions contain mitochondria believed melatonin production occurs cells organisms also specifically demonstrated human lung monocytesmacrophages <NUMBER> healthy cells including macrophages melatonin synthesis mitochondria maintained entrance pyruvate glucose metabolite mitochondria metabolized acetylcoenzyme enzyme pyruvate dehydrogenase complex pdc acetylcoenzyme feeds citric acid cycle supports atp synthesis also required cofactorsubstrate rate limiting enzyme melatonin synthesis arylalkylamine nacetyltransferase aanat fig <NUMBER> thus mitochondria adopt aerobic glycolysis pyruvate mitochondria longer converted acetylcoenzyme pdc inhibited enzyme pyruvate dehydrogenase kinase pdk therefore consequence covid<NUMBER> infection macrophage mitochondria cannot synthesize melatonin <NUMBER> melatonins potent antioxidant antiinflammatory activities would normally reduce highly proinflammatory cytokine storm neutralize generated free radicals thereby preserving cellular integrity preventing lung damage absence acetylcoenzyme mitochondrial melatonin longer available combat inflammatory response neutralize generated reactive oxygen species massive damage occurs respiratory tree resulting primary signs covid<NUMBER> disease importantly endogenous melatonin production diminishes markedly age especially frail older aerobic glycolysis important feature highly proinflammatory state since ensures necessary high levels atp abundant supply biomolecules ensure synthesis release damaging molecules constitute cytokine storm increased aerobic glycolysis coupled absence locallyproduced melatonin provides optimal environment perfect cytokine storm massive tissue damage occurs covid<NUMBER> disease given information use supplemental melatonin treatment overcome covid<NUMBER> infection justified exogenously administered melatonin reverses aerobic glycolysis repressing hif<NUMBER>α mtor thereby disinhibiting pdc activity allowing acetylcoenzyme synthesis also ensures locallyproduced melatonin production <NUMBER> functionally reinstated mitochondriagenerated melatonin combination parenteral melatonin provides formidable weapon reduce cytokine storm well damaging consequences thereby relieving signs covid<NUMBER> infection antiinflammatory antioxidant actions melatonin protecting lungs damage many experimental models involve inflammation oxidative stress well documented <NUMBER> moreover melatonin antiviral actions viruses covid<NUMBER> <NUMBER> <NUMBER> collective data addition high safety profile indicate melatonin would effective treatment covid<NUMBER> support recommendation published reports encourage use purpose <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> melatonin inexpensive nontoxic wide dose range long shelflife selfadministered fig <NUMBER> figure illustrates differential glucose metabolism healthy macrophage covid<NUMBER>activated macrophage healthy macrophage pyruvate glucose metabolite enters mitochondria enzymatically converted acetylcoenzyme enzyme pyruvate dehydrogenase complex pdc acetylcoenzyme feeds tricarboxylic acid cycle tca supports oxidative phosphorylation oxphos additionally acetylcoenzyme essential cofactorsubstrate rate limiting enzyme melatonin synthesis arylalkylamine nacetyltransferase aanat allows melatonin regularly produced healthy macrophages melatonin functions intracellularly released cellular microenvironment blood covid<NUMBER>activated mitochondria via hif<NUMBER>α mtor etc enzyme pyruvate dehydrogenase kinase pdk strongly upregulated inhibits pdc red x thus acetylcoenzyme synthesized mitochondrial oxphos falters atp synthesis occurring cytosol via aerobic glycolysis warburg effect similarly mitochondrial melatonin production shut cell deprived essential antioxidant antiinflammatory agent immuneenhancer elevated synthesis proinflammatory cytokines goes uncontested cytokine storm result <NUMBER>ht serotonin asmt acetylserotonin methyltransferase coa coenzyme imm inner mitochondrial membrane hif<NUMBER>α hypoxia inducible factor<NUMBER>α mtor mammalian target rapamycin nas nacetylserotonin omm outer mitochondrial membrane ppp pentose phosphate pathway figure <NUMBER> coronavirus disease <NUMBER> covid<NUMBER> infected <NUMBER> million people worldwide death toll <NUMBER> people emerging risk factors poor outcomes disease include age male sex cardiovascular comorbidities including hypertension prior cardiovascular disease diabetes recently obesity <NUMBER> centers disease control prevention atlanta georgia reported threefold increase death new orleans compared new york speculation grown whether worrying mortality statistics might part attributable higher levels morbid obesity <NUMBER> paper develop theoretical framework describes individuals obesity may increased risk poor outcomes compared counterparts without obesity <NUMBER> propose mechanism adverse consequences virus seeding adipose tissue potential prolonged viral shedding extended cytokine activation voluminous richly vascularized organ already perturbed metabolic inflammatory sense human individuals obesity <NUMBER> present rationale testing concept patients covid<NUMBER> prospective studies individuals without obesity accessible plasma determine whether inflammatory cytokine signature presages systemic cytokine storm clinical decline obesity specifically reported initial cohort studies covid<NUMBER> wuhan china <NUMBER> regional epidemiological data united states suggests least <NUMBER> patients die disease obesity similar reported rates cardiovascular disease highrisk group <NUMBER> <NUMBER> recently small retrospective study <NUMBER> individuals covid<NUMBER> identified obesity risk factor admission intensive care unit patients requiring increased medical attention <NUMBER> moreover influenza subtype h<NUMBER>n<NUMBER> pandemic obesity also strongly associated worse disease outcome death <NUMBER> together data raise questions whether mechanistic link obesity disease survival whether obesity endocrine cardiometabolic associations might independently contribute covid<NUMBER> risk clear obesity could contribute diabetic cardiovascular covid<NUMBER> risk elements risk addition thrombosis recently well described scientific literature <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover obesity independent risk factor hypoventilation syndrome patients intensive care unit <NUMBER> could thus contribute respiratory failure patients acute respiratory distress syndrome <NUMBER> propose additional unheralded pathophysiologic aspects increased burden morbid obesity may amplify proinflammatory response extensive viral infection viewed highly active organ interfacing immune endocrine metabolic homeostasis throughout body <NUMBER> individuals obesity marked dysregulation myeloid lymphoid responses within associated dysregulation cytokine profiles <NUMBER> intrinsically bound endocrine metabolic derangements including insulin resistance adipokine dysregulation dysfunctional lipid fatty acid metabolism <NUMBER> highly vascularized endothelial smoothmuscle cells well resident macrophages exhibit additional perturbations response activated renin angiotensin system local level attendant depletion dysfunction counterregulatory angiotensin converting enzyme <NUMBER> mas receptor system <NUMBER> <NUMBER> makes particularly visceral distributions proimmunogenic metabolically active highly integrated cardiovascular system capability drive acute disease augmented inflammation organ level heart vasculature pancreas liver kidneys <NUMBER> preactivation state obesity makes organ potential target immune amplification external pathogens viruses currently evidence direct severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection although angiotensin converting enzyme <NUMBER> receptor expression represents basis viral tropism several cells within tissue <NUMBER> including adipocytes smoothmuscle cells endothelial cells <NUMBER> moreover many atresident cells proven targets multiple viruses including adipocytes h<NUMBER>n<NUMBER> type influenza adenovirus <NUMBER> <NUMBER> <NUMBER> although sarscov<NUMBER> detected low levels blood small human study <NUMBER> cannot exclude hematogenous spread given high virus affinity target cell receptor alternative routes sarscov<NUMBER> spread include local egress virus organs known infected adjacent visceral fat deposits intrathoracic fat lungs epicardial fat heart perirenal fat kidneys mesenteric fat intestines finally shared viral tropism lung epithelium already shown h<NUMBER>n<NUMBER> virus infection <NUMBER> significantly prolongs duration viral shedding humans obesity infected influenza <NUMBER> similar tropism sarscov<NUMBER> occur within individuals covid<NUMBER> obesity exists potential prolonged viral shedding organ extended activation local preactivated immune systems resident cytokine signaling pathways resident myeloid lymphoid cells plentiful obesity associated macrophage <NUMBER> lymphocyte dysfunction <NUMBER> expansion distinct memory lymphocytes within also activate aberrant immune responses wider tissue damage viral challenge <NUMBER> recent report wuhan suggests sarscov<NUMBER> induces dysregulated immune response severely ill individuals covid<NUMBER> <NUMBER> characterized reduced numbers circulating memory lymphocytes well reduced helpersuppressor regulatory tcell subtypes tempting speculate whether already dysfunctional immune responses individuals obesity may accentuate sarscov<NUMBER> effect tcell function specific inflammatory cytokine programs tumor necrosis factor tnfα interleukin il<NUMBER> il<NUMBER> known preactivated context obesity <NUMBER> thus viral infection may similarly amplify already primed organ cytokine response cytokine storm identified multiple respiratory viral infections including covid<NUMBER> exhibits diverse interferon il chemokine tnf colonystimulating factor responses beyond scope paper comprehensively reviewed elsewhere <NUMBER> intensity inflammatory lung responses reflect imbalance proinflammatory cytokines tnf il<NUMBER>β soluble cognate receptors inhibit cytokine effects aqueous phase <NUMBER> il<NUMBER> produced macrophages lymphocytes helper <NUMBER> regulatory cells acts negative regulator inflammation whereas il<NUMBER> soluble receptor enhance activity il<NUMBER> target cells providing mechanism enhancement tnf il<NUMBER>β activity soluble cognate receptors particularly high <NUMBER> thus balance proand antiinflammatory mechanisms critical maintaining lungtissue homeostasis conceivable one regulatory elements absent dysfunctional might contribute cytokine storm lung tissues aberrant cytokine activation exists temporal studies cytokine dynamics human cytokine storm models show il<NUMBER> sustains activation multiple cytokine pathways many days initial immune insult <NUMBER> interestingly early covid<NUMBER> studies il<NUMBER> strong independent predictor mortality <NUMBER> human major source il<NUMBER> receptor il<NUMBER>r <NUMBER> thus may provide reservoir il<NUMBER> activation cascade signaling viral infection figure <NUMBER> viral spread affected organs adjacent may take days subsequent prolonged viral shedding contributing delayed cytokine storm consequences tissue injury patients covid<NUMBER> initial studies aim detect sarscov<NUMBER> autopsy individuals died covid<NUMBER> focus analysis specific cells evidence infection immunocytopathic situ viral detection techniques parallel studies identify whether specific cell types support sarscov<NUMBER> infection replication ex vivo respect cytokine storm integratedsystems biology approach would enable multiple pathways assessed simultaneously regard cytokine chemokine genomic data analysis blood would important first step moreover weighted gene correlation network analysis sarscov<NUMBER>mediated transcriptional response infected cells could also used model human analysis downstream <NUMBER> interesting aspects transcriptional network analysis could tested appropriate animal models determine pivotal components cytokine storm including key cytokine chemokine genes conserved across species <NUMBER> insights may allow rational diagnostics therapeutic strategies developed line il<NUMBER> inhibition already proposed treatment covid<NUMBER> results trials tocilizumab awaited <NUMBER> would interesting examine whether individuals obesity expected higher circulating il<NUMBER> levels compared lean counterparts respond favorably il<NUMBER> inhibition strategies covid<NUMBER> post hoc analysis review obesity biology integrated physiology randomized controlled trial similarly tissue systemic analysis cytokine dynamics may identify likely responders nonresponders therapy summary present rationale studying relationship obesity covid<NUMBER> disease severity provide theoretical framework whereby viral systemic spread entry prolonged viral shedding already inflamed may augment immune responses consequences cytokine cascade amplification highlight abundant source local systemic enrichment cytokines already independently associated increased covid<NUMBER> mortality finally suggest series research studies identify whether mechanistic link exists among sarscov<NUMBER> infection organ seeding infection immune activation delayed cytokine storm known presage rapid clinical decline highrisk patients covid<NUMBER>o disclosure authors declared conflict interest however currently little clinical data available regard evidence cytokine storms <NUMBER> covid<NUMBER> expression levels interleukin<NUMBER> receptor il<NUMBER>r il<NUMBER> sera <NUMBER> critical care cases found significantly higher p <NUMBER>•<NUMBER> severe cases <NUMBER> contrast statistically significant differences serum tumor <NUMBER> necrosis factor alpha tnfα il<NUMBER> il<NUMBER> il<NUMBER> two groups p <NUMBER>•<NUMBER> <NUMBER> <NUMBER> however following initially high expression th<NUMBER> cytokines eg interleukin il<NUMBER>β interferon <NUMBER> ifnγ interferoninducible protein <NUMBER> ip<NUMBER> monocyte chemoattractant protein<NUMBER> mcp<NUMBER> <NUMBER> th<NUMBER> cytokines eg il<NUMBER> il<NUMBER> may subsequently suppress inflammation sarscov<NUMBER> <NUMBER> infection <NUMBER> <NUMBER> furthermore observational covid<NUMBER> studies suggested cytokine <NUMBER> storms comprised il<NUMBER>β il<NUMBER>ra il<NUMBER> il<NUMBER> may associated disease severity<NUMBER> <NUMBER> <NUMBER> <NUMBER> example higher concentrations granulocyte colonystimulating factor gcsf ip<NUMBER> <NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα found patients required admission intensive care <NUMBER> unit icu <NUMBER> <NUMBER> taken together posit cytokine storms may associated <NUMBER> severity covid<NUMBER> however feasible conduct prospective study covid<NUMBER> <NUMBER> present current evidence cytokine storms covid<NUMBER> derived small <NUMBER> sample sizes also important consider patients different phases inflammation <NUMBER> corresponding samples collected likely also contribute increased variability cytokine <NUMBER> storm metrics however close relationship cytokine storms ards strongly <NUMBER> suggests excessive maladaptive cytokine release contributes unfavorable initiation <NUMBER> strengthening promotion ards covid<NUMBER> <NUMBER> biological indicators also closely related hyperinflammatory subphenotypes <NUMBER> ards novel indicator inflammation endocan promising biomarker predict <NUMBER> disease severity mortality patients ards <NUMBER> decrease plasmatic endocan <NUMBER> cleavage ratio ecr associated hyperinflammatory phenotypes ards also change <NUMBER> ecr <NUMBER>•<NUMBER> optimal cutoff value diagnosis hyperinflammatory subphenotype <NUMBER> sensitivity <NUMBER>•<NUMBER> specificity <NUMBER>•<NUMBER> <NUMBER> early vascular injury disrupted alveolarcapillary <NUMBER> barrier integrity also reflect differences subtypes inflammatory responses earlyonset <NUMBER> ards associated higher levels biomarkers srage ang<NUMBER> <NUMBER> subphenotypes <NUMBER> higher ang<NUMBER> levels characterized higher inflammatory biomarkers <NUMBER> hypotension may reflect endothelial permeability predilection extravascular fluid <NUMBER> accumulation responds favorably fluid restriction <NUMBER> however uncertainty remains <NUMBER> regarding diverse initial environmental injuries result sequence events culminating <NUMBER> clinical syndrome ards involving various molecular pathways along general <NUMBER> imbalance injurious reparative mechanisms classification patients ards <NUMBER> hyperand hypoinflammatory subphenotypes using plasma biomarkers may facilitate <NUMBER> effective targeted therapies <NUMBER> therefore elucidation phenotypes identifying <NUMBER> treatable traits represent future personalized medicine ards <NUMBER> covid<NUMBER> also suggestive evidence hyperinflammatory subphenotypes ards clinical evidence helps progress patientlevel populationlevel decision making <NUMBER> therefore need build upon prior experience identify similarities versus differences <NUMBER> among covid<NUMBER> patients <NUMBER> evidence able retrieve found <NUMBER> time onset symptoms mv reported <NUMBER>•<NUMBER> days <NUMBER>•<NUMBER>•<NUMBER> <NUMBER> days<NUMBER> patient identified hyperinflammatory subphenotype covid<NUMBER> <NUMBER> given targeted therapy approach would expected ameliorate probability <NUMBER> patient progressing severe critical condition therefore key treatment ards key <NUMBER> factor covid<NUMBER> deterioration closely related identification monitoring hyper<NUMBER> inflammatory subphenotypes <NUMBER> difficult distinguish hyperhypo inflammatory subphenotypes covid<NUMBER> since <NUMBER> currently little data phenomenon creactive protein crp levels patients <NUMBER> normal range<NUMBER> <NUMBER> additionally hypersensitive crp hscrp also found <NUMBER> increased authors declare competing interests regarding publication paper <NUMBER> pathological findings covid<NUMBER> associated acute respiratory distress syndrome  concern role nonsteroidal antiinflammatory drugs nsaids patients covid<NUMBER> led considerable speculation fang et al offered early commentary covid<NUMBER> suggested angiotensinconverting enzyme ace inhibitors angiotensinreceptor blockers arbs may associated worse covid<NUMBER> outcomes added ibuprofen may associated upregulation ace<NUMBER> receptors presumptive entry point sarscov<NUMBER> virus <NUMBER> <NUMBER> immune suppression may occur nsaids <NUMBER> limited ibuprofen however fang colleagues subsequently cautioned overinterpretation hypotheses cases led abrupt changes drug regimens state ace inhibitors nsaids important therapeutic drugs discontinued without careful clinical judgement <NUMBER> likewise website run prominent international specialists entitled ace<NUMBER> hypertension advises individuals taking ace inhibitors arbs change drug therapy unless physician advises <NUMBER> speculation nsaids patients covid<NUMBER> twofold first nsaids increase likelihood person contract covid<NUMBER> second patient covid<NUMBER> taking nsaids exacerbated symptoms evidence either case <NUMBER> observations worse outcomes covid<NUMBER> may associated nsaid use connection must pointed worse outcomes covid<NUMBER> typically occur older patients elderly likely younger patients take nsaids chronic pain also elevated risk covid<NUMBER> complications <NUMBER> ageadjusted reports association adverse covid<NUMBER> outcomes nsaid use published best knowledge authors thus older age higher rates comorbid conditions may confounding factors purpose article provide brief overview currently knownand knownabout use nsaids setting covid<NUMBER> article based previously conducted studies contain studies human participants animals performed authors siddiqi mehra staged progression covid<NUMBER> basis <NUMBER> cases observed china identified three stages stage mild disease represents majority infections stage ii moderate disease pulmonary involvement without hypoxia stage iii severe illness characterized extrapulmonary hyperinflammation particular observed biomarkers interleukin il<NUMBER> il<NUMBER> il<NUMBER> granulocyte colonystimulating factor gcsf macrophage inflammatory protein <NUMBER>alpha mip<NUMBER>a creactive protein crp ferritin high ddimer scores <NUMBER> prior outbreak covid<NUMBER> association intense cytokine activity adverse outcomes influenza reported <NUMBER> severity influenza results interplay viral virulence host resistance mild cases flu host degree resistance disruptions homeostasis quickly resolved normal balance restored resistance hyperactive exaggerated inflammatory response may occur called cytokine storm cytokine storm cause injury tissue morbidity mortality <NUMBER> sarsncov<NUMBER> virus targets epithelial cells respiratory system progeny viruses replicate infect cells producing inflammatory response cells die either necrosis apoptosis <NUMBER> high levels proinflammatory cytokines crp observed critically ill patients covid<NUMBER> <NUMBER> cytokine storm likewise observed patients infectious rheumatic diseases usually arising focal point infection spreading outward circulatory system <NUMBER> diseases associated coronaviruses middle eastern respiratory syndrome mers severe acute respiratory syndrome sars marked increase inflammatory cytokines parallels rapid replication virus resulting lung injury potentially lifethreatening acute respiratory distress syndrome ards <NUMBER> early evaluations patients covid<NUMBER> suggest similarly high levels proinflammatory cytokines along lines mers sars <NUMBER> china one diagnostic criteria covid<NUMBER> lymphocytopenia <NUMBER> patients covid<NUMBER> reduced levels cells natural killer nk cells critically ill patients covid<NUMBER> undetectable levels nk cells <NUMBER> speculated cytokine storm destroys lymphocytes destruction secondary lymphoid tissue observed autopsy patients covid<NUMBER> <NUMBER> cytokine storm likely plays major role adverse outcomes severely ill patients covid<NUMBER> role antiinflammatories ranging nsaids glucocorticoids hydroxychloroquine others would seem beneficial effort reduce inflammation overwhelms bodys systems tocilizumab il<NUMBER> inhibitor also discussed context along anakinra il<NUMBER>ra suppress cytokine storm <NUMBER> <NUMBER> tnfa blockade via etanercept receptor downregulates inflammatory response cytokine storm etanercept proposed potential pharmacological strategy controlling influenzainduced viral pneumonia <NUMBER> study mice infected influenza h<NUMBER>n<NUMBER> virus treating celecoxib plus mesalazine plus zanamivir significantly reduced cytokine dysregulation prevented apoptosis greater extent mesalazine zanamivir alone <NUMBER> addition celecoxib plus drugs reduced mortality infected mice treatment may value address patients hyperinflammatory state must recognized prognosis patients stage iii covid<NUMBER> poor antiinflammatory therapy influenza may associated certain drawbacks use antiinflammatory might potentially slow viral elimination elevate risk secondary infection antiinflammatory reduce inflammation may limited poorly understood effect cytokine storm involves multiple cytokines complex interactions words antiinflammatory agent may affect certain cytokines others <NUMBER> even antiinflammatory therapy advocated yet clear therapies best point disease doses duration course role nsaids viral infections kinds controversial <NUMBER> one argument use nsaids acetaminophen antipyretic drugs may mask rising fever associated covid<NUMBER> thus delay diagnosis rapid management infection <NUMBER> selective coxibs associated increased cardiovascular risk risk varies particular drug <NUMBER> <NUMBER> <NUMBER> since cox<NUMBER> associated prostaglandin <NUMBER> pgi <NUMBER> prostacyclin nsaids inhibit cox<NUMBER> reduce pgi<NUMBER> inhibit prothrombotic platelet thromboxane <NUMBER> production resulting selective reduction prostacyclin activity may set stage endothelial damage <NUMBER> <NUMBER> nsaids suppress production prostaglandins lipids associated fever pain ibuprofen widely used nsaid strongly selective blocks cox<NUMBER> cox<NUMBER> <NUMBER> <NUMBER> cases multiple organ failure happened sars mers possibly covid<NUMBER> use nsaids might easily associated gastrointestinal damage gastrointestinal symptoms occur carefully investigated treated <NUMBER> prostaglandin e <NUMBER> associated classic symptoms inflammation fever redness localized edema <NUMBER> confusion nsaids arises mainly prostaglandin production complex promote inhibit inflammatory processes nsaid indomethacin known block rna synthesis viruses mechanism independent cox inhibition clear antiviral activity applies sarsncov<NUMBER> virus <NUMBER> nsaids may contraindicated patients respiratory disorders nsaids administered patients acute respiratory infection implicated acute myocardial infarction adjusted odds ratio <NUMBER> <NUMBER> confidence interval <NUMBER> must noted patients acute respiratory infection adjusted odds ratio <NUMBER> <NUMBER> confidence interval <NUMBER> acute myocardial infarction even without nsaid use <NUMBER> risk much higher parenteral oral nsaid use adjusted odds ratio <NUMBER> <NUMBER> confidence interval <NUMBER> <NUMBER> similar increased risk stroke observed patients suffering acute respiratory infection taking nsaids particular parenteral route nsaids may alter intrinsic function neutrophils way change bacterial clearance delay resolution inflammatory process <NUMBER> date strong evidence favor disputing use nsaids patients diagnosed covid<NUMBER> <NUMBER> <NUMBER> expert working group commission human medicines uk issued statement currently insufficient evidence establish link use ibuprofen susceptibility contracting covid<NUMBER> worsening symptoms <NUMBER> indeed blanket statement topic would clinically realistic covid<NUMBER> oral nsaids might used intermittently short period time clear would chronic roundtheclock nsaid therapy parenteral nsaid administration <NUMBER> since nsaids available overthecounter accurate records taken doses often sparse collected patient memory would inherently unreliable furthermore even evidence emerged favoring rejecting one particular nsaid setting clear whether evidence would apply nsaids similar fashion covid<NUMBER> ravages globe clinicians scientists epidemiologists regulators politicians eager offer sane sound advice keep people safe unfortunately socialmediadriven era nonstop news compatible slow serious work science clinicians confronted hypotheses speculation anecdotal reports conjecture important topics use nsaids patients covid<NUMBER> little strong evidence guide first clinicians must consider taking nsaid evidence occasional use oral overthecounter nsaid days person suspected diagnosed mild covid<NUMBER> infection exacerbate infection second reason think patients taking prescribed nsaids chronic painful condition stop taking drug fear might increase risk contracting covid<NUMBER> exacerbate get <NUMBER> likely many patients mild cases covid<NUMBER> may take overthecounter remedy help manage symptoms muscle aches fever acetaminophen paracetamol proposed alternative nsaid use also issues acetaminophen toxicity <NUMBER> sure covid<NUMBER> cases nsaids used strong evidence must avoided patients covid<NUMBER> clinicians frontlines advising patients mild covid<NUMBER> cases managed home weigh considerations carefully funding funding sponsorship received study publication article authorship named authors meet international committee medical journal editors icmje criteria authorship article take responsibility integrity work whole given approval version published compliance ethics guidelines article based previously conducted studies contain studies human participants animals performed authors data availability data sharing applicable article datasets generated analyzed current study open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreativecommonsorglicensesbync<NUMBER> although severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> continues spread rapidly around world research actively conducted pathogenesis treatment options coronavirus disease <NUMBER> covid <NUMBER> still many unsolved aspects patients infected sarscov<NUMBER> usually mild moderate illness depending viral load immune system underlying comorbid diseases currently unknown factors approximately <NUMBER> patients develop critical disease respiratory failure organ dysfunctions <NUMBER> pneumonia frequent serious manifestation infection acute respiratory distress syndrome ards major complication patients severe illness complications include follows coagulopathy microvascular thrombosis myocardial infarction stroke arrhythmias acute cardiac injury liver injury acute kidney injury shock <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> series <NUMBER> severely ill patients admitted icu united states ards observed patients onethird developed cardiomyopathy <NUMBER> human angiotensinconverting enzyme <NUMBER> ace<NUMBER> functional receptor attacked sarscov<NUMBER> cell entry similar sarscov <NUMBER> ace<NUMBER> broadly expressed nasal mucosa bronchus lung heart esophagus kidney stomach bladder ileum human organs vulnerable sarscov<NUMBER> especially severe cases viremia <NUMBER> presumably viral replication sarscov<NUMBER> target organs well resulting cellular damage causes systemic inflammatory response cytokine storm mainly ards multiple organ damage autopsy studies support findings autopsy study <NUMBER> severe covid<NUMBER> patients primary cause death respiratory failure exudative diffuse alveolar damage massive capillary congestion accompanied microthrombi <NUMBER> another postmortem study conducted <NUMBER> patients high concentration sarscov<NUMBER> rna detected lung tissue patients around half high titers viral rna liver kidney heart addition viremia <NUMBER> according third international consensus definitions sepsis septic shock sepsis<NUMBER> sepsis defined lifethreatening organ dysfunction caused dysregulated host response infection <NUMBER> considering multisystemic clinical autopsy findings severe covid<NUMBER> patients viral sepsis would accurate term describe whole clinical picture fig <NUMBER> put simply mild moderate covid<NUMBER> considered wwwccejournalorg <NUMBER> • volume <NUMBER> • e<NUMBER> bad infection severe covid<NUMBER> viral sepsis bad viral sepsis viral sepsis caused variety viruses herpes simplex virus influenza enteroviruses human parechoviruses ebola dengue virus <NUMBER> common features viral sepsis intense cytokine release prolonged inflammation consequently immunosuppression cell exhaustion development multiple organ damage increased susceptibility secondary bacterial infections combination concepts led new approach severe covid<NUMBER> patients subset sepsis particularly profound cellular immunologic metabolic abnormalities associated higher risk mortality infection alone currently optimal approach treatment covid<NUMBER> uncertain classify treatment approaches three main headings potential antiinfectives supportive treatments specific target organ systems immunomodulators fig <NUMBER> understanding mechanism viral sepsis associated immunosuppression covid<NUMBER> vitally important way possible develop effective treatment approaches <NUMBER> identification tolllike receptors tlrs associated concept innate immunity based upon pathogenassociated molecular pattern molecules allowed significant advances understanding molecular biology pathophysiology sepsis <NUMBER> previous studies revealed lung epithelial cells macrophages dendritic cells express cytokines extent influenza infection via activation pattern recognition receptors including tlr<NUMBER> tlr<NUMBER> tlr<NUMBER> retinoic acidinducible gene nucleotidebinding oligomerization domainlike receptor family members <NUMBER> cytokine storm key factor rapid progression covid<NUMBER> induces inflammation also apoptosisrelated immunosuppression <NUMBER> <NUMBER> <NUMBER> primary features cytokine storm fever progressive dyspnea tachypnea elevated interleukin il<NUMBER> creactive protein ferritin inflammatory markers <NUMBER> <NUMBER> treatment cytokine storm vital importance associated severe mortal disease currently specific therapeutic agents sarscov<NUMBER> cytokine storm induced covid<NUMBER> however il<NUMBER> receptor antibodies immunotherapeutic agent compassionate use cytokine storm treatment covid<NUMBER> patients il<NUMBER> multifunctional cytokine produced different cells immune cells mesenchymal cells endothelial cells fibroblasts response infections tissue damage betacoronavirus infection monocytes macrophages dendritic cells results activation secretion il<NUMBER> inflammatory cytokines result cytokine release syndrome crs il<NUMBER> signal different pathways classic signaling transsignaling transpresentation <NUMBER> classical signaling il<NUMBER> binds membranebound il<NUMBER> receptor mil<NUMBER>r found mainly macrophages neutrophils cells etc shows pleiotropic effects acquired innate immune system hand transsignaling pathway il<NUMBER> forms complex soluble il<NUMBER> receptor sil<NUMBER>r activate virtually cells body especially endothelial cells develop inflammatory effects <NUMBER> classicand transsignals contribute development cytokine storm pulmonary dysfunction ards crs may also contributing factor cell exhaustion apoptosis lymphopenia tocilizumab humanized antiil<NUMBER>r monoclonal antibody binds mil<NUMBER>r sil<NUMBER>r inhibits classical transsignals small clinical trial china examined effectiveness tocilizumab patients met criteria severe covid<NUMBER> days tocilizumab treatment symptoms fever pulmonary infiltrates oxygenation improved also lymphocyte counts returned normal <NUMBER> unfortunately despite use tocilizumab antivirals severe covid<NUMBER> patients still lymphopenia prognosis patients poor point need alternative therapeutic agents boost immune system correct lymphopenia severe covid<NUMBER> patients cd<NUMBER> cytotoxic cells natural killer nk cells play critical role protection control viral infections lymphopenia commonly seen patients severe covid<NUMBER> disease may sign poor prognosis <NUMBER> immunopathologically severe covid<NUMBER> patients marked increase inflammatory cytokines il<NUMBER> il<NUMBER> combined lymphopenia <NUMBER> also unexpected increase antiinflammatory cytokines il<NUMBER> il<NUMBER> uncommon phenomenon acutephase viral infection <NUMBER> severity disease progresses patients covid<NUMBER> concomitant rise inflammatory cytokine levels may lead depletion exhaustion cell populations result adaptive immune response cannot effectively initiated substantial reduction dysfunction lymphocytes uncontrolled virus infection leads macrophage infiltration worsening organ injury degree lymphopenia shown correlate severity covid<NUMBER> mortality septic shock <NUMBER> <NUMBER> recent study conducted zheng et al <NUMBER> showed total number nk cells cd<NUMBER> lymphocytes decreased significantly severe covid<NUMBER> patients furthermore showed nkg<NUMBER>a expression significantly increased immune cells whose functions suppressed picture consistent cell exhaustion furthermore number nk cd<NUMBER> cells increased recovering patients expression nkg<NUMBER>a decreased similarly previous study shown nkg<NUMBER>a receptors cytotoxic lymphocytes overupregulated acute polyomavirus infection consequently noticeable decrease cytotoxic cellular immune response prevent viral clearance viral oncogenesis <NUMBER> cell exhaustion similar findings also seen hiv chronic hepatitis b hepatitis c infections <NUMBER> well known patients sepsis increased checkpoint molecule expressioncytotoxic lymphocyte antigen<NUMBER> ctla<NUMBER> programmed cell death protein <NUMBER> pd<NUMBER>and condition causes lymphopenia <NUMBER> <NUMBER> <NUMBER> another study involved patients candida bloodstream infection circulating immune effector cells displayed immunophenotype consistent immunosuppression evidenced cell exhaustion number pd<NUMBER> positive cd<NUMBER> cells significantly increased <NUMBER> taken together observations point common cascade events viral bacterial sepsis leads increased checkpoint molecule expression cell exhaustion developing efficient immunotherapeutic approach restoring cellmediated immunity may play essential role overcoming severe covid<NUMBER> act logic immune checkpoint inhibitors applied cancer treatments believe inhibition nkg<NUMBER>a receptors upregulated covid<NUMBER> boost antiviral activity cytotoxic cells nk cells immune checkpoint molecules ctla<NUMBER> pd<NUMBER> potent immunomodulators inhibitory effects cell activation cancer cells presumably cells infected viruses produce ligands stimulate inhibitory checkpoints inhibit activity cells checkpoints blocked cells able kill cancer cells virally infected cells strongly currently many monoclonal antibodies targeting immune checkpoints used cancer treatment <NUMBER> immune checkpoint inhibitors may also increase absolute lymphocyte count cancer patients finding good prognostic factor sign response treatment <NUMBER> regard upon extensive literature search monalizumab caught attention novel immune checkpoint inhibitor developed nkg<NUMBER>a receptors <NUMBER> monalizumab humanized antinkg<NUMBER>a monoclonal antibody increase degranulation nk cells hence production interferongamma vital cytokine natural adaptive immunity viral infections <NUMBER> herein propose combination nkg<NUMBER>a inhibitor immune system booster il<NUMBER> receptor antibody antiinflammatory agent may beneficial severe covid<NUMBER> cases inhibition pd<NUMBER> programmed cell death ligand <NUMBER> pdl<NUMBER> shown improve pathogen clearance viral infection models <NUMBER> hotchkiss et al <NUMBER> hypothesized blocking pd<NUMBER> pdl<NUMBER> antibodymediated immunotherapy reverse cell depletionmediated immunosuppression critically ill patients sepsis clinical evaluation pd<NUMBER>pdl<NUMBER> pathway inhibition sepsis monoclonal antibodies pd<NUMBER>pdl<NUMBER> well tolerated evidence druginduced hypercytokinemia cytokine storm higher doses indication restored immune status currently clinical studies registered clinicaltrialsgov aimed evaluating efficacy antibodies pd<NUMBER> receptors covid<NUMBER> urgently need consider use proven immunomodulatory agents treatment severe covid<NUMBER> sepsis effective vaccines antiviral drugs developed numerous reports described association elevated inflammatory markers poor outcomes covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> data sparked interest cytokine storm major driver illness severity covid<NUMBER> multiple clinical trials underway test efficacy immunosuppressive therapies including il<NUMBER> antagonists however unclear inflammatory cytokine levels truly higher patients severe covid<NUMBER> critically ill patients ards sepsis due causes ards sepsis recognized highly inflamed states largescale randomized controlled trials immune modulators eg antiil<NUMBER>b activated protein c steroids failed <NUMBER> <NUMBER> recent reporting il<NUMBER> levels severe covid<NUMBER> patients <NUMBER> pgml measured clinical labs <NUMBER> <NUMBER> <NUMBER> lower levels reported prior ards cohorts <NUMBER> pgml using elisa <NUMBER> <NUMBER> <NUMBER> given potential variability cytokine quantification across platforms measured plasma levels <NUMBER> cytokines including six inflammatory cytokines associated cytokine storm il<NUMBER>b il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> tnfα prospective cohort patients hospitalized covid<NUMBER> directly compared levels banked biospecimens ards sepsis patients enrolled stanford icu biobank prior covid<NUMBER> pandemic rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity levels il<NUMBER>b il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> tnfα significantly differ moderate covid<NUMBER> severe covid<NUMBER> ardssepsis group figure <NUMBER> adjustment multiple comparisons p values <NUMBER> trend towards higher levels il<NUMBER>ra il<NUMBER> patients severe covid<NUMBER> compared moderate covid<NUMBER> consistent prior reports <NUMBER> <NUMBER> <NUMBER> also trend towards higher il<NUMBER> severe covid<NUMBER> group compared critical illness group punadjusted <NUMBER> padjusted <NUMBER> extended exploratory analysis <NUMBER> additional cytokines three patient groups differ strongly principal component analysis supplemental figure s<NUMBER> available online supplement small statistically significant differences levels il<NUMBER> il<NUMBER> il<NUMBER>a ifnl<NUMBER> tslp three groups supplemental figure s<NUMBER> cytokine levels dramatically increased covid<NUMBER> compared causes critical illness supplemental figures s<NUMBER> s<NUMBER> together data suggest cytokine storm covid<NUMBER> distinct critical illness eg sepsis ards unlikely rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity primary goal directly compare levels six inflammatory cytokines commonly associated cytokine storm il<NUMBER>b il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> tnfα severe covid<NUMBER> patients patients ards sepsis due causes findings consistent previous data demonstrating higher levels inflammatory cytokines among covid<NUMBER> patients severe disease importantly however data suggest inflammatory biomarkers severe covid<NUMBER> patients markedly elevated directly compared critically ill patients ards sepsis il<NUMBER> levels measured clinical lab part clinical care <NUMBER> covid<NUMBER> patients including <NUMBER> severe disease though matched time points research blood collection levels ranged <NUMBER> pgml given small number patients clinical measurements available variation collection times unable derive accurate concentrations based mfi remaining patients nonetheless data points support findings il<NUMBER> levels particularwhile elevated levels found healthy subjectsare markedly elevated severe covid<NUMBER> patients compared critically ill patients brief report calls question idea cytokine storm major driver morbidity mortality severe covid<NUMBER> patients ritchie singanayagam stated equally possible higher levels proinflammatory cytokines seen severe covid<NUMBER> reflect increased burden virus rather inappropriate host response requires correction <NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity important limitation study small sample size even predetermined analysis six cytokines strongly associated cytokine storm lack power detect minor differences groups exploratory analyses additional <NUMBER> cytokines similarly limited provided reference field addition measurements cytokines time near point enrollment finally discussed report cytokine levels mfi per recommended luminex analysis methods <NUMBER> precluding direct comparison values previously published data report cytokine levels pgml certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint unit icu moderate require icu admission twentyeight critically ill subjects ards sepsis enrolled stanford icu biobank <NUMBER> selected comparison briefly stanford icu biobank recruits patients risk development respiratory failure ards admitted stanford hospital previously described <NUMBER> subjects eligible enrollment decision admit icu made either emergency department hospital wards goal enrollment <NUMBER>h icu transfer <NUMBER> patients phenotyped ards sepsis <NUMBER>physician consensus ajr jel based berlin criteria sepsis<NUMBER> criteria using available hospital clinical data including history physical exam laboratory microbiologic data invasive monitoring data autopsy results physician summaries stanford icu major referral center cancer thus typically high rates immunosuppression assess cytokine response infection patients normal immune system similar covid population ards sepsis patients therefore enriched normal baseline immune system eg metastatic cancer bone marrow transplant high dose steroids comparison biobank whole rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> statistical analyses performed using open source statistical software r httpswwwrprojectorg observed significant differences chex<NUMBER> mfi three groups tested corrected chex<NUMBER> nonspecific binding keeping clinical conditions severe covid<NUMBER> covicu moderate covid<NUMBER> covnoicu ards sepsis age sex covariates sample normalized according methods used human immune monitoring center stanford university <NUMBER> briefly median fluorescence intensity mfi cytokine corrected first platebatchlot artifacts linear mixed modeling average technical replicates log transformed log transformed average mfis corrected nonspecific binding local polynomial regression repeated crossvalidation resulting platedetrended mfi dpmfi values rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> study conducted according declaration helsinki principles approved stanford university hospital irb protocol <NUMBER> patients surrogates gave written informed consent participate stanford icu biobank rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint required significant impact clinical outcome immunomodulatory therapy downregulate cytokine storm may provide insights treatment covid<NUMBER> combined use immunomodulatory agentto reduce cytokine stormwith antiviral agent may give physicians time provide supportive treatment patients corticosteroids among commonly used drugs immunomodulatory therapy infectious diseases however use corticosteroids treatment covid<NUMBER> cause host immune suppression delay viral clearance recent study results provided information help handle dilemma study xian jiaotongliverpool university found use corticosteroids influence viral clearance time length hospital stay duration symptoms patients mild covid<NUMBER> <NUMBER> study included <NUMBER> patients covid<NUMBER> found treatment methylprednisolone decreased risk death hazard ratio <NUMBER> <NUMBER> confidence interval <NUMBER> among patients acute respiratory distress syndrome ards based findings use corticosteroids considered beneficial severe cases covid<NUMBER> especially partients ards mild cases <NUMBER> according treatment experiences china cautious use corticosteroids recommended certain critically ill patients eg hypoxaemia lowtomoderate doses <NUMBER> mgkgday methylprednisolone equivalent short duration <NUMBER> days stated diagnosis treatment protocol novel coronavirus pneumonia trial version <NUMBER> issued national health commission china <NUMBER> recently chloroquine derivative hydroxychloroquine used treatment covid<NUMBER> february <NUMBER> results <NUMBER> chinese patients covid<NUMBER> showed chloroquine phosphate good efficacy <NUMBER> french doctors conducted openlabel nonrandomized clinical trial <NUMBER> patients covid<NUMBER> received hydroxychloroquine treatment showed good efficacy <NUMBER> chloroquine hydroxychloroquine weak bases able accumulate acidic organelles eg lysosomes increase endosomallysosomal ph inhibit viral replication <NUMBER> addition antimalarial antiviral effects antiinflammatory properties demonstrated treatment autoimmune diseases rheumatoid arthritis lupus erythematosus chloroquine hydroxychloroquine inhibit major histocompatibility complex class ii expression antigen presentation immune activation reducing cd<NUMBER> expression cells via tolllike receptor signalling cgas stimulation interferon genes <NUMBER> thus chloroquine hydroxychloroquine reduce production various proinflammatory cytokines il<NUMBER> il<NUMBER> interferonα tumour necrosis factor involved cytokine storm <NUMBER> immunomodulatory effects synergize antiviral effects treatment covid<NUMBER> immunomodulatory agents directly target key cytokines involved covid<NUMBER> may also help alleviate hyperinflammation symptoms severe cases <NUMBER> elevated levels inflammatory indicator il<NUMBER> blood reported predictive fatal outcome patients covid<NUMBER> <NUMBER> tocilizumab specific monoclonal antibody blocks il<NUMBER> recommended use severe critically ill patients extensive lesions bilateral lungs confirmed elevated level il<NUMBER> diagnosis treatment protocol novel coronavirus pneumonia trial version <NUMBER> issued national health commission china <NUMBER> retrospective analysis <NUMBER> severe cases covid<NUMBER> showed treatment tocilizumab led reduction fever lung lesion opacity recovered percentage lymphocytes peripheral blood <NUMBER> il<NUMBER> bind transmembrane il<NUMBER> receptors mil<NUMBER>r soluble il<NUMBER> receptors sil<NUMBER>r resulting complex combine signal transducing component gp<NUMBER> activate inflammatory response tocilizumab bind specifically sil<NUMBER>r mil<NUMBER>r block signal transduction <NUMBER> tocilizumab good therapeutic option cytokine release syndrome chimeric antigen receptor tcell immunotherapy however clinical experience tocilizumab viral disease limited retrospective study patients juvenile idiopathic arthritis infected influenza reduced fever reduced level creactive protein observed patients received tocilizumab compared patients receive tocilizumab <NUMBER> meanwhile il<NUMBER> inhibition tocilizumab exacerbate increase susceptibility influenza virus infection <NUMBER> however well documented warnings increased risk opportunistic infections including tuberculosis fungal viral infections caused antiil<NUMBER> monoclonal antibodies treatment rheumatoid arthritis <NUMBER> high costs safety risks may barrier wide use tocilizumab treatment covid<NUMBER> early march <NUMBER> chinese clinicians investigated use immunomodulatory agents ulinastatin treatment cytokine storm covid<NUMBER> <NUMBER> ulinastatin serine protease inhibitor antiinflammatory properties including inhibition il<NUMBER> used treatment acute pancreatitis sepsis japan china <NUMBER> expert consensus shanghai ulinastatin recommended patients exacerbated lung lesions <NUMBER> overall certain immunomodulatory agents good safety profiles may considered use combination antiviral drugs treatment severe critical cases covid<NUMBER> competing interests none declared ethical approval required article edited extensivelyplease check proof carefully ensure meaning altered <NUMBER> covid<NUMBER> patients retrospectively assessed totally <NUMBER> patients covid<NUMBER> included study two moderately ill six seriously ill seven critically ill tcz used combination methylprednisolone eight patients five patients received tcz administration twice although tcz treatment ameliorated increased crp patients rapidly four critically ill patients received single dose tcz three <NUMBER> <NUMBER> <NUMBER> still dead crp level rest one patient <NUMBER> failed return normal range clinical outcome disease aggravation serum il<NUMBER> level tended spiked firstly decreased tcz therapy <NUMBER> patients persistent dramatic increase il<NUMBER> observed four patients failed treatment tcz appears effective treatment option covid<NUMBER> patients risk cytokine storms critically ill patients elevated il<NUMBER> repeated dose tcz recommended first report pathological characteristics patient died severe infection sarscov<NUMBER> showed increased concentration highly proinflammatory cytokines <NUMBER> actually cytokine storms mediated overproduction proinflammatory cytokines observed large population critically ill patients infected covid<NUMBER> <NUMBER> <NUMBER> patients suffered cytokine storms progress cardiovascular collapse multiple organ dysfunction death rapidly therefore early identification treatment prevention cytokine storms crucial importance patients il<NUMBER> cytokine plays important role inflammatory reaction immune response <NUMBER> recent clinical experiences china suggested il<NUMBER> one important cytokines retrospective observational study aimed present treatment responses tcz covid<NUMBER> patients extent provide guidance clinical use patients infected covid<NUMBER> treated tcz january <NUMBER> <NUMBER> march <NUMBER> zhongfaxincheng campus tongji hospital wuhan china recruited retrospective study patients anonymous study approved ethical committee huazhong university science technology data demographics comorbidities treatments laboratory results clinical outcomes patients obtained medical records based diagnosis treatment pneumonia infected novel coronavirus issued national health commission china covid<NUMBER> classified four types mildly ill moderately ill seriously ill critically ill <NUMBER> serum levels crp il<NUMBER> observed tcz administration crp acutephase reactant reflecting inflammatory activity defined elevated higher <NUMBER> mgl <NUMBER> level il<NUMBER> defined elevated higher <NUMBER> pgml <NUMBER> patients whose laboratory data crp il<NUMBER> complete deficiency tcz administration considered study dropouts recent crp il<NUMBER> values tcz administration selected value tcz therapy changes value tcz administration observed week clinical outcome patients evaluated within <NUMBER> week tcz therapy statistical analysis done spss version <NUMBER> data presented median minmax number percentage appropriate wilcoxon signedrank test used compare parameters whenever appropriate pvalue less <NUMBER> considered statistically significant fifteen patients <NUMBER> males <NUMBER> females covid<NUMBER> included study characteristics patients use tcz antiinflammatory drugs summarized table <NUMBER> median age minmax patients <NUMBER> <NUMBER> years two <NUMBER> patients moderately ill six <NUMBER> patients seriously ill seven <NUMBER> patients critically ill ten <NUMBER> patients one comorbidities including cadiocerebrovascular diseases endocrine system diseases eight <NUMBER> patients received tcz combination mp five <NUMBER> patients received tcz administration twice dose tcz used patients range <NUMBER> <NUMBER> mg per time laboratory findings <NUMBER> patients first week tcz treatment summarized table <NUMBER> crp levels far normal range patients start tcz therapy rapidly ameliorated tcz treatment value crp first time detected tcz therapy significantly decreased compared tcz therapy dropped <NUMBER> <NUMBER> <NUMBER> <NUMBER> mgl p <NUMBER> although tcz benefits relieving inflammatory activ present study suggested single dose tcz seems fail improve disease activity critically ill patients although used combination glucocorticoid however repeated doses even repeated lower dose tcz might improve condition critically ill patients therefore addition safety advantage repeated dose tcz likely effective glucocorticoid treatment covid<NUMBER> moreover single dose tcz might expected benefit seriously ill patients <NUMBER> times elevated il<NUMBER> moderately ill patient extremely higher level il<NUMBER> almost <NUMBER> times normal could also benefit repetitive tcz therapy nevertheless seems repeat dose frequency daily every day every <NUMBER> days totally two three doses would sensible critically ill patients result evaluated caution although reported good response patients tcz number cases reported still small using laboratory parameters define disease activity still challenging furthermore treatment duration observed study may sufficient make final conclusion therefore observation sufficient number covid<NUMBER> patients still needed document effectiveness tcz <NUMBER> april almost <NUMBER> million people globally diagnosed corona virus disease <NUMBER> pandemic evolved emergence new coronavirus strain acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> china <NUMBER> deaths reported certainly many cases milder disease diagnosed officially confirmed due limited testing capacity countries pandemic global emergency due rapid transmission disease potential overwhelm healthcare systems expected considerable economic health impacts possible contributing factors possible role relatively high infection death rates countries origin recently studied goumenou et al <NUMBER>a goumenou et al <NUMBER>b new outbreak additionally evaluated current knowledge coronaviruses based short history epidemiology pathogenesis clinical manifestation disease well treatment prevention strategies docea et al <NUMBER> search potential protective therapeutic antiviral strategies particular urgent concern skalny et al <NUMBER> cases especially young people without comorbidities disease expected relatively mild substantial proportion patients develop complications need intensive careunit support mechanical intubation one case series <NUMBER> patients china guan et al <NUMBER> <NUMBER> cases suffered primary composite endpoint admission intensive care unit use mechanical ventilation death patients severe disease typically present dyspnea hypoxemia shortly disease initiation may quickly progress respiratory failure acute respiratory distress syndrome ards multiorgan failure chen et al <NUMBER> predictors adverse outcomes include j u r n l p r e p r f elevated levels inflammatory markers proinflammatory cytokines study <NUMBER> covid<NUMBER> cases reported elevated levels creactive protein crp ferritin il<NUMBER> associated death ruan et al <NUMBER> il<NUMBER> important proinflammatory cytokine elevated fatal cases covid<NUMBER> another study <NUMBER> patients zhou et al <NUMBER> another study <NUMBER> patients reported severe disease showed lymphocytopenia neutrophilia low levels monocytes eosinophils basophils elevated levels infectionrelated biomarkers inflammatory cytokines qin et al <NUMBER> pathological examination case china revealed bilateral diffuse alveolar damage desquamation pneumocytes hyaline membrane formation interstitial mononuclear inflammatory infiltrates xu et al <NUMBER> flow cytometry peripheral blood revealed reduced levels cd<NUMBER> cd<NUMBER> cells however hyperactivated elevated concentration proinflammatory ccr<NUMBER> th<NUMBER> cd<NUMBER> cells findings hallmarks ards resemble features observed sars middle eastern respiratory syndrome ng et al <NUMBER> ding et al <NUMBER> systemic vasculitis also observed xu et al <NUMBER> therefore seems immune dysregulation may implicated pathophysiology severe covid<NUMBER> decades common thinking suggested every immune response antigenic invasion always beneficial averting potential damage studies <NUMBER>s identified immune cells produce proteins pleiotropic properties potential either beneficial harmful tracey <NUMBER> proteins called cytokines found cause clinical manifestations similar sepsis hemodynamic instability fever localized inflammation tracey et al <NUMBER> dinarello et al <NUMBER> cytokines important mediating immune cell recruitment complex intracellular signaling control mechanisms expressed numerous cells including macrophages monocytes b cells cells promote differentiation thelper cells stimulate cd<NUMBER> cells turner et al <NUMBER> activation immune system important fighting pathogens dysregulation cytokine production may lead uncontrolled effects ultimately detrimental health dinarello <NUMBER> turner et al <NUMBER> several animal experimental models inducing proinflammatory cytokines sepsis ischemiareperfusion pancreatitis shown vagus stimulation improves outcomes effect mediated nicotinic acetylcholine receptor nachr α<NUMBER> subunit macrophages wang et al <NUMBER> mice deficient α<NUMBER> subunit exhibited increased endotoxininduced tnf production electrical vagus innervation failed reduce serum tnf levels wang et al <NUMBER> blymphocytes also express α<NUMBER> nachrs macrophages appear sensitive acetylcholine suggests source acetylcholine even nonneuronal sources epithelial endothelial cells could also modulate activity adjacent macrophages tracey <NUMBER> besides tnf proinflammatory cytokines inhibited acetylcholine high mobility group b<NUMBER> hmgb<NUMBER> il<NUMBER> il<NUMBER> ulloa <NUMBER> modulation inflammatory immune response central nervous system cns vagus nerve based bidirectional communication immune nervous systems afferent vagus nerve fibers located nucleus tractus solitarius provide sensory input cns inflammatory status result transmission efferent signals originating dorsal motor nucleus control inflammatory response pavlov et al <NUMBER> response rapid localized unlike diffusible antiinflammatory network slow distributed nonintegrated dependent concentration gradients tracey <NUMBER> smoking known increase risk respiratory infection susceptibility severity cohen et al <NUMBER> millett et al <NUMBER> considering covid<NUMBER> declared world health organization pandemic substantial disease burden would expected among estimated <NUMBER> billion smokers especially countries high smoking prevalence therefore understandable concerns population subgroup berlin et al <NUMBER> additionally smokingrelated disease conditions cardiovascular disease copd also established risk factors adverse outcomes covid<NUMBER> wu mcgoogan <NUMBER> china first country affected pandemic high smoking prevalence <NUMBER> population smoking prevalence <NUMBER> much higher prevalence men <NUMBER> women <NUMBER> world health organization <NUMBER> therefore high smoking prevalence among patients covid<NUMBER> would expected even smoking adversely affect disease susceptibility severity obviously inappropriate suggest anyone initiate smoking continue smoke due wellestablished smokingrelated morbidities large number potentially toxic chemicals cigarette smoke furthermore unlikely compound tobacco cigarette smoke besides nicotine would implicated potential benefits observed smokers moreover due adverse effects smoking fact many smokers would suffer comorbidities cardiovascular disease copd etc expected potential benefits nicotine would blunted observed smokers nicotine cholinergic agonist therefore important inhibitor proinflammatory cytokines acting cholinergic antiinflammatory pathway via α<NUMBER>nachrs nicotine prominent feature covid<NUMBER> coagulopathy results thromboembolic complications venous thromboembolism reported <NUMBER> patients thromboprophylaxis associated higher mortality rate cui et al <NUMBER> abnormal coagulation parameters also associated poor survival tang et al <NUMBER> although antagonists acetylcholine α<NUMBER>nach receptor high affinity decided explore hypothesis sarscov<NUMBER> may acquired sequences potential defined yet intermediates genomic recombination compared protein sequences sarscov<NUMBER> snake venom neurotoxins able identify regions four five amino acids homology coronavirus several neurotoxin molecules eg sarscov<NUMBER> compared alpha bungarotoxin fig <NUMBER>a sarscov<NUMBER> alphacobratoxin fig <NUMBER>b j u r n l p r e p r f therefore hypothesize sequences sarscov<NUMBER> proteins similar active sites neurotoxin result binding nachrs adversely affecting function preventing action acetylcholine nicotine could act competitive agonist nachrs could restore compromised function nicotinic cholinergic system may feasible repurposing already approved indications pharmaceutical nicotine products nicotine patches use nonsmokers even using products already indicated ie smoking substitutes among current smokers products available overthecounter countries administered therapeutically nonsmokers neurological conditions inflammatory bowel disease larger periods would needed covid clinical trials dictate future approaches role nicotine covid<NUMBER> experimental studies examine affinity virus nachrs conclusion noticed clinical characteristics severe covid<NUMBER> could explained dysregulation cholinergic antiinflammatory system observation patients eventually develop cytokine storm results rapid clinical deterioration led development hypothesis series events associated adverse outcomes covid<NUMBER> fig <NUMBER> someone infected sarscov<NUMBER> immune system mobilized virus replicates cell viral debris virions may interact nachrs blocking action cholinergic antiinflammatory pathway initial immune response enough combat viral invasion early stage extensive prolonged replication virus j u r n l p r e p r f eventually block large part cholinergic antiinflammatory pathway seriously compromising ability control regulate immune response uncontrolled action proinflammatory cytokines result development cytokine storm acute lung injury leading ards coagulation disturbances multiorgan failure based hypothesis covid<NUMBER> appears eventually become disease nicotinic cholinergic system nicotine could maintain restore function cholinergic antiinflammatory system thus control release activity proinflammatory cytokines could prevent suppress cytokine storm hypothesis needs examined laboratory clinical setting ethics approval consent participate applicable june <NUMBER> <NUMBER> <NUMBER> million cases coronavirus disease <NUMBER> covid <NUMBER> identified united states <NUMBER> deaths reported <NUMBER> severity covid<NUMBER> ranges asymptomatic severe disease <NUMBER> <NUMBER> <NUMBER> severe disease often requires admission intensive care unit icu <NUMBER> <NUMBER> <NUMBER> mortality rates critically ill patients covid<NUMBER> range <NUMBER> <NUMBER> pharmacologic treatment options proposed covid<NUMBER> including antivirals immunomodulators <NUMBER> antivirals demonstrated reductions mortality date <NUMBER> <NUMBER> <NUMBER> <NUMBER> immunomodulators remain possible therapeutic option based pathophysiologic understanding covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> progress two overlapping phases described initial viral response followed host inflammatory response <NUMBER> host response includes unregulated proinflammatory cytokine storm resulting lung injury development acute respiratory distress syndrome ards death <NUMBER> <NUMBER> interleukin<NUMBER> il<NUMBER> theorized play significant role covid<NUMBER> related cytokine storm <NUMBER> <NUMBER> <NUMBER> <NUMBER> tocilizumab il<NUMBER> receptor antagonist garnered interest possible treatment option <NUMBER> <NUMBER> <NUMBER> use il<NUMBER> receptor antagonists recommended setting clinical trials <NUMBER> <NUMBER> risks immunomodulator use include propagation covid<NUMBER> progression interfering innate antiviral immunity development secondary infections adverse drug effects <NUMBER> <NUMBER> <NUMBER> <NUMBER> given high mortality rates observed severe covid<NUMBER> clinicians used offlabel tocilizumab immunomodulatory agents practice select cases <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> literature date tocilizumab covid<NUMBER> described outcomes <NUMBER> days predominately less severe disease limited descriptions adverse effects factors associated beneficial response tocilizumab unknown report clinical characteristics associated inhospital survival <NUMBER> days patients covid<NUMBER> receiving offlabel tocilizumab retrospective cohort study patients admitted fivehospital health system southeast southcentral michigan study approved henry ford health systems institutional review board irb <NUMBER> waiver consent patients hospitalized march <NUMBER> <NUMBER> april <NUMBER> <NUMBER> eligible inclusion <NUMBER> years age older confirmed covid<NUMBER> infection received tocilizumab patients excluded transferred outofsystem hospital positive microbiologic culture <NUMBER> hours prior <NUMBER> hours tocilizumab administration treated antimicrobial pregnant incarcerated confirmed case covid<NUMBER> defined patient positive reversetranscriptasepolymerasechainreaction rtpcr assay severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> nasopharyngeal sample tested michigan department health human services health systems centralized clinical microbiology laboratory patients risk stratified symptoms prior tocilizumab administration mild moderate severe covid<NUMBER> patients without hypoxia exertional dyspnea considered mild covid<NUMBER> patients presented infiltrates chest radiography required supplemental oxygen nasal cannula highflow nasal cannula hfnc classified moderate covid<NUMBER> patients respiratory failure requiring invasive mechanical ventilation classified severe covid<NUMBER> <NUMBER> patients followed <NUMBER> days first dose tocilizumab patient data censored april <NUMBER> <NUMBER> hospitalized patients covid<NUMBER> received supportive care comprised supplemental oxygen hfnc invasive mechanical ventilation antibiotics vasopressors renalreplacement therapy determined primary team patients progressed ards managed lung protective ventilation strategies <NUMBER> institutional treatment covid<NUMBER> guideline developed included lopinavirritonavir ribavirin hydroxychloroquine monotherapy based disease severity intravenous iv remdesivir available compassionate use within clinical trial institutional guidelines developed consensus based available literature experience wuhan china centers around world affected covid<NUMBER> michigan march <NUMBER> <NUMBER> lopinavirritonavir ribavirin removed <NUMBER> short course corticosteroids added institutional guideline patients moderate severe covid<NUMBER> march <NUMBER> <NUMBER> <NUMBER> <NUMBER> tocilizumab used casebycase basis patients exhibiting symptoms cytokine storm described assessed primary infectious disease physician patients eligible tocilizumab exhibiting persistent fevers <NUMBER> ⁰c greater <NUMBER> hours partial pressure oxygen fraction inspired oxygen ratio less <NUMBER> exhibited persistently rising inflammatory laboratory parameters ferritin ddimer lactate dehydrogenase ldh elevated inflammatory laboratory parameter defined ferritin ≥ <NUMBER> μgl ddimer ≥ <NUMBER> mgml ldh ≥ <NUMBER> ul il<NUMBER> level ≥ five times upper limits normal ≤ <NUMBER> pgml assessed addition parameters bacterial fungal alternate viral infections ruled prior tocilizumab administration tocilizumab administered <NUMBER> mgkg iv dose using actual body weight maximum dose <NUMBER> mg doses rounded <NUMBER> mg <NUMBER> mg <NUMBER> mg patients eligible second dose persistently febrile despite treatment due medication shortages tocilizumab dose changed fixed <NUMBER> mg iv dose patients march <NUMBER> <NUMBER> data ascertained health systems electronic medical record recorded standardized electronic case report form demographic data information clinical symptoms presentation vital signs laboratory tests chest radiograph results covid<NUMBER> treatments received prior tocilizumab length stay discharge disposition collected baseline data defined information collected within <NUMBER> hours emergency department presentation study day <NUMBER> defined first day tocilizumab administered comorbidity age lymphocyte ldh call score calculated baseline <NUMBER> score ranges <NUMBER> <NUMBER> increased values predicting higher likelihood progressing severe covid<NUMBER> sequential organ failure assessment sofa score sixpoint ordinal scale clinical status recommended world health organization rd blueprint group collected baseline tocilizumab administration <NUMBER> <NUMBER> sixcategory scale consists following categories <NUMBER> hospitalized <NUMBER> hospitalized requiring supplemental oxygen <NUMBER> hospitalized requiring supplemental oxygen <NUMBER> hospitalized requiring hfnc noninvasive mechanical ventilation <NUMBER> hospitalized requiring invasive mechanical ventilation ecmo <NUMBER> death american society transplantation cellular therapy astct consensus grading cytokine release syndrome crs used chimeric antigen receptor tcell therapy collected prior tocilizumab <NUMBER> astct grading ranges <NUMBER> <NUMBER> three features including temperature blood pressure oxygenation support denote crs grade ards diagnosed classified according berlin definition <NUMBER> adverse effects observed practice known associated chronic tocilizumab use collected infection tocilizumab defined positive microbiologic assay prompted antimicrobials identified pathogen characteristics nonsurvivors defined inhospital death within <NUMBER> days tocilizumab administration compared survivors comparisons included assessment demographics time symptom onset tocilizumab administration ≤ <NUMBER> days laboratory parameters alternative treatments received prognostic scores collected <NUMBER> endpoints evaluated included clinical response tocilizumab defined decline two levels sixcategory scale discharged alive hospital <NUMBER> comparison laboratory parameters sofa score sixcategory scale severity ards survivors nonsurvivors days <NUMBER> <NUMBER> completed sixcategory scale also assessed study day <NUMBER> continuous variables reported median interquartile range iqr compared using mannwhitney u test student ttest appropriate categorical data reported number percentage compared using chisquared test fishers exact test appropriate imputations made missing data points sample size derived eligible consecutive hospitalized patients study period twosided α <NUMBER> considered statistically significant bivariate multivariate logistic regression analysis planned apriori identify independent predictors associated <NUMBER> day inhospital survival covariates bivariate analysis pvalue <NUMBER> clinical rationale included multivariate regression model restricted subjecttovariable ratio <NUMBER> statistical analysis performed using ibm spss version <NUMBER> chicago il sas <NUMBER> cary nc total <NUMBER> patients order tocilizumab identified eleven excluded leaving <NUMBER> available analysis study supplemental index figure <NUMBER> median age <NUMBER> <NUMBER> years <NUMBER> male median time covid<NUMBER> symptom onset hospital admission <NUMBER> <NUMBER> days <NUMBER> day inhospital mortality <NUMBER> leaving <NUMBER> patients survivors <NUMBER> nonsurvivors group study day <NUMBER> patients classified mild moderate severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases respectively median sofa score <NUMBER> <NUMBER> day <NUMBER> median increase sofa score baseline <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> differences observed prevalence comorbidities rate obesity median sofa score day <NUMBER> median change sofa score baseline day <NUMBER> survivors nonsurvivors differences noted survivors nonsurvivors baseline day <NUMBER> table <NUMBER> supplemental index table <NUMBER> median days symptom onset tocilizumab administration <NUMBER> <NUMBER> days difference time symptom onset tocilizumab administration survivors nonsurvivors <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> p<NUMBER> differences noted covid<NUMBER> treatment characteristics prognostic scores survivors nonsurvivors table <NUMBER> single independent predictor <NUMBER> day inhospital survival receipt tocilizumab within <NUMBER> days symptom onset adjusted <NUMBER> <NUMBER> ci <NUMBER> sofa score ≥ <NUMBER> independently associated <NUMBER> day inhospital mortality adjusted <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> p <NUMBER> fourteen <NUMBER> patients remained hospitalized end study table <NUMBER> differences noted occurrence adverse effects survivors nonsurvivors supplemental table <NUMBER> retrospective cohort study clinical characteristics factors independently associated survival <NUMBER> day outcomes patients covid<NUMBER> tocilizumab administration described receipt tocilizumab within <NUMBER> days symptom onset patients covid<NUMBER> factor independently associated inhospital survival <NUMBER> days clinical response likely occur survived association improved survival remained intact adjusting sofa score male sex covid<NUMBER> progression characterized biphasic response latter phase consisting excessive hyperinflammatory response <NUMBER> early intervention mitigate cytokine storm immunomodulator may optimize patient outcomes study supports intervention timing relative disease onset key factor <NUMBER> study population high likelihood severe covid<NUMBER> mortality based presenting call sofa scores <NUMBER> <NUMBER> high rates obesity hypertension diabetes observed present study relative previous epidemiologic reports covid<NUMBER> <NUMBER> <NUMBER> rates mechanical ventilation mortality higher compared previous reports tocilizumab use covid<NUMBER> reasons difference mortality may explained difference severity illness high rates comorbidities associated severe covid<NUMBER> longer duration followup higher rate invasive mechanical ventilation rates ards <NUMBER> <NUMBER> <NUMBER> <NUMBER> mortality rates observed present study similar reported critically ill covid<NUMBER> populations general icu population ards <NUMBER> <NUMBER> <NUMBER> sofa score ≥ <NUMBER> day <NUMBER> independently associated mortality sofa score ≥ <NUMBER> hospital presentation described independent predictor mortality covid<NUMBER> population <NUMBER> improvement noted survivors sofa scores sixcategory scale ards severity also improved survivors finding consistent immunomodulatory trials <NUMBER> findings important guide use offlabel tocilizumab cytokine storm associated covid<NUMBER> results randomized controlled trials available standard definition cytokine storm related covid<NUMBER> exists previous studies defined cytokine storm associated covid<NUMBER> using various threshold values vital signs crp il<NUMBER> ferritin ldh <NUMBER> <NUMBER> <NUMBER> <NUMBER> crp common diagnostic marker amongst published reports date values <NUMBER> mgdl <NUMBER> times upper limits normal used define cytokine storm following tocilizumab administration present study crp reduced patients seen previous reports tocilizumab il<NUMBER> receptor antagonist anakinra <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> astct grading crs identified <NUMBER> patients cytokine storm may imperfect diagnostic tool setting covid<NUMBER> future research needed establish criteria define cytokine storm associated covid<NUMBER> identify progression disease viral phase hyperinflammatory phase <NUMBER> recent studies demonstrated effectiveness antivirals limiting disease severity <NUMBER> <NUMBER> stepwise treatment approach using antiviral immunomodulatory agents succession patients disease progression appears viable therapeutic approach may warrant research hypertriglyceridemia occurred frequently present cohort irrespective propofol use clinicians routinely monitor triglyceride levels markers pancreatitis secondary hemophagocytic lymphohistiocytosis shlh tocilizumab administered due inflammatory markers associated shlh il<NUMBER> antagonist may prevent complication continuous monitoring paramount <NUMBER> secondary infections noted <NUMBER> patients higher previous report <NUMBER> however rates epidemiologic reports critically ill covid<NUMBER> populations describe range <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> unable enroll patients clinical trial clinicians consider multidisciplinary approach weigh benefits potential risks offlabel tocilizumab covid<NUMBER> study several limitations study population included predominately one critically ill severe covid<NUMBER> results may applicable less severe populations study conducted within single health system limited sample size placebo comparator group study followup period <NUMBER> days tocilizumab administration limits assessment long term efficacy adverse effects however followup longer reported tocilizumab consistent duration followup antiviral agents <NUMBER> <NUMBER> health systems covid<NUMBER> guideline modified study period treatments received survivors nonsurvivors consistent receipt tocilizumab within <NUMBER> days symptom onset may key factor independently associated <NUMBER>day survival covid<NUMBER> research needed define diagnostic criteria cytokine storm associated covid<NUMBER> establish clinical efficacy tocilizumab placebocontrolled trials describe covid<NUMBER> populations may derive clinical benefit tocilizumab play significant role covid<NUMBER> related cytokine storm <NUMBER> <NUMBER> <NUMBER> <NUMBER> tocilizumab il<NUMBER> receptor antagonist garnered interest possible treatment option <NUMBER> <NUMBER> <NUMBER> use il<NUMBER> receptor antagonists recommended setting clinical trials <NUMBER> <NUMBER> risks immunomodulator use include propagation covid<NUMBER> progression interfering innate antiviral immunity development secondary infections adverse drug effects <NUMBER> <NUMBER> <NUMBER> <NUMBER> given high mortality rates observed severe covid<NUMBER> clinicians used offlabel tocilizumab immunomodulatory agents practice select cases <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> literature date tocilizumab covid<NUMBER> described outcomes <NUMBER> days predominately less severe disease limited descriptions adverse effects factors associated beneficial response tocilizumab unknown report clinical characteristics associated inhospital survival <NUMBER> days patients covid<NUMBER> receiving offlabel tocilizumab retrospective cohort study patients admitted fivehospital health system southeast southcentral michigan study approved henry ford health systems institutional review board irb <NUMBER> waiver consent patients hospitalized march <NUMBER> <NUMBER> april <NUMBER> <NUMBER> eligible inclusion <NUMBER> years age older confirmed covid<NUMBER> infection received tocilizumab patients excluded transferred outofsystem hospital positive microbiologic culture <NUMBER> h prior <NUMBER> h tocilizumab administration treated antimicrobial pregnant incarcerated confirmed case covid<NUMBER> defined patient positive reversetranscriptasepolymerasechainreaction rtpcr assay severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> nasopharyngeal sample tested michigan department health human services health systems centralized clinical microbiology laboratory patients risk stratified symptoms prior tocilizumab administration mild moderate severe covid<NUMBER> patients without hypoxia exertional dyspnea considered mild covid<NUMBER> patients presented infiltrates chest radiography required supplemental oxygen nasal cannula highflow nasal cannula hfnc classified moderate covid<NUMBER> patients respiratory failure requiring invasive mechanical ventilation classified severe covid<NUMBER> <NUMBER> patients followed <NUMBER> days first dose tocilizumab patient data censored april <NUMBER> <NUMBER> hospitalized patients covid<NUMBER> received supportive care comprised supplemental oxygen hfnc invasive mechanical ventilation antibiotics vasopressors renalreplacement therapy determined primary team patients progressed ards managed lung protective ventilation strategies <NUMBER> institutional treatment covid<NUMBER> guideline developed included lopinavirritonavir ribavirin hydroxychloroquine monotherapy based disease severity intravenous iv remdesivir available compassionate use within clinical trial institutional guidelines developed consensus based available literature experience wuhan china centers around world affected covid<NUMBER> michigan march <NUMBER> <NUMBER> lopinavirritonavir ribavirin removed <NUMBER> short course corticosteroids added institutional guideline patients moderate severe covid<NUMBER> march <NUMBER> <NUMBER> <NUMBER> <NUMBER> tocilizumab used casebycase basis patients exhibiting symptoms cytokine storm described assessed primary infectious disease physician patients eligible tocilizumab exhibiting persistent fevers <NUMBER>°c greater <NUMBER> h partial pressure oxygen fraction inspired oxygen ratio less <NUMBER> exhibited persistently rising inflammatory laboratory parameters ferritin ddimer lactate dehydrogenase ldh elevated inflammatory laboratory parameter defined ferritin ≥<NUMBER> μgl ddimer ≥ <NUMBER> mg ml ldh ≥ <NUMBER> ul il<NUMBER> level ≥ five times upper limits normal ≤<NUMBER> pgml assessed addition parameters bacterial fungal alternate viral infections ruled prior tocilizumab administration tocilizumab administered <NUMBER> mgkg iv dose using actual body weight maximum dose <NUMBER> mg doses rounded <NUMBER> mg <NUMBER> mg <NUMBER> mg patients eligible second dose persistently febrile despite treatment due medication shortages tocilizumab dose changed fixed <NUMBER> mg iv dose patients march <NUMBER> <NUMBER> data ascertained health systems electronic medical record recorded standardized electronic case report form demographic data information clinical symptoms presentation vital signs laboratory tests chest radiograph results covid<NUMBER> treatments received prior tocilizumab length stay discharge disposition collected baseline data defined information collected within <NUMBER> h emergency department presentation study day <NUMBER> defined first day tocilizumab administered comorbidity age lymphocyte ldh call score calculated baseline <NUMBER> score ranges <NUMBER> <NUMBER> increased values predicting higher likelihood progressing severe covid<NUMBER> sequential organ failure assessment sofa score sixpoint ordinal scale clinical status recommended world health organization rd blueprint group collected baseline tocilizumab administration <NUMBER> <NUMBER> sixcategory scale consists following categories <NUMBER> hospitalized <NUMBER> hospitalized requiring supplemental oxygen <NUMBER> hospitalized requiring supplemental oxygen <NUMBER> hospitalized requiring hfnc noninvasive mechanical ventilation <NUMBER> hospitalized requiring invasive mechanical ventilation ecmo <NUMBER> death american society transplantation cellular therapy astct consensus grading cytokine release syndrome crs used chimeric antigen receptor tcell therapy collected prior tocilizumab <NUMBER> astct grading ranges <NUMBER> <NUMBER> three features including temperature blood pressure oxygenation support denote crs grade ards diagnosed classified according berlin definition <NUMBER> adverse effects observed practice known associated chronic tocilizumab use collected infection tocilizumab defined positive microbiologic assay prompted antimicrobials identified pathogen characteristics nonsurvivors defined inhospital death within <NUMBER> days tocilizumab administration compared survivors comparisons included assessment demographics time symptom onset tocilizumab administration ≤<NUMBER> days laboratory parameters alternative treatments received prognostic scores collected <NUMBER> endpoints evaluated included clinical response tocilizumab defined decline two levels sixcategory scale discharged alive hospital <NUMBER> comparison laboratory parameters sofa score sixcategory scale severity ards survivors nonsurvivors days <NUMBER> completed sixcategory scale also assessed study day <NUMBER> continued next page continuous variables reported median interquartile range iqr compared using mannwhitney u test student ttest appropriate categorical data reported number percentage compared using chisquared test fishers exact test appropriate imputations made missing data points sample size derived eligible consecutive hospitalized patients study period twosided α <NUMBER> considered statistically significant bivariate multivariate logistic regression analysis planned apriori identify independent predictors associated <NUMBER> day inhospital survival covariates bivariate analysis pvalue <NUMBER> clinical rationale included multivariate regression model restricted subjecttovariable ratio <NUMBER> statistical analysis performed using ibm spss version <NUMBER> chicago il sas <NUMBER> cary nc total <NUMBER> patients order tocilizumab identified eleven excluded leaving <NUMBER> available analysis study supplemental fig <NUMBER> median age <NUMBER> <NUMBER> years <NUMBER> male median time covid<NUMBER> symptom onset hospital admission <NUMBER> <NUMBER> days <NUMBER> day inhospital mortality <NUMBER> leaving <NUMBER> patients survivors <NUMBER> nonsurvivors group study day <NUMBER> patients classified mild following variables assessed goodness fit within multivariate analysis fit model age <NUMBER> presence acute respiratory distress syndrome use prone mechanical ventilation body mass index greater <NUMBER> call score ≥<NUMBER> african american presence infection sofa denotes sequential organ failure assessment clinical outcomes end study day <NUMBER> moderate severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases respectively median sofa score <NUMBER> <NUMBER> day <NUMBER> median increase sofa score baseline <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> creactive protein higher nonsurvivors <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> mgdl p <NUMBER> differences observed prevalence comorbidities rate obesity median sofa score day <NUMBER> median change sofa score baseline day <NUMBER> survivors nonsurvivors differences noted survivors nonsurvivors baseline day <NUMBER> table <NUMBER> supplemental table <NUMBER> median days symptom onset tocilizumab administration <NUMBER> <NUMBER> days difference time symptom onset tocilizumab administration survivors nonsurvivors <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> p <NUMBER> differences noted covid<NUMBER> treatment characteristics prognostic scores survivors nonsurvivors table <NUMBER> single independent predictor <NUMBER> day inhospital survival receipt tocilizumab within <NUMBER> days symptom onset adjusted <NUMBER> <NUMBER> ci <NUMBER> sofa score ≥<NUMBER> independently associated <NUMBER> day inhospital mortality adjusted <NUMBER> <NUMBER> ci <NUMBER> table <NUMBER> patients survivor group likely clinical response tocilizumab day <NUMBER> <NUMBER> vs <NUMBER> p <NUMBER> hospital length stay longer survivors compared nonsurvivors <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> p <NUMBER> fourteen <NUMBER> patients remained hospitalized end study table <NUMBER> numerical reductions ferritin crp observed survivors nonsurvivors tocilizumab administration study day <NUMBER> lactate dehydrogenase declined survivors day <NUMBER> significant differences observed crp ldh ddimer ferritin levels comparing survivors nonsurvivors select study days depicted fig <NUMBER> improvements observed sixcategory scale sofa score ards severity comparing survivors nonsurvivors study day <NUMBER> fig <NUMBER> twentynine <NUMBER> patients experienced hypertriglyceridemia levels greater <NUMBER> mgdl patients developed hypertriglyceridemia eight receive propofol patients elevated amylase lipase levels received concurrent propofol total <NUMBER> <NUMBER> patients developed infection median time development infection tocilizumab <NUMBER> <NUMBER> days difference observed median time development infection survivors nonsurvivors total seventeen <NUMBER> bacterial infections three <NUMBER> fungal infections differences noted occurrence adverse effects survivors nonsurvivors supplemental table <NUMBER> retrospective cohort study clinical characteristics factors independently associated survival <NUMBER> day outcomes patients covid<NUMBER> tocilizumab administration described receipt tocilizumab within <NUMBER> days symptom onset patients covid<NUMBER> factor independently associated fig <NUMBER> temporal changes laboratory parameters tocilizumab administration fig <NUMBER> shows temporal changes creactive protein serum ferritin lactate dehydrogenase ddimer n values parenthesis represents evaluable population data representative entire cohort median values shown circles graphed line interquartile range denoted error bars circles p <NUMBER> nonsurvivors vs survivors study day crpcreactive protein ldh lactate dehydrogenase hospital survival <NUMBER> days clinical response likely occur survived association improved survival remained intact adjusting sofa score male sex covid<NUMBER> progression characterized biphasic response latter phase consisting excessive hyperinflammatory response <NUMBER> early intervention mitigate cytokine storm immunomodulator may optimize patient outcomes study supports intervention timing relative disease onset key factor <NUMBER> study population high likelihood severe covid<NUMBER> mortality based presenting call sofa scores <NUMBER> <NUMBER> high rates obesity hypertension diabetes observed present study relative previous epidemiologic reports covid<NUMBER> <NUMBER> <NUMBER> rates mechanical ventilation mortality higher compared previous reports tocilizumab use covid<NUMBER> reasons difference mortality may explained difference severity illness high rates comorbidities associated severe covid<NUMBER> longer duration followup higher rate invasive mechanical ventilation rates ards <NUMBER> <NUMBER> <NUMBER> <NUMBER> mortality rates observed present study similar reported critically ill covid<NUMBER> populations general icu population ards <NUMBER> <NUMBER> <NUMBER> sofa score ≥<NUMBER> day <NUMBER> independently associated mortality sofa score ≥<NUMBER> hospital presentation described independent predictor mortality covid<NUMBER> population <NUMBER> improvement noted survivors sofa scores sixcategory scale ards severity also improved survivors finding consistent immunomodulatory trials <NUMBER> findings important guide use offlabel tocilizumab cytokine storm associated covid<NUMBER> results randomized controlled trials available standard definition cytokine storm related covid<NUMBER> exists previous studies defined cytokine storm associated covid<NUMBER> using various threshold values vital signs crp il<NUMBER> ferritin ldh <NUMBER> <NUMBER> <NUMBER> <NUMBER> crp common diagnostic marker amongst published reports date values <NUMBER> mg dl <NUMBER> times upper limits normal used define cytokine storm following tocilizumab administration present study crp reduced patients seen previous reports tocilizumab il<NUMBER> receptor antagonist anakinra <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> astct grading crs identified <NUMBER> patients cytokine storm may imperfect diagnostic tool setting covid<NUMBER> future research needed establish criteria define cytokine storm associated covid<NUMBER> identify progression disease viral phase hyperinflammatory phase <NUMBER> recent studies demonstrated effectiveness antivirals limiting disease severity <NUMBER> <NUMBER> stepwise treatment approach using antiviral immunomodulatory agents succession patients disease progression appears viable therapeutic approach may warrant research hypertriglyceridemia occurred frequently present cohort irrespective propofol use clinicians routinely monitor triglyceride levels markers pancreatitis secondary hemophagocytic lymphohistiocytosis shlh tocilizumab administered due inflammatory markers associated shlh il<NUMBER> antagonist may prevent complication continuous monitoring paramount <NUMBER> secondary infections noted <NUMBER> patients higher previous report <NUMBER> however rates epidemiologic reports critically ill covid<NUMBER> populations describe range <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> unable enroll patients clinical trial clinicians consider multidisciplinary approach weigh benefits potential risks offlabel tocilizumab covid<NUMBER> study several limitations study population included predominately one critically ill severe covid<NUMBER> results may applicable less severe populations study conducted within single health system limited sample size placebo comparator group study followup period <NUMBER> days tocilizumab administration limits assessment long term efficacy adverse effects however followup longer reported tocilizumab consistent duration followup antiviral agents <NUMBER> <NUMBER> health systems covid<NUMBER> guideline modified study period treatments received survivors nonsurvivors consistent receipt tocilizumab within <NUMBER> days symptom onset may key factor independently associated <NUMBER>day survival covid<NUMBER> research needed define diagnostic criteria cytokine storm associated covid<NUMBER> establish clinical efficacy tocilizumab placebocontrolled trials describe covid<NUMBER> populations may derive clinical benefit tocilizumab research receive specific grant funding agencies public commercial notforprofit sectors severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> pathogen causes covid<NUMBER> although early studies suggested children adolescents could spared severe disease reports since published children hospitalised dying covid<NUMBER> <NUMBER> <NUMBER> report <NUMBER>yearold previously healthy individual presented institution <NUMBER>day history pyrexia abdominal pain nausea vomiting respiratory symptoms patients mother reported mild respiratory symptoms <NUMBER> weeks previously patient tested sarscov<NUMBER> admission day <NUMBER> patient febrile <NUMBER>·<NUMBER>°c cardiovascularly stable showed signs respiratory distress figure abdomen tense guarding right upper lower quadrants initial investigations showed lymphopenia <NUMBER>·<NUMBER> × <NUMBER> <NUMBER> cells per l normal range <NUMBER>·<NUMBER>·<NUMBER> signi ficant increase creactive protein <NUMBER> mgl normal range <NUMBER> sterile pyuria <NUMBER> cells patient started empiric piperacillintazobactam sus pected acute appendicitis nasopharyngeal swabs sent sarscov<NUMBER> pcr testing chest radiography figure abdominal ultrasound normal within <NUMBER> h admission patient developed increasing dyspnoea cough oxygen requirement <NUMBER> lmin finally escalating continuous positive airway pressure ventilation support patient seemed visually unwell inter acted less developed widespread maculopapular blanch ing rash figure b received fluid boluses persistent tachycardia chest ct showed typical findings sarscov<NUMBER> pneumonia figure c <NUMBER> diagnosis presumptive covid<NUMBER> made secondary multisystem inflammatory disease cytokine storm syndrome diagnosed based clinical symptoms lymphopenia anaemia thrombocyto penia increased acutephase pro teins ie creactive protein ferritin raised serum interleukin il<NUMBER> <NUMBER> pgml furthermore patient developed mild polyarticular arthritis small joints hands sub stan tial cervical lymphadenopathy conjunctivitis mucous mem brane changes seen suggest classic com plete kawasaki disease patient eligible remdesivir compassionate use sarscov<NUMBER> pcr negative patient showed clinical features sugges tive covid<NUMBER>associated cytokine storm syn drome <NUMBER> antiinflammatory treatment recombinant il<NUMBER> rec e ptor antagonist anakinra initiated multi disciplinary discussions anakinra started <NUMBER> mgkg per day <NUMBER> mg twice day subcutaneously increased <NUMBER> mgkg per day <NUMBER> mg twice day <NUMBER> h patient required inotropic support hypotension rising lactate <NUMBER> mmoll borderline leftventricular systolic dysfunction enzyme leak troponint <NUMBER> ngl aortic regurgitation pro gressive left coronary dilatation noted figure aspirin started <NUMBER> mgkg anti thrombotic effects note kawasaki diseaselike features including coronary aneurysms rep orted patients covid<NUMBER> <NUMBER> since coronary artery dilation occur context systemic inflammatory disease endothelial activation <NUMBER> patient show additional clinical features kawasaki disease start intravenous immuno globulin corticosteroids weighing risks associated intravenous immunoglobulin treatment ie thromboembolic events aseptic meningitis antibodydependent enhancement temporal relation anakinra treatment patients respiratory status stabilised clinical laboratory variables returned normal figure e exception coronary dilation persisted time discharge thus anakinra tapered discontinued <NUMBER> days subsequently serum tested positive sarscov<NUMBER> igg borderline day <NUMBER> positive day <NUMBER> sarscov<NUMBER> pcr three nasopharyngeal samples days <NUMBER> <NUMBER> <NUMBER> stool day <NUMBER> negative knowledge case first paediatric patient reported cytokine storm syndrome covid<NUMBER> pandemic presenting without respiratory symptoms hospital admission successfully treated il<NUMBER> inhibition although respiratory stool pcr testing negative ct chest findings biochemical haematological variables highly suggestive covid<NUMBER> evidence seroconversion considering pcr test sensitivity ranges around <NUMBER> three negative pcr results case could represent postcovid<NUMBER> inflammatory process alternative explanation could viral replication alternative site although patient developed earlystage acute respiratory distress syndrome ards hospital severe oxygenation defect bilateral pulmonary infiltrates respiratory symptoms part initial presentation thus case resembles previously unappreciated clinical phenotype covid<NUMBER> children rapid onset ards cytokine storm syndrome fever abdominal pain absence preceding respiratory symptoms <NUMBER> <NUMBER> based current pathophysiological standing sarscov<NUMBER> replicates respiratory intes tinal epithelial cells suppresses early type inter feron responses furthermore sarscov<NUMBER> abort ively infect innate immune cells monocytes macro phages facilitated immune com plexes accelerating viral replication amplify ing pro inflam matory cytokine il<NUMBER> il<NUMBER> tumour nec rosis factor tnf release process termed antibodydependent enhancement viral replication results tissue damage excessive recruitment innate adaptive immune cells mediates dysregulated hyperinflammatory response ferritin ngml creactive protein mgl ddimer ngml contributes cyto kine storm syndrome organ damage includ ing ards <NUMBER> addition direct cytopathic effect inflicted target organs pulmonary damage seen covid<NUMBER> probably augmented dominated unopposed dysregulated immune response ards occur patients primary secondary cytokine storm syndrome including systemic juvenile idiopathic arthritis resembling clinical picture reported patient finding could account rapid onset clinical imaging findings <NUMBER> since patient showed altered clotting prolonged prothrombin time activated partial thromboplastin time increased ddimer presence antiphospholipid antibodies pathologically reduced serum complement levels immune complex generation deposition could addition endothelial activation il<NUMBER> contributed activation complement clotting cascades <NUMBER> indeed postinfectious antiphospholipid syn drome thromboembolism reported context covid<NUMBER> <NUMBER> furthermore complement activa tion take place systemic inflammatory disorders systemic juvenile idiopathic arthritisassociated macrophage activa tion syndrome <NUMBER> offlabel treatment anakinra chosen limit proinflammatory cytokine expression could triggered antibodydependent enhancement invasion yet uninfected immune cells infected tissues note anakinra blocks il<NUMBER> receptor signalling induces expression il<NUMBER> il<NUMBER> tnf via activation nfκbdependent pathways <NUMBER> although clinical trials currently underway investigate il<NUMBER> blockade chose anakinra based action upstream il<NUMBER> less neutropenia liver enzyme elevation hypertriglyceridemia already present patients cytokine storm syndrome furthermore anakinra reduces mortality sepsis patients <NUMBER> whereas chronic use il<NUMBER> blocking agents might increase risk secondary infections anakinra treatment coincided clinical improvement stopped <NUMBER> days ongoing pandemic covid<NUMBER> must considered patients increased inflammatory vari ables abdominal symptoms onset cytokine storm syndrome ards rapid lifethreatening based time testing site infection pcr testing might remain negative anakinra safe effective inflammatory auto inflammatory disorders could beneficial covid<NUMBER>associated cytokine storm syndrome disordered host responses contribute path ology inflammatory endothelial activation antiphospho lipid antibodies complement activation promote pro inflammatory coagulopathic state anti thrombotic prophylaxis considered particularly presence coronary artery dilation aneurysm pros pective controlled trials necessary generate evidence stagespecific individualised treatment options covid<NUMBER> every minute american dies covid<NUMBER> cytokine storm multiorgan failure particularly acute respiratory distress syndrome ards leading causes mortality morbidity patients covid<NUMBER> fulminant ards kills majority covid<NUMBER> victims <NUMBER> also whispers survivors might develop pulmonary sequels investigations followups warranted case <NUMBER> <NUMBER> large number suggested treatments ivermectin hydroxychloroquine azithromycin currently investigation among hydroxychloroquine azithromycin recently remdesivir showed acceptable results clinical trials june <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> nevertheless results interventions completely satisfactory studies medications still warranted pirfenidone <NUMBER>methyl<NUMBER>phenyl<NUMBER>hpyridone novel antifibrotic agent trivial adverse effects <NUMBER> <NUMBER> <NUMBER> pirfenidone approved treatment idiopathic pulmonary fibrosis ipf humans patients mild moderate disease <NUMBER> <NUMBER> diverse action mechanisms suggested pirfenidone among downregulating effects series cytokines including transforming growth factor tgfβ<NUMBER> connective tissue growth factor ctgf plateletderived growth factors pdgf tumor necrosis factor tnfα <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> additionally pirfenidone reactive oxygen species ros scavenger last list pirfenidone downregulates expression ace receptor major cellular receptor covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> additioally characteristics pirfenidone makes appropriate treatment covid<NUMBER> among antiapoptotic antifibrotic effects pirfenidone details hypothesis discussed based known pirfenidone mechanism action pathophysiology covid<NUMBER> believe pirfenidone potential treatment covid<NUMBER> patients cytokine storm severe inflammation oxidative stress reactive oxygen species damage increased permeability vascular bed responsible development ards multiorgan damage patients covid<NUMBER> <NUMBER> <NUMBER> elderly patients particularly comorbidities dm cardiovascular disorder cancer increased risk severe manifestation covid<NUMBER> <NUMBER> <NUMBER> pathologic manifestation covid<NUMBER> microscope includes presence exudate vascular congestion inflammatory clusters fibrinoid material multinucleated giant cell reactive alveolar hyperplasia fibroblastic proliferation shown alive patients covid<NUMBER> underwent lung biopsy due cancer diagnosis covid<NUMBER> <NUMBER> <NUMBER> almost current promising treatments antiinflammatory characteristics beyond antibiotic effects example azithromycin hydroxychloroquine possess antiinflammatory effects <NUMBER> pirfenidone novel antifibrotic agent known several antifibrotic antiinflammatory oxygen radical scavengerantioxidant effects <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> antiinflammatory effects pirfenidone shown several experimental studies shown pirfenidone inhibits tnfα secretion decrease large number inflammatory cytokines well <NUMBER> <NUMBER> <NUMBER> <NUMBER> additionally li et al recent study shown pirfenidone ameliorates lipopolysaccharideinduced pulmonary inflammation fibrosis blocking nlrp<NUMBER> inflammasome activation <NUMBER> <NUMBER> shown several studies pirfenidone significantly inhibits tgfβ <NUMBER>induced fibronectin synthesis <NUMBER> <NUMBER> downregulating profibrotic gene expression collagen secretion shown humans animal models treated pirfenidone <NUMBER> <NUMBER> <NUMBER> reduction overexpression tgfβ inflammatory conditions plays key role antifibrotic activity pirfenidone <NUMBER> <NUMBER> pirfenidone inhibits collagen fibril formation causes reduction collagen fibril bundles <NUMBER> <NUMBER> <NUMBER> shown pirfenidone pleiotropic actions immune system extracellular matrix ecm hyaluronan major component ecm regulates tissue injury repair <NUMBER> recently upregulation rgs<NUMBER> suggested novel mechanism amelioration pulmonary fibrosis pirfenidone treatment <NUMBER> followings probable endpoints overactive inflammatory response wbc free radical formation microsome via microsomal nadph cytochrome c reductase mitochondria nadhquinone oxidoreductase innerouter membranes excitotoxicity damage lipids proteins apoptosis adpribosylation injury mitochondrial dna impaired activity <NUMBER> <NUMBER> <NUMBER> cytoskeletal damage lipid peroxidation destructive effects inflammation severe oxidative stress due cytokine storm <NUMBER> <NUMBER> <NUMBER> hence antioxidant character pirfenidone makes potent treatment hyperimmune response <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lipid peroxidation initiated generated superoxide cyclic reductionoxidation one mechanisms cytokine storminflammationoxidative stress endorgandamage pulmonary toxicity <NUMBER> shown pirfenidone could inhibit nadph dependent lipid peroxidation <NUMBER> <NUMBER> antiapoptotic effects pirfenidone shown fasdependent alveolar apoptosis results inflammatory reaction finally interstitial fibrosis responsible battle viruses also responsible sequels infections poxvirus bacterial lps etc <NUMBER> <NUMBER> hand shown pirfenidone could decrease apoptosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> regulation ace receptor expression ace receptors major covid<NUMBER>sars virus receptor humans trials targeted inhibition receptors antibodies investigation <NUMBER> surprisingly shown pirfenidone inhibits at<NUMBER>rp<NUMBER> mapk pathway decreased angiotensinconverting enzyme ace angiotensin ii angiotensin ii type <NUMBER> receptor expression strongly enhanced liver x receptorα expression <NUMBER> protect cells developing fibrosis lxrα also decreasing ace receptor expression decrease entrance covid<NUMBER>sars virus cells respect known characteristics pirfenidone antiinflammatory antifibrotic antioxidant current understanding severe covid<NUMBER> pathophysiology cytokine storm inflammation probable fibrosis hyperimmunity result oxidative stress rational suggest pirfenidone application treatment patients moderate severe covid<NUMBER>sars uncontrolled overreaction immune system virus leads release numerous inflammatory cytokines superoxide production ards development subsequently matrix remodeling overproduction collagen matrix components may cause fibrosis survivors <NUMBER> <NUMBER> <NUMBER> cytokine storm uncontrolled immune reaction responsible development multiorgan damage ards patients covid<NUMBER>sars <NUMBER> antiinflammatory effects pirfenidone shown several animal studies clinical trials antioxidant activity pirfenidone verified several experimental studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore antifibrotic effects pirfenidone shown several clinical trials tend fda approval drug treatment patients ipf <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> based pirfenidone characteristics therapeutic effects previously suggested treatment paraquat pirfenidone gradually opened space treatment protocols patients paraquat poisoning <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> previously saha et al successfully treated patients post h<NUMBER>n<NUMBER> ards pulmonary fibrosis combined pirfenidone azithromycin prednisolone <NUMBER> best knowledge mechanisms post h<NUMBER>n<NUMBER> ards fibrosis paraquat poisoning covid<NUMBER> share similarities additionally pirfenidone successfully improved treatment posth<NUMBER>n<NUMBER> ards fibrosis hence seems equitable evaluate potential pirfenidone treatment covid<NUMBER> <NUMBER> also pirfenidone suggested tried successfully treatment ards due white smokeinduced ards <NUMBER> another example zinc chloride smoke white smoke inhalation induced severe ards successfully treated combination pirfenidone corticosteroids <NUMBER> <NUMBER> verification hypothesis pirfenidone approved fda treatment patients ipf tolerated well trivial side effects <NUMBER> <NUMBER> <NUMBER> current situation enforced clinicians agencies relax strict preclinical approval extensive experimentation starting human experimental treatment clinical trials fact hands empty battle covid<NUMBER> urgent need treatment enforced us try possible probably safe treatment approved medications low side effects among suggested tried medications actually current standard care knowledge based experiments nevertheless limited number labs access animal models covid<NUMBER>sars conduct experimental studies parallel human trials time wait animal modeling animal models necessarily provide valid shreds evidence case terms toxicity efficacy treatments mortality virus almost always due interaction virus human immune system animals appropriate surrogate models <NUMBER> end day welldesigned doubleblind randomized controlled clinical trial best method appropriately analyze hypothesis limited number patients covid<NUMBER> present fulminant cytokine storm ards endorgan damage death toll limited number patients surpassed one half million recently human tragedy calls immediate intervention new therapeutic strategies considered treatment covid<NUMBER> however best knowledge pirfenidone tried yet discussed believe pirfenidone could safe add current protocols covid<NUMBER> treatment trivial side effects plenty potential benefits reviewing process article studies proposed similar point view <NUMBER> <NUMBER> <NUMBER> example parallel discussed george et also pointed shared risk factors covid<NUMBER> ipf mentioned burden lung fibrosis following covid<NUMBER> likely high concluded given scale pandemic global burden fibrotic lung disease probably increase considerably also suggested therapeutic rationale application approved antifibrotic therapy acute exacerbations ipf pirfenidone nintedanib among conclusion pirfenidone could inhibit apoptosis downregulate ace receptors expression decrease inflammation several mechanisms ameliorate oxidative stress hence protect pneumocytes cells covid<NUMBER> invasion cytokine storm simultaneously outbreak novel coronavirus disease <NUMBER> covid <NUMBER> induced severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> firstly found wuhan hubei province china december <NUMBER> rapidly spread worldwide becoming global public health emergency <NUMBER>th march <NUMBER> world health organization declared covid<NUMBER> pandemic <NUMBER> april <NUMBER> reports <NUMBER> million confirmed cases <NUMBER> <NUMBER> deaths worldwide <NUMBER> httpscovid<NUMBER>whoint isolation sarscov<NUMBER> viral genome sequenced thus facilitating diagnostic testing epidemiologic tracking well investigations potential preventive therapeutic strategies management covid<NUMBER> date despite intense scientific effort demonstrated <NUMBER> clinical trials currently underway typing sarscov<NUMBER> clinicaltrialsgov vaccines effective drugs approved prevent treat covid<NUMBER> current standard care supportive treatment therefore based fast global spread virus urgent investigations warranted order develop effective therapies within context treatments addressing immunopathology infection become major focus new humaninfecting sarscov<NUMBER> positivesense singlestranded rnaenveloped virus belonging cov family <NUMBER> among six covs pathogenic humans four associated mild respiratory symptoms <NUMBER> two sarscov middle east respiratory syndrome mers cov merscov whose epidemic outbreaks took place <NUMBER> <NUMBER> respectively caused severe respiratory diseases affected individuals <NUMBER> sarscov<NUMBER> seventh identified cov sarscov merscov third zoonotic virus covs transmitted animals humans via intermediate mammalian host <NUMBER> <NUMBER> particular based genetic analysis chinese horseshoe bats proposed serve natural reservoir hosts sarscov<NUMBER> similar sarscov merscov <NUMBER> <NUMBER> <NUMBER> moreover genomic analysis indicates sarscov<NUMBER> betacov clade sarscov merscov <NUMBER> particular sarscov<NUMBER> observed share almost <NUMBER> genome sarscov <NUMBER> almost encoded proteins sarscov<NUMBER> homologous sarscov proteins <NUMBER> contrast sarscov<NUMBER> found distant merscov <NUMBER> identity <NUMBER> moreover entry sarscov<NUMBER> human host cells found rely receptor sarscov surface angiotensinconverting enzyme <NUMBER> ace<NUMBER> expressed type ii surfactantsecreting alveolar cells lungs <NUMBER> <NUMBER> consistently despite amino acid variations specific key residues homology modeling revealed structural similarity receptorbinding domains sarscov sarscov<NUMBER> <NUMBER> however studies necessary compare sarscov sarscov<NUMBER> affinities ace<NUMBER> receptor might explain increased transmissibility greater virulence sarscov<NUMBER> compared sarscov <NUMBER> two independent groups provided key insights first step sarscov<NUMBER> infection demonstrating ace<NUMBER> host receptor required host cell entry sarscov<NUMBER> <NUMBER> <NUMBER> noteworthy expression ace<NUMBER> receptors restricted lung extrapulmonary spread sarscov aceexpressing tissues demonstrated <NUMBER> <NUMBER> <NUMBER> hence pattern may expected sarscov<NUMBER> human tissues oral mucosa gastrointestinal tract kidney heart blood vessels expressing ace<NUMBER> receptors particularly prone sarscov<NUMBER> infection <NUMBER> <NUMBER> viral entry sarscov<NUMBER> found prevented clinically proven inhibitor cellular host type <NUMBER> transmembrane serine protease tmprss<NUMBER> camostat mesylate <NUMBER> priming envelopelocated trimeric spike protein host proteases cleave s<NUMBER> s<NUMBER> s<NUMBER> sites described fundamental step viral entry host protease tmprss<NUMBER> emerged key cellular factor necessary priming protein consequent membrane fusion viral internalization endocytosis pulmonary epithelium <NUMBER> hence tmprss<NUMBER> proposed potential target clinical intervention <NUMBER> <NUMBER> inhibitor camostat mesylate approved human use japan treat pancreatic inflammation attracted attention scientific community currently randomized placebocontrolled phase iia trial investigating use camostat mesylate nct<NUMBER> expected run december <NUMBER> whereas another independent trial start june <NUMBER> evaluate efficacy camostat mesilate combination hydroxychloroquine hospitalized patients moderate covid<NUMBER> infection nct<NUMBER> detailed analysis additional mechanisms cellular viral infection sarscov<NUMBER> still missing would fundamental identify potential biological substrates target majority covid<NUMBER> cases <NUMBER> asymptomatic exhibits mild moderate symptoms approximately <NUMBER> progresses severe pneumonia <NUMBER> eventually develops acute respiratory distress syndrome ards septic shock andor multiple organ failure <NUMBER> <NUMBER> sars mers common symptoms covid<NUMBER> fever fatigue respiratory symptoms including cough sore throat shortness breath <NUMBER> <NUMBER> notably sarscov<NUMBER> infection activates innate adaptive immune response thus sustaining resolution covid<NUMBER> rapid wellcoordinated immune response represents first line defense viral infection excessive inflammatory innate response dysregulated adaptive host immune defense may cause harmful tissue damage site virus entry systemic level excessive proinflammatory host response hypothesized induce immune pathology resulting rapid course acute lung injury ali ards occurring sarscov<NUMBER> infected patients <NUMBER> <NUMBER> <NUMBER> example massive cytokine chemokine release socalled cytokine storm clearly reflects widespread uncontrolled dysregulation host immune defense thus given key role immune system covid<NUMBER> deeper understanding mechanism behind immune dysregulation well sarscov<NUMBER> immuneescape mechanisms might give us clues clinical management severe cases preventing transition mild severe stages moreover although within goal present review future investigations concerning systemic effects uncontrolled immune system physiological systems gastrointestinal tract neuroendocrine renal cardiovascular urgent immune response sarscov<NUMBER> several studies highlight relevant changes occurring innate adaptive immune system covid<NUMBER> patients particular lymphocytopenia modulation total neutrophils common hallmarks seem directly correlated disease severity death <NUMBER> <NUMBER> patients severe covid<NUMBER> marked decrease levels absolute number circulating cd<NUMBER> cells cd<NUMBER> cells b cells natural killers nk cells <NUMBER> <NUMBER> <NUMBER> well decrease monocytes eosinophils basophils reported <NUMBER> <NUMBER> <NUMBER> addition patients severe covid<NUMBER> displayed significantly increased serum levels proinflammatory cytokines eg il<NUMBER> il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> gcsf gmcsf ip<NUMBER> mcp<NUMBER> ccl<NUMBER> tnfα <NUMBER> <NUMBER> although direct evidence proinflammatory cytokines chemokines involvement lung pathology covid<NUMBER> reported increase serum cytokine chemokine levels well neutrophillymphocyteratio nlr sarscov<NUMBER> infected patients correlated severity disease adverse outcomes suggesting possible role hyperinflammatory responses covid<NUMBER> pathogenesis <NUMBER> moreover recent multicenter retrospective cohort study analyzing data early risk stratification novel coronavirus pneumonia erscovid<NUMBER> study chictr<NUMBER> showed patients covid<NUMBER> elevated highsensitivity creactive protein hscrp procalcitonin serum levels two major inflammation markers associated high risks mortality organ injury <NUMBER> noteworthy merscov demonstrated infect thp<NUMBER> cells human peripheral blood monocytederived macrophages dendritic cells sarscov directly infect macrophages cells <NUMBER> thereby inducing delayed elevated levels proinflammatory cytokines chemokines <NUMBER> <NUMBER> however ace<NUMBER> receptor minimally expressed monocytes macrophages cells lung hence mechanism sarscov directly infects immune cells still unknown <NUMBER> taking account similarities sarscov sarscov<NUMBER> likely also latter may infect monocytes macrophages mechanism still unveiled regard possible virus may capable bind specific receptors andor mechanisms viral entry mode exploited virus far concerns adaptive immunity novel sarscov<NUMBER> demonstrated mainly affect lymphocyte counting balance particular li et al reported compared survivors dead covid<NUMBER> patients showed lower percentage count cd<NUMBER> cd<NUMBER> cd<NUMBER> lymphocytes populations strong predictive values inhospital mortality organ injury severe pneumonia <NUMBER> retrospective singlecenter study enrolling cohort <NUMBER> patients covid<NUMBER> wuhan patients severe covid<NUMBER> displayed significantly lower number total cells helper cells suppressor cells <NUMBER> particular among helper cells decrease regulatory cells pronounced reduction according severity cases memory cells observed whereas percentage naïve cells found increased <NUMBER> notably naïve memory cells essential immune components whose balance crucial maintaining highly efficient defensive response naïve cells enable defenses new previously unrecognized infection massive tightly coordinated release cytokines whereas memory cells mediate antigenspecific immune response dysregulation balance favoring naïve cells activity compared regulatory cells could highly contribute hyperinflammation reduction memory cells hand could implicated covid<NUMBER> relapse since number recurrences reported recovered cases covid<NUMBER> <NUMBER> <NUMBER> data consistent results reported tan et al <NUMBER> overall lymphopenia observed covid<NUMBER> patients may depend fact sarscov<NUMBER> may directly infect lymphocytes minimally expressing ace<NUMBER> leading lymphocyte death alternatively may directly damage lymphatic organs since express ace<NUMBER> receptors <NUMBER> however date data available lymph nodes spleen shrinking lymphocytes functionalities hence speculations need investigated confirm hypotheses far concerns b cells using singlecell rna sequencing characterize transcriptome landscape blood immune cell subsets recovery stage covid<NUMBER> wen et al <NUMBER> found significant changes b cells particular naïve b cells reported decreased plasma cells found remarkably increased peripheral blood mononuclear cells <NUMBER> moreover several new b cellreceptor changes identified eg ighv<NUMBER> ighv<NUMBER> <NUMBER> addition isotypes including ighv<NUMBER> ighv<NUMBER> igkv<NUMBER> previously used virus vaccine development confirmed <NUMBER> strongest pairing frequencies ighv<NUMBER>ighj<NUMBER> suggested indicate monoclonal state associated sarscov<NUMBER> specificity <NUMBER> moreover given pivotal role b cells control infections tracking antibody seroconversion response important process clinical evaluation infections covid<NUMBER> patients serum samples patients covid<NUMBER> showed crossbinding s<NUMBER> subunit sarscov spike antigen crossreactivity serum samples observed patients covid<NUMBER> nucleocapsid antigens sarscov <NUMBER> interestingly study reports <NUMBER> tested patients achieved seroconversion igg igm within <NUMBER> days symptom onset titer plateaued within <NUMBER> days seroconversion <NUMBER> moreover <NUMBER> patients positive virusspecific igg approximately <NUMBER> days symptom onset <NUMBER> instead <NUMBER> patients showed positive virusspecific igm approximately <NUMBER> days symptom onset <NUMBER> addition observations immunity critical aspect raised concerning ability escape antiviral host defenses viral evasion host immune response fact believed play major role disease severity <NUMBER> example sarscov merscov escape suppress signaling pathways mediated type interferon ifn key cytokine secreted virusinfected cells enroll nearby cells heighten antiviral immune defenses <NUMBER> based genomic sequence comparison partial identity sarscov<NUMBER> sarscov speculative sarscov<NUMBER> adopt similar strategies modulate host innate immune response thus evading immune detection dampening human defenses inflammatory cytokine storm lung damage mounting clinical evidence severe covid<NUMBER> patients suggests extensive changes serum levels several cytokines play pivotal role pathogenesis covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> hypercytokinemia socalled cytokine storm proposed one key leading factors trigger pathological processes leading plasma leakage vascular permeability disseminated vascular coagulation observed covid<NUMBER> patients accounting lifethreatening respiratory symptoms <NUMBER> huang et al <NUMBER> found plasma concentrations il<NUMBER>β il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> basic fgf gcsf gmcsf ifnγ ip<NUMBER> mcp<NUMBER> mip<NUMBER>α mip<NUMBER>β pdgf tnfα vegf higher icu intensive care unit patients nonicu patients healthy adults moreover comparing icu nonicu patients plasma concentrations il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>α tnfα higher icu patients nonicu patients thus indicating cytokine storm might correlated disease severity <NUMBER> another study small set patients severe covid<NUMBER> pneumonia found <NUMBER> cytokines ifnα<NUMBER> ifnγ il<NUMBER>ra il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> chemokine ip<NUMBER> well gcsf mcsf associated lung injury based murray score <NUMBER> evidence literature indicates cytokine storm observed covid<NUMBER> resembles occurring cytokines release syndrome crs form systemic inflammatory response syndrome secondary haemophagocytic lymphohistiocytosis shlh hyperinflammatory syndrome characterized fulminant fatal hypercytokinemia multiorgan failure mainly induced viral infections <NUMBER> <NUMBER> therefore detailed existing pharmaceutical modulators cytokines might repurposed therapeutic strategy attenuate hypercytokinemia covid<NUMBER> patients interestingly gou et al <NUMBER> recently reported disruption gut microbiome features host environmental factors may predispose healthy individuals abnormal inflammatory response observed covid<NUMBER> particular authors constructed blood proteomic risk score prediction covid<NUMBER> progression clinically severe phase observed core gut microbiota features significantly correlated proinflammatory cytokines set <NUMBER> individuals using machine learning model <NUMBER> specifically bacteroides genus streptococcus genus clostridiales order negatively correlated tested inflammatory cytokines whereas ruminococcus genus blautia genus lactobacillus genus positively associated <NUMBER> moreover fecal metabolomics analysis indicated potential amino acidrelated pathways eg aminoacyltrna biosynthesis pathway arginine biosynthesis pathway valine leucine isoleucine biosynthesis pathway correlate core microbial features host inflammation among <NUMBER> participants <NUMBER> thus core intestinal microbiological characteristics along related metabolites investigated potential predictors individual susceptibility covid<NUMBER> progression severity might represent potential targets prevention susceptible populations well development therapeutic approaches manage covid<NUMBER> wellestablished upon binding viral spike protein host cells entry receptor ace<NUMBER> viral rnas pathogenassociated molecular patterns pamps detected pattern recognition receptors include family tolllike receptors tlrs particular rna virus covs viral genomic rna intermediates viral replication including dsrna recognized either endosomal rna receptors tlr<NUMBER> tlr<NUMBER> cytosolic rna sensor retinoic acidinducible gene rigimda<NUMBER> <NUMBER> consistently tlrs found activate different signaling pathways human cd<NUMBER> monocytes correlating differential type ifn cytokine secretion involved cd<NUMBER> cells polarization <NUMBER> result virus recognition downstream transduction pathways crucial proper antiviral response irf<NUMBER> ifn regulatory factor<NUMBER> nuclear factor κb nfκb jak janus kinasestat signal transducer activator transcription signaling pathways activated <NUMBER> identification relevant intracellular signaling pathways involved modulation host immune systems may give important hints overcome infectious disease driven sarscov<NUMBER> particular taking account structural similarities sarscov<NUMBER> well analogies infection mechanisms pathogenic sarscov tempting speculate viral infection may induce activation shared intracellular pathways particular mainly involved innate immune response however date demonstrated whether sequence similarities sarscov sarscov<NUMBER> directly translated similar biological outcomes taking account limitation identification signaling pathways altered viral infections may help unravel relevant molecular cascades implicated biological processes mediating viral infections unveil key molecular players may targeted advantage targeting intracellular molecules rather viral proteins effect likely negated mutations virus genome fact antiviral drugs inhibiting virus replication may select mutational escape thus rendering therapy ineffective thus modulation host immune response shows potential advantage exerting lessselective pressure viral populations <NUMBER> repurposing existing drugs targeting specific signal transducers discussed potential treatment options management covid<NUMBER> schematized fig <NUMBER> nfκbtnfα signaling pathway transcription factor nfκb critical regulator innate adaptive immunity <NUMBER> basal conditions nfκb retained cytoplasm inhibitory proteins iκbs variety cellular stimuli including pathogens induce iκb phosphorylation ubiquitination degradation proteasome thereby promoting nfκb nuclear translocation <NUMBER> nucleus nfκb induces transcription wide spectrum genes encoding proinflammatory cytokines chemokines stressresponse proteins antiapoptotic proteins nfκb activity essential survival activation initiating propagating optimal immune responses <NUMBER> contrast constitutive activation nfκb pathway often associated inflammatory diseases rheumatoid arthritis asthma notably exacerbation nfκb activation reported implicated lung inflammatory immunopathology induced respiratory viruses including sarscov <NUMBER> <NUMBER> moreover wang collaborators demonstrated murine macrophages cell line raw<NUMBER> exposure recombinant sarscov spike protein induced massive protein release il<NUMBER> tnfα timeand concentrationdependent manner supernatants increase il<NUMBER> tnfα secretion relies activation nfκb signaling pathway <NUMBER> fact sarscov spike protein associated increase iκbα degradation essential step required activation nfκb signaling pathway <NUMBER> accordingly transfection dominantnegative nik inhibits nfκb activation produced strong reduction spike protein il<NUMBER> tnfα release raw<NUMBER> cells thus demonstrating nfκb required induction il<NUMBER> tnfα sarscov spike protein <NUMBER> vitro data consistent results obtained vivo treatments drugs inhibiting nfκb activation caffeic acid phenethyl ester cape bay <NUMBER> parthenolide reduced inflammation suppressing mrna expression tnfα cxcl<NUMBER> mcp<NUMBER> lung sarscovinfected mice moreover pharmacological inhibition nfκb protected pulmonary pathology enhanced mice survival sarscov infection <NUMBER> line findings smits et al demonstrated sarscovinfected aged macaques show lungs increase nfκb nuclear translocation result nfκb activation developed stronger host response virus infection compared young adult macaques significant increase expression proinflammatory genes mainly regulated nfκb <NUMBER> taken together data suggest nfκb inhibition might effective strategy counteract pathogenic sarscov however targeting nfκb approach strongly limited intrinsic pathways complexity molecules blocking nfκb lack specificity interfere nfκb physiological roles cellular homeostasis resulting increased risk undesired side effects broad suppression innate immunity <NUMBER> moreover within context viral infection major limitation targeting nfκb signaling depends ability viruses efficiently escape encoding proteins specifically blocking pathway <NUMBER> thus promising strategy may rely directly targeting downstream effectors pathway tnfα whose expression mainly controlled nfκb transcriptional activity tnfα known play key role coordination development inflammatory response especially acute phase longlasting excessive production tnfα may become less effective possibly altering tnftnf receptor signaling threshold initial wave nfκb activation favors sustained basal nfκb activity <NUMBER> addition despite many proinflammatory cytokines mediators involved cytokine storm specific blockade tnfα reported clinically effective several pathological conditions accordingly tnfα blockers infliximab adalimumab successfully used treatment several immunemediated disorders psoriasis rheumatoid arthritis inflammatory bowel diseases ankylosing spondylitis <NUMBER> <NUMBER> hence antitnfα monoclonal antibodies likely attenuate inflammatory processes occurring covid<NUMBER> reducing release inflammatoryexacerbating mediators indeed antitnfα administrated patients active rheumatoid arthritis demonstrated induce rapid decrease broad spectrum cytokines eg il<NUMBER> il<NUMBER> well others acutephase related proteins vascular permeability factor <NUMBER> <NUMBER> <NUMBER> furthermore envelope viral spike protein sarscov found promote activity tnfαconverting enzyme tacedependent shedding ace<NUMBER> receptor fundamental step virus entry cell <NUMBER> thus tnfα blockers represent effective therapeutic tools counteract sarscov infection exerting dual mechanism action attenuation inflammation inhibition viral infection <NUMBER> however warnings potential increased risk bacterial fungal superinfections due antitnfα therapy taken account <NUMBER> taking account sequence similarities sarscov sarscov<NUMBER> strong limitation directly inhibiting nfκb date clinical trial investigating adalimumab management covid<NUMBER> registered chinese clinical trial registry chictr<NUMBER> expected run august <NUMBER> however investigations concerning use safety tnfαblockers covid<NUMBER> patients urgently needed addition concerning potential intervention nfκb signaling pathway serine protease inhibitors trypsinlike serine proteases eg camostat mesylate nafamostat mesylate gabexate mesylate ulinastatin used treatment pancreatitis disseminated intravascular coagulation anticoagulant hemodialysis <NUMBER> <NUMBER> found inhibit viral replication <NUMBER> <NUMBER> attenuate inflammatory processes different pathological contexts asthma chronic allergic pulmonary inflammation inflammatory myocardial injury <NUMBER> <NUMBER> <NUMBER> <NUMBER> instance nafamostat mesylate gabexate mesylate demonstrated attenuate allergeninduced airway inflammation eosinophilia mouse model allergic asthma <NUMBER> thus reducing mast cell activation eosinophils infiltrations lung dermatophagoides pteronyssinusdriven il<NUMBER> tnfα production bronchoalveolar lavage fluid <NUMBER> furthermore treatment nafamostat mesylate downregulated expression il<NUMBER>β tnfα il<NUMBER> eotaxin inducible synthase inos cd<NUMBER> nfκb activation enhanced expression il<NUMBER> il<NUMBER> dermatophagoides pteronyssinusdriven il<NUMBER> tnfα production bronchoalveolar lavage fluid <NUMBER> moreover gabexate mesylate found inhibit lpsinduced tnfα production human monocytes blocking nfκb mitogenactivated protein kinase activation <NUMBER> thus pharmacological profile serine protease inhibitors inhibitors complement pathways broadspectrum antiinflammatory agents provide strong rationale use management covid<NUMBER> however specific mechanism action serine protease inhibitors induce antiinflammatory effects still unknown il<NUMBER>jakstat signaling pathway first discovered primary mediator intracellular signaling induced ifn hematopoietic immune cells jakstat signaling key pathway transducing extracellular signals transmitted large number cytokines lymphokines growth factors particular subset cytokines employs jakstat signaling pathway order induce biological effects notably one major activators jakstat signaling cytokine il<NUMBER> reported dramatically increased covid<NUMBER> patients <NUMBER> strong implication acute inflammation cytokine storm particular il<NUMBER> reported activate numerous cell types expressing glycoprotein gp<NUMBER> receptor membranebound il<NUMBER> receptor well soluble form il<NUMBER> receptor interacting gp<NUMBER> thereby promoting downstream activation jakstat signaling <NUMBER> turn activation jakstat pathway reported stimulate production il<NUMBER> <NUMBER> signaling pathway reported aberrantly activated patients chronic inflammation conditions arthritis rheumatoid likely excessive overactivation may also occur covid<NUMBER> patients thereby exacerbating host inflammatory response noteworthy chronic elevation circulating il<NUMBER> widely recognized predictor increased risk cardiovascular events <NUMBER> <NUMBER> consistently il<NUMBER> produced several tissues including activated macrophages endothelial smooth muscle cells promotes secretion cytokines among others stimulates mcp<NUMBER> secretion macrophages promote atherogenesis <NUMBER> increases expression cell adhesion molecules <NUMBER> <NUMBER> stimulates proliferation migration vascular smooth muscle cells <NUMBER> thus abnormal increase il<NUMBER> levels may implicated least part occurrence cardiovascular diseases eg coronary atherosclerosis inflammation vascular system resulting diffuse microangiopathy thrombosis observed covid<NUMBER> patients <NUMBER> accordingly synthesis secretion il<NUMBER> demonstrated induced angiotensin ii locally produced inflamed vessels jakstatdependent manner <NUMBER> particular angiotensin ii binding angiotensin ii receptor type <NUMBER> <NUMBER> receptor found activate jak stat pathway promote downstream production il<NUMBER> <NUMBER> <NUMBER> increased angiotensin ii enhances il<NUMBER> production <NUMBER> jakstatdependent manner thus establishing positive inflammatory feedback loop interestingly spike protein sarscov demonstrated downregulate ace<NUMBER> expression thus resulting overproduction angiotensin ii related enzyme ace <NUMBER> <NUMBER> similar way could hypothesized sarscov<NUMBER> may downregulate ace<NUMBER> receptors thus leading overproduction angiotensin ii turn enhancing il<NUMBER> production <NUMBER> jakstatdependent manner ultimately driving vascular inflammation lung injury clinical signatures covid<NUMBER> fig <NUMBER> moreover angiotensin iiat <NUMBER> receptor axis reported also activate nfκb adam<NUMBER> <NUMBER> notably important substrate adam<NUMBER> ace<NUMBER> whose cleavage adam<NUMBER> reported inactivate enhancing angiotensin ii retention thus leading hypertension cardiovascular remodeling types pathophysiology associated enhancement reninangiotensin system <NUMBER> beside implication shedding ace<NUMBER> receptor fundamental virus entry <NUMBER> adam<NUMBER> induction found process membrane form il<NUMBER> receptor α il<NUMBER>rα soluble form sil<NUMBER>rα followed gp<NUMBER>mediated activation stat<NUMBER> via sil<NUMBER>rαil<NUMBER> complex variety il<NUMBER>rαnegative nonimmune cells <NUMBER> activation stat<NUMBER> reported required complete induction nfκb pathway <NUMBER> thus sarscov<NUMBER> infection may activate nfκb stat<NUMBER> signaling turn promote il<NUMBER> amplifier mechanism required hyperactivation nfκb stat<NUMBER> thereby inducing multiple inflammatory autoimmune diseases <NUMBER> il<NUMBER> amplifier promotes production secretion several proinflammatory cytokines chemokines il<NUMBER> recruitment lymphoid myeloid cells sustaining il<NUMBER> amplifierdriven positive feedback loop proposed hirano murakami <NUMBER> fig <NUMBER> furthermore metalloprotease adam<NUMBER> found mediate angiotensin iiinduced egfr epidermal growth factor receptor transactivation generating mature form heparinbinding egflike growth factor vascular smooth muscle cells thus leading vascular remodeling <NUMBER> notably egfr transactivation critical angiotensin iimediated cardiovascular complications <NUMBER> regard egfr kinase inhibitor erlotinib recently repurposed treatment covid<NUMBER> based capability reduce infectivity wide range viruses <NUMBER> <NUMBER> <NUMBER> beside antiviral activity implication egfr transactivation cardiovascular complications represent another theoretical foundation use erlotinib management covid<NUMBER> patients moreover given importance angiotensin iiat <NUMBER> receptor axis attempt use angiotensin iireceptor blockers therapeutic benefit covid<NUMBER> targeting host response virus made <NUMBER> however use needs deepened since ace inhibitors angiotensin iireceptor blockers suggested increase risk covid<NUMBER> infection upregulating ace<NUMBER> <NUMBER> whether patients fig <NUMBER> hypothetical mechanism sarscov<NUMBER> establishing inflammatory feedback loop il<NUMBER> angiotensin ii cytokine il<NUMBER> found increased covid<NUMBER> patients thus suggesting direct role sarscov<NUMBER> massive cytokine release il<NUMBER> able activate soluble form il<NUMBER> receptor interacting gp<NUMBER> thereby promoting downstream activation jakstat signaling thely production il<NUMBER> moreover sarscov<NUMBER> directly related occurrence cardiovascular implications coronary atherosclerosis inflammation vascular system diffuse microangiopathy thrombosis synthesis secretion il<NUMBER> directly implicated cardiovascular damages indeed il<NUMBER> production also induced angiotensin ii <NUMBER> jakstatdependent manner observed sarscov also sarscov<NUMBER> may hypothesized downregulate ace<NUMBER> expression thus resulting overproduction angiotensin ii related enzyme ace turn increased angiotensin ii enhances il<NUMBER> production via jakstat pathway thus establishing positive inflammatory feedback loop ultimately resulting exacerbation vascular lung injuries moreover angiotensin iiat <NUMBER> receptor axis activates adam<NUMBER> cleavages inactivates ace<NUMBER> enhancing angiotensin ii retention addition adam<NUMBER> induction found process membrane form il<NUMBER>rα soluble form sil<NUMBER>rα followed gp<NUMBER>mediated activation stat<NUMBER> via sil<NUMBER>rαil<NUMBER> complex variety il<NUMBER>rαnegative nonimmune cells il<NUMBER> amplifier promotes production secretion several proinflammatory cytokines chemokines il<NUMBER> sustaining il<NUMBER> amplifierdriven positive feedback sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> il<NUMBER> interleukin <NUMBER> ace<NUMBER> angiotensinconverting enzyme <NUMBER> <NUMBER> angiotensin ii receptor type <NUMBER> jak janus kinase stat signal transducer activator transcription adam<NUMBER> disintegrin metalloproteinase domaincontaining protein <NUMBER> affected covid<NUMBER> hypertension taking ace inhibitors angiotensin iireceptor blockers switch another antihypertensive drug still matter debate evidence required since il<NUMBER> appears key driver cytokine storm consequent detrimental effects monoclonal antibodies il<NUMBER> tocilizumab sarilumab also proposed dampen process tocilizumab monoclonal antibody il<NUMBER> receptor antagonist approved treatment rheumatoid arthritis crs used clinical practice order manage severe cases covid<NUMBER> included current chinese national treatment guidelines httpswwwchinalawtranslatecomwpcontentuploads<NUMBER> <NUMBER>whotranslationpdf date <NUMBER> clinical trials typing covid<NUMBER> tocilizumab clinicaltrialsgov clinicaltrialsregister eu underway test tocilizumab alone combination patients covid<NUMBER> moreover <NUMBER> clinical trials typing covid<NUMBER> tocilizumab clinicaltrialsgov clinicaltrialsregistereu study efficacy safety another il<NUMBER> receptor antagonist sarilumab approved treatment rheumatoid arthritis patients covid<NUMBER> beside monoclonal antibodies specifically targeting il<NUMBER> approved drugs inhibiting il<NUMBER>jakstat signaling may represent valuable tool particular jak signaling inhibitors baricitinib fedratinib ruxolitinibapproved indications rheumatoid arthritis myelofibrosishave reported attenuate host inflammatory response associated massive proinflammatory cytokine chemokine release <NUMBER> based antiinflammatory effect likely effective consequences elevated levels cytokines typically observed patients covid<NUMBER> <NUMBER> among baricitinib selective inhibitor jak <NUMBER> <NUMBER> predicted crystallographic studies inhibit two members numbassociated kinase family ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> cyclin gassociated kinase gak thus hindering viral endocytosis lung cells concentration approved treatment arthritis rheumatoid <NUMBER> however despite undeniable advantages repurposing baricitinib general jak inhibitors management covid<NUMBER> debated particular concerns arise mainly evidence reporting activation jakstat pathway mediated ifns required induction many ifnregulated genes playing pivotal role innate early defense system viral infections defensive role jakstat pathway corroborated evidence demonstrating majority virus developed escaping strategies production viralencoded factors blocking pathway recognized crucial determinants virulence <NUMBER> therefore inhibition jakstat signaling likely produce impairment ifnrelated antiviral response exacerbating sarscov<NUMBER> infection however since several benefits blockage virus entry attenuation host excessive inflammatory response well vascular lung damage provide strong rationale use baricitinib management covid<NUMBER> patients balance positive negative aspects jakstat signaling inhibition still drawn date several clinical trials testing efficacy safety jak inhibitors covid<NUMBER> patients typing covid<NUMBER> jak inhibitors clinicaltrialsgov clinicaltrialsregistereu sphingosine<NUMBER>phosphate receptor <NUMBER> pathway sphingosine<NUMBER>phosphate s<NUMBER>p <NUMBER> emerged crucial signaling lipid regulator inflammation immune response including lymphocyte trafficking vascular integrity cytokine chemokine production <NUMBER> beside s<NUMBER>p role second messenger inflammation s<NUMBER>p effects innate adaptive immunity mediated binding five gproteincoupled receptors s<NUMBER>prs <NUMBER> differentially expressed tissues <NUMBER> among s<NUMBER>p <NUMBER> receptor ubiquitously expressed coupled g inhibitory protein <NUMBER> activation s<NUMBER>p <NUMBER> receptor associated raserk pi<NUMBER>kaktenos plcca <NUMBER> downstream pathways <NUMBER> notably physiological pathological conditions s<NUMBER>ps<NUMBER>pr <NUMBER> axis demonstrated regulate trafficking migration numerous types immune cells including b lymphocytes nk cells dendritic cells <NUMBER> moreover s<NUMBER>p <NUMBER> receptor signaling pathways reported inhibit pathological damage induced host innate adaptive immune responses thus attenuating cytokine storm observed influenza virus infection <NUMBER> particular teijaro et al <NUMBER> demonstrated mice infected awisconsinwslh<NUMBER> influenza virus s<NUMBER>p <NUMBER> receptor subtype regulates crucial signaling loop fundamental initiation cytokine storm respiratory endothelial cells administration s<NUMBER>p <NUMBER> agonist blunted cytokine storm significantly inhibiting secretion cytokines chemokines associated influenza virusinduced pathology ifnα ccl<NUMBER> il<NUMBER> tnfα ifnγ <NUMBER> notably endothelial cells suppression early innate immune responses s<NUMBER>p <NUMBER> signaling found decrease mortality influenza virus infection mice <NUMBER> interestingly later work group activation s<NUMBER>p <NUMBER> signaling demonstrated block cytokine chemokine production well immune cell activation recruitment lungs mice infected h<NUMBER>n<NUMBER> wsn strain influenza virus <NUMBER> moreover s<NUMBER>p <NUMBER> agonism found reduce cytokine storm independently tlr<NUMBER> tlr<NUMBER> signaling well multiple endosome cytosolic innate pathogensensing pathways <NUMBER> contrast s<NUMBER>p <NUMBER> r agonism found suppress cytokine chemokine production targeting myd<NUMBER> myeloid differentiation primary response gene <NUMBER>trif tirdomaincontaining adapterinducing ifnβ signaling two common actors nfκb pathway <NUMBER> however s<NUMBER>p <NUMBER> r agonism likely modulate signaling pathways yet identified thus based effects s<NUMBER>p receptor signaling multiple immunological processes indicating pathway promising modulation harmful inflammatory responses application therapies targeting s<NUMBER>p s<NUMBER>p signaling may repurposed immunemediated disorders inflammatory conditions covid<NUMBER> instance sp<NUMBER> agonists approved multiple sclerosis fingolimod might used therapeutic tools dampen cytokine chemokine responses patients displaying excessive immune responses date one nonrandomized phase ii clinical trial underway establish efficacy fingolimod treatment covid<NUMBER> nct<NUMBER> typing covid<NUMBER> fingolimod clinicaltrialsgov covid<NUMBER> pandemic induced novel sarscov<NUMBER> represents one greatest global public health emergencies since pandemic influenza outbreak <NUMBER> provides unprecedented challenge identification preventive therapeutic drugs particular vaccines effective therapeutics tackle novel virus urgently needed fortunately last decade vaccine technology significantly evolved development several rna dna vaccine candidates licensed vectored vaccines recombinant proteins cell culturebased vaccines many indications <NUMBER> moreover given similarities sarscov<NUMBER> sarscov ideal target vaccine spike protein surface virus required viral entry quickly identified providing target antigen incorporate advanced vaccine platforms thus antibodies specifically targeting protein block binding sarscov<NUMBER> host ace<NUMBER> receptor thus neutralizing virus however given lesson learned sars mers development vaccine sarscov<NUMBER> likely uphill road several obstacles fact several vaccines sarscov including recombinant proteinbased vaccines already developed tested animal models many produce sterilizing immunity animal models andor induced severe side effects lung liver damage <NUMBER> <NUMBER> date human cov vaccines approved far moreover complicate scenario still unveiled whether infection covs induces longlived antibody response protecting risk relapsing infections thus scientific community overcome several issues development effective safe sarscov<NUMBER> vaccine regard ling et al recently detected sarscov<NUMBER>specific humoral cellular immunity <NUMBER> covid<NUMBER> patients recently become virusfree consequently discharged <NUMBER> addition neutralizing antibody titers significantly correlated numbers nucleocapsid proteinspecific cells <NUMBER> evidence indicates b cells cooperate protect host viral infection notably despite small sample size study laid theoretical foundation diagnosis infectious diseases tracing past infections well development therapeutic antibody drugs design effective vaccine consistently long et al reported acute antibody responses sarscov<NUMBER> cohort <NUMBER> patients covid<NUMBER> <NUMBER> particular <NUMBER> days symptom onset <NUMBER> patients tested positive antiviral igg seroconversion igg igm reported occur simultaneously sequentially <NUMBER> thus serological testing might useful identify suspected patients negative rtpcr results well asymptomatic infections <NUMBER> however speed sarscov<NUMBER> spreading emphasized urgent need identify alternative therapeutic strategies order contain viral infection attenuate excessive host immune response lag vaccine availability especially scenario virus may become endemic recurrent seasonal epidemics may occur regard several antiviral drugs remdesivir lopinavir ritonavir currently tested several clinical trials either alone combination compassionate use drugs already reported sarscov<NUMBER> <NUMBER> <NUMBER> however antiviral drugs might select mutational escape thus rendering therapeutic approach ineffective moreover still unconfirmed reports indicate sufficient preclinical rationale evidence regarding use chloroquine hydroxychloroquine prophylactic agent <NUMBER> evidence safety longtime use clinical practice treatment malaria autoimmune diseases <NUMBER> however use needs evidence clinical evaluation chloroquine hydroxychloroquine known potentially cause heart rhythm problems may exacerbated whether combined drugs similar effects heart induce adverse liver kidney cerebral effects <NUMBER> thus discussed review treatments addressing immunopathology infection immunomodulatory drugs approved different clinical indications become major focus approaches show advantage override viral mutational escape exert lessselective pressure viral population although prospective counteracting cytokine storm compelling major limitation relies limited understanding immune signaling pathways triggering process hence future dissection immune signaling pathways triggered sarscov<NUMBER> provide novel insight effects virus human immune system may reveal relevant biological players targeted blunt cytokine storm notably since well established innate immune responses trigger activation multiple redundant signaling pathways effective therapy may require acting time multiple signaling pathways regard cocktails immunomodulatory drugs monoclonal antibody targeting specific cytokine eg tnfinhibitors il<NUMBER>inhibitors il<NUMBER> inhibitors corticosteroids eg prednisone methylprednisolone dexamethasone s<NUMBER>pr <NUMBER> agonists eg fingolimod rather single drug might effective management covid<NUMBER> exerting either synergic additive effects regard would key importance assess whether patients immunemediated disorders treated immunomodulatory drugs cytokine blockers resistant excessive immune response observed covid<NUMBER> patients protected sarscov<NUMBER>driven pneumonia however date evidence reporting either decreased increased risk sarscovdriven pneumonia documented patients investigations required verify hypothesis furthermore another aspect better investigate concerns possibility uncontrolled immune response viral infection may cause detrimental systemic effects several physiological systems nervous endocrine renal cardiovascular systems accordingly likely massive cytokine chemokine release may critically impact physiological systems thereby inducing shortand longterm detrimental effects example neuroinvasive potential sarscov merscov previously reported <NUMBER> thus given high similarity sarscov sarscov<NUMBER> likely latter displays similar potential <NUMBER> matter fact study carried <NUMBER> covid<NUMBER> patients reported <NUMBER> severe covid<NUMBER> cases showed neurologic manifestations acute cerebrovascular diseases impaired consciousness <NUMBER> finally beside putative longterm effects directly induced sarscov<NUMBER> infection another key issue address concerns longterm effects empirical experimental treatments covid<NUMBER> patients regard study carried <NUMBER> recovered sars patients recruited <NUMBER> years viral infection reported significant differences serum metabolomes recovered sars patients compared controls <NUMBER> particular significant metabolic alterationincreased levels phosphatidylinositol lysophosphatidylinositolhas found coincide effect methylprednisolone administration <NUMBER> thus suggesting highdose pulses steroid treatment may induce longterm systemic damage associated serum metabolic alterations <NUMBER> therefore challenges discussed highlight major gaps knowledge covid<NUMBER> clinical spectrum underlying immune signaling pathways systemic effects longterm pathological signatures need urgently fulfilled future investigations coronavirus disease <NUMBER> covid <NUMBER> acute respiratory disease caused novel coronavirus severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> identified wuhan china december <NUMBER> <NUMBER> since covid<NUMBER> outbreak spread worldwide becoming pandemic causing public health emergency according world health organization resulting thousands deaths <NUMBER> sarscov<NUMBER> βcoronavirus enveloped nonsegmented positivesense rna virus could transmitted bats via unknown intermediate hosts infect humans using angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor <NUMBER> latter expressed adults children thus possibly explains disease aggressive older patients <NUMBER> covid<NUMBER> shows heterogeneous course patients affected mild flulike symptoms patients unremitting fever severe respiratory involvement basis markers poor prognosis recently investigated effectively prioritize resources patients severe symptoms <NUMBER> interestingly study identified hyperferritinemia interleukin il<NUMBER> predictors poor outcome thus suggesting hyperinflammatory process major cause death <NUMBER> <NUMBER> severe covid<NUMBER> specific cytokine profile resembling pattern secondary hemophagocytic lymphohistiocytosis hlh shown due significant increases il<NUMBER> il<NUMBER> granulocyte colony stimulating factor gcsf interferonγ inducible protein <NUMBER> ip<NUMBER> monocyte chemoattractant protein <NUMBER> mcp<NUMBER> macrophage inflammatory protein <NUMBER>α tumor necrosis factor tnf <NUMBER> contextualizing unremitting fever hyperferritinemia hyperinflammatory process severe covid<NUMBER> shows similarity disorders comprised socalled hyperferritinemic syndrome <NUMBER> syndrome includes adult onset stills disease aosd systemic juvenile idiopathic arthritis sjia secondary hlh catastrophic antiphospholipid syndrome caps septic shock <NUMBER> hyperferritinemia common trait forms could active pathogenic mediator consequence inflammation <NUMBER> bases aimed review similarities severe covid<NUMBER> diseases included hyperferritinemic syndrome pathogenic clinical therapeutic point view thus proposing new insights improve management patients coronavirus rnas may act pathogenassociated molecular patterns detected pattern recognition receptors activate downstream cascades proinflammatory pathways <NUMBER> <NUMBER> endosome tolllike receptor tlr <NUMBER> tlr<NUMBER> tlr<NUMBER> tlr<NUMBER> may sense viral rna dna <NUMBER> whereas cytoplasm viral rna receptor retinoicacid inducible gene <NUMBER> cytosolic receptor melanoma differentiationassociated gene <NUMBER> nucleotidyltransferase cyclic guanosine monophosphateadenosine monophosphate gmpamp synthase may recognize viral rna dna <NUMBER> consequently downstream cascades molecules triggered involving adaptor molecule myeloid differentiation primary response <NUMBER> myd<NUMBER> transcription factor nuclear factorκb nfκb interferon regulatory factor <NUMBER> leading production proinflammatory molecules <NUMBER> <NUMBER> fact plasma cytokines chemokines increased covid<NUMBER> patients including il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> interferonγ ifnγ tnf <NUMBER> severe covid<NUMBER> mechanisms could exaggerated probably specific genetic susceptibility <NUMBER> patients characterized high blood levels proinflammatory mediators ferritin <NUMBER> <NUMBER> latter ironbinding molecule produced proinflammatory stimuli addition iron availability <NUMBER> furthermore ferritin comprises <NUMBER> subunits codified according molecular weight heavy feh light fel subunits remarkably increased expression feh cd<NUMBER>feh macrophages may observed inflammatory infiltrate aosd secondary hlh <NUMBER> <NUMBER> additionally stimulatory effect feh nfkb described acting proinflammatory cytokine hepatic stellate cells <NUMBER> work ferritin shown regulate ironindependent signaling pathway resulted ultimately nfkb activation <NUMBER> thus converging pathway elicited sarscov<NUMBER> rnas <NUMBER> <NUMBER> contrary deletion feh reduced inflammatory burden model sepsis lipopolysaccharideinduced endotoxemia cecal ligation puncture <NUMBER> protection predominantly mediated compensatory increase fel associated inhibitory action nfkb <NUMBER> proinflammatory cytokines elevated hyperferritinemic syndrome also described severe covid<NUMBER> <NUMBER> may preferentially induce expression feh via fer<NUMBER> regulatory element acting binding site nfkb latter turn stimulates synthesis feh proinflammatory cytokines thus perpetuating vicious inflammatory loop <NUMBER> addition fehil<NUMBER> macrophages shown infiltrate aosd secondary hlh <NUMBER> <NUMBER> may release feh following inflammatory stimuli <NUMBER> thus contributing inflammatory loop <NUMBER> bases hypothesize severe covid<NUMBER> shares common pathogenic mechanisms diseases hyperferritinemic syndrome <NUMBER> ferritin enhancing inflammatory burden triggering vicious pathogenic loop lung involvement hyperinflammation crossroad severe covid<NUMBER> hyperferritinemic syndrome observed βcoronaviruses diseases covid<NUMBER> characterized fever dry cough increasing dyspnoea hypoxemia bilateral groundglass opacities patchy shadowing peripheral posterior distribution mainly lower lobes chest ct scans <NUMBER> fact anatomy report covid<NUMBER> pneumonia cadaver showed sarscov<NUMBER> invades respiratory mucosa infects cells thus provoking inflammatory response lower airway causes lung injury <NUMBER> considering coronavirus binds host cells using ace<NUMBER> receptor highly represented lower respiratory tract persistent repeated stimulation tlrs lung may occur hence triggering aberrant immune response production cytokine storm <NUMBER> latter result overwhelming systemic inflammation massive release proinflammatory cytokines quickly progressing multiple organ dysfunction syndrome eventually death <NUMBER> spite various inflammatory etiologies cytokine release syndrome supported essential underlying hypothesis massive release cytokines consequence excessive repeated inflammatory stimuli ii inadequate regulation inflammation iii uncontrolled release cytoplasmic cytokines destroyed lymphocytes anticancer therapies <NUMBER> <NUMBER> addition shown increased amounts proinflammatory cytokines including il<NUMBER>β il<NUMBER> il<NUMBER> ifnγ ip<NUMBER> mcp<NUMBER> associated pulmonary inflammation extensive lung damage sars patients <NUMBER> thus suggesting pathogenic loop inducing cytokine storm although mechanisms covid<NUMBER> general viral infections would prompt cytokine storm syndrome fully elucidated suggested ifnγ largely released variety hematopoietic cells response viral infection may facilitate occurrence hyperinflammation <NUMBER> patients sjia lung involvement may trigger systemic inflammation development secondary hlh ifnγ plays central pathogenic role <NUMBER> <NUMBER> fact lung biopsies patients sija analysis expressed genes revealed many upregulated targets gene pathways related ifnγ signature including human leukocyte antigen hlad family members ifnrelated genes <NUMBER> <NUMBER> two highly upregulated nonhla genes chemokine cxc motif cxcl<NUMBER> cxcl<NUMBER> <NUMBER> ifninduced chemokines strongly correlated occurrence secondary hlh <NUMBER> addition lung one major physiological producers il<NUMBER>β il<NUMBER> <NUMBER> also involved pathogenic steps leading occurrence secondary hlh <NUMBER> <NUMBER> considering findings possible postulate acute respiratory distress syndrome covid<NUMBER> sarscov<NUMBER> may trigger hyperinflammatory reaction strongly resembling observed lung involvement sjia lung acts trigger amplify immune response final result uncontrolled proliferation activated immune cells massive production proinflammatory mediators development cytokine storm syndrome either severe covid<NUMBER> sjia clinical point view severe covid<NUMBER> diseases included hyperferritinemic syndrome share fever main clinical symptom conditions analysis fever pattern would also suggest useful clue assess severity disease occurrence complications sjia aosd typical change highspiking intermittent typical quotidian pattern continuous unremitting pattern suggests occurrence secondary hlh worsening clinical situation toward lifethreatening hyperinflammatory complication <NUMBER> covid<NUMBER> basis observations clinicians frontlines occurrence unremitting fever would similarly identify aggressive subset patients higher risk poor prognosis addition severe covid<NUMBER> hyperferritinemia observed suggesting marker severity <NUMBER> <NUMBER> although poor specificity <NUMBER>fould increase ferritin strongly suggestive diseases included hyperferritinemic syndrome useful marker assess disease activity predict poor prognosis <NUMBER> fact hyperferritinemia associated increased mortality sepsis multiple organ dysfunction syndrome critical illness <NUMBER> <NUMBER> <NUMBER> thus clinical phenotype characterized unremitting fever hyperferritinemia identifies severe subset covid<NUMBER> observed diseases included hyperferritinemic syndrome considering lack efficacy antiviral therapy severe coronavirus infection reasonable postulate clinical usefulness specific immunomodulatory therapies figure <NUMBER> observed diseases included hyperferritinemic syndrome intravenous immunoglobulins ivigs tocilizumab humanized monoclonal antibody il<NUMBER> receptor <NUMBER> ex juvantibus one best criteria identifying common pathogenic mechanism among different diseases clinical manifestations reversed upon initiation therapy shown ivigs therapy significant reduction hyperferritinemia sepsis secondary hlh observed correlating improvement patients <NUMBER> considering proposed antiviral activity possibly comprising many crossreacting antiviral antibodies per se immunomodulatory activities <NUMBER> ivigs also proposed treat severe covid<NUMBER> <NUMBER> another therapeutic immunomodulatory possibility severe covid<NUMBER> administration hydroxychloroquine hcq drug licensed treatment rheumatoid arthritis many years shown reduce viral load favoring disappearance sarscov<NUMBER> <NUMBER> however although seems promising recent metaanalysis including <NUMBER> patients suggested data required definitive conclusion use hcq setting since difference observed virologic cure death clinical worsening disease hcqtreated patients control groups <NUMBER> far tocilizumab concerned rationale use severe covid<NUMBER> derived evidence beneficial effect cytokine release syndrome clinically significant ontarget offtumor side effect chimeric antigen receptor tcell therapies administered treatment malignancies <NUMBER> characteristics cytokinerelease syndrome include fever encephalopathy hypotension coagulopathy leading multiorgan failure associated pronounced levels hyperferritinemia il<NUMBER> <NUMBER> latter provided effective therapeutic target cytokine release syndrome <NUMBER> mirroring finding tocilizumab used treat severe covid<NUMBER> promising results observed diseases hyperferritinemic syndrome <NUMBER> furthermore reduction ferritin obtained combing immunomodulatory drugs associated lower mortality rate caps hlh <NUMBER> thus possibly suggesting use aggressive subset covid<NUMBER> combination therapy antiviral antiinflammatory drugs time <NUMBER> addition repurposing drugs severe covid<NUMBER> could benefit findings previous reports thus basis many clinical trials ongoing different countries chictr<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> far immunomodulatory strategies covid<NUMBER> concerned il<NUMBER> inhibition showed benefits sepsis hyperferritinemia hyperinflammation may observed contributing dysregulation host immune system <NUMBER> posthoc analysis data phase <NUMBER> randomized controlled trial showed improvement patients sepsis following anakinra recombinant nonglycosylated form human il<NUMBER> receptor antagonist thus suggesting possible use patients <NUMBER> consequence possible hypothesize anakinra may also relieve severe covid<NUMBER> reported data suggest possible efficacy emapalumab monoclonal antibody neutralizing ifny approved treatment hlh massive production proinflammatory cytokines <NUMBER> due important role ifny driving hyperinflammation viral infections emapalumab may additional immunomodulatory therapy could employed treatment severe covid<NUMBER> addition available literature suggests janus kinase jak inhibition might affect covid<NUMBER> twice much targeting inflammation cellular viral entry <NUMBER> proposed baricitinib jak<NUMBER>jak<NUMBER> inhibitor may control hyperinflammatory steps diseases characterized cytokine storm since plethora cytokine receptors indiscriminately use jaks mediators ligands binding consequent activation inflammatory cascade <NUMBER> furthermore disruption p<NUMBER>associated protein kinase <NUMBER> known regulator viral endocytosis cell baricitinib could possibly additional positive effect covid<NUMBER> decreasing viral entry <NUMBER> finally considering ferritin pathogenic mediator could also proposed therapeutic target conditions highvolume hemofiltration plasma exchange extracorporeal blood purification techniques employed treat secondary hlh sepsis <NUMBER> <NUMBER> <NUMBER> interestingly parallel clinical efficacy procedures induce ferritin reduction <NUMBER> <NUMBER> <NUMBER> suggesting mechanical removal ferritin could possible therapeutic role work discuss similarities pathogenic clinical therapeutic point view severe covid<NUMBER> four conditions secondary hlh aosd caps septic shock included hyperferritinemic syndrome diseases characterized high levels ferritin could product inflammation rather may play pathogenic role possibly inflammatory environment observed diseases hyperferritinemia may involved vicious pathogenic loop prompting proinflammatory properties severe covid<NUMBER> ferritin could possible enhancer cytokine storm clinically unremitting fever common feature severe covid<NUMBER> suggesting change intermittent quotidian pattern continuous unremitting form would indicate worsening toward cytokine storm aosd sjia hyperferritinemia seems marker poor prognosis response treatment severe covid<NUMBER> hyperferritinemic syndrome finally good response immunomodulatory therapies observed severe covid<NUMBER> strongly supports link form diseases included hyperferritinemic syndrome addition targeting hyperinflammatory process immunomodulatory therapies decreases high mortality rate diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> thus proposing additional therapeutic options improve survival severe covid<NUMBER> patients latter characterized overexuberant proinflammatory response viral load correlated worsening symptoms <NUMBER> conclusion hypothesize severe covid<NUMBER> shares pathogenic mechanisms clinical picture outcomes therapeutic strategies disorders included hyperferritinemic syndrome hyperferritinemia characterizing diseases may pathogenic mediator enhancing inflammatory burden observed aosd caps secondary hlh reduction associated lower mortality thus present severe covid<NUMBER> seems new entity hyperferritinemic syndrome addition since accumulating evidence suggests severe covid<NUMBER> associated cytokine storm syndrome therapeutic strategies combining immunomodulatory therapies may improve management patients furthermore setting high levels ferritin identifying aggressive subset covid<NUMBER> may drive clinicians apply aggressive therapies resources patients thus balancing appropriate escalation therapy minimizing exposure iatrogenic harm sarscov<NUMBER> consequent covid<NUMBER> new great challenge health systems worldwide requiring multidisciplinary approach large body knowledge authors meet criteria authorship icmje recommendations since authors made substantial contributions conception design work acquisition interpretation data authors contributed critical review revision manuscript approved final version authors agreed accountable aspects work severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus responsible infectious respiratory condition formally known coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> virus first identified wuhan hubei province china december <NUMBER> declared global pandemic world health organization march <NUMBER> <NUMBER> covid<NUMBER> symptoms cough fever shortness breath generally appear within <NUMBER> days exposure <NUMBER> patients progress severe disease <NUMBER> hallmarks complications severe covid<NUMBER> infection include acute respiratory distress syndrome ards pneumonia sepsis septic shock cardiomyopathy arrhythmia acute kidney injury prolonged hospitalization <NUMBER> based size scope covid<NUMBER> pandemic disease burden healthcare facilities hospitals severe point us continue experience widespread shortages critical standard care items ventilators <NUMBER> pathogenesis covid<NUMBER> still poorly defined believed involve viralinduced suppression innate pathogen surveillance systems normal conditions pathogen pattern recognition receptors ppr resident innate immune cells sense viral rna molecules trigger antiviral interferon ifn expression prevents replication promotes removal infected cells <NUMBER> however genomic studies conducted original severe acute respiratory syndrome coronavirus sarscov demonstrate virus encodes proteins serve innate immune antagonists suppressing expression ifn promoting evasion viral rna host defense mechanisms independent proinflammatory cytokine release <NUMBER> result early infection innate tolllike receptor tlr prr signaling pathways continue potentiate release proinflammatory mediators cytokines ie tnfα il<NUMBER> ip<NUMBER> cxcl<NUMBER> etc viral replication remains unchecked hence theorized coronaviruses pathogenesis involves delayed release ifn accumulation monocytemacrophages together inappropriate tcell response <NUMBER> adding support etiology severe cases covid<NUMBER> appear present dysregulated tcell counts elevated inflammatory cytokine levels <NUMBER> case severe covid<NUMBER> disruption leads condition described cytokine storm excessive amounts proinflammatory cytokines produced may contribute morbidity mortality patients potential infγrelated cytokine storm first identified patients suffering sarscov infection involving distinct pattern cytokines including ifnγ cxcl<NUMBER> il<NUMBER> <NUMBER> subsequently clinical studies confirming similar responses covid<NUMBER> patients study published lancet covid<NUMBER> patients exhibit increased plasma levels cytokines chemokines ifnγ cxcl<NUMBER> il<NUMBER>β tnfα <NUMBER> result therapeutic interventions covid<NUMBER> must address range proinflammatory cytokines chemokines direct arrival immune cells development late phase hyperactivation proposed hyperinflammatory response triggers violent attack body potentiates cytokine storm development <NUMBER> studies demonstrate viral infections result viralinduced cellular toxicity immune response drive production damageassociated molecular pattern damp molecules recognized innate tlrs example imai et al demonstrated oxidized phospholipids generated reactive oxygen species following exposure inactivated influenza virus lead tlr<NUMBER>mediated alveolar macrophage cytokine release acute lung injury ali mouse models <NUMBER> importantly also found inactivated influenza virus causes oxidative stress tlr<NUMBER> mobilization human peripheral blood mononuclear cells pbmc <NUMBER> addition viral infections shown induce tlr<NUMBER>mediated release proinflammatory cytokines release damp molecules s<NUMBER> calciumbinding protein a<NUMBER> high mobility group box <NUMBER> proteins normally sequestered inside cell <NUMBER> <NUMBER> functionally blocking tlr<NUMBER> protects tlr−− mice highly resistant influenzainduced lethality <NUMBER> <NUMBER> also important note tlr<NUMBER> signaling may contribute fibrosis complicating management covid<NUMBER> <NUMBER> observations suggest dampmediated tlr signaling important therapeutic target covid<NUMBER> reduce feedback loops potentially critical cytokine storm development interestingly tcells infected sarscov exhibit elevated expression tlr<NUMBER> <NUMBER> <NUMBER> demonstrating critical target coronavirus intervention <NUMBER> low molecular weight fraction commercial human serum albumin lmwf<NUMBER>a novel biologic drug development treatment inflammation associated osteoarthritis exhibits mechanisms action may complimentary addressing innateimmunemediated inflammation seen patients suffering covid<NUMBER> course development history biologic effects lmf<NUMBER>a established using variety human immune cell ex vivo vitro models stimulated using damp tlr<NUMBER> agonist lipopolysaccharide lps well relevant barrierfunction assays using human endothelial cells table <NUMBER> also see review lmwf<NUMBER>a mechanisms action <NUMBER> thus hypothesize lmwf<NUMBER>a could improve clinical outcomes covid<NUMBER> attenuating hyperinflammation potential development cytokine storm well resulting increase vascular permeability report discuss key findings support use lmwf<NUMBER>a therapeutic agent patients suffering covid<NUMBER> following provide translational links drawn literature searches bridge research modulation key inflammatory mediators function alveolarepithelial barrier presentation hypothesis lmwf<NUMBER>a inhibits release proinflammatory cytokines pbmc macrophages tcells one ways lmwf<NUMBER>a may address excessive cytokine production seen patients suppressing proinflammatory cytokines released mononuclear cells infiltrating blood reflected ability lmwf<NUMBER>a inhibit release key set cytokines chemokines associated sarscov<NUMBER> infection ex vivo human pbmc models activated innate pattern recognition pathways example lmwf<NUMBER>a reduces tnfα release human pbmc stimulated using lps agonist tlr<NUMBER> signaling fig <NUMBER> <NUMBER> lpsstimulation mimics pathogenassociated molecular pattern pamp damp signaling seen end stage disease excessive viral loads tissue damage trigger excessive induction immune response subsequent unpublished findings show response extends reduction cxcl<NUMBER> il<NUMBER>β il<NUMBER> well thus demonstrates lmwf<NUMBER>a treatment appears target release pattern cytokines observed covid<NUMBER> viral cytokine storms tissue resident bloodderived macrophages key contributors inflammatory response viral infections proinflammatory precursors ards activation transcription factor protective fibrosis increased cell survival <NUMBER> primary human endothelial cell permeability models lmwf<NUMBER>a treatment results ↑ acetylation αtubulin ↓ vascular leakage enhanced barrier function endothelial cells reduced vascular leakage also apparent stabilization microtubule network <NUMBER> <NUMBER> alveolar macrophages predominant tissue resident immune cells found lung likely involved early antiviral response trophic endstages tissue damage recovery addition pleiotropic monocytes invading across capillaryepithelial bed differentiate proinflammatory m<NUMBER> macrophages upon arrival may contribute excessive immune response lung <NUMBER> moreover macrophages develop inflammatory m<NUMBER> lineage become potent source inflammatory cytokines eg tnfα il<NUMBER>β il<NUMBER> il<NUMBER> cxcl<NUMBER> furthering inflammation <NUMBER> <NUMBER> note balance macrophage polarization microbialifnγinduced m<NUMBER> phenotypes antiinflammatory m<NUMBER> could dictate amplitude classical activation versus neutrophil efferocytosis immune resolution respectively pulmonary insult <NUMBER> vitro studies using human macrophages support immunomodulatory action lmwf<NUMBER>a treatment shifting macrophage phenotypes inflammatory m<NUMBER> lineage antiinflammatory m<NUMBER> lineage <NUMBER> experiments human thp<NUMBER> monocyte cell line differentiated induce macrophagelike characteristics treated lmwf<NUMBER>a stimulated lps reductions secreted cytokine mrna transcription observed m<NUMBER> markers il<NUMBER> cxcl<NUMBER> il<NUMBER> importantly cells exhibited increase release antiinflammatory m<NUMBER> marker il<NUMBER> lmwf<NUMBER>a treatment compared saline controls reduction inflammatory m<NUMBER>type cytokine release gene expression combined increased antiinflammatory m<NUMBER>type cytokine release indicates lmwf<NUMBER>a modulates immune response shifting cytokine profile towards homeostasis shift macrophage phenotype could reduce macrophage hyperactivity partially address overproduction inflammatory cytokines observed covid<NUMBER> although covid<NUMBER> may characterized innate response studies also indicate adaptive cells contribute etiology lung jury well animal models demonstrate tcells facilitate release proinflammatory cytokines tnfα arrival neutrophils lung <NUMBER> observed macrophage polarization may result imbalance inflammatory regulatory subsets example ratio proinflammatory th<NUMBER> regulatory cytokines peripheral blood patients found predictive <NUMBER>day mortality ards <NUMBER> support evidence activated proliferating proinflammatory tcells detected bronchoalveolar lavage samples taken ards patients <NUMBER> moreover lymphocyte counts associated increased disease severity covid<NUMBER> patients die exhibiting significant leukopenia <NUMBER> cells represent potentially <NUMBER> underappreciated source ifnγ proinflammatory cytokines tnfα contributors disease progression covid<NUMBER> lung infγ priming tcells provide intense superantigenlike signaling may exacerbate autocrine paracrine cytokine activity role covid<NUMBER> yet fully elucidated targeting persistent longlived immune regulators cells could prove valuable balancing immune response one earliest documented activities lmwf<NUMBER>a ability reduce cytokine release immune cells stimulated tcell receptor tcr cd<NUMBER> antibody specific antigen presentation lmwf<NUMBER>a found reduce tnfα ifnγ release cd<NUMBER>stimulated pbmc influenza ha antigenpresented human tcell clones <NUMBER> activity attributed part identified diketopiperazine molecule formed cleavage cyclization two nterminal amino acids human serum albumin dadkp present lmwf<NUMBER>a treatment cells dadkp resulted significant reductions tnfα ifnγ release antigen presented tcells clones <NUMBER> interestingly effect appears specific memory cd<NUMBER>ro naïve cd<NUMBER>ra phenotypes unpublished findings findings demonstrated lmwf<NUMBER>a reduce cytokine release adaptive immune response triggered presentation antigen activation tcells therefore respect covid<NUMBER> lmwf<NUMBER>a may shift overall inflammatory response away hypercytokine production observed disease transitions ards without impacting bodys ability fight primary viral infection mechanistically covid<NUMBER> pathogenesis seems conducted distinct transcriptional signaling pathways example activation nfκb appears hallmark alveolar macrophages found patients ards <NUMBER> importantly inhibition nfκb shown limit production proinflammatory cytokines like il<NUMBER> cxcl<NUMBER> mouse models resulting reduced mortality <NUMBER> dysregulation nfκb activity broadly implicated production inflammatory cytokines tnfα il<NUMBER>β il<NUMBER> cell apoptosis <NUMBER> <NUMBER> <NUMBER> also reported nfκb signaling pathways coordinate hallmark proinflammatory transcription factors immune response <NUMBER> another proinflammatory transcription factor associated lung inflammation signal transducer activator transcription stat canonical ifnγ signaling pathway involves activation janus kinase stat<NUMBER> promotes m<NUMBER> polarization macrophages augments tcr signaling priming <NUMBER> stat<NUMBER> stat<NUMBER> activation also shown driving factor lpsinduced lung injury mediating release il<NUMBER> tnfα <NUMBER> supporting mechanism inhibition stat<NUMBER> reduces accumulation immune cells well amount detectable tnfα il<NUMBER>β bronchoalveolar lavage fluid lpsinduced mouse lung ali models <NUMBER> several lines preliminary evidence demonstrate lmwf<NUMBER>a reduces activity nfκb stat nfκb luciferase hek<NUMBER> reporter cells treated lmwf<NUMBER>a stimulated tnfα exhibit dosedependent reductions nfκb expression measured luciferase activity stat preliminary experiments using lpsstimulated human pbmc model described indicate lmwf<NUMBER>a reduces stat<NUMBER> stat<NUMBER> activation measured dnabinding elisa nuclear cytoplasmic protein fractions taken cells <NUMBER> h culture findings need fully evaluated reduction nfκb activity could reduce overall inflammatory status covid<NUMBER> patients reduction stat could provide avenue help suppress robust ifnγ m<NUMBER> signaling appears trigger cytokine storm development patients conversely lmwf<NUMBER>a appears activate antiinflammatory andor immunoregulatory transcription factors aryl hydrocarbon receptor ahr peroxisome proliferatoractivated receptor ppar source endogenous ahr ligands tryptophan metabolites one active ingredients lmwf<NUMBER>a nacetyltryptophan suggesting ahr activation contributes immunomodulatory action lmwf<NUMBER>a effect ahr activity confirmed using ahr antagonist ch<NUMBER> thp<NUMBER> model described ahr antagonist added macrophagelike cultures il<NUMBER> response partially attenuated demonstrating ahr activation plays partial role reducing cytokine observed model however ahr antagonism significant effect cxcl<NUMBER> inhibition indicating pathways involved lmwf<NUMBER>a activity well <NUMBER> another target pathway activity identified based fact endogenous ppar ligands comprised fatty acids derivatives lmwf<NUMBER>a contains fatty acid caprylate furthermore <NUMBER>delta prostaglandin j<NUMBER> <NUMBER>dpgj<NUMBER> resolving prostaglandin known natural ligand pparγ upregulated lmwf<NUMBER>a discussed establish contribution ppar models dnabinding pathway specific antagonism evaluated preliminary findings suggest human pbmc treated lmwf<NUMBER>a exhibited increased ppar dna binding addition pparγ antagonist gw<NUMBER> cultures results attenuation lpsinduced tnfα inhibition together data indicate ahr ppar transcriptional pathways play role antiinflammatory responses observed lmwf<NUMBER>a large body evidence suggests ahr ppar signaling plays pivotal role immunosuppression direction regulatory immune cell phenotypes illustrate ahr shown suppress nfκb activity increasing dna binding nfκb subunit p<NUMBER> p<NUMBER>p<NUMBER> nfκb homodimer competitively inhibit active p<NUMBER> nfκb subunit p<NUMBER> rela heterodimer <NUMBER> sequestering coregulators rela nfκb subunit relb prevent translocation nucleus <NUMBER> direct transrepression presence stat<NUMBER> <NUMBER> ahr also promotes antiinflammatory cytokine production il<NUMBER> il<NUMBER> differentiation tcells regulatory phenotypes crosstalk transcription factors protooncogene cmaf stat<NUMBER> <NUMBER> <NUMBER> ahr ppar shown suppress nfκb activity binding dna directly interacting rela p<NUMBER> subunits nfκb inducing expression inhibitor nfκb protein sequestering coactivators required nfκb crebbinding protein releasing repressor bcell lymphoma <NUMBER> protein redirects activity towards nfκbmediated promoters <NUMBER> activity decreases production several proinflammatory cytokines regulated nfκb pathway including tnfα il<NUMBER> <NUMBER> <NUMBER> importantly pparγ agonist rosiglitazone protective endotoxin induced ards rat models marked reductions nitric oxide oxidative damage observed <NUMBER> based results suspect activation pathways could help suppress release key cytokines il<NUMBER> covid<NUMBER> provide additional control proinflammatory signaling pathways potentially rebalance inflammatory immune cells regulatory immunotolerant phenotypes appear missing critical stages ards one unique aspects lmwf<NUMBER>ainduced immunomodulation suppression proinflammatory cytokines concomitant enhancement proresolving molecules lpsstimulated pbmc investigations found unlike steroid dexamethasone reduces cytokine prostaglandin release lmwf<NUMBER>a inhibits tnfα release potentiating production proresolving prostaglandin e<NUMBER> pge<NUMBER> <NUMBER>dpgj<NUMBER> cultures fig <NUMBER> <NUMBER> hand treatment ibuprofen nonsteroidal antiinflammatory drug strongly attenuates prostaglandin release result significant reduction tnfα release consequently lmwf<NUMBER>a offers distinctive immunomodulatory profile hallmark antiinflammatory drugs western blot analysis shows lmwf<NUMBER>a accomplishes upregulating prostaglandinendoperoxide synthase <NUMBER> cox<NUMBER> expression <NUMBER> similar pge<NUMBER> response observed macrophagelike cell culture models using pmadifferentiated u<NUMBER> monocytic cells stimulated lps suggesting lmwf<NUMBER>a suppress proinflammatory cytokines healing resolution phase mediators still produced possibly enhanced treatment regard covid<NUMBER> appreciated cox<NUMBER> plays critical role protection resolution phase inflammation hangai et al found pge<NUMBER> release necrotic macrophages may represent mechanism suppress dampinduced inflammation inhibition cox<NUMBER> results elevated serum tnfα levels liver necrotic models <NUMBER> interestingly studies also shown pge<NUMBER> wound site sufficient drive reverse migration neutrophils well promote apoptosis neutrophils efferocytosis critical resolution phase inflammatory process <NUMBER> authors hypothesized activity temporally important part allow neutrophils perform critical functions provide timely resolution certain damp signaling evolved help achieve homeostasis insult injury excessive andor sustained responses exacerbate disease result compensatory mechanisms exist within biologic milieu appears lmwf<NUMBER>a may help drive lipidmediated feedback loops immunosuppression importantly pathway also appears critical viral immunity may afford protection robust inflammation late phase viral infection leads ards example coronavirus studies shown virus manipulates prostaglandin release infected cells different phases infection fang et al showed sarscov achieves membrane proteininduced regulation nfκb resulting reduction cox<NUMBER> expression <NUMBER> authors suggest protective measure virus evade immune response early stages infection addition host response molecules also appears dictate disease progression illustrate mouse studies agerelated differences pgd<NUMBER> release result defective migration dendritic cells cytotoxic cd<NUMBER> tcell activity lung <NUMBER> furthermore also found antiinflammatory pgd<NUMBER> signaling dprostanoid receptor <NUMBER> reduces inflammasomeinduced il<NUMBER>β release mortality coronavirusinfected mice <NUMBER> finally influenza studies established <NUMBER>dpgj<NUMBER> treatment protects mice lethal influenza infection pparγdependent mechanism marked reduction viral load lung inflammation observed <NUMBER> theorized bioactive lipids arachidonic acid may serve endogenous antiviral compounds thus together findings prostaglandins could provide therapeutic advantage ards secondary viral infections covid<NUMBER> <NUMBER> many clinical parameters may contribute pathogenesis morbidity associated covid<NUMBER> one dysregulation alveolarepithelial barrier results buildup proteinrich fluid decreased oxygen diffusion resolution repair widespread inflammation fig <NUMBER> differential modulation prostaglandins lpsstimulated pbmc pretreated lmwf<NUMBER>a antiinflammatory compounds pbmc incubated compounds <NUMBER> h followed overnight stimulation <NUMBER> ngml lps pge <NUMBER> <NUMBER>dpgj <NUMBER> release determined elisa percent changes presented mean ± sd n <NUMBER> p <NUMBER> versus saline control adapted modified thomas et al <NUMBER> <NUMBER> characteristic ards depends clearance infiltrating immune cells suppression inflammation also removal fluid restoration barrier function interventions enhance barrier function provide rational approach treatment prevention covid<NUMBER> research findings suggest lmwf<NUMBER>a may protect barrier integrity several ways first expanding intrinsic ability described prostaglandins cox<NUMBER>derived mediators also appear promote recovery barrier function endothelial epithelial cells illustrate pge<NUMBER> release lpsstimulated a<NUMBER> epithelial cells acting pge<NUMBER> receptor ep<NUMBER> shown enhance microvascular endothelial cell barrier function <NUMBER> moreover murine models indicate cox<NUMBER> derived mediators protective acidinduced ali selective inhibition delays resolution <NUMBER> thus authors propose increased cox<NUMBER> activity could provide level protection edema associated ali <NUMBER> equally significant lmwf<NUMBER>a component dadkp found impact activity enzymes link extracellular signals cytoskeletal rearrangements known small guanosine triphosphate hydrolases gtpases proteomic analysis pulldown assays human tcells stimulated tcr shows dadkp elevates phosphorylation activity gtpase rasrelated protein rap<NUMBER> rap<NUMBER> compared controls <NUMBER> changes activity gtpases also observed bonemarrow derived mesenchymal stems cells bmmsc treated lmwf<NUMBER>a following treatment lmwf<NUMBER>a bmmsc exhibit rapid reduction intracellular level active ras homolog family member rhoa together increase rac family small gtpase <NUMBER> rac<NUMBER> <NUMBER> finally dadkp treatment human umbilical vein endothelial cells appears reduce rhoa activation induced thrombin unpublished findings body evidence provides support idea lmwf<NUMBER>a treatment rapidly regulate gtpase activity culture molecular switches intimately linked variety cell processes help regulate barrier function endothelial epithelial cells critical importance specific exchange protein activated camp epac activation rap<NUMBER> prevents reverses dysregulation vascular function induced inflammatory cytokines stabilization cytoskeletal components <NUMBER> seen endothelial cells epithelial cell gtpase activity dictates arrangements status factin cytoskeletal elements cellular junction proteins <NUMBER> important note relevance finding covid<NUMBER> studies pathology severe coronavirusinduced ardsali hypothesize alveolar damage dependent balance coagulation fibrinolysin pathways <NUMBER> interestingly viral infection also appears activate rhoa activity models <NUMBER> one underlying features ards secondary covid<NUMBER> breakdown endothelialepithelial barrier alveoli activity could provide potential avenue reduce influx fluid alveolar spaces ancillary cytoskeletal rearrangement also observed following lmwf<NUMBER>a treatment human retinal endothelial cells treated cells observe rapid increase acetylated αtubulin modification associated stabilization longevity polymerized microtubules fig <NUMBER>a <NUMBER> posttranslational modification attributed release ca <NUMBER> intracellular stores model detected cells little <NUMBER> min posttreatment persists <NUMBER> h fig <NUMBER>b <NUMBER> put perspective destabilization microtubules shown integral endothelial barrier dysfunction result innate immune signaling oxidative stress <NUMBER> moreover inhibition histone deacetylase <NUMBER> resulting acetylation αtubulin shown reduce lpsinduced lung injury regulating caspase <NUMBER> activity resulting lowered il<NUMBER>β levels <NUMBER> ergo microtubule stabilization documented antiinflammatory barrier enhancement effect lung potential biologic relevance lmwf<NUMBER>a activity seen functional assays barrier activity microscopic examination cytoskeletal rearrangements treatment endothelial epithelial monolayers dadkp increases barrier function extended periods time measured increased trans endothelial electrical resistance moreover dadkp also attenuates rapid increases permeability promotes cortical factin rearrangement reduces stressfiber formation following thrombin stimulation endothelial cells activity suggested dependent epac<NUMBER> exchange factor aforementioned small gtpase rap<NUMBER> vecadherin organization unpublished findings altogether data molecular mechanisms general functional effects lmwf<NUMBER>a demonstrate biologic may prove useful treatment lung vasogenic edema enhancing alveolarepithelial barrier via altering gtpase activity promoting cortical factin rearrangement stabilizing microtubule network explore use lmwf<NUMBER>a indication randomized controlled trial evaluate safety efficacy nebulized lmwf<NUMBER>a adults ards secondary covid<NUMBER> infection supplement <NUMBER> developed review center biologics evaluation research division food drug administration briefly trial designed enroll ten <NUMBER> patients randomized <NUMBER> nebulized lmwf<NUMBER>a plus standard care soc ards active arm n <NUMBER> soc ards control arm n <NUMBER> primary trial objective evaluate safety tolerability nebulized lmwf<NUMBER>a patients ards secondary covid<NUMBER> infection secondary trial objectives evaluate efficacy nebulized ampion versus control improving clinical course outcomes patients ards secondary covid<NUMBER> infection including mortality ventilator free days pao<NUMBER>fio<NUMBER> ratio successful therapy may attenuate cytokine storm observed patients potentially reduce mortality increase ventilation free days improve oxygenation parameters consequently lessen burden patients intensive care unit initial study followed larger randomized controlled trial covid<NUMBER> positive patients exhibiting respiratory distress might avoid need mechanical ventilation conclusion vitro findings suggest immunomodulatory effects lmwf<NUMBER>a make viable candidate treating cytokine storm restoring homeostasis immune response covid<NUMBER> research receive specific grant funding data analyzed report included published articles available corresponding author reasonable request experiments referred report conducted commercially available cell lines andor primary human cells appropriate consents available suppliers applicable eg manuscript contains personal information data increase total perinuclear localization acetylated αtubulin observed following lmwf<NUMBER>a treatment representative immunofluorescence staining acetylated αtubulin hrec treated saline lmwf<NUMBER>a <NUMBER> <NUMBER> hours h acetylated αtubulin salinetreated controls primarily located microtubule organizing centers around nucleus lmwf<NUMBER>a treated hrec exhibit elevated cytoplasmic perinuclear staining green represents conjugated alexa fluor <NUMBER> antiacetylated αtubulin staining blue represents nuclear <NUMBER>′<NUMBER>diamidino<NUMBER>phenylindole dna staining b rapid increase acetylated αtubulin observed following lmwf<NUMBER>a treatment western blot analysis total protein extracts taken hrec <NUMBER> min <NUMBER> h post lmwf<NUMBER>a treatment compared total tubulin controls adapted modified thomas et al <NUMBER> <NUMBER> coronavirus enveloped nonsegmented positivesense singlestranded rna virus causes common colds severe respiratory diseases <NUMBER> middle east respiratory syndrome mers <NUMBER> severe acute respiratory syndrome sars <NUMBER> december <NUMBER> series unexplained pneumonia cases appeared wuhan hubei ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint province china clinical manifestations suggested viral pneumonia <NUMBER> deep sequencing lower respiratory tract samples identified novel coronavirus named sarscov<NUMBER> disease caused named covid<NUMBER> <NUMBER> clinical manifestations include fever cough sputum chest distress asthma fatigue myalgia diarrhea nausea vomiting <NUMBER> <NUMBER> <NUMBER> severe cases may progress rapidly acute respiratory distress syndrome metabolic acidosis septic shock coagulopathy organ failure eg liver kidneys heart pose serious threat human health march <NUMBER> <NUMBER> world health organization declared assessment covid<NUMBER> global pandemic sarscov<NUMBER> characterized long incubation period high infectivity multiple routes transmission <NUMBER> <NUMBER> according realtime statistics total number confirmed cases covid<NUMBER> worldwide march <NUMBER> <NUMBER> exceeded <NUMBER> <NUMBER> deaths however effective medicines currently available treated symptomatically worldwide patient base continues expand number severely critically ill patients increases rapidly determining mechanism patients progress mild severe severe critical main avenue discovering effective treatment strategies lymphopenia inflammatory cytokine storms typical abnormalities observed highly pathogenic coronavirus infections sars mers <NUMBER> believed associated disease severity <NUMBER> <NUMBER> <NUMBER> multiple studies shown cytokine storms important mechanisms disease exacerbation death patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> il<NUMBER> levels significantly higher severely ill patients covid<NUMBER> compared mild cases <NUMBER> cytokine storm may occur cytokines reach certain threshold body <NUMBER> reducing release activity il<NUMBER> prevent even reverse cytokine storm syndrome caused virus thereby improving condition patients covid<NUMBER> recent years large number studies revealed low molecular weight heparin lmwh various nonanticoagulant properties play antiinflammatory role reducing release biological activity il <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint however antiinflammatory effects lmwh covid<NUMBER> currently known best knowledge first retrospective cohort study analyze relieving effect lmwh patients covid<NUMBER> study aims review analyze treatment course patients covid<NUMBER> investigate antiinflammatory effects heparin delay disease progression provide guidance subsequent clinical practice cases study located union hospital tongji medical college <NUMBER> patients liver kidney insufficiency congenital heart disease <NUMBER> patients treated lmwh previous three months <NUMBER> patients previous history mental illness <NUMBER> pregnant lactating women <NUMBER> patients clinically classified critically ill housed intensive care unit icu <NUMBER> patients allergic lmwh contraindicated lmwh ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint basic patient information collected study electronic medical records included complete blood count coagulation function cytokines serum biochemical tests including liver function kidney function lactate dehydrogenase creactive protein crp electrolytes disease progression two researchers also independently reviewed data collected forms double check data collected data analysis performed using spss <NUMBER> statistical software data expressed mean ± standard deviation sd graphpad <NUMBER> software used plotting differences groups evaluated using ttest measurement data chisquare test count data kruskalwallis nonparametric test groups independent samples within groups related samples differences p <NUMBER> considered statistically significant shown table <NUMBER> heparin group consisted <NUMBER> males eight females aged <NUMBER> <NUMBER> years median age <NUMBER> years control group consisted <NUMBER> males seven females aged <NUMBER> <NUMBER> years median age <NUMBER> years significant difference two groups significant differences comorbidities hypertension diabetes cardiovascular disease carcinomas two groups similarly significant differences novel coronavirus pneumonia onset symptoms including fever body temperature ≥ <NUMBER>°c cough sputum chest distress asthma myalgia fatigue anorexia diarrhea nausea vomiting similarly significant difference antiviral treatment two groups results indicate general characteristics two groups patients consistent comparable lmwh effect days conversion negative duration hospitalization patients covid<NUMBER> shown table <NUMBER> number days conversion negative time ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> notably patients showed improvement treatment shown figure <NUMBER>a f significant difference lymphocyte percentage heparin control groups lmwh treatment however patients heparin group significantly increased percentage lymphocytes lmwh treatment addition changes lymphocyte percentages patients heparin group lmwh treatment significantly different control group results suggest lmwh increases lymphocyte percentage patients covid<NUMBER> indicating lmwh antiinflammatory effects compared control group platelets significantly increased lmwh treatment similarly changes platelet levels lmwh treatment heparin group significantly different control group however significant difference rbc wbc neutrophil monocyte levels two groups shown figure <NUMBER>g n patients administered lmwh levels ddimer fibrinogen degradation products fdp patients heparin group significantly higher compared control group indicating patients may hypercoagulable state administration lmwh ddimer fdp levels heparin group significantly decreased significant difference control group ddimer fdp levels patients heparin group lmwh administration significantly different results indicate lmwh improves hypercoagulable state patients covid<NUMBER> however significant difference tt ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint aptt pt fib atⅲ inr levels two groups shown figure <NUMBER>o significant differences crp levels two groups patients lmwh treatment significantly lower compared treatment similarly significant differences crp levels two groups patients investigate antiinflammatory effects lmwh performed statistical analyses levels inflammatory cytokines two groups figure <NUMBER> significant differences levels il<NUMBER> il<NUMBER> il<NUMBER> tnfα ifnγ heparin group control group lmwh treatment similarly changes il<NUMBER> il<NUMBER> il<NUMBER> tnfα ifnγ levels significantly different two groups notably significant difference il<NUMBER> levels heparin control groups lmwh treatment lmwh treatment il<NUMBER> levels heparin group significantly reduced compared control group similarly changes il<NUMBER> levels heparin group lmwh treatment significantly different control group results suggest antiinflammatory effects lmwh may associated reduction il<NUMBER> levels patients covid<NUMBER> march <NUMBER> <NUMBER> declared assessment covid<NUMBER> global pandemic although case fatality rate <NUMBER> <NUMBER> number severely critically ill patients increasing rapidly global patient base continues expand studies shown cytokine storms associated deterioration several infectious diseases including sars avian influenza <NUMBER> cytokine storms important mechanism exacerbation patients <NUMBER> recent years numerous studies revealed heparin various nonanticoagulant properties lmwh exert antiinflammatory effects reducing release biological activity il<NUMBER> however antiinflammatory effects heparin covid<NUMBER> yet ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint consider parameter evaluation index disease progression average values ddimer fdp treatment greater heparin group control group <NUMBER>p ＜ <NUMBER>p ＜ <NUMBER> result consistent goals lmwh treatment heparin group analysis differences showed lmwh better effect lowering ddimer fdp levels several studies recommended crp lymphocytes lymas indices evaluating effectiveness clinical drugs treatments <NUMBER> <NUMBER> analysis differences present study statistically significant difference crp groups indicating lmwh treatment effect parameter analysis differences lym mean value heparin group higher control group <NUMBER> <NUMBER> respectively lym higher heparin group treatment compared control group p <NUMBER> consistent results derhaschnig et al <NUMBER> suggests lmwh increase lym patients covid<NUMBER> improve condition two possible reasons one hand lmwh glycosaminoglycan <NUMBER> partially inhibits sarsrelated coronavirus strain hsr<NUMBER> <NUMBER> mycroftwest et al also showed lmwh bind sarscov<NUMBER> surface protein spike s<NUMBER> receptor binding domain block replication virus thus showing potential antiviral effects <NUMBER> additionally lmwh reduce lymphocyte death caused direct viral infection lymphocytes <NUMBER> hand preliminary research confirmed proinflammatory cytokines tnfα il<NUMBER> induce lymphopenia <NUMBER> therefore decreases number activity relevant inflammatory factors may significance increase lym studies shown cytokine storms important mechanisms exacerbation patients <NUMBER> il<NUMBER> levels severely ill patients covid<NUMBER> significantly higher patients mild cases <NUMBER> cytokine storm may occur cytokines reach certain threshold body <NUMBER> transition mild severe condition patients covid<NUMBER> may caused cytokine storms reducing il<NUMBER> release activity prevent even reverse cytokine storm syndrome caused ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> <NUMBER> multiple studies shown lmwh may reduce release il<NUMBER> body regulating plasma <NUMBER> apc <NUMBER> levels inhibiting expression nuclear factor κb nfκb <NUMBER> <NUMBER> <NUMBER> present study performed statistical analysis levels inflammatory cytokines two groups patients results showed il<NUMBER> significantly decreased heparin group compared control group whereas changes inflammatory factors statistically significant results consistent conclusions addition study mummery et al found lmwh bind il<NUMBER> competitively reduce binding il<NUMBER> sil<NUMBER>r sgp<NUMBER> <NUMBER> block signal transduction thereby inhibiting biological activity il<NUMBER> indicates lmwh reduces release il<NUMBER> also reducing biological activity also explains increase lym heparin group present study found conventional antiviral treatment regimens lmwh could improve hypercoagulability inhibit il<NUMBER> release inhibit il<NUMBER> biological activity patients lmwh potential antiviral effects helps delay block inflammatory cytokine storms increases lym may suitable covid<NUMBER> treatment addition confirm conclusions study conducted prospective clinical study evaluate efficacy safety enoxaparin sodium treatment hospitalized adult patients covid<NUMBER> chinese clinical trial registry，numberchictr<NUMBER> expectation providing powerful reference treatment study limitations first due retrospective design unable control time intervals examinations various indices patients lmwh dosing schedule could estimate effective dose timing lmwh second critical cases two groups patients trial treatment outcome cases improvement discharge deaths therefore reference value treatment outcomes critically ill patients limited finally sample size singlecenter design may ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint limited findings cs jp yz conceptualized designed study cs yz full access data took responsibility data integrity accuracy analysis cs cw hx wrote manuscript cy fc fz reviewed manuscript fc yh tt bd performed statistical analysis authors contributed data acquisition analysis interpretation approved final version submission authors declare competing interests data used support findings study included within article funding received work supported national key research development plan china <NUMBER>yfc<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> significant differences age sex comorbidities onset symptoms time hospitalization virus shedding length hospital stay antiviral treatment disease progression two groups data median iqr n p values comparing heparin group control nanot applicable data expressed mean ± standard deviation sd n <NUMBER> c<NUMBER> vs h<NUMBER> c<NUMBER> vs h<NUMBER> p <NUMBER> aa p <NUMBER> aaa p <NUMBER> c<NUMBER> vs c<NUMBER> h<NUMBER> vs h<NUMBER> b p <NUMBER> bb p <NUMBER> bbb p <NUMBER> c<NUMBER> vs h<NUMBER> c p <NUMBER> cc p <NUMBER> ccc p <NUMBER> c<NUMBER> control group indices admission c<NUMBER> control group indices discharge c<NUMBER> control group changes indices hospitalization h<NUMBER> heparin group indices lmwh treatment h<NUMBER> heparin group indices lmwh treatment h<NUMBER> heparin group changes indices lmwh treatment authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint two groups patients covid<NUMBER> data expressed mean ± standard deviation sd n <NUMBER> p <NUMBER> aa p <NUMBER> aaa p <NUMBER> c<NUMBER> vs c<NUMBER> h<NUMBER> vs h<NUMBER> b p <NUMBER> bb p <NUMBER> bbb p <NUMBER> c<NUMBER> vs h<NUMBER> c p <NUMBER> cc p <NUMBER> ccc p <NUMBER> c<NUMBER> control group indices admission c<NUMBER> control group indices discharge c<NUMBER> control group changes indices hospitalization h<NUMBER> heparin group indices lmwh treatment h<NUMBER> heparin group indices lmwh treatment h<NUMBER> heparin group changes indices lmwh treatment ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint abstract coronavirus disease <NUMBER> covid<NUMBER> could lead sharp increase levels inflammatory cytokines report efficacy therapeutic plasma exchange severe patients acute respiratory distress syndrome results suggested tpe could used strategy attenuate circulating cytokines inflammatory mediators article protected copyright rights reserved end december <NUMBER> outbreak coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> appeared wuhan china became emergency disease nationally internationally paules et al <NUMBER> covid<NUMBER> could damage respiratory system patients inducing symptoms fever cough shortness breath huang et al <NUMBER> date specific antiviral therapeutic agent vaccine recommended covid<NUMBER> although patients good prognosis receiving antiviral antibiotic oxygen therapy severe patients developed acute respiratory distress syndrome among would die multiple organ failure cause deterioration rapid aggravation even death might related cytokine storm also called inflammatory storm clear evidence specific treatment could useful cytokine storm covid<NUMBER> patients reported efficacy therapeutic plasma exchange tpe three severe covid<NUMBER> patients acute respiratory distress syndrome results suggested tpe could used strategy attenuate circulating cytokines inflammatory mediators study approved institutional ethics board first affiliated hospital bengbu medical three patients male aged <NUMBER> <NUMBER> <NUMBER> years acute respiratory distress syndrome related covid<NUMBER> confirmed qrtpcr chest ct patients receiving therapeutic plasma exchange first affiliated hospital bengbu medical college january <NUMBER> <NUMBER> march <NUMBER> <NUMBER> timelines symptom onset qrtpcr testing severe complications plasma exchange outcomes three severe patients shown figure three patients admitted hospital fever dry cough fatigue dizziness nausea three patients received various antiviral treatment including arbidol <NUMBER> mg three times daily interferon alpha<NUMBER>b atomization inhalation <NUMBER> million units twice daily however despite initial antiviral treatment therapeutic interventions three patients developed respiratory distress respiratory frequency ≥ <NUMBER>min pulse oximeter oxygen saturation ≤ <NUMBER> rest oxygenation index pao <NUMBER> fio <NUMBER> ≤ <NUMBER> mmhg lymphocyte counts patients lower normal range adults article protected copyright rights reserved contrast contents creactive protein neutrophil count lactate dehydrogenase interleukin <NUMBER> il<NUMBER> significantly higher normal reference ranges three severe patients transferred first affiliated hospital bengbu medical college designated hospital treatment severe cases according suggestion diagnosis treatment plan novel coronavirus pneumonia trial version <NUMBER> drawn national health commission peoples republic china therapeutic plasma exchange used emergency treatment three severe covid<NUMBER> patients tpe performed plasma separator multifiltration system <NUMBER> ml normal freshfrozen plasma exchanged one person patient received one treatment tpe <NUMBER> <NUMBER> days transferred designated hospital pao <NUMBER> fio <NUMBER> mmhg ranged <NUMBER> <NUMBER> time <NUMBER> hours plasma exchange increased improved three patients within <NUMBER> hours tpe ranged <NUMBER> <NUMBER> shown table pao <NUMBER> fio <NUMBER> significantly improved average <NUMBER> <NUMBER> p <NUMBER> one day treatment values crp decreased <NUMBER> levels il<NUMBER> also declined normal reference range treatment values neutrophiltolymphocyte ratio nlr significantly decreased four five days treatment patients changed receive lowflow oxygen highflow oxygen one day lowflow oxygen patients could breathe ambient air requirement oxygen supplementation ten days later tpe three patients met discharged criteria including nucleic acid tests negative twice separated least <NUMBER>day normal temperature <NUMBER> days showing resolved respiratory symptoms improved acute exudative lesions chest computed tomography images lengths hospital stay <NUMBER> <NUMBER> <NUMBER> days respectively time symptom onset recovery ranged <NUMBER> <NUMBER> days present main reason severity continuous progress covid<NUMBER> might cytokine storm mehta et al <NUMBER> also might reason induce terminal stage ebola virus disease evd younan et al <NUMBER> severe acute respiratory syndrome sars chien et al <NUMBER> clinic antiinfective drugs corticosteroid nutritional support artificial ventilation nonspecific combined treatment measures often used cytokine storm however clinical article protected copyright rights reserved evidence support covid<NUMBER> could benefit corticosteroid treatment russell et al <NUMBER> therapeutic plasma exchange effective cytokine storm widely used treatment variety severe critical patients pneumonia respiratory failure h<NUMBER>n<NUMBER> influenza virus patel et al <NUMBER> study results three severe cases suggested tpe immediate effect treatment cytokine storm similar previous research results hadem et al <NUMBER> nlr considered inflammatory marker could reflect systemic inflammatory response nlr values found increase significantly patients covid<NUMBER> severe disease fu et al <NUMBER> conclusion efficient rapid method remove abnormally elevated inflammatory factors supplement albumin improve coagulation function correct immune disorder therapeutic plasma exchange might rescue therapy severe covid<NUMBER> patient acute respiratory distress syndrome cytokine storm end <NUMBER> beginning <NUMBER> first china rest world confronted outbreak new airborne transmitted coronavirus disease <NUMBER> covid <NUMBER> viral infection caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> months later already millions infected worldwide borders closed strict travel bans imposed local transmission patterns place countries <NUMBER> covid<NUMBER> mortality rate appears range <NUMBER> <NUMBER> significantly higher seasonal flu caused influenza virus <NUMBER> lower severe acute respiratory syndrome sars <NUMBER> <NUMBER> middle east respiratory syndrome mers <NUMBER> <NUMBER> time covid<NUMBER> transmission rate much greater mers sars poses real threat life large number people worldwide especially older patients comorbidities <NUMBER> thus absence effective vaccines treatments early detection ability define prognostic parameters predicting course disease appear particular interest lymphocyte reduction <NUMBER> thus virus infection macrophages firstly enhances viral spread secondly triggers destructive events immune organs spleen lns recent data experiments using sarscov<NUMBER> capsid live virus infection cultured cell lines mt<NUMBER> a<NUMBER> provides first evidence sarscov<NUMBER> could also infects cells however expression level ace<NUMBER> cells low thus cd<NUMBER> considered mediate sarscov<NUMBER> entry cells <NUMBER> virus binds ace<NUMBER> fig<NUMBER> serine protease tmprss<NUMBER> cleaves viral spike protein another protease furin subsequently releases spike fusion peptide virus enters host cell endosomal pathway <NUMBER> <NUMBER> <NUMBER> following viral replication assembly release infected cells may undergo apoptosis necrosis triggering inflammatory response production proinflammatory cytokines activation macrophages th<NUMBER> cells well production ifnγ il<NUMBER>a il<NUMBER> il<NUMBER> neutrophils th<NUMBER> cd<NUMBER> cells turn sarscov<NUMBER> infection recruited immune cells may increase apoptosis exacerbate lymphocytosis <NUMBER> <NUMBER> finally may lead patients lifethreatening conditions respiratory distress syndrome cytokine storm secondary hemophagocytic lymphohistiocytosis covid<NUMBER> mortality strongly associated development severe respiratory distress syndrome requires invasive ventilation important identify patients likely develop severe form disease early possible based existing statistics number clinical predictors disease deterioration mortality including presence secondary infections lymphopenia <NUMBER> comorbidities cardiovascular chronic respiratory diseases diabetes hypertension obesity cancer <NUMBER> increased cytokine production serum ferritin <NUMBER> reported study showed elevated serum creatinine ddimers lactate dehydrogenase creactive protein procalcitonin well increased white blood cell counts may indicate impending respiratory failure need invasive oxygen supply <NUMBER> interestingly recently published reports elevated interleukin<NUMBER> il<NUMBER> level proposed relevant parameter predicting unwanted course disease need mechanical ventilation <NUMBER> <NUMBER> <NUMBER> assumptions consistent data clinical trial china demonstrated small number patients efficacy il<NUMBER> neutralization exacerbation covid<NUMBER> associated pneumonia <NUMBER> supplementary table <NUMBER> il<NUMBER> cytokine pleotropic functions ranging hematopoiesis metabolic regulation inflammation autoimmunity acute phase response il<NUMBER> modulates host defense number immune stimulating mechanisms control monocytes differentiation macrophages <NUMBER> modulation antigendependent b cell differentiation <NUMBER> increased igg production b cells <NUMBER> promotion th<NUMBER> response inhibiting th<NUMBER> polarization <NUMBER> several studies revealed strong correlation il<NUMBER> levels serum upcoming respiratory failure <NUMBER> <NUMBER> <NUMBER> shown even moderately elevated il<NUMBER> levels <NUMBER> pgml sufficient identify covid<NUMBER> infected patients high risk respiratory failure <NUMBER> moreover serum sarscov<NUMBER> nucleic acid rnaaemia strongly associated cytokine storm closely correlated extremely high il<NUMBER> serum levels <NUMBER> also suggested serial measurement circulating il<NUMBER> might important identifying disease progression evaluated immediately covid<NUMBER> diagnosis confirmation may predict upcoming respiratory failure alternatively asymptomatic disease among sarscov<NUMBER> infected patients <NUMBER> therefore would valuable explore potential contribution il<NUMBER> events occurring sarscov<NUMBER> infection next section discuss mechanisms il<NUMBER> may possibly affect disease exacerbation potential therapeutic approaches based antiil<NUMBER> biologics controversy concerning il<NUMBER> functions viral lung infections il<NUMBER> one key proinflammatory cytokines infection onset especially mucosal sites <NUMBER> however impact il<NUMBER> disease outcome may vary significantly fig <NUMBER> one hand il<NUMBER>dependent th<NUMBER> activation differentiation important effective neutrophil migration il<NUMBER> together il<NUMBER> modulate cytolytic capacity cd<NUMBER> cells <NUMBER> <NUMBER> finally il<NUMBER> pyrogenic cytokine contributes thermostatic regulation important effective antiviral response <NUMBER> <NUMBER> studies using il<NUMBER>deficient mice showed il<NUMBER> ameliorates acute lung injury influenza virus iav infection <NUMBER> il<NUMBER>deficient mice infected influenza virus exhibited higher lethality well increased weight loss fibroblast accumulation lungs associated virusinduced apoptosis lung epithelial cells neutrophils <NUMBER> indicating il<NUMBER> may promote repair following virusinduced lung injury <NUMBER> finally early il<NUMBER> signaling promotes il<NUMBER>dependent maturation treg cells lungs resolution viral immunopathology mouse model respiratory syncytial influenza virus infection <NUMBER> hand il<NUMBER> implicated progression viral infections regard il<NUMBER> synergizes il<NUMBER>b tnf upregulate trypsin expression activates matrix metalloproteinases causes breakdown basal membrane extracellular matrix turn results increased tissue permeability edema <NUMBER> th<NUMBER> cellderived ifnγ essential effective antiviral immune response however il<NUMBER> may inhibit th<NUMBER> polarization stimulating cd<NUMBER> cells differentiate th<NUMBER> cells suppressing ifnγ expression <NUMBER> <NUMBER> moreover il<NUMBER> promotes th<NUMBER> cell differentiation il<NUMBER>a secretion turn activates expression antiapoptotic molecules bclxl favoring survival virusinfected cells model persistent viral infection <NUMBER> time il<NUMBER> promotes migration <NUMBER> survival <NUMBER> neutrophils turn contribute pathogenesis covid<NUMBER>driven ards <NUMBER> finally contrast influenza virus infection il<NUMBER>deficient mice infected murine pneumonia virus characterized better survival wt mice decreased lung edema diminished neutrophil recruitment <NUMBER> taking account several experimental models viral lung infections il<NUMBER> demonstrates either pathogenic <NUMBER> protective <NUMBER> effects vivo role cytokine sarscov<NUMBER> infection carefully evaluated moreover consequences il<NUMBER> induction covid<NUMBER> may vary depending infection stage host immune status patients severe outcome sarscov<NUMBER> displayed high serum levels proinflammatory cytokines responsible cytokine storm induction <NUMBER> <NUMBER> interestingly majority severe covid<NUMBER> cases respiratory distress syndrome associated high systemic il<NUMBER>b tnf il<NUMBER> levels suggesting direct connection proinflammatory cytokine induction adverse effects covid<NUMBER> <NUMBER> sarscov<NUMBER> shows <NUMBER> nucleotide identity sarscov major pathogenic mechanisms including cytokine storm extensive lung damage sars covid<NUMBER> infection may similar cytokine storm condition caused extensive activation immune system result extremely high production cytokines chemokines since cytokine storm lead multiple organ failure important understand mechanisms driving condition lower respiratory tract sarscov<NUMBER> infects predominantly type <NUMBER> alveolar epitheliocytes cell type participate active gas exchange following replication disengagement lung epithelial layer virus enters underlying tissues infects captured macrophages dendritic cells neutrophils resulting viral spread <NUMBER> fig <NUMBER> time damaged epitheliocytes release danger molecules drive activation lung epithelium resident immune cells thus even early onset viral infection penetration mucosa epithelial layer activates innate immune response adaptive immunity also activated covid<NUMBER> mainly antigen presenting dendritic cells produce large amounts cytokines including il<NUMBER> il<NUMBER>b tnf migrate regional lymph nodes present viral antigen naïve cells pushing differentiation migration affected tissue <NUMBER> specific humoral response represented viralspecific antibodyproducing b cells also place <NUMBER> replication virus results damage affected organs together selfboosting immune response manifesting uncontrolled overexpression inflammatory mediators severe cases another mechanism driving cytokine storm viral infections increased blood vessel permeability enables infiltration effector cells producing additional amounts inflammatory molecules exacerbating hyper cytokine production <NUMBER> addition leakiness blood vessels allows virus spread tissues organs compromising functions finally persistence inflammatory factors increased number inflammatory exudates erythrocytes enter alveoli resulting lung damage respiratory failure syndrome mentioned severe covid<NUMBER> induced pneumonia marked hyperactivation immune system excessive production il<NUMBER> <NUMBER> <NUMBER> main source pathogenic il<NUMBER> appears myeloid cells number significantly increased among pbmc <NUMBER> balf severe covid<NUMBER> patients <NUMBER> myeloid cell recruitment activation lungs associated increased mortality morbidity sarscov mouse model <NUMBER> human primary macrophages dendritic cells infected fail support productive replication sarscov <NUMBER> <NUMBER> unlike alveocytes virus replicate quickly time sarscov apparently sarscov<NUMBER>infected macrophages demonstrate upregulation il<NUMBER> production low expression interferons <NUMBER> <NUMBER> interestingly patients requiring intensive care invasive lung ventilation display negative correlation il<NUMBER> tnf il<NUMBER>b concentrations cd<NUMBER> cd<NUMBER> cell counts <NUMBER> confirming previous studies animal models suggested cytokine storm actually dampens adaptive immunity sarscov infection <NUMBER> moreover production ifnγ cd<NUMBER> cells tended lower severe compared moderate cases suggesting sarscov<NUMBER> infection induces lymphopenia suppression antiviral ifnγ production <NUMBER> furthermore suggested pathogenic il<NUMBER> likely produced highly inflammatory macrophages <NUMBER> alveolar macrophages almost absent lung aspirates severely affected patients <NUMBER> time noted complete ablation il<NUMBER> early stages viral infection may result depressed tfh cell maturation delayed antiviral antibody response <NUMBER> known acute inflammation cytokine storm extreme manifestation significant effect hemodynamics also platelets erythrocytes dysregulated coagulation cascade subsequent formation intraalveolar systemic fibrin clots prominent findings previous zoonotic coronavirus infections sars mers orchestrated crs <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> patients also show significant changes coagulative status ie low platelet count increased ddimer fibrinogen levels dysfunction microvessels pulmonary circulation <NUMBER> <NUMBER> thus thrombosis pulmonary capillaries believed contribute rapidly developing hypoxia role il<NUMBER> inflammatory hypercoagulation controversial il<NUMBER> increase rate fibrotic clot formation whole blood effect less pronounced shown il<NUMBER> il<NUMBER> <NUMBER> hand il<NUMBER> important thrombus formation regulator mmps thrombolysisassociated genes macrophages <NUMBER> characteristic feature cytokine release syndrome change iron homeostasis hyperferritinemia indicated high levels serum ferritin <NUMBER> covid<NUMBER> patients ferritin elevation correlated poor prognosis <NUMBER> indication hemolytic events caused hypercoagulation hemophagocytosis general inadequate macrophage activation leads pathologic phagocytosis erythrocytes reutilization heme iron using ferritin <NUMBER> line high systemic ferritin may serve indicator developing macrophage activation syndrome rather factor driving covid<NUMBER> pathogenesis another key proinflammatory cytokine tnf also released abundantly cytokine storm caused sarscov<NUMBER> infection serum tnf levels found elevated severely affected covid<NUMBER> patients <NUMBER> previously shown sarscov spike protein able modulate tnf converting enzyme tacedependent shedding ace<NUMBER> ectodomain <NUMBER> tace expression coupled tnf production therefore hypothesized use tnf inhibitors may also show efficacy preventing viral entry <NUMBER> well decreasing immunopathology associated mortality shown preclinical studies mice infected severe respiratory syncytial virus <NUMBER> moreover antitnf therapy effective decreasing il<NUMBER> il<NUMBER>b serum levels lethal bacteremia suggesting treatment may provide complex antiinflammatory effect <NUMBER> data obtained covid<NUMBER> infected patients inflammatory bowel diseases undergoing antitnf therapy support safety intervention context sarscov<NUMBER> treatment <NUMBER> <NUMBER> findings argue potentially protective effect tnf inhibition covid<NUMBER> studies needed address possibility hypertension suggested risk factor severe covid<NUMBER> outcomes <NUMBER> early data literature already assumed association blood pressure circulating il<NUMBER> levels otherwise healthy individuals <NUMBER> moreover several studies reported increased il<NUMBER> expression patients hypertension <NUMBER> <NUMBER> il<NUMBER>transgenic mice characterized elevated plasma il<NUMBER> levels displayed pulmonary hypertension <NUMBER> <NUMBER> taken together data suggest il<NUMBER> might connected increased risk respiratory failure hypertensive patients covid<NUMBER> one mechanisms regulating blood pressure electrolyte balance angiotensinrenin system comprised two pathways normally functioning state dynamic equilibrium ace<NUMBER>angiotensin iiangiotensin <NUMBER> receptor axis activating vasoconstriction inflammatory response ace<NUMBER>angiotensin <NUMBER>mas receptor axis supporting vasodilation suppression inflammation fig <NUMBER> <NUMBER> changes reninangiotensin system activity related pathogenesis hypertension inflammatory lung diseases particular acute lung injury caused viral infections <NUMBER> <NUMBER> sarscov<NUMBER> uses ace<NUMBER> entry site thus reducing ace<NUMBER> availability promoting imbalance ace<NUMBER>angiotensin iiangiotensin <NUMBER> receptor axis ace<NUMBER>angiotensin <NUMBER>mas receptor axis <NUMBER> <NUMBER> line recent studies reported covid<NUMBER> patients increased angiotensin ii compared healthy individuals <NUMBER> altogether abovementioned data suggests covid<NUMBER> infection leads imbalanced angiotensin conversion shift towards proinflammatory signaling mediated angiotensin <NUMBER> receptor axis <NUMBER> fig <NUMBER> b angiotensin ii known significantly increase expression il<NUMBER> dosedependent manner <NUMBER> pleiotropic activation nfkb transcription factors <NUMBER> <NUMBER> angiotensin <NUMBER> receptor downstream activation nadph oxidase results elevated oxidative stress particularly superoxide activates transcriptional mechanisms directly promotes il<NUMBER> gene expression turn plasma il<NUMBER> concentrations correlate blood pressure plasma angiotensin ii levels vascular hypertrophy suggesting important role il<NUMBER> development maintenance hypertension specifically mediated angiotensin ii <NUMBER> <NUMBER> il<NUMBER> promotes angiotensin <NUMBER> receptor expression sensitizing vascular wall angiotensin iidependent signaling mechanisms activated cells release j u r n l p r e p r f cytokines including il<NUMBER> promote expression adhesion molecules induce endothelial activation inflammatory cell infiltration vascular inflammation <NUMBER> drives oxidative stress il<NUMBER> expression therefore plausible il<NUMBER> angiotensin ii activate positive feedback mechanism support hypothesis ace<NUMBER> protects lethal avian influenza h<NUMBER>n<NUMBER> infection <NUMBER> prevention oxidative stress acute respiratory distress syndrome moreover recently reported covid<NUMBER> patients hypertension angiotensin receptor blockade attenuated inflammatory response possibly il<NUMBER> inhibition <NUMBER> <NUMBER> taking together angiotensin ii accumulation due sarscov<NUMBER>mediated ace<NUMBER> downregulation may cause angiotensin <NUMBER> receptor downstream activation nadph oxidase turn leads elevated ros production induction transcriptional mechanisms directly promote il<NUMBER> expression implicated inflammationinduced injury immunopathology chronic inflammation one common feature hypertension diabetes obesity agethe risk factors associated covid<NUMBER> severe outcomes elderly obese diabetic persons affected lowgrade chronic inflammation characterized systemically increased levels proinflammatory cytokines may contribute facilitate cytokine storm main cause covid<NUMBER> mortality among conditions predisposing patients infected sarscov<NUMBER> severe outcomes diabetes prominent estimated mortality rate covid<NUMBER> diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> il<NUMBER> known dual role autoimmune diabetes involved development insulin resistance βcell dysfunction time antiinflammatory effects improves glucose metabolism <NUMBER> recent clinical data demonstrates significantly elevated systemic il<NUMBER> covid<NUMBER> patients diabetes compared without diabetes <NUMBER> covid<NUMBER> may exacerbate preexisting diabetes since entry site ace<NUMBER> expressed pancreas potential role development insulin resistance impaired insulin secretion <NUMBER> il<NUMBER> may link diabetes severe covid<NUMBER> outcomes ability modulate cell response indirect evidence support comes mouse studies closely related merscov infection demonstrating abnormal elevation il<NUMBER>a produced il<NUMBER>dependent th<NUMBER> cells exacerbates disease severity diabetic mice <NUMBER> consistent finding patients covid<NUMBER> higher proportion th<NUMBER> cells blood <NUMBER> suggesting diabetics due improper activation th<NUMBER> th<NUMBER> cells may compromised antiviral immune response <NUMBER> obese patients covid<NUMBER> likely develop severe respiratory distress syndrome <NUMBER> <NUMBER> diabetics obese patients higher concentration proinflammatory cytokines steady state <NUMBER> apparently covid<NUMBER> infection <NUMBER> addition decreased antiviral cell response enhanced il<NUMBER> production adipose tissue obese patients <NUMBER> may alter innate antiviral immune response neutrophils <NUMBER> cause uncontrolled replication virus early stages infection beginning covid<NUMBER> pandemic age identified risk factor <NUMBER> supporting idea ace<NUMBER> may marker cell senescence <NUMBER> myofibroblasts increase number age express high levels ace<NUMBER> <NUMBER> thus myofibroblasts susceptible sarscov<NUMBER> elderly people bearing higher proportion myofibroblasts might susceptible covid<NUMBER> infection reviewed <NUMBER> il<NUMBER> critical inflammatory regulator senescenceassociated secretory phenotype sasp <NUMBER> therefore il<NUMBER> overexpression may correlate senescent status cells tissues well increased expression ace<NUMBER> line idea hydroxychloroquine antimalaria drug approved countries covid<NUMBER> treatment effectively reduced salivary serum levels il<NUMBER> patients sjorgens syndrome <NUMBER> moreover azithromycin prescribed together hydroxychloroquine target selectively remove senescent cells <NUMBER> thus provide antifibrotic activity protecting lungs inflammationinduced injury <NUMBER> <NUMBER> another issue facing elderly patients covid<NUMBER> compromised activation status effector cells cells may display limited function prolonged infection result exhaustion associated surface expression immuneinhibitory factors pd<NUMBER> <NUMBER> since aging process known promote reorganization cell landscape <NUMBER> il<NUMBER> sasp predictor regulator cell exhaustion elderly patients covid<NUMBER> much evident due higher basal concentration il<NUMBER> enhance exhaustion process <NUMBER> <NUMBER> smoking another potential risk factor sarscov<NUMBER> infection smokers vulnerable influenza virus infections <NUMBER> <NUMBER> likely develop chronic obstructive pulmonary disease copd <NUMBER> enhanced ace<NUMBER> expression reported lungs healthy smokers <NUMBER> <NUMBER> line studies mice established cigarette smoke trigger expansion subpopulation respiratory epithelial cells express ace<NUMBER> dosedependent manner <NUMBER> patients copd well active smokers increased ace<NUMBER> expression lungs <NUMBER> may potentially explain fourfold increased risk adverse development severe outcome covid<NUMBER> <NUMBER> <NUMBER> taken together recent reports suggest smokers may higher risk infection examination factors predisposing severe covid<NUMBER> wuhan china revealed <NUMBER> patients severe disease smokers <NUMBER> hand preliminary metaanalysis based chinese patients suggest active smoking associated severity covid<NUMBER> <NUMBER> indicating impact smoking covid<NUMBER> progression controversial requires assessment intuitively patients preexisting asthma display higher proportion covid<NUMBER> severe cases however prevalence asthma covid<NUMBER> patients wuhan study markedly lower <NUMBER> reported adult population wuhan <NUMBER> <NUMBER> one possible explanation shift toward th<NUMBER>type immune response asthmatics opposed th<NUMBER>associated inflammatory response induced sarscov<NUMBER> infection <NUMBER> recent study reveals tmrss<NUMBER> expression upper respiratory tract correlates positively type <NUMBER> response genes especially il<NUMBER> whereas ace<NUMBER> expression suppressed il<NUMBER> considering low numbers cells coexpressing proteases upper respiratory tract proposed context il<NUMBER>dependent reduction ace<NUMBER> expression allergy promote resistance infection <NUMBER> line shown ace<NUMBER> expression decreased nasal bronchial epithelium allergic individuals following allergen challenge suggesting asthmaassociated immune response actually protects covid<NUMBER>induced pathology <NUMBER> nevertheless studies required reveal impact covid<NUMBER> severity patients preexisting asthma metaanalysis studies covid<NUMBER> cases china december <NUMBER> february <NUMBER> report lower incidence disease <NUMBER> risk death <NUMBER> women men similar data association gender poorer prognosis males obtained earlier sarscov <NUMBER> <NUMBER> merscov <NUMBER> <NUMBER> connection sarscov<NUMBER> xlinked ace<NUMBER> gene particular interest significant fraction genes encoded x chromosome undergo dosage compensation however ace<NUMBER> located xp<NUMBER> ie area genes may escape x chromosome inactivation <NUMBER> possibly contributing gender disparity disease susceptibility gender differences immune responses known depend genetic also endocrine factors <NUMBER> <NUMBER> high doses estradiol acting estrogen receptors decrease production proinflammatory cytokines via suppressing nfkb signaling pathway <NUMBER> relation covid<NUMBER> effects estrogens il<NUMBER> disease progression particular interest estrogen may suppress lpsmediated il<NUMBER> expression mouse macrophages blocking nfkb activation <NUMBER> <NUMBER> inhibiting p<NUMBER> mapk phosphorylation <NUMBER> furthermore downregulation il<NUMBER> expression kupffer cells appears erαdependent <NUMBER> overall immunomodulatory effects estrogens may contribute decreased susceptibility sarscov<NUMBER> infection women question requires study one common complications respiratory viral infections including sars <NUMBER> covid<NUMBER> <NUMBER> lung fibrosis characterized alveolar epithelial cell injury recruitment activation fibroblasts subsequent production extracellular matrix ecm presence specifically activated immune cells fibrosis develops exaggerated repair process following injury associated abnormal immune response leading chronic progressive disease <NUMBER> histological examination lung biopsies covid<NUMBER> patients show massive apoptosis pneumocytes hyaline membrane formation fibromyxoid exudates <NUMBER> manifestations characteristic ards represent key events preceding development fibrosis reviewed <NUMBER> significant profibrotic m<NUMBER>like spp<NUMBER> macrophage infiltration also described covid<NUMBER> correlating disease severity <NUMBER> damage epithelial layer caused virus attracts various immune cells participating inflammationrepair balance monocytes macrophages granulocytes cells addition viral components nprotein papainlike protease directly stimulate production tgfβ one profibrotic hallmarks respiratory epithelium similar previously reported sarscov <NUMBER> <NUMBER> role il<NUMBER> extensively studied bleomycin model lung fibrosis mice bleomycin chemotherapeutic antibiotic causes damage tissues lacking bleomycin hydrolase predominantly lungs <NUMBER> mice genetic ablation il<NUMBER> characterized impaired fibrosis <NUMBER> however model mice pharmacological rather genetic inhibition il<NUMBER> demonstrated opposing phenotypes depending phase inflammationrepair cycle specifically il<NUMBER> neutralization early inflammatory phase day <NUMBER> following bleomycininduced lung injury resulted apoptosis pneumocytes contributed pulmonary fibrosis whereas il<NUMBER> blockade early fibrotic stage day <NUMBER> following bleomycininduced lung injury significantly ameliorated lung fibrosis <NUMBER> interestingly treatment mice recombinant soluble gp<NUMBER>fc late stage chronic bleomycin model attenuated lung fibrosis emphasizing importance sil<NUMBER>ra il<NUMBER> transsignaling mediating condition <NUMBER> suggested m<NUMBER>like infiltrating macrophages major source soluble il<NUMBER>ra fibrotic foci whereas pulmonary fibroblasts recipient cells proliferate produce extracellular matrix transil<NUMBER> activation finally overexpression il<NUMBER> respiratory tract mediated adenoviral vectors also resulted exacerbation fibrosis associated increased levels m<NUMBER>macrophages profibrotic features <NUMBER> profibrotic macrophages also characterized increased il<NUMBER>ra expression <NUMBER> ace<NUMBER> expression reported lung heart kidney intestine liver brain thus similar fibrosisassociated complications expected respiratory tract also tissues organs correlation viral load severity cytokine release syndrome summarizing data available moment infectionfree experimental models fibrosis one conclude il<NUMBER> may affect fibroblast proliferation functions directly potentiation distinct macrophage phenotype taking account importance cytokine repair stage antiil<NUMBER> therapy may prove beneficial acute phase also subacute proliferative phase covid<NUMBER>related ards j u r n l p r e p r f sarscov<NUMBER> tropism neural system particular interest neurological symptoms dizziness headache ataxia anosmia often found mild covid<NUMBER> patients develop early infection <NUMBER> ace<NUMBER> expression cns attributed nuclei brain stem associated cardiorespiratory control <NUMBER> <NUMBER> recent study based scrna sequencing suggests coexpression ace<NUMBER> tmprss<NUMBER> olfactory epithelial cells mature olfactory sensory neurons initially considered obvious target population virus cns <NUMBER> even without understanding exact mechanisms sarscov<NUMBER> penetration distribution cns noted result disseminated intravascular coagulopathy cytokine storm caused infection bloodbrainbarrier permeability significantly increased lead negative consequences cns functioning <NUMBER> <NUMBER> effective therapeutic approach include combination specific antiviral drugs inhibit viral dissemination limit direct virusinduced cytopathic effects coupled antiinflammatory therapeutics directed immunopathology induced viral infection <NUMBER> sarscov<NUMBER>induced immunopathology exhibits features systemic hyperinflammation reminiscent cytokine storm macrophage activation syndrome secondary haemophagocytic lymphohistocytosis <NUMBER> since overexpression il<NUMBER> appears associated severe covid<NUMBER> outcomes neutralizing antibodies used treat number autoimmune diseases targeting exacerbated inflammatory immune response host may provide lifesaving approach preventing cytokine release syndrome line patients responding cd<NUMBER> car cell therapy experience cytokine release syndrome <NUMBER> well managed il<NUMBER> neutralizing antibodies <NUMBER> nonrandomized openlabel clinical trial <NUMBER> patients severe critical covid<NUMBER> treated single dose tocilizumab addition routine therapy <NUMBER> <NUMBER> patients recovered suggesting antiil<NUMBER> might powerful potential rescue therapy managing acute respiratory distress syndrome covid<NUMBER> inhibiting adverse outcome peripheral mononuclear cell scrnaseq profiling data obtained patients indicate treatment tocilizumab reduce number cytotoxic cd<NUMBER> plasma b cells thus interfere robust adaptive immune response <NUMBER> preliminary data <NUMBER> patients covid<NUMBER> developed acute respiratory distress syndrome participated compassionateuse program papa giovanni xxiii hospital bergamo italy indicate intravenous introduction siltuximab reduced creactive protein level patients significantly improved clinical conditions reduced need ventilation <NUMBER> patients <NUMBER> patients showed stabilization conditions <NUMBER> patients experienced worsening disease required intubation <NUMBER> sarilumab monoclonal antibody works inhibiting il<NUMBER> pathway binding blocking il<NUMBER> receptor recently another clinical trial initiated evaluate effects sarilumab patients severe covid<NUMBER> usbased multicenter doubleblind phase <NUMBER> trial begin medical centers new york anticipated enroll <NUMBER> patients <NUMBER> overview initiated clinical trials antiil<NUMBER> therapeutics covid<NUMBER> patients presented supplementary table <NUMBER> summary strong scientific evidence beneficial impact il<NUMBER> inhibitors modulation covid<NUMBER> infection requires clinical data face pandemic affecting millions people worldwide need develop new approaches reassess existing ones treatment severe viral infections j u r n l p r e p r f pressing ever despite fact humanity experienced viral infections causing deadly pneumonia twice past <NUMBER> years still drugs specific coronaviruses evidence discussed review suggests patients risk factors especially high systemic levels il<NUMBER> clinically approved neutralizing antibodies il<NUMBER> receptor il<NUMBER>r combination standard treatment protocols may provide benefit gaining deeper understanding factors affect immune response mechanistic link factors disease severity crucial effective clinical management covid<NUMBER> severely affected patients work supported ministry science higher education russian federation grant <NUMBER> authors declare conflict interest binding virion ace<NUMBER> followed serine protease tmprss<NUMBER> cleavage viral spike protein induction internalization complex subsequent reduction ace<NUMBER> surface availability another protease furin releases spike fusion peptide virus enters host cell endosomal pathway novel human coronavirus severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> declared global pandemic world health organization march <NUMBER> <NUMBER> <NUMBER> million confirmed cases <NUMBER> deaths identified worldwide <NUMBER> usa <NUMBER> deaths april <NUMBER> <NUMBER> <NUMBER> new york state epicenter pandemic <NUMBER> hence urgency find effective treatment patients afflicted united states many required treatment ventilator secondary acute respiratory distress syndrome pathogenesis severe acute respiratory syndrome sars related coronavirus involves cytokine storm high serum levels proinflammatory cytokines chemokines interleukin <NUMBER> il<NUMBER> proinflammatory cytokine il<NUMBER> seems prominent role inflammatory cascade may result increased alveolarcapillary bloodgas exchange dysfunction <NUMBER> <NUMBER> recent clinical experiences china italy <NUMBER> suggested patients admitted intensive care units cytokine storm syndrome proportional severity disease <NUMBER> often progressing cardiovascular collapse multiple organ dysfunction death rapidly <NUMBER> therefore early identification treatment prevention cytokine storms crucial importance patients tocilizumab blocker il<NUMBER>r effectively block il<NUMBER> signal transduction pathway safety tocilizumab phase iii doubleblind controlled trials studied patients rheumatoid arthritis complications associated tocilizumab history illness deterioration death overall risk secondary infection tocilizumab high <NUMBER> recommend treatment hyperinflammation using existing approved therapies proven safety profiles address immediate need reduce rising mortality data needed regarding benefit treatment prevention cytokine storms covid<NUMBER> patients tocilizumab currently small clinical trial china shown good efficacy tocilizumab days treatment patients experienced clinical improvement became afebrile gradually decreased oxygen consumption symptoms significantly improved ct chest showed regression pulmonary infiltrates ground glass appearance <NUMBER> laboratory examination showed improvement peripheral blood lymphocytes creactive protein suggesting tocilizumab could efficient treatment covid<NUMBER> patients multicenter randomized controlled trial efficacy safety tocilizumab treatment new coronavirus pneumonia covid<NUMBER> underway <NUMBER> <NUMBER> secondary haemophagocytic lymphohistiocytosis shlh underrecognized characterized fulminant fatal hypercytokinaemia multiorgan failure <NUMBER> cytokine profile resembling shlh associated covid<NUMBER> disease severity patients severe covid<NUMBER> screened hyperinflammation using laboratory trends eg increasing ferritin decreasing platelet counts crp hscore identify subgroup patients immunosuppression could improve mortality hscores greater <NUMBER> <NUMBER> sensitive <NUMBER> specific hlh <NUMBER> orange regional medical center serves racially ethnically diverse patient population hudson valley study patient data came icu floor coronavirus rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> pandemic included patients least <NUMBER> years old laboratory confirmed covid<NUMBER> infection admitted hospital mar <NUMBER> <NUMBER> apr <NUMBER> <NUMBER> confirmed case covid<NUMBER> defined positive reverse transcriptase polymerase chain reaction rtpcr assay specimen collected via nasopharyngeal swab orange regional medical center institutional review board approved research regulatory protocol allowing analysis limited patient data obtained demographics laboratory test results diagnosis codes international classification diseases<NUMBER> procedures icu floor progress notes hospitalization demographics included age sex bmi race ethnic group electronic health records laboratory values crp il<NUMBER> tgl ferritin fibrinogen ast ddimer fibrinogen ekg obtained part indicated clinical care treatment modalities used also compared tocilizumab dose mgkg one two doses hydroxychloroquine azithromycin steroids hydrocortisone methylprednisolone dexamethasone patients sustained acute kidney injury mode management hemodialysis crrt also obtained icu stay ventilator setting average peep average fio<NUMBER> average plateau pressure average driving pressure use paralytic medication cisatracurium atracurium rocuronium vecuronium infusions proning taken account data analysis defined comorbidities presence diagnosis codes associated asthma copd diabetes use immunosuppressant medications assessed length stay number days ventilator inhospital intensive care unit mortality survival discharge home rehab transfer outside facility admission used descriptive statistics summarize data results reported medians ranges averages pvalues appropriate categorical variables summarized counts percentages compared z score comparison mean tocilizumab nontocilizumab group within <NUMBER> standard deviation <NUMBER> confidence interval statistical tests <NUMBER>tailed statistical significance defined p <NUMBER> <NUMBER> httpswwwmedcalcorg total <NUMBER> patients covid<NUMBER> ards analyzed <NUMBER> study group <NUMBER> control group tried match group close possible terms age sex bmi hs scorecalculated using inflammatory markersferritin triglycerides ast fibrinogen median age <NUMBER> years study group <NUMBER> control group difference statistically significant average hs score <NUMBER> tocilizumab group <NUMBER> control group difference statistically significant p<NUMBER> also patients study group elevated levels il<NUMBER> triglycerides ast ferritin statistically significant p <NUMBER>when compared control group length stay longer average <NUMBER> days tocilizumab survival rate much lower <NUMBER> control group <NUMBER> patients received tocilizumab significant p value <NUMBER> number needed treat nnt <NUMBER> treat <NUMBER> patients tocilizumab <NUMBER> die covid<NUMBER> pandemic presents public health challenge emergency limited data available us guide management effective treatment best knowledge study compared outcome tocilizumab patients control group covid<NUMBER> infection clinical studies shown serum levels inflammatory mediators significantly higher patients severe disease excessive immune responses trigger cytokine storms cause damage multiple target organs recent guidelines also point progressive rise il<NUMBER> may clinical warning indicator deterioration covid<NUMBER> <NUMBER> tocilizumab monoclonal antibody interleukin<NUMBER> emerged alternative treatment covid<NUMBER> patients risk cytokine storms recently <NUMBER> study aim discuss treatment response therapy covid<NUMBER> infected patients terms survival outcome report provides perspective patients admitted confirmed covid<NUMBER> intensive care floor setting hospital serves ethnically socioeconomically diverse population close new york city significant number patients displayed abnormal laboratory measurements time admission covid<NUMBER> laboratory order set used emr order labs time hospital admission icu transfer included il<NUMBER> ferritin crp triglyceride fibrinogen ddimer cmp cbc differential majority patients admitted icu acute hypoxemic respiratory failure required respiratory support endotracheal intubation invasive mechanical ventilation needed significant proportion patients several key findings observed several key findings observed tocilizumab group laboratory values il<NUMBER> ferritin triglyceride fibrinogen significantly higher indicating patients demonstrated cytokine storms early laboratory evaluation may crucial identifying cytokine storm may also aid clinicians identifying patients high risk decompensation icu admission potentially even death study china reported increased expression interleukin il<NUMBER>r il<NUMBER> serum appears predict severity prognosis patients covid<NUMBER> <NUMBER> elevated levels inflammatory indicator il<NUMBER> blood reported predictive fatal outcome patients patients received tocilizumab <NUMBER> male <NUMBER> females overall survival rate <NUMBER> patients received tocilizumab compared <NUMBER> control group <NUMBER> percentage male patients survived compared <NUMBER> females received tocilizumab total <NUMBER> males <NUMBER> females enrolled study indicating male gender predominance affected covid<NUMBER> study considered light several limitations study group <NUMBER> patients fibrinogen level tested received tocilizumab control group <NUMBER> patients results fibrinogen context urgent need effective therapies current pandemic particularly severe cases however systematically recommended treatment covid<NUMBER> tocilizumab humanized monoclonal antibody interleukin<NUMBER> receptor il<NUMBER>r fdaapproved cytokine release syndrome recently administered experimentally treatment severe covid<NUMBER> pneumonia china italy promising results <NUMBER> cytokine release syndrome crs occurs large number patients severe covid<NUMBER> also important cause death il<NUMBER> key molecule crs tocilizumab may value improving outcomes study tocilizumab group seemed improved survival outcome results interpreted caution since retrospective study mortality affected multiple confounding factors largest clinical trials database clinicaltrialsgov <NUMBER> ongoing studies registered around world regarding use tocilizumab covid<NUMBER> patients await results ongoing randomized controlled trials definitely answer question whether tocilizumab improves survival covid<NUMBER> ards patients summarize relationship sarscov<NUMBER> cardiovascular diseases <NUMBER> discuss possible mechanisms action behind sarscov<NUMBER> infectioninduced damage <NUMBER> cardiovascular system ang ii production indirect inhibition ang ii upregulation ace<NUMBER> figure <NUMBER> <NUMBER> multicentered study involving <NUMBER> covid<NUMBER> patients combined hypertension <NUMBER> administration ace inhibitors arbs associated lower mortality rate <NUMBER> purpose novel coronavirus disease <NUMBER> covid<NUMBER> acute respiratory distress syndrome ards emerged wuhan recently become worldwide pandemic strangely ample evidences shown severity covid<NUMBER> infections varies widely children asymptomatic adults mild infection well elderly adults deadly critical proven covid<NUMBER> infection elderly critical adults leads cytokine storm characterized severe systemic elevation several proinflammatory cytokines cytokine storm induce edematous ards pneumonia well multiple organ failure aged patients far clear till cytokine storm induces covid<NUMBER> elderly patients young patients however seems aging associated mild elevated levels local systemic proinflammatory cytokines characterized inflammaging highly likely inflammaging correlated increased risk cytokine storm critical elderly patients covid<NUMBER> infection methods systematic search literature performed pubmed scopus embase cochrane library web science well google scholar preprint database using available mesh terms covid<NUMBER> coronavirus sarscov<NUMBER> senescent cell cytokine storm inflameaging ace<NUMBER> receptor autophagy vitamin electronic database searches combined duplicates removed results aim present review summarize experimental data clinical observations linked pathophysiology mechanisms inflammaging mildgrade inflammation cytokine storm elderly adults severe covid<NUMBER> infection possible pathophysiology mechanism cytokine storm elderly adults covid<NUMBER> infection contribution inflameaging summary recent studies provided novel evidence regarding effect nicotine agonists prevention modulation cytokines storm reduction infection study tried attempt address issues therapeutic perspective nicotine agonists manner describe one challenging theories immunotherapy coronavirus<NUMBER> analysis proposed mechanism goes beyond physiological consequences way design new strategies provide antiinflammatory drugs keywords covid<NUMBER> nicotinic agonist immunotherapy coronaviruses appear periodically unpredictably year <NUMBER> onset sarscov merscov covid<NUMBER> sarscov<NUMBER>this family viruses causing infectious diseases became constant threat human health definitive approved treatment cardiorespiratory sequels cov infections although pathophysiological point view deep understanding immune response virus approved treatment immunomodulation patients thus seems treatment immune system problems systemic pulmonary inflammatory responses associated cov necessitating immunity based treatment good alternative savior therapy antiviral treatment know cytokine storms lung tissue deadly events patients cov infection therefore cases cov induced pneumonia important control cytokine production inflammatory response although strategy challenging due lack clear immune response endangering host defense seem impossible attempt address issues therapeutic perspective describe hypothesis one challenging theories immunotherapy cov viruses replication rna viruses cov family accompanied excessive production interferons neutrophils macrophages brings massive immune response referred cytokine storm overproduction negatively affects balance inflammatory responses normal function cytokines immune system disorder lead series symptoms including fever edema hypotension mild cases severe cases cause systemic inflammation heart failure pulmonary failure consequently led acute respiratory syndrome eventually death covid<NUMBER> infection like coronavirus infections similar scenario expected varying degrees immune interference expected management activity performance cytokines might lead prevention severe endothelial dysfunctions pulmonary fibrosis patients affected previous studies demonstrated indicated impressive relation nervous system immune system studies demonstrated nervous system modulatory effects production multiple inflammatory cytokines lung tissue <NUMBER> <NUMBER> cholinergic pathway via acetylcholine neurotransmitters interact nicotinic acetylcholine receptors activation receptors apply suppressive effect production proinflammatory cytokines <NUMBER> figure<NUMBER> among nicotine receptor subtypes subunit <NUMBER>α<NUMBER> prominent due high expression immune cells b cells macrophages cells target cells association humoral intrinsic immunity therefore evaluation pharmacological approaches activate α<NUMBER>nachr inhibition immunologic phenomenon cytokine storm helpful nicotine nonselective agonist receptor mimics acetylcholine binding stimulate vagal activity decrease cytokine function block inflammatory pathway general algorithm idea illustrated figure<NUMBER> hence comprehension theory provide better therapeutic guidance treatment coronavirus infections especially covid<NUMBER> describe one trends decline cytokine storm seems lethality uncontrolled complications coronaviruses due lack control cytokine storms although pathogenesis coronaviruses complex requires specific treatment previous studies shown efficacy neutralizing antiinflammatory cytokines inflammatory conditions caused covid<NUMBER> <NUMBER> dosedependent antiinflammatory effects <NUMBER>nachr<NUMBER> agonist demonstrated previous studies shown activation receptor antiinflammatory role immune cells regulating <NUMBER> nicotine agonist mentioned receptor cannot used clinically due toxicity addictive nature lack specificity agonists <NUMBER>nachr<NUMBER> receptors group gts<NUMBER> produce nicotine effects without nicotine problems also studies reported limited use gts<NUMBER> clinical phase shown agent cause decrease cytokine levels significantly reduced inflammatory biomarker infection <NUMBER> <NUMBER> thought nicotine agonist compound like gts<NUMBER> able suppress production proinflammatory cytokines infection covid<NUMBER> fact nicotine agonists control allergic inflammation induced innate immune cellular immune pathways taken together according mentioned literature review concluded gts<NUMBER> potent <NUMBER>nachr<NUMBER> receptor agonist act antiinflammatory agent covid<NUMBER>infectioninduced cytokine storm inflammatory disturbances respiratory system reduced risk death infected subjects hypothetical cellular covid<NUMBER> inflammatory pathway virus influx neutrophils monocytesmacrophages results hyperproduction proinflammatory cytokines cytokine storm occurs weakened intensification immune systems inflammatory response seems nicotinic antiinflammatory pathway triggered a<NUMBER> nachr immune cells infection bacterial components intracellular mediators trigger proinflammatory pathways converge activation nfkb translocate nucleus induce transcriptional activation variety inflammatory cytokines nicotine inhibits production proinflammatory cytokines macrophages mechanism dependent a<NUMBER>nachr group patients pneumonia caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> reported china december <NUMBER> tu et al <NUMBER> clerkin et al <NUMBER> guo et al <NUMBER> rapidly spread throughout world led fatal pandemic clerkin et al <NUMBER> cao <NUMBER> although several antiviral drugs widely tested none approved specific antiviral therapy coronavirus disease <NUMBER> mainstay treatment based management patients symptoms tu et al <NUMBER> cao <NUMBER> therefore vaccines monoclonal antibodies mabs novel therapies interest worldwide tu et al <NUMBER> clerkin et al <NUMBER> cao <NUMBER> accumulating evidence established hyperinflammatory states cytokine storm covid<NUMBER> elevated levels inflammatory cytokines including interleukin<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER>β tumor necrosis factoralpha tnfα damage heart liver kidneys may play significant role pathogenesis covid<NUMBER> leading shock well respiratory multiorgan failure guo et al <NUMBER> cao <NUMBER> zhang et al <NUMBER> among cytokines il<NUMBER> plays key role cytokine storm predict adverse clinical outcomes fatality patients tu et al <NUMBER> guo et al <NUMBER> zhang et al <NUMBER> interleukin<NUMBER> towfaced cytokine considered proinflammatory antiinflammatory cytokine produced immune cells serum levels healthy state prepare immune responses host sustained overproduction il<NUMBER> involved number inflammatory diseases tue et al <NUMBER> cao <NUMBER> zhang et al <NUMBER> high level il<NUMBER> detected patients severe complicated covid<NUMBER> relationship decreased lung elasticity severe bronchoalveolar inflammation furthermore elevated levels circulating il<NUMBER> significantly correlated need mechanical ventilation poor outcome patients severe covid<NUMBER> complicated pneumonia acute respiratory distress syndrome ards tue et al <NUMBER> cao <NUMBER> zhang et al <NUMBER> interleukin<NUMBER> participates pathogenesis common comorbidities covid<NUMBER> eg diabetes mellitus dm cardiovascular diseases cvds gue et al <NUMBER> zhang et al <NUMBER> addition considerably elevated levels circulating il<NUMBER> seen covid<NUMBER> patients dm myocardial injury data supports fact dm risk factor rapid deterioration poor prognosis covid<NUMBER> clerkin et al <NUMBER> guo et al <NUMBER> based evidence significant role il<NUMBER> cytokine storm dm cvds seems anticytokine therapy tocilizumab antiil<NUMBER>r may useful patients severe covid<NUMBER> reduce mortality tu et al <NUMBER> clerkin et al <NUMBER> zhang et al <NUMBER> use tocilizumab preliminary investigation quickly reduced fever improved respiratory function patients ongoing clinical trials tu et al <NUMBER> clerkin et al <NUMBER> cao <NUMBER> recent studies demonstrated herbalderived natural products immunosuppressive antiinflammatory properties exhibited exceptional act mediators inflammation curcuma longa glycyrrhiza species camellia sinensis salvia miltiorrhiza tanacetum parthenium indicated immunomodulatory properties reducing proinflammatory cytokines mediators amirghofran <NUMBER> tanacetum parthenium commonly known feverfew prevents releasing proinflammatory mediators macrophages lymphocytes amirghofran <NUMBER> george et al <NUMBER> perennial plant frequently grows various regions world history medical application feverfew backs ancient greek dioscorides prescribed plant reducing fever hot inflammations therefore called medieval aspirin pareek et al <NUMBER> feverfew used traditional folk medicine treatment fever cold asthma migraine headache arthritis womens health issues inflammatory conditions etc george et al <NUMBER> pareek et al <NUMBER> although qualitative standard many trials phytopharmacological field less rigorous conventional pharmaceutical sector williamson et al <NUMBER> clinical evidence suggests feverfew extract might positive results migraine prevention lopresti et al <NUMBER> phytochemical studies shown presence many active ingredients feverfew including sesquiterpene lactones flavonoid glycosides sesquiterpenes monoterpenes parthenolide principal sesquiterpene lactones main biologically active constituent plant pareek et al <NUMBER> different pharmacological properties including antioxidant antiinflammatory analgesic antimicrobial antimigraine anticancer activities george et al <NUMBER> wang et al <NUMBER> moreover parthenolide shown potent inhibitory effects proinflammatory pathways nfkb lps pathways interestingly parthenolide could significantly reduce il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfα production pathways established several human cell line models vitro monocytes macrophages neutrophils vivo studies wang et al <NUMBER> magni et al <NUMBER> although specific blockade proinflammatory cytokines using mabs one main therapeutic article protected copyright rights reserved severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> emerged recently new challenge medical sciences although coronavirus disease <NUMBER> covid<NUMBER> primarily causes respiratory disease pathogenesis still poorly understood covid<NUMBER> considered pandemic world health organization march <NUMBER> <NUMBER> widely spread around globe presented high rate humantohuman transmission reported covid<NUMBER> progression involves initial symptoms mild chills dry cough followed fever fatigue shortness breath dyspnea severe cases hypoxemia oxygen saturation <NUMBER> <NUMBER> several signs symptoms presented patients covid<NUMBER> described asymptomatic patients mild cold important changes clinical laboratory examinations progress severe organ failure death changes observed include decreased total lymphocytes prolonged prothrombin time elevated lactate dehydrogenase cellular immune deficiency coagulation activation myocardial hepatic renal injury <NUMBER> <NUMBER> endotheliitis lung heart small bowel <NUMBER> <NUMBER> although mechanisms involved changes known observation naked eye lungs patients sarscov<NUMBER> showed pathological characteristics exudative proteinaceous lesion microscopic examination showed inflammatory lymphocytic infiltrates <NUMBER> biopsy postmortem studies show diffuse alveolar damage formation hyaline membranes mononuclear cells macrophages infiltrating air spaces diffuse thickening alveolar wall addition spleen atrophy hilar lymph node necrosis focal hemorrhage kidney enlarged liver inflammatory cell infiltration constitute considerable worsening disease <NUMBER> <NUMBER> patients poor outcomes covid<NUMBER> mostly correlates clinical laboratory features cytokine storm moreover hypercoagulation hypoxia multiple organs worst scenario oxidative stress reactive oxygen species ros related main changes observed inflammatory infectious diseases could connecting point unites events study focused hosts response viral infection emphasizing oxidative stress rather viruss mechanisms aggression many studies related cytokine storm deterioration patients condition covid<NUMBER> infection considered major factor development acute respiratory distress syndrome multiple organ dysfunction <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> previous study demonstrated influenza infection induced expression cytokines via activation pattern recognition receptors including tolllike receptors tlr<NUMBER> tlr<NUMBER> tlr<NUMBER> retinoic acidinducible gene nodlike receptor family members lung epithelial cells macrophages dendritic cells <NUMBER> <NUMBER> possible innate immune response covid<NUMBER> infection follows pathways inflammasome important element cytokine storm <NUMBER> studies shown ros potent ligand direct mediator triggering nlrp<NUMBER> nodlike receptors p<NUMBER> inflammasome additionally tlr nlr ligands enhanced nfκb driven transcriptional levels nlrp<NUMBER> nfκb turn activated ros thus direct indirectly inflammasome increased ros <NUMBER> <NUMBER> <NUMBER> besides ros h <NUMBER> <NUMBER> mainly activates nfκb produce inflammatory cytokines <NUMBER> <NUMBER> hyperproduction il<NUMBER> tnfα il<NUMBER>β interferongamma inducible protein <NUMBER> granulocytecolony stimulating factor monocyte chemoattractant macrophage inflammatory proteins <NUMBER>α elevated blood ferritin also observed covid<NUMBER> patients <NUMBER> similar influenza infection covid<NUMBER> infection appears initial pulmonary phase consists virus replication inflammation involvement ros direct indirect nlrp<NUMBER> inflammasome activator subsequent blood dissemination possibly associated adaptive immune response oxidative stress mechanism systemic injury important understand mechanism sarscov<NUMBER> induces pulmonary systemic injury whether virus solely responsible whether synergistic mechanisms sustain aggravate tissue damage observed disease disease progression patients covid<NUMBER> show disseminated intravascular coagulopathy characterized prominent elevation fibrinfibrinogen degradation products ddimer <NUMBER> <NUMBER> <NUMBER> translocate extravascular space damage cells tissue <NUMBER> hematological disorders also reported inflammation biomarkers hemoglobin levels metaanalysis study <NUMBER> covid<NUMBER> patients showed significant lower hemoglobin levels <NUMBER> gl even <NUMBER> gl severe cases <NUMBER> another study besides presenting decreased hemoglobin patients coronavirus pneumonia presented elevated serum ferritin erythrocyte sedimentation rate lactate dehydrogenase activity acidosis <NUMBER> addition inflammation markers disseminated intravascular coagulation contributes establishment organ failure due hypoxia <NUMBER> <NUMBER> treatment <NUMBER> coronavirus patients heparin promoted recovery <NUMBER> contributing proposal treatment protocol applied hospitalized patients another observation made patients severe covid<NUMBER> progression developed typical clinical manifestations shock characteristic evolution viral sepsis <NUMBER> shown free hemoglobin heme augmented blood patients sepsis due hemolysis <NUMBER> although several mechanisms involved hemolysis described viruses infections number studies showing ros play role damaging membrane erythrocytes <NUMBER> <NUMBER> production high ros levels septic patients leads alterations erythrocyte membrane turn induces phagocytosis macrophages neutrophils perpetuating cycle production ros <NUMBER> may contribute increased free hemoglobin low levels oxygen transport tissues <NUMBER> <NUMBER> free hemoglobin dissociated generating heme degraded heme oxygenase oh<NUMBER> produce free iron heme free iron harmful cells <NUMBER> murine study sepsis model cecal ligation puncture clp showed increased total body free iron three times higher compared control <NUMBER> addition administration apoferritin ferritin combined iron induction expression ferritin heavy chain decreases clp mice mortality <NUMBER> reduced oxygen saturation leads superoxide radical h <NUMBER> <NUMBER> generation mitochondria <NUMBER> <NUMBER> <NUMBER> superoxide anion radical reduces iron iii iron ii presence h <NUMBER> <NUMBER> also generated phagocytic cells inflammatory environment produces hydroxyl radicals • oh extremally toxic agent promotes formation cell membrane lipid peroxides protein oxidation triggering cell death apoptosis andor necrosis <NUMBER> also demonstrated iron iii induces blood coagulation <NUMBER> via hydroxyl radicals hydroxyl radicals convert soluble plasma fibrinogen abnormal fibrin clots form dense matted deposits resistant enzymatic degradation <NUMBER> <NUMBER> believe started events occur independent causative agent worsening patients condition disseminated intravascular coagulopathy sepsis decreased oxygen transport tissues main elements presented covid<NUMBER> patients <NUMBER> moreover free heme blood decreases circulating nitric oxide worsening ischemia organs <NUMBER> <NUMBER> <NUMBER> despite hypoxemia pulmonary compliance preserved <NUMBER> indicating possible mitochondrial impairment mitochondrial inability produce atp <NUMBER> described experimental human sepsis normal oxygen saturation tension points mitochondria dysfunction crucial role sepsis pathogenesis <NUMBER> impairment mitochondria leads cytopathic hypoxia <NUMBER> <NUMBER> <NUMBER> results oxygen partial reduction ros generation reduced energy production regard hypoxia accompanies sepsis known generate superoxide h <NUMBER> <NUMBER> reactive species mainly mitochondrial respiratory chain <NUMBER> <NUMBER> <NUMBER> <NUMBER> hydrogen peroxide triggers expression many genes upregulate proinflammatory cytokines il<NUMBER> il<NUMBER> tnfα inducible nitric oxide synthase inos via activation nfκb pathway <NUMBER> <NUMBER> <NUMBER> cyclic manner proinflammatory cytokines activate macrophages neutrophils endothelium cells via nadph oxidase nox produce superoxide h <NUMBER> <NUMBER> <NUMBER> superoxide radical reacts produced inos expressed via nfκb pathway yielding peroxynitrite peroxynitrite toxic mitochondria <NUMBER> may explain inability mitochondria utilize oxygen despite normal tissue oxygen saturation <NUMBER> interplay ros cytokines generates selfsustaining cycle cytokine storm oxidative stress production eventually leads multiorgan failure patients covid<NUMBER> progress sepsis shock several vitro vivo studies highlighted strategy viruses alter redox balance cell order survive initiation oxidative stress virus infection shown play key role activation innate immunity via nfκb generation cytokines fight pathogenic microbes <NUMBER> <NUMBER> <NUMBER> <NUMBER> respiratory syncytial virus rsv infection shown induce ros production turn induced expression proinflammatory cytokines innate immune defense <NUMBER> <NUMBER> <NUMBER> additionally several viruses induce oxidative stress order facilitate replication inside cell <NUMBER> way control ros levels viruses evolved acquire ability manipulate nrf<NUMBER> pathway favor <NUMBER> <NUMBER> <NUMBER> cases viruses ability suppress nrf<NUMBER> pathway <NUMBER> <NUMBER> instance rsv increases lipid peroxidation decreases gsh human alveolar type iilike epithelial cells small airway epithelial cells abrogate activation nrf<NUMBER> pathway resulting reduction expression nrf<NUMBER> target genes including hemoxigenase<NUMBER> ho<NUMBER> superoxide dismutase <NUMBER> sod<NUMBER> superoxide dismutase <NUMBER> sod<NUMBER> glutathione stransferase gst catalase cat glutathione peroxidase gpx <NUMBER> time tolllike receptor interferon ifn pathways triggered infectioninduced oxidative stress combat virus infection <NUMBER> <NUMBER> hand defective redox balance host cell shown contribute viral pathogenesis resulting massive induction cell death provoked oxidative stress <NUMBER> influenza virus shown induce apoptosis cytotoxicity alveolar epithelial cells accompanied increased expression caspase <NUMBER> <NUMBER> proinflammatory cytokine il<NUMBER> <NUMBER> virus induces oxidative stress time facilitates nuclear translocation nrf<NUMBER> subsequent expression ho<NUMBER> protective enzyme oxidative injury human alveolar epithelial cells <NUMBER> findings confirm idea oxidative stress importantly involved success failure response virus infection shaping therapy disease whose pathogeny unclear challenge oxidative stress believed link every mechanism known sarscov<NUMBER> infection use antioxidants vitamin e sh group donor nacetyl cysteine iron complexing agents deferoxamine inhibitors nfb activators nrf<NUMBER> curcumin resveratrol use specific proinflammatory cytokine inhibitors anticoagulants could help recovery patients covid<NUMBER> useful emphasize clinical experimental studies showing effectiveness antioxidants treatment many diseases vitro sepsis model showed vitamin e α tocopherol trolox soluble vitamin e motvit e polar derivative reduced mitochondrial damagedysfunction nfb transcription molecule cytokine expression motvit e accumulates inside mitochondria efficient protective effect genes linked tlrs <NUMBER> treatment animals vitamin e model acute sepsis also showed beneficial effects <NUMBER> triterpenoids oltipraz butylated hydroxyanisol sulphoraphane dimethyl fumarate curcumin silibinin resveratrol exert antioxidant activity activating nrf<NUMBER> inhibiting nfb pathways <NUMBER> high levels blood peroxynitrite <NUMBER> patients sepsis decreased using deferoxamine iron chelator used patients iron overload <NUMBER> indicates potential application drug iron complexing peroxynitrite scavenging patients sepsis glutathione gsh main antioxidant agent mammalians important antioxidant defense lungs <NUMBER> balance gshgssg disrupted increase h <NUMBER> <NUMBER> oxidative environment oxidizes proteins control activation localization transcription factors keap<NUMBER> regulates nrf<NUMBER> iκb regulates nfκb <NUMBER> thereby sh group donors activators nrf<NUMBER> nfkb inhibitors regulator molecules keap<NUMBER> iκb respectively potential therapeutic options sarscov<NUMBER> infection case report shows strategy successfully reverted severe symptoms covid<NUMBER> patients <NUMBER> lipoic acid also sh donor used randomized study reduced mortality rate <NUMBER> <NUMBER> <NUMBER> certainly different approach table one seek new drug strategies directly targeting host response viral aggression rather sarscov<NUMBER> virus antioxidants exert action breaking cytokine storm oxidative stress cycle decreasing hematological damage reducing cytopathic hypoxia appears oxidative stress plays role pathogenesis covid<NUMBER> perpetuates cytokine storm cycle blood clotting mechanism exacerbates hypoxia taken together evidence indicates important participation oxidative stress pathogenesis viral infection direct tissue injury including mitochondrial dysfunction signaling process indicates interplay oxidative stress cytokine storm mechanism sustains worsens tissue injury terminates hypoxia organ failure moreover reveals sarscov<NUMBER> virus may interfere equilibrium nfκb transcription molecule involved expression cytokines nrf<NUMBER> activation responsible expression antioxidant enzymes yet proved conclusively aware importance role oxidative stress pathogenesis viral infection sepsis however participation covid<NUMBER> disease remains unclear <NUMBER> believe crosstalk cytokine storm oxidative stress crosstalk may play important role severity symptoms presented patients covid<NUMBER> infection thus reasonable propose pathogenesis model coronavirus syndrome primary lung injury late hematological tissue hypoxemia cytopathic hypoxemia mitochondrial dysfunction due involvement oxidative stress supported robust experimental evidence presented scientific literature thereby aim contribute rational therapeutic decision overall low hemoglobincarrier high lung proteinaceous exudate leads pulmonary hypoxia cytopathic hypoxia endothelium damage disseminated coagulation results multiple organ collapse recover severe cases approximately <NUMBER> develop multi organ failure primarily respiratory failure requiring intensive care unit icu admission <NUMBER> <NUMBER> efficient immune response sarscov<NUMBER> may considered fundamental resolution covid<NUMBER> however studies shown significant relationship disease severity levels proinflammatory cytokines subsets immune cells <NUMBER> <NUMBER> suggested response sarscov<NUMBER> immune dysregulation high level proinflammatory cytokines could main cause tissue injury eventually exact pathophysiologic mechanism covid<NUMBER> remains still largely unknown basis genomic phylogenetic relationship subfamily orthocoronavirinae classified four genera alphacoronaviruses betacoronaviruses gammacoronaviruses deltacoronaviruses <NUMBER> alphacoronaviruses betacoronaviruses tend infect mammals cause respiratory gastrointestinal infection humans like sars coronavirus sarscov mers coronavirus merscov sarscov<NUMBER> gammacoranaviruses deltacoronaviruses ability infect birds addition mammals <NUMBER> <NUMBER> betacoronaviruses comprise sarscov merscov human coronaviruses hcovs batsarslike sl coronaviruses lastly identified sarscov<NUMBER> sarscov<NUMBER> possesses nonsegmented singlestranded positivesense rna ssrna <NUMBER>cap structure <NUMBER>polya tail typical genomic structure covs <NUMBER> genome analyses revealed genome sequence sarscov<NUMBER> <NUMBER> <NUMBER> identical bat coronavirus termed batcov ratg<NUMBER> sarscov respectively <NUMBER> therefore bat suggested natural host sarscov<NUMBER> transmission route sarscov<NUMBER> could unknown intermediate hosts genetic analyses sarscov<NUMBER> genomes <NUMBER> chinese patients demonstrated virus evolved two main types l type <NUMBER> type <NUMBER> l type aggressive infectious type ancestral version <NUMBER> genome cov contains six major open reading frames ofrs numerous accessory genes first ofrs ofr<NUMBER>ab encompasses twothird viral rna encode two large proteins covs polyprotein <NUMBER>a pp<NUMBER>a pp<NUMBER>ab polyproteins divided <NUMBER> nonstructural proteins nsps responsible viral rna replication transcription virally encoded chymotrypsinlike protease <NUMBER>clpro main protease mpro papainlike protease plpro <NUMBER> <NUMBER> remaining ofrs onethird genome encode major structural proteins including spike envelope e membrane nucleocapsid n proteins crucial viral infectivity seen figure covs possess lipid bilayer envelope e proteins <NUMBER> <NUMBER> n protein composed amino nterminal nt domain acarboxy cterminal cytoplasmic tail ct domain located core viral particle domains bind viral rna form helical nucleocapsid <NUMBER> <NUMBER> besides sarscov n protein acts antagonist interferon pathway regulating signaling synthesis type interferon ifn one important response innate immunity viral infection <NUMBER> protein abundant component viral envelope protein contains glycosylated nt ectodomain three transmembrane tm domains ct domain binds nucleocapsid protein gives shape virus promotes membrane curvature virus assembly interacting protein ribonucleoprotein <NUMBER> <NUMBER> <NUMBER> e protein small integral membrane protein including nt ectodomain tm domain ct endodomain e protein facilitates assembly budding envelope formation well protein <NUMBER> moreover e protein ionchannel activity contributing factor inflammasome activation animal study shown blocking ion channel activity sarscov e protein deletion associated genes leads reduction edema level inflammasomeactivated interleukin il<NUMBER>β il<NUMBER> tumor necrosis factor tnf important role progression ards <NUMBER> glycoproteins surface covs receptor binding proteins responsible attachment host cells viralhost cell membrane fusion internalization virus <NUMBER> genome sarscov<NUMBER> less <NUMBER> identical sequence previously known sarscovs except ratg<NUMBER> genome <NUMBER> identical sarscov<NUMBER> <NUMBER> besides another genome analyses elucidated sequence identity protein sarscov<NUMBER> sarscov <NUMBER> variation seen n terminus <NUMBER> <NUMBER> glycoprotein consists two domains s<NUMBER> domain includes receptorbinding domain rbd interacting angiotensinconverting enzyme <NUMBER> ace<NUMBER> human host cells sarscov s<NUMBER> domain mediates viruscell membrane fusion viral entry <NUMBER> <NUMBER> s<NUMBER> domain comprises three parts large ectodomain single tm domain ct domain <NUMBER> sequence rbd sarscov sarscov<NUMBER> exhibits <NUMBER> identity <NUMBER> current study indicated rbd sarscov<NUMBER> lower affinity ace<NUMBER> rbd sarscov <NUMBER> however result another study revealed sarscov<NUMBER>s protein binds ace<NUMBER> higher affinity sarscov <NUMBER> attachment sarscov<NUMBER> protein ace<NUMBER> host cells protein cleaved host cell proteases reveal s<NUMBER> domain viralhost membrane fusion viral entry coupled tnfα production <NUMBER> <NUMBER> <NUMBER> effective antiviral responses host innate adaptive immunity including production various proinflammatory cytokines activation cells cd<NUMBER> cd<NUMBER> cells essential controlling viral replication limiting spread virus inflammation cleaning infected cells <NUMBER> <NUMBER> nevertheless tissue protein attaches angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor host cell entry attachment host endosomal proteases mediate virus membraneendosome fusion release viral genome chloroquine cq hydroxycloroquine hcq block virusreceptor binding virusendosome fusion besides cq hcq intravenous immunoglobulin ivig inhibit production cytokines macrophages antigen presentation dendritic cells covid<NUMBER> count neutrophils leukosytes increase whereas total count lymphocytes cd<NUMBER> cells cd<NUMBER> cells regulatory reg cells memory cells natural killer cells b cells decrease another beneficial effect cq hcq increasing activity treg aberrant proinflammatory cytokine production observed covid<NUMBER> several immunomodulatory therapies including interleukin il<NUMBER> antagonists granulocyte colonystimulating factor gmcsf inhibitor il<NUMBER> antagonists il<NUMBER> antagonists antitumor necrosis factor tnf agents might used cytokine storm resolve limit inflammation tissue damage yellow arrow indicates decrease number cells blue arrow indicates increase number cells injury caused virus could induce exaggerated production proinflammatory cytokines recruitment proinflammatory macrophages granulocytes results cytokine storm cs termed macrophage activation syndrome mas secondary hemophagocytic lymphohistiocytosis shlh thus leading tissue damage <NUMBER> <NUMBER> <NUMBER> data obtained sarscov<NUMBER> infected patients shown severe cases may characterized cytokine storm inexorably progressing ards <NUMBER> <NUMBER> <NUMBER> several features covid<NUMBER> cytokine profile serological markers clinical symptoms resemble shlh commonly triggered viral infection <NUMBER> <NUMBER> furthermore another important evidence severity covid<NUMBER> related level proinflammatory cytokines subsets immune cells <NUMBER> <NUMBER> covid<NUMBER> possesses different levels various cytokines chemokines mild severe stage disease sarscov<NUMBER> infected patients retrospective analysis demonstrated initial plasma levels il<NUMBER>β il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> ifnɣ monocyte chemoattractant peptide mcp<NUMBER> macrophage inflammatory protein mip<NUMBER>a mip<NUMBER>b granulocytecolonystimulating factor gcsf tumor necrosis factoralpha tnfα increased patients covid<NUMBER> analysis shown plasma concentrations il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα icu patients higher nonicu patients <NUMBER> moreover plasma levels il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfα observed severe infection prominently greater nonsevere infection <NUMBER> retrospective studies revealed lung injury reported murray score strongly associated level il<NUMBER>α il<NUMBER>ra il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> ifnɣ inducible interferon protein ip<NUMBER> gcsf mcp<NUMBER> cytokines chemokines excluding mcp<NUMBER> positively related sarscov<NUMBER> viral load <NUMBER> <NUMBER> plasma level il<NUMBER> considered significant cytokine contributing mas increases mild severe patient groups covid<NUMBER> severe patients significantly higher level il<NUMBER> mild nonsevere patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore based assessment pulmonary infiltration patients ards large area lung injury ≥<NUMBER> closely correlated increased level il<NUMBER> subgroup lymphocytes peripheral blood <NUMBER> infection innate adaptive immune cells synergistically participate antiviral response <NUMBER> important increment number neutrophils leukocytes neutrophillymphocyteratio nlr observed severe covid<NUMBER> compared mild cases prominent lymphopenia indicating impairment immune system develops covid<NUMBER> patients especially severe ones <NUMBER> <NUMBER> therefore seems neutrophils leukocytes might reinforce cs lymphocytes covid<NUMBER> level lymphocytes subsets cells play significant role balancing immune response varies according type virus due possible viral pathologic mechanism previous investigations elicited total count lymphocytes subset cells reduced patients sarscov infection <NUMBER> <NUMBER> data recent studies suggested sarscov<NUMBER> infection lead immune dysregulation affecting subsets cells significant alleviation cells observed covid<NUMBER> pronounced severe cases patients covid<NUMBER> level helper cells cd<NUMBER> cd<NUMBER> cytotoxic suppressor cells cd<NUMBER> cd<NUMBER> regulatory cells normal level helper cells regulatory cells severe patients remarkably lower nonsevere patients regulatory cells responsible maintenance immune homeostasis suppressing activation proliferation proinflammatory function lymphocytes including cd<NUMBER> cells cd<NUMBER> cells nk cells b cells <NUMBER> <NUMBER> furthermore percentage naïve helper cells amplifies percentage memory helper cells cd<NUMBER> cytotoxic suppressor cells decreases severe covid<NUMBER> <NUMBER> <NUMBER> equilibrium naïve cells memory cells fundamental mediating efficient immune response <NUMBER> addition cells reduction b cells nk cells seen covid<NUMBER> another important result confirmed strong relationship inflammatory markers including esr crp il<NUMBER> subset lymphocytes <NUMBER> however previously shown significant correlation il<NUMBER> subsets lymphocytes <NUMBER> although reports indicated cd<NUMBER>cd<NUMBER> cell ratio sarscov<NUMBER> infection similar healthy group increase ratio decline cd<NUMBER> cells b cells considered poor predictor assessment posttreatment clinical followup <NUMBER> <NUMBER> taken together results indicate sarscov<NUMBER> responsible immune dysregulation induction aberrant cytokine chemokine response alteration level subgroup lymphocytes might result cytokine storm tissue damage excessive inflammatory response features cytokine storm cause severe disease course worsens prognosis covid<NUMBER> undoubtedly definitive effective treatments covid<NUMBER> drugs would antiviral agents directly target sarscov<NUMBER> considering lack proven antiviral agents hyperinflammation caused virus antiinflammatory drugs used daily rheumatology practice may constitute possible treatment options treatment covid<NUMBER> following antiinflammatory treatments potential candidates covid<NUMBER> preclinical limited clinical evidence systemic corticosteroids broadspectrum actions immune system may suppress exuberant systemic inflammatory response occurs ards severe multisource systemic inflammation associated adverse outcomes one may think corticosteroids may benefit broad spectrum immunosuppressive effects however evidence shown use corticosteroids delayed viral clearance sars mers infections similarly increased secondary infection rates mortality complications steroid therapy survivors influenza pneumonitis <NUMBER> randomized controlled trial included <NUMBER> nonicu sars patients early <NUMBER> days illness hydrocortisone therapy associated higher subsequent plasma viral load therefore corticosteroids used early phases disease unless clear indication use <NUMBER> sars infection patients showed severe inflammatory features despite reductions viral load subsequent seroconversion suggestive exuberant immune response independent viral load <NUMBER> two small observational study use corticosteroids show survival benefit covid<NUMBER> patients even increased mortality rates used high doses <NUMBER> <NUMBER> <NUMBER> moreover corticosteroid use prolonged sarscov<NUMBER> rna shedding observed sars mers infections <NUMBER> light preliminary data corticosteroids likely function inflammationmediated lung injury interstitial fibrosis latestage ards <NUMBER> however dose duration timing corticosteroids must individualized considering riskbenefit ratio results ongoing welldesigned prospective cohort studies obtained present several studies registered assess efficacy corticosteroids covid<NUMBER> chloroquine cq hydroxychloroquine hcq <NUMBER>aminoquinoline derivatives approved us food drug administration fda treatment malaria systemic lupus erythematosus rheumatoid arthritis ra decades experience use disorders also used q fever porphyria cutanea tarda hcq better side effect profile cq strongly recommended longterm treatment lupus unless occurrence severe side effect hcq increase risk infections lipidlowering antithrombotic antineoplastic properties <NUMBER> adult rheumatic diseases recommended dosage <NUMBER> <NUMBER> mg <NUMBER> <NUMBER> mg base cut <NUMBER> mgkgdaily usually welltolerated dreaded complication retinal toxicity rarely occurs long term use five years elders kidney failure tamoxifen users increased risk retinal toxicity cq hcq may prolong qt interval require routine ecg monitorization recommended doses higher doses drugs potential risk fatal arrhythmia combined qt prolonging medications well cardiac diseases <NUMBER> acute notable toxicities <NUMBER>aminoquinoline derivatives allergic reactions neuropsychiatric events <NUMBER> rarely may cause cardiomyopathy thought occur due lysosomal accumulation chronic use <NUMBER> oral absorption cq hcq good excreted primarily urine halflives cq hcq prolonged ranging <NUMBER> <NUMBER> days large volume distribution allows sustained sequestration tissues tissue concentrations may differ highest lung tissue <NUMBER>fold plasma concentrations shown animal models <NUMBER> known cq hcq antiviral activity including hepatitis b hiv h<NUMBER>n<NUMBER> zika virus <NUMBER> antiviral activity hcq first observed hiv hepatitis b infections early <NUMBER>s small studies showed favorable efficacy combination regimens hbv hcv hiv infections cq hcq thought exert antiviral activity via multiple mechanisms first agents interfere glycosylation proteolytic maturation proteins interfering terminal glycosylation ace<NUMBER> cellular receptor protein agents block virusreceptor binding cell entry <NUMBER> <NUMBER> second cq hcq weak bases concentrated acidic lowph organelles endosomes golgi vesicles lysosomes increasing ph <NUMBER> endosomal acidification required activation endosomal proteases responsible initiation coronavirusendosome fusion releases viral particles infected cells <NUMBER> therefore cq hcq inhibit viral release host cell blocking endosomal acidification third hcq inhibits protein glycosylation proteolytic maturation viral proteins budding sarscov occurs golgi apparatus results incorporation envelope spike glycoprotein virion <NUMBER> studies shown resulting accumulation noninfective viral particles hiv inability viral particles bud host cell reducing spread infection finally antimalarial drugs act protecting hemoglobin invasion malaria parasites effects heme metabolism abnormal heme metabolism covid<NUMBER> patients chloroquine phosphate competes porphyrin binds viral protein thereby inhibits viral proteins attack heme binding porphyrin according study cq could prevent orf<NUMBER>ab orf<NUMBER>a orf<NUMBER> attack heme form porphyrin inhibit binding orf<NUMBER> surface glycoproteins porphyrins certain extent <NUMBER> rheumatic diseases exact mechanism action hcq effects immune system largely unknown however beside interfering lysosomal activity autophagy mentioned cq hcq interact membrane stability alter signaling pathways transcriptional activity result inhibition cytokine production modulation certain costimulatory molecules drugs inhibit antigen presentation dendritic cells cytokine production macrophages calcium tolllike receptor tlr cgassting signaling b immune cells <NUMBER> <NUMBER> major proposed immunomodulatory mechanisms cq hcq following inhibition cytokine production release cells il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfα ifnγ reduced levels chemokines ccl<NUMBER> cxcl<NUMBER> inhibition microrna expression decreased th<NUMBER>related cytokines increased treg activity upregulated levels ifnα il<NUMBER> il<NUMBER> inhibition cytotoxic cell selfreactive cd<NUMBER> lymphocyte activities decreased dna rna protein synthesis thymocytes <NUMBER> antimalarials ironbinding hydroxyl radical scavenging actions may benefit considering disrupted heme metabolism oxidative stress <NUMBER> strong antiviral activity cq using sarscov<NUMBER>infected vero cells documented <NUMBER> physiologically based pharmacokinetic models pbpk drug hcq showed fivefold potency cq vitro <NUMBER> studies antiviral activity dosedependent achieved use routine safe dosages although several vitro studies report antiviral activity cq hcq sarscov<NUMBER> vivo data promising considerable limitations expert consensus group china suggested cq may improve lung involvement evaluated imaging shortening disease course <NUMBER> another highly debated openlabel nonrandomized controlled trial small number patients covid<NUMBER> treated hcq nasal sarscov<NUMBER> carriage found lower sixth day following hcq treatment compared nontreated patients <NUMBER> recent multicenter openlabel randomized controlled trial china find sarscov<NUMBER> negative conversion rates high dose hcq standard care <NUMBER> hospitalized patients reporting rapid resolution symptoms normalization crp lymphopenia however outcome data icu need mortality reported <NUMBER> another study comprising <NUMBER> hypoxic pneumonia patients france hcq avert icu admission mortality <NUMBER> dilemma clinical utility cq hcq covid<NUMBER> solved welldesigned clinical trials near future several countries despite weakness clinical studies based strong preclinic scientific rationale multimodal antiviral immunomodulatory actions cq hcq currently recommended treatment covid<NUMBER> optimal dosing uncertain several dosing regimens <NUMBER> mg high <NUMBER> mg daily treatment durations <NUMBER> days hcq found potent cq vitro better tolerated based pbpk models loading dose <NUMBER> mg twice day bid hcq given orally followed maintenance dose <NUMBER> mg bid <NUMBER> days commonly recommended strategy sarscov<NUMBER> infection reached three times greater potency cq given <NUMBER> mg twice daily <NUMBER> days advance <NUMBER> hcq recommended doses covid<NUMBER> routine doses used rheumatic diseases hence potential adverse events could experienced also brief standing treatment <NUMBER> vincent et al reported cq strong antiviral effects sarscov<NUMBER> infection primate cells use drug either exposure virus suggesting prophylactic therapeutic use <NUMBER> animal models shown prophylactic use cq may additional survival benefit enteroviral infections <NUMBER> however still robust evidence use cq hcq preor postexposure prophylaxis covid<NUMBER> several trials underway evaluate efficacy cq hcq prophylaxis highrisk individuals nct<NUMBER> nct<NUMBER> ivig blood product containing polyclonal immunoglobulin g isolated pooled healthy donors used treat immune thrombocytopenic purpura itp kawasaki disease various inflammatory neurologic myositis syndromes immunomodulatory functions unknown mechanism action one proposed mechanisms interaction iggfc fc gamma receptors located almost immune cells resulting pleiotropic functional consequences including expansion regulatory cell population phagocytosis antibodydependent cellular cytotoxicity adcc immune cell differentiation maturation apoptosis expression proinflammatory cytokines antigenpresentation <NUMBER> previous studies sars mers found ivig therapy effective thus proposing highdose ivig option severe covid<NUMBER> patients <NUMBER> covid<NUMBER> cases reported efficacy high dose ivig <NUMBER> however high cost limited supply restrict general use inferred rheumatic diseases covid<NUMBER> patients pregnancy secondary infections marked thrombocytopenia muscular myocardial neurologic manifestations would better candidates ivig treatment several studies already registered use covid<NUMBER> il<NUMBER> receptors ubiquitously expressed almost immune cells il<NUMBER> acts master player inducing proliferation differentiation immune cells healthy individuals il<NUMBER> levels circulation extremely low range <NUMBER> pgml marked elevations reported many inflammatory conditions including cytokine release syndrome <NUMBER> several therapeutic agents developed inhibiting cytokine signaling via il<NUMBER> receptor postreceptor downstream signaling pathways jakstat tocilizumab sarilumab siltuximab il<NUMBER> antagonists different pharmacologic properties tocilizumab approved treatment ra juvenile idiopathic arthritis giant cell arteritis cytokine release syndrome idiopathic multicentric castlemans disease imcd whereas siltuximab received approval imcd sarilumab ra <NUMBER> covid<NUMBER> patients high plasma il<NUMBER> levels especially severe disease presentation <NUMBER> il<NUMBER> production stimulated sarscov<NUMBER> stimulation immune cells <NUMBER> indeed shown covid<NUMBER> cd<NUMBER> lymphocytes rapidly activated differentiate pathogenic th<NUMBER> cells generating gmcsf proinflammatory cytokines induced activation monocytes high expression il<NUMBER> <NUMBER> clinical view striking correlation serum il<NUMBER> levels sarscov<NUMBER> rnaaemia strongly indicates worse outcome <NUMBER> besides cytokine storm recent studies experimentally infected animals suggest crucial role virusinduced immunopathological events causing fatal pneumonia coronavirus infections <NUMBER> hence blocking il<NUMBER> would potentially reduce detrimental immune response caused sarscov<NUMBER> covid<NUMBER> treatments robust evidence routinely suggest il<NUMBER> antagonists small clinical trial china examined effectiveness tocilizumab <NUMBER> patients met criteria severe critical covid<NUMBER> including respiratory failure requiring mechanical ventilation shock admission icu multiple organ failures tocilizumab improved hypoxemia fever lymphopenia crp lung infiltration patients treated without serious adverse events <NUMBER> recently favorable outcome patient limited cutaneous systemic sclerosis treatment tocilizumab reported <NUMBER> since urgent need severe covid<NUMBER> treatments based limited data tocilizumab included treatment algorithms many countries dose timing infusions determined yet numerous studies ongoing assess efficacy tocilizumab sarilumab siltixumab several countries current practice give tocilizumab <NUMBER> mg kg maximum <NUMBER> mg single infusion careful evaluation disease severity response initial treatment repeat infusion administered dose <NUMBER> h il<NUMBER> antagonists increase risk infections therefore must used severe patients end high viral load phase covid<NUMBER> along antiviral treatments <NUMBER> side effects including intestinal perforation opportunistic infections therefore prudent monitor patients potential side effects <NUMBER> jak inhibitors currently approved treatment ra psoriatic arthritis use inflammatory disorders continuously growing <NUMBER> many proinflammatory cytokines involved cytokine storm covid<NUMBER> might inhibited jak inhibitors besides mentioned common properties jak inhibitors baricitinib may block ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> cyclin gassociated kinase gak host kinases regulate viral endocytosis according artificial intelligence search viral characteristics sarscov<NUMBER> effect restricted baricitinib among jak inhibitors may block viral entry assembly virus particles pneumocytes therapeutic doses used ra <NUMBER> however hypothetical views merit evidence clinical use cytokine storm covid<NUMBER> currently baricitinib nct<NUMBER> nct<NUMBER> nct<NUMBER> tofacitinib nct<NUMBER> ruxolitinib nct<NUMBER> studies ongoing nodlike receptor family pyrin domaincontaining <NUMBER> nlrp<NUMBER> critical inflammasome acute protection body wide variety noxious stimuli including rna viruses <NUMBER> nlrp<NUMBER> activates caspase<NUMBER> molecule responsible activation exuberant release il<NUMBER>β il<NUMBER> previously sarscov shown induce nlrp<NUMBER> ion channelforming protein orf<NUMBER>b <NUMBER> shown sarscov<NUMBER> induces many cytokines including il<NUMBER> family <NUMBER> <NUMBER> il<NUMBER> family pleiotropic cytokines roles inflammation hematopoiesis fibrosis il<NUMBER>β tnfα promote vascular permeability leakage il<NUMBER>β il<NUMBER> fuel cytokine storm mas il<NUMBER> cytokines except il<NUMBER> successfully inhibited anakinra <NUMBER> anakinra recombinant antagonist human il<NUMBER> approved treatment ra certain autoinflammatory disorders recommended doses <NUMBER> mgkgday maximum daily dose <NUMBER> mgkg <NUMBER> <NUMBER> terms sepsis mas previous highly cited phase iii trial anakinra improve <NUMBER>day survival rate sepsis patients terminated early <NUMBER> however reanalysis data trial suggested significant improvement survival patients hepatobiliary dysfunction disseminated intravascular coagulation dic <NUMBER> anakinra administered intravenously <NUMBER> mgkghr <NUMBER> h continuously study without safety concerns dose extremely higher used rheumatology routine warrants careful monitoring several anakinra studies registered covid<NUMBER> testing <NUMBER> mg daily subcutaneous injection <NUMBER> days <NUMBER> mgday intravenous <NUMBER> days nct<NUMBER> nct<NUMBER> colchicine approved gout familial mediterranean fever recent years colchicine attracted attention management cardiovascular diseases suppressing inflammatory component <NUMBER> mechanism action thought inhibition tubulin polymerization microtubule generation possibly effects cellular adhesion molecules inflammatory chemokines inflammasome colchicine may inhibit activation nlrp<NUMBER> inflammasome additionally may inhibit directly synthesis tnfα il<NUMBER> <NUMBER> trials investigating efficacy conventional therapeutic doses colchicine registered treatment covid<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> tnfα one potent proinflammatory cytokines broad spectrum actions marked elevations reported many inflammatory conditions including cytokine release syndrome serum tnfα levels found elevated covid<NUMBER> patients pronounced severe patients <NUMBER> sarscov viral spike protein able modulate tnfαconverting enzyme tacedependent shedding ace<NUMBER> ectodomain required viral entry coupled tnfα production <NUMBER> therefore hypothesized use tnf inhibitors might effective blocking viral entry detrimental effects exuberant tnfα shown preclinical studies severe respiratory syncytial virus influenza infections <NUMBER> antitnfs enhance risk bacterial viral fungal infections therefore use covid<NUMBER> must supported preclinical studies one cytokines found abundant covid<NUMBER> patients il<NUMBER> found associated severe lung inflammation <NUMBER> il<NUMBER> wideranging proinflammatory effects induction cytokines il<NUMBER>β il<NUMBER> tnfα growth factors gcsf chemokines matrix metalloproteinases mouse model found h<NUMBER>n<NUMBER> cause acute lung injury il<NUMBER>dependent manner postulated blocking cytokine may effective reducing sarscov<NUMBER> related organ damage <NUMBER> mentioned gmcsf one key molecules involved cytokine storm excessively released covid<NUMBER> patients <NUMBER> blockage growth factor may halt immunopathology caused virus mavrilimumab gmcsf inhibitor developed refractory ra <NUMBER> new trial investigating efficacy covid<NUMBER> nct<NUMBER> mmf widely used treatment severe manifestations connective tissue disorders vasculitis syndromes mycophenolate exhibited strong antiviral effects sarscov merscov demonstrated vitro studies interaction viral proteases <NUMBER> small clinical study reported efficacy mmf combination ifnβ mers patients <NUMBER> however considering strong immunosuppressant effects mmf likely cause harm benefit covid<NUMBER> patients association ibuprofen worse outcome covid<NUMBER> patients speculated weak evidence <NUMBER> another nsaid indomethacin reported direct antiviral effect sarscov interfering viral rna synthesis independent cyclooxygenase inhibition vitro study registered trial currently recruiting patients determine efficacy naproxen potential interaction viral nucleoproteins nct<NUMBER> therefore although evidence limited indomethacin naproxen could preferred nsaids indicated <NUMBER> excessive inflammatory response features cytokine storm cause severe disease course worsens prognosis covid<NUMBER> undoubtedly drugs directly target sarscov<NUMBER> would effective treatments covid<NUMBER> hundreds trials ongoing find effective treatments covid<NUMBER> targeting virus consequent hyperinflammation including newly developed agents phase studies drugs approved indications effective treatment found drugs used daily rheumatology practice may constitute potential treatment options covid<NUMBER> patients antiinflammatory effects also inherent antiviral properties hence inclusion rheumatologists immunologists covid teams would improve patient outcomes covid<NUMBER> pandemic claiming many victims among infected worldwide patients prognosis depends primarily exclusively viral load response hosts immune system partly responsible either default immunocompromised patients paradoxically excess destructive cytokine storm occurs lung result exaggerated mobilization hosts immune cells cytokine storm seems serious prognostic factor aggravates inflammatory thrombophilic state leading disseminated intravascular coagulation dic situation difficult control potentially fatal clear scientific evidence yet indicate triggers cytokine storm highly contagious virus like influenza causes annual flu epidemics world known trigger cytokine storms leading inflammation need hospitalization even death mechanisms behind cytokine storms make individuals suffer flu others remain unclear however study influenza virus infection mice showed glucose metabolism driving force behind onset often fatal inflammatory response known cytokine storm mice treated glucosamine produced significantly higher levels inflammatory cytokines chemokines mice given glucosamine researchers analyzed blood glucose levels patients diagnosed influenza healthy controls found hexosamine biosynthetic pathway means <NUMBER> small portion glucose metabolized plays essential part cytokine storms triggered influenza virus findings may partly explain diabetics greater risk serious complications death influenza infections preliminary data indicate appears case covid<NUMBER> well <NUMBER> reported hypoglycemic conditions induce upregulation glut <NUMBER> glucose transporter plasma membrane monocytemacrophage <NUMBER> lps amplifies glut <NUMBER> overexpression <NUMBER> glut <NUMBER> upregulation selfregulating mechanism ensure adequate glucose supply cells thus protect monocytes harmful effects low glucose levels thus amplifying inflammatory cell activation presence lps wright et al showed acute hypoglycemia induced hyperinsulinemic clamping led increase cd<NUMBER> expression inflammatory activation index monocytes type <NUMBER> diabetic patients <NUMBER> vivo hypoglycemia may induce increase counterregulatory hormonal adrenergic activity well resulting inflammatory stress <NUMBER> <NUMBER> hypoglycemia therefore besides representing risk factor cardiovascular total mortality causes diabetic patients could represent trigger mechanism cytokine storm covid<NUMBER> disease <NUMBER> light experimental data recommend pursuing optimal glycemic control avoiding hyper hypoglycemia prevent mitigateany cytokine storms thus improve otherwise dismal prognosis diabetic diabetic patients admitted semiintensive icu covid<NUMBER> examples biosensors cytokine detection proposed last <NUMBER> years previous examples found biosensors bioelectronics <NUMBER> <NUMBER> <NUMBER> references therein ilod limit detection ideal conditions buffered solution mlod limit detection real matrix sarscov<NUMBER> outbreak originated province wuhan december <NUMBER> rapidly evolved worldwide pandemic <NUMBER> although many patients remain asymptomatic others develop severe pneumonia even acute respiratory distress syndrome ards ards patients require mechanical ventilation due sudden spike infections healthcare providers forced make dire decisions connect ventilators <NUMBER> currently common consensus hyperinflammatory syndrome cytokine storm indicative poor prognosis critical covid<NUMBER> cases cytokines useful prognosis biomarkers <NUMBER>−<NUMBER> spurred overuse immunomodulator drugs hope halting disease progression improving outcomes <NUMBER> effectiveness side effects treatments still analyzed although preliminary reports suggest timing dosage keys success <NUMBER> thus urgent need develop methods monitoring cytokine levels covid<NUMBER> patients methods would enable detecting covid<NUMBER> patients worsening treat become critically ill would improve outcomes also avoid oversaturation icu measuring cytokine levels could also useful personalizing antiinflammatory treatments monitoring efficacy designing prototyping biosensors cytokine detection context covid<NUMBER> unique technological translational challenges first cytokines il<NUMBER> intrinsically difficult detect found low levels serum typically <NUMBER> pg ml −<NUMBER> healthy individuals <NUMBER> second order pointofcare tests useful rapid detection whole blood preferred information obtained bedside oversaturation hospitals caused covid<NUMBER> forced healthcare providers especially hardhit areas decentralize covid<NUMBER> care including emergency field hospitals homebased quarantine patients may worsen require urgent care situations centralized facilities biochemical testing available similarly economic factors may limit intensive care regions well equipped laboratories may available thus order significant impact pandemic biosensors covid<NUMBER> management must rapid sufficiently sensitive detect cytokines whole blood independent centralized equipment summarize trajectory covid<NUMBER> cytokine storm including main inflammation biomarkers linked syndrome also summarize current therapies identify key points biosensors required manage recovery finally critically review recent literature cytokine detection propose future directions field sarscov<NUMBER> infects epithelial lung cells via specific interactions angiotensin converting enzyme <NUMBER> ace<NUMBER> <NUMBER> efforts made worldwide better understand cytokine storm characterizes progression severe pneumonia ards previous information sarscov merscov infections shown figure <NUMBER> indicates main factors <NUMBER>−<NUMBER> known virus replicates quickly early stages infection means high levels viral proteins known antagonize interferon ifn responses generated results strong yet delayed proinflammatory response site infection proinflammatory cytokines chemokines attract macrophages neutrophils also release proinflammatory agents amplifies inflammation giving rise ards sepsis multiorgan dysfunction syndrome mods associated poor outcomes <NUMBER> comprehensive review cytokines chemokines involved covid<NUMBER> cytokine storm already available although studies performed large cohorts patients performed <NUMBER> required order determine cutoff values diagnosis prognosis purposes proinflammatory cytokines il<NUMBER> il<NUMBER> il<NUMBER> tumor necrosis factor alpha tnfα found elevated sera severely critically ill covid<NUMBER> patients <NUMBER>−<NUMBER> indicates cytokines could good prognosis biomarkers could indicate progression severe critical covid<NUMBER> many recent cytokine profiling studies however performed small populations therefore cannot broadly generalized <NUMBER> <NUMBER> larger studies required establish cutoff values well determine intricate relationships proand antiinflammatory factors covid<NUMBER> progression based hyperinflammatory syndromes sepsis levels biomarkers likely fluctuate rapidly means patients inflammation biomarkers certain threshold value may evolve quickly require antiinflammatory treatments even though initial biomarker measurements indicated otherwise solution problem could perform periodic measurements biomarkers order evaluate kinetics <NUMBER> would require biosensors inexpensive easy use point care order overburden healthcare workers also noted although cytokines also present saliva urine sputum <NUMBER> information currently available function usefulness biomarkers cytokine storm monitoring covid<NUMBER> measuring cytokines sputum could particularly valuable would reveal information local inflammation however <NUMBER>−<NUMBER> covid<NUMBER> patients produce sputum <NUMBER> antiinflammatory cytokines il<NUMBER> also found sera covid<NUMBER> patients <NUMBER>−<NUMBER> known hyperinflammatory syndromes dysregulated inflammation often followed immune suppression <NUMBER> putting patients high risk opportunistic infections bacteria fungi even latent viruses human cytomegalovirus cmv <NUMBER>−<NUMBER> particularly problematic context icu since nosocomial infections multiresistant pathogens lethal promptly detected anticipate biosensors aimed detecting coinfections also required order manage critical covid<NUMBER> patients example biosensors detect procalcitonin pct could useful detect opportunistic bacterial infections <NUMBER>−<NUMBER> procalcitonin produced parenchymal cells response bacterial toxins pubsacsorgacssensors perspective healthy individuals pct considered undetectable <NUMBER> ng ml −<NUMBER> pct levels <NUMBER>−<NUMBER> ng ml −<NUMBER> usually considered warning potential bacterial sepsis <NUMBER> since pct levels rise large extent viral infections biosensors biomarker could indicate onset bacterial infections covid<NUMBER> patients ■ potential biosensorguided therapies table <NUMBER> summarizes antiinflammatory treatments proposed far ameliorating cytokine storm covid<NUMBER> patients noted evidence supporting treatments weak words randomized clinical trials drugs context covid<NUMBER> care yet completed use recommended official protocols clinical trials compassionate motives many repurposed drugs already use diseases syndromes infections <NUMBER> important highlight many pharmaceuticals immunosuppressive since covid<NUMBER> patients already immunosuppressed due ifn attenuation antiinflammatory responses administration immunomodulators may exacerbate risk opportunistic infection reduce effect antiviral drugs good example polemic surrounding antiinflammatory treatments use corticosteroids corticosteroids methylprednisolone inexpensive globally available routinely recommended sepsis care except cases septic shock previous evidence sarscov<NUMBER> mers patients treated corticosteroids yielded widely disparate outcomes <NUMBER> idsa discouraged use corticosteroids covid<NUMBER> care nevertheless several authors report good outcomes administering drugs cautious doses <NUMBER> <NUMBER> <NUMBER> reporting good outcomes dosing timing highlighted key factors successful corticosteroid therapy context sarscov infections kinetic profiles proinflammatory cytokines il<NUMBER> could provide crucial data guide onset corticosteroid treatment adjust doses order reduce inflammation minimizing side effects <NUMBER> nonspecific antiinflammatory treatments could benefit biosensorguided administration hydroxychloroquine <NUMBER> immunoglobulins azithromycin <NUMBER> convalescent plasma therapies <NUMBER> drugs based monoclonal antibodies recombinant proteins tocilizumab <NUMBER> anakinra <NUMBER> also proposed reducing hyperinflammation caused covid<NUMBER> treatments block specific proinflammatory signal pathways drugs could benefit companion diagnostics approach similar used cancer care administration drugs would guided measurements specific proinflammatory factors modulate example tocilizumab binds receptors il<NUMBER> soluble membranebound blocks interaction membranebound gp<NUMBER> turn prevents activation downstream janus kinase responsible signal cascading <NUMBER> proposed blockers il<NUMBER>mediated inflammatory response tocilizumab sarilumab guided il<NUMBER> measurements threshold value around <NUMBER> pg ml −<NUMBER> <NUMBER> <NUMBER> antibodies proven useful treat unwanted cytokine release syndromes immune anticancer therapies early reports benefits using tocilizumab encouraging although clinical trial sarilumab recently discontinued due lack clear positive outcomes interestingly serial il<NUMBER> measurements shown administration tocilizumab slight increase il<NUMBER> followed sharp decrease time <NUMBER> early reports highlight relevance performing kinetic measurements biomarkers monitoring progress inflammatory diseases table s<NUMBER> summarizes main features recent biosensor prototypes cytokine detection highlighted timedependent proand antiinflammatory responses involved covid<NUMBER> progression multisensor system capable detecting several biomarkers simultaneously would provide evidence determine disease stage guide personalized therapies example reported plasmonic nanosensor arrays detect <NUMBER> cytokines simultaneously il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> ifnγ tnfα figure <NUMBER>a <NUMBER> multisensors require minute sample size <NUMBER> μl show impressive dynamic range quantification <NUMBER> <NUMBER> <NUMBER> pg ml −<NUMBER> signal transduction mechanism consists measuring changes localized surface plasmon resonance lspr gold nanorods darkfield microscopy provides information cytokine binding antibodies real time informative traditional endpoint elisa total time required run whole chip <NUMBER> min rapid analysis time makes detection platform suitable aiding clinical decisionmaking emergency situations another interesting multisensor platform using electrochemical transducers shown figure <NUMBER>b contains <NUMBER> individually addressable electrodes one multiplexed <NUMBER>port manifold provide <NUMBER> measurements less <NUMBER> h <NUMBER> however also requires offline protein capture step magnetic nanobeads electrochemical immunoassays il<NUMBER> devices reported wide dynamic range <NUMBER> <NUMBER> <NUMBER> pg ml −<NUMBER> multiplexed cytokine measurements electrochemical biosensors also reported using graphene oxide fabricate nanoprobes <NUMBER> platform detects il<NUMBER> il<NUMBER>β tnfα spiked mouse serum sample multiplexed detection achieved using antibodies bound three different signal reporters nile blue nb methyl blue mb ferrocene fc covid<NUMBER> global challenge requires technologies easy implement many different scenarios oversaturation hospitals peak infection forced governments decentralize covid<NUMBER> care manage patients temporary field hospitals inhome quarantine scenarios detection systems bound centralized infrastructure play key role instance lateral flow immunoassay proposed detecting il<NUMBER> unprocessed blood high sensitivity <NUMBER> ability detect cytokines directly blood extremely useful decentralized healthcare scenarios since purifying serum plasma requires centrifugation step difficult perform bedside however blood contains cells like erythrocytes interfere colorimetric detection schemes lateral flow test used antibodydecorated nanoparticles probes surfaceenhanced raman spectroscopy sers signal transduction mechanism showed limit detection <NUMBER> pg ml −<NUMBER> whole blood limit detection however achieved dxr raman microscope suitable pointofcare use past decade growing trend biosensors interface mobile devices smartphones <NUMBER>−<NUMBER> appealing option smartphones already high global market penetration therefore require purchase additional readers mobile biosensors il<NUMBER> recently proposed <NUMBER> devices consist paper immunosensor colorimetric detection using gold nanoprobes figure <NUMBER>c gold nanoprobes generate colored spots detected real time smartphone app instead external attachments app uses augmented reality system order control photographic conditions system also compensates variable light conditions allowing user quantify colorimetric signals using unmodified smartphone biosensor able detect variations il<NUMBER> levels small <NUMBER> pg ml −<NUMBER> whole blood rapid assay time <NUMBER> min furthermore paper substrate makes particularly useful monitoring infectious diseases easily disposed incineration biosensors capable continuously monitoring cytokine levels would ideal detecting covid<NUMBER> patients progressing severe critical stages well check success antiinflammatory therapies best knowledge immunosensors continuous detection biomarkers blood yet proposed prototypes potential achieve feature found recent literature example needleshaped microelectrodes proposed detecting alterations il<NUMBER> levels real time figure <NUMBER>a <NUMBER> design interaction cytokine antibodies bound pubsacsorgacssensors perspective electrode changes impedance system without need detection antibodies labels authors suggest integrating sensors cannula within bloodstream could enable realtime monitoring il<NUMBER> levels although initial prototype tested surrogate serum samples recently electrochemical biosensor capable continuous monitoring blood samples proposed consists wire electrode modified aptamers change configuration upon binding target figure <NUMBER>b <NUMBER> changes position redox active molecule methylene blue respect electrode followed squarewave voltammetry figure <NUMBER>c authors demonstrated sensors implanted rat could detect vancomycin target molecule real time figure <NUMBER>d adapting technology detecting cytokines could enable precise profiling covid<NUMBER> inflammation <NUMBER> finally wearable detection platform also proposed could gamechanger inflammation monitoring <NUMBER> based intradermal delivery biocompatible nearinfrared nir quantum dots array nanosensors delivered using dissolvable microneedles fluorescence emission quantum dots finetuned would invisible naked eye detectable upon illumination nir light pattern emitted light generated array detected modified smartphone evaluated machine learning algorithm technology initially demonstrated way keep vaccination records adaptation continuous monitoring biomarkers could revolutionize field personalized medicine date <NUMBER> <NUMBER> deaths due covid<NUMBER> worldwide social distancing measures flattened virus propagation curve many countries relaxing confinement measures time also consensus view virus eradicated vaccine developed deployed new tools required order reduce burden covid<NUMBER> imperative avoid progression severe pneumonia critical ards measuring prognosis biomarkers combining knowledge clinical observations risk factors winning strategy stratifying patients according disease severity biosensors potential play central role process providing rapid information point care could also provide guidance administration immunomodulators deleterious effects dosed carefully happen several translational challenges need met technological perspective ensure rapid measurements point care devices must easy use frontline healthcare worker means analytical platforms enable detection cytokines one simple step also biosensors need inexpensive enough enable multiple measurements important inflammatory processes evolve rapidly therefore would ideal obtain personalized biomarker profile patient implanted biosensors could enable continuous monitoring patients however technology still needs development regulatory aspects future commercialization much tougher nonimplanted biosensors multisensors also seen key players precision medicine covid<NUMBER> provide information relative levels different proand antiinflammatory processes important design personalized therapies propose ideal device managing cytokine storm responsible severe critical covid<NUMBER> cases encompass features current biosensors monitor levels several cytokines simultaneously raw blood samples rapid turnaround time easy dispose use portable readers paper biosensors destroyed incineration important meet biosafety regulations readers also easily disinfected especially decentralized testing wearable biosensors would enable continuous monitoring patients muchdesired feature however technology still needs development ready clinical translation information provided devices combined patient data age comorbidities treatments microbiology results order assess risk poor prognosis using information biosensors train neural network potential achieve goal supporting information available free charge httpspubsacsorgdoi<NUMBER>acssensors<NUMBER>c<NUMBER> examples biosensors cytokine detection proposed last <NUMBER> years table s<NUMBER> pdf coronavirus disease covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> rapidly caused pandemic recent reports showed individuals obesity may vulnerable severe complications covid<NUMBER> virtue increased risk chronic diseases driven obesity <NUMBER> reasons well known chronic inflammation suspected one causes obesity state chronic lowgrade systemic inflammation characterized increased proinflammatory cytokine secretion adipose tissue infiltration leukocytes including macrophages adipose tissue thus chronic inflammation impairs insulin signaling adipocytes causing insulin resistance contributing development metabolic disorders cardiovascular disease type <NUMBER> diabetes hypertension <NUMBER> well known comorbidities adversely affect outcome patients covid<NUMBER> addition patients severe covid<NUMBER> commonly show cytokine storms refer excessive uncontrolled release proinflammatory cytokines tumor necrosis factorα monocyte chemotactic protein<NUMBER> interleukin<NUMBER> il<NUMBER> particular serum il<NUMBER> levels severe covid<NUMBER> significantly higher mild cases <NUMBER> <NUMBER> although people covid<NUMBER> develop symptoms mild illness evidence shows <NUMBER> covid<NUMBER> patients develop severe symptoms requiring hospitalization oxygen support <NUMBER> develop acute respiratory distress syndrome sepsis septic shock multiorgan failure <NUMBER> <NUMBER> related inflammatory responses individuals living obesity chronically higher leptin lower adiponectin concentrations unfavorable hormone status leads dysregulation immune response contribute pathogenesis obesityrelated complications <NUMBER> basal state individuals obesity higher concentration proinflammatory cytokines viral infection obesityrelated chronic inflammation causes reduced macrophage activation blunts proinflammatory cytokine production upon macrophage stimulation <NUMBER> reduced macrophage activation viral infection may explain poor vaccination response obese patients moreover band tcell responses impaired individuals obesity numerical functional alterations lymphocytes alterations may increase susceptibility viral infection thus dysregulated proinflammatory response contributes severe lung lesions seen covid<NUMBER> pandemic <NUMBER> based mechanism individuals obesity already lowlevel chronic inflammation may vulnerable cytokine storms covid<NUMBER> infection curb cytokine storms covid<NUMBER> patients antiinflammatory treatment may beneficial however use antiinflammatory treatments doubleedged sword antiinflammatory medications corticosteroids may delay elimination virus increase risk secondary infection especially impaired immune systems proinflammatory cytokine antagonists example il<NUMBER> antagonists inhibit specific inflammatory factors thus may eliminate adverse effects cytokine storms without preventing effects inflammatory cytokines removing sarscov<NUMBER> infected organs recent study showed colchicine treatment beneficial effect adults obesity metabolic syndrome reducing il<NUMBER> <NUMBER> may translate beneficial effect people obesity covid<NUMBER> infection however antiinflammatory medications janus kinase inhibitors recently reported treat covid<NUMBER> patients inhibit variety inflammatory cytokines including interferonα plays important role suppressing virus activity thus may suitable treatment inflammatory cytokine storms caused covid<NUMBER> <NUMBER> given viral nature cytokine storms substantial impairment immune systems severe cases critical strike balance upand downregulation inflammatory markers immune homeostasis addition starting antiinflammatory treatment right time pivotal importance tailored individual patients achieve favorable effects combined use antiinflammatory antiviral drugs may applied well mentioned antiinflammatory therapies may increase viral replication hand antiviral treatment inhibit sarscov<NUMBER> replication block sarscov<NUMBER> infection may induce proinflammatory cytokine production <NUMBER> therefore additional largecohort studies required substantiate dismiss possibility applying clinical trials studies suggesting individuals obesity may higher risk poor outcomes covid<NUMBER> hyperinflammation inflammatory response may uncontrolled due malfunctioning exhausted immune cells b cells macrophages obesity lowlevel chronic inflammation <NUMBER> therefore largescale studies needed confirm role obesityinduced inflammation pathogenesis covid<NUMBER> context wide variety strategies increased vigilance early detection testing aggressive treatment established patients obesity covid<NUMBER> infection therapeutic approaches mitigate severe acute lung injury associated severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection rapidly entered clinical trials primarily anecdotal observations clinical studies along clinical symptoms related viral invasion reported molecular response known cytokine storm attracted greatest attention scientific lay press cause organ injury hypothesis quelling storm antiinflammatory therapies directed reducing interleukin<NUMBER> il<NUMBER> il<NUMBER> even tumour necrosis factor α tnfα might beneficial led several ongoing trials anecdotal evidence noncontrolled clinical trials suggested possible beneficial effect antiil<NUMBER> shown effective chimeric antigen receptor cart cytokine response syndrome crs <NUMBER> however past attempts randomised clinical trials block cytokine storm associated microbial infections sepsis successful cases worsened outcomes <NUMBER> <NUMBER> redundancy cytokine action delayed intervention essential role cytokines recovery immune surveillance proposed possible explanations findings first reports china emphasised elevated plasma concentrations il<NUMBER> provided rationale introduction antiil<NUMBER> therapies tocilizumab sarulimab randomised clinical trials <NUMBER> <NUMBER> however closer examination plasma il<NUMBER> concentrations provided conflicting data results early studies suggested plasma il<NUMBER> concentrations although elevated hundreds picograms per µl values obtained healthy control patients modest especially compared cytokine storm associated septic shock concentrations might high hundreds thousands picograms per µl although recent controlled studies indicate plasma il<NUMBER> concentrations range seen bacterial infections time course change different cases concentrations patients coronavirus disease <NUMBER> covid<NUMBER> seem increase time illness severity worsening lung function <NUMBER> dynamics clearly distinguish sarscov<NUMBER> host response seen sepsis additionally previous sepsis studies established il<NUMBER> concentrations might indicator magnitude inflammatory response rather cause organ injury <NUMBER> therefore important ask whether current therapeutic approaches targeting symptoms modulating disease little known concentrations proinflammatory antiinflammatory mediators patients covid<NUMBER> landscape cytokine storm especially chemokines regulate distribution activity effector cell populations interpreting changes cytokine concentrationsall seem elevatedwithout additional immune cellular parameters provide clarity molecular basis covid<NUMBER> potential treatment strategies indeed measured patients infected sarscov<NUMBER> il<NUMBER> concentrations immunosuppressant cytokine body also elevated might lead different conclusion therapeutic approaches understanding disease pathophysiology similarly concern suppressing innate adaptive immune system address increased cytokine concentrations elevated il<NUMBER> could enable unfettered viral replication suppress adaptive immunity delay recovery processes lost current enthusiasm antiinflammatory approaches sarscov<NUMBER> infection growing recognition potent immunosuppressive mechanisms also prevalent patients focus reminiscent seen early investigations sepsisinduced inflammation since nearly decade later contribution immune suppression sepsis pathology generally accepted profound lymphopenia low absolute lymphocyte counts alc often levels seen septic shock near uniform finding severely ill patients covid<NUMBER> correlates increased secondary infections mortality <NUMBER> <NUMBER> loss immune effector cells occurs lymphocyte subsets including cd<NUMBER> natural killer cells important antiviral roles b cells essential making antibodies inactivate virus <NUMBER> <NUMBER> <NUMBER> autopsy results revealed near complete dissolution secondary lymphoid organs <NUMBER> unsurprisingly secondary nosocomial infections often pathogens usually associated immune suppression present <NUMBER> hospitalised patients <NUMBER> early immunological picture sarscov<NUMBER> infection one shares many similarities bacterial sepsis unique differences noted figure particular modest inflammatory response progressive profound suppression adaptive immunity covid<NUMBER> relative sepsis argues perhaps different therapeutic approach supporting host protective immunity must considered essential component therapeutic intervention equal importance perhaps greater importance targeting cytokine storm rational approach supporting host protective immunity several immune stimulants clinical armamentarium available patients infected sarscov<NUMBER> focusing agents target adaptive immunity general tcell function particular appears rational approach based observation progressive loss cells <NUMBER> <NUMBER> programmed death ligand pathway eg pd<NUMBER> inhibitors nivolumab pembrolizumab game changers cancer viral infections <NUMBER> <NUMBER> cells patients covid<NUMBER> show evidence tcell exhaustion associated increased cd<NUMBER> pd<NUMBER> expression <NUMBER> <NUMBER> addition checkpoint inhibitors pluripotent cytokine il<NUMBER> effective multiple viral infections <NUMBER> <NUMBER> <NUMBER> early clinical trials treatments initiated sepsis shown safe biological activity <NUMBER> il<NUMBER> shown benefit raising lymphocyte counts septic patients low alc <NUMBER> restoring protective immunity jc virusinduced progressive multifocal leukoencephalopathy <NUMBER> <NUMBER> <NUMBER> <NUMBER> effectiveness immune stimulants begun explored sepsis considered sarscov<NUMBER> infection although immune stimulants il<NUMBER> nivolumab could theoretically feed cytokine storm given patients sepsis il<NUMBER> concentrations similar patients covid<NUMBER> without exacerbation inflammatory responses <NUMBER> randomised clinical trials based best observational findings remain paramount moving forward would propose starting il<NUMBER> complexity host response fact monotherapies worked sepsis trials past suggest priority given biological response modifiers pluripotent il<NUMBER> combination therapies target multiple immunological pathways simultaneously il<NUMBER> antipd<NUMBER> treating patients sepsis taught us treatment approaches patients covid<NUMBER> like sepsis antimicrobials antivirals case supportive therapies likely remain bedrock therapeutic interventions sarscov<NUMBER> infection however sarscov<NUMBER> infection similar chronic inflammatory immune suppressive diseases sepsis argue immune stimulants antiinflammatory agents considered firstline treatment option however fully recognise pathophysiology mechanisms sarscov<NUMBER> still elucidated great uncertainty predicting efficacy current therapeutic approaches starting explore interplay virusmediated endothelial damage pathogenreceptor signalling effects including ace<NUMBER> alterations haemostasis coagulation basis heterogeneous clinical pathologies seen patients undeniably might subset patients exaggerated proinflammatory cytokine release could derive benefit antiil<NUMBER> antiil<NUMBER> therapies however better methods available determine among heterogeneity clinical phenotypes patients meet criteria difficult establish benefit observations clinical centres dealing large volumes patients covid<NUMBER> show compelling evidence patient mortality directly related multiorgan failure including coagulopathy probably damage endothelium patients also altered immune function shown lymphopenia suspect balanced biologically plausible approach would provide antiinflammatory treatment early disease course coupled antiviral therapies remdesivir however disease transitions suppressed state therapies restore host protective immunity considered high priority patients intensive care progressing lung injury else needs considered first better methods needed assess functional status immune cells patients covid<NUMBER> circulating cytokine concentrations might reflect degree systemic inflammation indicative functional state individual lymphocyte myeloid populations readily applicable tests inform whether adaptive immune system exhausted whether myeloid cells activated tolerant would better guide application drugs appropriately modulate immune response would also enable balanced immune therapies targeted either innate adaptive immune cells approach used cancer immunotherapy today tested treatment sepsis balanced therapeutic approach allow precise deployment inhibitory antiil<NUMBER> antiil<NUMBER> restorative il<NUMBER> checkpoint inhibitors therapies probably adjuvants antiviral drugs second need better measures viral load rapid turnaround time recognise ability identify quantitate bacterial infections patients sepsis still quite rudimentary quantifying viral loads qpcr provided required precision hindered ability assess effectiveness interventions importantly designing conducting interventional trials patients covid<NUMBER> need remember lessons learned ongoing sepsis epidemic kills <NUMBER> <NUMBER> people annually usa inflammation often transitory surviving sepsis campaign shown earlier recognition immediate implementation best practices reduce early mortality organ injury due cytokine storm conversely immune suppression prolonged progressive ultimately lethal effective treatment patients pandemic needs balanced administered precision individual patients build knowledge past failures achieve future successes scb reports support revimmune bristol myers squibb outside submitted work bf reports personal fees biomérieux aridis ashaikasai polyphor ampharma ferring inotrem enlivex transgene outside submitted work csd reports grants national institute general medical sciences nigms support enlivex nonfinancial support la jolla pharmaceuticals outside submitted work rsh principal investigator clinical trial il<NUMBER> sepsis received reimbursement travel lodging expenses steering committee meeting reports grants nigms llm reports grants nigms outside submitted work ker rj td gm pfl declare competing interests recently read interest article acharya et al entitled sarscov<NUMBER> infection leads neurological dysfunction acharya et al <NUMBER> reviewed current literature neurological complications manifestations covid<NUMBER> however able identify limited number studies fact latest paper provided deeper insight pathophysiology central nervous system involvement covid<NUMBER> discussed neuropsychiatric manifestations related covid<NUMBER> might associated involvement direct viral transmission neuroimmune response yesilkaya balcioglu <NUMBER> latter includes heightened systemic proinflammatory response closely associated socalled cytokine storm wellknown phenomenon led sarscov<NUMBER> infection viral replication progressively decreases latter days infection pathogenesis covid<NUMBER> thought predominantly related aggressive inflammatory response thus intense release proinflammatory cytokines viz cytokine storm host leads diffuse alveolar damage severe hypoxemia promotes development fatal secondary sepsis serranocastro et al <NUMBER> even though cytokine storm welldefined condition many viral infections including influenza coronavirus liu et al <NUMBER> appreciation effects central nervous system cns remained limited primary targets sars cov<NUMBER> respiratory epithelial cells alveolar macrophages following infection respiratory cells rapid production release many chemokines cytokines initiate macrophages activated proinflammatory chemokines cytokines key components innate immune system dendritic cells lead extensive immune response initiates cytokine storm circulating chemokines attract inflammatory cells make migrate blood vessels site inflammation cells release additional chemokinescytokines amplify cytokine storm liu et al <NUMBER> although tnfα il<NUMBER> il<NUMBER> primary cytokines acute immune response interferons key cytokines antiviral immune response excessive response proinflammatory mediators considered major triggers sepsis multiorgan failure unal et al <NUMBER> hand cns might first affected organ due compromised bloodbrain barrier closely associated increased circulating levels cytokines cytokines induce production reactive oxygen species stimulation astrocytes glial cells meneses et al <NUMBER> reactive oxygen species peripheral cytokines activate two different types microglia microglia<NUMBER> m<NUMBER> microglia<NUMBER> m<NUMBER> m<NUMBER> involve inflammatory processes cns m<NUMBER> responsible antiinflammatory processes thus m<NUMBER> activation results increase proinflammatory cytokines m<NUMBER> initiate astrogliosis order cns protection opposite reactions induced sarscov<NUMBER> may cause cns dysfunction becomes apparent encephalopathy another pathologic reaction related sarscov<NUMBER> might involve sensorial olfactory nerves olfactory nerves activated pathogenassociated molecular patterns pamps inflammatory cytokines viral transmission olfactory bulb leads neuroinflammatory response excessive release cytokines protect cns therefore anosmia initial symptom covid<NUMBER> might result neuroinflammatory response meneses et al <NUMBER> despite arguments identified knowledge still limited extent neuroinflammatory reactions sarscov<NUMBER> associate would like emphasize importance long term followup neuropsychiatric monitoring performed patients covid<NUMBER> psychoneuroimmunological characteristics covid<NUMBER> seem key neurological involvement disease still needs elucidated indeed conflict interest authors declared potential conflicts interest respect research authorship andor publication article impact sarscov<NUMBER> infection onset progression neurodegenerative neuropsychiatric diseases neuroinflammatory origin regarded potential cause delayed pandemic may major public health impact medium long term cognitive neuropsychological function closely monitored covid<NUMBER> survivors © <NUMBER> sociedad española de neurología published elsevier españa slu open access article cc byncnd license httpcreativecommonsorglicensesbyncnd <NUMBER> covid<NUMBER> sarscov<NUMBER> neuroinflamación enfermedades neurodegenerativas enfermedades neuropsiquiátricas tormenta de citoquinas influencia de la infección sarscov<NUMBER> sobre enfermedades neurodegenerativas neuropsiquiátricas ¿una pandemia demorada introducción la infección por el coronavirus sarscov<NUMBER> originada en diciembre de <NUMBER> en la región china de wuhan ha adquirido proporciones pandémicas día de hoy ha ocasionado más de <NUMBER> millones de contagios más de <NUMBER> muertes en todo el mundo la investigación científica actual se centra en el mejor conocimiento de la infección aguda de sus estrategias terapéuticas dada la magnitud de la epidemia planteamos una revisión especulativa sobre las posibles consecuencias en patología neurológica mediolargo plazo con especial atención enfermedades neurodegenerativas neuropsiquiátricas con base neuroinflamatoria teniendo en cuenta la evidencia directa de afectación neurológica causa de la infección aguda december <NUMBER> new coronavirus detected q<NUMBER> chinese city wuhan association lifethreatening severe acute respiratory syndrome sars <NUMBER> <NUMBER> <NUMBER> world health organization named novel virus sarscov<NUMBER> due similarities sarscov terms virology clinical expression latter virus caused syndrome similar characteristics also originated chinese animal markets <NUMBER> sarscov<NUMBER> rapidly spread across world result declared associated disease pandemic <NUMBER> march <NUMBER> time writing article sarscov<NUMBER> infected <NUMBER> million people <NUMBER> countries caused <NUMBER> <NUMBER> deaths however figures probably underestimated <NUMBER> according official name disease caused sarscov<NUMBER> coronavirus disease human coronaviruses whose natural reservoir source transmission wild animals eg bats classified lowpathogenic hcov<NUMBER>e hcovnl<NUMBER> hcovoc<NUMBER> hcovhku<NUMBER> highly pathogenic latter category includes sarscov caused <NUMBER> outbreak merscov caused <NUMBER> outbreak middle east respiratory syndrome mers recently described sarscov<NUMBER> last <NUMBER> viruses categorised ␤cov ␤cov become major public health problem due high pathogenicity infectivity <NUMBER> outbreak sarscov infected approximately <NUMBER> people mortality rate <NUMBER> <NUMBER> merscov infected total <NUMBER> people caused <NUMBER> deaths corresponds mortality rate <NUMBER> <NUMBER> sarscov<NUMBER> infection asymptomatic certain risk groups may develop severe highly lethal syndromes characterised severe respiratory involvement bilateral atypical pneumonia associated severe respiratory dysfunction secondary diffuse alveolar damage constitutes pathological hallmark cases sarscov<NUMBER> also infect organs cell types course disease including intestinal mucosa cells renal tubular cells lymphatic cells reticuloendothelial cells nervous system cells <NUMBER> virus capacity infect nervous system subject present review address hypothesis sarscov<NUMBER> infection may cause neurological symptoms medium term analyse potential impact neurodegenerative processes clinical expression sarscov infection served model understanding sarscov<NUMBER> infection due similar infectivity mechanisms eg angiotensinconverting enzyme <NUMBER> ace<NUMBER> comprises <NUMBER> stages initial stage characterised high viral replication fever cough general discomfort several days duration second stage associated high fever hypoxaemia progression respiratory symptoms bilateral pneumonia although laboratory analyses reveal lower rates viral replication toward end stage <NUMBER> third stage approximately <NUMBER> patients develop sars frequently fatal <NUMBER> viral replication progressively decreases final stage pathogenesis sars thought explained exacerbated inflammatory response host socalled cytokine storm causes diffuse alveolar damage severe hypoxaemia promoting development fatal secondary sepsis understand inflammatory response cov infection must first understand human immune response viral infection due recent appearance sarscov<NUMBER> total lack immunological memory antigen community human immune system never previously encountered type coronavirus situations innate immune system first line defence fact excessive dysregulated innate immune response may explain severity associated symptoms <NUMBER> <NUMBER> sarscov invades haematopoietic stem cells dendritic cells monocytes macrophages inducing lowlevel expression antiviral cytokines eg ifn␣␤ upregulation proinflammatory cytokines tnf il<NUMBER> inflammatory chemokines ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> cxcl<NUMBER> <NUMBER> contrast patients sarscov infection sars show extremely low levels antiinflammatory cytokines il<NUMBER> <NUMBER> high levels ifn␣ ifn␥ inflammatory chemokines cxcl<NUMBER> ccl<NUMBER> compared patients pneumonia suggests ifn plays role immunopathogenesis sars humans <NUMBER> time writing published studies addressed dynamics cytokine storm context sarscov<NUMBER> infection recently chen et al <NUMBER> reported severe sarscov<NUMBER> infection associated lymphocytopaenia low levels cd<NUMBER> cd<NUMBER> cells normal b cell levels increased levels cytokines il<NUMBER> il<NUMBER>r soluble il<NUMBER> receptor il<NUMBER> tnf␣ ccl<NUMBER> reduced expression ifn␥ cd<NUMBER> cells il<NUMBER> il<NUMBER>r il<NUMBER> tnf␣ levels slightly elevated remain within normal range patients moderate symptoms covid<NUMBER> high severe cases fig <NUMBER> researchers suggest cytokine storm associated severe covid<NUMBER> similarly observations reported sarscov infection important question whether neuroinflammatory response shortterm occurrence rather persists certain circumstances immune dysregulation may persist infection form persistent inflammation immunosuppression catabolism syndrome pics immune state thought triggered cytokine storm acute infection covid<NUMBER> results continuous release endogenous alarmins dangerassociated molecular patterns damp damaged organs leads chronic systemic inflammation shift production bone marrow stem cells myeloid cells promotes chronic anaemia lymphocytopaenia <NUMBER> obvious reasons conclusive data possibility persistent inflammation covid<NUMBER> survivors available however hypothesis plausible considering pics associated severity acute infection cytokine storm devastating effects respiratory system largely responsible fatal outcomes disease neurological viewpoint however would interesting determine whether cytokine storm occurring final stage disease may cause acute subacute central nervous system cns involvement poyiadji et al <NUMBER> recently reported case woman covid<NUMBER> several days fever cough altered mental status presented acute necrotising haemorrhagic encephalopathy rare condition associated intracranial cytokine storm bloodbrain barrier disruption without direct viral invasion available evidence suggests chronic neuroinflammation associated high levels cytokineschemokines involved pathogenesis neurodegenerative diseases multiple sclerosis ms parkinsons disease alzheimer disease huntington disease amyotrophic lateral sclerosis <NUMBER> immune mechanisms trigger cytokine storm typical sars frequently involved pathogenesis progression wide range neurodegenerative diseases alzheimer disease example presence proinflammatory cytokines mainly il<NUMBER> il<NUMBER> inhibits beta amyloid a␤ phagocytosis microglial cells leads pathogenic a␤ deposition <NUMBER> observation supports hypothesis persistence accumulation amyloid plaques vivo may direct consequence neuroinflammation furthermore patients alzheimer disease display greater numbers il<NUMBER>␣ microglial cells cortical layers presenting amyloid plaque deposition <NUMBER> patients parkinsons disease inflammatory mediators including tnf il<NUMBER>␤ il<NUMBER> ifn␥ found csf brain tissue studied post mortem <NUMBER> <NUMBER> another study monkeys mptpinduced parkinsonism continued show elevated tnf levels one year mptp administration suggests tnf may play role neuronal death toxic parkinsonism <NUMBER> post mortem studies reveal increased expression proinflammatory cytokines ifn␥ tnf il<NUMBER> il<NUMBER> molecules involved sustained bcell activity lymphoid neogenesis cxcl<NUMBER> cxcl<NUMBER> lt␣ il<NUMBER> il<NUMBER> meninges csf patients ms displaying high levels meningeal inflammation similar proinflammatory pattern increased levels cxcl<NUMBER> tnf ifn␥ cxcl<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> observed csf patients ms showing severe grey matter damage time diagnosis findings may support role neuroinflammation neurodegenerative phase ms <NUMBER> interestingly neuroinflammation also found play major role pathogenesis psychiatric diseases neuroinflammation induce changes neurotransmitter metabolism cause hypothalamicpituitaryadrenal axis dysregulation activate microglia alter neuroplasticity trigger structural functional changes brain may affect cognition behaviour proinflammatory cytokine dysregulation constitutes starting point disruption systems explaining pathogenesis affective disorders disorders schizophrenia bipolar disorders substance abuse especially alcohol abuse <NUMBER> hypothesis neuroinflammation plays major role pathophysiology acute neurological symptoms increasingly accepted instance involvement neuroinflammation pathogenesis epileptic seizures epileptic syndromes widely acknowledged case secondary microglial astrocyte activation release inflammatory markers il<NUMBER>␤ il<NUMBER> tnf various brain regions including hippocampus neocortex <NUMBER> lastly neuroinflammation known play role pathogenesis wide range neurological diseases including immunemediated postinfectious encephalitis cerebrovascular disease peripheral nervous system disorders strikingly however immune response varies age among patients sarscov<NUMBER> infection older individuals displaying greater severity innate immune response less efficient older age makes patients vulnerable infection <NUMBER> numerous studies suggest proinflammatory environment promotes development agerelated diseases association demonstrated immunosenescence neuroinflammation neurodegeneration observed alzheimer disease microglial dysfunction results a␤ accumulation loss peripheral immune response <NUMBER> given evidence nervous system seems target neuroinflammatory mechanisms light special emphasis placed understanding effects sarscov<NUMBER> infection development progression neurodegenerative diseases also aware possibility long term infection may associated cognitive psychiatric disorders children adolescents despite seemingly mild course population groups immunological alterations associated sarscov<NUMBER> infection may alter synaptic pruning childhood adolescence causing problems become apparent adulthood question whether sarscov<NUMBER> neuroinvasive important line research beginning see published evidence subject molecular mechanisms underlying cell invasion sarscov<NUMBER> associated virus capacity bind ace<NUMBER> receptors similarly sarscov ace<NUMBER> receptors highly expressed epithelial cells respiratory digestive systems <NUMBER> <NUMBER> <NUMBER> <NUMBER> well neurons glial cells cns makes cns potential target sarscov<NUMBER> <NUMBER> furthermore sarscov shown induce neuronal death mice invading cns via cribriform plate ethmoid bone subsequently olfactory neuroepithelium <NUMBER> sarscov<NUMBER> may also enter cns via haematogenous route virus detected general circulation light given slow flow blood cerebral microcirculation virus may interact ace<NUMBER> receptors expressed capillary endothelium <NUMBER> interestingly mechanism may also involved endothelial damage subsequent cerebral bleeding observed patients acute covid<NUMBER> furthermore preliminary evidence suggests neuroinvasive potential sarscov<NUMBER> may prognostic implications even acute phase hypothesised death due severe respiratory involvement least partially mediated central hypoventilation syndrome secondary invasion cns <NUMBER> retrospective review <NUMBER> consecutive patients covid<NUMBER> wuhan reports neurological symptoms <NUMBER> sample patients neurological manifestations severe covid<NUMBER> frequently reported neurological symptoms impaired consciousness acute stroke ischaemic haemorrhagic skeletal muscle damage <NUMBER> patients sarscov<NUMBER> infection subsequently displayed evidence cns invasion using genome sequencing researchers beijing ditan hospital detected model impact sarscov<NUMBER> infection neurodegenerative neuropsychiatric diseases <NUMBER> q<NUMBER> sarscov<NUMBER> csf patient covid<NUMBER> clinical encephalitis <NUMBER> yet determined whether sarscov<NUMBER> remains cns medium long term however viral latency cns described viruses including coronaviruses instance hcovoc<NUMBER> detected cns year inoculation murine model coronavirus encephalitis <NUMBER> question virus able persist cns subject debate suggested cytolytic inflammatory strategies effective controlling viral infection organs cannot employed immune system brain due potentially devastating consequences result different type immune response induced cns favouring viral latency cns reactivation favourable situations <NUMBER> cannot rule possibility sarscov<NUMBER> may remain latent cns may observe delayedonset neurological symptoms due viral reactivation medium long term may result reactivation series neuroinflammatory processes associated neurodegenerative disease sarscov<NUMBER> infection may indirect effect cns specifically development neurodegenerative diseases recent years strong association described gut microbiota neuroinflammation cns diseases sarscov<NUMBER> known infect intestinal mucosa cells triggering inflammation intestinal dysbiosis potentially resulting shortand longterm alterations gut microbiota may contribute neuroinflammation leading neurodegeneration development neurodegenerative diseases <NUMBER> covid<NUMBER> pandemic represents greatest public health problem recent history due high spreadability lethality also potential health consequences medium long term evidence nervous system may escape infection could become major focus future recent spanishlanguage review topic focused conditions directly associated sarscov<NUMBER> infection <NUMBER> study provides complementary data addressing incidence neurological diseases neuroinflammatory origin sarscov<NUMBER> infection triggers cytokine storm whose effects cns may unpredictable consequences short long term numerous neurological diseases known neuroinflammatory component involving factors stimulated final stage covid<NUMBER> matter particular interest impact molecular mechanisms may development progression neurodegenerative diseases alzheimer disease parkinsons disease neurodegenerative phase ms well psychiatric disorders especially affective disorders whose pathogenesis recently found involve neuroinflammatory mechanisms surviving patients severe covid<NUMBER> undergo close cognitive psychiatric followup particularly important considering neuroinflammatory dysregulation may persist severe cases leading pics furthermore sarscov<NUMBER> direct neuroinvasive potential previous experience sarscov may help us understand mechanisms sarscov<NUMBER> may infect cns special emphasis placed understanding virus behaviour cns sarscov<NUMBER> remains latent cns occurs coronaviruses cannot rule persistence exacerbation inflammatory cascade may promote development progression neurodegenerative diseases aware review highly speculative however hypotheses presented prove true covid<NUMBER> may lead neurological pandemic medium term cns infection may accelerate onset neurodegenerative diseases genetically environmentally predisposed individuals cause direct effects cns result neuroinflammatory response must consider pandemic irrelevant field neurology contrary covid<NUMBER> direct impact specialty near future affecting clinical research work neuroreca developed prospective multicentre research project aimed gathering cognitive psychiatric virological neurophysiological quality life data patients surviving severe covid<NUMBER> first year hospital discharge project endeavours answer questions posed article authors declare conflicts interest q<NUMBER> neuroreca research network clinical translational neurology funded andalusian regional governments department health family services financing programme biomedical health science research development innovation project ric<NUMBER> includes <NUMBER> researchers <NUMBER> neurology healthcare clinical research centres preclinical neuroscience research groups region andalusia neuroreca supported andalusian molecular biology regenerative medicine centre cabimer andalusian network design translation advanced therapies spanish society family community medicine spanish society primary care physicians year<NUMBER> million people contract bacterial viral pneumonia <NUMBER> usually overcome local immuneinflammatory response severe cases figure <NUMBER>a pathogen overwhelms host defenses causing massive lung damage compromising organs patients pathological immune activation hyperinflammation occurs lungs systemically <NUMBER> infection immunemediated damage compromise gas exchange leading acute respiratory distress syndrome ards need mechanical ventilation organ systems may also fail dysregulated immune responses contribute substantially global pneumonia death toll <NUMBER> million per year <NUMBER> clinical picture similar coronavirus disease <NUMBER> covid<NUMBER> caused sarscov<NUMBER> including hyperinflammation lungs organs ultimately compromising function causing high morbidity mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> diseasemodifying strategies conditions include targeting virus antivirals preventing hyperinflammation immunomodulators immunosuppressors propose approach using latter strategy hyperinflammation prevention <NUMBER> <NUMBER> specialized cells immuneinflammatory response communicate secreting peptides called cytokines amplify response restore homeostasis threat receded however hyperinflammation cytokines molecules trigger immune cells produce even cytokines forming cytokine storm damage healthy tissue overwhelm host patients covid<NUMBER> experience cytokine storm syndrome css characterized elevated proinflammatory cytokines including interleukin il<NUMBER> il<NUMBER>r tumor necrosis factorα granulocytecolony stimulating factor among others <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> one proposed immunosuppressive approach ameliorating css blocking il<NUMBER> signaling il<NUMBER> levels predict covid<NUMBER> severity inhospital mortality <NUMBER> <NUMBER> <NUMBER> monoclonal antibodies il<NUMBER> siltuximab receptor tocilizumab sarilumab clinical trials covid<NUMBER>induced css <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however utility antibodies likely restricted prohibitive costs risks suppressing antiviral host responses include prolonged immunosuppression potential adverse reactions another potential target preventing hyperinflammation catecholamine system catecholamine release precedes hyperinflammation enhances inflammatory injury augmenting cytokine production via selfamplifying process requires alpha<NUMBER> adrenergic receptor ⍺ <NUMBER> ar signaling <NUMBER> mice catecholamine synthesis inhibition reduced cytokine responses increased survival inflammatory stimuli ⍺ <NUMBER> ar antagonist prazosin clinically realistic dosagesbut betaadrenergic receptor βar antagonistsoffered similar protection showing drug class prevent cytokine storm syndrome <NUMBER> preclinical findings provide rationale clinical studies assess whether ⍺ <NUMBER> ar antagonists prevent css sequelae date controlled trials studied whether ⍺ <NUMBER> ar antagonism reduces css ards mortality patients acute respiratory distress pneumonia therefore conducted retrospective analysis two cohorts hospitalized patients marketscan research database <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients taking ⍺ <NUMBER> ar antagonists doxazosin alfuzosin prazosin silodosin terazosin tamsulosin treat chronic conditions unrelated ards benign prostatic hyperplasia bph hypertension posttraumatic stress disorder ptsd medication considered active use admission date drugs medication possession ratio ≥<NUMBER> year prior admission due transitions medicare coverage age <NUMBER> <NUMBER> ⍺ <NUMBER> ar antagonist users male due bph studied <NUMBER>to <NUMBER>yearold men estimated odds ratios adjusted odds ratios aor using logistic regression relate receipt ⍺ <NUMBER> ar antagonists two outcome measures progression mechanical ventilation progression inhospital death used profile maximum likelihood estimate confidence intervals ci <NUMBER> reported p values use onesided wald statistic test alternative hypothesis treatment reduces risk models adjusted age fiscal year prior inpatient admissions total prior days inpatient comorbidities identified healthcare encounters prior year hypertension ischemic heart disease acute myocardial infarction heart failure chronic obstructive pulmonary disease diabetes mellitus ptsd first cohort comprised <NUMBER> patients diagnosed acute respiratory distress icd<NUMBER> code <NUMBER> often precursor ards figure <NUMBER>b cohort taking ⍺ <NUMBER> ar antagonists compared nonusers associated <NUMBER> lower incidence relative risk reduction mechanical ventilation p ≤ <NUMBER> <NUMBER> lower incidence ventilation death p ≤ <NUMBER> next specifically assessed commonly used ⍺ <NUMBER> ar antagonist tamsulosin selective ⍺ <NUMBER>a ⍺ <NUMBER>d receptor subtypes tamsulosin used almost exclusively bph thus reducing likelihood confounding indication acute respiratory distress patients taking tamsulosin <NUMBER> lower incidence mechanical ventilation <NUMBER> lower incidence ventilation death p ≤ <NUMBER> p ≤ <NUMBER> respectively contrast βar antagonist use affect either clinical outcome second cohort <NUMBER> patients diagnosed pneumonia identified agency healthcare research qualitys ahrq pneumonia category figure <NUMBER>c found taking ⍺ <NUMBER> ar antagonists compared nonusers associated <NUMBER> lower incidence mechanical ventilation p ≤ <NUMBER> <NUMBER> lower incidence ventilation death p ≤ <NUMBER> pneumonia patients taking tamsulosin specifically <NUMBER> lower incidence mechanical ventilation compared nonusers ⍺ <NUMBER> ar antagonist <NUMBER> lower incidence ventilation death p ≤ <NUMBER> p ≤ <NUMBER> respectively βar antagonist use affect either clinical outcome stated results robust multiple alternative analysis approaches including <NUMBER> propensity score matching <NUMBER> restricting sample range propensity score overlap <NUMBER> using cochranmantelhaenszel test using nonparametric causal forests <NUMBER> <NUMBER> results retrospective clinical study extend preclinical findings support hypothesis ⍺ <NUMBER> ar antagonists may reduce morbidity mortality patients risk developing cytokine storm syndrome <NUMBER> fact patients generally ⍺ <NUMBER> ar antagonists reasons unrelated ards ability match groups set observed characteristics leads particularly strong retrospective design believe consequences unobserved confounder would minimal possible unobserved factors differ exposure groups thus randomized prospective trials needed test hypothesis specifically patients risk cytokine storm due covid<NUMBER> trials early administration ⍺ <NUMBER> ar antagonists prior development severe symptoms required goal prevent rather treat hyperinflammation ⍺ <NUMBER> ar antagonists various receptor subtype specificities used treat millions patients benign prostatic hyperplasia hypertension disorders history supports safety profile <NUMBER> although caution warranted using medication first time new disease covid<NUMBER> given poorly understood relationship covid<NUMBER> hypertension <NUMBER> important note nonreceptorsubtype selective ⍺ <NUMBER>a ⍺ <NUMBER>b ⍺ <NUMBER>d ⍺ <NUMBER> ars prazosin used reduce blood pressure whereas receptorsubtype selective drugs tamsulosin ⍺ <NUMBER>a ⍺ <NUMBER>d ⍺ <NUMBER>b fewer hemodynamic effects disclosures <NUMBER> johns hopkins university jhu filed patent application use various drugs prevent cytokine release syndromes vs rb np bv kwk sz listed inventors jhu assert patent rights filing treatment related covid<NUMBER> pandemic coronavirus disease <NUMBER> covid<NUMBER> emerged major health crisis severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infected million people around world within months identification human pathogen initially sarscov<NUMBER> infects cells since december <NUMBER> acute severe viral infectionivolving primarily respiratory system emerged rapid transmission around world million people within months named coronavirus disease <NUMBER> world health organization <NUMBER> disease pandemic resulted major health crisis pathogen covid<NUMBER> attributed severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> novel beta coronavirus closely related severe acute respiratory syndrome coronavirus sarscov <NUMBER> resulted many infections death throughout world <NUMBER> unlike seen influenza morbidity transmission modality covid<NUMBER> appear severe uncontrollable <NUMBER> primary pulmonary injury subsequent cardiovascular complications constitute key pathophysiology deadly disease review updates summarizes pathophysiological features possible underlying mechanisms clinical characteristics pulmonary cardiovascular injury covid<NUMBER> highly contagious virus sarscov<NUMBER> identified primary pathogen responsible development covid<NUMBER> belongs coronaviridae family <NUMBER> structurally functionally similar members betacoranavirus subgroup b sarscov<NUMBER> fig <NUMBER> thought descended bat gene pool seventh member coronavirus family known infect humans comprises positivesense singlestranded rna <NUMBER>nm size <NUMBER> among <NUMBER> coronaviruses capable causing illnesses sarscov middle east respiratory syndrome coronavirus merscov reportedly cause severe disease fatalities <NUMBER> infection <NUMBER> coronaviruses remains asymptomatic mildly symptomatic normal people according fulllength genome sequencing sarscov<NUMBER> <NUMBER> homologous sarscov like sarscov sarscov<NUMBER> infects lung alveolar epithelial cells receptormediated endocytosis association angiotensin converting enzyme ii ace<NUMBER> <NUMBER> epidemiological study enrolling <NUMBER> confirmed cases china indicated overall casefatality rate sarscov<NUMBER> <NUMBER> <NUMBER> whereas <NUMBER> <NUMBER> sarscov epidemic <NUMBER> <NUMBER> <NUMBER> merscov outbreak <NUMBER> mortality italy spain france may higher closer sarscov may due strain variation yet determined however consideration rapidly increasing numbers confirmed cases evidence humantohuman transmission <NUMBER> <NUMBER> sarscov<NUMBER> infectivity seems stronger sarscov merscov ultrastructural examination sarscov<NUMBER> cryoelectron microscopy demonstrated binding affinity sarscov<NUMBER> ace<NUMBER> appears approximately <NUMBER>to <NUMBER>fold higher sarscov structurally explaining sarscov<NUMBER> high contagiousness <NUMBER> spite fact sarscov<NUMBER> infected million individuals largely unknown virus evolving interacts microorganisms table <NUMBER> lung vital organs heart brain shen et al <NUMBER> recently reported genomic diversity sarscov<NUMBER> patients covid<NUMBER> observed metatranscriptomal sequencing bronchoalveolar lavage fluid samples covid<NUMBER> communityacquired pneumonia healthy individuals observed limited polymorphism diversity intrahost setting substantial proportion bacteria several covid<NUMBER> patients similar patients noncoronaviral pneumonia common complication viral infection especially respiratory viruses secondary bacterial infection often results significant increase morbidity even mortality indeed retrospective observational study <NUMBER> fatal cases covid<NUMBER> du et al <NUMBER> reported addition sarscov<NUMBER> infection simultaneously secondarily pathogens may participate covid<NUMBER> development complications contributing severity mortality covid<NUMBER> thus coinfection pathogens certainly complicates pathogenesis management covid<NUMBER> recommended countries including united states adapted similar diagnostic procedures covid<NUMBER> harvest certain clinical epidemiologic information diagnosis initially testing sources respiratory infection implemented assessing epidemiologic factors assist diagnosis including information whether person close contact patient laboratoryconfirmed covid<NUMBER> within <NUMBER> days symptom onset history travel affected geographic areas epicenters within <NUMBER> days clinical profiles diagnosis covid<NUMBER> well documented date however new evidence emerging deadly disease far mystery previously thought many cases appeared atypical easily misdiagnostic <NUMBER> table <NUMBER> wang et al <NUMBER> suggest diagnosing confirmed case base suspected case one item pathogenic serological evidence following <NUMBER> realtime pcr test positive sarscov<NUMBER> <NUMBER> viral whole genome sequencing showing high homogeneity known novel coronaviruses <NUMBER> positive specific igm antibody igg antibody sarscov<NUMBER> serum test change sarscov<NUMBER>specific igg antibody negative positive titer rising ≥<NUMBER> times recovery phase acute phase sarscov<NUMBER> mainly attacks respiratory system clinically characterized rapid development pneumonia severe cases acute respiratory distress syndrome ards multiple organ dysfunction syndrome <NUMBER> death rate remains high admitted intensive care ventilator due complications respiratory cardiac failure <NUMBER> epidemiology high prevalence cardiovascular dysfunction recently reported covid<NUMBER> patients especially critical medical conditions <NUMBER> study <NUMBER> covid<NUMBER> patients <NUMBER> patients <NUMBER> diagnosed acute myocardial injury based elevation highsensitivity cardiac troponin hsctni <NUMBER> admitted intensive care unit icu <NUMBER> injury independently associated higher risk inhospital mortality <NUMBER> hence early myocardial injury covid<NUMBER> leads poor prognosis covid<NUMBER> patients changes cardiacspecific biomarkers peripheral blood reported patients covid<NUMBER> stated hsctni acts one specific biomarkers myocardial injury <NUMBER> binding sarscov spike protein ace<NUMBER> cardiomyocyte surface also triggers raserkap<NUMBER> pathway activates cc motif chemokine ligand <NUMBER> ccl<NUMBER> profibrosis factor <NUMBER> theories supported autopsy report heart samples sars patients presence sarscov heart associated marked downregulation ace<NUMBER> expression well significant increase macrophage infiltration interstitial fibrosis verifying ace<NUMBER> inhibition involved sarscovdriven myocardial injury <NUMBER> specific cellular mechanism sarscov<NUMBER> invading damaging cardiomyocytes clearly demonstrated yet probable sarscov<NUMBER> shares similar mechanism relative sarscov recent study investigated ultrastructure fulllength human ace<NUMBER> cryoem <NUMBER> indicating sarscov<NUMBER> also invaded host cells via spike protein trimers binding ace<NUMBER> homodimer addition interface receptor binding domains spike proteins sarscov<NUMBER> quite similar sarscov ace<NUMBER> furthermore serine protease tmprss<NUMBER> also indispensable entry sarscov<NUMBER> <NUMBER> given high similarity cellular entry sarscov reasonable speculate sarscov<NUMBER> interferes ace<NUMBER> expression way however needs verified cardiomyocytes study myocardial oxygen supply determined coronary blood flow oxygen carrying capacity myocardial oxygen demand determined systolic wall tension contractility heart rate <NUMBER> physiological mechanism may involved sarscov<NUMBER>induced myocardial injury wellknown pulmonary dysfunction primary insult sarscov<NUMBER> induces hypoxemia hypotension cases shock <NUMBER> <NUMBER> consequencet insufficient oxygen supply may occur multiple organs including heart concomitantly myocardial oxygen demand increased virusinfection states high metabolic rate induces augmented burden myocardium <NUMBER> <NUMBER> <NUMBER> among many cytokines il<NUMBER> serves core cytokine storm given il<NUMBER> amplifies cytokine storm stimulating production proinflammatory cytokines also results vascular leakage interstitial edema <NUMBER> moreover il<NUMBER> also shown weaken papillary muscle contraction causes myocardial dysfunction <NUMBER> addition ifnγ also regarded marker cytokine storm causing cell apoptosis regulating jakstat<NUMBER> axis p<NUMBER>mapk<NUMBER> <NUMBER> however antiinflammatory cytokines il<NUMBER> il<NUMBER> also increased covid<NUMBER> patients levels also related disease severity <NUMBER> <NUMBER> demonstrating close relation proand antiinflammation cytokine storm clear contributor covid<NUMBER>related myocardial injury demonstrated study revealed increased levels il<NUMBER> significantly associated high hstni levels <NUMBER> cardiacselective biomarker myocardial infarction injury <NUMBER> studies needed explore cytokine expression cardiomyocytes promote better understanding sarscov<NUMBER>induced inflammation cardiac tissue overall direct infection ace<NUMBER> imbalance myocardial oxygen supply demand abnormal immune response constitute plausible explanations myocardial injury associated covid<NUMBER> noted however speculation mostly based clinical observation covid<NUMBER> therefore indepth research required understand pathophysiology sarscov<NUMBER>induced myocardial injury order contribute future development effective treatment general clinical symptoms found covid <NUMBER> suggesting myocardial inflammation occurred covid<NUMBER> patients <NUMBER> cytokine storm consequent inflammatory response suggested mechanisms contributing myocardial injury low eat density showed chest ct scan appears highrisk factor myocardial injury however low eat density optimal imaging parameter covid<NUMBER>related myocardial injury since indirect sign inflammation may substantively influenced subjective factors clinical practice imaging modalities high sensitivity specificity echocardiography myocardial magnetic resonance imaging preferentially chosen appropriate treatment covid<NUMBER> mostly restricted supportive measures date specific therapy available treat disease preexisting poorhealth conditions increase risk cardiovascular comorbidity poorer hydroxychloroquine chloroquine traditional antimalarial autoimmune disease drugs shown control sarscov<NUMBER> infection vitro <NUMBER> <NUMBER> underlying mechanism may involve increase endosomal ph required viruscell fusion， interference glycosylation ace<NUMBER> <NUMBER> structural evidence sarscov<NUMBER> invasion cells via ace<NUMBER> led hypothesis aceiarb treatment potentially induces overexpression ace<NUMBER> subsequently increases susceptibility host cells sarscov<NUMBER> invasion risk infection worsening severity disease <NUMBER> therapies less evidencebased foundation also worth mentioning plasma treatment means transfusing convalescent plasma containing antivirus polyclonal antibodies proved effective treating sars patients covid<NUMBER> patients observational studies <NUMBER> <NUMBER> although number patients treated small make scientific sense dilated horse antisarscov<NUMBER> serum could crossneutralize sarscov<NUMBER> vitro study <NUMBER>  general discomforts typically fever fatigue headache muscle ache diarrhea etc  signs symptoms lung airway abnormalities typically cough dyspnea  total white blood cell counts showing normal decreased reduced lymphocyte count early onset stage increased neutrophils advanced cases  realtime pcr test positive sarscov<NUMBER>  viral sequencing showing high homogeneity sarscov<NUMBER>  serum test positive sarscov<NUMBER> specific igm igg  chest radiography ct scan showing multiple mottling groundglass opacities without consolidation lung periphery schematic demonstration viral injury lung heart triggering lungheart syndromes combination respiratory cardiovascular adverse events conditions agree authors topic important speed kind research covid<NUMBER> global urgent problem reasoned quickly read manuscript send comments authors speedily improve manuscript need time next reading major part kind paper methods background relatively important ethical assessment whether sound biological rational background less essential statistical assessment protocol comments background focus mainly methods also discussion section view removed discussion needed consideration results results general consideration kind paper background section english second language somewhat hesitate comment peoples language however view language confusing quite many parts cases difficult understand meaning large part background discusses biology authors discuss previous human studies part objective literature description need detailed cover relevant studies related topic mention fujii study published jama well submission manuscript httpswwwncbinlmnihgovpubmed<NUMBER> study negative patients septic shock treatment intravenous vitamin c hydrocortisone thiamine compared intravenous hydrocortisone alone significantly improve duration time alive free vasopressor administration <NUMBER> days first describe positive findings citris study secondary outcomes mention mention negative findings primary outcome obviously findings primary outcome relevant described first citris study <NUMBER> icu participants httpswwwncbinlmnihgovpubmed<NUMBER> recent metaanalysis combined results <NUMBER> trials <NUMBER> patients evidently statistical power observe differences vitamin c control greater citris trial httpswwwncbinlmnihgovpubmed<NUMBER> another recent metaanalysis pooled eight trials including <NUMBER> patients total power greater <NUMBER> participant citris trial httpswwwncbinlmnihgovpubmed<NUMBER> three studies relevant background page <NUMBER> line <NUMBER> authors state whether <NUMBER> sd se given inaccuracy relevance decimals giving many irrelevant decimals may give impression authors understand meaning dispersion parameters vasopressin duration varies <NUMBER> <NUMBER> <NUMBER> hours <NUMBER> <NUMBER> <NUMBER> hours obvious <NUMBER> <NUMBER> <NUMBER> <NUMBER> irrelevant make reading difficult objectives short <NUMBER> <NUMBER> sentences clear statement goal positive results previously performed clinical trials infusing highdose vitamin c patients severe sepsis ards reasoned etc relevant objectives risks adverse effects discussed page <NUMBER> however methods issues bakcground furthermore personally convinced vitamin c safe kind issue need justification page <NUMBER> line <NUMBER> statement references line <NUMBER> references kind statements absolutely need references preferably one also deaths caused vitamin c none described protocol eg httpswwwncbinlmnihgovpubmed<NUMBER> httpswwwncbinlmnihgovpubmed<NUMBER> httpswwwncbinlmnihgovpubmed<NUMBER> httpswwwncbinlmnihgovpubmed<NUMBER> expect literature search reported harms vitamin c dont consider acceptable none cited discussed page <NUMBER> line <NUMBER> two arms vc placebo sterile water injection primary outcome ventilationfree days within <NUMBER> vfd<NUMBER> observational days first two arms vitamin c may indicate two vitamin c arms one example difficult language reordered confusing second intervention outcomes power calculation subtitles methods section repeated repetition makes text long frustrating pi mentioned dont see elsewhere page <NUMBER> states authors contributed equally work refers <NUMBER> persons authors give description random number list transferred patient level description whether allocation concealment primary investigator generates list treats patients situation somewhat concerning nonblinded study blinding accept reasoning need hasty necessarily time organize proper doubleblind trial however prevent consideration minimize knowledge example primary investigator could collaborate nurses administer treatments physicians would remain least somewhat blinded treatment highly controversial kinds issues much critical standard drugs vc injection sterile water injection colorless transparent liquids contained brown syringes different marks without explanations order make sure patients cannot tell cannot clinicians blinded difficult understand section infusion pump speed <NUMBER>mlh total volume vc carrier fluids sterile water injection <NUMBER>ml infusion pump speed <NUMBER> mlhour <NUMBER> hours gives <NUMBER> ml <NUMBER> ml use <NUMBER> ml speed mean <NUMBER> hours <NUMBER>g vc per day mean <NUMBER> grams vitamin c per <NUMBER> ml concentrated solution sterile water mean essentially always people using saline <NUMBER> nacl placebo vitamin c infusions far understand salt sterile water could irritate veins use control point anyone use variable ambiguous ventilationfreetime duration ventilation sample size cannot make sense section confusing far used power calculation based assumed notreatment baseline guessed effect upon baseline guessed treatment level cannot see data n <NUMBER> calculated assumed levels two groups assumed effect vitamin c cannot also see rationale interim analysis need <NUMBER> participants much random variation <NUMBER> participants looking looking control group get accurate basis baseline assumption cannot look difference arms since large random variation page <NUMBER> line <NUMBER> secondary analysis comparison primary outcome secondary outcomes two groups two groups page <NUMBER> line <NUMBER> able pause trial investigate give suggestions potential safety issues improve study poor english mean able stop trial author names severely wrong reference <NUMBER> compare httpsjitcbiomedcentralcomarticles<NUMBER>s<NUMBER> think names also wrong references <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ref <NUMBER> chinese dont think reasonable english readers chinese names could brackets spirit checklist <NUMBER> correct objectives described <NUMBER> page <NUMBER> objectives revised focused <NUMBER> incorrect see comments description abut issues manuscript <NUMBER>a authors write na first na appropriate second abstract write findings trial disseminated peerreviewed journals scientific conferences third write text section references <NUMBER> <NUMBER> look like might paper lot overlap details overall editing english grammar carried major part kind paper methods background relatively important ethical assessment whether sound biological rational background less essential statistical assessment protocol comments background focus mainly methods also discussion section view removed discussion needed consideration results results general consideration kind paper background section english second language somewhat hesitate comment peoples language however view language confusing quite many parts cases difficult understand meaning reply thank comments try keep discussion section shorter put related description background section asked native english speaker medical doctor md student university maryland school medicine usa revise english grammar attached certificate englishrevising background <NUMBER> authors discuss previous human studies background part objective literature description detailed fujii study presented negative results published jama well submission manuscript mentioned manuscript findings primary outcome citris study described first besides two recent metaanalysis recommended relevant backgrounds reply thank suggestion studied comment carefully made large correction based comments firstly deleted lot unnecessary description literature secondly read fujii study investigated combined therapy vitamin c hydrocortisone thiamine actually another reference ref <NUMBER> previous draft cited manuscript also investigated combination three drugs considered weak evidence support using vc deleted suggested reviewer <NUMBER> reason difficult distinguish components take effects combination therapy thus deleted reference <NUMBER> reviewer <NUMBER> suggested cite fujii study well thirdly added descriptions citris study demonstrated negative primary outcome well two metaanalysis page <NUMBER> revised version full text hope revision make background objective persuasive <NUMBER> risks adverse events background rather methods reply thank valuable suggestions moved descriptions methods risk adverse events background besides still kept small part risks adverse events consent methods required clinical trials mainly focused definition adverse events method vitamin cs administration minimize possibility side effects <NUMBER> furthermore personally convinced vitamin c safe kind issue need justification page <NUMBER> previous draft line <NUMBER> statement references line <NUMBER> references kind statements absolutely need references preferably one also deaths caused vitamin c none described protocol acceptable literature reported harms vitamin c cited discussed background reply added literatures side effects including death vitamin c explanations well one paragraph background page <NUMBER> revised draft <NUMBER> active kidney stone mentioned kidney diseases exclusion criteria reply thank question existed severe kidney diseases also needed exclude right determined exclusion criteria initially based report jama active kidney stone excluded ref <NUMBER> revised version addition active kidney stone specific side effect longterm use highdose vitamin c infusion confirmed drug instructions kidney diseases listed side effects instructions vitamin c however drug instructions remind vitamin c infusion applied caution patients oxalate nephropathy severe kidney injury actually didnt take patients existed severe kidney injury study add exclusion criterion page <NUMBER> <NUMBER> authors mean ae adverse events ae severe adverse events sae recorded event reply thank comment added definition ae sae ae defined untoward medical events occur human subject receives drug serious adverse events sae refers events occurs subjects participation research results hospitalization prolonged hospital length stay disability threat life death occur subjects participation research causal relationship treatment thus section ae still reserved ensure rigor integrity trial untoward event happens researchers report dsmb define nature event make decision deal added page <NUMBER> <NUMBER> pi authors give description random number list transferred patient level description whether allocation concealment primary investigator generates list treats patients situation somewhat concerning nonblinded study reply thank primary investigator prof zhiyong peng also corresponding author revised manuscript descried procedure allocation concealment details page <NUMBER> pi generated two independent random numeric tables one icu zhongnan hospital wuhan university icu leishenshan hospital wuhan city tables kept carried investigators charge drug assignment participants patient transferred icu investigators informed clinician duty judge whether patients achieves requirement recruitment patient signs informed consent clinician get number investigators prescribe corresponding medication medical orders system process pi treat patients clinician cannot predict patient enrolled group either added page <NUMBER> <NUMBER> treatment highly controversial blinding issues much critical standard drugs measures taken minimize knowledge vc injection sterile water injection colorless transparent liquids contained brown syringes different marks without explanations order make sure patients cannot tell cannot clinicians blinded reply thank question pandemic affair doctors nurses overloaded state enough medical staff specifically assigned trial however research team responsible trial kept blind collect data run analysis order minimize bias policy allocation concealment blinding strictly followed researcher generating allocation number treat patients attending clinician cannot predict determine patient enrolled group added page <NUMBER> <NUMBER> difficult understand infusion pump speed <NUMBER>mlh total volume vc carrier fluids sterile water injection <NUMBER>mland <NUMBER>g vc per day reply thank comment sorry vague expression time infusion total volume <NUMBER>g vitamin c carrier fluid sterile water injection <NUMBER>ml infused infusion pump speed <NUMBER>mlh finish <NUMBER> hours vitamin c infused every <NUMBER> hours total dosage <NUMBER>gd revised description clearer way page <NUMBER> <NUMBER> corresponding tests completed within <NUMBER> hours study interventions subtitles reply thank deleted sentence study interventions <NUMBER> trial lasts <NUMBER> days correct reply thank correction revised intervention lasts <NUMBER> days page <NUMBER> <NUMBER> vasopressor days ventilation days length icu stay length hospital stay icu mortality inhospital mortality recorded <NUMBER> observational days afterwards participants scheduled followup visit <NUMBER>th day track longterm prognosis namely <NUMBER>days mortality outcomes data collection reply thank suggestion found parameters actually included section secondary outcomes deleted paragraph except participants scheduled followup vise <NUMBER>th day track longterm prognosis page <NUMBER> <NUMBER> rationale calculate ventilationfree days rather ventilation days reply thank question referred fowlers study ref <NUMBER> chose ventilationfree days vfd<NUMBER> firstly vfd<NUMBER> proper index reflect patients pulmonary respiratory function secondly vfd<NUMBER> recorded medical system every patient data missing collect data participants actually difference clinical meaning vfd ventilation days vd however vfd<NUMBER> excludes bias induced mild patients without ventilation supports vd<NUMBER> dead patients short ventilation days <NUMBER> section sample size confusing <NUMBER> calculated rationale interim analysis reply thank question power calculation based primary endpoint however since trial began early stage covid<NUMBER> data lacked thus considered three available variables calculating sample size icu mortality <NUMBER> rate noninvasive ventilation <NUMBER> rate invasive ventilation <NUMBER> used noninferiority test formula calculate sample size onesided type error rate α <NUMBER> power <NUMBER> <NUMBER> withdrawal rate group according three variables respectively finally chose largest number namely <NUMBER> calculated icumortality <NUMBER> sample size trial however calculated sample size accurate thus arrange interim analysis second stage calculation <NUMBER> patients enrolled clinical data including <NUMBER>days followup visits collected conduct complete statistical analysis get relatively accurate sample size think get preliminary data enrolled <NUMBER> patients n<NUMBER> revise sample size based preliminary data added explanation page <NUMBER> <NUMBER> secondary analysis comparison primary outcome secondary outcomes two groups two groups reply thank question missing definite article two groups two groups refers treatment group vitamin c control group sterile water injection sorry vague expression page <NUMBER> <NUMBER> able pause trial investigate give suggestions potential safety issues improve study poor english mean able stop trial reply thank question intended express dsmb able stop trial refers dsmb revised expression according suggestion make statement clear page <NUMBER> <NUMBER> author names severely wrong reference <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> reference <NUMBER> chinese reasonable english readers reply thank criticism sorry typos checked revised references besides made big revision background deleted chinese reference <NUMBER> comments spirit checklist <NUMBER> incorrect objectives described <NUMBER> page <NUMBER> objectives revised focused <NUMBER> incorrect <NUMBER> incorrect description power calculation confusing <NUMBER>b incorrect description whether allocation concealment <NUMBER>c incorrect description issues manuscript <NUMBER>a na appropriate reply thank careful review comment <NUMBER> <NUMBER> <NUMBER> <NUMBER>b <NUMBER>c stated reasons revisions text <NUMBER>a sorry misunderstood meaning column findings trial disseminated peerreviewed journals scientific conferences wrote statement abstract added consent publication section declarations page <NUMBER> reviewer <NUMBER> <NUMBER> evidence circumstances highdose ascorbate given intravenous injection hivc substantial oxidant activity rather antioxidant activity presumed happen super high doses oncology patients rather icu patients thus statement deleted reply thank suggestion found comment extremely helpful deleted sentence page <NUMBER> <NUMBER> sample size primary outcome secondary outcomes dont match clinicaltrialsgov reply thank comment sample size calculated based primary endpoints however data lacked since covid<NUMBER> new disease thus initially chosen sample size based pervious studies ards registered clinicaltrials website got <NUMBER> icu mortality data calculated sample size based figure found total <NUMBER> study participants <NUMBER> group would result power <NUMBER> onesided type<NUMBER> error rate α <NUMBER> allowing <NUMBER> withdrawal rate group revised version protocol well first one reviewed approved ethics committee zhongnan hospital wuhan university attached supplementary files editors added detailed description sample size calculation page <NUMBER> <NUMBER> reference <NUMBER> <NUMBER> irrelevant reviews would better reply thank suggestion deleted references cited reviews instead section page <NUMBER> <NUMBER> reference <NUMBER> required reply thank correction mostly refers pharmacology vitamin cs function generating ascorbate radical hydrogen peroxide intended cancer deleted reference <NUMBER> page <NUMBER> <NUMBER> sure trial ref <NUMBER> included vitamin c monotherapy rather combination treatment reply thank appreciate insightful comment discussed carefully decided delete study cited two metaanalysis large samples make background persuasive <NUMBER> study showed higher dosages vc appliedthe findings trial cannot used say higher doses vc requiredthis valid conclusion reply thank comment revised sentence page <NUMBER> <NUMBER> positive results previously performed clinical trials sure valid statement eithershould less strongly worded outcomes definitivemany metaanalyses carried different conclusions reply thank comment suggestion extremely helpful indeed expression strongly worded changed searched literatures rewrote background make persuasive objective page <NUMBER> <NUMBER> one primary outcome reply thank suggestion totally agree decided ventilationfree days within <NUMBER> days vfd<NUMBER> primary outcome main goal research investigate efficacy vitamin c pulmonary function patients covid<NUMBER> however early stage covid<NUMBER> relative data outcome lack calculated sample size based three variables outcome vfd<NUMBER> chosen appropriate one mentioned page <NUMBER> adjust sample size based preliminary data trial detailed explanation seen page <NUMBER> responses authors reviewer comments appropriate revised manuscript satisfactory small new issues strengths limitations section independent text people read without reading abstract therefore hivc defined strengths trial exaggerated neither understated old literature single blind indicated patients blinded researchers doubleblind indicated researchers patients blinded however several roles researchers roles blinded therefore current consort recommendations bmj <NUMBER>c<NUMBER> doi <NUMBER>bmjc<NUMBER> instruct description blinding specific response <NUMBER> reviewer <NUMBER> authors write research team responsible trial kept blind collect data run analysis order minimize bias policy allocation concealment blinding strictly followed researcher generating allocation number treat patients attending clinician cannot predict determine patient enrolled group added page <NUMBER> much stronger blinding singleblinding old literature encourage authors explicitly briefly describe rolesstages researchers blinded remove term singleblinded strengths also methods section happened note ref <NUMBER> correct us culture boys sometimes given names fathers case write <NUMBER>nd ii <NUMBER>rd iii son grandson recent jama report name alpha fowler <NUMBER>rd doi <NUMBER>jama<NUMBER> thus iii ref <NUMBER> initials middle names easy remove university otago christchurch new zealand review returned <NUMBER>jun<NUMBER> bottom page <NUMBER> thus wonder… stated terminology hypothesisparticularly one relates directly primary outcome interest wording paragraph little confusing particularly last sentence objectives page <NUMBER> still mentioning ventilation free days murray injury scores primary outcomes major objective <NUMBER> provide evidence treatment diseases characterized cytokine storm immune dysfunction wouldnt actually tested diseases provide evidence deleted objectivebut could perhaps mentioned elsewhere hypothesis generating although directly tested study study outcomes page <NUMBER> murray lung injury score crp levels deleted primary outcomes included secondary outcomesis correctare longer going measured outcomes abstractintroductionpotential attenuation cytokine storm mentioned likely mechanism action cytokines assessed secondary outcomes page <NUMBER> submitting author right grant grant behalf authors work defined author licence exclusive licence andor nonexclusive licence contributions authors uk crown employees ii bmj agreed ccby licence shall apply andor iii accordance terms applicable us federal government officers employees acting part official duties worldwide perpetual irrevocable royaltyfree basis bmj publishing group ltd bmj licensees relevant journal coowned bmj coowners journal publish work journal bmj products exploit rights set licence submitting author accepts understands supply made terms made bmj submitting author unless acting employee behalf employer postgraduate student affiliated institution paying applicable article publishing charge apc open access articles submitting author wishes make work available open access basis intends pay relevant apc terms reuse open access shall governed creative commons licence details licences creative commons licence apply work set licence referred permitted relevant bmj authors self archiving policies confirm work accepted publication elsewhere considered publication elsewhere duplicate material already published confirm authors consent publication work authorise granting licence first prospective randomized controlled trial applying hivc treating covid <NUMBER> hivc advantages terms stability availability safety cost compared treatments sample size calculated twostage way order ensure calculation reasonable maximize possibility obtain significant results provide credible data outcomes study singleblinded since complete blinding feasible due lack manpower material resource public emergency duration distribution infected cases unpredictable geographically temporally number recruitments centre also unpredictable though competitive enrolment adopted end december <NUMBER> unexplained pneumonia appeared wuhan hubei china january <NUMBER> <NUMBER> new type coronavirus detected laboratory <NUMBER> later named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> officially world health organization february <NUMBER> meanwhile pneumonia caused sarscov<NUMBER> infection named coronavirus disease <NUMBER> disease highly contagious spreading inside outside china causing global threat panic april <NUMBER> <NUMBER> <NUMBER> cases confirmed worldwide <NUMBER> died <NUMBER> covid<NUMBER> acute infectious pneumonia infected cases presented predominantly fever cough well dyspnea myalgia metaanalysis <NUMBER> concluded among patients <NUMBER> presented ards <NUMBER> cases transferred intensive care unit icu <NUMBER> fatal outcomes according previous research <NUMBER> patients presenting ards accounted <NUMBER> icu rate mechanical ventilation high <NUMBER> <NUMBER> noninvasive invasive way respectively however specific treatment available present turns traditional antiviral drugs well antibiotic therapy mainly intended secondary bacterial infections work well covid<NUMBER> urgent explore effective therapies considering grim situation cytokine storm triggered variety factors infections potentially fatal immune reaction associated clinical symptoms severe inflammation highly elevated levels proinflammatory cytokines interleukin il<NUMBER> plays vital role <NUMBER> <NUMBER> virus invades immune cells macrophagocytes lymphocytes natural killer cells activated produce mass cytokines including proinflammatory factors activate immune cells turn antiinflammatory factors proinflammatory factors gain advantage accumulate certain level cytokine storms happen damage pulmonary capillary endothelium alveolar structure causing pulmonary dysfunction <NUMBER> previous studies <NUMBER> manifested cytokine storms may main pathophysiological mechanism highly pathogenichuman coronaviruses hcovs infected pneumonia severe acute respiratory syndrome sars middle east respiratory syndrome mers autopsy report patient critical covid<NUMBER> <NUMBER> also drew similar conclusions study discovered diffuse alveolar damage cellular fibromyxoid exudates evident desquamation pneumocytes pulmonary oedema hyaline membrane formation findings indicated patient developed acute respiratory distress syndrome ards addition flow cytometric analysis peripheral blood showed peripheral cd<NUMBER>t cells cd<NUMBER>t cells exhausted state considering counts substantially reduced status hyperactivated clinical characteristics covid<NUMBER> also support conclusions huang et al first reported increase several plasma cytokines infected cases <NUMBER> comparison showed plasma concentrations il<NUMBER>beta β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> granulocyte colony stimulating factor gcsf interferoninducible protein<NUMBER> ip<NUMBER> monocyte chemotactic protein<NUMBER> mcp<NUMBER> macrophage inflammatory protein <NUMBER> alpha mip<NUMBER>a tumor necrosis factor alpha tnfα higher icu patients nonicu patients suggesting cytokine storms may positively related severity disease besides wan et al summarized <NUMBER> cases <NUMBER> found plasma concentration il<NUMBER> il<NUMBER> higher patients severe covid<NUMBER> mild cases levels cd<NUMBER> cd<NUMBER>t cells lower study suggested cell subsets cytokines indicators predicting prognosis indicating transition mild severe cytokine storm whereafter immunopathology report <NUMBER> based <NUMBER> patients covid<NUMBER> detected immunological indices revealed possible mechanism covid<NUMBER> study speculated th<NUMBER> cell key cell il<NUMBER> granulocytemacrophage colonystimulating factor gmcsf main cytokines hyperinflammatory response caused covid<NUMBER> especially transferred icus sarscov<NUMBER> infection cd<NUMBER>t cells rapidly activated become pathogenic th<NUMBER> cells generate gmcsf etc cytokines environment induces inflammatory cd<NUMBER>cd<NUMBER> monocytes high expression il<NUMBER> accelerates inflammation immune cells cytokines pour pulmonary circulation cause pulmonary dysfunction even rapid demise vitamin c vc common wellknown necessary nutrient also known antioxidant despite role metabolism human body including energy transformation collagen biosynthesis repair production adrenal steroids catecholamines iron absorption etc <NUMBER> <NUMBER> <NUMBER> <NUMBER> also possesses antimicrobial properties thus reducing risk infections immunomodulatory functions particularly high concentration <NUMBER> specifically vc inhibit generation il<NUMBER> tnfα <NUMBER> <NUMBER> appeared dosedependent effect <NUMBER> downmodulate gmcsf signaling responses <NUMBER> functioning regulator cytokine redoxsignal transduction host defense cells possible role controlling inflammatory responses high dose vc disrupt important events associated cells proliferation cytokine secretion <NUMBER> verified vc inhibit activation nfκb primary proinflammatory transcription factor plays pivotal role global immunity including gene regulation chemokines cytokines adhesion molecules inflammatory mediators apoptosis inhibitors <NUMBER> <NUMBER> besides reported vitamin c inhibited replication simplex virus <NUMBER> poliovirus type <NUMBER> influenza virus vitro <NUMBER> previous research <NUMBER> <NUMBER> demonstrated intravenous vc ivc achieve higher plasma concentration millimolar oral vc micromolar due intestinal absorption tissue transport renal reabsorption efficacy safety intravenous highdose vc hivc critical patients validated via several clinical trials phase trial ivc patients severe sepsis <NUMBER> reported side effects participants divided lowascorbic acid asca group <NUMBER> mgkg<NUMBER>h highasca group <NUMBER> mgkg<NUMBER>h placebo group receive intervention every <NUMBER> hours <NUMBER> days concluded highdose vc correct low vc concentration patients severe sepsis also reduce extent multiple organ failure attenuate circulating injury biomarker levels another phase ii placebo controlled trial <NUMBER> applied <NUMBER>g vc every <NUMBER> hours combined thiamine hydrocortisone management sepsis septic shock concluded significant difference decreasing duration vasopressor use control group <NUMBER>±<NUMBER>h treatment group <NUMBER>±<NUMBER>h p value<NUMBER> improving lactate clearance <NUMBER> control group vs <NUMBER> treatment group p value<NUMBER> case report <NUMBER> recorded patient virusinduced ards tested positive enterovirusrhinovirus viral screening treatment highdose vitamin c <NUMBER>mgkg<NUMBER>h every <NUMBER> hours onset <NUMBER> hours following initiation extracorporeal membrane oxygenation ecmo patient recovered rapidly vc infusion longterm ards sequelae indicating intravenous highdose vc might new therapy ards many causes citrisali randomized clinical trial <NUMBER> published jama last year investigated effect intravenous vc infusion primary outcomes organ failure scores biological markers inflammation vascular injury patients sepsis ards trial recruited <NUMBER> participants sepsis undergoing mechanical ventilation fully developed ards vc intravenously infused treatment group <NUMBER>mgkg every <NUMBER> hours <NUMBER> days study concluded significant reduction <NUMBER>day mortality icufree days day <NUMBER> hospitalfree days day <NUMBER> difference primary outcomes noticed study showed higher dosages vc applied longer administration period intervention initiate earlier stage positive results previously performed clinical trials infusing highdose vitamin c patients severe sepsis ards reasoned infusing highdose vc patient covid<NUMBER> would safe therapeutic considering progression covid<NUMBER> faster severe speculated higher dosage may required thus intravenous <NUMBER>g vc <NUMBER> days applied tentatively trial main goal clarify effect hivc prognosis patients covid<NUMBER> especially respiratory function assessed ventilationfree days murray injury scores aimed investigate new therapy covid <NUMBER> furthermore also expected provide evidence treatment diseases characterized cytokine storm immune dysfunction protocol written accordance standard protocol items recommendations interventional trials spirit guidelines <NUMBER> see attached research checklist summarized fig<NUMBER> fig<NUMBER> study multicenter prospective single blind randomized placebocontrolled trial planned conducted zhongnan hospital wuhan university leishenshan hospital wuhan city february <NUMBER> <NUMBER> september <NUMBER> <NUMBER> interventional study two arms vc placebo sterile water injection primary outcome ventilationfree days within <NUMBER> vfd<NUMBER> observational days sample size calculated <NUMBER> participants study welldesigned according concept pragmatic trial <NUMBER> broad inclusion criteria reasonable sample size study procedures embedded clinical routine care executed clinical personnel trial conducted <NUMBER> icus zhongnan hospital wuhan university leishenshan hospital wuhan city zhongnan hospital wuhan university possessed comprehensive icu <NUMBER> beds tertiary hospital integrating clinic scientific research teaching epidemic pneumonia takes charge leishenshan hospital wuhan city second specialized hospital build wuhan government within half month accommodate treat patients icu enroll patients competitively <NUMBER> months patients admitted <NUMBER> icus consistent following inclusion criteria exclusion criteria time randomization considered enroll enrollment must completed within <NUMBER> hours recognized onset participants inclusion criteria follows <NUMBER> trial considered safe firstly vc essential nutrient human body ivc widely used clinical practice drug <NUMBER> decades secondly according instructions prolonged infusion highdose vc may induce scurvy withdrawal calculus urate cysteine oxalate rapid infusion may induce syncope minimize risks trial patients diseases excluded vc infusion applied <NUMBER> days infusion rate slow <NUMBER>mlh thirdly highdose vc used previous studies critically ill patients previous trials raise obvious adverse events <NUMBER> adverse events ae severe adverse events sae recorded <NUMBER> days observation enrollment investigators evaluate relationship events intervention report ethical committee dsmb benefits potential risks written informed consent document patients informed purpose intervention benefits possible risks study icu assigned independent random numeric table generated excel<NUMBER> microsoft primary investigator alone table equal number <NUMBER> <NUMBER> represents placebo group sterile water injection treatment group vc respectively participants enrolled corresponding group orderly trial singleblind study epidemic covid<NUMBER> public emergency putting medical system overloaded state thus enough manpower material resources modifying medical orders system connecting ward pharmacy assigning special nurse configure label infusions implement doubleblind method therefore grouping intervention unknown participants known investigators clinical staff vc injection sterile water injection colorless transparent liquids contained brown syringes different marks without explanations order make sure patients cannot tell investigators clinicians dsmb monitor whole process treatment pause trial potential aes occur participants interests damaged need unblinding patients trial interventional study <NUMBER> arms treatment group assigned <NUMBER>g vc per day <NUMBER> days patients infused <NUMBER>g vc every <NUMBER> hours infusion pump speed <NUMBER>mlh total volume vc carrier fluids sterile water injection <NUMBER>ml control group assigned placebo <NUMBER>ml sterile water method speed administration identical treatment group medications therapeutic schedules standard critical supportive care applied study intervention commenced within <NUMBER> hours corresponding tests completed within <NUMBER> hours enrollment delivery assigned vc injection placebo injection achieved medical orders system pharmacy supply clinical routine hospital vc injection common basic drug widely used hospital problems inventory logistics trial lasts <NUMBER> days enrolled patients observed <NUMBER> days <NUMBER>daytrial period interventions applied baseline data including demographic characteristic main diagnosis assigned group changes acute physiology chronic health evaluation apache ii scores sequential organs failure assessment sofa scores multiorgan function especially respiratory function indices collected first day general vital signs chest radiographycomputed tomographic ct scans respiratory cardiac ultrasound respiratory indices rif parameters ventilation etc infection indices white blood cells count neutrophil count lymphocyte count procalcitonin creactive protein cytokine test il<NUMBER> il<NUMBER> etc immunologic indices lymphocyte subpopulation organ function indices cardiac function hepatic function renal function coagulation function blood gas analysis detected first third seventh day vasopressor days ventilation days length icu stay length hospital stay icu mortality inhospital mortality recorded <NUMBER> observational days afterwards participants scheduled followup visit <NUMBER>th day track longterm prognosis namely <NUMBER>days mortality sequelae data collected clinical information system hospital recorded case report format crf every participant recognized study identifier initials without full name electronic passwordprotected document containing information crfs set statistical analysis whole process executed primary investigator designated teammates well trained trial crfs relevant documents stored department critical care medicine zhongnan hospital wuhan university research confidentiality safety participants data guaranteed data reserved <NUMBER> years purpose another analysis investigation investigators primary outcome study vfd<NUMBER> changes murray lung injury scores creactive protein crp levels since epidemic covid<NUMBER> uncertain unpredictable sample size calculated twostage way set adjust statistical power determine promising trend first stage data covid<NUMBER> regarding primary outcome available icumortality <NUMBER> reported february <NUMBER> <NUMBER> chosen calculation sample size noninferiority test maximize possibility obtain significant results rate noninvasive ventilation <NUMBER> rate invasive mechanical ventilation <NUMBER> reported previous study <NUMBER> taken consideration allowable error <NUMBER> total <NUMBER> study participants <NUMBER> group would result power <NUMBER> onesided type<NUMBER> error rate α <NUMBER> allowing <NUMBER> withdrawal rate group <NUMBER> patients enrolled completed followup interim analysis conducted second stage sample size recalculated based vfd<NUMBER> interim analysis data <NUMBER> patients used processed according following methods results analysis reported dsmb measurement data described mean standard deviation sd median interquartile range iqr according distribution count data represented frequencies proportions univariate analysis difference measurement data compared ttestmannwhitney u test vitamin c placebo groups chisquare test fishers exact test applied rate comparison mixed linear model used assess effect treatment outcomes fit repeatedmeasures analysis variance kaplanmeier analysis wilcoxon test processed show effect vc patients survival probability testing two sided p value <NUMBER> considered statistically significant spss <NUMBER> graphpad prism version <NUMBER> used complete data processing statistical analysis analysis performed enrolled subjects completed followup variables tabulated study groups presented graphically order describe patients baseline characteristics ensure differences distribution eliminate confounding factors primary analysis intentiontotreat comparison general characteristicssex age race group assignment principle diagnosis etcand random effects secondary analysis comparison primary outcome secondary outcomes two groups statistical methods mentioned applied according characteristics distribution data number enrolled patients permits fewer <NUMBER> patients subgroup interest stratified analysis carried following subgroups order clarify suitable population applying hivct <NUMBER> patients without ventilation patients mechanical ventilation ventilation requirement within <NUMBER> hours admission icu <NUMBER> patients high median low median murray lung injury scores time randomization <NUMBER> patients high median low median apache ii scores time randomization <NUMBER> patients different severity ards stratified mild moderate severe groups based rif <NUMBER> patients receiving receiving renal replacement therapy days mechanical ventilation every patient ventilator parameters recorded medical record system thus data primary outcome would unlikely missing secondary outcomes might missing due record keeping errors multiple imputation methods including mean completer hot deck imputation regression used minimize effect missing data much possible data patients complete outcomes conservative imputation included comparison treatment control groups study follows principles helsinki declaration <NUMBER> whole protocol reviewed approved ethics committee zhongnan hospital wuhan university identifiers clinical ethical approval <NUMBER> note zhongnan hospital wuhan university took charge management leishenshan hospital wuhan city including affairs clinical trials ethical approval document also applicable leishenshan hospital independent data safety monitoring board dsmb comprised two academic intensivists outside study experienced conduct clinical trials critical illness monitoring progress safety trial able pause trial investigate give suggestions potential safety issues improve study previous reports revealed cytokine storm suppressed vc believed main mechanism disease deterioration covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> vc traditionally considered dietary supplement proved properties antimicrobial immunomodulatory function hivc proven safe therapeutic precedents applying era critical care medicine primarily adjunct treatment septic shock multiple organ failure shown improve outcomes reduce mortality <NUMBER> knowledge first prospective randomized controlled study highdose intravenous vc treatment covid<NUMBER> specific treatments covid<NUMBER> available present several clinical trials exploring immunotherapy stem cell therapy tocilizumab il<NUMBER> receptor antagonist <NUMBER> documenting efficacy approaches requires time adequate numbers patients careful analysis vaccine development sarscov<NUMBER> virus require even time safety efficacy testing although blood plasma treatment critical covid<NUMBER> patients recommended national health commission peoples republic china plasma recovered patients rare resource compared therapies hivc great advantages terms stability availability safety cost perspective trial highly meaningful potentially saving lives expected improve pulmonary function reduce mortality patients covid<NUMBER> furthermore also provide basis evidence applying hivc treat diseases similar mechanisms however also limitations study design uncertainties implementation noted firstly sarscov<NUMBER> novel type coronavirus never reported duration distribution infected cases unpredictable geographically temporally number recruitments clinical centers may low due unpredictability disease thus competitive enrollment multiple clinical trial centers needed ensure adequate number subjects secondly mentioned due sudden outbreak covid<NUMBER>，complete blindness feasible lack available resources placebos package vc study singleblinded unblinding dosing nurse attending physician blinding maintained patients members clinical research team statistical staff minimize bias thirdly patients may received relative nonspecific tentative explorative symptomatic treatment interferon chinese medicine etcetera effective standardized guideline treating covid<NUMBER> early stage eruption even despite national health commission issued recommendation diagnosis management covid<NUMBER> <NUMBER> continues updated therapies expected effective might also act confounding factors trial revised version protocol reviewed approved february <NUMBER>th <NUMBER> first version approved january <NUMBER> <NUMBER> patient recruitment started february <NUMBER> <NUMBER> completed september <NUMBER> <NUMBER> written informed consent obtained participants informed purpose intervention possible risksbenefits study patients public involved design conduct reporting dissemination plans research consent publication applicable crfs final dataset accessible study investigators none declared work supported science technology department hubei province grant number <NUMBER>fca<NUMBER> foundation reviewed approved project primary investigator supposed report progress trial department regularly author contributions fl yz jz yl zp designed study fl yz jz designed statistical analysis plan jz yl wrote bid research project obtained permission every ethics committee fl yz jz yl carried trial fl yz drafted manuscript zp yl jz carefully reviewed manuscript authors read approved final manuscript complete checklist entering page numbers manuscript readers find items listed article may currently address items checklist please modify text include missing information certain item apply please write na provide short explanation upload completed checklist extra file submit journal methods section say used spiritreporting guidelines cite allocation implementation <NUMBER>c generate allocation sequence enrol participants assign participants interventions <NUMBER> blinding masking <NUMBER>a blinded assignment interventions eg trial participants care providers outcome assessors data analysts reported mechanism covid<NUMBER> related cytokine storms subsequent immunogenic damage especially endothelial alveolar membrane damage vitamin c vc also known lascorbic acid shown properties antimicrobial immunomodulatory function high dose intravenous vc hivc proven block several key links cytokine storms showed safety varying degrees efficacy clinical trials conducted patients bacterial induced sepsis acute respiratory distress syndrome ards therefore hypothesize hivc could added treatment ards multiorgan dysfunction mods related covid<NUMBER> investigators designed multicenter prospective randomized placebocontrolled trial planned recruit <NUMBER> adults diagnosed covid<NUMBER> transferred intensive care unit icu participants randomly receive hivc diluted sterile water placebo <NUMBER> days enrolled patients history allergy vc endstage pulmonary disease advanced malignancy glucose<NUMBER>phosphate dehydrogenase g<NUMBER>pd deficiency excluded primary outcome ventilationfree days within <NUMBER> observational days vfd<NUMBER> one first clinical trials applying hivc covid<NUMBER> supposed provide credible data efficacy safety presume hivc could suppress cytokine storms caused covid<NUMBER> help improve pulmonary function reduce risk ards covid<NUMBER> study protocol approved ethics committee zhongnan hospital wuhan university identifiers clinical ethical approval <NUMBER> findings trial disseminated peerreviewed journals scientific conferences one first prospective randomized controlled trials applying hivc treating covid<NUMBER> hivc advantages terms stability availability safety cost compared treatments sample size calculated two stages order ensure calculation reasonable maximize possibility obtain significant results provide credible data outcomes study singleblinded since complete blinding feasible due lack manpower material resource public health emergency duration distribution infected cases unpredictable geographically temporally number recruitments centre also unpredictable though competitive enrolment adopted <NUMBER> lopinavirritonavir <NUMBER> negative results therefore urgent explore effective therapies considering grim situation mechanism covid<NUMBER> involves cytokine storm potentially fatal immune reaction triggered variety factors including infections cytokine storm associated clinical manifestation severe inflammation highly elevated levels proinflammatory cytokines <NUMBER> previous research <NUMBER> suggested cytokine storms may main mechanism highly pathogenic human coronaviruses hcovs infected pneumonia severe acute respiratory syndrome sars middle east respiratory syndrome mers member coronavirus family <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> exhibits similar clinical features clinical characteristics covid<NUMBER> indicated cytokine storms may positively correlated severity disease <NUMBER> <NUMBER> <NUMBER> moreover cytokines cell subsets may indicators predicting prognosis <NUMBER> immunopathology report <NUMBER> speculated il<NUMBER> granulocytemacrophage colonystimulating factor gmcsf main cytokines hyperinflammatory response caused covid<NUMBER> th<NUMBER> cell key cell especially patients transferred icus findings speculations verified autopsy report confirmed patients critically ill covid<NUMBER> <NUMBER> developed ards addition also found overactivation cells decrease counts may verify occurrence cytokine storms degree explain severe immune injury indicated decreasing cytokine storms immunogenetic damage may main direction treatment critically ill covid<NUMBER> vitamin c vc common necessary nutrient also known antioxidant addition role metabolism human body including energy transformation collagen biosynthesis repair production adrenal steroids catecholamines iron absorption etc <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> also possesses antimicrobial properties <NUMBER> firstly vc plays crucial role immunomodulation inhibit activation nfκb primary proinflammatory transcription factor plays pivotal role global immunity including gene regulation chemokines cytokines adhesion molecules inflammatory mediators apoptosis inhibitors <NUMBER> verified vc inhibit generation il<NUMBER> tnfα <NUMBER> <NUMBER> appeared dosedependent effect <NUMBER> vc downmodulate gmcsf signaling responses <NUMBER> functioning regulator cytokine redoxsignal transduction host defense cells possible role controlling inflammatory responses addition highdose vc regulate proliferation function cells b cells nk cells <NUMBER> may help inhibit progress cytokine storms improve hosts immunity secondly previous studies <NUMBER> demonstrated vc inhibit oxidative stress important part innate immune response viral respiratory infection <NUMBER> <NUMBER> contributes lung injury barrier dysfunction <NUMBER> may also play role mechanism covid<NUMBER> <NUMBER> reported vc repair oxidative damage human bronchial epithelial modulating reacted oxygen ros generation inflammation expressions <NUMBER> prevent rosinduced lung damage <NUMBER> thirdly vc regulate alveolar fluid clearance enhancing lung epithelial barrier function epigenetic transcriptional enhancement proteinchannels regulate alveolar fluid clearance <NUMBER> <NUMBER> may help decrease symptoms ards improve respiratory function fourthly vc may antiviral effects reported vc inhibited replication herpes simplex virus <NUMBER> poliovirus type <NUMBER> influenza virus vitro <NUMBER> previous research <NUMBER> demonstrated intravenous vc ivc achieve higher plasma concentration oral vc due intestinal absorption tissue transport renal reabsorption efficacy safety intravenous highdose vc hivc critical patients investigated via several clinical trials recent metaanalysis <NUMBER> included trials cardiac surgery revealed vc shortened icu length stay duration mechanical ventilation icu patients addition effect vc significantly greater patients severe illness <NUMBER> <NUMBER> patients sepsis ards phase trial ivc patients severe sepsis <NUMBER> reported vc significantly reduced multiorgan failure scores circulating injury biomarker levels notably effect appeared greater high dose group <NUMBER>mgkg low dose group <NUMBER>mgkg however another study conducted patients sepsis ards <NUMBER> concluded difference primary outcome organ failure scores inflammation biomarkers found significant reduction <NUMBER>day mortality longterm prognosis study applied <NUMBER>mgkg vc intravenously late stage patients undergoing mechanical ventilation addition also case report <NUMBER> applying hivc <NUMBER>mgkg treating virusinduced ards successfully rapid recovery receiving extracorporeal membrane oxygenation ecmo without longterm sequelae major concern use high dose vitamin c potential side effects many reported side effects highdose vc insignificant rare little consequence <NUMBER> reported highdose vc related hemolysis glucose<NUMBER>phosphate dehydrogenase g<NUMBER>pd deficiency acute kidney injury aki acute oxalate nephropathy <NUMBER> <NUMBER> <NUMBER> <NUMBER> however side effects mostly reported cases related large doses <NUMBER> <NUMBER> <NUMBER> <NUMBER> nonstandard administration <NUMBER> highrisk underlying diseases <NUMBER> clinical trials large sample size conducted icu patients <NUMBER> <NUMBER> reported adverse events besides survey <NUMBER> also indicated known complications kidney damage g<NUMBER>pd deficiency hivc appeared remarkably safe patients hemochromatosis g<NUMBER>pd deficiency renal dysfunction renal stone oxaluria administration vc need careful adequate hydration appropriate dilution slow rate infusion recommended hivc <NUMBER> thus wonder whether applying hivc early stage ards covid<NUMBER> would result better outcomes trial explore safety efficacy hivc used covid<NUMBER> new therapy ards could added treatment viral pneumonia tentatively main goals <NUMBER> investigate new potential therapy covid<NUMBER> clarifying effect hivc prognosis patients covid<NUMBER> especially respiratory function assessed ventilationfree days murray injury scores <NUMBER> provide evidence treatment diseases characterized cytokine storm immune dysfunction protocol written accordance standard protocol items recommendations interventional trials spirit guidelines <NUMBER> see attached research checklist summarized fig<NUMBER> fig<NUMBER> study multicenter prospective single blind randomized placebocontrolled trial interventional study two arms group vc group placebo study welldesigned according concept pragmatic trial <NUMBER> broad inclusion criteria reasonable sample size study procedures embedded clinical routine care executed clinical personnel  patients admitted <NUMBER> icus consistent following inclusion criteria exclusion criteria time randomization considered enroll enrollment must completed within <NUMBER> hours patients admitted icu participants inclusion criteria follows exclusion criteria follows <NUMBER> history allergy vc <NUMBER> dyspnea caused cardiogenic pulmonary edema <NUMBER> pregnant lactating women <NUMBER> patients expected survival duration less <NUMBER> hours <NUMBER> previous history endstage pulmonary disease endstage malignant tumor g<NUMBER>pd deficiency diabetic ketoacidosis active kidney stone disease existed severe kidney diseases <NUMBER> patients already enrolled another clinical trial mentioned trial considered safe firstly vc essential nutrient human body ivc widely used clinical practice drug <NUMBER> decades <NUMBER> secondly patients potential risks side effects excluded based exclusion criteria thirdly rate infusion slow <NUMBER>mlh however adverse events ae serious adverse events sae needed observe follow accordance good clinical practice gcp issued national medical products administration people republic china <NUMBER> ae refers untoward medical event occurred human subject receives drug sae includes prolonged hospital length stay disability death etc ae sae recorded <NUMBER> days observation enrollment occur subjects participation research need causal relationship treatment investigators evaluate relationship events intervention report ethical committee dsmb benefits potential risks written informed consent document patients informed purpose intervention benefits possible risks study icu assigned independent random numeric table generated primary investigator alone microsoft excel<NUMBER> carried investigators table equal number <NUMBER> <NUMBER> represents placebo group sterile water injection treatment group vc respectively generated list stay unchanged reserved primary investigator participate treatment patients patient transferred icu meets enrollment criteria clinician duty inform investigators get number list according chronological order icu recruitment participants enrolled corresponding group trial singleblind study covid<NUMBER> pandemic public health emergency overwhelming medical system thus enough manpower material resources modifying medical orders system connecting ward pharmacy assigning special nurse configure label infusions implement doubleblind method therefore grouping intervention unknown participants investigators responsible data collection statistical analysis known clinical staff vc injection sterile water injection colorless transparent liquids contained brown syringes different marks without explanations order make sure patients cannot distinguish investigators clinicians dsmb monitor whole process treatment determine whether continue trial potential aes occur participants interests damaged need unblinding grouping trial interventional study <NUMBER> arms intervention lasts <NUMBER> days time treatment group <NUMBER>g vc diluted sterile water total volume <NUMBER>ml infused within <NUMBER> hours infusion pump treatment repeated every <NUMBER> hrs thus total dosage vitamin c treatment group <NUMBER>g per day control group assigned placebo <NUMBER>ml sterile water method speed administration identical treatment group sterile water used dilution fluid well placebo fluid combination vc saline reported irritate vein <NUMBER> medications therapeutic schedules standard critical supportive care applied study intervention commenced within <NUMBER> hours enrollment delivery assigned vc injection placebo injection achieved medical orders system pharmacy supply clinical routine hospital vc injection common basic drug widely used hospital problems inventory logistics baseline data including demographic characteristics main diagnosis assigned group changes acute physiology chronic health evaluation apache ii scores sequential organs failure assessment sofa scores multiorgan function <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> f r p e e r r e v e w n l <NUMBER> especially respiratory function indices collected first day general vital signs chest radiographycomputed tomographic ct scans respiratory cardiac ultrasounds respiratory indices rif parameters ventilation etc infection indices white blood cells count neutrophil count lymphocyte count procalcitonin creactive protein cytokine tests il<NUMBER> il<NUMBER> etc immunologic indices lymphocyte subpopulation organ function indices cardiac function hepatic function renal function coagulation function blood gas analysis detected first third seventh day participants scheduled followup visit <NUMBER>th day track longterm prognosis sequelae data collected clinical information system hospital recorded case report format crf every participant recognized study identifier initial without full name electronic passwordprotected document containing information crfs set statistical analysis whole process executed primary investigator designated teammates well trained trial crfs relevant documents stored department critical care medicine zhongnan hospital wuhan university study confidentiality safety participants data guaranteed data reserved <NUMBER> years purpose another analysis investigation investigators primary outcome study ventilationfree days <NUMBER> days vfd<NUMBER> since admitted icu since covid<NUMBER> pandemic uncertain unpredictable sample size calculated two stages set adjust statistical power determine promising trend first stage data covid<NUMBER> regarding primary outcome available icumortality <NUMBER> reported february <NUMBER> <NUMBER> chosen instead calculation sample size noninferiority test maximize possibility significant results allowable error <NUMBER> total <NUMBER> study participants <NUMBER> group would result power <NUMBER> onesided type<NUMBER> error rate α <NUMBER> allowing <NUMBER> withdrawal rate group course calculated sample size accurate needs revise based real situation thus arranged secondstage calculation <NUMBER> patients enrolled completed followup interim analysis conducted second stage sample size recalculated interim analysis data <NUMBER> patients used processed according following methods results analysis reported dsmb measurement data described mean standard deviation sd median interquartile range iqr according distribution count data represented frequencies proportions univariate analysis difference measurement data compared ttestmannwhitney u test vitamin c placebo groups chisquare test fishers exact test applied rate comparison mixed linear model used assess effect treatment outcomes fit repeatedmeasures analysis variance kaplanmeier analysis wilcoxon test processed show effect vc patients survival probability testing two sided p value <NUMBER> considered statistically significant spss <NUMBER> graphpad prism version <NUMBER> used complete data processing statistical analysis order describe patients baseline characteristics ensure differences distribution eliminate confounding factors primary analysis intentiontotreat comparison general characteristics sex age race group assignment principle diagnosis etc random effects secondary analysis comparison primary outcome secondary outcomes treatment group control group statistical methods mentioned applied according characteristics distribution data number enrolled patients permits fewer <NUMBER> patients subgroup interest stratified analysis carried following subgroups order clarify suitable population applying hivc <NUMBER> patients without ventilation patients mechanical ventilation ventilation requirement within <NUMBER> hours admission icu <NUMBER> patients high median low median murray lung injury scores time randomization <NUMBER> patients high median low median apache ii scores days mechanical ventilation every patient ventilator parameters recorded medical record system thus data primary outcome would unlikely missing secondary outcomes might missing due record keeping errors multiple imputation methods including mean completer hot deck imputation regression used minimize effect missing data much possible data patients complete outcomes conservative imputation included comparison treatment control groups study follows principles helsinki declaration <NUMBER> whole protocol reviewed approved ethics committee zhongnan hospital wuhan university identifiers clinical ethical approval <NUMBER> zhongnan hospital wuhan university also took charge management leishenshan hospital wuhan city including affairs clinical trials ethical approval document also applicable leishenshan hospital independent data safety monitoring board dsmb comprised two academic intensivists outside study experienced conducting clinical trials critical illness monitoring progress safety trial dsmb able pause trial investigate give suggestions potential safety issues improve study design implementation previous reports revealed cytokine storm suppressed vc believed main mechanism disease deterioration covid<NUMBER> <NUMBER> <NUMBER> vc traditionally considered dietary supplement properties antimicrobial immunomodulatory function hivc proven safe therapeutic critical care medicine primarily adjunct treatment septic shock multiple organ failure shown improve outcomes reduce mortality <NUMBER> <NUMBER> knowledge one first prospective randomized controlled studies highdose intravenous vc treatment covid<NUMBER> specific treatments covid<NUMBER> available present several clinical trials exploring immunotherapy <NUMBER> documenting efficacy approaches requires time adequate numbers patients careful analysis vaccine development require even time safety efficacy testing although blood plasma treatment critical covid <NUMBER> patients recommended national health commission peoples republic china plasma recovered patients rare resource compared therapies hivc great advantages terms stability availability safety cost therefore trial highly meaningful potentially saving lives lower price expected improve pulmonary function reduce mortality patients covid<NUMBER> furthermore also provide basis evidence applying hivc treat diseases similar mechanisms however also limitations study design uncertainties implementation firstly sarscov<NUMBER> novel coronavirus duration distribution infected cases unpredictable geographically temporally number recruitments clinical centers may low thus competitive enrollment multiple clinical trial centers needed ensure adequate number subjects secondly complete blindness feasible lack available resources placebos package vc unblinding dosing nurse attending physician blinding maintained patients members clinical research team statistical staff minimize bias thirdly patients may received nonspecific tentative explorative symptomatic treatment interferon traditional chinese medicine effective standardized guideline treating covid<NUMBER> early stage despite national health commission recommendation diagnosis management covid<NUMBER> <NUMBER> continues updated therapies expected effective may act confounding factors trial must taken account conducting data analysis revised version protocol reviewed approved <NUMBER> february <NUMBER> first version approved <NUMBER> january <NUMBER> patient recruitment started february <NUMBER> <NUMBER> completed <NUMBER> september <NUMBER> written informed consent obtained participants informed purpose intervention possible risksbenefits study patients public involved design conduct reporting dissemination plans research findings trial disseminated peerreviewed journals scientific conferences consent publication obtained patients patients family members crfs final dataset accessible contact study investigators none declared work supported science technology department hubei province grant number <NUMBER>fca<NUMBER> foundation reviewed approved project primary investigator supposed report progress trial department regularly author contributions fl yz jz yl zp designed study fl yz jz designed statistical analysis plan jz yl wrote bid research project obtained permission every ethics committee fl yz jz yl carried trial fl yz drafted manuscript zp yl jz carefully reviewed manuscript authors read approved final manuscript trial conducted <NUMBER> hospitals zhongnan hospital wuhan university leishenshan hospital wuhan city authors thank patients family members nurses pharmacy staff fellows clinicians icus complete checklist entering page numbers manuscript readers find items listed article may currently address items checklist please modify text include missing information certain item apply please write na provide short explanation upload completed checklist extra file submit journal methods section say used spiritreporting guidelines cite implementation <NUMBER>c generate allocation sequence enrol participants assign participants interventions <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> confidentiality <NUMBER> personal information potential enrolled participants collected shared maintained order protect confidentiality trial <NUMBER> declaration <NUMBER> financial competing interests principal <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> one first prospective randomized controlled trials applying hivc treat covid<NUMBER> highdose vitamin c therapy lacks universal definition previous metaanalysis considered high doses equal greater <NUMBER> gd trial administer <NUMBER> g vitamin c per day <NUMBER> days intravenously hivc advantages terms stability availability safety cost compared treatments sample size calculated two stages ensure calculation reasonable maximizes possibility obtaining significant results provides credible outcome data duration distribution infected cases unpredictable geographically temporally number recruited patients centre also unpredictable spite competitive enrolment <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> f r p e e r r e v e w n l introduction background rationale covid<NUMBER> pandemic threat caused panic global level <NUMBER> june <NUMBER> <NUMBER> cases confirmed worldwide resulting <NUMBER> deaths <NUMBER> infected patients presented predominantly fever cough well dyspnea myalgia <NUMBER> <NUMBER> <NUMBER> metaanalysis <NUMBER> concluded among patients <NUMBER> presented acute respiratory distress syndrome ards <NUMBER> transferred intensive care unit icu <NUMBER> died according previous research <NUMBER> patients ards accounted <NUMBER> covid<NUMBER> patients icu rates noninvasive invasive mechanical ventilation <NUMBER> <NUMBER> respectively however specific treatment currently available traditional antiviral drugs work well covid<NUMBER> recent clinical trials exploring new therapies including remdesivir <NUMBER> hydroxychloroquine <NUMBER> lopinavirritonavir <NUMBER> covid<NUMBER> negative results therefore urgent explore effective therapies considering grim situation mechanism covid<NUMBER> involves cytokine storm potentially fatal immune reaction triggered variety factors including infections cytokine storms associated clinical manifestation severe inflammation highly elevated levels proinflammatory cytokines <NUMBER> previous research <NUMBER> suggested cytokine storms may main mechanism highly pathogenic human coronavirus hcovinfected pneumonia severe acute respiratory syndrome sars middle east respiratory syndrome mers member coronavirus family <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> exhibits similar clinical features clinical characteristics covid<NUMBER> indicate cytokine storms may positively correlated severity disease <NUMBER> <NUMBER> <NUMBER> moreover cytokines cell subsets may indicators predicting prognosis <NUMBER> immunopathology report <NUMBER> speculated il<NUMBER> granulocytemacrophage colonystimulating factor gmcsf main cytokines hyperinflammatory response caused covid<NUMBER> th<NUMBER> cells key cells involved especially patients transferred icus findings speculations verified autopsy study confirmed patients critically ill covid<NUMBER> <NUMBER> developed ards addition also found overactivation cells decrease cell counts may explain occurrence cytokine storms degree severe immunemedicated injury results indicated decreasing cytokine storms immunogenetic damage may main treatment option critically ill patients covid<NUMBER> vitamin c vc common necessary nutrient also antioxidant addition role metabolism human body including energy transformation collagen biosynthesis repair adrenal steroid catecholamine production iron absorption etc <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> vc also possesses antimicrobial propertiesthus reducing <NUMBER> first vc plays crucial role immunomodulation inhibit activation nfκb primary proinflammatory transcription factor plays pivotal role overall immunity including genetic regulation chemokines cytokines adhesion molecules inflammatory mediators apoptosis inhibitors <NUMBER> vc inhibit production il<NUMBER> tnfα <NUMBER> <NUMBER> effect appears dose dependent <NUMBER> vc reduce gmcsf signaling responses <NUMBER> functioning regulator cytokine redoxsignal transduction host defense cells possible role controlling inflammatory responses addition highdose vc regulate proliferation function cells b cells nk cells <NUMBER> may help inhibit progression cytokine storms improve hosts immunity second previous studies <NUMBER> demonstrated vc inhibit oxidative stress important part innate immune response viral respiratory infection <NUMBER> <NUMBER> contributes lung injury barrier dysfunction <NUMBER> vc may also play role mechanism covid<NUMBER> <NUMBER> reported vc repair oxidative damage human bronchial epithelium modulating reactive oxygen species ros generation inflammatory expression <NUMBER> prevent rosinduced lung damage <NUMBER> third vc regulate alveolar fluid clearance enhancing lung epithelial barrier function epigenetic transcriptional enhancement protein channels regulate alveolar fluid clearance <NUMBER> <NUMBER> vc may help decrease symptoms ards improve respiratory function fourth vc may antiviral effects vc reported inhibit replication herpes simplex virus <NUMBER> poliovirus type <NUMBER> influenza virus vitro <NUMBER> previous research <NUMBER> demonstrated intravenous vc ivc achieve higher plasma concentration oral vc due losses intestinal absorption tissue transport renal reabsorption efficacy safety intravenous highdose vc hivc critically ill patients investigated via several clinical trials recent metaanalysis <NUMBER> mostly cardiac surgery trials revealed vc shortened icu length stay duration mechanical ventilation icu patients addition effect vc significantly greater patients severe illness <NUMBER> <NUMBER> regarding patients sepsis ards phase trial ivc patients severe sepsis <NUMBER> reported vc significantly reduced multiorgan failure scores circulating injury biomarker levels notably effect appeared greater highdose group <NUMBER>mgkg lowdose group <NUMBER> mgkg however another study conducted patients sepsis ards <NUMBER> reported difference primary outcome organ failure scores inflammation biomarkers found significant reduction <NUMBER>day mortality longterm prognosis study applied <NUMBER> mgkg vc intravenously late stage patients undergoing mechanical ventilation addition also case report <NUMBER> administered hivc <NUMBER>mgkg successfully treat virusinduced ards patients making rapid recovery receiving extracorporeal membrane oxygenation ecmo without longterm sequelae major concern regarding use highdose vitamin c potential side effects many reported side effects highdose vc insignificant rare little consequence <NUMBER> reported highdose vc related hemolysis glucose<NUMBER>phosphate dehydrogenase g<NUMBER>pd deficiency acute kidney injury aki acute oxalate nephropathy <NUMBER> <NUMBER> <NUMBER> <NUMBER> however adverse effects mostly reported cases related large doses <NUMBER> <NUMBER> <NUMBER> <NUMBER> nonstandard administration <NUMBER> highrisk underlying diseases <NUMBER> clinical trials large sample sizes conducted icu patients <NUMBER> <NUMBER> reported adverse events addition survey <NUMBER> also indicated known complications kidney damage g<NUMBER>pd deficiency hivc appeared remarkably safe patients hemochromatosis g<NUMBER>pd deficiency renal dysfunction renal stones oxaluria vc carefully administered adequate hydration appropriate dilution slow infusion rates recommended hivc <NUMBER> thus hypothesize administering hivc early stage ards covid<NUMBER> would result better outcomes trial tentatively explore safety efficacy hivc used covid<NUMBER> main goal investigate new potential therapy covid<NUMBER> clarifying effect hivc prognosis patients covid<NUMBER> especially respiratory function assessed ventilationfree days protocol written accordance standard protocol items recommendations interventional trials spirit guidelines <NUMBER> see attached research checklist protocol summarized fig<NUMBER> fig<NUMBER> study multicenter prospective randomized placebocontrolled trial interventional study two arms vc group placebo group study welldesigned according concept pragmatic trial <NUMBER> broad inclusion criteria reasonable sample size study procedures embedded clinical routine care executed clinical personnel table equal numbers <NUMBER> <NUMBER> represent placebo group sterile water injection treatment group vc respectively generated list remain unchanged kept primary investigator participate treatment patients patient transferred icu meets enrollment criteria clinician duty inform investigators obtain number list according chronological order icu recruitment participants enrolled corresponding group trial completely blinded covid<NUMBER> pandemic public health emergency overwhelms medical system thus enough manpower material resources implement doubleblind method requires modifying medical orders system connecting ward pharmacy assigning special nurse configure label infusions therefore grouping intervention unknown participants investigators responsible data collection statistical analysis known clinical staff investigators responsible recruiting participants vc injection sterile water injection colorless transparent liquids contained brown syringes different marks without explanations syringe make sure patients cannot distinguish treatment receive investigators clinicians dsmb monitor whole process treatment determine whether continue trial potential aes occur participants best interests stop treatment need unblinding study grouping trial interventional study <NUMBER> arms intervention lasted <NUMBER> days treatment group <NUMBER> g vc diluted sterile water total volume <NUMBER> ml infused within <NUMBER> hours infusion pump treatment repeated every <NUMBER> hours thus total dosage vitamin c treatment group <NUMBER> g per day control group assigned placebo <NUMBER> ml sterile water method speed administration identical treatment group sterile water used dilution fluid well placebo fluid combination vc saline reported irritate vein <NUMBER> medications therapeutic schedules standard critical supportive care applied study intervention commenced within <NUMBER> hours enrollment delivery assigned vc injection placebo injection achieved medical orders system pharmacy supply clinical routine hospitals vc injection common basic drug widely used hospital problems inventory logistics baseline data including demographic characteristics main diagnosis assigned group changes acute physiology chronic health evaluation apache ii scores sequential organs failure assessment sofa scores multiorgan function especially respiratory function indices collected first day general vital signs chest radiography computed tomography ct scans respiratory cardiac ultrasounds respiratory indices rif parameters ventilation etc infection indices white blood cell count neutrophil count lymphocyte count procalcitonin creactive protein cytokine tests il<NUMBER> il<NUMBER> etc immunologic indices lymphocyte subpopulation organ function indices cardiac function hepatic function renal function coagulation function blood gas analyses collected first third seventh days participants scheduled followup visit <NUMBER>th day track longterm prognosis sequelae data collected clinical information system hospital recorded case report format crf every participant distinguished study identifier initial without full name electronic passwordprotected document containing information crfs set statistical analysis analysis process performed primary investigator designated teammates experienced trial crfs relevant documents stored department critical care medicine zhongnan hospital wuhan university study confidentiality safety participants data guaranteed data reserved <NUMBER> years purpose analysis investigation primary outcome study ventilatorfree days <NUMBER> days vfd<NUMBER> since admission icu secondary outcomes include following <NUMBER> icu mortality <NUMBER>day mortality <NUMBER> changes sofa scores <NUMBER> changes plasma biomarkers inflammation including white blood cell counts neutrophil countspercentage lymphocyte countspercentage procalcitonin pct creactive protein crp cytokines il<NUMBER> il<NUMBER> etc <NUMBER> changes pulmonary infection estimated chest radiographyct imaging lung ultrasound changes pulmonary function measured murray lung injury scores <NUMBER> rate organ failure including ards diagnosed berlin definition <NUMBER> acute kidney injury aki diagnosed kidney disease improving global outcomes kdigo criteria <NUMBER> coagulation disorders immune dysfunction characterized changes lymphocytes etc <NUMBER> clinical outcomes including ventilation days vasopressor days icu length stay hospital length stay day <NUMBER> since covid<NUMBER> pandemic uncertain unpredictable sample size calculated two stages set adjust statistical power determine whether promising trend first stage data covid<NUMBER> regarding <NUMBER> chosen instead calculation sample size noninferiority test maximize possibility significant results allowable error <NUMBER> total <NUMBER> study participants <NUMBER> group would result power <NUMBER> onesided type<NUMBER> error rate α <NUMBER> allowing <NUMBER> withdrawal rate group course calculated sample size accurate needs revision based real situation thus arranged secondstage calculation <NUMBER> patients enrolled completed followup interim analysis conducted second stage required sample size recalculated interim analysis data <NUMBER> patients used processed according following methods results analysis reported dsmb measurement data described mean standard deviation sd median interquartile range iqr according distribution count data represented frequencies proportions univariate analysis difference measurement data compared vitamin c placebo groups using ttestmannwhitney u test chisquare test fishers exact test used rate comparisons mixed linear model used assess effect treatment outcomes fit repeatedmeasures analysis variance kaplanmeier analysis wilcoxon test used show effect vc patient survival probability testing two sided p value <NUMBER> considered statistically significant spss <NUMBER> graphpad prism <NUMBER> used complete data processing statistical analysis describe patients baseline characteristics ensure differences distribution eliminate confounding factors primary analysis intentiontotreat comparison general characteristicssex age race group assignment principle diagnosis etc random effects secondary analysis comparison primary outcome secondary outcomes treatment group control group statistical methods mentioned applied according characteristics distribution data number enrolled patients permits fewer <NUMBER> patients subgroup interest stratified analyses carried following subgroups clarify suitable population administering hivc <NUMBER> patients without ventilation patients mechanical ventilation ventilation requirement within <NUMBER> hours admission icu <NUMBER> patients high median low median murray lung injury scores every patient days mechanical ventilation ventilator parameters recorded medical record system thus data primary outcome unlikely missing secondary outcome data might missing due recordkeeping errors multiple imputation methods including mean completer hotdeck imputation regression used minimize effect missing data much possible data patients complete outcomes conservative imputation included comparison treatment control groups study follows principles helsinki declaration <NUMBER> entire protocol reviewed approved ethics committee zhongnan hospital wuhan university identifier clinical ethical approval <NUMBER> zhongnan hospital wuhan university also took charge management leishenshan hospital wuhan city including affairs clinical trials ethical approval document also applicable leishenshan hospital independent data safety monitoring board dsmb comprised two academic intensivists outside study experienced conducting clinical trials critical illness monitoring progress safety trial dsmb able pause trial investigate give suggestions potential safety issues improve study design implementation previous reports revealed cytokine storms suppressed vc believed main mechanism deterioration patients covid<NUMBER> <NUMBER> <NUMBER> vc traditionally considered dietary supplement antimicrobial immunomodulatory properties hivc proven safe therapeutic critical care medicine primarily adjunct treatment septic shock multiple organ failure shown improve outcomes reduce mortality <NUMBER> <NUMBER> highdose vc therapy lacks universal definition previous metaanalysis <NUMBER> considered high doses equal greater <NUMBER> gd <NUMBER> g vc trial higher dosage vc previous clinical trials conducted critically ill patients severe infection <NUMBER> <NUMBER> knowledge one first prospective randomized controlled studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> f r p e e r r e v e w n l highdose intravenous vc treatment covid<NUMBER> specific treatments covid<NUMBER> available present several clinical trials exploring immunotherapy <NUMBER> documenting efficacy approaches requires time adequate patient numbers careful analysis vaccine development require even time safety efficacy testing although blood plasma treatment critical covid<NUMBER> patients recommended national health commission peoples republic china plasma recovered patients rare resource compared therapies hivc great advantages terms stability availability safety cost therefore trial highly meaningful could potentially save lives low price hivc expected improve pulmonary function reduce mortality patients covid<NUMBER> furthermore may also provide basis reference hivc treatment diseases similar mechanisms however also limitations study design uncertainties implementation first sarscov<NUMBER> novel coronavirus duration distribution infected cases unpredictable geographically temporally number recruited patients clinical centers may low thus competitive enrollment multiple clinical trial centers needed ensure adequate number subjects second complete blinding feasible due lack available resources placebos package vc study unblinded dosing nurses attending physicians investigators charge enrolling participants blinding maintained patients members clinical research team statistical staff minimize bias third patients may received nonspecific tentative explorative symptomatic treatment interferon traditional chinese medicine effective standardized guideline treating covid<NUMBER> early stage despite national health commission recommendations diagnosis management covid<NUMBER> <NUMBER> continues updated therapies expected effective may act confounding factors trial must taken account data analysis patient recruitment started <NUMBER> february <NUMBER> completed <NUMBER> september <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> trial registered clinicaltrialsgov identifier nct<NUMBER> <NUMBER> february <NUMBER> note manuscript revised version protocol reviewed approved <NUMBER> february <NUMBER> first version approved <NUMBER> january <NUMBER> compared first version registered clinicaltrialsgov sample size secondary outcomes version revised insufficient information covid<NUMBER> early stage learned covid<NUMBER> time protocol reviewed approved ethics committee zhongnan hospital wuhan university identifiers clinical ethical approval <NUMBER> written informed consent obtained participants informed purpose intervention possible risksbenefits study patients public involved design conduct reporting dissemination plans research findings trial disseminated peerreviewed journals scientific conferences consent publication obtained patients patients family members crfs final dataset accessible contact study investigators none declared work supported science technology department hubei province grant number <NUMBER>fca<NUMBER> foundation reviewed approved project primary investigator supposed report progress trial department regularly author contributions fl yz jz yl zp designed study fl yz jz designed statistical <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> f r p e e r r e v e w n l <NUMBER> analysis plan jz yl wrote bid research project obtained permission ethics committees fl yz jz yl carried trial fl yz drafted manuscript zp yl jz carefully reviewed manuscript authors read approved final manuscript <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> complete checklist entering page numbers manuscript readers find items listed article may currently address items checklist please modify text include missing information certain item apply please write na provide short explanation upload completed checklist extra file submit journal methods section say used spiritreporting guidelines cite <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> implementation <NUMBER>c generate allocation sequence enrol participants assign participants interventions <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> pandemic threat caused panic global level <NUMBER> june <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases confirmed worldwide resulting <NUMBER> <NUMBER> deaths <NUMBER> infected patients presented predominantly fever cough well dyspnoea myalgia <NUMBER> <NUMBER> <NUMBER> metaanalysis <NUMBER> concluded among patients <NUMBER> presented acute respiratory distress syndrome ards <NUMBER> transferred intensive care unit icu <NUMBER> died according previous research <NUMBER> patients ards accounted <NUMBER> patients covid<NUMBER> icu rates noninvasive invasive mechanical ventilation <NUMBER> <NUMBER> respectively however specific treatment currently available traditional antiviral drugs work well covid<NUMBER> recent clinical trials exploring new therapies including remdesivir <NUMBER> hydroxychloroquine <NUMBER> lopinavirritonavir <NUMBER> covid<NUMBER> negative results therefore urgent explore effective therapies considering grim situation mechanism covid<NUMBER> involves cytokine storm potentially fatal immune reaction triggered variety factors including infections cytokine storms strengths limitations study ► one first prospective randomised controlled trials applying high dose intravenous vitamin c hivc treat covid<NUMBER> ► highdose vitamin c therapy lacks universal definition previous metaanalysis considered high doses equal greater <NUMBER> gday trial administer <NUMBER> g vitamin c per day <NUMBER> days intravenously ► hivc advantages terms stability availability safety cost compared treatments ► sample size calculated two stages ensure calculation reasonable maximises possibility obtaining significant results provides credible outcome data ► duration distribution infected cases unpredictable geographically temporally number recruited patients centre also unpredictable spite competitive enrolment open access associated clinical manifestation severe inflammation highly elevated levels proinflammatory cytokines <NUMBER> previous research <NUMBER> suggested cytokine storms may main mechanism highly pathogenic human coronavirus infected pneumonia severe acute respiratory syndrome middle east respiratory syndrome member coronavirus family <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> exhibits similar clinical features clinical characteristics covid<NUMBER> indicate cytokine storms may positively correlated severity disease <NUMBER> <NUMBER> <NUMBER> moreover cytokines cell subsets may indicators predicting prognosis <NUMBER> immunopathology report <NUMBER> speculated interleukin il<NUMBER> granulocytemacrophage colonystimulating factor gmcsf main cytokines hyperinflammatory response caused covid<NUMBER> th<NUMBER> cells key cells involved especially patients transferred icus findings speculations verified autopsy study confirmed patients critically ill covid<NUMBER> <NUMBER> developed ards addition also found overactivation cells decrease cell counts may explain occurrence cytokine storms degree severe immunemedicated injury results indicated decreasing cytokine storms immunogenetic damage may main treatment option critically ill patients covid<NUMBER> vitamin c vc common necessary nutrient also antioxidant addition role metabolism human body including energy transformation collagen biosynthesis repair adrenal steroid catecholamine production iron absorption <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> vc also possesses antimicrobial propertiesthus reducing risk infectionsand immunomodulatory functions particularly high concentrations <NUMBER> first vc plays crucial role immunomodulation inhibit activation nuclear factor kappab nfκb primary proinflammatory transcription factor plays pivotal role overall immunity including genetic regulation chemokines cytokines adhesion molecules inflammatory mediators apoptosis inhibitors <NUMBER> vc inhibit production il<NUMBER> tumor necrosis factor alpha tnfα <NUMBER> <NUMBER> effect appears dose dependent <NUMBER> vc reduce gmcsf signalling responses <NUMBER> functioning regulator cytokine redoxsignal transduction host defence cells possible role controlling inflammatory responses addition highdose vc regulate proliferation function cells b cells natural killer nk cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> may help inhibit progression cytokine storms improve hosts immunity second previous studies <NUMBER> demonstrated vc inhibit oxidative stress important part innate immune response viral respiratory infection <NUMBER> <NUMBER> contributes lung injury barrier dysfunction <NUMBER> oxidative stress may also play role mechanism covid<NUMBER> <NUMBER> reported vc repair oxidative damage human bronchial epithelium modulating reactive oxygen species ros generation inflammatory expression <NUMBER> prevent rosinduced lung damage <NUMBER> third vc regulate alveolar fluid clearance enhancing lung epithelial barrier function epigenetic transcriptional enhancement protein channels regulate alveolar fluid clearance <NUMBER> <NUMBER> vc may help decrease symptoms ards improve respiratory function fourth vc may antiviral effects vc reported inhibit replication herpes simplex virus <NUMBER> poliovirus type <NUMBER> influenza virus vitro <NUMBER> previous research <NUMBER> demonstrated intravenous vc ivc achieve higher plasma concentration oral vc due losses intestinal absorption tissue transport renal reabsorption efficacy safety intravenous highdose vc hivc critically ill patients investigated via several clinical trials recent metaanalysis <NUMBER> mostly cardiac surgery trials revealed vc shortened icu length stay duration mechanical ventilation icu patients addition effect vc significantly greater patients severe illness <NUMBER> <NUMBER> regarding patients sepsis ards phase trial ivc patients severe sepsis <NUMBER> reported vc significantly reduced multiorgan failure scores circulating injury biomarker levels notably effect appeared greater highdose group <NUMBER> mgkg lowdose group <NUMBER> mgkg however another study conducted patients sepsis ards <NUMBER> reported difference primary outcome organ failure scores inflammation biomarkers found significant reduction <NUMBER>day mortality longterm prognosis study applied <NUMBER> mgkg vc intravenously late stage patients undergoing mechanical ventilation addition also case report <NUMBER> administered hivc <NUMBER> mgkg successfully treat virusinduced ards patients making rapid recovery receiving extracorporeal membrane oxygenation without longterm sequelae major concern regarding use highdose vc potential side effects many reported side effects highdose vc insignificant rare little consequence <NUMBER> reported highdose vc related haemolysis glucose<NUMBER>phosphate dehydrogenase g<NUMBER>pd deficiency acute kidney injury aki acute oxalate nephropathy <NUMBER> <NUMBER> <NUMBER> <NUMBER> however adverse effects mostly reported cases related large doses <NUMBER> nonstandard administration <NUMBER> highrisk underlying diseases <NUMBER> clinical trials large sample sizes conducted icu patients <NUMBER> <NUMBER> reported adverse events aes addition survey <NUMBER> also indicated known complications kidney damage g<NUMBER>pd deficiency hivc appeared remarkably safe patients haemochromatosis g<NUMBER>pd deficiency renal dysfunction renal stones oxaluria vc carefully administered adequate hydration appropriate dilution slow infusion rates recommended hivc <NUMBER> open access thus hypothesise administering hivc early stage ards covid<NUMBER> would result better outcomes trial tentatively explore safety efficacy hivc used covid<NUMBER> main goal investigate new potential therapy covid<NUMBER> clarifying effect hivc prognosis patients covid<NUMBER> especially respiratory function assessed ventilationfree days protocol written accordance standard protocol items recommendations interventional trials guidelines <NUMBER> see attached research checklist protocol summarised figures <NUMBER> <NUMBER> study multicentre prospective randomised placebocontrolled trial interventional study two arms vc group placebo group study well designed according concept pragmatic trial <NUMBER> broad inclusion criteria reasonable sample size study procedures embedded clinical routine care executed clinical personnel trial conducted icu zhongnan hospital wuhan university icu leishenshan hospital wuhan city <NUMBER> february <NUMBER> <NUMBER> september <NUMBER> zhongnan hospital wuhan university comprehensive <NUMBER>bed icu tertiary hospital integrating clinical care scientific research teaching covid<NUMBER> pandemic took charge leishenshan hospital wuhan city second specialised hospital built wuhan government within half month accommodate treat patients covid<NUMBER> icu enrol patients competitively <NUMBER> months patients admitted <NUMBER> icus consistent following inclusion criteria exclusion criteria time randomisation considered enrolment enrolment must completed within <NUMBER> hours patients admitted icu participants inclusion criteria follows open access <NUMBER> patients expected survival duration less <NUMBER> hours <NUMBER> patients previous history endstage pulmonary disease endstage malignant tumour g<NUMBER>pd deficiency diabetic ketoacidosis active kidney stone disease severe kidney diseases <NUMBER> patients already enrolled another clinical trial mentioned trial considered safe first vc essential nutrient human body ivc widely used clinical practice five decades <NUMBER> second patients greater potential risks side effects excluded based exclusion criteria third rate infusion slow <NUMBER> mlhour however aes serious adverse events saes must observed followed accordance good clinical practice guidelines issued national medical products administration peoples republic china <NUMBER> ae refers untoward medical event occurs human subject receives drug saes include prolonged hospital length stay disability death aes saes recorded <NUMBER> days observation enrolment either may occur subjects participation research need causal relationship treatment investigators evaluate relationship events intervention report ethical committee data safety monitoring board dsmb benefits potential risks written informed consent document patients informed purpose intervention benefits possible risks study icu assigned independent random numeric table generated primary investigator alone microsoft excel <NUMBER> carried investigators table equal numbers <NUMBER> <NUMBER> represent placebo group sterile water injection treatment group vc respectively generated list remain unchanged kept primary investigator participate treatment patients patient transferred icu meets enrolment criteria clinician duty inform investigators obtain number list according chronological order icu recruitment participants enrolled corresponding group trial completely blinded covid<NUMBER> pandemic public health emergency overwhelms medical system thus enough manpower material resources implement doubleblind method requires modifying medical orders system connecting ward pharmacy assigning special nurse configure label infusions therefore grouping intervention unknown participants investigators responsible data collection statistical analysis known clinical staff investigators responsible recruiting participants vc injection sterile water injection colourless transparent liquids contained brown syringes different marks without explanations syringe make sure patients cannot distinguish treatment receive investigators clinicians dsmb monitor whole process treatment determine whether continue trial potential aes occur participants best interests stop treatment need unblinding study grouping trial interventional study two arms intervention lasted <NUMBER> days treatment group <NUMBER> g vc diluted sterile water total volume <NUMBER> ml infused within <NUMBER> hours infusion pump treatment repeated every <NUMBER> hours thus total dosage vc treatment group <NUMBER> g per day control group assigned placebo <NUMBER> ml sterile water method speed administration identical treatment group sterile water used dilution fluid well placebo fluid combination vc saline reported irritate vein <NUMBER> medications therapeutic schedules standard critical supportive care applied study intervention commenced within <NUMBER> hours enrolment delivery assigned vc injection placebo injection achieved medical orders system pharmacy supply clinical routine hospitals vc injection common basic drug widely used hospital problems inventory logistics baseline data including demographic characteristics main diagnosis assigned group changes acute physiology chronic health evaluation apache ii scores sequential organs failure assessment sofa scores multiorgan function especially respiratory function indices collected first day general vital signs chest radiography ct scans respiratory cardiac ultrasounds respiratory indices rif parameters ventilation infection indices white cell count neutrophil count lymphocyte count procalcitonin pct c reactive protein crp cytokine tests il<NUMBER> il<NUMBER> immunological indices lymphocyte subpopulation organ function indices cardiac function hepatic function renal function coagulation function blood gas analyses collected first third seventh days participants scheduled followup visit <NUMBER>th day track longterm prognosis sequelae data collected clinical information system hospital recorded case report format crf every participant distinguished study identifier initial without full name electronic passwordprotected document containing information crfs set statistical analysis analysis process performed primary investigator designated teammates experienced trial crfs relevant documents stored department critical care medicine zhongnan hospital wuhan university study confidentiality safety participants data guaranteed data reserved <NUMBER> years purpose analysis investigation primary outcome study ventilatorfree days <NUMBER> days since admission icu secondary outcomes include following since covid<NUMBER> pandemic uncertain unpredictable sample size calculated two stages set adjust statistical power determine whether promising trend first stage data covid<NUMBER> regarding primary outcome available icu mortality <NUMBER> reported <NUMBER> february <NUMBER> chosen instead calculation sample size noninferiority test maximise possibility significant results allowable error <NUMBER> total <NUMBER> study participants <NUMBER> group would result power <NUMBER> onesided type <NUMBER> error rate α <NUMBER> allowing <NUMBER> withdrawal rate group course calculated sample size accurate needs revision based real situation thus arranged secondstage calculation <NUMBER> patients enrolled completed followup interim analysis conducted second stage required sample size recalculated interim analysis data <NUMBER> patients used processed according following methods results analysis reported dsmb measurement data described mean sd median iqr according distribution count data represented frequencies proportions univariate analysis difference measurement data compared vc placebo groups using ttestmannwhitney u test χ <NUMBER> test fishers exact test used rate comparisons mixed linear model used assess effect treatment outcomes fit repeatedmeasures analysis variance kaplanmeier analysis wilcoxon test used show effect vc patient survival probability testing two sided p value <NUMBER> considered statistically significant spss v<NUMBER> graphpad prism v<NUMBER> used complete data processing statistical analysis describe patients baseline characteristics ensure differences distribution eliminate confounding factors primary analysis intentiontotreat comparison general characteristics sex age race group assignment principle diagnosis random effects secondary analysis comparison primary outcome secondary outcomes treatment group control group statistical methods mentioned applied according characteristics distribution data number enrolled patients permits fewer five patients subgroup interest stratified analyses carried following subgroups clarify suitable population administering hivc <NUMBER> patients without ventilation patients mechanical ventilation ventilation requirement within <NUMBER> hours admission icu <NUMBER> patients high median low median murray lung injury scores time randomisation <NUMBER> patients high median low median apache ii scores time randomisation <NUMBER> patients different severities ards stratified mild moderate severe groups based rif <NUMBER> patients receiving receiving renal replacement therapy handling missing data every patient days mechanical ventilation ventilator parameters recorded medical record system thus data primary outcome unlikely missing secondary outcome data might missing due recordkeeping errors multiple imputation methods including mean completer hotdeck imputation regression used minimise effect missing data much possible data patients complete outcomes conservative imputation included comparison treatment control groups independent dsmb comprised two academic intensivists outside study experienced conducting clinical trials critical illness monitoring progress safety trial dsmb able pause trial investigate give suggestions potential safety issues improve study design implementation previous reports revealed cytokine storms suppressed vc believed main mechanism deterioration patients covid<NUMBER> <NUMBER> <NUMBER> vc traditionally considered dietary supplement antimicrobial immunomodulatory properties hivc proven safe therapeutic critical care medicine primarily adjunct treatment septic shock multiple organ failure shown improve outcomes reduce mortality <NUMBER> <NUMBER> highdose vc therapy lacks universal definition previous metaanalysis <NUMBER> considered high doses equal greater <NUMBER> gday twentyfour grams vc trial higher dosage vc previous clinical trials conducted critically ill patients severe infection <NUMBER> <NUMBER> knowledge one first prospective randomised controlled studies highdose intravenous vc treatment covid<NUMBER> specific treatments covid<NUMBER> available present several clinical trials exploring immunotherapy <NUMBER> documenting efficacy approaches requires time adequate patient numbers careful analysis vaccine development require even time safety efficacy testing although blood plasma treatment critical patients covid<NUMBER> recommended national health commission peoples republic china plasma recovered patients rare resource compared therapies hivc great advantages terms stability availability safety cost therefore trial highly meaningful could potentially save lives low price hivc expected improve pulmonary function reduce mortality patients covid<NUMBER> furthermore may also provide basis reference hivc treatment diseases similar mechanisms however also limitations study design uncertainties implementation first sarscov<NUMBER> novel coronavirus duration distribution infected cases unpredictable geographically temporally number recruited patients clinical centres may low thus competitive enrolment multiple clinical trial centres needed ensure adequate number subjects second complete blinding feasible due lack available resources placebos package vc study unblinded dosing nurses attending physicians investigators charge enrolling participants blinding maintained patients members clinical research team statistical staff minimise bias third patients may received nonspecific tentative explorative symptomatic treatment interferon traditional chinese medicine effective standardised guideline treating covid<NUMBER> early stage despite national health commission recommendations diagnosis management covid<NUMBER> <NUMBER> continues updated therapies expected effective may act confounding factors trial must taken account data analysis patient recruitment started <NUMBER> february <NUMBER> completed <NUMBER> september <NUMBER> acknowledgements trial conducted two hospitals zhongnan hospital wuhan university leishenshan hospital wuhan city authors would like thank patients family members nurses pharmacy staff fellows clinicians intensive care units hospitals making study possible would also like express gratitude medical assistance teams help sacrifice wuhan contributors fl yz jz yl zp designed study fl yz jz designed statistical analysis plan jz yl wrote bid research project obtained permission ethics committees fl yz jz yl carried trial fl yz drafted manuscript zp yl jz carefully reviewed manuscript authors read approved final manuscript funding work supported science technology department hubei province grant number <NUMBER>fca<NUMBER> special project significant new drug research development major national science technology projects china grant number <NUMBER>zx<NUMBER> foundations reviewed approved project primary investigator supposed report progress trial departments regularly competing interests none declared patient public involvement patients andor public involved design conduct reporting dissemination plans research ethics approval study follows principles helsinki declaration <NUMBER> entire protocol reviewed approved ethics committee zhongnan hospital wuhan university identifier clinical ethical approval <NUMBER> zhongnan hospital wuhan university also took charge management leishenshan hospital wuhan city including affairs clinical trials ethical approval document also applicable leishenshan hospital written informed consent obtained participants informed purpose intervention possible risksbenefits study • novel coronavirus<NUMBER> sarscov<NUMBER> already shown induce systemic inflammatory response accompanied excessive release proinflammatory cytokines • furthermore covid<NUMBER> commonly accompanied hemodynamic abnormalities increased coagulation activity increasing risk venous thromboembolic events • short communication focus relation cytokines chemokines release influence coagulation factors inflammatory response peripheral mononuclear blood cells pbmcs • <NUMBER> h incubation time <NUMBER> serum main trigger release several cytokines chemokines comparison heparinized plasma furthermore shown addition fibrin pbmcs resulted significant increase cytokines chemokines measured dosedependent manner • anticoagulation could constitute potential tool handle treat circle inflammation thrombosis covid<NUMBER> reducing profound cytokine storm thrombotic complications december <NUMBER> new coronavirus severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> emerged causing coronavirus disease <NUMBER> covid<NUMBER> sarscov<NUMBER> found infect lung alveolar cells cardiac myocytes vascular epithelial endothelial cells well inflammatory cells including macrophages monocytes lymphocytes <NUMBER> <NUMBER> phenomenon primarily due virus portal entry angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor highly expressed vascular tissues <NUMBER> consequently endothelial injury crucial indicator sarscov<NUMBER> infection <NUMBER> clinically disease manifests symptoms including fever cough dyspnea myalgia infection mortality rate subject debate likely higher seasonal influenza <NUMBER> higher risk mortality primarily due risk severe illnesses systemic inflammatory response syndrome septic shock multiorgan involvement notably acute respiratory distress syndrome ards <NUMBER> also increasing evidence covid<NUMBER> differs classic ards regards respiratory characteristics optimal ventilatory management <NUMBER> generally acute inflammation intravascular coagulation platelet activation characterize ards covid<NUMBER> patients excessive cytokine release cytokine storm reported response sarscov<NUMBER> infection particular vast amounts proinflammatory cytokine interleukin<NUMBER> il<NUMBER> released although whether il<NUMBER> foremost marker severe illness diseases mediator still unknown yet levels circulation seem correlate disease severity propensity procoagulant status addition il<NUMBER> also higher levels il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> interferongamma ifnγ ifγinduced protein <NUMBER> ip<NUMBER> tumor necrosis factoralpha tnfα granulocytecolony stimulating factor macrophage inflammatory protein <NUMBER>alpha myocyte chemotactic protein mcp<NUMBER> well creactive protein crp ddimer found circulation cytokine storm may also seem correlate severity disease mortality <NUMBER> due lack appropriate vaccine also effective antiviral treatment sarscov<NUMBER> anticytokine therapies targeting il<NUMBER> il<NUMBER> proposed serve potential therapy ongoing cytokine storm <NUMBER> <NUMBER> il<NUMBER> inhibitor tocilizumab currently investigation serve treatment option covid<NUMBER> <NUMBER> <NUMBER> furthermore recent studies revealed sarscov<NUMBER> infections commonly accompanied hemostatic abnormalities elevated coagulation activity leading disseminated intravascular coagulation dic <NUMBER> complement activation one initiating pathway responsible innate immune responses promotes inflammation often defends bacteria virus infections furthermore complement system coagulation cascade closely linked may provoke hypercoagulability thrombosis excessive activation complement system therefore associated several pathologic events thrombotic microangiopathy organ dysfunction fig <NUMBER> already described patients sarscov<NUMBER> infections exhibit higher risk venous thromboembolic events including pulmonary embolism clinical parameters patients suffering severe covid<NUMBER> correlate excessive complement activity high lactate dehydrogenase ddimer bilirubin concerning increased levels ddimer shown serve particularly important marker coagulopathy <NUMBER> pulmonary embolism <NUMBER> additionally vitro study vero cells infected sarsassociated cov outlined potential heparin inhibit infection <NUMBER> <NUMBER> vivo heparin already proven significantly lower rate mortality due sarscov<NUMBER> infection <NUMBER> consequently evidence suggesting use anɵvirals eg remdesivir link coagulation pathway inflammatory response prove assumption performed vitro study investigate potential activated coagulation cascade clotting factors trigger expression release proinflammatory cytokines human peripheral mononuclear blood cells pbmcs healthy volunteers n <NUMBER> treated either autologous serum heparinized plasma respectively serum coagulation cascade already progressed final state addition autologous serum used clarify influence coagulation factors released serum pbmcs contrary heparinized plasma coagulation cascade inhibited due presence heparin presenting hypocoagulable environment addition different doses coagulation factor fibrin sigmaaldrich usa used unveil effect specific coagulation factor cytokine expression secretion cells incubated <NUMBER> °c <NUMBER> co <NUMBER> different treatment conditions negative control autologous serum autologous heparinized plasma fibrin <NUMBER> h h <NUMBER> h <NUMBER> h respectively supernatant cytokine chemokine concentrations measured using commercially available enzymelinked immunosorbent assay kits purchased rd systems minneapolis mn usa human il<NUMBER> beta il<NUMBER>f<NUMBER> duoset human il<NUMBER> duoset human il<NUMBER> cxcl<NUMBER> duoset human ccl<NUMBER>mcp<NUMBER> duoset human tnfalpha duoset human il<NUMBER>ra results calculated graphpad prism software graphpadsoftware la jolla ca usa due nongaussian approximation results given median ± interquartile range iqr results revealed treatment pbmcs <NUMBER> autologous serum <NUMBER> h comparison heparinized plasma led greatest inflammatory response outlined significant alteration inflammatory cytokines chemokines secretome particular proinflammatory cytokines il<NUMBER>β il<NUMBER> significantly elevated pbmcs supernatant rising <NUMBER> ± <NUMBER> pgml baseline <NUMBER> ± <NUMBER> pgml p <NUMBER> <NUMBER> h il<NUMBER>β il<NUMBER> concentration <NUMBER> ± <NUMBER> pgml baseline <NUMBER> ± <NUMBER> pg ml p <NUMBER> also tnfα il<NUMBER>ra significantly altered treatment pbmcs autologous serum moreover chemokine il<NUMBER> increased markedly <NUMBER> ± <NUMBER> pgml baseline <NUMBER> ± <NUMBER> pgml <NUMBER> h p <NUMBER> case mcp<NUMBER> <NUMBER> ± <NUMBER> pgml baseline <NUMBER> ± <NUMBER> pgml <NUMBER> h p <NUMBER> although treatment pbmcs heparinized plasma resulted significant increment supernatant il<NUMBER> mcp<NUMBER> levels increase high case autologous serum furthermore cytokines chemokines measured markedly higher serum heparinized plasma <NUMBER> h see fig <NUMBER> analyzed secretome pbmcs treated rising concentrations fibrin <NUMBER> µg <NUMBER> µg <NUMBER> µg <NUMBER> µg <NUMBER> µg <NUMBER> µg <NUMBER> h data unveiled significant rise il<NUMBER> tnfα il<NUMBER> concentrationdependent manner treatment pbmcs <NUMBER> µg fibrin resulted greatest cytokine chemokine values instance il<NUMBER> supernatant levels rose <NUMBER> ± <NUMBER> pgml baseline <NUMBER> ± <NUMBER> pgml p <NUMBER> due treatment <NUMBER> µg fibrin addition chemokine il<NUMBER> significantly altered treatment fibrin <NUMBER> ± <NUMBER> pgml <NUMBER> ± <NUMBER> pgml p <NUMBER> see fig <NUMBER> vitro results confirm association coagulation inflammatory response immune system data support findings yang et al <NUMBER> plasma samples patients infected sarscov<NUMBER> examined outlined increase <NUMBER> cytokines triggering inflammation response covid<NUMBER> many evidence activation coagulation marked impact cytokinestorm associated infection recently reviewed bikdeli et al <NUMBER> among others several hemostatic changes response sarscov<NUMBER> infection including mild thrombocytopenia increased ddimer levels furthermore case studies indicate association severity disease potential prolongation prothrombin time thrombin time well shortened activated partial thromboplastin time concerning study confirms coagulation may increase inflammatory response eventually resulting feedback loop triggering hypercoagulable state although data outline reverse progress inflammation may serve trigger hypercoagulable state already known eg sepsis may complicated dic supporting data speculations recent study patel et al addressed expression inflammatory markers sepsis dic could unveil positive correlation il<NUMBER> il<NUMBER> il<NUMBER> tnfα dic score <NUMBER> addition severe cases covid<NUMBER> exhibit increased risk developing venous thromboembolism vte chinese study reported <NUMBER> covid<NUMBER> patients highly prone vte <NUMBER> also danzi et al <NUMBER> reported case study woman infected sarscov<NUMBER> hospitalized due severe bilateral pneumonia ct scans unveiled severe pulmonary embolism although predisposing factors vte known addition patients severe pneumonia due covid<NUMBER> higher platelet count contributing increased risk thrombosis <NUMBER> small case series relation covid<NUMBER> largevessel stroke also proposed <NUMBER> based available vitro data first clinical impressions anticoagulation could cornerstone successfully managing covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> besides preventing thrombotic complications anticoagulation could mitigate vicious circle inflammation thrombosis covid<NUMBER> therapeutic anticoagulation might warranted critically sick covid<NUMBER> patients nonseverely ill covid<NUMBER> patients preventive anticoagulation could reduce thrombotic complications potential help minimize risk fullblown cytokine storm although covid<NUMBER> patients could benefit yet proven usage would also reduce inflammatory response due sarscov<NUMBER> infection far safety treatment oral anticoagulants concerned risk advanced bleeding covid<NUMBER> patients considered open access article licensed creative commons attribution <NUMBER> international license permits use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreat iveco mmons orglicen sesby<NUMBER> particulate matter pm air pollution concentrations frequently encountered major cities trigger release proinflammatory interleukins eg il<NUMBER> alveolar macrophages promoting acceleration arterial thrombosis <NUMBER> analogously infection novel sarscov<NUMBER> coronavirus stimulate toolittletoolate typei interferonmediated innate immune response inherently accompanied dysregulated secretion il<NUMBER> alveolar macrophages <NUMBER> <NUMBER> socalled cytokine storminvolving overproduction proinflammatory cytokines overactivation immune cells hyperinflammationultimately drives acute respiratory distress syndrome ards one leading causes mortality patients severe covid<NUMBER> disease <NUMBER> <NUMBER> intriguingly patients severe covid<NUMBER> admitted intensive care unit highest thrombotic risk acute pulmonary embolism common thrombotic complication <NUMBER> ability covid<NUMBER> predispose thromboembolism fuel futile cycles hyperinflammatory responses aggravate sarscov<NUMBER> pathogenesis <NUMBER> <NUMBER> increasingly viewed major factor disease severity mortality thus surprising longterm exposure pm recently proposed key contributor covid<NUMBER> mortality united states <NUMBER> likewise elevated levels pm air pollution northern italy central spain postulated putative risk factor underlying extremely high covid<NUMBER> fatality rates observed european regions <NUMBER> <NUMBER> <NUMBER> link air pollution covid<NUMBER> severity viewed merely passive result carrier action virus particles pm yet one acknowledge pm air pollution also principal cause chronic systemic airway inflammation ultimately leading innate immune system hyperactivation elevated production proinflammatory cytokines thrombosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> physiopathological overlap pmdriven inflammatory cytokine production cytokinethrombotic storm patients covid<NUMBER> might also suggest boosting action former sarscov<NUMBER> mechanism disease figure <NUMBER> therapeutically chronic pulmonary effects pm impact prognosis covid<NUMBER> follows small molecules acceptable risk profiles block molecular triggers il<NUMBER> release alveolar macrophages response pm might also mitigate aggressive proinflammatoryprothrombotic nature covid<NUMBER> using sophisticated cell mouse models groundbreaking study budinger group established antidiabetic drug metforminthrough capacity inhibit mitochondrial complex isuppressed mitochondrial reactive oxygen species ros signaling necessary opening ca <NUMBER> releaseactivated ca <NUMBER> crac channels generation il<NUMBER> alveolar macrophages upon exposure pm figure <NUMBER> <NUMBER> use respiratory filter people residing areas high levels pm air pollution validated causal link pm partially overlaps caused severe sarscov<NUMBER>covid<NUMBER> namely release proinflammatory interleukins eg il<NUMBER> alveolar macrophages via mitochondrial reactive oxygen species rosdriven activation ca <NUMBER> releaseactivated ca <NUMBER> crac channels lastly promoting acceleration thrombotic events patients already experiencing chronic cytokine response might higher risk covid<NUMBER> lethal complications sarscov<NUMBER> infection bottom given linkage mitochondrial functionality ion channels inflammation human aging therapeutic interventions capable targeting mitochondrial electron transport prevent mitochondrial roscracmediated il<NUMBER> release eg metformin might illuminate preventiveprophylactic mechanism action quell raging cytokine thromboticlike storms leading causes covid<NUMBER> morbidity mortality older people acute scenario sarscov<NUMBER>driven hyperinflammation small molecule crac channel inhibitors may also contemplated means treating patients severe covid<NUMBER> risk progressing typicalatypical ards aging exposure levels il<NUMBER>related systemic markers <NUMBER> findings altogether support metformin use preventive strategy mortality attributable pm air pollution worldwide <NUMBER> line would relevant test whether metformin could suppress cytokine thromboticlike storms covid<NUMBER> begin thereby lowering risk severe disease highrisk individuals roscracil<NUMBER>targeted activity metformin preventive therapy premature death attributable pm air pollution geroprotector gerophilic gerolavic traits sars severe covid<NUMBER> illness death common people aged <NUMBER> older underlying conditions include chronic respiratory system disease due chronic exposure pm air pollution also immunosenescence inflammaging phenomena <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> given linkage mitochondria functionality ion channels including crac inflammaging <NUMBER> ability metformin target mitochondrial electron transport prevent roscracmediated il<NUMBER> release might illuminate preventive prophylactic measure quell raging cytokine thromboticlike storms leading causes covid<NUMBER> morbidity mortality older people cracrelated mechanism action <NUMBER> capable preventing systemically il<NUMBER>driven thrombotic events <NUMBER> together multifaceted capacity metformin ameliorate immunometabolismrelated inflammation alleviate ards <NUMBER> <NUMBER> <NUMBER> believed main risk factors worse outcome elderly covid<NUMBER> <NUMBER> <NUMBER> could provide novel mechanistic basis recently proposed geroprotective role metformin gerophilic gerolavic traits sarscov<NUMBER> infection <NUMBER> previous randomized clinical trials numerous retrospective observational studies consistently associated metformin administration significant improvement risk factors agingrelated diseases cardiovascular neurodegenerative cancer beyond type <NUMBER> diabetes <NUMBER> <NUMBER> <NUMBER> research urgently needed test whether metformin might additionally aging reduce comorbidity infection rate severity lethality sarscov<NUMBER> infection special emphasis elderly risk groups accounting majority severe covid<NUMBER> disease fatalities date clinical trial strategies tame targeting aging metformin study plans enroll <NUMBER> older subjects ages <NUMBER> without type <NUMBER> diabetes randomly assigned <NUMBER> mg metformin daily placebo <NUMBER> years measure time new occurrence composite outcome includes cardiovascular events cancer dementia mortality <NUMBER> <NUMBER> provides ideal opportunity explore recently proposed strategy metformin lowcost geroprotector prevention sarscov<NUMBER> <NUMBER> meanwhile observational studies residential care nursing homes daycare centers older adults significant risk covid<NUMBER> outbreaks receiving metformin treatment type <NUMBER> diabetes along assessment bronchialserological levels inflammatory cytokines markers prothrombotichypercoagulable states ddimers might provide deeper comprehension metformin protect potentiate common preventive strategies distancing measures maskwearing handwashing targeting hyperinflammation severe covid<NUMBER> patients may critical reducing mortality one might therefore wonder whether treatment indirect eg metformin <NUMBER> direct eg cm<NUMBER> <NUMBER> smallmolecule inhibitors crac channels could improve clinical outcomes hospitalized patients moderatesevere covid<NUMBER> cm<NUMBER>ie potent selective small molecule crac channel inhibitor prevents channel overactivation demonstrated efficacy patients hypoxemia secondary systemic inflammatory response syndrome acute pancreatitis <NUMBER> trialed patients severe covid<NUMBER> pneumonia risk progressing ards clinicaltrialsgov identifier nct<NUMBER> subset severe covid<NUMBER> infections delayed onset respiratory distress despite severity hypoxemia clearly differs classic ards principally involves catastrophic microvascular injury thrombosis <NUMBER> <NUMBER> <NUMBER> might relevant carefully evaluate impact targeting mitochondrial roscracil<NUMBER> signaling cascade respiratory inflammatory survival outcomes typical atypical presentation ards covid<NUMBER> patients nonetheless findings clinical testing cractargeting drugs might link mechanistic level metformin lessons air pollution ride cytokinethrombotic storm severe sarscov<NUMBER>covid<NUMBER> perspective merely aims stimulate new ideas part global efforts aimed develop new preventivetreatment strategies sarscov<NUMBER>covid<NUMBER> outbreak accordingly perspective represent medical advice therapeutic recommendations either covid<NUMBER> patients people risk sarscov<NUMBER> infection manuscript written course second month lockdown spain due sarscov<NUMBER> coronavirus pandemic marchmay <NUMBER> paper dedicated memory succumbed covid<NUMBER> hard days author would like thank dr kenneth mccreath editorial support author declares conflicts interest funding received writing perspective work menendez laboratory supported spanish ministry science innovation grant saf<NUMBER>p plan nacional de idi founded european regional development fund spain unrestricted research grant fundació oncolliga girona lliga catalana dajuda al malalt de càncer girona cardiac damage evidence pulmonary groundglass opacities patients groundglass opacities detected subpleural regions lungs may lead systemic localized immune responses exacerbating inflammation cases treatment inhalers interferon positive effects also worsened clinical symptoms progression pulmonary opacities <NUMBER> <NUMBER> patients advanced age underlying conditions eg hypertension chronic obstructive pulmonary disease diabetes andor cardiovascular disease etc higher risk rapid progression acute respiratory distress syndrome septic shock metabolic acidosis coagulation dysfunction arrhythmia kidney damage heart failure liver dysfunction andor secondary infection often resulting death <NUMBER> <NUMBER> treatment options new disease mainly limited mitigation clinical symptoms especially affecting respiratory system including application oxygen therapy provision extracorporeal membrane oxygenation patients refractory hypoxemia treatments hyperimmune plasma immunoglobulin g also received critically ill patients <NUMBER> <NUMBER> administration antivirals corticosteroids contraindicated <NUMBER> <NUMBER> remdesivir adenosine nucleotide analog proven effective vitro animal studies one patient usa <NUMBER> <NUMBER> antiretrovirals used human immunodeficiency virus hiv lopinavirritonavir also found reduce viral load sarscov<NUMBER> <NUMBER> chloroquine also proposed candidate drug treatment covid<NUMBER> based immunomodulatory properties capacity suppress tumor necrosis factor  tnf interleukin<NUMBER> il<NUMBER> inhibit autophagy <NUMBER> <NUMBER> general especially patients suffering cytokine storm clinicians focus reduction uncontrolled inflammation blocking il<NUMBER> tnf eliminating cytokines via hemoperfusion <NUMBER> table <NUMBER> cytokine hyperproduction often followed edema gas exchange dysfunction acute respiratory syndrome acute cardiac damage secondary infection <NUMBER> regard pathophysiological mechanism virus enters cell via angiotensinconverting enzyme<NUMBER> ace<NUMBER> mainly tolllike receptor<NUMBER> majority patients infected covid<NUMBER> normal reduced white cell counts lymphocytopenia severe disease shown significantly elevated levels neutrophils dimerd urea blood continuing decrease lymphocytes increases certain cytokines chemokines eg il<NUMBER> il<NUMBER> tnf also observed patients thus patients admitted intensive care units icus found elevated serum levels il<NUMBER> il<NUMBER> il<NUMBER> macrophage colonystimulating factor mcsf granulocyte colonystimulating factor gcsf granulocytemacrophage colony stimulating factor gmcsf <NUMBER> kd interferongammainduced protein ip<NUMBER> monocyte chemoattractant protein<NUMBER> mcp<NUMBER> macrophage inflammatory protein <NUMBER> mip <NUMBER> tnf <NUMBER> <NUMBER> <NUMBER> fig <NUMBER> essential analyze factors underlying physiopathology pandemic disease certain cytokines appear play key role objective study review data cytokines influence progression covid<NUMBER> order support efforts manage highly virulent disease immediate immune response infection viruses bacteria microorganisms involves mobilization cells molecules draws energetic enzymatic biosynthetic resources ie metabolic resources <NUMBER> <NUMBER> <NUMBER> metabolic dysfunctions caused viral infection requires reprograming host metabolism generate effective antiviral defense responses data published interferences actions viruses cytokines reveal molecular mechanisms underlying innate immune response viral infection <NUMBER> <NUMBER> <NUMBER> cytokines group polypeptide signaling molecules responsible regulating large number biological processes via cell surface receptors <NUMBER> key cytokines include involved adaptive immunity eg il<NUMBER> il<NUMBER> proinflammatory cytokines interleukins ils eg interferon ifni ii iii il<NUMBER> il<NUMBER> il<NUMBER> tnf antiinflammatory cytokines eg il<NUMBER> response stressgenerating internal processes eg cancer microbial infection host cells secrete cytokines highly important role cell metabolism reprogramming defensive response <NUMBER> <NUMBER> <NUMBER> concerning covid<NUMBER> disease blancomello et al described distinctive unsuitable inflammatory response related sarscov<NUMBER> infection authors revealed inappropriate weak immune response appears frequently patients comorbidities thus could favor virus replication enhance complications related severe cases disease <NUMBER> short time since emergence covid<NUMBER> numerous studies described abnormal levels following cytokines chemokines patients il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> mcsf gcsf gmcsf ip<NUMBER> ifn mcp<NUMBER> mip <NUMBER> hepatocyte growth factor hgf tnf vascular endothelial growth factor vegf <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> key point sarscov<NUMBER> infection could depletion antiviral defenses related innate immune response well elevated production inflammatory cytokines <NUMBER> il<NUMBER> actively participates inflammatory response infection <NUMBER> main sources activated monocytes macrophages <NUMBER> sarscov<NUMBER> appears act activation maturation il<NUMBER> turn activates proinflammatory cytokines il<NUMBER> tnf <NUMBER> <NUMBER> <NUMBER> hence il<NUMBER> forms part cytokine storm produced coronavirus infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> yang et al detected elevated levels antagonistic receptor il<NUMBER> il<NUMBER>ra <NUMBER> severe cases covid<NUMBER> marker associated increased viral load loss pulmonary function lung damage mortality risk <NUMBER> liu et al also found elevated il<NUMBER> levels patients severe covid<NUMBER> strongly associated lung injury <NUMBER> il<NUMBER> levels related virulence process significantly higher serum levels observed sarscov<NUMBER> cases severe symptoms mild cases infected <NUMBER> sarscov <NUMBER> mers coronavirus <NUMBER> covid<NUMBER> patients severe symptoms elevated levels il<NUMBER> associated sars hypercoagulation disseminated intravascular coagulation <NUMBER> reason therapeutic strategies used inhibition il<NUMBER> attempt avoid cytokine storm <NUMBER> <NUMBER> way mesenchymal stem cells mscs used inhibit proinflammatory cytokines il<NUMBER> tnf <NUMBER> il<NUMBER> plays key role proliferation cells generation effector memory cells <NUMBER> involved adaptive immunity increases glucose metabolism promote proliferation activation b nk cells <NUMBER> hence il<NUMBER> participates prevention autoimmune diseases essential control immune responses maintain selftolerance <NUMBER> absence interleukin associated poor control effector cells consequent development autoimmunity <NUMBER> huang et al detected elevated levels il<NUMBER> receptor il<NUMBER>r patients covid<NUMBER> reported increases directly proportional severity disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> elevation interleukin association disease severity also reported patients types coronavirus <NUMBER> <NUMBER> <NUMBER> il<NUMBER> also involved adaptive immunity playing crucial role immune regulation governed activated helper th cells preferentially acts activation proliferation differentiation b lymphocytes promotion immunoglobulin e isotype therefore decisively intervenes induction humoral immunityregulating th<NUMBER> cells <NUMBER> <NUMBER> proposed il<NUMBER> antiinflammatory function specific tissue present reflecting metabolic plasticity different tissues <NUMBER> respect viral infections target respiratory system bot et al observed expression infection influenza virus negative effects cd<NUMBER> memory cells <NUMBER> various studies covid<NUMBER> patients detected elevated il<NUMBER> levels part cytokine storm associated severe respiratory symptoms <NUMBER> <NUMBER> <NUMBER> <NUMBER> j u r n l p r e p r f il<NUMBER> involved inflammation immune response hematopoiesis <NUMBER> pleiotropic biomolecule secreted multiple cell types regulates wide variety physiological processes <NUMBER> initial stages inflammation secreted il<NUMBER> travels liver induces large number acutephase proteins including creactive protein crp serum amyloid saa fibrinogen haptoglobin <NUMBER>antitrypsin addition il<NUMBER> found diminish production fibronectin albumin transferrin <NUMBER> reported regenerative antiinflammatory effects mediated conventional signaling process although also exerts proinflammatory effects mediated transsignaling case viral infections <NUMBER> relation different types coronavirus elevated il<NUMBER> levels observed sars cases related severity symptoms <NUMBER> <NUMBER> <NUMBER> sarscov implicated possible tcell dysfunctionality observed sarscovinduced cytokines may damage capacity cells relation dendritic cells compromising viability cells macrophages eliminate pathogen <NUMBER> <NUMBER> similar observations made relation mers <NUMBER> <NUMBER> proportional association elevated il<NUMBER> levels cell counts <NUMBER> another study patients severe symptoms described elevated serum levels il<NUMBER> crp <NUMBER> study <NUMBER> patients infected sarscov<NUMBER> also reported elevation il<NUMBER> levels marked severe symptoms <NUMBER> levels higher observed patients sarscov mers <NUMBER> <NUMBER> il<NUMBER> levels also found markedly higher patients died covid<NUMBER> recovered <NUMBER> noted activation il<NUMBER> sarscov<NUMBER> turn activates il<NUMBER> tnf <NUMBER> <NUMBER> <NUMBER> also demonstrated high expression il<NUMBER> patients covid<NUMBER> accelerate inflammatory process contributing cytokine storm worsening prognosis <NUMBER> cytokine storm including elevated levels il<NUMBER> also associated cardiac damage patients <NUMBER> regard important role il<NUMBER> sarscov<NUMBER>induced cytokine storm evasion reported monoclonal antibody tocilizumab acts blocking receptor il<NUMBER> reported reverse cytokine hyperproduction <NUMBER> <NUMBER> <NUMBER> <NUMBER> inflammation pulmonary fibrosis <NUMBER> <NUMBER> fact multicenter clinical trial way china usefulness tocilizumab treat patients covid<NUMBER> nct<NUMBER> nct<NUMBER> already included clinical practice guidelines china italy <NUMBER> <NUMBER> polyol myoinositol also described bizzarri et al potential candidate drug reduce il<NUMBER> levels risk cytokine storm <NUMBER> addition capacity macrolide azithromycin combination hydroxychloroquine reduce nasopharyngeal levels sarscov<NUMBER> attributed capacity block il<NUMBER> tnf <NUMBER> <NUMBER> chloroquine also capacity inhibit il<NUMBER> tnf tested covid<NUMBER> <NUMBER> <NUMBER> finally blood purification therapy proposed eliminate pathological antibodies il<NUMBER> among cytokines given successful application diseases <NUMBER> il<NUMBER> plays important role lymphocyte differentiation participating development cells peripheral homeostasis <NUMBER> main cd<NUMBER> cell subgroups cd<NUMBER> immature memory th<NUMBER> cells depend cytokine peripheral homeostasis <NUMBER> <NUMBER> <NUMBER> <NUMBER> il<NUMBER> activates cells increases production proinflammatory cytokines negatively regulates transforming growth factor beta tgf role biomolecule depends il<NUMBER> <NUMBER> suggested il<NUMBER> secretion induced viral infections <NUMBER> case cytokines reported il<NUMBER> levels elevated patients covid<NUMBER> directly related disease severity <NUMBER> <NUMBER> <NUMBER> il<NUMBER> type <NUMBER> cytokine inhibits production proinflammatory cytokines eg ifn tnf il<NUMBER> il<NUMBER> various cell types prevents dendritic cell maturation blocking il<NUMBER> hampers expression major histocompatibility j u r n l p r e p r f complex costimulatory molecules important role cell immunity however il<NUMBER> immunostimulatory effects including stimulation ifn production cd<NUMBER> cells also powerful factor growth differentiation b cells mast cells thymocytes <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> numerous authors described viruses epstein barr virus cytomegalovirus herpesvirus contain il<NUMBER> homologs may contribute presentation different binding profiles receptors biological activities increase viral resistance <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however il<NUMBER> regulation decreased infection viruses hiv contributing tcell depletion <NUMBER> <NUMBER> <NUMBER> animal studies shown antibodymediated inhibition il<NUMBER> signaling improves tcell response contributes eliminating viral resistance hence effective blocking il<NUMBER> signaling may useful resistant viral infections <NUMBER> <NUMBER> various authors detected interleukin patients covid<NUMBER> related levels disease severity progression case cytokines <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> reported possible prognostic value <NUMBER> fact authors indicate il<NUMBER> may hyperexpressed antisarscov<NUMBER> immunity higher patients advanced age respect hyperinflammatory response possibly related reduction tcell receptors elderly <NUMBER> cytokines il<NUMBER> levels found higher patients covid<NUMBER> sarscov mers <NUMBER> il<NUMBER> one group heterodimeric biomolecules distinctive characteristics including pairing versality also observed il<NUMBER> il<NUMBER> il<NUMBER> involved molecular processes functions crucial role positive negative feedback <NUMBER> <NUMBER> il proinflammatoryprostimulatory cytokine produced response microbial agents dendritic cells b cells monocytes macrophages among others key functions development th<NUMBER> th<NUMBER> cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> il<NUMBER> also induces production ifn nk cells positive feedback mechanism <NUMBER> action cytokine viral infections based direct chemotactic effects infiltration nk cells increasing binding vascular endothelial j u r n l p r e p r f cells nk cells secrete ifn participates positive feedback increasing production il<NUMBER> <NUMBER> <NUMBER> viral infections rapidly induce gene expression il<NUMBER> also acts viral replication <NUMBER> <NUMBER> <NUMBER> instance il<NUMBER> endogenously induced pneumonia produced influenza activates nk cells secrete ifn thereby inhibit viral replication il<NUMBER> found produce improvement response cd<NUMBER> cells <NUMBER> elevated serum il<NUMBER> levels observed patients infected sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> infected coronaviruses sarscov <NUMBER> mscs inhibit secretion il<NUMBER> well ifn tnf proposed effective therapy covid <NUMBER> <NUMBER> il<NUMBER> secreted activated th<NUMBER> cells constituting counterregulatory system th<NUMBER>type immune response considered important regulator immune responses mediated th<NUMBER>type cytokines <NUMBER> il<NUMBER> varied functions implicated development bronchial asthma inducing production tgf eotaxin<NUMBER> mucin <NUMBER> <NUMBER> <NUMBER> <NUMBER> also participates activation mast cells de vries je <NUMBER> il<NUMBER> il<NUMBER> involved allergic processes asthma regulation th<NUMBER> lymphocytes <NUMBER> il<NUMBER> mediates tissue responses infections including mobilization eosinophils expulsion parasites <NUMBER> data available presence il<NUMBER> patients covid<NUMBER> huang et al found difference serum il<NUMBER> levels requiring icu admission <NUMBER> however liu et al observed directly proportional association il<NUMBER> levels viral load sarscov<NUMBER> <NUMBER> il<NUMBER> synthetized th<NUMBER> lymphocytes elevated inflammatory processes autoimmune diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> also produced cd<NUMBER> cells various sets immature lymphocytes including gammadelta cells nk cells group <NUMBER> innate lymphoid cells <NUMBER> il<NUMBER> alongside il<NUMBER> tnf also induces j u r n l p r e p r f production antimicrobial peptides <NUMBER> hence il<NUMBER> proinflammatory cytokine plays role tissue damage physiological stress infection functions vary according tissue il<NUMBER> expressed particularly important gastrointestinal tract skin <NUMBER> <NUMBER> elevated il<NUMBER> levels reported patients sarscov<NUMBER> part cytokine storm <NUMBER> associated viral load disease severity <NUMBER> contrast wan et al found il<NUMBER> levels normal patients covid<NUMBER> significant differences patients severe versus mild symptoms <NUMBER> elevated il<NUMBER> levels previously described patients sarscov mers <NUMBER> <NUMBER> fact th<NUMBER> cells produce il<NUMBER> among others led proposals therapeutic approach covid<NUMBER> focused janus kinase <NUMBER> jak<NUMBER> inhibitor named fedratinib jak<NUMBER> inhibitor decreases il<NUMBER> expression th<NUMBER> cells murine models <NUMBER> mcsf also known colonystimulating factor<NUMBER> primary growth factor belongs family colonystimulating factors <NUMBER> regulates growth even higher requiring icu admission <NUMBER> could lead multiorgan failure related severe cases <NUMBER> <NUMBER> wu yang xo <NUMBER> associated gcsf levels response th<NUMBER> lymphocytes patients sarscov<NUMBER> finding il<NUMBER> produced cells induce production gcsf among others also reported th<NUMBER> contributes cytokine storm triggered sarscov<NUMBER> <NUMBER> liu et al directly related gcsf levels viral load sarscov<NUMBER> associated lung damage <NUMBER> gmcsf heterodimeric complex consists specific alpha chain gmcsf signal transduction subunit shared il<NUMBER> il<NUMBER> receptors singlemembrane protein homodimerizes binding gcsf <NUMBER> <NUMBER> <NUMBER> main sources biomolecule fibroblasts endothelial epithelial stromal hematopoietic cells <NUMBER> secreted epithelial cells lung <NUMBER> <NUMBER> unlike mcsf gcsf gmcsf virtually undetectable blood although found locally produced activated tissues affected inflammatory processes serum gmcsf levels also elevated response endotoxins hence gmcsf plays important role inflammatory process <NUMBER> <NUMBER> <NUMBER> stimulating proliferation activation macrophages eosinophils neutrophils monocytes dendritic cells microglial cells besides role hematopoietic growth factor cytokine increases production proinflammatory cytokines favors antigenic presentation phagocytosis promotes chemotaxis leukocyte adhesion major importance maintaining immune homeostasis lung gut <NUMBER> elevated serum gmcsf levels detected acute phase infection sarscov<NUMBER> comparison healthy individuals required icu admission <NUMBER> th<NUMBER> cells produce gmcsf high th<NUMBER> counts associated elevated gmcsf levels <NUMBER> also observed activation th<NUMBER> cells pathogens generate gmcsf among cytokines <NUMBER> ip<NUMBER> initially identified chemokine whose secretion induced ifn ip<NUMBER> secreted neutrophils endothelial cells keratinocytes fibroblasts dendritic cells astrocytes hepatocytes binding chemokine receptor <NUMBER> cxcr<NUMBER> regulates immune system responses activating recruiting leukocytes including cells monocytes nk cells therefore ip<NUMBER> cxcr<NUMBER> play key role recruiting leukocytes inflamed tissues perpetuating inflammation thereby making major contribution tissue damage <NUMBER> elevated ip<NUMBER> concentrations found numerous infections mainly viral infections <NUMBER> serum ip<NUMBER> levels found elevated patients covid<NUMBER> even higher required icu admission suggesting relationship lung damage disease severity <NUMBER> high levels biomolecule previously found patients sarscov <NUMBER> levels even higher sarscov<NUMBER> <NUMBER> thus hyperproduction ip<NUMBER> among others considered contribute disease progression <NUMBER> liu monocytes macrophages dendritic cells neutrophil granulocytes also produce cytokine although numerous cells source ifn mainly produced nk cells mscs also secrete low ifn levels regulate hematopoiesis <NUMBER> ifn participates numerous immune adaptive immunological functions inflammatory processes promotes macrophage activation antigen presentation highly involved antibacteria antivirus immunity signal transduction difficult classify ifn proor antiinflammatory cytokine given complex varied roles <NUMBER> <NUMBER> observed elevated ifn levels associated greater viral load lung damage <NUMBER> sun et al found ifn il<NUMBER> il<NUMBER> levels higher patients infection sarscov<NUMBER> differ patients required icu admission <NUMBER> fact authors found levels cytokine lower cd<NUMBER> tcells patients severe versus mild symptoms suggested infection may initially affect cd<NUMBER> cd<NUMBER> tcells reducing production ifn <NUMBER> protein belongs cc chemokine family powerful monocyte chemotactic factor constitutively produced induced oxidative stress cytokines growth factors expressed endothelial cells fibroblasts epithelial cells smooth muscle cells mesangial cells astrocytes monocytes microglial cells play important role antiviral response peripheral circulation tissues monocytes macrophages main source mcp<NUMBER> regulates migration infiltration monocytes memory cells nk cells <NUMBER> huang et al found mcp<NUMBER> levels higher patients covid<NUMBER> even higher among admitted icu <NUMBER> reported mcp<NUMBER> increases rapidly early acute phase infection progressively decreases advance disease <NUMBER> xiong et al detected elevated levels mcp<NUMBER> cytokines bronchoalveolar lavage fluid patients covid<NUMBER> associated pathogeny virus cytokines <NUMBER> elevated levels protein also detected lung tissue patients infected sarscov<NUMBER> <NUMBER> tnf produced various cell types monocytes macrophages cells among others cytokine related proinflammatory responses mediated il<NUMBER> il<NUMBER> alongside cytokines tnf involved regulation inflammatory processes infectious diseases malignant tumors <NUMBER> observed serum tnf levels elevated patients covid<NUMBER> higher severe disease <NUMBER> <NUMBER> <NUMBER> diao et al reported similar results sample <NUMBER> patients covid<NUMBER> found inverse relationship tnf levels tcell counts <NUMBER> contrast wan et al described normal tnf levels patients covid<NUMBER> <NUMBER> tnf one cytokines whose overproduction related poor prognosis patients sarscov mers <NUMBER> <NUMBER> <NUMBER> <NUMBER> zhang et al proposed administration certolizumab antitnf antibody might beneficial effects patients covid<NUMBER> <NUMBER> another possible therapeutic approach use mscs inhibit tnf il<NUMBER> among cytokines <NUMBER> biomolecules besides cytokines shown increased expression patients covid<NUMBER> including growth factors j u r n l p r e p r f vegf vegf essential vascular endothelial homeostasis present numerous cells tissues also found participate pathogenesis tumor growth metastasis vegf plays essential role endothelial cell activation binding cell surface receptors vegfr integrity endothelial barrier lung tissue crucial alveolar immune regulation severe inflammation associated immune responses induce apoptosis epithelial endothelial cells increasing production vegf exacerbating edema extravasation immune cells <NUMBER> pathogenic effects factor related action vascular permeability neoangiogenesis <NUMBER> <NUMBER> vegf hyperregulation observed various viral infections attempts made stimulate factor using vegf homologs present viruses activating inflammatory mediators trigger overexpression vegf <NUMBER> serum vegf levels found higher patients sarscov<NUMBER> although differ admitted icu <NUMBER> noted therapeutic application mscs consideration due regenerative immunomodulatory potential besides vegf mscs also secrete vegf among others would useful approach respiratory distress syndrome regeneration lung tissue treatment lung fibrosis induced infections <NUMBER> hepatocyte growth factor hgf synthesized fibroblasts endothelial hepatic cells among cell populations active form produced action serine protease enzyme released damaged tissues lungs hgf sequested pulmonary fibroblasts secretion increased tissue damaged <NUMBER> serum hgf mip <NUMBER> levels found elevated patients covid<NUMBER> even higher mip <NUMBER> levels found requiring icu admission <NUMBER> immunological reaction triggered infection sarscov<NUMBER> mobilizes numerous cytokines mainly proinflammatory character changes levels associated presence disease severe prognosis study summarizes findings role cytokines onset outcomes sarscov<NUMBER> infection possible therapeutic approaches involving inhibition activity authors declare competing financial interests chen et al <NUMBER> retrospective study describe epidemiological clinical features sarscov<NUMBER> pneumonia patients wuhan jinyintan hospital approximately <NUMBER> subjects developed disease exposed huanan seafood market affects men often average age <NUMBER> approximately half subjects comorbidities main symptomatology characterized fever cough shortness breath muscle pain among others ct scan revealed <NUMBER> patients developed bilateral pneumonia cases evolved acute respiratory distress syndrome ards died multiple organ failure huang et al <NUMBER> descriptive study describe epidemiological clinical laboratory radiological characteristics treatment outcomes patients infected covid<NUMBER> wuhan make comparison patients intensive care unit icu infection sarscov<NUMBER> caused clusters severe respiratory disease associated icu admission high mortality infected patients male different comorbidities average age <NUMBER> years disease mainly manifested fever cough myalgia fatigue dyspnea occurred <NUMBER> patients lymphopenia present <NUMBER> cases patients admitted icu found higher plasma levels il<NUMBER> il<NUMBER> il<NUMBER> gscf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα liu et al <NUMBER> descriptive study describe epidemiology clinical features possible treatments prognosis patients infected sarscov<NUMBER> hubei initial manifestations sarscov<NUMBER> fever cough muscle pain fatigue patients normal decreased white blood cell count <NUMBER> lymphocytopenia lung involvement observed cases treatment based symptom control respiratory support immunoglobulin g administered critically ill patients systemic corticosteroids showed significant benefit risk death related age comorbidities period initial symptoms dyspnea wang et al <NUMBER> retrospective study describe cytokine release syndromelike crsl occurs patients affected covid<NUMBER> pneumonia identify risk factors possible treatments average age <NUMBER> years old gender men mostly extensive pulmonary inflammation ards <NUMBER> symptoms fever hypoxia shock <NUMBER> laboratory findings decrease cd<NUMBER> cd<NUMBER> cd<NUMBER> nk cells increase il<NUMBER> cd<NUMBER>cd<NUMBER> ratio crsl <NUMBER> <NUMBER> manifested pulmonary inflammation decrease cd<NUMBER> cd<NUMBER> nk increase il<NUMBER> dysfunction nonpulmonary organs management ventilation antiinflammatory therapy mechanicalventilation chen et al <NUMBER> literature review review literature relationship covid<NUMBER> cytokine storm well possible immutherapic treatments available effectiveness therapies demonstrated use stem cells inhibit activation tlymphocytes macrophages induce differentiation regulatory subpopulations tcells antiinflammatory macrophages also inhibit secretion il<NUMBER>α tnfα il<NUMBER> il<NUMBER> γinterferon controlling cytokine storm conti et al <NUMBER> literature review clarify relationship il<NUMBER> il<NUMBER> proinflammatory cytokines lung inflammation antiinflammatory strategies infection covid<NUMBER> causes release il<NUMBER>β il<NUMBER> lead lung inflammation fever fibrosis therapeutic potential several severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> member coronaviridae causes respiratory disorders infection large amounts inflammatory cytokines secreted known cytokine storm cytokines cause pulmonary damage induced inflammation resulting acute respiratory distress syndrome ards even death one therapeutic approaches treatment ards mesenchymal stem cell msc mscs suppress inflammation reduce lung injury immunomodulatory properties mscs also potential prevent apoptosis lung cells regenerate suggestion using mscsderived exosomes exosomes apply immunomodulatory tissue repair effects mscs dont problems associated cell maintenance injections investigation hypothesis mscs isolated tissues characterized exosomes isolated supernatants characterized exosomes injected transgenic animal covid<NUMBER> final section lung function assessment histological examination microct differential leukocyte viral load analysis cytokine assay crp level analysis investigated covid<NUMBER> treatment currently focused supportive therapies vaccine developed numerous research studies needed find potential since pathogenesis disease identified previous studies cause lung injury ards investigation therapeutic approaches suppress inflammation cytokine storm ards helpful finding novel therapeutic approach disease severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> member family coronaviridae like two members family coronavirus sarscov middle east respiratory syndrome coronavirus merscov causes respiratory disorders <NUMBER> <NUMBER> virus first detected wuhan china december <NUMBER> disease caused virus coronavirus disease covid <NUMBER> characterized pandemic <NUMBER> march <NUMBER> world health organization <NUMBER> <NUMBER> encode number structural proteins matrix e envelope n nucleocapsid spike protein well number nonstructural proteins among structural proteins protein binds angiotensinconverting enzymes <NUMBER> ace<NUMBER> present surface human cells especially alveolar type ii cells highly express receptor virus enters host lung cells <NUMBER> <NUMBER> effective immune responses viral infections depend ifni production innate immune cells subsequently cell mediated immunity helper <NUMBER> cytotoxic cells <NUMBER> virus enters cell genome recognized various pattern recognition receptors prrs tolllike receptor<NUMBER> tlr<NUMBER> tlr<NUMBER> retinoic acidinducible genei rigi melanomadifferentiationassociated gene <NUMBER> mda<NUMBER> cyclic gmpamp synthase cgas signaling pathways initiated following incidences large amounts type interferons inflammatory cytokines secreted <NUMBER> <NUMBER> <NUMBER> <NUMBER> following inflammatory conditions lungs also increase proliferation virus sharp increase inflammatory cytokines il<NUMBER> il<NUMBER> il<NUMBER> gcsf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tnfα reported patients covid known cytokine storm <NUMBER> cytokine storm similar seen sars mers caused lack proper regulation inflammatory immune responses <NUMBER> <NUMBER> clinical evidences demonstrated cytokine storm main cause acute respiratory distress syndrome ards covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> pathogenic cells produce inflammatory cytokines activation subsequently inflammatory monocytes leukocytes migrate lung <NUMBER> increased neutrophil counts reported symptom number patients <NUMBER> activated immune cells may cause pulmonary damage induced inflammation resulting complications pneumonia loss lung function ards even death fig <NUMBER>a <NUMBER> <NUMBER> <NUMBER> <NUMBER> since ards recognized one leading causes mortality patients appears caused cytokine storm suppression inflammation may cause decrease inflammatory cytokine production consequently reduce inflammation lung injury shown use antiil<NUMBER> patients covid<NUMBER>induced pneumonia useful approved china <NUMBER> currently approved treatment sarscov<NUMBER> usually supportive treatments use ventilators muscle relaxants used patients <NUMBER> <NUMBER> <NUMBER> numerous therapeutic interventions performed treat ards since mechanisms damage ards complex diverse seems therapeutic strategies target single pathway mediator cannot useful achieving therapeutic outcome <NUMBER> therefore interventions target several aspects immunopathogenesis associated injuries helpful find appropriate treatment strategy <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> mscs multipotent cells obtained different tissues adipose tissue bone marrow cells selfrenewing capacity differentiated chondrogenic osteogenic adipogenic lineages <NUMBER> several features cells made appealing candidate treatment many diseases including ards  immunomodulatory properties mscs able alter function immune cells modulate immune response <NUMBER> example lpsinduced ards animal models shown mscs suppress inflammation reduce inflammationinduced lung injury immunomodulatory properties cells affect macrophages releasing prostaglandin e<NUMBER> pge<NUMBER> reduce production inflammatory cytokines increase il<NUMBER> production il<NUMBER> reduced neutrophils recruitment lungs attenuated inflammatory cytokine production <NUMBER> <NUMBER> <NUMBER> mscs also increase regulatory cells alter phenotype macrophages m<NUMBER> macrophages <NUMBER>  tissue repair characteristic mscs also potential repair tissue prevent apoptosis lung cells regenerate especially type ii alveolar cells producing growth factors keratinocyte growth factor kgf vascular endothelial growth factor vegf hepatocyte growth factor hgf characteristic important people ards develop pulmonary fibrosis even surviving acute phase disease <NUMBER> <NUMBER> <NUMBER> mscs restore epithelial protein permeability secretion angiopoietin<NUMBER> cells increase phagocytosis capacity macrophages transferring microvesicles <NUMBER>  studies shown mscs could imply antiviral activity shown gammaherpesvirus infected mscs could limit replication virus sensing dna cgas initiation stingtbk<NUMBER> signaling pathway pathway resulted ifnγ production along ifnγ independent manner could responsible antiviral response mscs <NUMBER> addition studies shown ido expressed mscs could responsible antiviral activity mscs <NUMBER> <NUMBER> <NUMBER> idopositive mscs triggered inflammatory cytokines demonstrated antimicrobial effector function pathogens viruses <NUMBER> study performed <NUMBER> shown ifnγ stimulated expression ido mscs replication cmv hsv<NUMBER> decreased <NUMBER> summary suggested mscs attractive candidates improving covid<NUMBER>induced ards lung injury due immunomodulatory tissue repair antiviral characteristics fig <NUMBER>b suggestion using mscsderived exosomes shown msc significantly decreased <NUMBER> study performed <NUMBER> intravenous injection mscexosomes reduced tnfα il<NUMBER>β nfκb matrix metallopeptidase <NUMBER> lung another study mentioned exosomes could decrease endothelial cell apoptosis il<NUMBER> production increase il<NUMBER> production also observed <NUMBER> addition due specific structure exosomes mirnas well various drugs inserted administration exosomes trapped lung tissue reached target cells mirnas drugs target specific molecules inside infected cells diminish local inflammation prevent apoptosis lung cells <NUMBER> song et al study showed pretreatment mscs il<NUMBER>β augmented immunomodulatory effects exosomes transfer mir<NUMBER>a target cells <NUMBER> advantages exosomes include ease access lack problems associated cell maintenance injections proper size finally nature phospholipid membranes enable fuse target cell membrane transfer cargo cytoplasm additionally special structure protects contents exosomes degradation <NUMBER> investigate effects exosomes derived mscs study performed according following steps characteristics first section study mscs isolated tissues different sources chosen adipose tissue bone marrow wharton jelly etc second cells cultured differentiation potential homogenous population spindleshaped mscs determined using vitro adipogenic osteogenic induction addition immunophenotype mscs confirmed measurement cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> hladr cell surface marker using flowcytometry adaptation cells serumfree medium supernatants collected good manufacturing practice gmpgrade method used isolation exosomes supernatants medicinal product <NUMBER> next step characterize exosomes purpose size distribution isolated exosomes evaluated using dynamic light scattering dls nanosight nanoparticle tracking analysis nta morphology vesicles determined using scanning electron microscopy sem transmission electron microscopy tem analysis addition expression exosome membrane specific markers including cd<NUMBER> cd<NUMBER> cd<NUMBER> assessed using western blot flowcytometry second section study related animal model preparation exosome injection better choose two ards models induced different condition compare example hace<NUMBER> transgenic animal infected sarscov<NUMBER> <NUMBER> lpsinduced ards animal <NUMBER> next isolated exosomes injected animals intravenous intratracheal injection performed suggested use routes compare injection program designed like pbs exosomes derived sources fibroblasts mscexosomes dose <NUMBER> mscexosomes dose <NUMBER> doses final section study effects exosome injection different groups measured lung function assessment investigated arterial oxygenation static lung compliance evaluation <NUMBER> addition histological examination microct done assessment lung injury ball important sample evaluating effects mscexorcisms lung inflammation collection ball sample differential leukocyte count done monitoring viral load real time pcr beneficial technique evaluating cytokine profile using elisa useful another sample blood differential leukocyte count inflammatory cytokines crp level important data evaluating mscexosomes effects ards cytokine storm procedure performed clinical trials studies confirmation animal models fig <NUMBER> since covid<NUMBER> treatment currently focused supportive therapies vaccine developed <NUMBER> numerous research studies needed find potential therapies control virus soon possible sarscov<NUMBER> high transmission potential spreads rapidly throughout world causes many deaths since pathogenesis disease identified partially previous studies similarities pathogenesis viruses family bacterial infections cause lung injury ards <NUMBER> <NUMBER> <NUMBER> investigation therapeutic approaches suppress inflammation cytokine storm ards helpful finding novel therapeutic approach disease therefore use mscs one immunomodulating tissue regenerating cells previously shown satisfactory effects ards cytokine storms <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> could considered since cells exert effects variety ways exosomes secretion use exosomes considered cellfree therapy <NUMBER> exosomes antiinflammatory effects lung tissue transferring mrnas mirnas various proteins secretory cell target cell <NUMBER> previously shown exosomes reduce inflammatory cytokines increase regulatory cytokines suppress inflammation <NUMBER> monsel et al also showed mscexosomes could increase survival alveolar type ii cells increasing intracellular atp levels <NUMBER> introduced hypothesis order study future hope see satisfactory results authors conflict interest financial support used development writing manuscript ■the authors declare known competing financial interests personal relationships could appeared influence work reported paper ☐the authors declare following financial interestspersonal relationships may considered potential competing interests family coronaviruses cov enveloped rna viruses highly pathogenic human beings <NUMBER> long epidemics two highly infectious coronaviruses severe acute respiratory syndrome coronavirus sarscov <NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> resulted disastrous effects human beings globally outbreak severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> coronavirus disease<NUMBER> covid<NUMBER> originated wuhan china end <NUMBER> caused thousands deaths <NUMBER> phylogenetic analysis sarscov<NUMBER> indicated closely related sarscov <NUMBER> little distant merscov<NUMBER> <NUMBER> pathological changes covid<NUMBER> dead puncture suggest pathological characteristics similar sarscov merscovinduced viral pneumonia <NUMBER> thus critical identify common patterns lethal pathogens immune response coronavirus specific immune response immune escape characteristics causes severe pathogenic mechanisms inflammation leaded severe pneumonia pulmonary oedema ards multiple organ failure even death <NUMBER> cytokine storm also known cytokine cascade hypercytokinemia caused infection drugs autoimmune diseases bodys excessive immunity response <NUMBER> pioneering investigations confirmed increased volumes proinflammatory cytokines serum eg il<NUMBER>b il<NUMBER> il<NUMBER> ifnγ correlated pulmonary inflammation severe lung impairment sars patients <NUMBER> merscov infection also described provoke increased concentrations cytokines il<NUMBER>il<NUMBER> aging tnfα ifnγ <NUMBER> reported victims infected sarscov<NUMBER> also demonstrate high amounts il<NUMBER>b ifnγ ip<NUMBER> mcp<NUMBER> may attribute activated th<NUMBER> helper cell responses <NUMBER> although virus invaded human bodies various proteinssarscov angiotensinconverting enzyme <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> merscov dipeptidyl peptidase<NUMBER> ddp<NUMBER> sarscov<NUMBER> ace<NUMBER> possibly similar cytokine cascade immune response caused severe damage widely covered <NUMBER> hence identifying key cytokines induced coronavirus infection cells involved regulation cytokine storms blocking signal transduction greatly reduce inflammatory response damage lung tissue multiple organs patients sarscov<NUMBER> shows <NUMBER> identity sequence sarslike coronaviruses <NUMBER> sequence merscov due similar structure pathogenesis similar sarscov<NUMBER> like sarscov requires ace<NUMBER> merscov enters target cells via ace<NUMBER> via binding dpp<NUMBER> ace<NUMBER> dpp<NUMBER> expressed several human tissues virus enters cells antigen presentation subsequently stimulates bodys humoral cellular immunity mediated virusspecific immune cells immune response causes lot symptoms main death cause coronavirus cytokine storm deadly uncontrolled systemic inflammatory response covid<NUMBER> induced strong immune response resulting release large amounts proinflammatory cytokines chemokines similar symptoms sarscov merscov infections hence although pathogenesis covid<NUMBER> poorly understood similar mechanisms sarscov merscov still give us lot information pathogenesis sarscov<NUMBER> infection facilitate recognition covid<NUMBER> figure <NUMBER> explore sarscov induced immune responses infected mice group analyzed lungs mice harvested <NUMBER> <NUMBER> <NUMBER> hours postinfection least <NUMBER> biological replicates collected pneumonia elderly susceptible infection symptoms heavier changes inflammatory factors <NUMBER> <NUMBER> <NUMBER> hours infection sars virus elderly rats analyzed multiple factors found occur il<NUMBER>α il<NUMBER> β il<NUMBER> il<NUMBER> presented significant higher level obvious <NUMBER> hours level il<NUMBER> showed moderate fluctuation il<NUMBER>α decreased trend figure <NUMBER> results showed sarscov infection induced cytokine storm interferon system protects mammals virus infections analyzed changes interferon <NUMBER>h <NUMBER>h <NUMBER>h infection sars virus elderly rats found ifnα<NUMBER> ifnβ<NUMBER> ifn<NUMBER> demonstrated higher expression volumes especially <NUMBER>h figure <NUMBER> suggest onset plasmacytoid dendritic cells pdcs proinflammatory monocytes terms changes chemokines synergistically induce proinflammatory recruitment level ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> drastically elevated <NUMBER>h remained high level <NUMBER>h meantime cxcl<NUMBER> expression increased <NUMBER>h decreased <NUMBER>h cxcl<NUMBER> expression showed decreased trend <NUMBER>h <NUMBER>h compared <NUMBER>h figure <NUMBER> taken together rising molecules reflected antiviral response host early phase order explore common pattern immune response coronavirus contagion analyzed situation merscov infected human microvascular endothelial cells analyzed expression genes interleukins interferons <NUMBER>h found interleukins il<NUMBER> il<NUMBER>α il<NUMBER> il<NUMBER> il<NUMBER>α il<NUMBER>β interferons ifnα<NUMBER> ifn<NUMBER> ifnγ increased dramatically figure <NUMBER> indicated elevated antivirus immune response explore immune differences young aged mice analyzed cytokine variation sarscov infected <NUMBER> <NUMBER> hours results showed several cytokines increase significantly aged mice young mice figure <NUMBER> indicated coronavirus may cause severe cytokine storms elderly patients quantify immune response cell level applied ssgsea method compare variation different immune cells aged young mice sarscov infection level cells nk cells monocytes increased significantly aged young mice lymphoid cells show elevated level young mice remained stable comparatively aged mice aging granulocytes tend decrease aged young mice infection interestingly monocytes aged mice increased quickly <NUMBER>h young mice <NUMBER>h figure <NUMBER> results showed coronavirus infection cause strong immune response young old mice lymphocytemediated immune responses severe young mice monocytemediated immune responses rapid older mice study analyzed immune cells peripheral blood <NUMBER> patients covid<NUMBER> disease table <NUMBER> found total lymphocytes cd<NUMBER> cd<NUMBER> cd<NUMBER> lymphocytes significantly went severe type patients compared common type figure <NUMBER> indicated sarscov<NUMBER> impose hard blows human lymphocyte resulting lethal pneumonia moreover total lymphocytes cd<NUMBER> lymphocyte counts decreased severely patients <NUMBER> years old <NUMBER> suggest young patients likely bounce back cd<NUMBER> cd<NUMBER> lymphocyte counts showed significant difference different age groups pathological manifestations covid<NUMBER> greatly resemble seen sars mers infection massive interstitial inflammatory infiltrates diffused lung <NUMBER> cellular fibromyxoid exudate caused severe alveolar impairment postmortem autopsy indicates cytokine storm may play critical role patient rapid death study found genes coding interleukinsil<NUMBER>α il<NUMBER>β il<NUMBER> il<NUMBER> chemokines ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> interferons ifnα<NUMBER> ifnβ<NUMBER> ifn<NUMBER> raised significantly sarscov treated mice within <NUMBER>h line elevated infiltration cells nk cells monocytes similar pattern cytokine projection found merscov infected group investigating inflammatory profile sars mers may advance knowledge immunepathological process covid<NUMBER> treatment study reviewed sarsinfected mice merstreated human micro vascular endothelial cells clarify association temporal changes cytokine chemokine profiles six immune cell infiltration patterns retrospectively reviewed clinical data <NUMBER> cases common severe type covid<NUMBER> discharged february <NUMBER> <NUMBER> found severe type patients suffered serious symptoms like higher fever took time recover may suggest fluctuation immune indices predictive value explore specific mechanism immune environment changes analyzed potential influencing factors cytokines merely aid process antimicrobial immunity liable immunepathological damage owner cells causing significant morbidity even fatality multiple respiratory disorders well <NUMBER> <NUMBER> chemokines like cxcl<NUMBER> ip<NUMBER> ccl<NUMBER> mcp<NUMBER> proved upregulated monocytesmacrophages sarscov consistent results <NUMBER> clinical progression mers cases proves secretion monocyte chemoattractant protein<NUMBER> mcp<NUMBER> cxcl<NUMBER> control <NUMBER> proinflammatory cytokines il<NUMBER> ccl<NUMBER> interferonstimulated genes cxcl<NUMBER> involved tolllike receptors tlr signaling <NUMBER> molecules effectors process respiratory virus infections towards context acute respiratory distress syndrome ards lethal covid<NUMBER> patients <NUMBER> il<NUMBER> main cytokine secreted dcs manages differentiation cd<NUMBER> cells th<NUMBER> cells serves essential duty cellmediated immunity il<NUMBER> includes il<NUMBER> family aging predominantly proinflammatory cytokines contribute critical roles growth th<NUMBER> cells <NUMBER> <NUMBER> increased expression il<NUMBER> il<NUMBER> sarsinfected lung tissue mice may indicate activated response th<NUMBER> th<NUMBER> cells observed mers victims well <NUMBER> interesting sarscov infected cells ace<NUMBER> significantly correlated neutrophils nk cells th<NUMBER> cells th<NUMBER> cells th<NUMBER> cells dc may call investigations <NUMBER> ifnαβ regarded one bodys primary antiviral defenses ifnβ exerts effects intercellular communication resulting induction ifnαβ interferonstimulated genes isgs make important aspect host antiviral defense <NUMBER> notwithstanding particular cell types pdcs monocytes confirmed produce ifn cell types viral infection committed <NUMBER> elevated level ifn monocyte infiltration analysis validates aging innate immune response basis pdcs monocytes may play substantial role formation cytokine storm damages lung severely lymphopenia common covid<NUMBER> patients severe lymphocyte reduction occurred <NUMBER> patients especially heavy group consistent latest reported results <NUMBER> flow cytometry showed cd<NUMBER> cd<NUMBER> cd<NUMBER> lymphocytes decreased varying degrees aged patients suffered severe decrease total lymphocytes cd<NUMBER> lymphocytes <NUMBER> patients decrease cd<NUMBER> lymphocytes incidence higher heavy group common group shows sarscov<NUMBER> may mainly attack lymphocytes body cause reduction cd<NUMBER> lymphocytes resulting decreased immune function infection severe cases severe pneumonia word analyze cytokine profiles sarscov infected mice merscov infected human micro vascular cells interleukin il<NUMBER>α il<NUMBER> β il<NUMBER> il<NUMBER> chemokine ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> interferon ifnα<NUMBER> ifnβ<NUMBER> ifn<NUMBER> increased dramatically sarscov treated mice within <NUMBER>h merscov treated cells interleukins il<NUMBER> il<NUMBER>α il<NUMBER> il<NUMBER> il<NUMBER>α il<NUMBER>β interferon ifnα<NUMBER> ifn<NUMBER> ifnγ showed significant ascending trend <NUMBER>h subsequent analysis revealed elevated abundance cells nk cells monocytes young aged mice group treated sarscov impaired lymphocyte system severe aged covid<NUMBER> patients indicates disease likely progress cytokines exhausted functional lymphocytes suppressed thus catching window treatment covid<NUMBER> according immune molecules may critical microarray datasets related gene expression obtained geo database sarscov dataset gse<NUMBER> young <NUMBER> weeks old aged <NUMBER> year old female balbc mice intranasally infected <NUMBER> pfu ma<NUMBER> epsilon sarscov pathogenic virus merscov dataset gse<NUMBER> human microvascular endothelial cells infected merscov<NUMBER> merscov pathogenic virus mocks <NUMBER>h postinfection time point picked analysis gene expression datasets independently log<NUMBER> transformed quantile normalized linear models microarray data limma package r language environment patients diagnosed covid<NUMBER> collected wuhan jinyintan hospital january <NUMBER> february <NUMBER> <NUMBER> collected study approved ethics review committee wuhan jinyintan hospital diagnostic criteria according diagnosis treatment new coronavirus pneumonia issued general office national health health commission diagnostic standard <NUMBER> classified patients <NUMBER> types <NUMBER> common fever respiratory tract symptoms without pneumonia manifestations imaging <NUMBER> severe meet following ① respiratory distress rr ≥ <NUMBER> beats min ② resting state refers oxygen saturation ≤ <NUMBER> ③ partial pressure arterial oxygen pao<NUMBER> oxygen concentration fio<NUMBER> ≤ <NUMBER>mmhg wilcoxon ttest used determine differences two groups continuous variables kruskal wallis rank sum test two groups respectively applied single cell gene set enrichment analysis ssgsea estimate infiltration immune cells <NUMBER> using gsva r package <NUMBER> fingerprint genes granulocytes monocytes nk cells activated naive cells b cells lymphoid cells extracted previous study <NUMBER> statistical analyses performed r version <NUMBER> language environment pvalue <NUMBER> twosided considered significant jhz conceived initial concept designed study kw zz zxy participated design study data extraction zz zxy wrote manuscript authors read approved final manuscript viruses including sars influenza change quickly thereby negating efficacy developed vaccines targetted antiviral drugs <NUMBER> consequently important utilize substance widely limit viral effects often case covid<NUMBER> little likelihood developing vaccine antiviral within year emergence devastating infection utilizing developing generic antivirals significant challenge given viruses vary considerably effects including immune system example general antiviral requirement influenza covid<NUMBER> would treatment limits initial innate immuneassociated cytokine storm evident also acting increase efficacy adaptive immune response <NUMBER> however ebola virus initial dampening innate immune response clinically relevant allowing variability virus effects melatonin emerged top candidate protection array different viruses including coronavirus <NUMBER> <NUMBER> <NUMBER> would seem arise close evolution melatonin within emerging mitochondria first singlecellular organsims allowing melatonin intimately associated mitochondrial function thereby immune system regulation <NUMBER> interactions bacterialdriven coexistence viruses provided war worlds plant animal evolution emerged evolution acted tolerate limit rather annihilate melatonin important aspect interactions viruses data pertaining pathophysiology covid<NUMBER> still emerge current article focusses primarily role melatonergic pathway management influenza viruses well highlighting potential utility supporting people high risk fatality influenza viruses covid<NUMBER> time writing data china italy indicate elderly far higher risk covid<NUMBER> linked mortality primarily consequence ageingassociated conditions cardiovascular pulmonary diabetic disorders well immunecompromised conditions melatonin clinical utility health conditions suggesting utility buffering covid<NUMBER> interactions medical conditions however interactions melatonergic pathway viruses may complex ameliorative effects ageingassociated preexisting medical conditions first melatonergic pathway reviewed pathway may interact effects influenza covid<NUMBER> viruses treatment implications well providing indications important future research understanding human physiological systems provide treatment targets regulate impact viral infections including influenza covid<NUMBER> driven pathophysiology melatonin classically associated nighttime release pineal gland effects circadian entrainment long recognized melatonin modulates cellular function via number processes including activation intracellular signalling pathways transcription factors act dampen inflammatory activity melatonin also powerful antioxidant antiinflammatory mediates many effects via optimization mitochondrial function emerging data indicate melatonergic pathway evident cells pineal gland may predominantly present within mitochondria figure <NUMBER> shows enzymes factors forming melatonergic pathway different processes modulate pathway melatonin derived tryptophan via conversion serotonin arylalkylamine nacetyltransferase aanat converts serotonin nacetylserotonin nas converted melatonin acetylserotonin methyltransferase asmt however variations nasmelatonin ratio occur largely ignored previous research melatonin synthesis seen ultimate aim melatonergic pathway number factors may act regulate nasmelatonin ratio variety mechanisms different cell types including odemethylation cytochrome p<NUMBER> cyp<NUMBER>c<NUMBER> cyp<NUMBER>b<NUMBER> atp purinergic receptor p<NUMBER>y<NUMBER> well intercellular glutamate metabotropic glutamate receptor mglur<NUMBER> activation <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> variations nasmelatonin ratio exist may significant clinical importance range medical conditions including glioblastoma <NUMBER> multiple sclerosis <NUMBER> although nas melatonin similar antioxidant antiinflammatory effects nasmelatonin ratio may importance given nas activates brain derived neurotrophic factor bdnf receptor trkb well inducing bdnf two products kynurenine pathway kynurenic acid kynurenine activate aryl hydrocarbon receptor ahr induces cyp<NUMBER>b<NUMBER> allows proinflammatory cytokines cortisol oxidative stress increase indoleamine <NUMBER>dioxygenase ido tryptophan <NUMBER>dioxygenase tdo increase ahr ligands well kynurenine pathway products consequently proinflammatory conditions well heightened levels psychological stress oxidative stress decrease tryptophan availability serotonergic melatonergic pathways may also modulate nasmelatonin ratio including via ahr activation figure <NUMBER> data would indicate nasmelatonin ratio may important sensor wider body systems consequences intracellular extracellular function circadian entrainment induced pineal melatonin strongly driven melatonins upregulation circadian gene bmal<NUMBER> seems mediate many melatonins effects mitochondria bmal<NUMBER> inhibits pyruvate dehydrogenase kinase pdk leading disinhibition pyruvate dehydrogenase complex pdc pdc drives conversion pyruvate acetylcoenzyme acetylcoa mitochondria thereby increasing tricarboxylic acid tca cycle oxidative phosphorylation oxphos atp production acetylcoa also necessary cosubstrate aanat therefore allows pineal melatonin via bmal<NUMBER>pdkpdc path increase activation mitochondrial melatonergic pathway happen aanat needs stabilized <NUMBER> protein present within mitochondrial matrix <NUMBER> <NUMBER> proposed aanat may also stabi acetylcoa symptom severity cytokine storm stress increase gut dysbiosispermeability contributing cytokine induced ido tdo leading kynurenine kynurenic acid activate ahr increase cyp<NUMBER>b<NUMBER> regulate nasmelatonin ratio factors including cyp<NUMBER>c<NUMBER> mglur<NUMBER> p<NUMBER>y<NUMBER> odemethylation also regulate nasmelatonin ratio mirnas mir<NUMBER> mir<NUMBER> mir<NUMBER> increased following many viral infections thereby suppressing <NUMBER> stabilization aanat leading melatonergic pathway inhibition suppression melatonin including increase nasmelatonin ratio attenuates melatonins induction bmal<NUMBER> therefore circadian regulation mitochondria bmal<NUMBER> induces pdc leading increase oxphos tca cycle acetylcoa necessary cosubstrate aanat melatonergic pathway activation decrease pineal mitochondrial melatonin contributes increase replication severity many viral infections arrows indicate stimulation crossedline indicating inhibitory <NUMBER>like motif cterminal within mitochondrial matrix <NUMBER> pineal melatoninmitochondrial melatonin path may important immune cells although relevant cells subject circadian regulation pineal melatonin daytime activation immune cells associated glycolytic metabolism pineal melatonin resets oxphos thereby inducing quiescent immune cell phenotyes processes immune cells dampened night however presence indicants required immuneinflammatory activity night proinflammatory cytokines switch pineal melatonin production thereby forming another branch immunepineal axis <NUMBER> circadian rhythm driven pineal melatonin powerful immune regulator effects include viruses quite distinct interactions host course infection making generalizations across different viruses impossible however factors found regulate effects many different viruses one factor ahr ahr number endogenous exogenous ligands includ overall ahr may important link initial cytokine storm alterations mitochondrial immune cell function including via alterations melatonergic pathway influence circadian rhythm also seen following influenza vaccination timing vaccination sample collection modulates bcell response measures especially elderly <NUMBER> host circadian rhythm significant regulator response viral infection preclinical data show irrespective viral burden survival following influenza viral infection determined circadian influence patterning immune response <NUMBER> circadian gene bmal<NUMBER> significant inhibitor herpes simplex virus hsv<NUMBER> influenza viruses highlighting role circadian factors regulation viral infections <NUMBER> loss circadian rhythm increase viral replication viruses act sabotage circadian regulation exemplified hsv<NUMBER> suppression bmal<NUMBER> <NUMBER> overlaps data lung pulmonary airway epithelial cell bmal<NUMBER> regulates response influenza virus <NUMBER> influenza virus also decreasing bmal<NUMBER> thereby contributing circadian disruption induced virus <NUMBER> data highlight circadian nature host physiology including many virusrelevant pathways upon viruses act promote survival proliferation noted effects pineal melatonin include bmal<NUMBER> induction major driver pineal melatonins influence circadian rhythms bmal<NUMBER> acting regulate mitochondrial metabolism importance processes given support data humans severe influenza infection associated poor survival rates severe influenza covid<NUMBER> infections seem driven initial cytokine storm increase proinflammatory cytokines acting suppress pineal melatonin production <NUMBER> essence immunepineal axis <NUMBER> whereby proinflammatory cytokines act signal need ongoing immune response thereby prevent suppression pineal melatonin major driver multiorgan failure evident severe influenza infection dysregulation mitochondrial metabolism <NUMBER> lost influence decreased pineal melatonin metabolic dysregulation elevation cellular trypsin hemagglutinin processing protease viral multiplication often aspect leading influenza viruscytokinetrypsin cycle coupled decrease mitochondrial atp <NUMBER> work influenza viruscytokinetrypsin cycle led new proposed treatments target atp crisis multi inflammasome <NUMBER> regulation nlrp<NUMBER> inflammasome taken viruses <NUMBER> melatonin significant inhibitor nlrp<NUMBER> inflammasome <NUMBER> suppression melatonin production pineal mitochondrial viruses likely important aspect viruses disengage nlrp<NUMBER> inflammasome physiological processes also noted il<NUMBER> induced along il<NUMBER>β nlrp<NUMBER> inflammasome activation il<NUMBER> relatively underinvestigated viral research many medical conditions <NUMBER> growing interest role gut microbiome across host diverse medical conditions including neurodegenerative psychiatric conditions <NUMBER> also immunemediated conditions multiple sclerosis arthritis <NUMBER> <NUMBER> line recent data show many viral infections including influenza drive changes gut lung microbiomes <NUMBER> viralmediated changes gut including gut dysbiosis increased gut permeability authors also show changes gut microbiomepermeability contribute secondary bacterial pneumonia <NUMBER> butyrate also immunesuppressant via capacity disinhibit pdc thereby increase mitochondrial oxphos tca cycle acetylcoa melatonergic pathway <NUMBER> seems unlikey butyrate therefore acts mitochondrial melatonergic pathway increase melatonin production suggested induction melatonergic pathway intestinal epithelial cells <NUMBER> increase proinflammatory cytokines cytokine storm contribute viral infection severity fatality positively regulated activation sympathetic nervous system shown influenza virus infection <NUMBER> authors also showed sympathetic nervous system activation increase pulmonary pneumonia preclinical model inhibition sympathetic nervous system increasing survival <NUMBER> effects sympathetic nervous system may mediated increase release catecholamines also neuropeptide npy release monocytes also contributes influenzaassociated fatality <NUMBER> contrast activation parasympathetic nervous system following vagal nerve release acetylcholine affords protection viral infections via activation alpha <NUMBER> acetylcholine nicotinic receptor α<NUMBER>nachr <NUMBER> including decreasing macrophage inflammatory responses <NUMBER> noted α<NUMBER>nachr intimately associated melatonin positively regulated pineal melatonin circadian rhythm <NUMBER> whilst impact melatonin preventing gut permeability challenge mediated induction vagal nerve ach release subsequent α<NUMBER>nachr activation <NUMBER> viral suppression melatonin associated decrease induction α<NUMBER>nachr vagal ach thereby decreasing viraland immunesuppressive activity vagal activated α<NUMBER>nachrs also noted α<NUMBER>nachr expressed mitochondria outer membrane suggesting direct impacts mitochondrial function including immune cells regulation mitochondria ca<NUMBER> influx <NUMBER> <NUMBER> overall shifts balance sympatheticparasympathetic nervous systems may another aspect viral infections another route whereby viral regulation melatonergic pathway act wider systemic regulatory processes manner increase viral severity decrease host survival also noteworthy increased gut dysbiosispermeability fre drial optimization effects well induction melatonergic pathway ability decrease gut permeability associated high risk preexisting medical conditions overall biomedical financial moral reasons developing testing interventions may immediately limit impact viral infections applicable <NUMBER> introduction influenza viruses corona viruses related pneumotropic viruses cause sickness death partly inducing hyperproinflammatory immune response host airway immune overreaction called cytokine storm lead multiorgan failure death tisoncik et al <NUMBER> example influenza h<NUMBER>n<NUMBER> shown activate tnfadriven nfkb signaling pathway mouse host viral infection generating cytokine storm schmolke et al <NUMBER> anticipated inhibitors nfkb acutely suppress cytokine storm increase survival mouse model sars cov infection dediego et al <NUMBER> recent data show covid<NUMBER> also activates nfkb guo et al <NUMBER> cytokine storm marks airways sarscov<NUMBER>infected patients admitted intensive care unit icu severe disease since multiple strains influenza well coronavirus might advantage develop therapies suppress hostinduced cytokine storm addition developing strainspecific vaccines clinical problem limited options treating respiratory cytokine storm predicated inhibiting nfkbactivated cytokine expression yang et al <NUMBER>a teijaro et al <NUMBER> yang et al <NUMBER> absence nfkb inhibitory drugs human formulary due candidate drugs either neurotoxic nephrotoxic administered chronically zhang et al <NUMBER> one drug lacks toxicities cardiac glycoside digitoxin previously shown digitoxin among potent inhibitors proinflammatory tnfanfkb pathway human airway epithelial cells vitro srivastava et al <NUMBER> vivo zeitlin et al <NUMBER> pollard et al <NUMBER> yang et al <NUMBER> corroborating screen <NUMBER> drugs bioactive compounds found digitoxin <NUMBER>nd potent inhibitor tnfanfkb activity miller et al <NUMBER> digitoxin drug treat heart failure decades safe children adults normal hearts hoffman bigger <NUMBER> clinical trial digitoxin administered young adults proinflammatory lung disease cystic fibrosis digitoxin safe study showed mrnas encoding chemokinecytokine cell surface receptors immune cells decreased nasal epithelial cellsleading pathwaymediated reductions il<NUMBER> il<NUMBER> lung epithelial inflammation neutrophil recruitment mucus hypersecretion zeitlin et al <NUMBER> test ability digitoxin inhibit cytokine storm related pneumotropic viruses used cotton rat model influenza infection investigate effects digitoxin influenzainduced cytokine storm cotton rat model important advantage susceptibility influenza infection without engineered adaptation addition shown response cotton rat virus strain evokes pattern pulmonary cytokine changes parallel human response ottolini et al <NUMBER> digitoxin blocks cytokine storm figure <NUMBER> shows changes cytokine protein lung due digitoxin administration cotton rat intranasally infected <NUMBER> <NUMBER> tcid<NUMBER> gm animal influenza strain awuhanh<NUMBER>n<NUMBER> virus animals given three different doses digitoxin starting one day prior virus administration continuing daily dose sacrifice day <NUMBER> maximum dose digitoxin <NUMBER> µgkg calculated similar human dose routinely used treat heart failure shown figure <NUMBER> protein data collected ifng interferon gamma grokc rodent equivalent human il<NUMBER> mip<NUMBER> chemokine cxc motif ligand <NUMBER> cxcl<NUMBER> macrophage inflammatory protein <NUMBER>alpha tnfa tumor necrosis factor alpha il<NUMBER>b interleukin one beta mcp<NUMBER> monocyte chemoattractant protein <NUMBER> ccl<NUMBER> tgfb transforming growth factor beta summarized table <NUMBER> digitoxindependent changes protein found significant <NUMBER> <NUMBER> cytokines digitoxindependent reductions specific saturating cytokine reduce zero table <NUMBER> shows greatest significant digitoxindependent reductions cytokine proteins found ifng <NUMBER> grokc <NUMBER> mcp<NUMBER> <NUMBER> smaller still significant reductions cytokine proteins found mip<NUMBER> <NUMBER> tnfa <NUMBER> also shown table <NUMBER> significant reduction <NUMBER> found tgfb cytokine protein concentration <NUMBER> µgkg trending significance noted higher digitoxin concentrations case il<NUMBER>b highest digitoxin concentration trended towards significance thus digitoxin independently dosedependently significantly lowers individual concentrations lung least six cytokines induced viral exposure data show administration digitoxin cotton rat inhibits expression many cytokines lung induced influenza strain awuhanh<NUMBER>n<NUMBER> including tnfa key activator tnfanfkb inflammation pathway digitoxin inhibits cytokine storm without compromising entire immune system physiologically responding viral infection data also indicate digitoxin acts multiple cell types example ifng secreted activated lymphocytes nk cells immune system mah cooper <NUMBER> remainder cytokines secreted epithelial cells airway well endothelial cells immune cells others mills et al <NUMBER> liu et al <NUMBER> grokc cxcl<NUMBER> rodent equivalent human il<NUMBER> key target nfkb signaling powerful known chemoattractant drawing neutrophils lung mip<NUMBER> mcp<NUMBER> induce entry accumulation monocytes macrophages lung targets nfkb tgfb drives driven nfkbsignaling inflammation fibrosis il<NUMBER>b also drives nfkb driven nfkb appears digitoxindependent reduction tnfanfkb signaling sufficient suppress influenza adriven cytokine storm cotton rat lung ifng mrna expression response infection biphasic ottolini et al <NUMBER> early phase <NUMBER> hours infection day <NUMBER> day <NUMBER> may reflect presence activated nk cells late phase day <NUMBER> day <NUMBER> may product incoming antigenspecific cells importantly simply neutralizing infg mouse model infection influenza virus strain acalifornia<NUMBER> h<NUMBER>n<NUMBER>v swine flu sufficient alleviate acute lung injury also increase weight survival rate liu et al <NUMBER> reduced ifng associated reduced tnfa nfkb activation data also show digitoxin treatment causes profound reduction infg expression known ifng expression driven combination nfkb nfat sica et al <NUMBER> summarized figure <NUMBER> digitoxin reduces nfkb expression also reduces nfat digitoxindependent activation caspase <NUMBER> yang et al <NUMBER>b finally since antiviral properties reported digitoxin cardiac glycosides limitation study cannot exclude antiviral effects digitoxin contributing reduction influenzadependent cytokine concentrations burkard et al <NUMBER> amarelle lecuona <NUMBER> wei et al <NUMBER> conclusion data show digitoxin blocks host cytokine storm induced influenza strain awuhanh<NUMBER>n<NUMBER> cotton rat lung since digitoxin already shown safe cf patients pulmonary disease normal heart caused similar reduction nfkb driven cytokine expression drug may good candidate investigation therapy influenza potentially covid<NUMBER> cotton rat experiments performed previously described ottolini et al <NUMBER> experiments performed using protocols followed federal guidelines approved institutional animal care use committee animals sacrificed carbon dioxide inhalation drugs protocol drug preparation digitoxin µgkg obtained sigmaaldrich <NUMBER> pure drug prepared stock solution <NUMBER> ethanol diluted pbs administration digitoxin administered cotton rats intraperitoneally one day intranasal infection <NUMBER> <NUMBER> tcid<NUMBER> gm cotton rat influenza strain awuhanh<NUMBER>n<NUMBER> daily digitoxin treatment continued harvest day <NUMBER> experiment day <NUMBER> experiment animals sacrificed left lung first tied reserved cytokine analysis lung samples immediately frozen dry ice kept <NUMBER> c processed remaining lung tissue processed histological analysis histology revealed apparent change due administration drug frozen tissues transferred silver pharmaceuticals coronavirus disease <NUMBER> caused infection severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> spread across world serious pandemic <NUMBER> <NUMBER> sarscov<NUMBER> enveloped virus nonsegmented singlestranded positivesense rna genome <NUMBER> member coronaviridae cov family causes predominantly respiratory illness wide range clinical severity ranging asymptomatic mildly symptomatic fever cough dyspnea myalgias fatigue diarrhea large proportion patients severe acute respiratory distress syndrome ards fatal multiorgan failure <NUMBER> <NUMBER> <NUMBER>•• disease casefatality rate ranges less <NUMBER> <NUMBER> average<NUMBER> <NUMBER> infectivity greater influenza <NUMBER> high transmissibility relatively high rate causing serious complications led covid<NUMBER> become serious public health threat worldwide among various physiological consequences severe covid<NUMBER> cardiovascular complications emerged significant life threatening covid<NUMBER> may present respiratory failure pneumonia ards without distributive ± cardiogenic shock <NUMBER> <NUMBER> <NUMBER>• severe cardiac injury manifesting markedly elevated troponin heart failure <NUMBER>• <NUMBER> cardiac injury also associated increased mortality <NUMBER>•• cohort study <NUMBER> patients confirmed covid<NUMBER> elevated troponin present <NUMBER> patients hospitalization found independent risk factor inhospital mortality <NUMBER>•• increased incidence cardiac injury among severe systemic inflammatory response syndromes sirs shock setting covid<NUMBER> also highlights important relationship immune response virus cardiovascular system addition high prevalence preexisting cardiometabolic disease noted among severe covid<NUMBER> <NUMBER> <NUMBER> preexisting cardiovascular conditions suffer increased mortality covid<NUMBER> infection <NUMBER> particular reported case fatality rates covid<NUMBER> <NUMBER> patients cardiovascular disease <NUMBER> patients diabetes <NUMBER> hypertension higher casefatality rate <NUMBER> observed worldwide patients without comorbidities <NUMBER>•• last least increased frequency adverse cardiovascular events following resolution covid<NUMBER> similar viral infections influenza <NUMBER> may also play role worsening mortality patients covid<NUMBER> thus understanding relationship viralhost immune response cardiovascular system critically important care management patients covid<NUMBER> going forward order better understand biology viral immune response impacts heart explore basic biological mechanisms underlying viral entry host cells subsequent immune response coronaviruses enveloped viruses singlestrand positivesense rna genome approximately <NUMBER> kilobases size largest known genome rna virus six coronaviruses covs known infect humans <NUMBER>e oc<NUMBER> sarscov nl<NUMBER> hku<NUMBER> merscov <NUMBER> humans cov infections primarily involve upper respiratory tract gi tract <NUMBER> studies demonstrated sarscov<NUMBER> well corona viruses requires angiotensinconverting enzyme <NUMBER> ace<NUMBER> cellular entry <NUMBER> ace<NUMBER> type integral membrane protein serves important role cardiorenal homeostasis also highly expressed lung alveolar cells providing main entry site virus human hosts <NUMBER> plausible high expression ace<NUMBER> lung gut heart kidneys may facilitate direct damage virus throughout course infection one key protein virusthe spike protein sfacilitates viral entry target cells binding surface unit s<NUMBER> ace<NUMBER> receptor host cell <NUMBER> <NUMBER> <NUMBER> followed cleavage hostcell protease tmprss<NUMBER> <NUMBER> important sarscov<NUMBER> components include hemagglutininesterase protein membrane protein nucleocapsid protein small envelope protein internal protein groupspecific proteins could become targets vaccines future <NUMBER> note sarscov<NUMBER> also contains rnadependent rna polymerase target antiviral agent remdesivir currently studied randomized clinical trials use covid<NUMBER> disease <NUMBER> host immune response viral entry also important discuss pathogenesis later stages sarscov sarscov<NUMBER> infection results direct viral toxicity also immune dysregulation hyperactivity <NUMBER> <NUMBER> progress field however hindered failure replicate mice ferrats nonhuman primates lethal human immune response ards original sarscov strain <NUMBER> <NUMBER> led development mouseor ratadapted strains sarscov able replicate extensive often lethal pulmonary disease <NUMBER> majority studies addressing immune response respiratory viral infections involve mice infected variety natural mouseadapted pathogens process respiratory viral invasion body begins infection airway epithelial cells activation lungresident dentritic cells rdcs via acquisition invading pathogen antigens infected epithelial cells rdcs become activated process antigen migrate draining mediastinal cervical lymph nodes dln naïve circulating cells dlns recognize antigens presented dcs form mhcpeptide complexes combination additional costimatory signals cells become activated proliferate migrate infected site <NUMBER> <NUMBER> upon arrival site infection cells produce release antiviral cytokines including interferon ifnγ tumor necrosis factor tnfα interleukin il<NUMBER> chemokines including cxc chemokine ligand cxcl<NUMBER> <NUMBER> <NUMBER> cytotoxic molecules perforin granzyme b <NUMBER> ifnγ effector cytokines directly inhibit viral replication enhance antigen presentation chemokines released activated cells recruit innate adaptive cells combat pathogen granzyme b cytotoxic molecules also directly kill infected cells eliminate pathogen <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent data china sarscov<NUMBER> <NUMBER> <NUMBER> well prior data sarscov <NUMBER> demonstrate rapid reduction lymphocytes cd<NUMBER> cd<NUMBER> peripheral blood infected patients <NUMBER> <NUMBER> <NUMBER> direct contrast proliferative lymphocyte responses seen viral infections epsteinbarr virus ebv human immunodeficiency virus hiv<NUMBER> cytomegalovirus cmv similar happens acute viral infections influenza loss lymphocytes precedes even abnormal radiographic changes chest xray <NUMBER>• despite reduction lymphocyte counts peripheral blood analysis patient infected sarscov<NUMBER> demonstrated increased markers lymphocyte activation <NUMBER> evidenced high proportions hladr cd<NUMBER> doublepositive fractions <NUMBER> additionally increased percentage highly proinflammatory ccr<NUMBER> th<NUMBER> among cd<NUMBER> cells increased concentration cytotoxic granules cd<NUMBER> cells <NUMBER> perforin positive <NUMBER> granulysin positive <NUMBER> granulysinperforin doublepositive <NUMBER> interestingly one group found production ifnγ cd<NUMBER> cells cd<NUMBER> cells nk cells tended lower severe cases compared moderate cases <NUMBER> cd<NUMBER> cells particular felt especially important hostimmune defense sarscov infections <NUMBER> addition disturbances regulatory cells tregs noted severe caseswith significantly lower proportion c<NUMBER>ra naïve tregs ntregs slightly higher proportion memory counterparts cd<NUMBER>ro memory tregs mtregs <NUMBER> recovery rapid significant restoration cd<NUMBER> cd<NUMBER> cd<NUMBER> cells along b cell nk cell counts <NUMBER> months onset disease <NUMBER> memory cd<NUMBER> cells returned normal <NUMBER> year onset whereas cell counts including total lymphocytes cd<NUMBER> cd<NUMBER> naïve cd<NUMBER> cells still lower healthy controls <NUMBER>• mechanism lymphocytopenia peripheral blood unclear thought due sequestration release sequestered cells upon recovery <NUMBER> taken together changes lymphocyte populations suggest dramatic dysregulation evidence cell exhaustion shifts adaptive immune response sarscov sarscov<NUMBER> infections <NUMBER> addition changes lymphocyte populations changes innate immunity likely also contribute viral pathogenesis particularly seen severe lung systemic inflammation secondary cytokine storm ards increased levels cytokines tnfα ifn inducible protein <NUMBER> ip<NUMBER> il<NUMBER> il<NUMBER> thought contribute tissue destruction poor outcomes <NUMBER> attributed hyperactivation macrophagemonocyte lineage cells sarscov<NUMBER>infected patients high levels il<NUMBER> beta ifnγ ip<NUMBER> monocyte chemoattractant protein<NUMBER> mcp<NUMBER> probably leads activated thelper<NUMBER> cell response <NUMBER> compared patients require icu admission requiring icu admission higher conentrations granulocyte colonystimulating factors gcsf ip<NUMBER> mcp<NUMBER> macrophage inflammatory protein<NUMBER> α mip<NUMBER>α tnfα suggesting cytokine storm might affect disease severity <NUMBER> additionally increased levels type ifn dysregulated ifnstimulated gene isg response seen patients severe sars <NUMBER> <NUMBER> last least sarsspecific igg antibodies produced late acute stage <NUMBER> weeks symptom onset gradually increase throughout course disease felt associated disease outcome <NUMBER> development antisarscov<NUMBER> antibodies highly relevant protecting viral replicationexpansion infected host well providing source antisarscov<NUMBER> convalescent plasma treat patients severe disease although supporting data efficacy currently lacking tested covid<NUMBER> positive patients expanded access program fda <NUMBER> myocardial injury manifesting elevated serum troponin levels described many patients infected covid<NUMBER> mortality associated increase troponin levels <NUMBER>th percentile upper limit normal electrocardiographic echocardiographic abnormalities <NUMBER>• <NUMBER> <NUMBER> addition reports rarer manifestation fulminant myocarditis markedly elevated troponin levels reported <NUMBER>• <NUMBER> <NUMBER> several thoughts mechanism injury including direct myocardial injury virus ace<NUMBER> entry hypoxiainduced myocardial injury microvascular damage endothelial shedding cytokine inflammationmediated damage <NUMBER>•• direct viral toxicity cardiomyocytes occurred setting viral infections coxsackievirusinduced myocarditis case entry coxsackievirus coxsackievirus adenovirus receptor car release protease <NUMBER>a coded coxsackievirus particles disrupting dystrophin cytoskeleton complex <NUMBER> <NUMBER> <NUMBER> case coronavirus mentioned spike protein coronaviruses facilitates viral entry target cells entry depends binding surface unit s<NUMBER> protein ace<NUMBER> allowing virus attach surface target cell addition entry requires protein priming cellular proteases entails protein cleavage s<NUMBER>s<NUMBER> s<NUMBER> site allows fusion viral cellular membranes process driven s<NUMBER> subunit <NUMBER> found sars<NUMBER>s shares <NUMBER> amino acid identity sarss engage ace<NUMBER> employ cellular serine protease tmprss<NUMBER> protein priming host cell entry <NUMBER> interestingly injection sarscov spike protein mice worsened acute lung failure vivo attenuated blockade reninangiotensin pathway <NUMBER> also note tmprss<NUMBER> highly expressed lung kidneys present low moderate levels heart blood vessels suggesting mechanisms injury latter organ systems <NUMBER> lastly amount viral load sarscov<NUMBER> infection correlates disease severity higher viral loads presentation correlating worse disease outcomes <NUMBER> study highlights potential importance direct viral toxicity pathogenesis covid<NUMBER> infections addition direct damage caused virus also speculation ischemic effect either form demand ischemia lung pathology direct toxicity virus macroor microvascular level suggested ace<NUMBER> expressed endothelium may induce endothelial shedding dysfunction contributing vascular damage local inflammation production procoagulant factors predisposing thrombosis similar increase myocardial infarctions observed influenza infections <NUMBER> <NUMBER> addition endothelial inflammation dysfunction increased incidence abnormal coagulation parameters disseminated intravascular coagulation dic noted patients sarscov<NUMBER> infection <NUMBER> <NUMBER> contributing risk thrombosis ischemic events could damage myocardium early reports fulminant myocarditis alerted medical scientific communities myocardial inflammation may play role cardiac injury viral infection <NUMBER>• <NUMBER> <NUMBER> however exact mechanism currently unclear <NUMBER>• <NUMBER> acute lymphocyte infiltrates noted myocardium sarscov<NUMBER>infected ards patient autopsy <NUMBER> mononuclear inflammatory cells seen currently great interest obtaining pathological specimens patients presenting markedly elevated troponin fulminant myocarditis order evaluate lymphocyteinduced myocardial injury sarscov<NUMBER> infection consistent myocardialspecific epitopes thus far identified setting sarscov sarscov<NUMBER> infection several hlaa<NUMBER>specific cells recognizing sarscov epitopes identified peripheral blood mononuclear cells pbmc sarsrecovered individuals including immunogenic epitopes localized spike nucleocapsid n protein sarscov <NUMBER> <NUMBER> note mriverified acute myocarditis reported association merscov <NUMBER> although exact mechanism occurs unknown although evidence direct lymphocytic infiltration myocardium exists dysregulation cells likely contribute cytokine storm multiorgan damage setting coronavirus infection recent retrospective multicenter study <NUMBER> patients confirmed inflammatory markers including elevated ferritin mean <NUMBER> ngml nonsurvivors vs <NUMBER> ngml survivors p <NUMBER> il<NUMBER> p <NUMBER> associated severe covid<NUMBER> infection suggesting systemic inflammation may significant driver multiorgan damage <NUMBER> <NUMBER> separate group also reported serum cytokines il<NUMBER>r il<NUMBER> il<NUMBER> tnfα increased patients severe disease <NUMBER> systemic release cytokines characterized increased il<NUMBER> il<NUMBER> il<NUMBER> gcsf ifnγ mcp<NUMBER> mip<NUMBER>α tnfα likely contributes cardiac injury situation analogous cardiotoxicity setting chimeric antigen receptor cart cell therapy prior study demonstrated cardiac injury cardiovascular events form elevated troponin left ventricular systolic dysfunction common postcart cohort <NUMBER> patients postcart cytokine release syndrome crs <NUMBER> elevated troponin <NUMBER> developed cardiovascular events including cardiac arrest decompensated heart failure arrhythmias <NUMBER> notably study shorter time crs onset administration il<NUMBER> inhibitor tocilizumab associated lower rate cardiovascular events <NUMBER> note tociluzumab may benefit covid<NUMBER> infection suggesting common mechanism injury two settings <NUMBER> exact mechanism cytokineschemokines damage myocardium unknown cardiomyocyte endothelial cell death presence inflammatory cytokines tnfα well documented literature <NUMBER> <NUMBER> age gender differences covid<NUMBER> infection rates raised interest possible differences ageand genderdependent immune responses viral exposure children account minority laboratoryconfirmed cases covid<NUMBER> china appear less susceptible severe disease <NUMBER> although functions innate adaptive immune immunity declines aging typically start late adulthood thus would fully explain decreased severity disease children compared even young adults <NUMBER> <NUMBER> <NUMBER> effect age immune system demonstrated low protective titers among <NUMBER> adults older <NUMBER> receive influenza vaccine <NUMBER> additional information differential response sarscovand sarscov<NUMBER> aging comes animal models comparison sarscovma<NUMBER>infected young c<NUMBER>bl<NUMBER> mice infection aged mice <NUMBER> months associated severe reduction number virusspecific cd<NUMBER> cells lungs <NUMBER> addition effect aging gender also thought play role outcomes sarscov<NUMBER> infection one study demonstrated higher incidence sarscov<NUMBER> infection older adult males compared females <NUMBER> sex differences immune response noted literature although reasons clear males experience greater severity prevalence bacterial viral fungal parasitic infections females also mount robust response antigenic challenges including infection vaccination <NUMBER> <NUMBER> <NUMBER> <NUMBER> davis et al used machine learning approaches identify cluster genes involved lipid biosynthesis previously shown upregulated testosterone correlates poor virusneutralizing activity men <NUMBER> interestingly stronger immune response females thought explain females prone immunemediated pathologies including autoimmune disease cytokine storm <NUMBER> however case covid<NUMBER> data currently support femalepredominance toward cytokine storm anything males prone severe disease mortality <NUMBER> thus would important gather data larger number cohort studies current sarscov<NUMBER> pandemic study delineate whether genderdependent risk cytokine storm subsequent cardiac injury covid<NUMBER> infection various therapies emerged treat various aspects viral pathogenesis subsequent immune response understanding aspect disease pathogenesis target may aide clinician knowing use treatments target steps early infection process respiratory phase fig <NUMBER> meant suppress viral replication aid host immune response fight virus immune response becomes hyperactive sepsisshock phase fig <NUMBER> cytokine storm immunomodulators target various harmful inflammatory cytokines may help mitigate endorgan toxicity unfortunately currently fdaapproved therapies sarscov<NUMBER> substantial randomized trial data support therapy thus far however several promising therapies actively test patients including recently announced multicenter randomized solidarity trial remdesivir hydroxychloroquine sponsored world health organization <NUMBER> antimicrobial agents target early presystemic phase infection include remdesivir hydroxychloroquine azithromycin remdesivir drug targets rna polymerase suppresses viral replication strong vitro evidence efficacy sarscov<NUMBER> <NUMBER> although randomized trial data still pending <NUMBER> anecdotal reports improvement compassionate use remdesivir <NUMBER> lopinavirritonavir another rna polymerase inhibitor showed initial promise recently published study beijing showed significant difference treatment versus control group suggesting effect present insufficient cause significant clinical response <NUMBER> chloroquine traditionally used antimalaria drug shown reasonable efficacy sarscov<NUMBER> vitro <NUMBER> single arm study <NUMBER> covid<NUMBER>positive patients treated france demonstrated efficacy combination azithromycin hydroxychloroquine safer variation chloroquine sarscov<NUMBER> <NUMBER> another small nonrandomized study showed similar results <NUMBER> however small nonrandomized studies whose definition efficacy based viral clearance rather mortality benefit subsequent pilot randomized trial shanghai comparing hydroxychloroquine placebo shown difference virologic clearance <NUMBER> azithromycin antimicrobial agent generally used antibacterial purposes however also shown inhibit zika virus tropism human brain suggested adjunct treatment intracellular microbes past <NUMBER> <NUMBER> since chloroquine hydroxychloroquine azithromycin lead corrected qt qtc prolongation use either alone combination monitored potential cardiotoxic side effect <NUMBER> second group therapies immunomodulators used target immune hyperactivity cytokine storm occurs later stages covid<NUMBER> infection <NUMBER> monoclonal antibodies shown promise early studies il<NUMBER> inhibitors tocilizumab sarilumab shown early benefit studied ongoing randomized trials <NUMBER> therapies including meplazumab anticd<NUMBER> eculizumab targets complement adalimumab tnfα inhibitor ivig saturation fc receptors macrophages suppression chemokinescytokines also intended toward reduction deleterious immune effects <NUMBER> interestingly immune stimulatory agents aimed enhancing beneficial aspects immune response also testedincluding ifnβ<NUMBER>a pd<NUMBER> inhibitors donor convalescent plasma <NUMBER> conflicting data support use glucocorticoids covid<NUMBER> related ards <NUMBER> even potential evidence harm form decreased viral clearance sars mers <NUMBER> increased mortality sarscov<NUMBER> <NUMBER> without evidence acute lymphocytic myocarditis cardiovascular injury currently advocate routine administration glucocorticoids elevated troponin covid<NUMBER> patients randomized trials glucocorticoids ivig severe cases covid<NUMBER> ongoing <NUMBER> sarscov<NUMBER> become worldwide health threat numbers infected patients growing rapidly increased incidence cardiac injury observed among severe infection mechanism cardiac injury unclear likely involves combination direct viral damage immunemediated damage inflammatory cytokineschemokines cytotoxic immune cell response later stages infection host immune response contributors cytokine storm sarscov<NUMBER> infection complex significant depletion dysregulation lymphocytes may contribute immune dysregulation hyperactivity cardiac damage setting cytokine storm may analogous seen cardiotoxicity cart treatments covid<NUMBER> bimodal one group treatments targeted toward early infection viral replication another group targeted toward immune modulation later systemic inflammatory phase infection advent single cell immune phenotyping technologies important perform comprehensive immune surveys infected patients better understand systemic perturbations infection downstream cardiovascular effects data needed help guide us toward definitive treatment protection cardiovascular system covid<NUMBER> infection <NUMBER> hypothesis sarscov<NUMBER> pathogenesis immune response cardiovascular injury spike protein sars<NUMBER>s virus activated cellular serine protease tmprss<NUMBER> highly expressed lung renal gastrointestinal cells engages angiotensinconverting enzyme <NUMBER> ace<NUMBER> highly expressed respiratory epithelial cells entry host cell early infection characterized viral replication direct damage virus host cells via ace<NUMBER>tmprss<NUMBER>mediated cell entry infection progresses proinflammatory signals upregulate inflammatory cytokine production cells adaptive innate immune system leading cytokine storm multiorgan damage letter editor pathogenesis coronavirus disease <NUMBER> covid<NUMBER> remains unclear presently evidence efficient therapeutics pathogenesis severe acute respiratory syndrome sars related coronavirus involves cytokine storm high serum levels proinflammatory cytokines chemokines interleukin <NUMBER> il<NUMBER> tumor necrosis factor tnfalpha interferongamma il<NUMBER> il<NUMBER> il<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> similarly covid<NUMBER> higher plasma levels cytokines il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> interferon gamma inducible protein ip<NUMBER> monocyte chemo attractant protein mcp<NUMBER> macrophage inflammatory protein mip<NUMBER>a tnfalpha found patients admitted intensive care units cytokine storm syndrome proportional severity disease <NUMBER> proinflammatory il<NUMBER> appears one key cytokines leading inflammatory storm may result increased alveolarcapillary bloodgas exchange dysfunction <NUMBER> <NUMBER> proinflammatory cytokine il<NUMBER> seems prominent role inflammatory cascade <NUMBER> data suggest il<NUMBER> may potential actionable target cytokine treat covid<NUMBER>related acute respiratory distress syndrome ards report case patient respiratory failure linked covid<NUMBER> rapid favorable outcome two infusions antiinterleukin <NUMBER> receptor inhibitor tocilizumab suggests antiil<NUMBER> receptor inhibitor treatment could decrease risk progression toward sars mitigating cytokine storm lungs covid<NUMBER> figure <NUMBER> antiviral therapy lopinavirritonavir use <NUMBER>mg<NUMBER>mg orally begun d<NUMBER> maintained <NUMBER> days according local guidelines day <NUMBER> sudden dyspnea saturation drop required oxygen supplementation increase <NUMBER> lmin without need artificial ventilation received two doses tocilizumab <NUMBER> mgkg intravenously dose <NUMBER> hours apart good tolerability thereafter experienced clinical improvement rapidly afebrile gradually decreased oxygen consumption fully discontinued day <NUMBER> figure <NUMBER> chest ct day <NUMBER> confirmed improvement showing partial regression pulmonary infiltrates ground glass appearance figure <NUMBER> creactive protein blood surrogate marker cytokine storm decreased <NUMBER> mgl <NUMBER> mgl <NUMBER> days figure <NUMBER> major change observed circulating lymphocytic subpopulations tocilizumab percentage cd<NUMBER> cd<NUMBER> lymphocytes found high tocilizumab figure <NUMBER> patient ultimately clinically fully recovered covid<NUMBER> symptoms recombinant humanized antihuman il<NUMBER> receptor monoclonal antibody tocilizumab specifically bind soluble il<NUMBER> receptor inhibit signal transduction <NUMBER> tocilizumab currently mainly used treat patients rheumatoid arthritis given every <NUMBER> weeks <NUMBER> weeks favorable safety profile <NUMBER> indications tocilizumab juvenile arthritis giant cell arthritis recentlycytokine release syndromes associated chimeric antigen receptor cell therapies <NUMBER> <NUMBER> mainly rheumatologic indications tolerance tocilizumab generally good main adverse events transient decrease leukocytes increase liver enzymes slight increase bacterial infection <NUMBER> <NUMBER> patients covid<NUMBER> safety profile especially potential drug interactions antivirals remain investigated clinical trials clinical trials also required explore whether tocilizumab used effectively patients respiratory failure due covid<NUMBER> investigate stage disease treatment could appropriate report first successful treatment patient respiratory failure related covid<NUMBER> treated tocilizumab present report several limitations first patient immunosuppressed cancer case therefore generalizable noncancer population interestingly lymphocytic subpopulation presented high level senescence frequently observed cancer patients data shown extent could explain sensitivity tocilizumab explored second patient received concomitant therapies especially lopinavirritonavir seems unlikely changed disease trajectory since lopinavirritonavir recently shown effective patients severe covid<NUMBER> randomized controlled trial <NUMBER> thus seems likely rapid control pulmonary hyperinflammation resulted tocilizumab treatment summary covid<NUMBER> hyperinflammatory pulmonary symptoms associated cytokine storm involving interleukins chemokine dysregulation among actionable proinflammatory interleukin <NUMBER> axis seems play major role report first observation patient severe covid<NUMBER>related lung disease successfully treated antiinterleukin <NUMBER> receptor treatment blocking cytokine axis il<NUMBER> appears us promising therapy studied urgently patients developing severe acute respiratory syndrome related coronavirus dr jeanmarie michot jmm reports sponsored research gustave roussy cancer center abbvie agios amgen covid<NUMBER> caused novel severe acute respiratory coronavirus <NUMBER> sarscov<NUMBER> emerged wuhan china <NUMBER> resulted current pandemic disease continues pose major therapeutic challenge patient mortality ultimately caused acute respiratory distress syndrome ards cytokine release syndrome cytokine storm likely contributing factor ards many patients interleukin <NUMBER> il<NUMBER> known play key role inflammation il<NUMBER> receptor inhibitors tocilizumab may potentially treat covid<NUMBER> attenuating cytokine release present case <NUMBER>yearold male severe covid<NUMBER> verge meeting intubation requirements needed progressive oxygen support respiratory distress patient treated nonweightbased dosage tocilizumab prevent onset cytokine storm chose administer il<NUMBER> inhibitor gradually increasing levels acute phase reactants identified serial blood draws well declining respiratory status treatment welltolerated conjunction standard drug therapies covid<NUMBER> hydroxychloroquine azithromycin zinc patient subsequently experienced marked improvements respiratory symptoms overall clinical status following days believe tocilizumab played substantial role ability avert clinical decline particularly need mechanical ventilation ultimately patient downgraded icu discharged within days highlight potential il<NUMBER> inhibitors prevent progression respiratory disease point requiring ventilator support case underscores potential importance early serial measurements il<NUMBER> cytokine stormassociated acute phase reactants ferritin ddimer creactive protein guiding clinical decisionmaking management patients suspected covid<NUMBER> conclusion early proactive identification serum acute phase reactants implemented treatment covid<NUMBER> order screen primary contributor mortalitythe cytokine storm screening followed aggressive early treatment cytokine storm may optimal therapeutic benefits obviate need mechanical ventilation thereby decreasing mortality additionally review current evidence regarding cytokine release syndrome covid<NUMBER> use il<NUMBER> receptor inhibition therapeutic strategy examine reported cases literature describing il<NUMBER> antagonist treatment patients covid<NUMBER> treatment severe covid<NUMBER> tocilizumab mitigates cytokine storm averts mechanical ventilation acute respiratory distress case report literature review covid<NUMBER> caused coronavirus sarscov<NUMBER> cases covid<NUMBER> asymptomatic severe lethal mortality simplest marker covid<NUMBER> vulnerability covid<NUMBER> vulnerability defined chance death covid<NUMBER> infected age studies conducted countries mortality rate covid<NUMBER> increases exponentially age <NUMBER>–<NUMBER> exact mortality rates varied hundreds studies depend testing therapeutic interventions rule clear mortality rate increasing exponentially age agerelated diseases mortality especially high patients preexisting conditions <NUMBER> <NUMBER> <NUMBER> <NUMBER>–<NUMBER> italy <NUMBER> patients died least one illness httpswwwbloombergcomnewsarticles<NUMBER>ofthosewhodiedfromvirushadotherillnessitalysays words infected people without preexisting diseases die may seem paradoxical discussed age sufficient increase mortality exponentially preexisting conditions manifestations biological age whereas aging diseases two sides coin <NUMBER>–<NUMBER> conditions typical agerelated diseases hypertension diabetes obesity ischemic heart disease ihd chronic obstructive pulmonary disease copd diseases <NUMBER> <NUMBER>–<NUMBER> course patients agerelated diseases die covid<NUMBER> words agerelated diseases necessary sufficient mortality covid<NUMBER> age preexisting agerelated diseases interdependent number severity diseases correlate age average <NUMBER> year old person agerelated diseases average <NUMBER> old person yet particular <NUMBER> year old person may agerelated diseases whereas particular <NUMBER> year old person may multiple diseases including hypertension diabetes obesity cancer case chronologically younger person biologically older biological age determines likelihood death covid<NUMBER> male gender age mortality rate twice higher men women <NUMBER> <NUMBER> <NUMBER> part men age faster women chronological age men biologically older women <NUMBER> three rules combined one covid<NUMBER> vulnerability determined biological age biological age combines chronological age agerelated diseases gender combination agerelated diseases prediseases biomarker biological age figuratively sarscov<NUMBER> “measure” biological age thus best predictor mortality covid<NUMBER> diseases aging measured increase probability death age mortality increases exponentially starting age <NUMBER> men higher “normal” agerelated death rate women men age faster women <NUMBER> covid<NUMBER> mortality rate parallels “expected” agingrelated death rate supplementary figure <NUMBER> see second graph httpsmediumcomwintoncentrehowmuchnormalriskdoescovidrepresent<NUMBER>e<NUMBER> chances die covid<NUMBER> proportional chances die aging age discrepancy natural covid<NUMBER> mortality observed age <NUMBER> years old whereas natural death rate relatively high covid<NUMBER> mortality low mortality <NUMBER> discrepancy discussed later first animals including humans die aging humans animals including worm <NUMBER> fly <NUMBER> die aging agerelated diseases ischemic heart disease ihd hypertension diabetes cancer alzheimer’s parkinson’s diseases agerelated macular degeneration osteoporosis sarcopenia discuss even seemingly nondeadly diseases osteoporosis lead deadly complications incidence diseases increases exponentially age diseases obesity hypertension diabetes develop earlier course aging diseases alzheimer’s disease macular degeneration usually diagnosed later <NUMBER> <NUMBER> agerelated diseases may also occur younger people genetic predisposition environmental exposure hazards even without factors diseases develop quasiprogrammed see “quasiprogrammed aging section” diseases diseases civilization may seem humans simply live long enough develop course “hazards civilization” accelerate younger age aging diseases cannot separated healthy aging aging without diseases merely slow aging biological age less chronological age period seemingly healthy aging preprediseases prediseases progressing eventually reach clinical manifestations thus healthy aging progress unhealthy prediseases become diseases <NUMBER> agerelated diseases covid<NUMBER> vulnerability highly intertwined patients die covid<NUMBER> otherwise would die agerelated diseases heart disease cancer diabetes hypertension year later covid<NUMBER> approximately doubles patient’s agingdependent risk dying one year example numbers approximate sixty year old woman <NUMBER> chance die aging <NUMBER>st birthday age infected death rate covid<NUMBER> around <NUMBER> females infected patient approximately doubled chances die compared usual agerelated mortality one year david spiegelhalter put “getting covid<NUMBER> like packing year’s worth risk week two” httpsmediumcomwintoncentrehowmuchnormalriskdoescovidrepresent<NUMBER>e<NUMBER> children young adults low risk death agingrelated diseases risk remains extremely low even doubled although natural mortality relatively high youngest age group especially infants die agerelated diseases course instead infants vulnerable bacterial infections candida infections due underdeveloped immune system <NUMBER> low covid<NUMBER> mortality pediatric age group <NUMBER> consistent notion covid<NUMBER> vulnerability due “weak” immune system contrast discuss next section hyperfunctional immune response leads death covid<NUMBER> elderly causing cytokine storm severe covid<NUMBER> characterized hyperinflammation cytokine storm acute respiratory distress syndrome ards damage lung heart kidneys <NUMBER>–<NUMBER> response viral replication hyperfunctional monocytes macrophages infiltrate lung causing hyperinflammation hypersecretion cytokines interleukin il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER>ra interferonγ inducible protein ip<NUMBER> tumor necrosis factor tnfα ferritin monocyte chemoattractant protein mcp<NUMBER> macrophage inflammatory protein mip <NUMBER>α granulocytecolony stimulating factor gcsf creactive protein crp procalcitonin <NUMBER> <NUMBER>–<NUMBER> leads leukocyte recruitment vascular permeability edema pulmonary damage vicious cycle <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> hyperinflammation becomes systemic turn causing hypercoagulation thrombosis disseminated intravascular coagulation <NUMBER> causes injury distant organs kidneys preexisting organ damage late stages agerelated diseases exacerbates organ damage caused cytokine storm <NUMBER> <NUMBER> <NUMBER> addition cellular hyperfunctions systemic hyperinflammation may lead cellular exhaustion exhaustion lymphocytes lymphopenia <NUMBER>–<NUMBER> hypercoagulation associated hyperactive fibrinolysis increased ddimer blood levels <NUMBER> cytokine storm systemic hyperfunctional response figure <NUMBER> course agerelated hyperfunctional response cytokine storm caused lifelong accumulation molecular damage aging caused molecular damage instead it’s continuation developmentalgrowth programs lead hyperfunctions turn eventually dysfunctions “quasi” means “resembling” “seemingly really” quasiprogram aging program continuation developmental programs switched upon completion <NUMBER> <NUMBER> purposelessly unfold leading agerelated diseases secondary organ failure death quasiprogrammed programlike aging associated higher optimal cellular systemic functions eventually via cellular exhaustion organ damage lead functional decline figure <NUMBER> example starting birth blood pressure increases continues increase organismal growth completed therefore hypertension prevalent agerelated disease turn hypertension cause organ damage stroke infarction renal failure similarly obesity develops postdevelopment continuation growth yet prevented low caloric diets illustrating quasiprogram aging decelerated hyperfunction excessive normal cellular function contraction smooth muscle cells smc adhesion aggregation blood platelets insulin secretion betacells lipid accumulation adipocytes secretion stromal immune cells oxidative burst leukocytes name higher optimal cause vasoconstriction hypertension thrombosis hyperinsulinemia hypertrophy hyperplasia obesity hypersecretory phenotype senescenceassociated secretory phenotype sasp hyperinflammation hyperfunction necessarily absolutely increased function may also insufficiently decreased function relative hyperfunction levels igf<NUMBER> growth hormone decrease lifespan despite decrease igf<NUMBER> levels still higher optimal relative hyperfunction genetic decrease igf<NUMBER> levels genetic means extends health span lifespan mammals <NUMBER>–<NUMBER> cellular hyperfunctions may eventually switch cellular exhaustion loss functions late stages course type ii diabetes mtor overactivation hyperinsulinemia eventually lead betacell exhaustion insulin insufficiency prediabetes diabetes <NUMBER> <NUMBER> another example puberty hyperstimulation ovary eventually leads oocyte exhaustion menopause see figure <NUMBER> ref <NUMBER> depletion naïve lymphocytes another example reviewed later agerelated alterations mostly noticed switch functional decline late event cases functional decline primary programmed example thymus involution replacement cells adipocytes starts early life accelerates puberty continues later still loss thymocytes niches may part due adipocyte hyperplasia hypertrophy <NUMBER> fact obesity accelerates involution whereas calorie restriction decelerates <NUMBER> <NUMBER> furthermore oblation sex hormones decelerates even reverses thymus involution <NUMBER> thus involution triggered adipocyte hyperplasia increased production sex hormones puberty <NUMBER> quasiprogrammed aging driven molecular damage driven nutrienthormonecytokinesensing growthpromoting signaling pathways target rapamycin tor mtor involved developmental growth later cause hyperfunctional aging diseases <NUMBER> <NUMBER> causeeffect relationship agerelated diseases covid<NUMBER> lethality patients die agerelated diseases complicated covid<NUMBER> contrast various diseases make covid<NUMBER> infection lethal scenarios take place extent however relationship mostly indirect agerelated diseases covidvulnerability result underlying cause figure <NUMBER> highly correlated cause aging aging manifested sum deadly deadly diseases conditions ranging cancer grey hair although diseases seem deadly cause complications stroke ventricular fibrillation renal failure lung edema even sarcopenia osteoporosis lead falls broken bones culminating deadly sequence events cosmetic manifestations aging spots wrinkles deadly manifestations diseases example baldness correlates prostate enlargement <NUMBER> later lead urinary obstruction renal failure diseases occur together example chronic obstructive pulmonary disease copd associated diabetes cardiovascular disease hypertension <NUMBER> person one disease eg diabetes patient higher chances diseases eg hypertension ihd cancer conditions including covid<NUMBER> vulnerability revealed infection predicted preexisting diseases aging initially driven increase cellular systemic functions hyperfunction leading agerelated conditions example hypertension systemic hyperfunction due hyperfunction multiple cell types arterial smooth muscle cells asmc similarly covid<NUMBER>vulnerability associated hyperfunction inflammatory cells response covid<NUMBER> infection causes cytokine storm hypercoagulation damage lung distant organs covid<NUMBER> vulnerability syndrome agingrelated disease strictly dependent biological age associated agerelated diseases exemplified hyperfunctional response infection hundreds cell types acting concert immune system complex cannot discuss agerelated alterations without oversimplification noticeable alteration memory b cells replace naive b cells <NUMBER> seems natural since lifelong exposure pathogens replaces naïve cells memory cells replacement naïve immune cells decreases adaptive responses novel antigens sarscov<NUMBER> contrast immune protection memory cells viral reinfection known pathogens usually increased age <NUMBER> immune responses roughly divided innate responses carried mostly neutrophils macrophages nk cells react pathogen rapidly nonspecifically b adaptive responses carried b lymphocytes delayed slower specific eg antigenspecific clonal expansion b lymphocytes antibody production b lymphocytes <NUMBER>–<NUMBER> elderly immune responses sarscov<NUMBER> “stuck innate immunity” insufficient progression adaptive immunity <NUMBER> however decline adaptive response antibody production plays little role covid<NUMBER> mortality hyperfunctional innate immunity hyperinflammation cytokine storm hypercoagulation lead organ failure death agreement hyper inflammatory response rather high virus numbers leads death sarscovinfected old nonhuman primates <NUMBER> aging associated diseases immune hyperfunction autoimmune disorders paradoxical increase certain signaling pathways cytokine levels <NUMBER>–<NUMBER> elderly innate immune cells state sustained activation producing proinflammatory cytokines <NUMBER> <NUMBER>–<NUMBER> increased proinflammatory activity innate immune system especially monocytesmacrophages state alertness hyperreactivity cost potential agerelated inflammatory diseases <NUMBER> <NUMBER>–<NUMBER> whereas functions decreased others increased according inflammaging concept innate immune system overtakes adaptive immune system aging causeeffect relationships bidirectional immunosenescence namely decrease adaptive response cause consequence inflammaging <NUMBER> <NUMBER>–<NUMBER> consider inflammaging example hyperfunction functions decreased others increased hyperfunction damaging analogy increased electric power without adaptor would damage laptop damaging hyperfunctions lead loss function cellular exhaustion vice versa loss function may cause compensatory hyperfunctions another components cellular senescence continuation cellular growth actual growth completed <NUMBER> <NUMBER> proliferating cells cellular mass growth balanced cell division cells grow size divide cell cycle blocked eg p<NUMBER> p<NUMBER> growthpromoting pathways mtor mapk drive conversion senescence geroconversion <NUMBER> <NUMBER> <NUMBER> geroconversion cells become hypertrophic “fat” cellular functions increase hypersecretion lysosomal hyperfunction manifested sasp betagal staining hyperactivated growthpromoting pathways cause compensatory resistance growth factorsinsulin permanent loss reproliferative potential <NUMBER> rapamycin everolimus panmtor mapk inhibitors slows geroconversion maintaining reversible quiescence instead senescence <NUMBER> <NUMBER>–<NUMBER> geroconversion continuation cellular growth <NUMBER> <NUMBER> similarly aging continuation developmental growth see figure <NUMBER> ref <NUMBER> developmental program completed becomes quasiprogram aging discussed detail chronically activated nutrientsensing growthpromoting pathways drive agerelated diseases culminating organismal death <NUMBER> <NUMBER> agerelated diseases quasiprogrammed aging common cause agerelated diseases sum agerelated diseases diseases hyperfunction secondary hypofunction compensation reactions <NUMBER> deadly manifestations aging activation cellular functions systemic hyperfunctions diseases organ damage death hyperfunction theory quasiprogrammed aging describes sequence events <NUMBER> discussed <NUMBER> suppression aging gerosuppressants rapamycin prevent treat agerelated diseases <NUMBER> point view becoming widely accepted recent literature quasiprogrammed model diseases <NUMBER> called “geroscience hypothesis” <NUMBER> <NUMBER> aging functional decline due accumulation molecular damage would near impossible restore functions rejuvenate immune system contrast functional decline secondary hyperfunctions see figure <NUMBER> ref <NUMBER> hyperfunctions suppressed pharmacologically restore lost functions typical drugs inhibitors targets rather activators decrease functions targets decreasing hyperfunctions otherwise lead secondary loss functions rapamycin may restore “lost” functions figure <NUMBER> rapamycin improves vaccination viruses influenza old mice monkeys humans <NUMBER>–<NUMBER> importantly rapamycin increases pathogenspecific graftreactive cd<NUMBER> cell responses <NUMBER> <NUMBER> therefore rapamycin everolimus used prevent donor organ rejection improve adaptive immunity new pathogens <NUMBER> differentiation increase tissuespecific cellular functions terminally differentiated b nk cells rapidly react already known pathogens <NUMBER> decrease naïve b lymphocytes thus diminished response novel antigens results part cellular hyperdifferentiation immune system <NUMBER> <NUMBER> hyperfunctional differentiation counteracted rapamycin <NUMBER> another example agerelated exhaustion stem cells partially due loss quiescence caused growth overstimulation <NUMBER> <NUMBER>–<NUMBER> general senescent cells characterized hyperproliferative drive coupled cell cycle arrest <NUMBER> young mice mtor hyperactivation causes senescence hematopoietic stem cells hsc decreases lymphopoiesis <NUMBER> old mice rapamycin rejuvenates hematopoiesis improves vaccination influenza virus <NUMBER> third production lymphoid cells may decreased disruption hypoxic niches due adipocytes hyperplasia <NUMBER> <NUMBER> hypoxic niches preserve hsc <NUMBER> <NUMBER> probably hypoxia inhibits mtor cellular senescence <NUMBER> agreement rapamycin preserves hscs <NUMBER> <NUMBER> <NUMBER> <NUMBER> reduces proportion memory cells maintains pool naïve cells <NUMBER> <NUMBER> fourth growth factor gf insulinresistance loss function cells cannot respond gfinsulin may caused overactivated mtor via s<NUMBER>kirs feedback loop blocks insulin gf signaling rapamycin abrogates loop restoring signaling <NUMBER>–<NUMBER> high prevalence agerelated diseases often called “diseases civilization” success story modern medicine past people live long enough develop agerelated diseases developed died soon due medical advances people survive <NUMBER> average despite suffering agerelated diseases standard medicine preferentially extends life span without necessarily affecting health span see figure <NUMBER> ref <NUMBER> example defibrillation coronary stenting save life cure heart disease antiaging interventions extend health span delaying diseases thus extending lifespan aging common cause agerelated diseases suppressing aging antiaging interventions may delay agerelated diseases <NUMBER> wellknown example low calorie diets calorie restriction intermittent fasting low carbohydrate diets extend health lifespan figuratively low calorie diets prolong life improving health nutrients obesity activate growthpromoting pathways eg mtor thus accelerating development quasiprogrammed agerelated diseases obesity associated agerelated diseases cancer alzheimer’s diabetes sarcopenia covid<NUMBER> vulnerability also associated obesity <NUMBER> <NUMBER> <NUMBER> <NUMBER> according hyperfunction theory obesity accelerates aging agerelated conditions including covid<NUMBER> vulnerability diabetes one main risk factors death covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> type <NUMBER> diabetes agerelated disease reversed remarkable studies shown brief course <NUMBER> weeks low calorie diets vlcds reverse type ii diabetes one study vlcd reversed diabetes <NUMBER> patients <NUMBER>year history diabetes <NUMBER> vlcd effective prevention early stages diabetes <NUMBER> antiaging modality simple remission achieved home healthmotivated individuals <NUMBER> simultaneously treats agerelated diseases hypertension <NUMBER> obesity associated diseases hyperfunction diabetes sarcopenia cancer alzheimer’s’ disease since agerelated diseases predictors covid<NUMBER> mortality vlcd theory may decrease covid<NUMBER> vulnerability soil easter island complex bacteria produces antifungal antibiotic rapamycin suppress yeast growth byproduct also suppresses yeast aging quasiprogramed aging continuation growth approved human use <NUMBER> rapamycin sirolimus close analog everolimus widely used several diseases including cancer organ transplantation hundreds clinical trials twenty years clinical practice ensured safety good tolerability especially healthy older adults <NUMBER> currently several antiaging clinics prescribe rapamycin label prevent agerelated diseases slow aging hundreds recent reviews discussed rapamycin everolimus detail emphasize points soon covid<NUMBER> epidemic started become clear covid<NUMBER> vulnerability agingdependent condition use rapamycin sirolimus immediately suggested independent researchers <NUMBER> <NUMBER> <NUMBER>–<NUMBER> proposals based mixture several rationales need clearly distinguished theory least three independent applications rapamycin everolimus covid<NUMBER> currently still hypothetical <NUMBER> potential suppression cytokine storm hyperinflammation figure <NUMBER> discussed section “cytokine storm hyperfunction” cytokine storm hyperinflammation main cause death covid<NUMBER> pneumonia <NUMBER>–<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER>–<NUMBER> rapamycin antiinflammatory agent inhibits hyperfunctions cellular senescence decrease secretion cytokines <NUMBER> <NUMBER> <NUMBER> rapamycin inhibits jak<NUMBER>stat<NUMBER> signaling pathway <NUMBER> reduces ifγ tnfα levels <NUMBER> rapamycin sirolimus treatment improves outcomes patients severe h<NUMBER>n<NUMBER> pneumonia acute respiratory failure associated improvement virus clearance shortened ventilator days <NUMBER> clinical trial “sirolimus treatment hospitalized patients covid<NUMBER> pneumonia scope” started httpsclinicaltrialsgovct<NUMBER>shownct<NUMBER> review intended professional audience stimulate new ideas aid global efforts develop effective treatments covid<NUMBER> disease article represent medical advice recommendations patients media exercise caution seek expert medical advice interpretation referring article covid<NUMBER> term used describe disease caused severe acute respiratory syndrome coronavirus<NUMBER> sars cov<NUMBER> originated december <NUMBER> wuhan hubei province china owing ability transmitted humans via respiratory droplets <NUMBER> since spread globally within united kingdom uk mounting concerns regarding multiple reports elevated relativerisk covid<NUMBER> mortality amongst black minority ethnic bame population <NUMBER> adjusting sociodemographic characteristics selfreported comorbiditydisability office national statistics ons estimates indian females <NUMBER> times pakistani bangladeshi males <NUMBER> times black males females <NUMBER> times likely die covid<NUMBER> relative white counterparts <NUMBER> pattern broadly reflected uk critical care admission outcome data intensive care national audit research centre report <NUMBER> well data united states america usa <NUMBER> urgent national enquiry possible reasons phenomenon thus issued sars cov<NUMBER> positivesense enveloped singlestranded rna virus bind angiotensin converting enzyme <NUMBER> ace<NUMBER> receptor humans <NUMBER> <NUMBER> ace<NUMBER> receptors expressed widely throughout body believed sars cov<NUMBER> uses ace<NUMBER> receptors expressed respiratory epithelial cells gain entry host <NUMBER> entering respiratory epithelium replicate cause pyroptosis thus release pathogen associated molecular patterns pamps damage associated molecular patterns damps <NUMBER> damps pamps recognised pattern recognition receptors surrounding epithelial cells alveolar macrophages vascular endothelial cells respond releasing wide array proinflammatory cytokines cxc motif chemokine<NUMBER> cxcl<NUMBER> interleukin<NUMBER> il<NUMBER> macrophage inflammatory protein <NUMBER>α mip<NUMBER>α macrophage inflammatory protein <NUMBER>α mip<NUMBER>β monocyte chemoattractant protein <NUMBER> mcp<NUMBER> inflammatory cytokines chemokines recruit monocytes macrophages tcells local tissue release proinflammatory cytokines positive feedback loop mechanism resulting cytokine storm <NUMBER> evidence support confirmed levels various inflammatory cytokines il<NUMBER> il<NUMBER> il<NUMBER> granulocyte colonystimulating factor gcsf cxcl<NUMBER> mcp<NUMBER> mip<NUMBER>α tumour necrosis factor tnf elevated severe covid<NUMBER> patients required critical care admission usually initial phase viral infection <NUMBER> one major complications covid<NUMBER> acute respiratory distress syndrome ards lead death respiratory failure indeed associated systemic inflammation <NUMBER> aforementioned cytokine storm also lead sepsis multiorgan failure <NUMBER> <NUMBER> another emerging frequently fatal complication covid<NUMBER> venous thromboembolisms vte namely pulmonary embolisms pe hypothesized arise due proinflammatory hypercoagulable state described extensively literature <NUMBER> peak il<NUMBER> levels directly associated covid<NUMBER> disease severity <NUMBER> tocilizumab il<NUMBER> inhibitor amongst many promising antiinflammatory drugs undergoing clinical trials treat covid<NUMBER> <NUMBER> <NUMBER> inflammation thus forefront covid<NUMBER> research <NUMBER> postulated disease severity outcomes correlate proinflammatory cytokine dysregulation <NUMBER> <NUMBER> therefore undertook synthesis narrative review aims shed light novel acuteonchronic pathophysiological role inflammation contributing towards increased mortality risk covid<NUMBER> amongst bame population propose bame population may subjected elevated levels chronic systemic inflammation due various reasons discussed may augment acute covid<NUMBER> cytokine storm described potentiate multiorgan failure death genetic reference list study identified initial database search library coauthor also reviewed identify potentially relevant studies study selection titles abstracts key words studies identified electronic search screened eligibility included narrative review studies deemed relevant retrieved standardized checklist used determine eligibility inclusion review based information within full article original research articles selected participate study relevant study hypothesis contained highest quality evidence pertaining given subject systematic reviews used preferentially possible studies confined local indigenous populations published year <NUMBER> excluded key epidemiological data also extracted government reports synthesis narrative review synthesized using included articles order summarize key information hypothesize pathophysiological mechanisms draw inferences suggest recommendations public health policy <NUMBER> suggests childhood metabolic risk bame population higher indeed evidence suggest genetic predisposition metabolic syndrome amongst bame population <NUMBER> <NUMBER> osa associated exacerbation metabolic syndrome <NUMBER> <NUMBER> <NUMBER> increased intubation risks <NUMBER> respiratory failure <NUMBER> furthermore obesity contribute nonalcoholic fatty liver disease nafld commonly found ethnic minorities <NUMBER> <NUMBER> thus covid<NUMBER> cytokine storm patients nafld may prone acuteonchronic liver failure <NUMBER> obesity insulin resistance also contribute chronic inflammatory state may potentiate cytokine storm within context acute covid<NUMBER> infection excess fat particular visceral fat broadly measured waist circumference associated chronic systemic inflammation <NUMBER> covid<NUMBER> severity <NUMBER> furthermore densely populated urban areas london suffered deaths covid<NUMBER> likewise population london also comprises <NUMBER> bame <NUMBER> overcrowded housing innercity living pose huge impediment social distancing also associated psychological stress mental health disorder inflammation <NUMBER> <NUMBER> <NUMBER> finally whilst <NUMBER> covid<NUMBER> related deaths amongst nhs frontline staff bame <NUMBER> <NUMBER> nhs workforce bame <NUMBER> highlights enormous relative risk greater general bame population raising questions regarding occupational hazard may partially explained fact frontline nhs workers likely exposed higher viral loads covid<NUMBER> however healthcare workers often experience psychological stress burnout <NUMBER> emerging evidence bame nhs staff may encounter greater workrelated psychological stress <NUMBER> amongst nonmedical nhs workforce hierarchal correlation observed whereby prevalence white staff positively bame staff negatively correlate seniority <NUMBER> indeed lack decision making identified potent source occupationrelated psychological stress <NUMBER> <NUMBER> similarly various occupations chefs taxi drivers security guards also encountered disproportionately higher number covid<NUMBER> related deaths <NUMBER> occupations contain higher representations minority ethnics amongst staff <NUMBER> may also involve less decision making well night shifts sedentary work viral load exposure overall mechanism psychological stress contribute chronic inflammation yet fully elucidated two mechanisms described addition well evidenced pathophysiological mechanisms discussed may also smaller role played chronic infections tuberculosis tb chronic hepatitis human immunodeficiency virus hiv prevalent migrants developing countries <NUMBER> <NUMBER> <NUMBER> <NUMBER> tb known contribute various chronic lung changes cavitation fibrosis bronchiectasis impairment lung function may contribute impaired pulmonary immunity <NUMBER> based pathophysiological mechanisms identified review well surrounding literature suggested multidisciplinary interventions reduce health inequalities highlighted covid<NUMBER> pandemic summarized table <NUMBER> income inequalities younger generations targeted investing education deprived populations innercity schools universities given subsidies grants facilitate awareness government schemes also addressed diversifying advertising platforms example via social media housing inequalities addressed allocating housing benefit claimants council properties throughout country rather specific innercity areas barriers preventing elderly bame individuals utilizing care homes tackled reduce overcrowded housing certain populations containing bame may excluded receiving high quality healthcare firstly prisons blacks overrepresented lammy review identifies scope improvement mental health awareness health literacy amongst prison staff often first point contact prisoners seeking medical attention <NUMBER> additionally improving staffing levels prisons would help overcome added barrier escort requirements prisoners require secondary care secondly undocumented migrants may entitled nonemergency healthcare may delay presentation healthcare services due deportation fears government supportively work populations prevent resultant health impairments introducing crossborder health social care bame population increased risks unhealthy behaviours physical inactivity highfat highsugar diets <NUMBER> <NUMBER> <NUMBER> dietary advice offered multiple languages focussing healthy food interventions cuisines rather western cuisines importance benefits healthy eating exercise taught schools social media certain occupations suffered disproportionate covid<NUMBER> deaths example taxi drivers councils areas suffered higher levels covid<NUMBER> deaths given subsidies focus health promotion could involve supermarket food stamps healthy food discounted gym memberships cycle lanes cycletowork schemes subsidies convert fastfood restaurants health food restaurants delivery healthylifestyle talks community gatherings places worship gypsy communities bame population elevated risks various diseases could contributing severe covid<NUMBER> phenotype guidelines reflect incorporating ethnicity relevant risk factor assist determining initiate treatment may involve starting oral hypoglycaemic agents lower hba<NUMBER>c levels nhs provision bariatric surgery lower bmi threshold perhaps use statins aspirin percutaneous coronary intervention lower cardiovascular risk thresholds bame individuals nonenglish speakers may lack confidence use nhs <NUMBER> services thus imperative increase provision translators multilingual nhs services language barriers may also reduce effectiveness talking therapies cognitive behavioural therapy reason nhs provision evidencebased nonverbal psychotherapies yoga taichi dance movement psychotherapy music therapy may thus benefit cultural barriers often influence interaction bame individuals healthcare services example stigma associated mental health disorder often higher amongst bame population healthcare staff community mental health teams equipped deal stigmas well cultural barriers furthermore use alternative medicine may prevalent amongst bame population <NUMBER> possible evidence based alternative therapies acupuncture mindfulness fasting considered health professionals various drugs dexamethasone convalescent plasma tocilizumab remdesivir undergoing clinical trials assess efficacy treating covid<NUMBER> <NUMBER> important increase bame individuals participating studies even conduct separate studies focussed bame population recognition reporting ethnicity crucial demographic risk factor like age gender also encouraged amongst healthcare research mechanisms discussed throughout review summarized figure <NUMBER> figure <NUMBER> illustrating complex acuteonchronic interplay social determinants health acute covid<NUMBER> pathophysiology chronic diseases discussed review prevalent black minority ethnic bame population chronic diseases disease processes could contributing severe covid<NUMBER> phenotype observed bame population include metabolic syndrome review aims shed light ongoing national enquiry investigating disproportionate effect covid<NUMBER> bame population first time inflammation discussed common framework regards covid<NUMBER> ethnicity suggest novel pathophysiological mechanism acute inflammation arising covid<NUMBER> may augment existing chronic inflammation secondary medical comorbidity order potentiate cytokine storm thus severe disease phenotype observed bame population obesity insulin resistance cardiovascular disease psychological stress chronic infections genetic predispositions relevant factors may contributing elevated chronic systemic inflammation amongst bame population suggest various interventions reduce prevalence severe covid<NUMBER> disease phenotype amongst bame population subsequent systemic immune response syndrome sirs multiorgan failure secondary covid<NUMBER> manifest acute coronary syndrome acs myocarditis venous thromboembolism vte acute liver failure respiratory failure acute renal injury directly potentiated aforementioned preexisting comorbidities relevant conflicts interest declare past decades two known pathogenic human coronaviruses severe acute respiratory syndrome cov sarscov middle east respiratory syndrome cov merscov reported damage respiratory tract cause high morbidity mortality <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> newly discovered coronavirus reported december <NUMBER> <NUMBER>ncov city wuhan hubei province china <NUMBER> <NUMBER>th march <NUMBER> <NUMBER> cases reported <NUMBER> fatal cases according chinese center disease control prevention cdc meanwhile <NUMBER> cases reported <NUMBER> fatal cases countries except china italy date <NUMBER> infected <NUMBER> deaths <NUMBER> global outbreak sarscov<NUMBER> caused corona virus disease covid<NUMBER> seems inevitable among covid<NUMBER> patients common symptoms including fever cough myalgia fatigue onset majority patients recover however <NUMBER> patients progress severe complications including acute respiratory distress syndrome ards may worsen rapidly respiratory failure need intensive care unit icu even cause multiple organ failure <NUMBER> <NUMBER> therefore exploration mortality causes advancing novel therapeutic development severe covid<NUMBER> crucially important moment although virusinduced cytopathic effects viral evasion host immune responses believed important disease severity studies humans died journal translational medicine sars mers suggested aberrant host immune response resulting inflammatory cytokine storm lethal disease <NUMBER> similar inflammatory cytokines sars mers patients covid<NUMBER> also increased plasma concentrations inflammatory cytokines tumour necrosis factor α tnfαinterleukins il <NUMBER> <NUMBER> <NUMBER> granulocytecolony stimulating factor gcsf monocyte chemoattractant protein <NUMBER> macrophage inflammatory protein <NUMBER> alpha interferonγinducible protein <NUMBER> especially icu patients implied cytokine storm occurred <NUMBER> moreover covid<NUMBER> patients decreased lymphocytes peripheral blood characteristic pulmonary ground glass changes imaging <NUMBER> <NUMBER> importantly biopsy samples autopsy patients died covid<NUMBER> histological examination showed bilateral diffuse alveolar damage including edema proteinaceous exudate focal reactive hyperplasia pneumocytes patchy inflammatory cellular infiltration multinucleated giant cells <NUMBER> <NUMBER> also recovered autopsy examination type ii alveolar epithelial cells proliferate markedly cells exfoliated alveolar septum hyperemic edematous clear intravascular thrombosis focal monocytes lymphocytes plasma cells infiltrating pulmonary interstitium immunohistochemistry results showed positive immunity cells including cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER> cd<NUMBER>a cd<NUMBER> cd<NUMBER> cd<NUMBER> <NUMBER> phenomena suggest severe pulmonary inflammatory immune cells exist sarscov<NUMBER> infection therefore increased alveolar exudate caused aberrant host immune response inflammatory cytokine storm probably impedes alveolar gas exchange contributes high mortality severe covid<NUMBER> patients inflammatory storm refers excessive inflammatory response flaring control immune system gone awry identify kind immune cells involved inflammatory cytokine critical target severe covid<NUMBER> patients analyzed peripheral blood samples patients severe critical covid<NUMBER> first affiliated hospital university science technology china observed monocytes cells severe critical covid<NUMBER> patients decreased significantly compared normal controls aberrant pathogenic cells critical icu care covid<NUMBER> patients showed activated characteristic accompanied coexpressing ifnγ gmcsf phenomenon aroused alarm gmcsf capability control diverse pathogenic capabilities inflammatory myeloid cells especially monocytes <NUMBER> expected inflammatory monocyte cd<NUMBER> cd<NUMBER> phenotype exists peripheral blood covid<NUMBER> patients larger population critical covid<NUMBER> patients icu note without restimulation pma incubation monensin large amount il<NUMBER> could tested inflammatory monocytes especially icu patients therefore pathogenic th<NUMBER> cells gmcsf ifnγ inflammatory monocytes cd<NUMBER> cd<NUMBER> high expression il<NUMBER> exist especially critical icu covid<NUMBER> patients <NUMBER> given large amount mononuclear inflammatory lymphocytes observed biopsy samples autopsy covid<NUMBER> patients believe pathogenic cells inflammatory monocytes may enter pulmonary circulation large numbers incite inflammatory storm severe critical covid<NUMBER> patients fig <NUMBER> tocilizumab first marketed il<NUMBER> blocking antibody targeting il<NUMBER> receptors proved safety effectiveness therapy rheumatoid arthritis fig <NUMBER> order verify whether targeted il<NUMBER> may potentially effective safe way reduce mortality covid<NUMBER> <NUMBER> patients diagnosed severe critical covid<NUMBER> first affiliated hospital university science technology china anhui fuyang second peoples hospital recruited given tocilizumab therapy table <NUMBER> patients received standard treatment according diagnosis treatment protocol covid<NUMBER> <NUMBER> th edition including lopinavir methylprednisolone symptom relievers oxygen therapy results tocilizumab treatment inspiring temperature patients returned normal quickly respiratory function symptoms improved remarkably among <NUMBER> patients <NUMBER> patients recovered discharged within <NUMBER> weeks tocilizumab therapy one left patient recovering icu care adverse drug reactions reported treatment tocilizumab <NUMBER> promising preliminary clinical results launched multicenter largescale clinical trials chictr<NUMBER> already <NUMBER> severe critical patients treated way immunotherapy strategy tocilizumab treatment formally included diagnosis treatment program covid<NUMBER> <NUMBER>th edition national health commission china since <NUMBER>th march <NUMBER> following tocilizumab used patients extensive bilateral lung lesions opacity severe critical patients elevated laboratory detected il<NUMBER> levels first dose <NUMBER> mg kg recommended dose <NUMBER> mg diluted <NUMBER> ml <NUMBER> normal saline infusion time <NUMBER> h patients poor initial efficacy additional application made <NUMBER> h dose maximum number times administration two maximum dose single dose exceed <NUMBER> mg note patients allergic reactions tuberculosis active infection contraindicated suggest il<NUMBER> concentrations detected fever persists <NUMBER> days chemiluminescence detection serum il<NUMBER> content <NUMBER> pgml tocilizumab used il<NUMBER> temporarily increased serum next days receptors blocked tocilizumab together tocilizumab treatment recommended reduce mortality severe covid<NUMBER> three coronaviruses including sarscov merscov sarscov<NUMBER> induce aberrant noneffective host immune responses associated severe lung pathology new sarscov<NUMBER> additionally causes serious alveolar mucus infiltration multiple organ failure sarscov<NUMBER> continues spread numbers fatal cases rise exponentially many countries advancing novel therapeutic development becomes crucial minimize number deaths covid<NUMBER> absence specific antiviral drugs existing hostdirected therapies could potentially repurposed treat covid<NUMBER> chinas plan tocilizumab treatment shown remarkable effectiveness safety clinical practice past <NUMBER> months hoping benefit countries fighting pandemic reduce mortality severe covid<NUMBER> well ready submit research choose bmc benefit received <NUMBER> march <NUMBER> accepted <NUMBER> april <NUMBER> present effective therapy covid<NUMBER> therefore group diseases assessment prognosis become important <NUMBER> severity diseases according covid<NUMBER> diagnosis treatment scheme issued national health committee patients divided four groups including light groups medium groups severe groups critically ill groups however platelettolymphocyte ratio plr covid<NUMBER> severe nonsevere cases fully reported may prognostic values important therapeutic targets study number platelets dynamic changes treatment plr <NUMBER> laboratoryconfirmed cases admitted huizhou municipal central hospital showed difference severe nonsevere cases investigated multivariate analysis independent risk factors relationship plr prognosis data presented mean standard deviation unless stated otherwise nonparametric twotailed student test used analyze variables differences values tested groups regarded significant value p ≤ <NUMBER> correlation analysis used simple linear correlation multifactor logistic regression analysis data analyzed using spss <NUMBER> optimal cutoff value sensitivity sensitivity specificity specificity plr determined analysis receiver operating characteristic roc curve statistical graphs drawn using graphpad prism <NUMBER> software total <NUMBER> patients admitted median age correlation two groups terms age length hospitalization absolute value lymphocytes platelets shown table <NUMBER> figures <NUMBER> <NUMBER> table <NUMBER> shows difference nonsevere group severe group average age <NUMBER> vs <NUMBER> years average length hospitalization <NUMBER> vs <NUMBER> days statistics two groups statistical significance p <NUMBER> also analyze indicators two groups platelet value absolute lymphocyte values plr alt ast ldh admission significance unexpectedly comparing peak platelet found average platelet peak treatment severe patients <NUMBER> × <NUMBER> <NUMBER> l significantly higher nonsevere patients <NUMBER> × <NUMBER> <NUMBER> l plr <NUMBER> significantly higher plr nonsevere patients <NUMBER> date two groups statistically significant p <NUMBER> terms hormone use total <NUMBER> nonsevere patients used hormones treatment accounting <NUMBER> nonsevere patients <NUMBER> severe patients used hormones accounting <NUMBER> two groups data statistical significance multivariate logistic regression analysis age platelet peak plr platelet peak treatment showed plr platelet peak treatment independent influencing factor critically ill patients results shown table <NUMBER> <NUMBER> correlation platelet trend course disease treatment figure <NUMBER> shows trend platelet three severe patients found trend three nonsevere patients platelet value <NUMBER> × <NUMBER> <NUMBER> l platelet peak group <NUMBER> × <NUMBER> <NUMBER> l treatment platelet peak group b <NUMBER> × <NUMBER> <NUMBER> l treatment shown table <NUMBER> patients group older patients group b patients group longer average hospitalization day difference two groups statistically significant p <NUMBER> comparing correlation difference δplr plr time admission maximum plr treatment length hospitalization day data shown covid<NUMBER> <NUMBER> <NUMBER> however many factors affect platelet changes clinic patients study use invasive procedures tracheal intubation deep vein catheterization therefore impact invasive procedures platelet changes considered article <NUMBER> seen foregoing use hormones treatment patients significantly different severe nonsevere patients effects platelets also ruled new type inflammation index plr mainly reflects level systemic inflammation previous studies confirmed plr closely related tumors diabetes coronary heart disease connective tissue diseases increase plr related tumor size lymph node infiltration distant metastasis prognosis used potential inflammatory indicator clinical diagnosis communityacquired pneumonia <NUMBER> indicator inflammation plateletreleased platelet factor<NUMBER> prevent agglutinina inhibiting lymphocyte generation activated platelets enhance lymphocyte adhesion endothelium thereby promoting lymphocyte homing endothelial veins migration inflammatory sites plr refers ratio platelettolymphocyte count advantage plr selection reflects aggregation inflammatory pathways maybe valuable predicting various inflammations platelet lymphocyte counts alone pathogenesis covid<NUMBER> also related virusinduced inflammatory response vivo <NUMBER> <NUMBER> <NUMBER> according current clinical relevant data patients lower lymphocyte levels first diagnosis seriously ill progressive decline lymphocyte proportion indicates poor prognosis according prior analysis propose plr indicator reflects severity inflammation process treatment comparing changes plr treatment found higher δplr longer hospital stay showed linear correlation therefore speculated changes plateletlymphocyte ratio peripheral blood treatment could reflect disease progression prognosis covid<NUMBER> patients larger δplr severe cytokine storm longer hospital stay worse prognosis δplr increases severe patients increase thymosin regulate immune elevate lymphocyte therapy improve situation prevent development severe patients promote improvement symptoms severe patients active symptomatic treatment three severe patients successfully treated successfully discharged hospital results treatment also seem confirm conjecture also calculated cutoff value δplr δplr <NUMBER> must actively intervene prevent deterioration disease however due lack clinical data conclusion may biased larger number samples needed confirmation coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus may lead severe inflammatory response cytokine storm <NUMBER> immune dysfunction untreated crohns disease may augment risk severe inflammatory response covid<NUMBER> <NUMBER> describe pediatric patient recently diagnosed crohns disease developed severe covid<NUMBER> infection successfully treated infliximab <NUMBER> year old male recently diagnosed small bowel perianal crohns disease presented <NUMBER> days fevers abdominal pain without respiratory symptoms physical exam notable tachycardia erythematous maculopapular facial rash abdominal tenderness perianal lesion purulent drainage initial laboratory tests revealed creactive protein crp <NUMBER> mgl normal <NUMBER> mgl erythrocyte sedimentation rate esr <NUMBER> mmhr normal <NUMBER> mmhr hypoalbuminemia <NUMBER> gdl sarscov<NUMBER> pcr positive magnetic resonance mr enterography revealed <NUMBER> cm ileitis <NUMBER> cm perianal abscess fistula chest xray negative acute pulmonary process blood culture stool pcr negative treatment initiated intravenous iv piperacillintazobactam perianal abscess hydroxychloroquine azithromycin sarscov<NUMBER> infection enoxaparin prophylaxis venous thromboembolism iv fluids repeat concentrations il<NUMBER> il<NUMBER> tnfα rising table <NUMBER> multidisciplinary discussion potential therapeutic options included remdesivir antiviral therapy tocilizumab il<NUMBER> inhibitor treatment covid<NUMBER> iv immune globulin treatment immunemediated vasculitis infliximab antitnfα therapy infliximab would address management crohns disease potentially cytokine storm attributable misc associated covid<NUMBER> given possible dual role rapid clinical deterioration received <NUMBER> milligramskilogram mgkg infliximab day cytokines improved normalization tnfα decrease il<NUMBER> il<NUMBER> progression rash halted infliximab treatment hospitalization day <NUMBER> significantly improved discharge figure <NUMBER> crp normalized given second infusion infliximab<NUMBER> mgkg prior discharge <NUMBER> days initial dose due high inflammatory burden presence active perianal disease prometheus infliximab concentration prior second infusion <NUMBER> ugml without antibodies follow two weeks discharge revealed complete resolution clinical symptoms normalization labs previously elevated first reported case patient recently diagnosed crohns disease suspected misc temporally related covid<NUMBER> treated infliximab comanage entities despite surgical management active perianal disease antibiotic therapy patient continued worsen clinically clinical deterioration unclear ibd misc temporally related covid<NUMBER> could implicated infectious studies negative proinflammatory cytokines tnfα il<NUMBER>β il<NUMBER> overproduced ibd patients <NUMBER> elevated levels tnfα mean <NUMBER> pgml described intestinal mucosa ibd patients <NUMBER> serum concentration tnfα il<NUMBER> median <NUMBER> pgml <NUMBER> pgml respectively also associated severe covid<NUMBER> illness <NUMBER> peak patients illness serum concentrations tnfα <NUMBER> pgml il<NUMBER> <NUMBER> pgml higher reported either ibd severe covid<NUMBER> inflammatory disease overlap possibly contributed cytokine storm misc cytokine storm found major cause morbidity patients severe covid<NUMBER> infection <NUMBER> <NUMBER> treatment targeting proinflammatory cytokines il<NUMBER> inhibition tocilizumab shown evidence clinical benefit subsets severe covid<NUMBER> patients <NUMBER> tnfα also implicated severe covid<NUMBER> cases blockade tnfα effective treatment autoinflammatory conditions several cytokines elevated suggesting antitnfα therapy alone may inhibit cytokine cascade <NUMBER> currently therapy targeting tnfa associated negative outcomes ibd patients covid<NUMBER> <NUMBER> case supports role blockade tnfα treatment covid<NUMBER> inflammatory cascade whether specific immune dysfunction setting ibd nonibd covid<NUMBER> patient requires investigation overall increased tnfα levels seen cytokine storm due covid<NUMBER> active ibd treatment infliximab known effective treatment children crohns disease evidenced case effectual halting systemic inflammatory response patient covid<NUMBER> role antitnf agents patients misc temporally related covid<NUMBER> requires investigation purpuric rash dorsum hand antecubitalfossa treatment infliximab hospitalization day <NUMBER> figure <NUMBER>a <NUMBER>b represent rash dorsum hand antecubital fossa prior infliximab treatment hospitalization day <NUMBER> figure <NUMBER>c <NUMBER>d demonstrate improvement rash day <NUMBER> prior discharge 